<SEC-DOCUMENT>0001193125-13-159002.txt : 20130417
<SEC-HEADER>0001193125-13-159002.hdr.sgml : 20130417
<ACCEPTANCE-DATETIME>20130417172307
ACCESSION NUMBER:		0001193125-13-159002
CONFORMED SUBMISSION TYPE:	PRE 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20130529
FILED AS OF DATE:		20130417
DATE AS OF CHANGE:		20130417

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DYNAVAX TECHNOLOGIES CORP
		CENTRAL INDEX KEY:			0001029142
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				330728374
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		PRE 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-34207
		FILM NUMBER:		13767659

	BUSINESS ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
		BUSINESS PHONE:		5108485100

	MAIL ADDRESS:	
		STREET 1:		2929 SEVENTH STREET
		STREET 2:		SUITE 100
		CITY:			BERKELEY
		STATE:			CA
		ZIP:			94710
</SEC-HEADER>
<DOCUMENT>
<TYPE>PRE 14A
<SEQUENCE>1
<FILENAME>d484784dpre14a.htm
<DESCRIPTION>PRELIMINARY PROXY STATEMENT
<TEXT>
<HTML><HEAD>
<TITLE>Preliminary Proxy Statement</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>UNITED STATES </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="5"><B>SECURITIES AND EXCHANGE COMMISSION </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>Washington, D.C. 20549
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="5"><B>SCHEDULE 14A INFORMATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="3"><B>Proxy Statement Pursuant to Section&nbsp;14(a) </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="3"><B>of the Securities
Exchange Act of 1934 </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filed&nbsp;by&nbsp;the&nbsp;Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filed by a Party other than the Registrant&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; margin-left:2%; text-indent:-2%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check the appropriate box: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="96%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary Proxy Statement</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Confidential, for Use of the Commission Only (as permitted by Rule&nbsp;14a-6(e)(2))</B></FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Proxy Statement</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Definitive Additional Materials</FONT></TD></TR>
<TR>
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Soliciting Material Pursuant to &#167;240.14a-12</FONT></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="6"><B>DYNAVAX TECHNOLOGIES CORPORATION </B></FONT></P> <P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:0px; margin-left:2%; text-indent:-2%" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(Name of Registrant as Specified In Its Charter) </B></FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P>
<P STYLE="line-height:3px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(Name of Person(s) Filing Proxy
Statement if Other Than the Registrant) </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Payment of Filing Fee (Check the appropriate box) </FONT></P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="3%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>

<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#120;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">No fee required.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee computed on table below per Exchange Act Rules&nbsp;14a-6(i)(1) and 0-11.</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Title of each class of securities to which transaction applies:</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Aggregate number of securities to which transaction applies:</FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set&nbsp;forth the amount on which
the filing fee is calculated and state how it was determined):</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposed maximum aggregate value of transaction:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(5)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total fee paid:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P></TD></TR>
<TR>
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Fee paid previously with preliminary materials.</FONT></TD></TR>
<TR>
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-before:always">
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify
the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</FONT></TD></TR>
<TR>
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(1)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Amount Previously Paid:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(2)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Form, Schedule or Registration Statement No.:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(3)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Filing Party:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD></TR>
<TR>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">(4)</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Date Filed:</FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<P STYLE="margin-top:0px;margin-bottom:1px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></FONT></P></TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DYNAVAX TECHNOLOGIES CORPORATION </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2929 Seventh Street, Suite&nbsp;100 Berkeley, California 94710 </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>NOTICE OF 2013 ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>May&nbsp;29, 2013
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dear Stockholder: </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You are cordially invited to attend the 2013 Annual Meeting of Stockholders of Dynavax Technologies Corporation, a Delaware corporation,
or the Company. The meeting will be held on May&nbsp;29, 2013, at 9:00 a.m. Pacific Time, at the Company&#146;s executive offices at 2929 Seventh Street, Suite&nbsp;100, Berkeley, California 94710 for the following purposes: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To elect our nominees for Class I directors to hold office until the 2016 Annual Meeting of Stockholders or until their respective successors are duly elected and
qualified. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To approve an amendment to the Company&#146;s Sixth Amended and Restated Certificate of Incorporation to increase the authorized number of shares of common stock from
250,000,000 to 350,000,000 shares. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To amend the Company&#146;s 2011 Equity Incentive Plan (the &#147;2011 Plan&#148;) to increase the aggregate number of shares of common stock authorized for issuance
under the plan by 10,000,000. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To ratify the selection of Ernst&nbsp;&amp; Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December&nbsp;31,
2013. </FONT></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">To conduct any other business properly brought before the meeting or any adjournment(s) thereof. </FONT></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">These items of business are more fully described in the Proxy Statement accompanying this Notice. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The record date for the 2013 Annual Meeting is April&nbsp;10, 2013. Only stockholders of record at the close of business on that date may
vote at the meeting or any adjournment thereof. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><div style="width:100%;margin-left:0%; margin-right:0%;border:solid 1pt;padding-top:2px;padding-bottom:3px">
<P STYLE="margin-top:0px;margin-bottom:0px;padding-top:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Important Notice Regarding the Availability of Proxy Materials for the Stockholders&#146; Meeting to Be Held at 9:00
a.m., local time, on May&nbsp;29, 2013 at 2929 Seventh Street, Suite&nbsp;100, Berkeley, California 94710. </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The proxy
statement and annual report to stockholders </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>are available at http://www.dynavax.com/2013proxy.html. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px;padding-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Board of Directors recommends that you vote FOR the proposals identified above. </B></FONT></P></div>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT><FONT SIZE="">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Secretary</FONT></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Berkeley, California </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2">April<U> &nbsp;&nbsp;&nbsp;&nbsp;</U>,&nbsp;2013 </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><div style="width:100%;margin-left:0%; margin-right:0%;border:solid 1pt;padding-top:2px;padding-bottom:3px">
<P STYLE="margin-top:0px;margin-bottom:0px;padding-top:0px; margin-left:2%;margin-right:2%; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Your vote is very important, regardless of the number of shares you own. Whether or not
you expect to attend the meeting, please complete, date, sign and return the enclosed proxy as promptly as possible in order to ensure your representation at the meeting. A return envelope (which is postage prepaid if mailed in the United States) is
enclosed for your convenience. Even if you have voted by proxy, you may still vote in person if you attend the meeting. Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the
meeting, you must obtain a proxy issued in your name from that record holder. </B></FONT></P></div>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DYNAVAX TECHNOLOGIES CORPORATION </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2929 Seventh Street, Suite&nbsp;100 </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Berkeley, California 94710 </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROXY STATEMENT </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>FOR THE 2013 ANNUAL MEETING OF STOCKHOLDERS </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2">May&nbsp;29, 2013 </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>QUESTIONS AND ANSWERS ABOUT THIS PROXY MATERIAL AND VOTING
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Why am I receiving these materials? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We have sent you this proxy statement and the enclosed proxy card because the Board of Directors, or Board, of Dynavax Technologies Corporation, or the Company or Dynavax, is soliciting your proxy to vote
at the 2013 Annual Meeting of Stockholders, or Annual Meeting. You are invited to attend the Annual Meeting to vote on the proposals described in this proxy statement. However, you do not need to attend the Annual Meeting to vote your shares.
Instead, you may simply complete, sign and return the enclosed proxy card. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We intend to mail this proxy statement and
accompanying proxy card on or about May&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2013, to all stockholders of record entitled to vote at the Annual Meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>How do I attend the Annual Meeting? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Annual Meeting will be held on
May&nbsp;29, 2013, at 9:00 a.m. Pacific Time, at the Company&#146;s executive offices at 2929 Seventh Street, Suite 100, Berkeley, California 94710. Directions to the Annual Meeting may be found at http://www.dynavax.com/contact_berk.html.
Information on how to vote in person at the Annual Meeting is discussed below. For admission to the Annual Meeting, stockholders may be asked to present proof of identification and a statement from their bank, broker or other nominee reflecting
their beneficial ownership of our common stock as of April&nbsp;10, 2013, as well as a proxy from the record holder to the stockholder. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Who can vote at the Annual Meeting? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Only stockholders of record at the close of business on April&nbsp;10, 2013, will be entitled to vote at the Annual Meeting. On this record date, there were 182,886,013 shares of common stock outstanding
and entitled to vote. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stockholder of Record: Shares&nbsp;Registered in Your Name </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If on April&nbsp;10, 2013, your shares were registered directly in your name with the Company&#146;s transfer agent, then you are a
stockholder of record. As a stockholder of record, you may vote in person at the Annual Meeting or vote by proxy. Whether or not you plan to attend the Annual Meeting, we urge you to fill out and return the enclosed proxy card to ensure your vote is
counted. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Beneficial Owner: Shares&nbsp;Registered in the Name of a Broker or Bank </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If on April&nbsp;10, 2013, your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer or other
similar organization, then you are the beneficial owner of shares held in &#147;street name&#148; and these proxy materials are being forwarded to you by that organization. The organization holding your account is considered to be the stockholder of
record for purposes of voting at the Annual Meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to attend the Annual Meeting. However, since
you are not the stockholder of record, you may not vote your shares in person at the Annual Meeting unless you request and obtain a valid proxy from your broker or other agent. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">1 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What am I voting on? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We are asking you to vote on four (4)&nbsp;proposals: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 1: To elect our nominees for Class I directors. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 2: To approve an amendment to the Company&#146;s Sixth Amended and Restated Certificate of Incorporation to increase the authorized number of
shares of common stock from 250,000,000 to 350,000,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3: To amend the Dynavax Technologies Corporation 2011 Plan to increase the aggregate number of shares of common stock authorized for issuance
under the plan by 10,000,000; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 4: To ratify the selection of Ernst&nbsp;&amp; Young LLP as the independent registered public accounting firm of the Company for its fiscal
year ending December&nbsp;31, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Why are we proposing to increase the authorized number of shares of common stock
pursuant to Proposal 2? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We desire to have additional shares available to provide the flexibility to use our capital stock
for business and financial purposes in the future. The additional shares may be used for various purposes without further stockholder approval. These purposes may include raising capital; establishing strategic relationships with other companies;
expanding our business or product candidates through the acquisition of other businesses or products; providing equity incentives to employees, officers or directors; and, other purposes related to our business. The additional shares of common stock
that would become available for issuance if the proposal were adopted could also be used by us to oppose a hostile takeover attempt or to delay or prevent changes in control or our management. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Why are we seeking stockholder approval of the increase in the authorized number of shares of common stock in Proposal 2? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;242 of the Delaware General Corporation Law requires stockholder approval of an amendment to our certificate of
incorporation, which is required in order to increase the authorized number of shares of our common stock. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Why is Dynavax&#146;s Board of
Directors recommending approval of the increase in the authorized number of shares of common stock in Proposal 2? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As of
our record date of April&nbsp;10, 2013, our total common stock outstanding was 182,886,013. Taking into account shares of common stock reserved for issuance upon the exercise of outstanding warrants as well as shares of common stock reserved for
issuance upon exercise of outstanding employee stock options and delivery of restricted stock units, our total common stock outstanding on a fully diluted basis would represent approximately 213,630,011 of our currently authorized 250,000,000
shares. In developing its recommendation to the stockholders to vote in favor of the increase to the authorized number of shares of our common stock, our Board of Directors considered many factors, including but not limited to the following:
</FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The benefits to us of having additional flexibility to use our capital stock for business and financial purposes in the future, including raising
additional capital, establishing strategic relationships with other companies, and expanding our business or product candidates through the acquisition of other businesses or products. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The benefits to the stockholders of using the additional shares to oppose a hostile takeover attempt or to delay or prevent changes in control or our
management in order to maximize the value for our stockholders. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The dilution of the ownership interests in Dynavax held by our existing stockholders as a result of the potential issuance of the additional shares.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The consequences of our failure to increase the authorized number of shares of our common stock, including a lack of equity incentives to employees,
officers or directors. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">2 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What happens if the increase in the authorized number of shares of common stock in Proposal 2 is
approved? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the increase in the authorized number of shares of our common stock is approved, we will file with the
Secretary of State of Delaware a Certificate of Amendment to our Sixth Amended and Restated Certificate of Incorporation to increase our authorized number of shares of common stock from 250,000,000 shares to 350,000,000 shares. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What happens if the increase in the authorized number of shares of common stock in Proposal 2 is not approved? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the increase in the authorized number of shares of our common stock is not approved, our Sixth Amended and Restated Certificate of
Incorporation will remain as it is, and the authorized number of shares of our common stock will remain at 250,000,000. Our ability to use our capital stock for business and financial purposes will be limited to the number of authorized shares of
our common stock available for issuance, and we may lose the flexibility to operate our business optimally. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Why are we proposing to amend
the 2011 Plan pursuant to Proposal 3? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2011 Plan has 3,195,828 shares remaining available for grant as of
April&nbsp;10, 2013. Once we exhaust our remaining share reserve, we will be unable to issue new equity awards to our new and existing employees, consultants, officers or directors. We are asking you to approve an increase in the number of shares
available for issuance under the 2011 Plan which was approved by stockholders in January 2011 and contains provisions that are designed to protect our stockholders&#146; interests and to reflect compensation and corporate governance best practices.
The 2011 Plan will provide us with sufficient shares to enable us to grant equity awards to our employees for approximately two more years, and we anticipate seeking stockholder approval to increase the number of shares available for issuance under
the 2011 Plan in fiscal year 2015. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Why are we seeking stockholder approval to amend the 2011 Plan in Proposal 3? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">NASDAQ Marketplace Rule 5635(c) generally requires stockholder approval when an equity compensation plan or other arrangement is
established or materially amended, unless an exemption applies. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Why is Dynavax&#146;s Board of Directors recommending amendment of the
2011 Plan in Proposal 3? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In developing its recommendation to the stockholders to vote in favor of amending the 2011 Plan,
our Board of Directors considered many factors, including but not limited to the following: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The need to attract and retain highly qualified employees in a competitive market. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The desire to provide long term incentives that align employee compensation with stockholder interests. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our gross burn rates for the last three years. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>What happens if the amendment to the 2011 Plan in Proposal 3 is approved? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the 2011 Plan amendment is approved by our stockholders, the 2011 Plan amendment will become effective immediately. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What happens if the amendment to the 2011 Plan in Proposal 3 is not approved? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the 2011 Plan amendment is not approved by our stockholders, the 2011 Plan amendment will not become effective, and we will continue to
issue awards to existing employees, consultants, officers and directors until our share reserve under such plan is exhausted. In addition, we may need to issue equity awards to newly-hired employees under a non-stockholder approved plan intended to
rely on an exemption from stockholder approval under certain NASDAQ rules for equity awards to newly-hired employees as a material inducement to the individual&#146;s entering into employment with us. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">3 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What if another matter is properly brought before the Annual Meeting? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly
brought before the Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with her or his best judgment. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>How do I vote? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may either vote &#147;For&#148; all the nominees to the
Board or you may &#147;Withhold&#148; your vote for any nominee you specify. For each of the other matters to be voted on, you may vote &#147;For&#148; or &#147;Against&#148; or abstain from voting. The procedures for voting are fairly simple:
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stockholder of Record: Shares&nbsp;Registered in Your Name </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a stockholder of record, you may vote in person at the Annual Meeting or vote by proxy using the enclosed proxy card. Whether
or not you plan to attend the Annual Meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the Annual Meeting and vote in person even if you have already voted by proxy. </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote in person, come to the Annual Meeting and we will give you a ballot when you arrive. Directions to the Annual Meeting location are available at
http://www.dynavax.com/contact_berk.html. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote using the proxy card, simply complete, sign and date the enclosed proxy card and return it promptly in the envelope provided. If you return
your signed proxy card to us before the Annual Meeting, we will vote your shares as you direct. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote using the telephone, simply follow the instructions on the enclosed proxy card. Voting by telephone has the same effect as voting by mail. You
may vote by telephone until 11:59&nbsp;p.m., Eastern Daylight Time, May&nbsp;28, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">To vote using the internet, simply follow the instructions on the enclosed proxy card. You may vote by using the internet until 11:59&nbsp;p.m.,
Eastern Daylight Time, May&nbsp;28, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Beneficial Owner: Shares&nbsp;Registered in the Name of
Broker or Bank </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner of shares registered in the name of your broker, bank or other agent, you
should have received a proxy card and voting instructions with these proxy materials from that organization rather than from Dynavax. Simply complete and mail the proxy card to ensure that your vote is counted. To vote in person at the Annual
Meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow the instructions from your broker or bank included with these proxy materials, or contact your broker or bank to request a proxy form. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><div style="width:100%;margin-left:0%; margin-right:0%;border:solid 1pt;padding-top:2px;padding-bottom:3px">
<P STYLE="margin-top:0px;margin-bottom:0px;padding-top:0px; margin-left:2%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We provide internet proxy voting to allow you to vote your shares online, with procedures designed to ensure the
authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies.
</B></FONT></P></div> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How many votes do I have? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">On each matter to be voted upon, you have one vote for each share of common stock you own as of April&nbsp;10, 2013. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>What happens if I do not vote? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Stockholder of Record: Shares
Registered in Your Name </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a stockholder of record and do not vote by completing your proxy card, by
telephone, through the internet or in person at the Annual Meeting, your shares will not be voted. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">4 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Beneficial Owner: Shares Registered in the Name of Broker or Bank </I></B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you are a beneficial owner and do not instruct your broker, bank, or other agent how to vote your shares, the question of whether your
broker or nominee will still be able to vote your shares depends on whether the New York Stock Exchange, or NYSE, deems the particular proposal to be a &#147;routine&#148; matter. Brokers and nominees can use their discretion to vote
&#147;uninstructed&#148; shares with respect to matters that are considered to be &#147;routine,&#148; but not with respect to &#147;non-routine&#148; matters. Under the rules and interpretations of the NYSE, &#147;non-routine&#148; matters are
matters that may substantially affect the rights or privileges of stockholders, such as mergers, stockholder proposals, elections of directors (even if not contested), executive compensation (including any advisory stockholder votes on executive
compensation and on the frequency of stockholder votes on executive compensation), and certain corporate governance proposals, even if management-supported. Accordingly, your broker or nominee may not vote your shares on Proposals 1, 2, or 3 without
your instructions, but may vote your shares on Proposal 4. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What if I return a proxy card but do not make specific choices? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If you return a signed and dated proxy card without marking any voting selections, your shares will be voted: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 1: &#147;For&#148; election of our nominees for Class I directors. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 2: &#147;For&#148; the approval of an amendment to the Company&#146;s Sixth Amended and Restated Certificate of Incorporation to increase the
authorized number of shares of common stock from 250,000,000 to 350,000,000 shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3: &#147;For&#148; the approval of an amendment to the Dynavax Technologies Corporation 2011 Plan to increase the aggregate number of shares
of common stock authorized for issuance under the plan by 10,000,000; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 4: &#147;For&#148; the ratification of the selection of Ernst&nbsp;&amp; Young LLP as the independent registered public accounting firm of the
Company for its fiscal year ending December&nbsp;31, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If any other matter is properly presented at the
Annual Meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Who is paying for this proxy solicitation? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We will pay for the entire cost of soliciting proxies. In addition to mailing these proxy materials, our directors and employees may also solicit proxies in person, by telephone, or by other means of
communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What does it mean if I receive more than one proxy card? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If you receive more than one proxy card, your shares are registered in more than one name or are registered in different accounts. Please complete, sign and return each proxy card to ensure that all of
your shares are voted. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Can I change my vote after submitting my proxy? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Yes. You can revoke your proxy at any time before the final vote at the Annual Meeting. If you are the record holder of your shares, you
may revoke your proxy in any one of three ways: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may submit another properly completed proxy card with a later date. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may send a timely written notice that you are revoking your proxy to Dynavax, Attention: Secretary, at 2929 Seventh Street, Suite 100, Berkeley,
California 94710. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">You may attend the Annual Meeting and vote in person. Simply attending the Annual Meeting will not, by itself, revoke your proxy.
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">5 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Your proxy card with the most recent date is the one that will be counted. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your broker or bank.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>When are stockholder proposals due for next year&#146;s Annual Meeting? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To be considered for inclusion in next year&#146;s proxy materials, your proposal must be submitted in writing by January&nbsp;26, 2014,
to Michael S. Ostrach, Esq., Corporate Secretary. However, if our 2014 Annual Meeting of Stockholders is not held between April&nbsp;26, 2014, and June&nbsp;26, 2014, then the deadline will be a reasonable time before we begin to print and send our
proxy materials. If you wish to submit a proposal that is not to be included in next year&#146;s proxy materials or nominate a director, you must do so by March&nbsp;30, 2014, and no earlier than February&nbsp;28, 2014. However, if our 2014 Annual
Meeting of Stockholders is not held between April&nbsp;26, 2014, and June&nbsp;26, 2014, then you must submit your proposal not less than 60 days nor more than 90 days prior to the time we send our proxy materials. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How are votes counted? </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Votes will be counted by the inspector of election appointed for the Annual Meeting, who will separately count, with respect to the
proposal to elect directors, votes &#147;For&#148; and &#147;Withhold&#148;; and, with respect to other proposals, votes &#147;For&#148; and &#147;Against,&#148; abstentions and broker non-votes. Abstentions will be counted towards the vote total
for each proposal, and will have the same effect as &#147;Against&#148; votes. Broker non-votes have no effect and will not be counted towards the vote total for any proposal. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>How many votes are needed to approve each proposal? </B></FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 1, to elect our four nominees for Class I directors, the three nominees receiving the most &#147;For&#148; votes from the holders of votes of
shares present in person or represented by proxy and entitled to vote on the election of directors will be elected. Only votes &#147;For&#148; or &#147;Withhold&#148; will affect the outcome. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 2, to approve the amendment of the Company&#146;s Sixth Amended and Restated Certificate of Incorporation to increase the authorized number of
shares of common stock from 250,000,000 to 350,000,000 shares, must receive &#147;For&#148; votes from the holders of a majority of the Company&#146;s outstanding shares entitled to vote. If you fail to return your proxy card, it will have the same
effect as an &#147;Against&#148; vote. If you return your proxy card and select &#147;Abstain,&#148; it will have the same effect as an &#147;Against&#148; vote. Broker non-votes will have the same effect as &#147;Against&#148; votes.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 3, to amend the Dynavax Technologies Corporation 2011 Plan to increase the aggregate number of shares of common stock authorized for issuance
under the plan by 10,000,000, must receive &#147;For&#148; votes from the holders of a majority of shares present either in person or by proxy, if a quorum of stockholders is achieved. If you return your proxy and select &#147;Abstain,&#148; it will
have the same effect as an &#147;Against&#148; vote. Broker non-votes will have no effect. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Proposal 4, to ratify the selection of Ernst&nbsp;&amp; Young LLP as the Company&#146;s independent registered public accounting firm for our fiscal
year ending December&nbsp;31, 2013, must receive &#147;For&#148; votes from the holders of a majority of shares present in person or by proxy and entitled to vote. If you &#147;Abstain&#148; from voting, it will have the same effect as an
&#147;Against&#148; vote. Broker non-votes will have no effect; however, Proposal 4 is considered a &#147;routine&#148; matter, and therefore no broker non-votes are expected to exist in connection with Proposal 4. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What is the quorum requirement? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A quorum of stockholders is necessary to hold a valid Annual Meeting. A quorum will be present if stockholders holding at least a majority of the outstanding shares entitled to vote are present at the
Annual </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">6 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Meeting in person or represented by proxy. On the record date, there were 182,886,013 shares outstanding and entitled to vote. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank
or other nominee) or if you vote in person at the Annual Meeting. Abstentions and broker non-votes will be counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares present at the Annual Meeting in person or
represented by proxy may adjourn the Annual Meeting to another date. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>How can I find out the results of the voting at the Annual Meeting?
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Preliminary voting results will be announced at the Annual Meeting. Final voting results will be published in a current
report on Form&nbsp;8-K within four business days following the voting. If we are unable to obtain final results in that time, we will announce the preliminary results and subsequently file a second current report on Form 8-K with the final results.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>What proxy materials are available on the internet? </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The 2013 proxy statement and 2012 Annual Report on Form 10-K are available at http://www.dynavax.com/2013proxy.html. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Householding of Proxy Materials </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Securities and Exchange Commission, or
SEC, has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Annual Meeting materials with respect to two or more stockholders sharing the same address by delivering a single set of Annual
Meeting materials addressed to those stockholders. This process, which is commonly referred to as &#147;householding,&#148; potentially means extra convenience for stockholders and cost savings for companies. A number of brokers with account holders
who are Dynavax stockholders will be &#147;householding&#148; our proxy materials. A single set of Annual Meeting materials will be delivered to multiple stockholders sharing an address unless contrary instructions have been received from the
affected stockholders. Once you have received notice from your broker that they will be &#147;householding&#148; communications to your address, &#147;householding&#148; will continue until you are notified otherwise or until you revoke your
consent. If, at any time, you no longer wish to participate in &#147;householding&#148; and would prefer to receive a separate set of Annual Meeting materials, please notify your broker and we will promptly deliver to you a separate set of our
Annual Meeting materials. Direct your written request to Corporate Secretary, Dynavax Technologies Corporation, 2929 Seventh Street, Suite&nbsp;100, Berkeley, California 94710, (510)&nbsp;858-5100. Stockholders who currently receive multiple copies
of the Annual Meeting materials at their addresses and would like to request &#147;householding&#148; of their communications should contact their brokers. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">7 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL&nbsp;1 </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>ELECTION OF DIRECTORS </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our Board is divided into three classes, and each class has a three-year term. Vacancies on the Board may be filled only by persons elected by a majority of the remaining directors. A director elected by
the Board to fill a vacancy in a class, including vacancies created by an increase in the number of directors, shall serve for the remainder of the full term of that class and until the director&#146;s successor is elected and qualified. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board presently has ten members. There are four directors in the class whose term of office expires in 2013: Dennis Carson, M.D.,
Dino Dina, M.D., Denise Gilbert, Ph.D., and Mark Kessel. Mr.&nbsp;Kessel has chosen not to stand for election for another term. Drs. Carson, Dina and Gilbert, each a nominee for director, are currently directors of the Company and were previously
elected by the stockholders. If each nominee is elected at the Annual Meeting, each of these nominees would serve until the 2016 Annual Meeting and until his or her successor is elected and has qualified, or, if sooner, until the director&#146;s
death, resignation or removal. It is the Company&#146;s policy to invite directors and nominees for director to attend the Annual Meeting of the stockholders. There were three directors in attendance at our 2012 Annual Meeting. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Directors are elected by a plurality of the votes of the holders of shares present in person or represented by proxy and entitled to vote
on the election of directors. The three nominees receiving the highest number of affirmative votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the nominees named
below. If any nominee becomes unavailable for election as a result of an unexpected occurrence, your shares will be voted for the election of a substitute nominee proposed by our Board. Each person nominated for election has agreed to serve if
elected. Our Board has no reason to believe that any nominee will be unable to serve. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T<SMALL>HE</SMALL>
B<SMALL>OARD</SMALL> O<SMALL>F</SMALL> D<SMALL>IRECTORS</SMALL> R<SMALL>ECOMMENDS </SMALL>A V<SMALL>OTE</SMALL>&nbsp;I<SMALL>N</SMALL> F<SMALL>AVOR</SMALL> O<SMALL>F</SMALL> E<SMALL>ACH</SMALL> N<SMALL>AMED</SMALL> N<SMALL>OMINEE</SMALL>.</B>
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Set forth below is certain biographical information as of March&nbsp;29, 2013, for the nominees and each person whose term as
a director will continue after the Annual Meeting. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="44%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Age</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:27pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Position</B></FONT></P></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arnold L. Oronsky, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">73</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chairperson of the Board</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Francis R. Cano, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">68</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dennis Carson, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer and Director</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Denise M. Gilbert, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mark Kessel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">71</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Daniel Kisner, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Director</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peggy V. Phillips</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">59</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stanley A. Plotkin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Director</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>LASS</SMALL>&nbsp;I D<SMALL>IRECTOR</SMALL> N<SMALL>OMINEES</SMALL></B><SMALL></SMALL> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dennis Carson,&nbsp;M.D. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Carson has been a member of our Board since December 1997. Dr.&nbsp;Carson is a noted researcher in the fields of autoimmune and
immunodeficiency diseases and is co-discoverer with Dr.&nbsp;Eyal Raz of the immunostimulatory sequences (ISS) that form the basis of our technology. He has played key roles in the founding of Vical, Inc., a gene therapy company, IDEC
Pharmaceuticals, a biopharmaceutical company, and Triangle Pharmaceuticals, a pharmaceutical company. Dr.&nbsp;Carson is a director of Biomerica, Inc. Dr.&nbsp;Carson is director of the Rebecca and John Moores Cancer Center at the University of
California, San Diego and has been a professor in the Department of Medicine at the University of California, San Diego since 1990. The Board </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">8 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
believes that Dr.&nbsp;Carson&#146;s significant experience in research and development provides important insights for the strategy of the Company, particularly with regard to scientific
opportunities for development by our Company. He is a member of the National Academy of Sciences, the American Academy of Arts and Sciences, and the Institute of Medicine, as well as the American Association for Cancer Research, the American Society
for Clinical Investigation, the American Society of Hematology and the Association of American Physicians. He received his M.D. from Columbia University and his B.A. from Haverford College. Dr.&nbsp;Carson completed his residency in internal
medicine and a postdoctoral fellowship at the University of California, San Diego. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Dino Dina,&nbsp;M.D. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Dina has been a member of our Board since May 1997 and our Chief Executive Officer since May 1998. From May 1997 to June 2010,
Dr.&nbsp;Dina was also our president. From 1982 until he joined us in 1997, Dr.&nbsp;Dina was an employee of Chiron Corporation, a pharmaceutical company. At Chiron, Dr.&nbsp;Dina held a series of positions with increasing responsibility. He
ultimately served as president of Chiron Vaccines (formerly Biocine Company), which he directed from its inception in 1987. Under Dr.&nbsp;Dina&#146;s direction, Chiron Vaccines received the first-ever approval of an adjuvanted influenza vaccine in
Italy, successfully completed development of the first genetically engineered pertussis vaccine and conducted clinical trials for vaccines to prevent HIV, herpes simplex type II, cytomegalovirus and hepatitis B infections. The virology group he
directed was responsible for several key scientific findings, including the discovery, cloning and sequencing of the hepatitis C virus, and the cloning and sequencing of the viral genomes for HIV and hepatitis A viruses. Prior to joining Chiron,
Dr.&nbsp;Dina was employed at Albert Einstein College of Medicine in Bronx, New York, as an assistant professor of genetics from 1977 to 1982. The Board believes that Dr.&nbsp;Dina&#146;s extensive involvement with the founding and development of
the Company provides experience invaluable to understanding the science of the Company, and his scientific and commercial experience, particularly in vaccines, provides both the scientific and strategic leadership that are essential for the future
success of our Company. He received his M.D. from the University of Genoa Medical School in Italy. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Denise M. Gilbert,&nbsp;Ph.D.
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Gilbert has been a member of our Board since March 2004. From 2001 to 2002, she served as Chief Executive Officer
of Entigen Corporation, a private life science information technology company. From 1995 to 1999, Dr.&nbsp;Gilbert served as Chief Financial Officer and Executive Vice President of Incyte Pharmaceuticals (now Incyte Corporation), a genomic
technologies company, and from 1993 to 1995, she was Chief Financial Officer and Executive Vice President of Affymax, a biopharmaceutical company. From 1986 through 1993, Dr.&nbsp;Gilbert was a Managing Director and senior biotechnology analyst at
Smith Barney Harris&nbsp;&amp; Upham and Vice President and biotechnology analyst at Montgomery Securities. The Board believes that Dr.&nbsp;Gilbert&#146;s unique background in finance and support of growing life sciences companies provides
particularly important strategic insights for the Board in setting strategy and reviewing the operations of the Company. Dr.&nbsp;Gilbert is also the Chairperson of the Audit Committee of the Board, or the Audit Committee, and the Audit Committee
financial expert. Dr.&nbsp;Gilbert serves on the board of Cytokinetics, Inc., a public biopharmaceutical company, and KaloBios Pharmaceuticals, Inc., a private company. Dr.&nbsp;Gilbert holds a B.S. from Cornell University and a Ph.D. in Cell and
Developmental Biology from Harvard University. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>LASS</SMALL> I D<SMALL>IRECTORS</SMALL> C<SMALL>ONTINUING</SMALL> I<SMALL>N</SMALL>
O<SMALL>FFICE</SMALL> U<SMALL>NTIL</SMALL> T<SMALL>HE</SMALL> 2013 A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Mark Kessel
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Kessel has been a member of our Board since December 2009. Mr.&nbsp;Kessel is a Partner of Symphony Capital LLC,
co-founded Symphony in 2002 and serves as of counsel to Shearman&nbsp;&amp; Sterling, an international law firm, and is widely recognized as a leader in structuring product development investments for the biopharmaceutical industry. Mr.&nbsp;Kessel
is a director of the Foundation for Innovative New Diagnostics and Foundation Sante&acute;. Mr.&nbsp;Kessel was formerly the Managing Partner of Shearman&nbsp;&amp; Sterling LLP, with day-to-day operating responsibility. He received a B.A. with
honors in Economics from the City College of New York and a </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">9 </FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
J.D. magna cum laude from Syracuse University College of Law. Mr.&nbsp;Kessel has written on financing for the biotech industry for Nature Reviews Drug Discovery, Nature Biotechnology and other
publications, and on issues related to governance and audit committees for such publications as The Wall Street Journal, Financial Times, The Deal and Euromoney. Mr.&nbsp;Kessel has chosen not to stand for election for another term. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>LASS</SMALL> II D<SMALL>IRECTORS</SMALL> C<SMALL>ONTINUING</SMALL> I<SMALL>N</SMALL> O<SMALL>FFICE</SMALL> U<SMALL>NTIL</SMALL>
T<SMALL>HE</SMALL> 2014 A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Daniel Kisner, M.D. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Kisner has been a member of our Board since July 2010. He most recently served as a partner at Aberdare Ventures and prior to
that as President and CEO of Caliper Technologies, leading its evolution from a start-up focused on microfluidic lab-on-chip technology to a publicly traded, commercial organization. Prior to Caliper, he was the President and Chief Operating Officer
of Isis Pharmaceuticals, Inc., a biomedical pharmaceutical company. Previously, Dr.&nbsp;Kisner was Division Vice President of Pharmaceutical Development for Abbott Laboratories and Vice President of Clinical Research and Development at SmithKline
Beckman Pharmaceuticals. In addition, he held a tenured position in the Division of Oncology at the University of Texas, San Antonio School of Medicine and is certified by the American Board of Internal Medicine in Internal Medicine and Medical
Oncology. Dr.&nbsp;Kisner serves as Chairman of the board for Tekmira Pharmaceuticals, a biopharmaceutical company. Our Board believes that Dr.&nbsp;Kisner&#146;s background with larger, complex technology-based organizations as well as his
significant experience with corporate transactions, including investing in venture-backed life science companies provides the Board with insights for setting strategy and reviewing the operations of the Company. He holds a B.A. from Rutgers
University and an M.D. from Georgetown University. Dr.&nbsp;Kisner was appointed as a director pursuant to that certain Corporate Governance Agreement, dated December&nbsp;30, 2009, by and between us and Symphony Dynamo Holdings LLC, or the
Corporate Governance Agreement. See &#147;<I>Transactions with Related Persons</I>&#148; for a description of this agreement. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>J. Tyler
Martin, M.D. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Martin joined Dynavax in February 2009 as Chief Medical Officer and was appointed as the
Company&#146;s President and to our Board in July 2010. Dr.&nbsp;Martin has nearly 20 years of drug development experience. From 2007 to 2008, Dr.&nbsp;Martin was President of Humabs Llc. Previously, Dr.&nbsp;Martin worked at Chiron Corporation as
the Vice President, Development from 2004 until 2006 and the Director, Clinical Research from 1994 until 1997. In his seven years at Chiron, Dr.&nbsp;Martin led the team responsible for the development of the novel vaccine adjuvant MF59, the first
vaccine adjuvant licensed by regulatory agencies since alum, and approved as FLUAD influenza vaccine in Europe. He has also held senior development and research positions at Sangamo, Inc., Valentis, Inc. and SyStemix/GTI. The Board believes that
Dr.&nbsp;Martin&#146;s extensive clinical research experience in vaccine development and approval provides the Board with first-hand experience as its lead vaccine candidate completes Phase 3 clinical studies. Dr.&nbsp;Martin received a B.S. in
Chemistry and an M.D. from the University of Nebraska. He completed his fellowship in pediatric infectious diseases and molecular microbiology at Washington University in St. Louis, Missouri. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Stanley A. Plotkin,&nbsp;M.D. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Plotkin has been a member of our
Board since August 2005. Dr.&nbsp;Plotkin is Emeritus Professor of the University of Pennsylvania. Until 1991, he was Professor of Pediatrics and Microbiology at the University of Pennsylvania and Professor of Virology at the Wistar Institute and,
at the same time, Director of Infectious Diseases and Senior Physician at the Children&#146;s Hospital of Philadelphia. In 1991, Dr.&nbsp;Plotkin left the University to join the vaccine manufacturer Pasteur-M&eacute;rieux-Connaught (today, Sanofi
Pasteur), where for seven years he was Medical and Scientific Director, based at Marnes-la-Coquette, outside Paris. Until 2011, he was an Executive Advisor to Sanofi Pasteur. The Board believes that Dr.&nbsp;Plotkin&#146;s significant experience in
development and manufacturing of vaccines provides significant insights for the strategy of the Company with respect to key technical and operational issues in vaccine development. Dr.&nbsp;Plotkin&#146;s career included internship at Cleveland
Metropolitan General Hospital, residency in pediatrics at the Children&#146;s Hospital of Philadelphia and the Hospital for Sick Children in London and three years in the Epidemic Intelligence Service of the Centers for Disease Control of the U.S.
Public Health </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">10 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Service. He has been chairman of the Infectious Diseases Committee and the AIDS Task Force of the American Academy of Pediatrics, liaison member of the Advisory Committee on Immunization
Practices and Chairman of the Microbiology and Infectious Diseases Research Committee of the National Institutes of Health. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>LASS</SMALL>&nbsp;III D<SMALL>IRECTORS</SMALL> C<SMALL>ONTINUING</SMALL> I<SMALL>N</SMALL> O<SMALL>FFICE</SMALL> U<SMALL>NTIL</SMALL>
T<SMALL>HE</SMALL> 2015 A<SMALL>NNUAL</SMALL> M<SMALL>EETING</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Arnold L. Oronsky,&nbsp;Ph.D. </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Oronsky has been a member of our Board since November 1996 and became Chairman in February 2006. Dr.&nbsp;Oronsky is a managing
director with InterWest Partners, a venture capital firm. Prior to joining InterWest Partners in 1994, Dr.&nbsp;Oronsky was Vice President of Discovery Research for the Lederle Laboratories division of American Cyanamid, a pharmaceutical company.
From 1973 until 1976, Dr.&nbsp;Oronsky was head of the inflammation, allergy and immunology research program at Ciba-Geigy Pharmaceutical Company. Dr.&nbsp;Oronsky also serves as a senior lecturer in the Department of Medicine at The Johns Hopkins
Medical School. Dr.&nbsp;Oronsky has won numerous grants and awards and has published over 125 scientific articles. Dr.&nbsp;Oronsky served on the board of directors of Anesiva, Inc., from 2005 to 2010. Anesiva filed a voluntary petition for relief
under Chapter 7 of the U.S. Bankruptcy Code in the U.S. Bankruptcy Court for the Northern District of California in January 2010. The Board believes that Dr.&nbsp;Oronsky&#146;s significant experience in growing and developing life sciences
companies, particularly in the immunology area, provides significant leadership and insights for the Board in defining the strategy of the Company. He received his Ph.D. from Columbia University, College of Physicians and Surgeons and his A.B. from
New York University. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Francis R. Cano, Ph.D. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Cano was appointed to our Board in November 2009. Dr.&nbsp;Cano is President and Founder of Cano Biotech Corp., a consulting firm focusing on the vaccine business, and also serves on the boards
of Biomerica, Inc., a developer and manufacturer of diagnostic products, and Arbor Vita Corporation, a biopharmaceutical company. From 1993 to 1996, Dr.&nbsp;Cano was President and Chief Operating Officer for Aviron, a biopharmaceutical company,
which was later acquired by MedImmune in 2001. As a Co-Founder of Aviron, he completed two rounds of venture financing, a licensing agreement with SmithKline Biologicals and in-licensed Flu-Mist influenza vaccine from the National Institutes of
Health. For 21 years, Dr.&nbsp;Cano worked with the Lederle Laboratories Division of American Cyanamid, most recently as Vice President and General Manager of the Biologicals unit. The Board believes that Dr.&nbsp;Cano&#146;s experience as a founder
of and advisor to established vaccine businesses provides significant insights for the strategy of the Company with respect to key technical and operational issues in vaccine development. He earned a Ph.D. in Microbiology from Pennsylvania State
University, served as a Research Associate at Rutgers Institute of Microbiology, and holds a M.S. in Microbiology and a B.S. in Biology from St. John&#146;s University. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Peggy V. Phillips </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Phillips has been a member
of our Board since August 2006. Ms.&nbsp;Phillips currently also serves on the board of directors of Portola Pharmaceuticals, a biopharmaceutical company, and she served on the board of Western Wireless, a cellular network operator, from 2004 until
the acquisition of the company by Alltel in mid-2005. From 2003 until 2011, Ms.&nbsp;Phillips served on the Board of the Naval Academy Foundation. From 1996 until 2002, she served on the board of directors of Immunex Corporation, a biotechnology
company, and, from 1999, she served as the Chief Operating Officer until the company was acquired by Amgen in 2002. During her career at Immunex, she held positions of increasing responsibility in research, development, manufacturing, sales and
marketing. As senior vice president for pharmaceutical development and general manager for Enbrel<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, she was
responsible for clinical development and regulatory affairs as well as the launch, sales and marketing of the product. Prior to joining Immunex, Ms.&nbsp;Phillips worked at Miles Laboratories. The Board believes that Ms.&nbsp;Phillips provides
significant experience in development and commercialization of biotechnology products. Her background and experience with larger, complex organizations provides significant operational and strategic insights in assessing the strategy of the Company.
Ms.&nbsp;Phillips holds a B.S. and a M.S. in microbiology from the University of Idaho. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">There are no family relationships
among any of our executive officers and directors. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">11 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL 2 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>APPROVAL OF INCREASE IN NUMBER OF AUTHORIZED SHARES OF COMMON STOCK </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Board of Directors is requesting stockholder approval of an amendment to the Company&#146;s Sixth Amended and Restated Certificate of Incorporation to increase the Company&#146;s authorized number of shares of common stock from 250,000,000 shares to
350,000,000 shares. As of our record date of April&nbsp;10, 2013, our total common stock outstanding was 182,886,013. Taking into account shares of common stock reserved for issuance upon the exercise of outstanding warrants as well as shares of
common stock reserved for issuance upon exercise of outstanding employee stock options and delivery of restricted stock units our total common stock outstanding on a fully diluted basis would represent approximately 213,630,011 of our currently
authorized 250,000,000 shares. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2">Although, at present, the Board of Directors has no other plans to issue
additional shares of common stock other than under the terms of our equity incentive plans, the Board of Directors believes it is prudent to have the shares available to provide additional flexibility to use its capital stock for business and
financial purposes in the future. We may need to raise additional capital, for example through the At Market Issuance Sales Agreement we put into effect March&nbsp;29, 2013, to fund the advancement of HEPLISAV</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">TM</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">, our lead product candidate, through the regulatory approval
process, and for other general corporate purposes, including working capital. The additional shares may be used for various purposes without further stockholder approval. These purposes may include raising capital; providing equity incentives to
employees, officers or directors; establishing strategic relationships with other companies; expanding the Company&#146;s business or product lines through the acquisition of other businesses or products; and, other corporate purposes. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The additional shares of common stock that would become available for issuance if the proposal were adopted could also be used by Dynavax
to oppose a hostile takeover attempt or to delay or prevent changes in control or management of Dynavax. For example, we have a &#147;poison pill&#148; which would, under certain circumstances related to an acquisition of shares not approved by the
Board of Directors, give certain holders the right to acquire additional shares of common stock at a low price, or the Board of Directors could strategically sell shares of common stock in a private transaction to purchasers who would oppose a
takeover or favor the current Board of Directors. Although this proposal to increase the authorized common stock has been prompted by business and financial considerations and not by the threat of any hostile takeover attempt (nor is the Board of
Directors currently aware of any such attempts directed at Dynavax), nevertheless, stockholders should be aware that approval of this proposal could facilitate future efforts by Dynavax to deter or prevent changes in control of Dynavax, including
transactions in which the stockholders might otherwise receive a premium for their shares over then-current market prices. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In
developing its recommendation to the stockholders to vote in favor of the increase to the authorized number of shares of our common stock, our Board of Directors considered many factors, including but not limited to the following: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The benefits to us of having additional flexibility to use our capital stock for business and financial purposes in the future, including establishing
strategic relationships with other companies and expanding our business or product candidates through the acquisition of other businesses or products. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The benefits to the stockholders of using the additional shares to oppose a hostile takeover attempt or to delay or prevent changes in control or our
management in order to maximize the value for our stockholders. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The dilution of the ownership interests in Dynavax held by our existing stockholders as a result of the potential issuance of the additional shares.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If our stockholders do not approve the proposal, we may not be able to complete activities in connection
with the advancement of HEPLISAV or other strategic transactions, access the capital markets, retain employees and pursue other business opportunities integral to our growth and success. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">12 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The additional common stock to be authorized by adoption of the amendment would have rights
identical to the currently outstanding common stock of the Company. Adoption of the proposed amendment and issuance of the common stock would not affect the rights of the holders of currently outstanding common stock of the Company, except for
effects incidental to increasing the number of shares of the Company&#146;s common stock outstanding, such as dilution of the earnings per share and voting rights of current holders of common stock. If the amendment is adopted, it will become
effective upon filing of a Certificate of Amendment of the Company&#146;s Sixth Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The form of proposed certificate of amendment to the Company&#146;s Sixth Amended and Restated Certificate of Incorporation to increase
the authorized shares of our common stock is attached to this proxy statement as Annex A. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of the holders
of a majority of the outstanding shares of the common stock will be required to approve this amendment to the Company&#146;s Sixth Amended and Restated Certificate of Incorporation. As a result, abstentions and broker non-votes will have the same
effect as negative votes. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL> O<SMALL>F</SMALL> D<SMALL>IRECTORS</SMALL>
R<SMALL>ECOMMENDS</SMALL> </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A V<SMALL>OTE</SMALL> I<SMALL>N</SMALL> F<SMALL>AVOR</SMALL> O<SMALL>F</SMALL>
P<SMALL>ROPOSAL</SMALL> 2. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">13 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL 3 </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>APPROVAL OF AN AMENDMENT TO THE 2011 EQUITY INCENTIVE PLAN </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of
Directors is requesting stockholder approval of an amendment to the Company&#146;s 2011 Equity 2011 Plan (the &#147;2011 Plan&#148;) to add an additional 10,000,000 shares to the number of shares of our common stock authorized for issuance under the
2011 Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Why You Should Vote for the 2011 Plan </B></FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Equity Incentive Awards Are an Important Part of Our Compensation Philosophy </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2011 Plan is critical to our ongoing effort to build stockholder value through retaining and motivating key employees. The purpose of
the increase in available shares under the 2011 Plan is to provide us with a sufficient reserve of common stock to offer appropriate incentives to our employees, consultants and directors. Dynavax is a clinical-stage biopharmaceutical company whose
lead product candidate is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine. Our success in developing marketable products, achieving a competitive position and implementing our current initiatives, particularly for HEPLISAV, will depend
on our ability to attract and retain qualified personnel in areas requiring specific technical, medical or commercial expertise. Like all biotechnology companies, we actively compete for highly-qualified employees. Our equity programs are key
components of our strategy to attract and retain those individuals. We continue to believe that equity compensation is a critical component to motivate key employees and effectively aligns employee compensation with stockholder interests.
Traditionally, stock options have been the primary focus of our equity program. The potential value of stock options is realized only if our share price increases, and so we believe stock options provide a strong incentive for individuals to work to
grow our business and build stockholder value and are most attractive to individuals who share our entrepreneurial spirit. In addition, we have also granted a limited number of restricted stock awards in recent years in order to attract and retain
exceptional employees. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>We Manage Our Equity Incentive Award Use Carefully, and Dilution Is Reasonable </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We continue to believe that equity awards such as stock options are a vital part of our overall compensation program. Our compensation
philosophy reflects broad-based eligibility for equity incentive awards, and we grant awards to substantially all of our employees. However, we recognize that equity awards dilute existing stockholders, and, therefore, we must responsibly manage the
growth of our equity compensation program. We are committed to effectively monitoring our equity compensation share reserve, including our burn rate, to ensure that we maximize stockholders&#146; value by granting the appropriate number of equity
incentive awards necessary to attract, reward, and retain employees. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows our responsible historical
dilution and burn rate percentages. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="80%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:64pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>As of December&nbsp;31</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2011</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2010</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Full Dilution</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10.44</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12.76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Gross Burn Rate</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.72</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.45</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Full dilution is calculated as (shares available for grant + shares subject to outstanding equity incentive awards)/(common stock outstanding + shares
available for grant + shares subject to outstanding equity incentive awards). </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Gross Burn Rate is calculated as (shares subject to options granted + shares subject to other equity incentive awards granted)/weighted average common
shares outstanding. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The Size of Our Share Reserve Increase Request Is Reasonable </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If our request to increase the share reserve of the 2011 Plan by 10,000,000 shares is approved, we will have approximately 13,195,828
shares available for grant after our annual meeting, which we anticipate being a two-year pool of shares and necessary to provide a predictable amount of equity for attracting, retaining, and motivating employees. We anticipate returning to
stockholders for additional shares in 2015. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">14 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We ask that you consider that our stockholders will have the opportunity to judge our
executive compensation practices next year in 2014 through our advisory vote on executive compensation. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>The 2011 Plan Combines
Compensation and Governance Best Practices </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2011 Plan includes provisions that are designed to protect our
stockholders&#146; interests and to reflect corporate governance best practices including: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder approval is required for additional shares</I>.&nbsp;&nbsp;&nbsp;&nbsp;The 2011 Plan does not contain an annual &#147;evergreen&#148;
provision. The 2011 Plan authorizes a fixed number of shares, so that stockholder approval is required to issue any additional shares. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Repricing is not allowed</I>.&nbsp;&nbsp;&nbsp;&nbsp;The 2011 Plan prohibits the repricing of stock options and stock appreciation rights without
prior stockholder approval. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>No discounted stock options or stock appreciation rights.</I>&nbsp;&nbsp;&nbsp;&nbsp;All stock options and stock appreciation rights must have an
exercise price equal to or greater than the fair market value of our common stock on the date the stock option or stock appreciation right is granted. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Reasonable share counting provisions</I>.&nbsp;&nbsp;&nbsp;&nbsp;In general, when awards granted under the 2011 Plan lapse or are canceled, the
shares reserved for those awards will be returned to the share reserve and be available for future awards. However, shares of common stock received from the exercise of stock options or withheld for taxes will not be returned to our share reserve.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Summary of the 2011 Plan </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A summary of the principal features of the 2011 Plan follows below. The summary is qualified by the full text of the 2011 Plan that is attached as Annex B to this proxy statement. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Types of Awards </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The 2011 Plan provides for the following types of awards: incentive stock options, nonstatutory stock options, restricted stock awards, restricted stock unit awards, stock appreciation rights, performance
stock awards, performance cash awards, and other stock-based awards. We refer to these stock awards in this Proposal collectively as the stock awards or awards. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Eligibility </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock awards may be granted under the 2011 Plan to employees
(including officers) and consultants of Dynavax or our affiliates, and members of our Board of Directors. Pursuant to applicable tax law, we may only grant incentive stock options to our employees (including officers) and employees of our
affiliates. As of December&nbsp;31, 2012, we had a total of 119 employees and 8 non-employee directors who would be eligible to be granted awards from the 2011 Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">No person may be granted stock awards covering more than 2,000,000 shares of our common stock under our 2011 Plan during any calendar year pursuant to stock options, stock appreciation rights and other
stock awards whose value is determined by reference to an increase over an exercise or strike price of at least 100% of the fair market value on the date the stock award is granted. Additionally, no person may be granted a performance stock award
covering more than 1,500,000 shares or a performance cash award having a maximum value in excess of $5,000,000 in any calendar year. Such limitations are designed to help assure that any deductions to which we would otherwise be entitled with
respect to such awards will not be subject to the $1,000,000 limitation on the income tax deductibility of compensation paid to any covered executive officer imposed by Section&nbsp;162(m) of the Internal Revenue Code of 1986, as amended (the
&#147;Code&#148;). </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">15 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Administration </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2011 Plan is administered by our Board of Directors, which may in turn delegate authority to administer the 2011 Plan to a committee.
Our Board of Directors has delegated administration of the 2011 Plan to the Compensation Committee of the Board of Directors (the &#147;Compensation Committee&#148;), but has retained the authority to concurrently administer the 2011 Plan with the
Compensation Committee and may, at any time, revest in itself some or all of the powers previously delegated to the Compensation Committee. Subject to the terms of the 2011 Plan, the Compensation Committee may determine the recipients, numbers and
types of stock awards to be granted, and terms and conditions of the stock awards, including the period of their exercisability and vesting. Subject to the limitations set forth below, the Compensation Committee also determines the fair market value
applicable to a stock award and the exercise price of stock options and stock appreciation rights granted under the 2011 Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In the discretion of the Board of Directors, the Compensation Committee may consist solely of two or more &#147;non-employee
directors&#148; within the meaning of Rule 16b-3 of the Exchange Act, or solely of two or more &#147;outside directors&#148; within the meaning of Section&nbsp;162(m) of the Code. The Compensation Committee has the authority to delegate its
administrative powers under the 2011 Plan to a subcommittee consisting of members of the Compensation Committee. The 2011 Plan also permits delegation to one or more officers of the ability to determine the recipients, number of shares and types of
stock awards (to the extent permitted by law) to be granted to employees other than our officers, subject to a maximum limit on the aggregate number of shares subject to stock awards that may be granted by such officers. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stock Available for Awards </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">If this Proposal 3 is approved (and if Proposal 2 is also approved), the total number of shares of our common stock reserved for issuance under the 2011 Plan will consist of: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,733,704 shares currently reserved for issuance under the 2011 Plan; plus </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000,000 shares subject to approval of the stockholders under this Proposal 3; plus </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the number of shares that are subject to stock awards outstanding under each of the 1997 Equity Incentive Plan, 2004 Stock Incentive Plan and 2010
Employment Inducement Award Plan, which we refer to collectively as the Prior Plans that, on or after the effective date of the 2011 Plan, expire or terminate prior to exercise or settlement, or are forfeited because of a failure to meet a
contingency or condition required to vest such shares, to the extent such shares would otherwise have returned to the Prior Plan. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We call this total number the &#147;Share Reserve.&#148; In no event will the Share Reserve exceed 31,015,853 shares. The Share Reserve does not limit the number of equity awards granted under the 2011
Plan so long as the number of shares of common stock issued under equity awards made under the 2011 Plan does not exceed the Share Reserve. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following table provides certain additional information regarding the 2011 Plan, which is our only active equity incentive plan, and all outstanding stock awards as of April&nbsp;10, 2013. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="83%"></TD>
<TD VALIGN="bottom" WIDTH="14%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>As&nbsp;of&nbsp;April&nbsp;10,&nbsp;2013</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Shares Available for Grant under the 2011 Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3,195,828</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Stock Options Outstanding</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,812,876</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Other Awards Outstanding</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,725,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighted-Average Exercise Price of Stock Options Outstanding</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.27</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Weighted-Average Remaining Term of Stock Options Outstanding</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8.65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Common Stock Outstanding</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">182,886,013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Closing Price of Common Stock as Reported on NASDAQ Global Select Market</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.37</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">16 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The shares of common stock subject to stock awards granted under the 2011 Plan that expire,
are forfeited because of a failure to vest, or otherwise terminate without being exercised in full will return to the Share Reserve and be available for issuance under the 2011 Plan. However, any shares that are withheld to satisfy tax requirements
or that are used to pay the exercise or purchase price of a stock award will not return to the 2011 Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Appropriate
adjustments will be made to the Share Reserve, to the other numerical limits described in the 2011 Plan (such as the limit on the number of shares that may be issued as incentive stock options and the limit on the number of shares that may be
awarded to any one person in any calendar year for purposes of Section&nbsp;162(m) of the Code) and to outstanding awards in the event of any change in our common stock without the receipt of consideration by the Company through merger,
consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, liquidating dividend, combination of shares, exchange of shares, change in
corporate structure or any similar equity restructuring transaction, other than the conversion of convertible securities. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Repricing Prohibition </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The 2011 Plan expressly provides that, without the approval of a majority of the votes cast in person or by proxy at a meeting of our stockholders, the Board of Directors may not provide for either the
cancellation of underwater stock options or stock appreciation rights outstanding under the 2011 Plan in exchange for cash or the grant of a new award, or the amendment of outstanding stock options or stock appreciation rights to reduce the exercise
price. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Terms of Options </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">A stock option is the right to purchase shares of our common stock at a fixed exercise price for a fixed period of time. Stock option grants may be incentive stock options or nonstatutory stock options.
Each option is evidenced by a stock option agreement. The Board of Directors determines the terms of a stock option including the exercise price, the form of consideration paid on exercise, the vesting schedule, restrictions on transfer and the
term. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Generally, the exercise price of a stock option may not be less than 100% of the fair market value of the stock subject
to the option on the date of grant. Options granted under the 2011 Plan will vest at the rate specified in the option agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In general, the term of an option granted under the 2011 Plan may not exceed ten years. Unless the terms of an optionee&#146;s stock option agreement provides otherwise, if an optionee&#146;s continuous
service relationship with us, or any of our affiliates, ceases for any reason other than disability or death, the optionee may generally exercise any vested options for a period of three months following the cessation of service. The option term may
be extended in the event that exercise of the option following such a termination of service is prohibited by applicable securities laws or our insider trading policy. If an optionee&#146;s service relationship with us, or any of our affiliates,
ceases due to disability or death, or an optionee dies within a certain period following cessation of service, the optionee or a beneficiary may generally exercise any vested options for a period of 12 months in the event of disability and 18 months
in the event of death. In no event may an option be exercised beyond the expiration of its term. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Acceptable forms of
consideration for the purchase of our common stock issued under the 2011 Plan may include cash, payment pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board, common stock previously owned by the optionee,
payment through a net exercise feature, or other approved forms of legal consideration. Generally, an optionee may not transfer a stock option other than by will or the laws of descent and distribution or pursuant to a domestic relations order.
However, to the extent permitted under the terms of the applicable stock option agreement, an optionee may designate a beneficiary who may exercise the option following the optionee&#146;s death. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">17 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Tax Limitations on Incentive Stock Options </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The aggregate fair market value, determined at the time of grant, of shares of our common stock with respect to incentive stock options
that are exercisable for the first time by an optionee during any calendar year under all of our stock plans may not exceed $100,000. The options or portions of options that exceed this limit are generally treated as nonstatutory stock options. In
addition, the maximum number of shares that may be issued pursuant to the exercise of incentive stock options under the 2011 Plan is 50,000,000 shares. No incentive stock option may be granted to any person who, at the time of the grant, owns or is
deemed to own stock possessing more than 10% of our total combined voting power or that of any of our affiliates unless the following conditions are satisfied: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the option exercise price must be at least 110% of the fair market value of the stock subject to the option on the date of grant; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the term of any incentive stock option award must not exceed five years from the date of grant. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Terms of Restricted Stock Awards </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Restricted stock awards are awards of shares of our common stock. Each restricted stock award is evidenced by an award agreement that sets forth the terms and conditions of the award. A restricted stock
award may be granted in consideration for cash, the recipient&#146;s services performed for us or an affiliate of ours or other form of legal consideration. Shares of our common stock acquired under a restricted stock award may be subject to
forfeiture in accordance with the vesting schedule determined at the time of grant. Rights to acquire shares of our common stock under a restricted stock award may be transferred only upon such terms and conditions as are set forth in the restricted
stock award agreement. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Terms of Restricted Stock Unit Awards </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">A restricted stock unit is a right to receive stock or cash (or a combination of cash and stock) equal to the value of a share of stock at
the end of a set period. No stock is issued at the time of grant. Each restricted stock unit award is evidenced by an agreement that sets forth the terms and conditions of the award. Restricted stock unit awards may be subject to vesting in
accordance with a vesting schedule determined at grant. Dividend equivalents may be credited in respect of shares of our common stock covered by a restricted stock unit award. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">When a participant&#146;s continuous service with us or any of our affiliates, terminates for any reason, the unvested portion of the restricted stock unit award will be forfeited unless otherwise
provided in the restricted stock unit award agreement. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Terms of Stock Appreciation Rights </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stock appreciation rights will be granted pursuant to a stock appreciation rights agreement. Each stock appreciation right is denominated
in common stock share equivalents. The Board of Directors determines the strike price for a stock appreciation right, which generally cannot be less than 100% of the fair market value of our common stock on the date of grant. A stock appreciation
right granted under the 2011 Plan vests at the rate specified in the stock appreciation right agreement as determined by the Board of Directors. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">When a stock appreciation right is exercised, the holder is entitled to an amount equal to the product of (a)&nbsp;the excess of the per share fair market value of our common stock on the date of exercise
over the strike price, multiplied by (b)&nbsp;the number of shares of common stock with respect to which the stock appreciation right is exercised. We may pay the amount of the appreciation in cash or shares of our common stock or a combination of
both. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors determines the term of stock appreciation rights granted under the 2011 Plan, up to a maximum of
10 years. Unless the terms of an optionee&#146;s stock option agreement provides otherwise, if a </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">18 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
participant&#146;s continuous service with us, or any of our affiliates, ceases for any reason other than disability or death, the participant may generally exercise any vested stock appreciation
right for a period of three months following the cessation of service. The stock appreciation right term may be further extended in the event that exercise of the stock appreciation right following such a termination of service is prohibited by
applicable securities laws or our insider trading policy. If a participant&#146;s service relationship with us, or any of our affiliates, ceases due to disability or death, or a participant dies within a certain period following cessation of
service, the participant or a beneficiary may generally exercise any vested stock appreciation right for a period of 12 months in the event of disability and 18 months in the event of death. In no event may a stock appreciation right be exercised
beyond the expiration of its term. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Terms of Performance Awards </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2011 Plan provides for the grant of performance stock awards and performance cash awards. A performance award may vest or be exercised
upon achievement of pre-determined performance goals during a specified period. A performance award may also require the completion of a specified period of continuous service. The length of any performance period, the performance goals to be
achieved during the performance period, and the measure of whether and to what degree such performance goals have been attained will be determined by the Board of Directors or, to the extent necessary to comply with Section&nbsp;162(m) of the Code,
the Compensation Committee. Performance goals will generally be established not later than ninety (90)&nbsp;days into a performance period. As soon as administratively practicable following the end of the performance period, the Compensation
Committee will certify (in writing) whether the performance goals have been satisfied. The maximum performance award that may be granted to any individual in a calendar year is 1,500,000 shares of our common stock and $5,000,000. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;162(m) of the Code disallows a deduction to any publicly held corporation and its affiliates for certain compensation paid
to &#147;covered employees&#148; in a taxable year to the extent that compensation to a covered employee exceeds $1 million. However, some kinds of compensation, including qualified &#147;performance-based compensation,&#148; are not subject to this
deduction limitation. While we believe it is in the best interests of Dynavax and our stockholders to preserve the ability to grant &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code, in certain circumstances, we may
determine to grant compensation to covered employees that will not qualify as &#147;performance-based compensation&#148; for purposes of Section&nbsp;162(m) of the Code. Moreover, even if we intend to grant compensation that qualifies as
&#147;performance-based compensation,&#148; we cannot guarantee that such compensation ultimately will be deductible by us. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="2">In granting a performance award intended to qualify as &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code, the Compensation Committee will set a period of time, or a
performance period, over which the attainment of one or more goals, or performance goals, will be measured. Within the time period prescribed by Section&nbsp;162(m) of the Code, at the time when the achievement of the performance goals remains
substantially uncertain (typically no later than the earlier of the 90</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"> day of the performance period and the date on which 25% of the performance period has elapsed), the Compensation Committee will establish the performance goals, based upon one or more criteria, or
performance criteria, enumerated in the 2011 Plan and described below. Prior to the payment of any compensation under any award intended to qualify as &#147;performance-based compensation&#148; under Section&nbsp;162(m) of the Code, the Compensation
Committee will certify (in writing) whether the performance goals have been satisfied. Notwithstanding satisfaction of the achievement of any performance goals, the number of shares of common stock, stock options, cash or other consideration
granted, issued, retainable or vested under an award on account of such satisfaction may be reduced by the Compensation Committee, as determined in its sole discretion. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Performance-based stock and cash awards may be made subject to one or more of the following criteria: (i)&nbsp;earnings (including earnings per share and net earnings); (ii)&nbsp;earnings before interest,
taxes and depreciation; (iii)&nbsp;earnings before interest, taxes, depreciation and amortization (EBITDA); (iv)&nbsp;total stockholder return; (v)&nbsp;return on equity or average stockholder&#146;s equity; (vi)&nbsp;return on assets, investment,
or capital employed; </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">19 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
(vii)&nbsp;stock price; (viii)&nbsp;margin (including gross margin); (ix)&nbsp;net income (before or after taxes); (x)&nbsp;operating income; (xi)&nbsp;operating income after taxes;
(xii)&nbsp;pre-tax profit; (xiii)&nbsp;operating cash flow; (xiv)&nbsp;sales or revenue targets; (xv)&nbsp;increases in revenue or product revenue; (xvi)&nbsp;expenses and cost reduction goals; (xvii)&nbsp;improvement in or attainment of working
capital levels; (xviii)&nbsp;economic value added (or an equivalent metric); (xix)&nbsp;market share; (xx)&nbsp;cash flow; (xxi)&nbsp;cash flow per share; (xxii)&nbsp;share price performance; (xxiii)&nbsp;debt reduction; (xxiv)&nbsp;implementation
or completion of projects or processes; (xxv)&nbsp;customer satisfaction; (xxvi)&nbsp;stockholders&#146; equity; (xxvii)&nbsp;capital expenditures; (xxviii)&nbsp;debt levels; (xxix)&nbsp;operating profit or net operating profit; (xxx)&nbsp;workforce
diversity; (xxxi)&nbsp;growth of net income or operating income; (xxxii)&nbsp;billings; (xxxiii)&nbsp;submission to, or approval by, a regulatory body (including but not limited to the U.S. Food and Drug Administration) of an applicable filing or a
product candidate; and (xxxiv)&nbsp;to the extent that an award is not intended to comply with Section&nbsp;162(m) of the Code, other measures of performance selected by the Board of Directors. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The performance goals may be based on a company-wide basis, with respect to one or more business units, divisions, affiliates, or
business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise (i)&nbsp;in the award agreement at the time the award
is granted or (ii)&nbsp;in such other document setting forth the performance goals at the time the goals are established, we will appropriately make adjustments in the method of calculating the attainment of performance goals as follows: (1)&nbsp;to
exclude restructuring and/or other nonrecurring charges; (2)&nbsp;to exclude exchange rate effects, as applicable, for non-U.S. dollar denominated goals; (3)&nbsp;to exclude the effects of changes to generally accepted accounting principles;
(4)&nbsp;to exclude the effects of any statutory adjustments to corporate tax rates; (5)&nbsp;to exclude the effects of any &#147;extraordinary items&#148; as determined under generally accepted accounting principles; (6)&nbsp;to exclude the
dilutive effects of acquisitions or joint ventures; (7)&nbsp;to assume that any business divested by us achieved performance objectives at targeted levels during the balance of a performance period following such divestiture; (8)&nbsp;to exclude the
effect of any change in the outstanding shares of our common stock by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar
corporate change, or any distributions to common shareholders other than regular cash dividends; (9)&nbsp;to exclude the effects of stock based compensation and/or the award of bonuses under our bonus plans; and (10)&nbsp;to exclude the effect of
any other unusual, non-recurring gain or loss or other extraordinary item. In addition, we retain the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of the goals. The performance goals may differ from
participant to participant and from award to award. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Terms of Other Stock Awards </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors may grant other forms of stock awards that are valued in whole or in part by reference to the value of Dynavax
common stock. Subject to the provisions of the 2011 Plan, the Board of Directors has the authority to determine the persons to whom and the dates on which such other stock awards will be granted, the number of shares of common stock (or cash
equivalents) to be subject to each award, and other terms and conditions of such awards. Such awards may be granted either alone or in addition to other stock awards granted under the 2011 Plan. Such other forms of stock awards may be subject to
vesting in accordance with a vesting schedule determined at grant. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Corporate Transactions; Changes in Control
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Corporate Transaction</I>. In the event of certain corporate transactions (as defined below), the Board of Directors
has the discretion to take one or more of the following actions with respect to outstanding stock awards under the 2011 Plan: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">arrange for the assumption, continuation, or substitution of a stock award by a surviving or acquiring entity (or its parent company);
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">arrange for the assignment of any reacquisition or repurchase rights applicable to any shares of our common stock issued pursuant to a stock award to
the surviving or acquiring corporation (or its parent company); </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">20 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">accelerate the vesting and exercisability of a stock award followed by the termination of the stock award; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">arrange for the lapse of any reacquisition or repurchase rights applicable to any shares of our common stock issued pursuant to a stock award;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">cancel or arrange for the cancellation of a stock award, to the extent not vested or not exercised, in exchange for such cash consideration, if any, as
the Board of Directors may determine in its sole discretion; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">arrange for the surrender of a stock award in exchange for a payment equal to the excess of (a)&nbsp;the value of the property the holder of the stock
award would have received upon the exercise of the stock award, over (b)&nbsp;any exercise price payable by such holder in connection with such exercise. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors need not take the same action for each stock award. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For
purposes of the 2011 Plan, a corporate transaction will be deemed to occur in the event of (i)&nbsp;the consummation of a sale of all or substantially all of our consolidated assets, (ii)&nbsp;the consummation of a sale of at least 90% of our
outstanding securities, (iii)&nbsp;the consummation of a merger or consolidation in which we are not the surviving corporation, or (iv)&nbsp;the consummation of a merger or consolidation in which we are the surviving corporation but shares of our
outstanding common stock are converted into other property by virtue of the transaction. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Change in Control.</I> A stock
award may be subject to additional acceleration of vesting and exercisability upon or after specified change in control transactions (as defined in the 2011 Plan), as provided in the stock award agreement or in any other written agreement between us
or any affiliate and the participant, but in the absence of such provision, no acceleration shall occur. The acceleration of vesting of an award in the event of a corporate transaction or a change in control event under the 2011 Plan may be viewed
as an anti-takeover provision, which may have the effect of discouraging a proposal to acquire or otherwise obtain control of Dynavax. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Duration, Suspension, Termination, and Amendment </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors
may suspend or terminate the 2011 Plan at any time. Unless sooner terminated by our Board of Directors, the 2011 Plan shall automatically terminate on November&nbsp;11, 2020, which is the day before the tenth anniversary of the date the 2011 Plan
was adopted by the Compensation Committee of the Board of Directors. No awards may be granted under the 2011 Plan while the 2011 Plan is suspended or after it is terminated. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors may amend the 2011 Plan at any time. However, no amendment or termination of the plan will adversely affect any rights under awards already granted to a participant unless agreed to
by the affected participant. We will obtain stockholder approval of any amendment to the 2011 Plan as required by applicable law or listing requirement. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Tax Withholding </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board of Directors may require a participant to
satisfy any federal, state, local, or foreign tax withholding obligation relating to a stock award by (a)&nbsp;causing the participant to tender a cash payment; (b)&nbsp;withholding shares of common stock from the shares of common stock issued or
otherwise issuable to the participant in connection with the award; (c)&nbsp;withholding cash from an award settled in cash or from other amounts payable to the participant; or (d)&nbsp;by other method set forth in the award agreement. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Federal Income Tax Information </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following is a summary of the principal U.S. federal income taxation consequences to participants and Dynavax with respect to participation in the 2011 Plan. The information is based upon current
federal income tax </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">21 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
rules and therefore is subject to change when those rules change. Because the tax consequences to any recipient may depend on his or her particular situation, each recipient should consult the
recipient&#146;s tax adviser regarding the federal, state, local, and other tax consequences of the grant or exercise of an award or the disposition of stock acquired as a result of an award. The 2011 Plan is not qualified under the provisions of
Section&nbsp;401(a) of the Code, and is not subject to any of the provisions of the Employee Retirement Income Security Act of 1974. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our ability to realize the benefit of any tax deductions described below depends on our generation of taxable income as well as the requirement of reasonableness, the provisions of Section&nbsp;162(m) of
the Code and the satisfaction of our tax reporting obligations. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Incentive Stock Options </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The 2011 Plan provides for the grant of stock options that qualify as &#147;incentive stock options,&#148; as defined in Section&nbsp;422
of the Code. Under the Code, an optionee generally is not subject to ordinary income tax upon the grant or exercise of an incentive stock option. If the optionee holds a share received on the exercise of an incentive stock option for more than two
years from the date the option was granted and more than one year from the date the option was exercised, which is referred to as the required holding period, the difference, if any, between the amount realized on a sale or other taxable disposition
of that share and the holder&#146;s tax basis in that share will be long-term capital gain or loss. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If, however, an optionee
disposes of a share acquired on exercise of an incentive stock option before the end of the required holding period, which is referred to as a disqualifying disposition, the optionee generally will recognize ordinary income in the year of the
disqualifying disposition equal to the excess, if any, of the fair market value of the share on the date the incentive stock option was exercised over the exercise price. However, if the sales proceeds are less than the fair market value of the
share on the date of exercise of the option, the amount of ordinary income recognized by the optionee will not exceed the gain, if any, realized on the sale. If the amount realized on a disqualifying disposition exceeds the fair market value of the
share on the date of exercise of the option, that excess will be short-term or long-term capital gain, depending on whether the holding period for the share exceeds one year. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">For purposes of the alternative minimum tax, the amount by which the fair market value of a share of stock acquired on exercise of an incentive stock option exceeds the exercise price of that option
generally will be an adjustment included in the optionee&#146;s alternative minimum taxable income for the year in which the option is exercised. If, however, there is a disqualifying disposition of the share in the year in which the option is
exercised, there will be no adjustment for alternative minimum tax purposes with respect to that share. In computing alternative minimum taxable income, the tax basis of a share acquired on exercise of an incentive stock option is increased by the
amount of the adjustment taken into account with respect to that share for alternative minimum tax purposes in the year the option is exercised. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We are not allowed an income tax deduction with respect to the grant or exercise of an incentive stock option or the disposition of a share acquired on exercise of an incentive stock option after the
required holding period. If there is a disqualifying disposition of a share, however, we are allowed a deduction in an amount equal to the ordinary income includible in income by the optionee. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Nonstatutory Stock Options </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Generally, there is no taxation upon the grant of a nonstatutory stock option if the option is granted with an exercise price equal to the fair market value of the underlying stock on the grant date. On
exercise, an optionee will recognize ordinary income equal to the excess, if any, of the fair market value on the date of exercise of the stock over the exercise price. If the optionee is employed by us or one of our affiliates, that income will be
subject to withholding tax. Generally, the optionee&#146;s tax basis in those shares will be equal to their fair market value on the date of exercise of the option, and the optionee&#146;s capital gain holding period for those shares will begin on
that date. We will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the optionee. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">22 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Restricted Stock Awards </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Generally, the recipient of a restricted stock award will recognize ordinary compensation income at the time the stock is received equal
to the excess, if any, of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. If, however, the stock is not vested when it is received (for example, if the employee is required to work for a
period of time in order to have the right to sell the stock), the recipient generally will not recognize income until the stock becomes vested, at which time the recipient will recognize ordinary compensation income equal to the excess, if any, of
the fair market value of the stock on the date it becomes vested over any amount paid by the recipient in exchange for the stock. A recipient may, however, file an election with the Internal Revenue Service, within 30 days of his or her receipt of
the stock award, to recognize ordinary compensation income, as of the date the recipient receives the award, equal to the excess, if any, of the fair market value of the stock on the date the award is granted over any amount paid by the recipient in
exchange for the stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The recipient&#146;s basis for the determination of gain or loss upon the subsequent disposition of
shares acquired from stock awards will be the amount paid for such shares plus any ordinary income recognized either when the stock is received or when the stock becomes vested. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Subject to the requirement of reasonableness, the provisions of Section&nbsp;162(m) of the Code and the satisfaction of a tax reporting
obligation, we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock award. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Restricted Stock Units </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Generally, no taxable income is recognized upon
receipt of a restricted stock unit award. The participant will recognize ordinary income in the year in which the shares subject to that unit are actually issued to the participant in an amount equal to the fair market value of the shares on the
date of issuance. Generally, we will be entitled to an income tax deduction equal to the amount of ordinary income recognized by the participant at the time the shares are issued. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Stock Appreciation Rights </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Generally, stock appreciation rights are subject to similar tax rules as nonstatutory stock options. This means that, generally, no taxable income is realized upon the receipt of a stock appreciation
right. Upon exercise of the stock appreciation right, the fair market value of the shares (or cash in lieu of shares) received, less any strike price paid for such shares, is recognized as ordinary income to the participant in the year of such
exercise. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Generally, with respect to employees, we are required to withhold from the payment made on exercise of the stock
appreciation right or from regular wages or supplemental wage payments an amount based on the ordinary income recognized. We will generally be entitled to an income tax deduction equal to the amount of ordinary income recognized by the participant.
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Section&nbsp;162(m) </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Compensation of persons who are &#147;covered employees&#148; of the Company is subject to the tax deduction limits of Section&nbsp;162(m) of the Code. Awards that qualify as &#147;performance-based
compensation&#148; are exempt from the limitations of Section&nbsp;162(m), thereby permitting us to claim the full federal tax deduction otherwise allowed for such compensation. The 2011 Plan is intended to enable us to grant awards that will be
exempt from the deduction limits of Section&nbsp;162(m). Under Section&nbsp;162(m), compensation attributable to stock options and stock appreciation rights generally may be eligible to qualify as performance-based compensation if, among other
requirements, (i)&nbsp;such awards are approved by a compensation committee composed solely of &#147;outside directors,&#148; (ii)&nbsp;the plan contains a per-employee limitation on the number of shares for which such awards may be granted during a
specified period, (iii)&nbsp;the per-employee limitation is approved by the stockholders, and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">23 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
(iv)&nbsp;the exercise or strike price of the award is no less than the fair market value of the stock on the date of grant. Compensation attributable to restricted stock, restricted stock units,
performance awards and other stock-based awards generally may be eligible to qualify as performance-based compensation, if, among other requirements, (i)&nbsp;the award is approved by a compensation committee composed solely of &#147;outside
directors,&#148; (ii)&nbsp;the award is granted, becomes vested or is settled, as applicable, only upon the achievement of an objective performance goal established in writing by the Compensation Committee while the outcome is substantially
uncertain, (iii)&nbsp;a committee of outside directors certifies in writing prior to the granting (or vesting or settlement) of the award that the performance goal has been satisfied, and (iv)&nbsp;prior to the granting (or vesting or settlement) of
the award, the stockholders have approved the material terms of the award (including the class of employees eligible for such award, the business criteria on which the performance goal is based, and the maximum amount, or formula used to calculate
the amount, payable upon attainment of the performance goal). </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Awards Granted Under the 2011 Plan </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth, for each of the individuals and various groups indicated, including each nominee for election as a
director, the number of shares of our common stock subject to awards granted under the 2011 Plan as of April&nbsp;10, 2013: </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2011 Equity Incentive Plan </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;Shares</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Subject&nbsp;
to&nbsp;</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Options</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of&nbsp;
Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards<BR>Outstanding<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,250,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">950,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">525,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert L. Coffman, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">660,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">David F. Novack</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">630,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck Ph.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">380,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">125,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dennis Carson, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Denise Gilbert Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All Current Executive Officers as a Group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,995,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">675,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All Current Non-Executive Directors as a Group</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">220,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">240,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All Current Employees as a Group (including all current non-executive officers)</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,030,877</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">810,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">RSUs granted in 2012 to select employees with certain performance-based vesting criteria. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Ms.&nbsp;Larson served as the Company&#146;s Vice President and Chief Financial Officer from August 2012 through February 2013. Upon her departure,
225,000 of her original 300,000 options were forfeited. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dr.&nbsp;Tuck served as the Company&#146;s Vice President, Global Technical Operations from November 2010 through March 2013. Under the terms of a
consulting agreement described below, Dr.&nbsp;Tuck&#146;s options will continue to vest through the period of continuous service. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>New Plan Benefits under Amendment of the 2011 Plan </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Awards granted under
the 2011 Plan to our executive officers and employees are discretionary and are not subject to set benefits or amounts, and we have not approved any awards that are conditioned on stockholder approval of the amendment to the 2011 Plan described in
this Proposal 3. Accordingly, we cannot currently determine the benefits or number of shares subject to awards that may be granted in the future to our executive officers or employees under the 2011 Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Grants to our directors are made as follows: On the date of the annual meeting, each continuing non-employee director will receive an
option to purchase 15,000 shares of our common stock, with such numbers of </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">24 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
shares reduced pro rata if such non-employee director has served on the Board for less than one year. The dollar value of such awards is not determinable at this time because such value is based
on the fair market value of our common stock on the date of grant. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Vote Required </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of the holders of a majority of votes cast either in person or by proxy at the Annual Meeting will be required to
approve the amendment to the Incentive Plan. Abstentions and broker non-votes are counted towards a quorum but are not counted for any purpose in determining whether Proposal 3 has been approved. </FONT></P>
<P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL> O<SMALL>F</SMALL> D<SMALL>IRECTORS</SMALL> R<SMALL>ECOMMENDS</SMALL> </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A V<SMALL>OTE</SMALL>&nbsp;I<SMALL>N</SMALL> F<SMALL>AVOR</SMALL> O<SMALL>F</SMALL> P<SMALL>ROPOSAL</SMALL>&nbsp;3. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">25 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>PROPOSAL&nbsp;4 </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>RATIFICATION OF SELECTION OF </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee has
selected and the Board has approved Ernst&nbsp;&amp; Young LLP, or Ernst&nbsp;&amp; Young, as our independent registered public accounting firm for the fiscal year ending December&nbsp;31, 2013. Ernst&nbsp;&amp; Young has audited our financial
statements since 2001. Representatives of Ernst&nbsp;&amp; Young are expected to be present at the Annual Meeting. They will have an opportunity to make a statement if they so desire and will be available to respond to appropriate questions.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">If the stockholders fail to ratify the selection of Ernst&nbsp;&amp; Young, the Board will reconsider whether or not to
retain that firm. Even if the selection is ratified, the Board in its discretion may direct the appointment of a different independent registered public accounting firm at any time during the year if it determines that such a change would be in the
best interests of the Company and its stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The affirmative vote of the holders of a majority of the shares present
in person or represented by proxy and entitled to vote at the Annual Meeting will be required to ratify the selection of Ernst&nbsp;&amp; Young. Abstentions will be counted toward the tabulation of votes cast on proposals presented to the
stockholders and will have the same effect as negative votes. Broker non-votes are counted towards a quorum but are not counted for any purpose in determining whether this matter has been approved; however, Proposal 4 is considered a
&#147;routine&#148; matter, and therefore no broker non-votes are expected to exist in connection with Proposal 4. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL> O<SMALL>F</SMALL> D<SMALL>IRECTORS</SMALL> R<SMALL>ECOMMENDS </SMALL>A
V<SMALL>OTE</SMALL>&nbsp;I<SMALL>N</SMALL> F<SMALL>AVOR</SMALL> O<SMALL>F</SMALL> P<SMALL>ROPOSAL</SMALL> 4.</B> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>UDIT</SMALL>
F<SMALL>EES</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In connection with the audit of our 2012 financial statements, we entered into an engagement agreement
with Ernst&nbsp;&amp; Young which sets forth the terms by which Ernst&nbsp;&amp; Young will perform audit services for the Company. That agreement is subject to alternative dispute resolution procedures and an exclusion of punitive damages.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table represents aggregate fees billed to the Company for the fiscal years ended December&nbsp;31, 2012 and
2011 by Ernst&nbsp;&amp; Young, our principal auditors. All fees described below were pre-approved by the Audit Committee. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="82%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fiscal Year Ended</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2011</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit Fees</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">843,621</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">796,463</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Audit Related Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Tax Fees</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,475</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">68,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All Other Fees</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,455</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,995</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Fees</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">866,551</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">866,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Audit fees include fees for the audit of our consolidated financial statements and interim reviews of our quarterly financial statements, including
compliance with the provisions of Section&nbsp;404 of the Sarbanes-Oxley Act as well as fees related to registration statements, consents and other services related to SEC matters. In each of 2012 and 2011, audit fees included fees related to a
comfort letter in connection with an equity offering.</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Tax fees include international tax planning activities and analysis of net operating losses following changes in stock
ownership.</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">All other fees represent subscription fees for an online accounting research tool and related database. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">26 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>P<SMALL>RE</SMALL>-A<SMALL>PPROVAL</SMALL> P<SMALL>OLICIES</SMALL> A<SMALL>ND</SMALL>
P<SMALL>ROCEDURES</SMALL></B><SMALL></SMALL> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Audit Committee has adopted a policy and procedures for the pre-approval of
audit and non-audit services rendered by our independent registered public accounting firm, Ernst&nbsp;&amp; Young. Under the policy, the Audit Committee pre-approves specified services in the defined categories of audit services, audit-related
services, tax services and all other services up to specified amounts. Pre-approval may be given as part of the Audit Committee&#146;s approval of the scope of the engagement of the independent registered public accounting firm or on an individual
express case-by-case basis before the independent registered public accounting firm is engaged to provide each service. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The
Audit Committee has determined that services rendered by Ernst&nbsp;&amp; Young LLP are compatible with maintaining the principal auditors&#146; independence. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">27 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EXECUTIVE OFFICERS </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth certain information with respect to our executive officers as of March&nbsp;29, 2013: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="39%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="55%"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Age</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE="border-bottom:1px solid #000000;width:27pt" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Position</B></FONT></P></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer and Director</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">53</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Director</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Former Vice President and Chief Financial Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President, Finance and Principal Accounting Officer</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Robert L. Coffman,&nbsp;Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">66</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President and Chief Scientific Officer</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">David F. Novak</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Senior Vice President, Operations and Quality</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">61</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President, Chief Business Officer and General Counsel</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Former Vice President, Global Technical Operations</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Please see &#147;Class&nbsp;I Director Nominees&#148; in this proxy statement for more information about Dr.&nbsp;Dina. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Please see &#147;Class&nbsp;II Directors Continuing In Office Until The 2014 Annual Meeting&#148; in this proxy statement for more information about
Dr.&nbsp;Martin. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>HRISTINE</SMALL> R. L<SMALL>ARSON</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Larson served as the Company&#146;s Vice President and Chief Financial Officer from August 2012 through February
2013.&nbsp;Prior to joining Dynavax, Ms.&nbsp;Larson was Vice President and Chief Financial Officer at PDL BioPharma, Inc. (PDL), where she was responsible for leading all financial functions and investor relations. Prior to PDL, Ms.&nbsp;Larson
served as a Director at Grant Thornton, LLP, and as Chief Financial Officer for Trinity Learning Corporation, a publicly-held workforce learning company. From 1985 to 1999, Ms.&nbsp;Larson was with Bank of America Corporation, most recently as
Senior Vice President and Managing Director responsible for business development in their Global Capital Markets group. Ms.&nbsp;Larson received a B.S. in Food and Nutritional Sciences from the University of California, Berkeley, and an M.B.A. from
California State University, East Bay. Ms.&nbsp;Larson is a Certified Public Accountant in the State of California (inactive status). </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>J<SMALL>ENNIFER</SMALL> L<SMALL>EW</SMALL> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Lew joined Dynavax in December 2004 and is the Company&#146;s Vice President, Finance, and Principal Accounting Officer. Ms.&nbsp;Lew previously served as Senior Director and Corporate Controller
for Dynavax. Prior to joining the Company, Ms.&nbsp;Lew was with QRS Corporation, a publicly-held technology company, as Assistant Controller from 2002 until 2004 and Director of Finance from 2000 until 2002. From 1994 to 1999, Ms.&nbsp;Lew worked
for Ernst&nbsp;&amp; Young, most recently as Manager. She earned a B.A. in Economics/Accounting and Government from Claremont McKenna College and is a Certified Public Accountant (inactive status). </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>R<SMALL>OBERT</SMALL> L. C<SMALL>OFFMAN</SMALL>,&nbsp;P<SMALL>H</SMALL>.D. </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Coffman has been our Vice President and Chief Scientific Officer since December 2000. Dr. Coffman joined Dynavax from the DNAX
Research Institute where he had been since 1981, most recently as Distinguished Research Fellow. Prior to that, he was a postdoctoral fellow at Stanford University Medical School. Dr. Coffman has made fundamental discoveries about the regulation of
immune responses in allergic and infectious diseases. He shared the William S. Coley Award for Research in Immunology for discovery of the Th1 and Th2 subsets of T lymphocytes, the two major types of T cells that control most immune responses.
Dr.&nbsp;Coffman received his Ph.D. from the University of California, San Diego and his A.B. from Indiana University. In 2006, Dr. Coffman was elected to the National Academy of Sciences. Since May 2011, Dr. Coffman has held the position of
Investigator at the Baylor Research Institute. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">28 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>D<SMALL>AVID</SMALL> F. N<SMALL>OVACK</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Novack joined Dynavax in March 2013 as Senior Vice President, Operations and Quality. Mr.&nbsp;Novack was formerly with Novartis
Vaccines&nbsp;&amp; Diagnostics where he served since 2009 as the Global Head of Technical Operations and Supply Chain for Diagnostics and previously from 2007 to 2009 as the Global Head of Vaccine Manufacturing Strategy. Prior to Novartis,
Mr.&nbsp;Novack was the Vice President, Business Development for Vaxin, Inc., a vaccine company, from 2004 to 2006. From 1993 until 2004, Mr.&nbsp;Novack worked at MedImmune, formerly Aviron, serving in several capacities including business
development, manufacturing, contract operations and most recently as Senior Director, Supply Chain Operations. Previously, from 1989 to 1993, Mr.&nbsp;Novack was with American Cyanamid Company in various roles. Mr.&nbsp;Novack received a B.S. in
Biology from State University of New York and an M.B.A. from Columbia University. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>M<SMALL>ICHAEL</SMALL> S. O<SMALL>STRACH</SMALL>
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mr.&nbsp;Ostrach joined Dynavax in October 2006 as Vice President, Chief Business Officer and General Counsel. From 2005
to 2006, he was Chief Operating Officer, Chief Financial Officer and General Counsel at Threshold Pharmaceuticals. From 1997 to 2004, Mr.&nbsp;Ostrach was at Kosan Biosciences, most recently as President and Chief Operating Officer. Mr.&nbsp;Ostrach
began his corporate career at Cetus Corporation, where he served in several capacities between 1981 and 1991, initially as general counsel and finally as Senior Vice President of corporate affairs and General Counsel. Following the acquisition of
Cetus by Chiron Corporation in 1991, Mr.&nbsp;Ostrach became President of Chiron Technologies. He holds a B.A. from Brown University and a J.D. from Stanford Law School. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>S<SMALL>TEPHEN</SMALL> F. T<SMALL>UCK</SMALL>, P<SMALL>H</SMALL>.D. </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Tuck served as the Company&#146;s Vice President, Global Technical Operations from November 2010 through March 2013. Prior to joining Dynavax, Dr.&nbsp;Tuck was an independent consultant to
biotechnology and pharmaceutical clients from 2007 to 2010, which included Dynavax. From 1997 until 2007, Dr.&nbsp;Tuck was an employee of Dynavax and held a series of positions with increasing responsibility and ultimately served as our Vice
President of Biopharmaceutical Development. Prior to joining Dynavax in 1997, Dr.&nbsp;Tuck was employed by Chiron Corporation, where he served in various capacities in the Technical Affairs and Process Development departments. At Chiron,
Dr.&nbsp;Tuck was involved in the development of Fluad<FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">&reg;</SUP></FONT>, a novel adjuvanted influenza vaccine, various subunit
vaccines, adjuvants and protein therapeutics. Prior to joining Chiron, Dr.&nbsp;Tuck was a post-doctoral fellow at Johns Hopkins University School of Medicine and the University of California, San Francisco. He has over 20 years of experience in
pharmaceutical chemistry. Dr.&nbsp;Tuck received his Ph.D. and B.Sc. from Imperial College, University of London. </FONT></P> <P STYLE="margin-top:24px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>EXECUTIVE
COMPENSATION </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>OMPENSATION</SMALL> D<SMALL>ISCUSSION</SMALL> A<SMALL>ND</SMALL> A<SMALL>NALYSIS</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">This Compensation Discussion and Analysis explains our executive compensation philosophy, policies and practices for the following
executives, who are referred to in the Compensation Discussion and Analysis and in the subsequent tables as our named executive officers: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D., Chief Executive Officer and Director; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D., President and Director; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson, Vice President and Chief Financial Officer; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew, Vice President, Finance and Principal Accounting Officer; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach, Vice President, Chief Business Officer and General Counsel; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck, Ph.D., Vice President , Global Technical Operations. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">29 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>XECUTIVE</SMALL> S<SMALL>UMMARY</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dynavax, a clinical-stage biopharmaceutical company, is focused on discovering and developing novel products to prevent and treat
infectious and inflammatory diseases. Our lead product candidate is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine. To achieve our corporate mission, we rely on our employees. We encourage teamwork and collaboration among our
employees, and we demand accountability and strong results. Accordingly, we have designed our executive compensation program to provide a compensation package that focuses employees on corporate and individual performance, that is internally fair
and consistent, that attracts, retains and motivates key employees, and that is consistent with the interests of our stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Through the delivery of performance-based compensation, we believe that our executive compensation philosophy has assisted us in achieving outstanding results in 2012, both on an absolute level and as
compared with our peers. In 2012, we accomplished several critical milestones related to HEPLISAV development, including submission of the Biologics License Application (&#147;BLA&#148;) in the U.S. and the Marketing Authorization Application in
Europe, strengthening the organization in its transition toward commercialization, raising capital and advancing our pipeline of early programs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The highlights of our executive compensation program include: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Performance vesting criteria is utilized from time to time in some of our option grants to our named executive officers, such that these grants will
only be eligible for vesting if we achieve certain long-term corporate milestones related to our HEPLISAV program. This structure motivates our executives to achieve our critical near-term strategic business goals while at the same time focusing on
creating meaningful stock price appreciation that can be sustained over multiple years. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We did not provide our executive officers (including our Chief Executive Officer and President) with any tax reimbursement rights or supplemental
deferred compensation/retirement benefits. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We maintain a &#147;no-hedging&#148; policy in our insider trading policy that prohibits our directors and executive officers from hedging the economic
interest in the Company shares they hold. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our 2011 Plan, adopted by our stockholders in January 2011, replaced our prior plans and reflects best practices in equity compensation, including an
express prohibition on repricings or exchanges of underwater stock options and notably does not include either an &#147;evergreen&#148; feature or accelerated vesting provisions upon a change in control transaction, or upon a qualifying termination
of employment in connection with a change in control transaction. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have been working to increase the focus of our executive compensation program on pay for performance. For 2012, performance-based compensation (all
elements other than base salary) represented: </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">approximately 85% of the target total direct compensation for our Chief Executive Officer; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="9%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">approximately 78% of the target total direct compensation for our other named executive officers other than our Chief Executive Officer.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Objectives, Elements and Process </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Objectives</I>. Our executive compensation program is designed to: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Attract and retain talented executive officers; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Align the interests of executives and our stockholders; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Motivate our executives to achieve our business plans and strategic objectives over the short- and long-term; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Create a team-oriented workplace that promotes innovation, high quality scientific and technical accomplishments and calculated risk-taking to achieve
our objectives. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">30 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Mix of Key Compensation Elements.&nbsp;&nbsp;&nbsp;&nbsp;</I>To achieve these objectives,
our executive compensation program provides a mix of compensation elements, including base salary, annual cash-based incentive awards, equity compensation, broad-based employee benefits as well as severance and change of control benefits. We do not
use a strict weighting system among compensation elements for each named executive officer but instead consider the total compensation necessary to motivate and retain these individuals with a mix that places greater weight on performance-based
components, including annual cash incentive compensation and equity compensation. We believe that a mix of both cash and equity incentives is appropriate, as cash incentives reward named executive officers for near-term results, while equity
incentives motivate them to increase stockholder value over the longer term. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Role of our Compensation
Committee.&nbsp;&nbsp;&nbsp;&nbsp;</I>The Compensation Committee of the Board, or the Compensation Committee, has the primary responsibility for setting our named executive officer compensation each year. In particular, our Compensation Committee is
tasked with: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Setting the compensation levels for each of our named executive officers; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reviewing and approving the corporate goals and objectives relevant to the named executive officers&#146; compensation and evaluating their performance
at year end in light of such goals and objectives; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reviewing and making recommendations to the Board with respect to the adoption of incentive compensation plans and equity-based plans;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Administering the Company&#146;s incentive compensation plans and equity-based plans; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Approving the terms of any employment agreements, severance agreements, and change of control agreements and provisions for the named executive
officers; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Approving any other compensation elements for our named executive officers. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As part of its deliberations, in any given year, the Compensation Committee may review and consider materials such as company reports and
financial projections, historical achievement of company-wide operational and financial objectives, operational data, tax and accounting information, total compensation that may become payable to our named executive officers in various hypothetical
scenarios, executive stock ownership information, company stock performance data, analyses of historical compensation levels for our named executive officers and current company-wide compensation levels, and the recommendations of our Chief
Executive Officer, our President and our human resources department as well as the advice and guidance of the Compensation Committee&#146;s independent compensation consultant. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Role of the Compensation Committee&#146;s Independent Compensation Consultant.&nbsp;&nbsp;&nbsp;&nbsp;</I>In making its decisions, the
Compensation Committee may from time to time obtain advice from an independent compensation consultant engaged directly by the Compensation Committee. Beginning in August 2010, the Compensation Committee retained Arnosti Consulting, Inc., or
Arnosti, as its independent compensation consultant, and, since then, the Committee has met regularly with Arnosti, both with and without management present, depending upon the topic being discussed. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee has analyzed whether the work of Arnosti as a compensation consultant has raised any conflict of interest,
taking into consideration the following factors: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The provision of other services to the Company; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amount of fees paid to Arnosti by the Company; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arnosti&#146;s policies and procedures that are designed to prevent conflicts of interest; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Any business or personal relationship of Arnosti or the individual compensation advisors employed by Arnosti with an executive officer of the Company;
and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Any Dynavax stock owned by Arnosti or the individual compensation advisors employed by Arnosti. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">31 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee determined, based on its analysis of the above factors, that the
work of Arnosti and the individual compensation advisors employed by Arnosti as compensation consultants does not create any conflict of interest. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In general, Arnosti assists the Compensation Committee in evaluating the effectiveness of our compensation strategy and practices in achieving our compensation objectives. Specifically, in 2012, Arnosti
provided the Compensation Committee with the following services: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reviewed and provided recommendations for updating our Peer Companies (as defined below) for use in reviewing executive compensation for purposes of
setting 2012 and 2013 compensation; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reviewed and analyzed existing compensation levels and practices for our named executive officers in comparison to those of our Peer Companies that are
reflected in Radford&#146;s 2011 Global Life Sciences survey data (described below) as well as 2010 proxy data accessed through Equilar Data Services, Inc., or Equilar; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Provided recommendations to improve our cash- and equity-based compensation governance practices, including offering benchmarking and tools for
developing a compensation strategy; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reviewed Board compensation data as disclosed by our Peer Companies. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Updated the Compensation Committee on emerging trends/best practices in the area of executive and non-employee director compensation;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Conducted a review of compensation for our Board, and provided recommendations to the Compensation Committee and the Board regarding the compensation
structure for non-employee directors; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Reviewed the Compensation Discussion and Analysis for inclusion in our proxy statement. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arnosti took direction from the Compensation Committee Chair and interacted with management, including our human resources, finance, and
legal departments, as well as our Chief Executive Officer and our President, to obtain financial data and information about the organization and employee performance. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Company pays the cost for Arnosti&#146;s services. However, the Compensation Committee retains the sole authority to direct, terminate or continue Arnosti&#146;s services. The total cost of
Arnosti&#146;s services was approximately $22,000 for 2012. The Compensation Committee determined that the provision of non-executive compensation services provided by Arnosti to the Company did not compromise the independence of Arnosti&#146;s
services in respect of executive compensation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Role of our Management</I>.&nbsp;&nbsp;&nbsp;&nbsp;For executives other
than our President and our Chief Executive Officer, the Compensation Committee solicits and considers the recommendations of the President and the Chief Executive Officer, including their review of the officer&#146;s performance and contributions in
the prior year and their recommendations for the potential compensation levels that should be set for the other executive officers. In the case of each of the President and the Chief Executive Officer, the Compensation Committee solicits and
considers the evaluations and recommendations submitted by other members of the Board. The Compensation Committee then reviews and assesses the performance of the President and the Chief Executive Officer. This assessment is reported to, and
discussed with, the Board. Based on the recommendations of the Compensation Committee, the Board remains solely responsible for making the final decisions on compensation for our executive officers, including our President and our Chief Executive
Officer. No executive officer participates directly in approving the amount of any component of his or her own compensation package. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Factors Considered in Establishing Compensation.&nbsp;&nbsp;&nbsp;&nbsp;</I>In any given year, our Compensation Committee may consider some or all of the following factors in determining the amount and
form of each of the key elements of our compensation program: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The compensation levels paid to similarly-situated executives at our Peer Companies (defined below), without necessarily benchmarking to a specific
percentile for any particular element. We believe this </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">32 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
helps us in determining the total amount of compensation that is needed to retain and motivate our executives while still maintaining a responsible cost structure; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A review of the named executive officer&#146;s existing compensation as set forth in tally sheets that include: (i)&nbsp;current and proposed base
salary, (ii)&nbsp;current and proposed target annual cash incentive compensation, and (iii)&nbsp;existing outstanding equity awards, including number of shares and potential value realizable; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The desired mix of compensation elements, including the amount of compensation that will be earned based on target corporate or individual performance;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Historical and anticipated future corporate and individual performance, including the need to motivate named executive officers to address particular
business challenges that are unique to any given year; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The philosophy that the total compensation opportunity should increase as the level of responsibility rises &#150; for example, because our Chief
Executive Officer and our President have greater responsibilities covering the operations of our entire company, their total compensation opportunities are significantly greater than any of our other named executive officers;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The belief that internal pay equity needs to be considered and that compensation levels should be set within a relatively narrow band for
comparably-situated executives after considering the named executive officers&#146; responsibilities, the scope of their position and the complexity of the departments or functions they manage, relative to their internal peers;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our President&#146;s and our Chief Executive Officer&#146;s recommendations, because of their direct knowledge of the role and contributions of each
named executive officer (other than themselves); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The recommendations of Arnosti, our independent compensation consultant; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Budget constraints for salary, bonus and equity adjustments; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The potentially dilutive effect of our equity compensation practices on our stockholders; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Broader economic conditions, to ensure that our compensation strategies are effective yet responsible, particularly in light of unanticipated
consequences of the macroeconomic environment on our business; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">The experiences and individual knowledge of the members of our Board regarding executive compensation programs generally and at other companies.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The relative weight, if any, given to each of the factors above varies with each individual named executive
officer and with respect to each element of compensation at the sole discretion of the Compensation Committee. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Stockholder
Say-on-Pay Votes.&nbsp;&nbsp;&nbsp;&nbsp;</I>At the Company&#146;s Annual Meeting of Stockholders held in June 2011, we conducted our first advisory vote on executive compensation, commonly referred to as a &#147;say-on-pay&#148; vote. The
stockholders also voted on and approved a preferred frequency of every three years for stockholder advisory votes on compensation of named executive officers, and, in accordance with the stockholders&#146; indicated preference, the Board has
resolved that we will hold such advisory votes on executive compensation every three years going forward. The Board believes that a triennial advisory vote on the compensation of our named executive officers is appropriate in light of our goal to
tie our pay programs to the long-term performance of our Company and given the time required to develop, seek approval and commercialize a product in our industry and the impact of forces external to our business on our results. Holding a say-on-pay
vote every three years also permits our stockholders to fully assess the effectiveness of our pay programs in incentivizing our executives to perform with the long-term interests of our stockholders in mind. The Board and the Compensation Committee
value the opinions of the stockholders in this matter, and, to the extent there is any significant vote in favor of one frequency over the other options, even if less than a majority, the Board will consider the stockholders&#146; concerns and
evaluate any appropriate next steps. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">33 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">At our 2011 Annual Meeting of Stockholders, approximately 99% of the votes affirmatively
cast on the say-on-pay proposal were voted in favor of the proposal to approve, on an advisory basis, the compensation of the Company&#146;s named executive officers. The Compensation Committee believes this affirms stockholders&#146; support of the
Company&#146;s approach to executive compensation. Based on the stockholders&#146; support for the Company&#146;s say-on-pay proposal in 2011, the Company did not make fundamental changes to its approach to executive compensation in 2012.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Use of Peer Data.&nbsp;&nbsp;&nbsp;&nbsp;</I>As mentioned above, the Compensation Committee reviews
market practices for compensating our named executive officers using data for similarly-situated executives to evaluate the three major components of our compensation program &#150; base salary, annual cash incentive compensation, and equity awards.
For 2012 decisions regarding cash-based compensation, our human resources department and Arnosti provided the Compensation Committee with data for similarly-situated executives drawn from two sources: 2010 proxy data from Peer Companies accessed
through Equilar that participated in the 2011 Radford Global Life Sciences Survey (&#147;Radford&#148;) because the number of our Peer Companies who reported proxy data for certain positions was deemed to be too low. For 2012 decisions regarding
equity-based compensation, our human resources department and Arnosti provided the Compensation Committee with data obtained from Equilar on equity awards granted to similarly-situated executives at our Peer Companies, as Equilar provided the
necessary level of detail (as compared to Radford) desired by the Compensation Committee to make its decisions. For 2012, the Compensation Committee considered base salary, annual incentive compensation and target total cash compensation for our
executive officers ranging from the 25</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th </SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2">to 75</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentiles of competitive market data as described above. For
equity compensation, the Compensation Committee considered grant size and ownership levels ranging from the
25</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> to 75</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentile for our Peer Companies. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee, however, does not set compensation components to meet specific benchmarks. Rather, the Compensation Committee
reviews peer data as a reference point in determining whether the target total cash compensation opportunity and the target total equity compensation opportunity are likely to provide sufficient motivation and retention as well as whether the amount
properly reflects the named executive officer&#146;s role and scope of responsibilities. The Compensation Committee chooses the actual amount of each element of compensation and the total compensation opportunity of each named executive officer
based in part on this peer data and in part on the factors discussed above under &#147;Factors Considered in Establishing Compensation,&#148; with the factors that were material for 2012 described below under the discussion of each specific element
of compensation. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For compensation decisions in 2012, our Compensation Committee chose not to change our list of Peer
Companies from 2011, except to remove Micromet, Inc. due to its acquisition by Amgen in 2012, as the Committee believed the list remained an appropriate reference group. The list of our Peer Companies was originally chosen because these companies
had an established business within the biotechnology/pharmaceutical industry, were at a stage of product development similar to Dynavax, and were of similar size to Dynavax as measured by number of employees, revenue and market capitalizations. Our
Peer Companies are set forth below: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="23%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="24%"></TD></TR>


<TR>
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Affymax, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Alexza Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arena Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Biocryst Pharmaceuticals, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Cytokinetics, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Depomed Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Durect Corporation</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dyax Corporation</FONT></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Genomic Health</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Geron Corporation</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Idenix Pharmaceuticals</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Intermune, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jazz Pharmaceuticals plc</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Maxygen, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Medivation, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Opko Health, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Nektar Pharmaceuticals</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Novavax Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Onyx Pharmaceuticals Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sangamo Biosciences, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pharmasset, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Questcor Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Rigel Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Synta Pharmaceuticals Corp</FONT></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Sciclone Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stemcells Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Supergen, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vical, Inc.</FONT></TD></TR>
<TR>
<TD VALIGN="top" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Targacept, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Theravance, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">Trubion Pharmaceuticals, Inc.</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:8px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Xenoport, Inc.</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">34 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee believes that this list represents the companies with which we
believe we generally compete for executive talent. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Reasons for Providing, and Manner of Structuring, the Key Compensation Elements in 2012
</B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our 2012 executive compensation program consists of three principal components: base salary; annual cash-based incentive
awards; and equity-based awards. In addition, we provide broad-based employee benefits as well as severance and change in control benefits to our named executive officers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><I>Base Salary.&nbsp;&nbsp;&nbsp;&nbsp;</I>Base salary represents a fixed component of the total target compensation opportunity that we provide to our named executive officers. Base salaries provide our
named executive officers with a degree of certainty in the face of having a majority of their compensation &#147;at risk&#148; in the form of annual cash incentive bonuses and stock-based incentive compensation. Our Compensation Committee recognizes
the importance of base salaries as an element of compensation that helps to retain and motivate our named executive officers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our Compensation Committee generally reviews base salaries in the first quarter of every year. In early 2012, the Compensation Committee considered the base salary, target cash incentive compensation and
target total cash compensation ranging from the 25</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> to
75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentiles of the Radford survey data. The
Compensation Committee also took into consideration the Company&#146;s 2012 salary increase budget of 4% for all employees (including our named executive officers) and its desire to have a significant portion of a named executive officer&#146;s
target total cash opportunity subject to the achievement of performance goals. In addition, as further described above under the heading &#147;Factors Considered in Establishing Compensation,&#148; the Compensation Committee considered each named
executive officer&#146;s current responsibilities, the importance of his or her role in achieving the Company&#146;s needs and objectives for the coming year, and the named executive officer&#146;s level of performance in 2011. Based on its
subjective assessment of all of these factors, the Compensation Committee set 2012 base salaries for the named executive officers, as set forth in the table below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The 2012 base salaries for each of our named executive officers and the relative position of these base salaries against market data, including Radford survey data, were as follows: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="75%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012 Base<BR>Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market&nbsp;Position&nbsp;for</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012 Base
Salary</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>(percentile)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">460,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&lt;25</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">412,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&lt;25</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">350,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">229,408</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&lt;25</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">332,210</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&gt;50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck, Ph.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">334,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Ms.&nbsp;Larson departed the Company in February 2013. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dr.&nbsp;Tuck departed the Company in March 2013. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B></B><I>Annual Cash-Based Incentive Awards.&nbsp;&nbsp;&nbsp;&nbsp;</I><B></B>We have structured our annual cash incentive compensation program to align our named executive officers&#146; pay with our
overall financial and strategic performance and to reward our named executive officers&#146; achievement of, or contributions to, specifically-identified corporate and individual performance objectives. Our Compensation Committee recognizes the
important role that annual cash incentive compensation plays in motivating and retaining our executives.<B> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%;padding-bottom:0px; "><FONT
STYLE="font-family:Times New Roman" SIZE="2">As in prior years, in early 2012, our Compensation Committee reviewed the target bonus amounts for the named executives expressed as a percentage of base salary. The Compensation Committee conducted its
review in connection with establishing base salary levels (as described above), and therefore considered base salary, target cash incentive compensation and target total cash compensation at the 25</FONT><FONT
STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> through 75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"> percentiles using </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">35 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
both 2010 proxy and Radford survey data, given the desire to have a significant portion of the target total cash opportunity subject to the achievement of performance goals. In addition, as
further described above under the heading &#147;Factors Considered in Establishing Compensation,&#148; the Compensation Committee also considered each named executive officer&#146;s current responsibilities, the importance of his or her in achieving
the Company&#146;s needs and objectives for the coming year, and the named executive officer&#146;s level of performance in 2011. Based on its subjective assessment of all of these factors, the Compensation Committee set target bonuses for the named
executive officers as set forth in the table below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The named executive officers&#146; 2012 target bonuses and relative
position of the bonuses and total target compensation against market data, including Radford survey data, were as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012 Base<BR>Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target<BR>Bonus<BR>%</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target<BR>Bonus</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market<BR>Position&nbsp;for<BR>Target<BR>Annual<BR>Incentive<BR>(percentile)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market<BR>Position for<BR>Target Total<BR>Cash<BR>Compensation<BR>(percentile)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">460,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">276,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&lt;25</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">412,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">226,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&gt;75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&gt;75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">350,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">175,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">229,408</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">91,763</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">332,210</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">166,105</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&gt;75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&gt;50</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">334,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">167,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&gt;75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&gt;75</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee also approved the terms of the executive annual cash bonus plan. Under the
plan, named executive officers are eligible to earn a bonus based on the achievement of corporate and individual goals, with the weighting of corporate and individual goals determined for each named executive officer as follows: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="68%"></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Allocation&nbsp;of&nbsp;Target<BR>Bonus to Corporate<BR>Goals</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Allocation&nbsp;of&nbsp;Target<BR>Bonus to Individual<BR>Goals</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee believed this allocation best reflected the importance of the role of each
named executive officer to the achievement of the 2012 corporate goals chosen and/or individual goals (if any) established for the named executive officer. In 2012, the corporate goals, their respective weighting and the actual achievement for 2012,
were as follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="93%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:53pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Corporate Goal</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weight</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp; Deliver on HEPLISAV, including activities to enable successful regulatory submission, product
launch and manufacture of product for commercial use, and enabling Dynavax to have at least one year of cash at the end of 2012</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp; Strengthen the organization, including hiring and planning to enable commercialization of
HEPLISAV</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.50em"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;&nbsp;&nbsp;&nbsp;&nbsp; Advance the pipeline of early development programs</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Corporate Result Factor</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:2.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Overall Achievement Factor of 2012 Corporate Goals</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">36 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In 2012, we accomplished critical milestones related to HEPLISAV&#146;s development,
including filing the U.S. and European licensure applications, completing a U.S. Food and Drug Administration (&#147;FDA&#148;) inspection of our D&uuml;sseldorf manufacturing facility and other third-party sites, preparing for the FDA&#146;s
Vaccines and Related Biological Products Advisory Committee meeting, and working extensively with the FDA to complete its review of the U.S. application by the assigned Prescription Drug User Fee Action (&#147;PDUFA&#148;) date. During 2012, we
completed a successful public offering for shares of our common stock that resulted in $70 million in net proceeds, allowing us to end the year with $125 million in cash, cash equivalents and marketable securities. We engaged in market research
activities focused on the U.S. adult hepatitis B vaccine market and completed other product marketing activities to prepare and transition the company toward commercialization. In addition, we achieved several important milestones for our early
stage programs, particularly those funded by collaboration partners and our contract with the National Institutes of Health, which resulted in additional cash inflows to the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee evaluated the accomplishments and performance of the Company as a whole and took into consideration that on
the PDUFA date in February 2013, the FDA did not approve the application for HEPLISAV in its current form, instead issuing a Complete Response Letter which will require the Company to perform additional work and delay the timeframe for HEPLISAV to
reach the market. As a result, the Compensation Committee determined that our efforts represented achievement of a total of 50% of our 2012 corporate goals. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Drs. Dina and Martin&#146;s 2012 target bonus opportunity was based solely on the achievement of our 2012 corporate goals. With regard to the individual component of the 2012 target bonus opportunities
for Ms.&nbsp;Lew, Mr.&nbsp;Ostrach and Dr.&nbsp;Tuck, the Compensation Committee, with input from the Chief Executive Officer and President, reviewed the performance of each of these named executive officers in light of the goals and the
achievements for 2012. The individual goals for Ms.&nbsp;Larson are not listed because she departed the Company prior to the payment date. The individual goals of each of Ms.&nbsp;Lew, Mr.&nbsp;Ostrach and Dr.&nbsp;Tuck, which were not given
specific weighting, were as follows: </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><U>Jennifer Lew</U> </B></FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Develop accounting policies, procedures and infrastructure requirements to support HEPLISAV commercialization </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Conduct investor relations activities contributing to the growth in stockholder base and research coverage by additional research analysts
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Conduct long-range budgetary planning activities and assist with fundraising to maintain Company&#146;s cash position </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><U>Michael S. Ostrach</U> </B></FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Develop and maintain patent strategy for Company&#146;s programs </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Conduct business development and financing activities resulting in successful fundraising to meet Company objectives </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Conduct investor relations activities contributing to the growth in stockholder base and research coverage by additional research analysts
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px; margin-left:3%"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B><U>Stephen F. Tuck, Ph.D.</U> </B></FONT></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Complete manufacturing components of U.S. and European licensure applications for HEPLISAV </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Conduct manufacturing of drug product to support HEPLISAV commercialization and initiate activities to improve manufacturing capacity for HEPLISAV
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee determined that, based on the achievement of the goals identified above,
Ms.&nbsp;Lew, Mr.&nbsp;Ostrach and Dr.&nbsp;Tuck each achieved 100% of their individual performance goals for 2012. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">37 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As a result of these determinations regarding corporate and individual performance, the
Compensation Committee recommended and the Board approved the actual bonus payouts listed below, calculated based on the weightings and achievements and with the exercise of discretion: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012&nbsp;Target&nbsp;Bonus</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012&nbsp;Actual&nbsp;Bonus</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">276,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">138,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">226,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">113,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">175,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">91,763</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">73,410</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">166,105</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">124,759</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">167,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">125,531</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Ms.&nbsp;Larson did not receive a bonus for 2012 as she departed the Company prior to the payment date. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Equity-Based Awards.&nbsp;&nbsp;&nbsp;&nbsp;</I>The Compensation Committee believes that properly-structured equity compensation
programs align the long-term interests of our stockholders and our employees by creating a strong, direct link between employee compensation and stock price appreciation. The Compensation Committee believes that, if our officers own shares of our
common stock with values that are significant to them, they will have additional incentive to act to maximize long-term stockholder value. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">We have historically granted stock options to our named executive officers. These options have an exercise price equal to the fair market value of our common stock on the date of grant and generally vest
based on continued service over a four-year period. As a result of this structure, options provide a return to the named executive officer only if he or she remains employed by us, and then only if the market price of our common stock appreciates
over the period in which the option vests. We do not grant stock options at a discount to fair market value or engage in underwater stock option repricings or exchanges. We do not grant options with so-called &#147;reload&#148; features
(<I>i.e.</I>, options upon the exercise of an option using shares already in the holder&#146;s possession), and we do not loan funds to named executive officers. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In determining the aggregate size of equity grants in any given year, the Compensation Committee may consider one or more of the factors described above under &#147;Factors Considered in Establishing
Compensation.&#148; In making grants to named executive officers during 2012, the Compensation Committee considered each named executive officer&#146;s total options outstanding as of December&nbsp;31, 2011, their performance during 2011, the
potential amount that could be realized at different hypothetical stock prices upon exercise of those awards, the named executive officer&#146;s percentage of ownership of the Company, and Peer Company data from Equilar regarding ownership levels of
similarly situated executives. Based on the Equilar data, the average equity ownership for a chief executive officer ranged between 3% and 5% of total common stock outstanding, and for the remaining named executive officers, the average equity
ownership was up to 1% of total common stock outstanding. Due to a greater number of shares outstanding (relative to many of our Peer Companies) and the desire to manage the share reserve under the 2011 Plan over three years, the Compensation
Committee has historically made grants at a level that would result in ownership at approximately 25%-50% of the ownership levels for similarly-situated executives at our Peer Companies. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">38 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to stock options, during 2012 we granted restricted stock units, or RSUs, to
certain of our key employees, including our named executive officers. The Compensation Committee determined that our Peer Companies were increasingly granting full value awards, in addition to options, and therefore RSUs could be part of a
competitive compensation package to attract and retain highly-qualified executives. In addition, because RSUs do not have an exercise price and provide some level of certain return since, unlike options, they are not subject to becoming
&#147;underwater,&#148; the Compensation Committee could award fewer RSUs than it would grant shares under a stock option award. In 2012, we granted 1,815,000 RSUs to select employees, including named executive officers with certain
performance-based vesting criteria. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012&nbsp;Option<BR>Award</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012&nbsp;RSU<BR>Award</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant&nbsp;Date&nbsp;Aggregate<BR>% Ownership</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">500,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">400,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">180,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">180,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">125,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>Ms.&nbsp;Larson did not receive an RSU award for 2012 as she was not
employed with the Company on the grant date. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Severance and Change of Control
Benefits.&nbsp;&nbsp;&nbsp;&nbsp;</I>The employment of each of our named executive officers is &#147;at will.&#148; However, each of the named executive officers has entered into a management continuity agreement with the Company. The material terms
of these agreements are substantially the same for each named executive officer and provide cash severance, accelerated vesting of equity-based compensation, extended option exercise periods and continuation of benefits coverage in connection with
an involuntary termination of employment, with increased benefits if such termination is related to a &#147;change in control&#148; of the Company. These agreements also provide for accelerated vesting of equity awards in connection with a change in
control, whether or not the named executive officer terminates employment in connection with the change in control event. The terms of these agreements with our named executive officers are discussed more fully in the section below under the heading
&#147;Summary of Change In Control And Involuntary Termination Arrangements.&#148; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee believes that
the severance benefits and accelerated vesting offered to our named executive officers serve to minimize the distractions to our executive team and helps our named executive officers maintain a balanced perspective in making overall business
decisions during periods of uncertainty. We believe that these existing arrangements are consistent with market practices and are critical to attracting and retaining high quality executives. The Compensation Committee is aware of the sentiment of
current stockholder and proxy advisory firms regarding single-trigger vesting as well as the provision of severance benefits upon a voluntary termination within a short period of time following a change in control. However, these existing rights
date back to contracts entered into prior to our initial public offering. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In late 2010, the Compensation Committee revisited
the terms of these management continuity agreements as part of the promotion of Dr.&nbsp;Martin and the transition of certain duties from Dr.&nbsp;Dina to Dr.&nbsp;Martin. The amounts, terms and conditions of the severance benefits reflect the
negotiations between our officers and the Company, the benefits provided by our Peer Companies to similarly situated executives, as well as our desire for internal pay equity among our named executive officers. Dr.&nbsp;Martin&#146;s management
continuity agreement was further amended in late 2012. The Compensation Committee determined that it was in the best interests of our stockholders to retain the services of Dr.&nbsp;Dina and Dr.&nbsp;Martin at this critical time in the
Company&#146;s development, and these benefits were critical to achieve that retention goal. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The amendments in 2010 to the
management continuity agreements for our other named executive officers were primarily to address an immediate concern regarding compliance of these documents with the requirements of Section&nbsp;409 of the Internal Revenue Code and not to
materially enhance or reduce the benefits. Considering </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">39 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
these factors and the Compensation Committee&#146;s determination of the need to retain these employees at a critical time in the Company&#146;s development, the Compensation Committee chose to
retain the original level of benefits. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee will continue to monitor our stockholders&#146; preferences
with respect to these agreements and will take them into consideration as it makes compensation decisions in the future. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Broad Based Employee Benefits, Limited Perquisites, Signing Bonuses.&nbsp;&nbsp;&nbsp;&nbsp;</I>In order to attract and retain
qualified named executive officers and other employees, we must offer a competitive package of retirement, health, and welfare programs. We maintain medical, vision, dental and accidental death and disability insurance as well as paid time off and
paid holidays for all of our employees. Our named executive officers are eligible to participate in these programs along with and on the same basis as our other employees. Like all of our full-time employees, our named executive officers are
eligible to participate in our 401(k) plan. We believe that these benefits are consistent with the practices of our Peer Companies, and therefore are a necessary element of compensation in attracting and retaining employees. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition to the benefits listed above, the Compensation Committee provides, from time to time, limited perquisites to our key
employees. In considering potential perquisites, the Compensation Committee reviews the cost to the Company of such benefits as compared to the perceived value we receive. In 2012, the Company continued to provide to employees at and above the level
of Vice President supplemental medical insurance benefits through Exec-U-Care. The Company believes that ensuring that our executives are in good health is in the best interests of our stockholders, and the Exec-U-Care benefit comes at a reasonable
cost to the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We do not sponsor any defined benefit pension plan or supplemental employee retirement plans or
arrangements for any of our employees. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Equity Compensation Policies.&nbsp;&nbsp;&nbsp;&nbsp;</I>Our policy is to generally
make new-hire and annual equity grants as follows: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">During the first quarter of the calendar year, management requests Compensation Committee approval of guidelines and a new hire option pool. Individual
new hire awards for vice president level employees were and will continue to be approved by the Compensation Committee. Awards may have a vesting schedule that is time-based and/or performance-based for management new hires; and
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">During the first quarter of the calendar year, management requests Compensation Committee approval for a pool of annual awards to be granted to
then-current employees based on the assessment of individual and corporate performance by the Compensation Committee and management. The Compensation Committee and the Board made the final determination of annual awards to named executive officers.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The exercise price of the stock options is not less than the closing price of our common stock on the
NASDAQ Capital Market on the grant date of the stock option. It is our policy not to purposely accelerate or delay the public release of material information in consideration of a pending equity grant to allow the grantee to benefit from a more
favorable stock price. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We encourage our named executive officers to hold a significant equity interest in our Company, but we
have not set specific stock ownership guidelines. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have a policy that prohibits our executive officers, directors and other
members of management from engaging in short sales, transactions in put or call options, hedging transactions or other inherently speculative transactions with respect to our stock. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Tax Deductibility of Executive Compensation.&nbsp;&nbsp;&nbsp;&nbsp;</I>Section&nbsp;162(m) of the Code generally limits the corporate
deduction by a public company for compensation paid to its chief executive officer and certain other named </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">40 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
executive officers during any single year to $1 million per individual, unless certain requirements are met which qualify that compensation as performance-based under these tax rules. Our
Compensation Committee considers the impact of this deduction limitation rule in establishing and implementing compensation policies and practices.&nbsp;The Compensation Committee may grant compensation that qualifies as performance-based
compensation when it determines that it is in the best interest of the Company. However, we have not established a policy whereby all compensation paid to our named executive officers must be fully deductible.&nbsp;Rather, the deductibility of such
compensation is one of the factors considered in establishing and implementing our executive compensation programs, along with the need to design compensation programs that appropriately motivate our senior management and our goal to attract and
retain key executives by remaining competitive in our pay practices.</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under the 2004 Stock Incentive Plan and 2011 Plan, stock
options and performance-based stock awards may be granted in a manner that satisfies the deductibility requirements of Section&nbsp;162(m) of the Code. However, the Compensation Committee deemed it desirable to retain adequate flexibility in
designing compensation programs that motivate executives to achieve extraordinary results. This flexibility is often not available in quantitative plans required for qualification of compensation as performance-based compensation under
Section&nbsp;162(m) of the Code. Therefore, in certain years, the annual cash-based incentive awards may not be structured to qualify as performance-based compensation under Section&nbsp;162(m) of the Code and so compensation payable thereunder may
not be fully deductible by us in all circumstances. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Accounting Considerations.&nbsp;&nbsp;&nbsp;&nbsp; </I>The Company
accounts for equity compensation paid to our employees under the Financial Accounting Standards Board Accounting Standards Codification Topic 718, Compensation&#151;Stock Compensation, or ASC 718, which requires us to estimate and record an expense
over the service period of the equity award. Our cash compensation is recorded as an expense at the time the obligation is accrued. The accounting impact of our compensation programs are one of many factors that the Compensation Committee considers
in determining the structure and size of our executive compensation programs. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><I>Compensation Recovery
Policy.&nbsp;&nbsp;&nbsp;&nbsp;</I>We do not have a policy to attempt to recover cash bonus payments paid to our executive officers if the performance objectives that led to the determination of such payments were to be restated, or found not to
have been met to the extent the Compensation Committee originally believed. However, as a public company subject to the provisions of Section&nbsp;304 of the Sarbanes-Oxley Act of 2002, if we are required as a result of misconduct to restate our
financial results due to our material noncompliance with any financial reporting requirements under the federal securities laws, our Chief Executive Officer and principal financial officer may be legally required to reimburse us for any bonus or
other incentive-based or equity-based compensation they receive. In addition, we will comply with the requirements of the Dodd-Frank Wall Street Reform and Consumer Protection Act and will adopt a compensation recovery policy once the SEC adopts
final regulations on the subject. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>OMPENSATORY</SMALL> R<SMALL>ISK</SMALL> A<SMALL>NALYSIS</SMALL> D<SMALL>ISCUSSION</SMALL>
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Compensation Committee has reviewed our compensation policies as generally applicable to our employees and believes
that our policies do not encourage excessive or inappropriate risk taking and that the level of risk that they do encourage is not reasonably likely to have a material adverse effect on the Company. As part of its assessment, the Compensation
Committee considered, among other factors, the allocation of compensation among base salary and short- and long-term compensation, our approach to establishing Company-wide and individual financial, operational and other performance targets, and the
nature of our key performance metrics. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">41 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>QUITY</SMALL> C<SMALL>OMPENSATION</SMALL> P<SMALL>LANS</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows activity under our equity compensation plans as of the fiscal year ended December&nbsp;31, 2012. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="47%"></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="11%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:49pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Plan Category</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>securities
to<BR>be&nbsp;issued&nbsp;upon&nbsp;exercise<BR>of outstanding options,<BR>warrants and rights</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Weighted-average<BR>exercise price of<BR>outstanding<BR>options, warrants<BR>and rights</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of&nbsp;securities&nbsp;
remaining</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>available for future<BR>issuance under</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>equity compensation<BR>plans (excluding<BR>securities reflected
in<BR>the first column)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity compensation plans approved by security holders:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">1997 Equity Incentive Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">471,788</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.84</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2004 Stock Incentive Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4,298,027</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.74</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011 Equity Incentive Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,012,406</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.54</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,751,298</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Equity compensation plans not approved by security holders:</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010 Employment Inducement Award Plan</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">779,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.64</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:1px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,561,221</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,751,298</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1px">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="border-top:3px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In order to induce qualified individuals to join our Company, our Board adopted the 2010 Employment
Inducement Award Plan, or the 2010 Inducement Plan, effective January&nbsp;8, 2010, which provides for the issuance of up to 1,500,000 shares of Dynavax common stock to new employees of Dynavax. Stockholder approval of the 2010 Inducement Plan was
not required under NASDAQ Marketplace Rule 5635(c)(4). Upon the effectiveness of the 2011 Plan, no additional awards were granted under either the 2004 Stock Incentive Plan or the 2010 Inducement Plan. All shares currently subject to awards
outstanding under the 1997 Equity Plan, 2004 Stock Incentive Plan or 2010 Inducement Plan, which awards expire or are forfeited, will be included in the reserve for the 2011 Plan to the extent such shares would otherwise return to such plans. Awards
granted under the 2010 Inducement Plan have a term of 10 years. Exercisability, option price and other terms are determined by the plan administrator, but the option price cannot be less than 100% of fair market value of those shares on the date of
grant. Stock options granted under the 2010 Inducement Plan generally vest over a period of four years, with the exception of performance based awards which will vest upon achievement of certain performance conditions. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">42 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>S<SMALL>UMMARY</SMALL> C<SMALL>OMPENSATION</SMALL> T<SMALL>ABLE</SMALL></B><SMALL></SMALL> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows for the fiscal years ended December&nbsp;31, 2012, 2011, and 2010, compensation awarded to or paid to, or earned
by, the named executive officers. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="38%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Year</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Salary</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock<BR>Awards<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Awards<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></B></FONT></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Non-Equity<BR>Incentive<BR>Compensation<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)
</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All
Other<BR>Compensation<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">460,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">633,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,652,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">138,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,934</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,893,684</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Chief Executive Officer and Director</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">448,800</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,111,925</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">215,424</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,498</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,787,647</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">408,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">214,140</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">195,840</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">23,661</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">841,641</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">412,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">633,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,322,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">113,300</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,132</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,506,632</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">President and Chief Medical Officer</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">400,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,548,745</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">176,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">30,973</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,155,718</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">350,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">874,763</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">157,641</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33,288</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,415,692</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">350,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">973,290</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,366</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,338,656</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President and Chief Financial Officer</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">229,408</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">211,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">234,420</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">73,410</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,167</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">772,405</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President, Finance</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">224,910</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">844,770</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80,968</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,172,648</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">214,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">71,380</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">68,544</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,512</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">372,636</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">332,210</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">422,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">562,608</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">124,759</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,809</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,469,386</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President, Chief Business Officer and General Counsel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">322,534</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">316,210</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">
&#151;&nbsp;&nbsp;</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">703,975</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">71,380</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">145,140</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">126,484</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">28,212</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29,878</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></P></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,199,861</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">543,952</FONT></P></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT><BR> <P STYLE="margin-bottom:1px; margin-top:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></P></TD></TR>
<TR>
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">334,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">527,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">562,608</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">125,531</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">19,595</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,569,984</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top" ROWSPAN="2"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President, Global Technical Operations</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2011</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">325,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">146,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11,379</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">482,629</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">51,875</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">148,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">311,535</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">544,148</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,106,058</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents the aggregate grant date fair value of stock awards granted in the fiscal year in accordance with ASC 718. See note 13 of our &#147;Notes to
Consolidated Financial Statements&#148; in our annual report on Form 10-K filed with the SEC on March&nbsp;8, 2013, for a discussion of assumptions we made in determining the compensation costs included in this&nbsp;column. With regard to stock
awards with performance-based vesting, the grant date fair value assumes the probable outcome of related performance conditions. The grant date fair value for stock awards with performance-based vesting, assuming the highest level of achievement had
been met, is as follows: </FONT></P></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="71%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards with Performance-<BR>based Vesting</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2011<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2010</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">633,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">633,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">211,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">422,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen Tuck</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">527,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">148,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents the aggregate grant date fair value of option awards granted in the fiscal year in accordance with ASC 718. See note 13 of our &#147;Notes
to Consolidated Financial Statements&#148; in our annual report on Form 10-K filed with the SEC on March&nbsp;8, 2013, for a discussion of assumptions we made in determining the compensation costs included in this column. With regard to option
awards with performance-</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">43 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">
based vesting, the grant date fair value assumes the probable outcome of related performance conditions. The grant date fair value for option awards with performance-based vesting, assuming the
highest level of achievement had been met, is as follows: </FONT></TD></TR></TABLE> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="92%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="75%"></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards with<BR>Performance-based Vesting</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2012<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2011<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>2010</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">214,140</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">71,380</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">71,380</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">71,380</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen Tuck</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">89,010</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">The non-equity incentive plan compensation represents payments pursuant to an approved incentive plan earned for the fiscal year reported, although
amounts were paid in the subsequent fiscal year. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>Represents the total amount paid by the Company during the fiscal year for
life insurance premiums and medical claims under the Exec-U-Care healthcare expense reimbursement program. In 2011, the Company paid $14,638 for the cost of legal services provided to Dr.&nbsp;Dina in negotiating his amended Management Continuity
Agreement with the Company. Dr.&nbsp;Tuck was a consultant to Dynavax prior to joining the Company in November 2010 and received payments of $544,148 related to services provided as a consultant. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Dr.&nbsp;Martin was promoted to President in July 2010, and his salary was increased from $325,000 to $375,000. The actual amounts paid in 2010 and
2011 were $383,000 and $366,925, respectively, which included a correction of $33,075 between years 2010 and 2011. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>G<SMALL>RANTS</SMALL> O<SMALL>F</SMALL> P<SMALL>LAN</SMALL>-B<SMALL>ASED</SMALL> A<SMALL>WARDS</SMALL> </B> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows certain information regarding grants of plan-based awards to the named executive officers during the fiscal
year ended December&nbsp;31, 2012. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Date</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Estimated&nbsp;Future&nbsp;Payouts<BR>Under&nbsp;Non-Equity&nbsp;Incentive</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Plan Awards<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>All</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Other<BR>Option<BR>Awards:
<BR>Number</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>of&nbsp;Securities</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Underlying<BR>Options<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP><BR>(#)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise<BR>or Base<BR>Price of<BR>Option<BR>Awards</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>($/Share)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Grant Date<BR>Fair&nbsp;Value&nbsp;of</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Stock and<BR>Option<BR>Awards<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP> ($)</B></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Target ($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">276,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/1/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">500,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.68</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,652,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">226,600</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/1/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">400,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.68</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,322,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">175,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8/13/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">973,290</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">91,763</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/31/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">234,420</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">166,105</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/31/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">180,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">562,608</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">125,531</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/31/2012</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">180,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">562,608</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>Represents the target cash incentive compensation in fiscal year 2012 that
could have been earned based on performance in fiscal year 2012 pursuant to our annual cash incentive compensation program. Actual cash incentive awards earned in fiscal year 2012 by the named executive officers are shown in the column titled
&#147;Non-Equity Incentive Plan Compensation&#148; in the &#147;Summary Compensation Table&#148;. Accordingly, the amounts set forth in this column do not represent additional compensation earned by NEOs for the year ended December&nbsp;31,
2012.</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>This column represents awards of stock options granted under our 2011 Plan
in fiscal 2012.</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>Represents the aggregate grant date fair value of option awards granted in
fiscal year 2012 in accordance with ASC 718. See Note 13 of our &#147;Notes to Consolidated Financial Statements&#148; in our annual report on Form 10-K filed with the SEC on March&nbsp;8, 2013, for a discussion of the assumptions we made in
determining the compensation costs included in this column. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">44 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>N<SMALL>ARRATIVE</SMALL> D<SMALL>ISCLOSURE</SMALL> <SMALL>TO</SMALL> S<SMALL>UMMARY</SMALL>
C<SMALL>OMPENSATION</SMALL> T<SMALL>ABLE</SMALL> <SMALL>AND</SMALL> G<SMALL>RANTS</SMALL> <SMALL>OF</SMALL> P<SMALL>LAN</SMALL>-B<SMALL>ASED</SMALL> A<SMALL>WARDS</SMALL> T<SMALL>ABLE</SMALL></B><SMALL></SMALL> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The material terms of the named executive officers&#146; annual compensation and the explanations of the amounts of base salary, annual
cash-based incentives, and equity-based awards in proportion to total compensation are described under &#147;Compensation Discussion and Analysis&#148; in this proxy statement. Our severance and change in control benefits are described under
&#147;Summary of Change in Control and Involuntary Termination Arrangements&#148; in this proxy statement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As discussed in
greater detail in &#147;Compensation Discussion and Analysis,&#148; the fiscal year 2012 cash incentive amounts were paid pursuant to the annual cash incentive compensation program, with amounts earned based on the achievement of certain corporate
and individual performance goals. Cash incentive awards were fully vested when earned. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As discussed in greater detail in
&#147;Compensation Discussion and Analysis,&#148; equity-based awards were granted in 2012 under the 2011 Plan and vest over four years from the date of grant, subject to continued employment, and the exercise price was the closing market price of
our common stock on the grant date. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We did not pay dividends on our common stock during fiscal year 2012. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>O<SMALL>UTSTANDING</SMALL> E<SMALL>QUITY</SMALL> A<SMALL>WARDS</SMALL> A<SMALL>T</SMALL> F<SMALL>ISCAL</SMALL> Y<SMALL>EAR</SMALL> E<SMALL>ND</SMALL>
</B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows certain information regarding outstanding equity awards for the named executive officers as of
December&nbsp;31, 2012. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Exercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Unexercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares&nbsp;or&nbsp;Units<BR>that Have Not<BR>Vested (#)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market&nbsp;Value&nbsp;of<BR>Shares of Stock<BR>that Have Not<BR>Vested ($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">399,999</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12/17/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.49</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/19/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/22/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">250,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/1/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/29/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.54</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/9/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/18/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">479,165</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">270,835</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">500,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.68</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/31/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;427,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/26/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,241</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/18/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">225,774</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">258,622</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.72</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8/24/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">351,388</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">198,612</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">400,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.68</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/31/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> 427,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.70</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">8/12/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">45 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="37%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>

<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Exercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options (#)<BR>Unexercisable</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Exercise<BR>Price<BR>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option<BR>Expiration<BR>Date</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number&nbsp;of<BR>Shares&nbsp;or&nbsp;Units<BR>that Have Not<BR>Vested (#)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Market&nbsp;Value&nbsp;of<BR>Shares of Stock<BR>that Have Not<BR>Vested ($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">15,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.65</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11/30/2014</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.06</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/29/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/4/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.55</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/2/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2.33</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/4/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.54</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/9/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/18/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">191,666</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">108,334</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/30/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">142,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">250,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.17</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">10/30/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">40,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/2/2018</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,745</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">0.54</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3/9/2019</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">26,725</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.58</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/18/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">159,722</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">90,278</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/5/2021</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">180,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/30/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">100,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">285,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen Tuck</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">50,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.50</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/21/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,081</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12/17/2013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">29,166</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.49</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/19/2015</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">12,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/13/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,918</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.00</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/31/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,834</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.49</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5/31/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.85</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/13/2016</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">25,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">6.19</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2/1/2017</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">112,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">62,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.98</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">11/11/2020</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">180,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3.48</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1/30/2022</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2"></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">)</SUP></FONT><FONT
STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">125,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">356,250</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options vest annually over 4 years. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">This amount represents the maximum number of shares subject to this stock option. Options will be earned upon achievement of certain performance
conditions.</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options vest at the rate of 1/3 of the shares on the first anniversary of the vesting commencement date, with 1/36 of the total number of shares
vesting each month thereafter. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Options vest at the rate of 1/4 of the shares on the first anniversary of the vesting commencement date, with 1/48 of the total number of shares
vesting each month thereafter. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">46 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>O<SMALL>PTION</SMALL> E<SMALL>XERCISES</SMALL> A<SMALL>ND</SMALL> S<SMALL>TOCK</SMALL>
V<SMALL>ESTED</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Option exercises and stock vested during the fiscal year ended December&nbsp;31, 2012, were as
follows: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="64%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Option Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Stock Awards</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number<BR>of Shares<BR>Acquired<BR>on<BR>Exercise</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value<BR>Realized</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>on</B></FONT><br><FONT
STYLE="font-family:Times New Roman" SIZE="1"><B>Exercise</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number<BR>of Shares<BR>Acquired<BR>on<BR>Vesting</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value<BR>Realized</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>on&nbsp;
Vesting</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>($)</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">199,998</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">701,993</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">293,607</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,168,714</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">84,831</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">60,780</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">313,625</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151;&nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;360,750</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>P<SMALL>OTENTIAL</SMALL> P<SMALL>AYMENTS</SMALL> U<SMALL>PON</SMALL> C<SMALL>HANGE</SMALL> <SMALL>IN</SMALL>
C<SMALL>ONTROL</SMALL> <SMALL>OR</SMALL> I<SMALL>NVOLUNTARY</SMALL> T<SMALL>ERMINATION</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B><I>Summary of Change in
Control and Involuntary Termination Arrangements</I></B><B>.</B> <B><I> </I></B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To promote retention of certain key officers,
our Board has authorized the Company to enter into Management Continuity and Severance Agreements, or Management Agreements, with each of the named executive officers. These agreements have been amended in previous years for compliance with
applicable tax laws. Drs. Dina&#146;s and Martin&#146;s agreements were amended in the fall of 2010 to reflect their changing responsibilities with the Company and for compliance with applicable tax laws. Dr.&nbsp;Martin&#146;s agreement was further
amended in October 2012 to ensure the Company retained his services through a critical time in the Company&#146;s development, and these benefits were critical to that retention goal In addition, as a general matter, in order to be eligible to
receive benefits under the Management Agreements, our named executive officers and other officers must execute a general waiver and release of claims, and such release must become effective in accordance with its terms. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Change in Control</U>.&nbsp;&nbsp;&nbsp;&nbsp;Immediately prior to the effective date of a Change in Control, the named executive
officer shall receive accelerated vesting (full vesting for Drs. Dina and Martin and two years vesting for our other officers) of employee stock options to purchase Dynavax common stock that are held by the named executive on the effective date of
such Change in Control. The Management Agreements generally define a Change in Control to mean the occurrence of a change in the majority ownership of the voting securities of the Company, a merger that results in change in the majority ownership of
the voting securities of the Company, or the sale of all or substantially all of the assets (including as part of a liquidation of the Company).The table below outlines the potential payments and benefits payable to each current named executive
officer in the event of a Change in Control of Dynavax, assuming such event had occurred on December&nbsp;31, 2012. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="56%"></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="15%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Aggregate&nbsp;Number&nbsp;of&nbsp;
Shares</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Subject to Accelerated</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Vesting on CIC</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value&nbsp;of&nbsp;Accelerated&nbsp;
Stock</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Awards<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">820,835</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">115,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">932,234</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">462,493</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">300,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">190,124</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> 14,438</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">289,028</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> 43,313</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">242,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents the value of accelerated stock option vesting if the event took place on December&nbsp;31, 2012. The value is calculated based on the
&#147;spread&#148; between the closing price per share on December&nbsp;31, 2012 of $2.85 and the exercise price of the vested awards to the extent such vested awards were &#147;in the money&#148;.
</FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">47 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Qualifying Termination in connection with a Change in
Control</U>.&nbsp;&nbsp;&nbsp;&nbsp;If, on or during the two-year period following a Change in Control, the named executive officer&#146;s employment is terminated for any reason (or, in the case of Dr.&nbsp;Martin, is terminated without cause at
any time following the Change in Control), the named executive officer will, subject to the execution of a release of claims, be entitled to receive: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a lump-sum cash payment equal to a specified number of months (ranging from 12 to 24) of the executive&#146;s then-effective annual base salary;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a lump-sum cash payment equal to the named executive officer&#146;s target annual bonus (ranging from 100% to 200%) for the year of termination;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">cash payments equal to the applicable COBRA premiums for up to the same number of months as the named executive officer receives in base salary, as set
forth in the first bullet (the &#147;COBRA Payment&#148;); </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">accelerated vesting of all outstanding time-vesting options for Drs. Dina and Martin; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the extension of exercisability of all stock options to purchase the Company&#146;s Common Stock for a period of 3 years following termination of
employment (but in any event not beyond each option&#146;s expiration date). </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In addition, if any payments
or benefits would constitute a &#147;parachute payment&#148; within the meaning of Section&nbsp;280G of the Code and such payments would be subject to the excise tax imposed by Section&nbsp;4999 of the Code, then such payments will either be
(1)&nbsp;provided to the named executive officer in full or (2)&nbsp;reduced to such lesser amount that would result in no portion of such payments being subject to the excise tax, whichever amount after taking into account all applicable taxes,
including the excise tax, would result in the named executive officer&#146;s receipt, on an after-tax basis, of the greatest amount of such payments. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Under the terms of the Management Agreements: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Dina will receive 24 months of base salary, 100% of his target annual bonus, the COBRA Payment, accelerated vesting of all outstanding
time-vesting options and up to 3 years to exercise his vested options; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Martin will receive 24 months of base salary, 200% of his target annual bonus, the COBRA Payment, accelerated vesting of all outstanding
time-vesting options and up to 3 years to exercise his vested options; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our other named executive officers will receive 12 months of base salary, 100% of the target annual bonus the COBRA Payment, an additional two years of
accelerated vesting of outstanding time-vesting options and up to 3 years to exercise their vested options. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The table below outlines the potential payments and benefits payable to each named executive officer in the event of such
executive&#146;s termination in connection with a Change in Control of Dynavax had occurred on December&nbsp;31, 2012. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Severance<BR>Payment</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Continuation<BR>of Benefits</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value of<BR>Accelerated&nbsp;Stock<BR>Awards<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,196,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43,867</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">115,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,355,367</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,277,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57,265</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">462,493</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,796,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">525,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,659</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">549,659</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">321,171</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,823</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,438</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">367,432</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">483,801</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">33,899</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43,313</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">561,013</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen Tuck</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">502,125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">27,199</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">529,324</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents the value of accelerated stock option vesting if the event took place on December&nbsp;31, 2012. The value is calculated based on the
&#147;spread&#148; between the closing price per share on December&nbsp;31, 2012 of $2.85 and the exercise price of the vested awards, to the extent such vested awards were &#147;in the money. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">48 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><U>Involuntary Termination</U>.&nbsp;&nbsp;&nbsp;&nbsp;Under the terms of the Management
Agreements, upon an &#147;involuntary&#148; termination without &#147;cause&#148; or, if applicable, upon a resignation for &#147;good reason&#148; (as defined below), the named executive officer will, subject to the execution of a release of
claims, be entitled to receive: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">a lump-sum cash payment equal to the specified number of months (ranging from 6 to 24) of the executive&#146;s then-effective annual base salary;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">the COBRA Payment; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">accelerated vesting of all time-vesting options to purchase the Company&#146;s Common Stock that are held by Drs. Dina and Martin (and six additional
months of accelerated vesting for all other named executive officers) on the effective date of termination; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">for Drs. Dina and Martin, the extension of exercisability of all stock options to purchase the Company&#146;s Common Stock for a period of 3 years
following termination of employment (but in any event not beyond each option&#146;s expiration date). </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under
the terms of the Management Agreements: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Dina will receive 24 months of base salary, the COBRA Payment, accelerated vesting of his then-outstanding employee stock options, and up to 3
years to exercise the vested options; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Martin will receive 24 months of base salary, 200% of his target annual bonus, the COBRA Payment, accelerated vesting of his employee stock
options with time-based vesting criteria granted prior to October&nbsp;31, 2012, and up to 3 years to exercise the vested options; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our named executive officers (other than Drs. Dina and Martin) will receive 6 months of base salary and the COBRA Payment.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The table below outlines the potential payments and benefits payable to each named executive officer in the
event of such named executive officer&#146;s involuntary termination had occurred on December&nbsp;31, 2012. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="52%"></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Severance<BR>Payment</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Continuation<BR>of Benefits</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Value of<BR>Accelerated&nbsp;Stock<BR>Awards<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">920,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43,867</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">115,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,079,367</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,277,200</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">57,265</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">462,493</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,796,958</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">175,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,595</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">192,595</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">114,704</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">21,178</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,438</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">150,320</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">161,267</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">22,215</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">43,313</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">226,795</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck, Ph.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">167,375</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18,866</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"> &#151; &nbsp;&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">186,241</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents the value of accelerated stock option vesting if the event took place on December&nbsp;31, 2012. The value is calculated based on the
&#147;spread&#148; between the closing price per share on December&nbsp;31, 2012 of $2.85 and the exercise price of the vested awards, to the extent such vested awards were &#147;in the money&#148;. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Effective as of March&nbsp;29, 2013, we and Dr.&nbsp;Tuck entered into agreements following his departure from the Company, including (i)&nbsp;a
consulting agreement with the Company pursuant to which Dr.&nbsp;Tuck will provide advice and perform activities relating to his former areas of responsibility for a period of six months, payable upon satisfactory completion of the services,
(ii)&nbsp;execution and delivery of a general release by Dr.&nbsp;Tuck in favor of the Company and related parties (iii)&nbsp;payment by the Company of COBRA continuation costs for an additional 6 months, (iv)&nbsp;extension of the exercise period
for stock awards from 90 days to 12 months from the end of continuous service with the Company and (v)&nbsp;payment by the Company of three months of executive outplacement services with a firm selected by the Company. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For purposes of the Management Agreements, &#147;cause&#148; generally means (1)&nbsp;gross negligence or willful misconduct in the
performance of duties to the Company, where such gross negligence or willful misconduct has resulted or is likely to result in substantial and material damage to the Company or its subsidiaries; (2)&nbsp;repeated unexplained or unjustified absence
from the Company; (3)&nbsp;a material and willful violation of any federal or state </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">49 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
law; (4)&nbsp;commission of any act of fraud with respect to the Company; or (5)&nbsp;conviction of a felony or a crime involving moral turpitude causing material harm to the standing and
reputation of the Company, in each case as determined in good faith by the Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For purposes of the Management Agreements
with Dr.&nbsp;Dina, &#147;good reason&#148; generally means the named executive officer&#146;s voluntary termination following (1)&nbsp;a material reduction or change in job duties, responsibilities, and requirements inconsistent with the named
executive officer&#146;s position with the Company and his or her prior duties, responsibilities, and requirements; (2)&nbsp;the requirement that the named executive officer report to a corporate officer or employee rather than the Board;
(3)&nbsp;any material reduction in base salary or bonus (other than in connection with a general decrease in base salaries for most officers of the successor corporation); (4)&nbsp;the refusal to relocate to a facility or location that increases the
named executive officer&#146;s one-way commute by more than 35 miles; or (5)&nbsp;any other action that constitutes a material breach by the Company of the Management Agreement. The named executive officer must provide 90 days&#146; notice of the
event giving rise to good reason, give the Company 30 days&#146; to cure (if curable), and any resignation for good reason must occur within 180 days after the occurrence of the event giving rise to such resignation right. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">For purposes of the Management Agreements with our named executive officers other than Drs. Dina and Dr.&nbsp;Martin (who does not have a
good reason definition), &#147;good reason&#148; generally means the named executive officer&#146;s voluntary termination following (1)&nbsp;a material reduction or change in job duties, responsibilities, and requirements inconsistent with the named
executive officer&#146;s position with the Company and his or her prior duties, responsibilities, and requirements, or a material change in the level of management to which the named executive officer reports; (2)&nbsp;any material reduction of base
compensation (other than in connection with a general decrease in base salaries for most officers of the successor corporation); or (3)&nbsp;the refusal to relocate to a facility or location more than 35 miles from the Company&#146;s current
location. The named executive officer must provide 90 days&#146; notice of the event giving rise to good reason, give the Company 30 days&#146; to cure (if curable), and any resignation for good reason must occur within 180 days after the occurrence
of the event giving rise to such resignation right. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">50 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DIRECTOR COMPENSATION </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>ASH</SMALL> C<SMALL>OMPENSATION</SMALL> A<SMALL>RRANGEMENTS</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pursuant to our compensation program for non-employee directors, during 2012, each member of our Board who was not an employee or officer
of the Company received the following cash compensation for Board services: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A $65,000 annual retainer for service as chairman of the Board and a $40,000 annual retainer for service as a member of the Board.
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A $20,000 annual retainer for the Chair of the Audit Committee. Each member of the Audit Committee shall receive a fee of $1,500 for each committee
meeting attended in person or $500 for each committee meeting attended by telephone. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A $15,000 annual retainer for the Chair of the Compensation Committee. Each member of the Compensation Committee shall receive a fee of $1,000 for each
committee meeting attended in person or $500 for each committee meeting attended by telephone. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">A $5,000 annual retainer for the Chair of the Nominating and Governance Committee. Each member of the Nominating and Governance Committee shall receive
a fee of $1,000 for each committee meeting attended in person or $500 for each committee meeting attended by telephone. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">We reimburse our non-employee directors for their reasonable expenses incurred in attending meetings of our Board and committees of our Board.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>QUITY</SMALL> A<SMALL>WARDS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Pursuant to our compensation program for non-employee directors, each director and the chairman of the Board receive an initial equity award, or Initial Grant, consisting of a non-qualified stock option
to purchase 20,000 shares and 30,000 shares, respectively, of Dynavax common stock upon the date each such person is elected or appointed to the Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">In addition, on the date of each annual meeting of the Company&#146;s stockholders, each non-employee director receives a subsequent equity award, or Subsequent Grant, consisting of a non-qualified stock
option to purchase 17,500 shares of Dynavax common stock. Based on the non-employee director&#146;s election date, the first subsequent grant shall be reduced to 75% of the Subsequent Grant if the service period from the election date to the annual
meeting is between 7 and 10 months, 50% of the Subsequent Grant if the service period from the election date to the annual meeting is between 4 and 7 months, and 25% of the Subsequent Grant if the service period from the election date to the annual
meeting is between 1 and 4 months. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each Initial Grant will vest in equal annual installments over 4 years on the anniversary
of the grant date. Each Subsequent Grant will vest in full on the one-year anniversary of the grant date. The exercise price per share of each Initial Grant and Subsequent Grant shall be one hundred percent of the fair market value per share on the
date of grant. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>ONSULTING</SMALL> A<SMALL>RRANGEMENTS</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">On May&nbsp;1, 2012, the Company entered into a Consulting Agreement with Dr.&nbsp;Cano to provide manufacturing guidance and as a liaison
for the Board with the CEO and President. Dr.&nbsp;Cano earned $105,000 under this agreement in 2012. On November&nbsp;14, 2012, the Company entered into a Consulting Agreement with Dr.&nbsp;Plotkin to provide consulting services related to the
Company&#146;s meeting with the U.S. Food and Drug Administration Vaccines and Related Biological Products Advisory Committee. Dr.&nbsp;Plotkin earned $1,000 under this agreement in 2012. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">51 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>D<SMALL>IRECTOR</SMALL> C<SMALL>OMPENSATION</SMALL> T<SMALL>ABLE</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The following table shows for the fiscal year ended December&nbsp;31, 2012, certain information with respect to the compensation of all
non-employee directors of the Company: </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="70%"></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Fees&nbsp;Earned</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>or Paid in<BR>Cash<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Options<BR>and&nbsp;Awards</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Granted<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)(3)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Total</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arnold L. Oronsky, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">72,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">183,419</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">255,919</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Francis R. Cano, Ph.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">164,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">183,419</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">347,919</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dennis Carson, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">183,419</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">227,919</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Denise M. Gilbert, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">69,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">183,419</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">252,919</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mark Kessel</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">45,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">183,419</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">228,919</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Daniel Kisner, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">68,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">183,419</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">251,919</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peggy V. Phillips</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">72,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">183,419</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">255,419</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stanley A. Plotkin, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">44,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">183,419</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">$</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">227,419</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of fees earned or paid in 2012 for Board and committee meeting attendance as described above. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Represents the aggregate grant date fair value of stock awards granted in the fiscal year in accordance with ASC 718. See note 13 of our &#147;Notes to
Consolidated Financial Statements&#148; in our annual report on Form 10-K filed with the SEC on March&nbsp;8, 2013, for a discussion of assumptions we made in determining the compensation costs included in this column.</FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">As of December&nbsp;31, 2012, each non-employee director held stock options and performance based stock awards to purchase the following numbers of
shares of our common stock: Dr.&nbsp;Oronsky held options and stock awards to purchase 137,500 shares of our common stock; Dr.&nbsp;Cano held options and stock awards to purchase 82,500 shares of our common stock; Dr.&nbsp;Carson held options and
stock awards to purchase 127,500 shares of our common stock; Dr.&nbsp;Gilbert held options and stock awards to purchase 137,500 shares of our common stock; Mr.&nbsp;Kessel held options and stock awards to purchase 82,500 shares of our common stock;
Dr.&nbsp;Kisner held options and stock awards to purchase 77,500 shares of our common stock; Ms.&nbsp;Phillips held options and stock awards to purchase 115,000 shares of our common stock; and Dr.&nbsp;Plotkin held options and stock awards to
purchase 127,500 shares of our common stock. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Includes $105,000 earned under Dr.&nbsp;Cano&#146;s consulting agreement. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Includes $1,000 earned under Dr.&nbsp;Plotkin&#146;s consulting agreement. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">52 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CORPORATE GOVERNANCE </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>I<SMALL>NDEPENDENCE</SMALL> O<SMALL>F</SMALL> T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL> O<SMALL>F</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">As required under the NASDAQ Capital Market, or NASDAQ listing standards, a majority of the members of a listed company&#146;s board of
directors must qualify as &#147;independent,&#148; as affirmatively determined by the board of directors. Our Board consults with the Company&#146;s counsel to ensure that the Board&#146;s determinations are consistent with relevant securities and
other laws and regulations regarding the definition of &#147;independent,&#148; including those set forth in pertinent listing standards of the NASDAQ, as in effect from time to time. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Consistent with these considerations, after review of all relevant transactions or relationships between each director, or any of his or
her family members, and the Company, its senior management and its independent registered public accounting firm, the Board has affirmatively determined that the following directors are independent directors within the meaning of the applicable
NASDAQ listing standards: Ms.&nbsp;Phillips as well as Drs.&nbsp;Carson, Cano, Gilbert, Kisner, Oronsky and Plotkin. In making these determinations, the Board found that none of these directors has a material or other disqualifying relationship with
the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In determining the independence of Dr.&nbsp;Carson, the Board took into account his role as the
university-nominated representative on the evaluation committee to oversee aspects of the agreement between the Regents of the University of California and Dynavax and determined that this relationship would not interfere with Dr.&nbsp;Carson&#146;s
exercise of independent judgment in carrying out his responsibilities as a director. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Dina, our Chief Executive
Officer, and Dr.&nbsp;Martin, our President, are not independent directors by virtue of their employment with the Company. In determining the independence of Mark Kessel, the Board took into account that he is a Partner of Symphony Capital LLC, and
initially was designated as a member of the Board due to Symphony Capital&#146;s ownership of the Company&#146;s equity securities, currently approximately 9% of the Company&#146;s outstanding common stock, under the Corporate Governance Agreement
described under &#147;<I>Transactions with Related Persons</I>.&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>B<SMALL>OARD</SMALL> L<SMALL>EADERSHIP</SMALL>
S<SMALL>TRUCTURE</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board is currently chaired by Dr.&nbsp;Oronsky. The duties of the chairman include presiding
over all meetings of the Board; preparing the agenda for Board meetings in consultation with the Chief Executive Officer, President and other members of our Board; calling and presiding over meetings of non-employee directors; and managing the
Board&#146;s process for annual evaluation of the Chief Executive Officer and President. Accordingly, the chairman has substantial ability to shape the work of our Board. Our Board believes that separation of the positions of chairman and Chief
Executive Officer reinforces the independence of our Board in its oversight of our business and affairs. In addition, such separation helps create an environment that is more conducive to objective evaluation and oversight of management&#146;s
performance, increasing management accountability and improving the ability of our Board to monitor whether management&#146;s actions are in the best interests of our Company and its stockholders. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board also believes there may be advantages to having an independent chairman for matters such as communications and relations
between our Board, the Chief Executive Officer, President and other senior management and in assisting our Board in reaching consensus on particular strategies and policies. Having a chairman separate from the Chief Executive Officer also allows the
chairman to focus on assisting the Chief Executive Officer, President and other senior management in seeking and adopting successful business strategies and risk management policies and in making successful choices in management succession. The
Board also believes that it is advantageous to have a chairman with extensive history with and knowledge of our Company. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>B<SMALL>OARD</SMALL>&#146;<SMALL>S</SMALL> R<SMALL>OLE</SMALL> <SMALL>IN</SMALL> R<SMALL>ISK</SMALL> O<SMALL>VERSIGHT</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Risk assessment and oversight are an integral part of our governance and management processes. Our Board encourages management to promote
a culture that incorporates risk management into our corporate strategy and </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">53 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
day-to-day business operations. Management discusses strategic and operational risks at regular management meetings, and conducts specific strategic planning and review sessions during the year
that include a focused discussion and analysis of the risks facing our Company. Throughout the year, senior management reviews these risks with the Board at regular Board meetings as part of management presentations that focus on particular business
functions, operations or strategies, and presents the steps taken by management to mitigate or eliminate such risks. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our
Board does not have a standing risk management committee but. Rather. administers this oversight function directly through our Board as a whole as well as through various standing committees of our Board that address risks inherent in their
respective areas of oversight. In particular, our Board is responsible for monitoring and assessing strategic risk exposure. Our Audit Committee has the responsibility to oversee our major financial risk exposures and the steps our management has
taken to monitor and control these exposures as well as oversight of our enterprise risk management program. The Audit Committee also monitors compliance with legal and regulatory requirements, oversees the performance of our internal audit function
and approves or disapproves any related-persons transactions. Our Nominating and Governance Committee monitors the effectiveness of our corporate governance guidelines and manages the process for annual director self-assessment and evaluation of the
Board. Our Compensation Committee assesses and monitors whether any of our compensation policies and programs has the potential to encourage excessive risk-taking. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>M<SMALL>EETINGS</SMALL> O<SMALL>F</SMALL> T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL> O<SMALL>F</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our Board met 14 times during fiscal year 2012. Dr.&nbsp;Plotkin attended 9 and Dr.&nbsp;Carson attended 10 of the Board meetings held in 2012. All other Board members attended 75% or more of the
aggregate of the meetings of the Board and of the committees on which the member served, held during the period of services as a director or committee member. The Company does not have a formal policy with respect to attendance at its annual meeting
of stockholders. Three directors attended the 2012 annual meeting. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>OMMITTEES</SMALL> O<SMALL>F</SMALL> T<SMALL>HE</SMALL>
B<SMALL>OARD</SMALL> O<SMALL>F</SMALL> D<SMALL>IRECTORS</SMALL> </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Board has three committees: an Audit Committee, a
Compensation Committee and a Nominating and Governance Committee. The following table provides membership and meeting information for fiscal 2012 for each of the Board committees: </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="73%"></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:20pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Audit</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Compensation</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Nominating</B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Francis R. Cano, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Denise M. Gilbert, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Daniel Kisner, M.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peggy V. Phillips</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">*&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arnold L. Oronsky, Ph.D.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">X</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Members</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Total Meetings</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">18</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">16</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">*</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">Committee Chairperson </FONT></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex"></SUP>As of December&nbsp;31, 2012. </FONT></P></TD></TR></TABLE>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Below is a description of each committee of our Board. Each of the committees has authority to engage legal counsel or other experts or
consultants as it deems appropriate to carry out its responsibilities. Our Board has determined that each member of each committee meets the applicable NASDAQ listing standards and related rules and regulations regarding &#147;independence&#148; and
that each member is free of any relationship that would impair his or her individual exercise of independent judgment with regard to the Company. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>Audit Committee </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Audit Committee is composed of three directors:
Dr.&nbsp;Gilbert (Chairperson), Dr.&nbsp;Oronsky and Ms.&nbsp;Phillips. In addition to determining that all members of the Audit Committee are independent (as </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">54 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
independence is currently defined in Rule&nbsp;5605(c)(2)(A)(i) and (ii)&nbsp;of the NASDAQ listing standards), the Board determined that Dr.&nbsp;Gilbert qualifies as an &#147;audit committee
financial expert,&#148; as defined in applicable SEC rules. The Board made a qualitative assessment of Dr.&nbsp;Gilbert&#146;s level of knowledge and experience based on a number of factors, including her formal education and experience as a chief
financial officer for public reporting companies. The Audit Committee was established by the Board in accordance with Section&nbsp;3(a)(58)(A) of the Exchange Act to oversee the Company&#146;s corporate accounting and financial reporting processes
and audits of its financial statements. The Audit Committee operates under a written charter that is available on the Company&#146;s website at <U>http://investors.dynavax.com/governance.cfm</U>. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Among other things, the charter specifically requires our Audit Committee to: </FONT></P>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">review and monitor the policies and procedures adopted by the Company to fulfill its responsibilities regarding the fair and accurate presentation of
the Company&#146;s financial statements; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">appoint, compensate, and oversee the work of the Company&#146;s independent registered public accounting firm; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">approve and monitor all audit and non-audit services performed by the Company&#146;s independent registered public accounting firm;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">investigate, review and report the propriety and ethical implications of any transactions between the Company and any related persons;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">consult and discuss with management and the independent registered public accounting firm regarding the effectiveness of the Company&#146;s internal
controls over financial reporting; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">establish procedures, as required under applicable law, for the receipt, retention and treatment of complaints received by the Company regarding
accounting, internal controls or auditing matters and the confidential and anonymous submission by employees of concerns regarding questionable accounting or auditing matters; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">review and evaluate the Company&#146;s accounting principles and systems of internal controls; and </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">review and discuss the disclosure of the Company&#146;s annual audited financial statements and quarterly financial statements, including reviewing the
Company&#146;s disclosures under &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations.&#148; </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Management is responsible for the financial reporting process, including the system of internal controls and for the preparation of consolidated financial statements in accordance with accounting
principles generally accepted in the United States. Ernst&nbsp;&amp; Young, the Company&#146;s independent registered public accounting firm, is responsible for auditing or reviewing those financial statements. The Audit Committee monitors and
reviews these processes. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Report of the Audit Committee of the Board of Directors </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">During 2012, the Audit Committee met on four occasions. We also met periodically throughout the year in executive sessions with
Ernst&nbsp;&amp; Young, without the presence of the Company&#146;s management. During the course of these meetings, and at other times during 2012, we: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">discussed with management and Ernst&nbsp;&amp; Young management&#146;s continued testing and evaluation of its system of internal control over
financial reporting. We also reviewed Ernst&nbsp;&amp; Young&#146;s Report of Independent Registered Public Accounting Firm included in the Annual Report on Form 10-K, or Annual Report, related to its audit of the effectiveness of the Company&#146;s
internal control over financial reporting; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewed and discussed with management and Ernst&nbsp;&amp; Young the annual audited financial statements before filing the Annual Report with the SEC,
addressing the acceptability of the Company&#146;s </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">55 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="8%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top"> <P><FONT STYLE="font-family:Times New Roman" SIZE="2">
accounting principles and such other matters as applicable auditing standards require us to discuss (including the matters required to be discussed by the statement on Auditing Standards
No.&nbsp;61, as amended (AICPA, <I>Professional Standards</I>, Vol. 1. AU section 380), and recommended to the Board that the financial statements should be included in the Annual Report; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewed and discussed with management and Ernst&nbsp;&amp; Young the Company&#146;s quarterly unaudited financial statements before the issuance of
its quarterly financial results press releases and the filing of its Quarterly Reports on Form 10-Q with the SEC; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">discussed with management and Ernst&nbsp;&amp; Young significant financial reporting matters, including liquidity and capital requirements, the
accounting for significant transactions, revenue and financing arrangements and stock-based compensation; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">appointed and oversaw the work and compensation of Ernst&nbsp;&amp; Young; </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewed and provided guidance with respect to the external audit and the Company&#146;s relationship with Ernst&nbsp;&amp; Young by (1)&nbsp;reviewing
Ernst&nbsp;&amp; Young&#146;s proposed audit scope, approach, compensation and independence; (2)&nbsp;obtaining statements from Ernst&nbsp;&amp; Young regarding relationships and services with the Company which may impact independence as required by
Ethics and Independence Rule 3526, &#147;Communications with Audit Committees Concerning Independence&#148;; (3)&nbsp;discussing with Ernst&nbsp;&amp; Young the financial statements and audit findings, including any significant adjustments,
management judgments and accounting estimates, significant new accounting policies and whether there were disagreements with management; and (4)&nbsp;obtaining assurance from Ernst&nbsp;&amp; Young that the requirements of Section&nbsp;10A of the
Exchange Act have been met; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">received the written disclosures and the letter from Ernst&nbsp;&amp; Young required by the applicable requirements of the PCAOB regarding
Ernst&nbsp;&amp; Young&#146;s communications with us concerning independence, and discussed with Ernst&nbsp;&amp; Young their independence; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewed, in conjunction with the Company&#146;s legal counsel, all legal matters that could have a significant impact on the Company&#146;s financial
statements or compliance policies. </FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Based on our reviews and discussions as described above, and based on
the report of Ernst&nbsp;&amp; Young, we recommended to the Board, and the Board approved, that the audited financial statements be included in the Company&#146;s Annual Report for the year ended December&nbsp;31, 2012, filed with the SEC. We also
recommended to the Board, and the Board approved, that Ernst&nbsp;&amp; Young be appointed as the Company&#146;s independent registered public accounting firm for 2013. In making this recommendation, we considered whether Ernst&nbsp;&amp;
Young&#146;s provision of services other than audit services is compatible with maintaining independence of our independent registered public accounting firm. Although we have the sole authority to appoint the independent registered public
accounting firm, we continued the long-standing practice of recommending that the Board ask the stockholders at their Annual Meeting to ratify the appointment of Ernst&nbsp;&amp; Young as the Company&#146;s independent registered public accounting
firm. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The material in this report is not &#147;soliciting material,&#148; is not deemed &#147;filed&#148; with the Commission
and is not to be incorporated by reference in any filing of the Company under the Securities Act or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Denise M. Gilbert, Chairperson </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Arnold L. Oronsky </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Peggy V.
Phillips </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Committee </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Our Compensation Committee is composed of three directors: Ms.&nbsp;Phillips (Chairperson) and Drs. Kisner and Cano. All members of the Compensation Committee are independent (as independence is currently
defined </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">56 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
in Rule&nbsp;5605(a)(2) of the NASDAQ listing standards), are &#147;outside directors&#148; for purposes of Section&nbsp;162(m) of the Internal Revenue Code and are &#147;non-employee
directors&#148; for purposes of Rule 16b-3 under the Exchange Act. Dr.&nbsp;Kisner was appointed as a director pursuant to the Corporate Governance Agreement described under &#147;<I>Transactions with Related Persons.</I>&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Compensation Committee acts on behalf of the Board to review, recommend for adoption, and oversee the Company&#146;s compensation
strategy, policies, plans and programs. The Compensation Committee operates under a written charter that is available on the Company&#146;s website at <U>http://investors.dynavax.com/governance.cfm</U>. Among other things, the charter specifically
requires our Compensation Committee to: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">annually review and approve the Company&#146;s corporate goals and objectives relevant to compensation for the Chief Executive Officer and President,
evaluate the Chief Executive Officer&#146;s and President&#146;s performance in light of such goals and objectives, and set the Chief Executive Officer&#146;s and President&#146;s compensation level based on this evaluation;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">annually review and make recommendations to the Board with respect to incentive compensation plans and equity-based plans;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">administer the Company&#146;s incentive compensation plans and equity-based plans as in effect and as adopted from time to time by the Board provided
that the Board shall retain the authority to interpret such plans; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">annually review and approve for the Company&#146;s executive officers: i) annual base salary levels; ii) annual incentive compensation levels; iii)
long-term incentive compensation levels; iv) employment agreements, severance agreements, and change of control agreements/provisions, in each case as, when and if appropriate; and v) any supplemental or special benefits.
</FONT></P></TD></TR></TABLE> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Under its charter, our Compensation Committee may form, and delegate authority to, subcommittees, as
appropriate. In 2011, our Compensation Committee authorized a subcommittee, currently composed of Drs.&nbsp;Dina and Martin, to which it delegated authority to grant, without any further action required by our Compensation Committee, stock options
or restricted stock to employees and consultants who are not officers of the Company. The purpose of this delegation of authority is to enhance the flexibility of option administration within the Company and to facilitate the timely grant of options
to non-executive employees and consultants, particularly new employees, within specified limits approved by our Compensation Committee. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Committee Report </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">During 2012, our Compensation Committee met 18 times to review new disclosure and certification requirements regarding executive compensation and discuss our current compensation practices. During the
course of these meetings, we: </FONT></P> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">assessed the achievement of corporate goals as they related to executive compensation during the first quarter of the year;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewed and recommended to the Board annual compensation, bonus payment and equity incentive awards to Drs. Dina and Martin;
</FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">approved performance and related compensation payments to the Company&#146;s other named executive officers, including annual compensation, bonus
payments and equity incentive awards; </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">reviewed the terms of employment or service, including severance and change-in-control arrangements, of the Company&#146;s named executive officers in
light of the company&#146;s circumstances, changes in federal income tax provisions and current legislation governing corporate pay practices; and </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="5%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">&#149;</FONT></TD>
<TD WIDTH="1%" VALIGN="top"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2">approved an aggregate limit on options subject to grant by Drs. Dina and Martin based on approved hiring plans and ranges of grants for prospective
hires and consultants. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">57 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In early 2013, the Compensation Committee discussed with management the Compensation
Discussion and Analysis, or CD&amp;A, contained in this proxy statement. Based on this review and discussion, the Compensation Committee has recommended to the Board that the CD&amp;A be included in this proxy statement and incorporated into our
Annual Report on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2012. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The material in this report is not
&#147;soliciting material,&#148; is furnished to, but not deemed &#147;filed&#148; with, the Commission and is not deemed to be incorporated by reference in any filing of the Company under the Securities Act or the Exchange Act, other than the
Company&#146;s Annual Report on Form 10-K, where it shall be deemed to be &#147;furnished,&#148; whether made before or after the date hereof and irrespective of any general incorporation language in any such filing. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Ms.&nbsp;Peggy V. Phillips, Chairperson </FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Francis Cano </FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dr.&nbsp;Daniel Kisner
</FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Compensation Committee Interlocks and Insider Participation </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">During the fiscal year ended December&nbsp;31, 2012, Ms.&nbsp;Peggy&nbsp;V. Phillips, Dr.&nbsp;Francis Cano, and Dr.&nbsp;Daniel Kisner each served as a member of the Compensation Committee. None of the
members of our Compensation Committee at any time has been one of our officers or employees or an officer or employee of one of our subsidiaries at any time during the fiscal year ended December&nbsp;31, 2012. None of our named executive officers
currently serve, or in the past year has served, as a member of the board of directors or compensation committee of any entity that has one or more executive officers on our Board or Compensation Committee. Dr.&nbsp;Kisner was appointed as a
director pursuant to the Corporate Governance Agreement described under &#147;<I>Transactions with Related Persons.</I>&#148; </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Nominating
and Governance Committee </B></FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Our Nominating and Governance Committee is composed of two directors: Drs. Kisner (Chairperson)
and Cano. All members of the Nominating and Governance Committee are independent (as independence is currently defined in Rule&nbsp;5605(a)(2) of the NASDAQ listing standards). The Nominating and Governance Committee is responsible for identifying,
reviewing and evaluating candidates to serve as directors of the Company (consistent with criteria approved by the Board), reviewing and evaluating incumbent directors and identifying with the Chief Executive Officer candidates for appointment or
election to the Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">In identifying potential director candidates, the Nominating and Governance Committee considers Board
candidates through a variety of methods and sources. These include suggestions from current Board members, senior management, stockholders, professional search firms and other sources. At this time, the Nominating and Governance Committee does not
have a policy with regard to the consideration of director candidates recommended by stockholders. Our Nominating and Corporate Governance Committee reviews all candidates in the same manner regardless of the source of the recommendation. In the
case of a new director candidate, the Nominating and Governance Committee also determines whether the nominee is independent based upon applicable NASDAQ listing standards, applicable SEC rules and regulations and the advice of counsel, if
necessary. Among the qualifications to be considered in the selection of candidates are broad experience in business, finance or administration, familiarity with the Company&#146;s industry, and prominence and reputation. Since prominence and
reputation in a particular profession or field of endeavor are what bring most persons to the Board&#146;s attention, there is further consideration of whether the individual has the time available to devote to the work of the Board and one or more
of its committees. In addition, our Nominating and Governance Committee will consider whether the candidate assists in achieving a mix of members that represents a diversity of backgrounds and experience, including with respect to age, gender,
international background, race and specialized experience. Each year, our Nominating and Governance Committee reviews its Board membership criteria and assesses the composition of the Board against the criteria. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">58 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Nominating and Governance Committee met 14 times during the fiscal year. The Nominating
and Governance Committee has adopted a written charter that is available to stockholders on the Company&#146;s website at http://investors.dynavax.com/governance.cfm. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>S<SMALL>TOCKHOLDER</SMALL> C<SMALL>OMMUNICATIONS</SMALL> W<SMALL>ITH</SMALL> T<SMALL>HE</SMALL> B<SMALL>OARD</SMALL> O<SMALL>F</SMALL> D<SMALL>IRECTORS</SMALL></B><SMALL></SMALL> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stockholders may communicate with our Board by directing comments, concerns, and questions to the Corporate Secretary at Dynavax
Technologies Corporation, 2929 Seventh Street Suite 100, Berkeley, California 94710. Communications will be distributed to the Board, or to any individual directors as appropriate, depending on the facts and circumstances outlined in the
communication. In that regard, our Board has requested that certain items that are unrelated to the duties and responsibilities of the Board be filtered, including product complaints or inquiries, new product suggestions, r&eacute;sum&eacute;s and
other forms of job inquiries, surveys, or business solicitations or advertisements. In addition, material that is unduly hostile, threatening, illegal or similarly unsuitable will be excluded, with the provision that any communication that is
filtered out must be made available to any non-employee director upon request. Stockholders may also communicate with our Board as a group through our website at http://investors.dynavax.com/contactBoard.cfm. All communications directed to the Audit
Committee in accordance with our whistleblower policy that relate to questionable accounting or auditing matters involving the Company will be promptly and directly forwarded to the chairperson of the Audit Committee. Every effort has been made to
ensure that the views of stockholders are heard by the Board or individual directors, as applicable, and that appropriate responses are provided to stockholders in a timely manner. The Company believes its responsiveness to stockholder
communications to the Board has been excellent. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T<SMALL>RANSACTIONS</SMALL> W<SMALL>ITH</SMALL> R<SMALL>ELATED</SMALL>
P<SMALL>ERSONS</SMALL></B><SMALL></SMALL> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">It is the Company&#146;s policy that the Audit Committee investigate, review and
report to the Board the propriety and ethical implications of any transactions, as reported or disclosed to the Audit Committee by management, the independent auditors, employees, officers, members of the Board or otherwise, between (a)&nbsp;Dynavax
and (b)&nbsp;any employee, officer or member of the Board, or any affiliates of the foregoing. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have entered into indemnity
agreements with each of our officers and directors which provide, among other things, that the Company will indemnify such officer or director, under the circumstances and to the extent provided for therein, for expenses, damages, judgments, fines
and settlements he or she may be required to pay in actions or proceedings which he or she is or may be made a party by reason of his or her position as a director, officer or other agent of the Company, and otherwise to the fullest extent permitted
under Delaware law. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We are party to a Corporate Governance Agreement, dated December&nbsp;30, 2009, with Symphony Dynamo
Holdings LLC, or Holdings. For as long as Holdings and its affiliates, which include Symphony Capital Partners LLC, or Symphony, beneficially own 10% or more of our outstanding common stock, we agreed to use our commercially reasonable efforts to
cause to be elected and remain as directors on our Board one individual designated by Holdings and a second individual who shall be an independent third party designated by Holdings and reasonably acceptable to us. Holdings designated Mark Kessel, a
partner of Symphony, as its designee and Mr.&nbsp;Kessel has been appointed to our Board. Holdings designated Daniel Kisner as the independent third party, and Dr.&nbsp;Kisner has been appointed to our Board. </FONT></P>
<P STYLE="margin-top:18px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>S<SMALL>ECTION</SMALL>&nbsp;16(<SMALL>A</SMALL>) B<SMALL>ENEFICIAL</SMALL> O<SMALL>WNERSHIP</SMALL> R<SMALL>EPORTING</SMALL>
C<SMALL>OMPLIANCE</SMALL></B><SMALL></SMALL> </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Section&nbsp;16(a) of the Exchange Act requires the Company&#146;s directors and
executive officers, and persons who own more than ten percent of a registered class of the Company&#146;s equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity
securities of the Company. Officers, directors and greater-than-ten-percent stockholders are required by SEC regulation to furnish the Company with copies of all Section&nbsp;16(a) forms they file. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">59 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">To the Company&#146;s knowledge, based solely on a review of the copies of such reports
furnished to the Company and written representations that no other reports were required, during the fiscal year ended December&nbsp;31, 2012, such SEC filing requirements were satisfied. </FONT></P> <P STYLE="margin-top:18px;margin-bottom:0px"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>ODE</SMALL> O<SMALL>F</SMALL> E<SMALL>THICS</SMALL></B><SMALL></SMALL> </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">We have adopted the Dynavax Code of Business Conduct and Ethics that applies to all officers, directors and employees. Our Code of
Business Conduct and Ethics is available upon written request. We will provide a written copy of the Dynavax Code of Business Conduct and Ethics to anyone without charge, upon request written to Dynavax Technologies Corporation, Attention: Jennifer
Lew, 2929 Seventh Street, Suite 100, Berkeley, California 94710-2753, (510)&nbsp;848-5100. If the Company makes any substantive amendments to the Code of Business Conduct and Ethics or grants any waiver from a provision of the Code to any executive
officer or director, the Company will promptly disclose the nature of the amendment or waiver on its website. There have been no waivers to the Code of Business Conduct and Ethics as of April&nbsp;10, 2013. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">60 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>SECURITY OWNERSHIP OF </B></FONT></P>
<P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>CERTAIN BENEFICIAL OWNERS AND MANAGEMENT </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The following table sets forth certain information regarding the ownership of the Company&#146;s common stock as of January&nbsp;25, 2013 by: (i)&nbsp;each director and nominee for director; (ii)&nbsp;the
named executive officers; (iii)&nbsp;all executive officers and directors of the Company as a group; and (iv)&nbsp;all those known by the Company to be beneficial owners of more than five percent of its common stock. </FONT></P>
<P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE" ALIGN="center">


<TR>
<TD WIDTH="75%"></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:135pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Name and Address of Beneficial Holder</B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Number of</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Shares<SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP></B></FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Percent&nbsp;of&nbsp;
Shares</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Beneficially</B></FONT><br><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Owned<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP></B></FONT></TD>

<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>


<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Federated Investors, Inc.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">31,942,154</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17.5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Federated Investors Tower</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Pittsburgh, PA 15222-3779</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">State Street Corporation</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,168,898</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">State Street Financial Center, One Lincoln Street</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Boston, MA 02111</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vanguard Group, Inc.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,358,383</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">100 Vanguard Blvd.</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Malvern, PA 19355</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">HealthCor Management, L.P.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">17,600,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Carnegie Hall Tower, 152 West 57th Street, 43rd Floor</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">New York, New York 10019</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">FMR LLC</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">24,912,228</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">13.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">82 Devonshire Street</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Boston, MA 02109</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">S.A.C. Capital Advisors, L.P.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">9,341,708</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">5.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">72 Cummings Point Road</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:3.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stamford, CT 06902</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1px solid #000000;width:146pt"><FONT STYLE="font-family:Times New Roman" SIZE="1"><B>Named Executive Officers and Directors
<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP></B></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD COLSPAN="2" VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dino Dina, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">2,462,747</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">J. Tyler Martin, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1,817,244</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">1.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Christine R. Larson</FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">75,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">375,560</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(13)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">671,244</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stephen F. Tuck, Ph.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(14)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">399,899</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Arnold L. Oronsky, Ph.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(15)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">279,008</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Francis R. Cano, Ph.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(16)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">92,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Dennis Carson, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(17)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">148,119</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Denise M. Gilbert, Ph.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(18)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">90,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Daniel Kisner, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(19)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">20,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Peggy V. Phillips</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(20)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">112,500</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Stanley A. Plotkin, M.D.</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(21)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">80,000</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">*</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">Mark Kessel</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(22)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7,577,148</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">4.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
<TR BGCOLOR="#cceeff">
<TD VALIGN="top"> <P STYLE="margin-left:1.00em; text-indent:-1.00em"><FONT STYLE="font-family:Times New Roman" SIZE="2">All executive officers and directors as a group (14 persons)</FONT><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP
STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(23)</SUP></FONT><FONT STYLE="font-family:Times New Roman" SIZE="2"></FONT></P></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">14,200,469</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2">7.6</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">%&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="line-height:8px;margin-top:0px;margin-bottom:2px;border-bottom:0.5pt solid #000000;width:10%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">*</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Less than one percent. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(1)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">The address of each of the named executive officers and directors is c/o Dynavax Technologies Corporation, 2929 Seventh Street, Suite 100, Berkeley,
California 94710. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(2)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">To our knowledge, except as set forth in the footnotes to this table, and subject to applicable community property laws, each person named in this
table has sole voting and investment power with respect to the shares set forth opposite such person&#146;s name. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">61 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(3)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Beneficial ownership is determined in accordance with the rules of the Securities and Exchange Commission (&#147;SEC&#148;) and generally includes
voting or investment power with respect to the securities. Shares of our common stock subject to options currently exercisable or that will become exercisable within 60 days after January&nbsp;25, 2013, are deemed outstanding for computing the
percentage of the person holding such options but are not deemed outstanding for computing the percentage of any other person. Applicable percentages are based on 182,818,515 shares of our common stock outstanding as of January&nbsp;25, 2013,
adjusted as required by the rules of the Securities and Exchange Commission. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(4)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Based on a Schedule 13G filed by Federated Investors, Inc., on February&nbsp;12, 2013, with the SEC. Federated Investors, Inc., is the parent holding
company of Federated Equity Management Company of Pennsylvania and Federated Global Investment Management Corp. (the &#147;Investment Advisers&#148;), which act as investment advisers to registered investment companies and separate accounts that own
shares of common stock in the Company. The Investment Advisers are wholly-owned subsidiaries of FII Holdings, Inc., which is a wholly-owned subsidiary of Federated Investors, Inc. (&#147;the Parent&#148;). All of the Parent&#146;s outstanding voting
stock is held in the Voting Shares Irrevocable Trust (the &#147;Trust&#148;) for which John F. Donahue, Rhodora J. Donahue and J. Christopher Donahue act as trustees (collectively, the &#147;Trustees&#148;). The Trustees have joined in filing this
Schedule 13G because of the collective voting control they exercise over the Parent. In accordance with Rule 13d-4 under the Securities Act of 1934, as amended, the Parent, the Trust and each of the Trustees declare that this statement should not be
considered an admission that they are the beneficial owners of Reported Securities, and the Parent, the Trust, and each of the Trustees disclaim beneficial ownership of the Reported Securities. The address of the principal business and office of
Federated Investors, Inc. and its affiliates is Federated Investors Towers, 1001 Liberty Avenue, Pittsburgh, PA 15222-3779. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(5)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Based on a Schedule 13G filed by State Street Corporation, on February&nbsp;11, 2013, with the SEC. State Street Corporation and its direct and
indirect subsidiaries had shared voting power with respect to 9,168,898 shares of the Company&#146;s Common Stock and shared dispositive power with respect to 9,168,898 shares of the Company&#146;s Common Stock. The address of the principal business
and office of State Street Corporation is State Street Financial Center, One Lincoln Street. Boston, MA 02111. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(6)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Based on a Schedule 13G filed by Vanguard Group, Inc., on February&nbsp;12, 2013, with the SEC. Vanguard Group and its direct and indirect subsidiaries
had sole voting power with respect to 235,881 shares of the Company&#146;s Common Stock, sole dispositive power with respect to 9,132,702 shares of the Company&#146;s Common Stock and shared dispositive power with respect to 235,881 shares of the
Company&#146;s Common Stock. Vanguard Fiduciary Trust Company (&#147;VFTC&#148;), a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 225,681 shares of the Common Stock outstanding of the Company as a result of its
serving as investment manager of collective trust accounts. Vanguard Investments Australia, Ltd. (&#147;VIA&#148;), a wholly-owned subsidiary of The Vanguard Group, Inc., is the beneficial owner of 10,200 shares of the Common Stock outstanding of
the Company as a result of its serving as investment manager of Australian investment offerings. The address of the principal business and office of Vanguard Group, Inc., is 100 Vanguard Blvd., Malvern, PA 19355. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(7)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Based on a Schedule 13G filed by HealthCor Management, L.P., and related entities, on February&nbsp;14, 2013, with the SEC. Collectively, HealthCor
Offshore Master Fund, L.P., HealthCor Hybrid Offshore Master Fund, L.P., and HealthCor Long Offshore Master Fund, L.P. (each a &#147;Fund&#148; and together, the &#147;Funds&#148;), are the beneficial owners of a total of 17,600,000 shares of the
Common Stock of the Company. HealthCor Offshore GP, LLC, is the general partner of HealthCor Offshore Master Fund, L.P. Accordingly, HealthCor Offshore GP, LLC, may be deemed to beneficially own the shares of Common Stock that are beneficially owned
by HealthCor Offshore Master Fund, L.P. HealthCor Group, LLC, is the general partner of HealthCor Offshore GP, LLC, and, therefore, may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Offshore Master
Fund, L.P. HealthCor Hybrid Offshore GP, LLC, is the general partner of HealthCor Hybrid Offshore Master Fund, L.P. Accordingly, HealthCor Hybrid Offshore GP, LLC, may be deemed to beneficially own the shares of Common Stock that are beneficially
owned by HealthCor Hybrid Offshore Master Fund, L.P. HealthCor Group, LLC, is the general partner of HealthCor Hybrid Offshore GP, LLC, and, therefore, may be deemed to beneficially own the shares of Common Stock that are beneficially owned by
HealthCor Hybrid Offshore Master Fund, L.P. HealthCor Long Master GP, LLC, is the general partner of HealthCor Long Offshore Master Fund, L.P. Accordingly, HealthCor Long Master GP, LLC, may be deemed to beneficially own the shares of Common Stock
that are beneficially owned by HealthCor Long Offshore Master Fund, L.P. HealthCor Group, LLC, is the general partner of HealthCor Long Master GP, LLC, and, therefore, may be deemed to beneficially own the shares of Common Stock that are
beneficially owned by HealthCor Long Offshore Master Fund, L.P. By virtue of its position as the investment manager of the Funds, HealthCor Management, L.P., may be deemed a beneficial owner of all the shares of Common Stock owned by the Funds.
HealthCor Associates, LLC, is the general partner of HealthCor Management, L.P., and, thus, may also be deemed to beneficially own the shares of Common Stock that are beneficially owned by the Funds. The address of the principal business and office
of HealthCor Management, L.P., is Carnegie Hall Tower, 152 West 57<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">th</SUP> Street. 43<SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">rd</SUP> Floor, New York,
New York 10019. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(8)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Based on a Schedule 13G/A filed by FMR LLC, on February&nbsp;14, 2013, with the SEC. Fidelity Management&nbsp;&amp; Research Company
(&#147;Fidelity&#148;) is a wholly-owned subsidiary of FMR LLC and an investment adviser registered under Section&nbsp;203 of the Investment Advisers Act of 1940 and is the beneficial owner of 24,568,928 shares of the Common Stock outstanding of the
Company as a result of acting as investment adviser to various investment companies registered under Section&nbsp;8 of the Investment Company Act of 1940. Edward C. Johnson III and FMR LLC, through its control of Fidelity and its related funds (the
&#147;Fidelity Funds&#148; or the &#147;Funds&#148;), each has sole power to dispose of the 24,568,928 shares owned by the Funds. Members of the family of Edward C. Johnson III, Chairman of FMR LLC, are the predominant owners, directly or through
trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. Neither FMR LLC nor Edward C. Johnson III, Chairman of FMR LLC, has the sole power to vote or direct the voting of the shares owned directly by the
Fidelity Funds, which power resides with the Funds&#146; Boards of Trustees. Fidelity carries out the voting of the shares under written guidelines established by the Funds&#146; Boards of Trustees. Pyramis Global Advisors Trust Company
(&#147;PGATC&#148;), 900 Salem Street, Smithfield, Rhode Island, 02917, an indirect wholly-owned subsidiary of FMR LLC and a </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">62 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="1">
bank as defined in Section&nbsp;3(a)(6) of The Securities Exchange Act of 1934, is the beneficial owner of 343,000 shares of the outstanding Common Stock of the Company as a result of its serving
as investment manager of institutional accounts owning such shares. Edward C. Johnson III and FMR LLC, through its control of Pyramis Global Advisors Trust Company, each has sole dispositive power over 343,000 shares and sole power to vote or to
direct voting of 343,000 shares of common Stock owned by the institutional accounts managed by PGATC. The address of the principal business and office of FMR LLC is 82 Devonshire Street, Boston, MA, 02109. </FONT></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(9)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Based on a Schedule 13G filed by (i)&nbsp;S.A.C. Capital Advisors L.P., on February&nbsp;14, 2013, with the SEC with respect to the shares of Common
Stock, par value $0.001 per share (&#147;Shares&#148;) of the Company beneficially owned by S.A.C. Capital Associates, LLC, and S.A.C. MultiQuant Fund, L.P., (ii)&nbsp;S.A.C. Capital Advisors, Inc. with respect to Shares beneficially owned by SAC
Capital Advisors LP, SAC Capital Associates, LLC, and S.A.C. MultiQuant Fund, L.P., (iii)&nbsp;SAC Capital Associates, LLC, with respect to Shares beneficially owned by it; and (iv)&nbsp;Steven A. Cohen with respect to the Shares beneficially owned
by SAC Capital Advisors LP, SAC Capital Advisors Inc., SAC Capital Associates and S.A.C. MulitQuant Fund, L.P. S.A.C. Capital Advisors LP is a Delaware limited partnership. SAC Capital Advisors Inc. is a Delaware corporation. SAC Capital Associates,
LLC, is an Anguillan limited liability company. Mr.&nbsp;Cohen is a United States citizen. SAC Capital Advisors LP, SAC Capital Advisors Inc. and Mr.&nbsp;Cohen own directly no shares. Pursuant to an investment management agreement, SAC Capital
Advisors LP maintains investment and voting power with respect to securities held by SAC Capital Associates, LLC, and S.A.C. MultiQuant Fund, L.P. SAC Capital Advisors Inc. is the general partner of SAC Capital Advisors LP. Mr.&nbsp;Cohen controls
SAC Capital Advisors Inc. As of December&nbsp;31, 2012, by reason of the provisions of Rule&nbsp;13d-3 of the Securities Exchange Act of 1934, as amended, each of SAC Capital Advisors LP, SAC Capital Advisors Inc. and Mr.&nbsp;Cohen may be deemed to
beneficially own 9,341,708 shares. The address of the principal business and office of S.A.C. Capital Advisors Inc. and its affiliates is 72 Cummings Point Road, Stamford, Connecticut 06902. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(10)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of (i)&nbsp;203,214 shares held by the Dino Dina 1999 Revocable Trust, of which Dr.&nbsp;Dina is trustee, (ii)&nbsp;40,669 shares purchased
through the employee stock purchase plan, (iii)&nbsp;256,784 shares owned directly by Dr.&nbsp;Dina, (vi)&nbsp;35,000 shares of common stock issuable upon exercise of warrants outstanding held by Dr.&nbsp;Dina and (v)&nbsp;options to purchase
1,927,080 shares of common stock exercisable within 60 days of January&nbsp;25, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(11)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 293,607 shares of common stock owned directly by Dr.&nbsp;Martin and options to purchase 1,523,637 shares of common stock exercisable
within 60 days of January&nbsp;25, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(12)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 2,332 shares purchased through the employee stock purchase plan and options to purchase 373,228 shares of common stock exercisable within
60 days of January&nbsp;25, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(13)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 87,720 shares of common stock owned directly by Mr.&nbsp;Ostrach and options to purchase 583,524 shares of common stock exercisable within
60 days of January&nbsp;25, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(14)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 106,151 shares of common stock owned directly by Mr.&nbsp;Tuck and options to purchase 293,748 shares of common stock exercisable within 60
days of January&nbsp;25, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(15)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 189,008 shares of common stock owned directly by Dr.&nbsp;Oronsky and options to purchase 90,000 shares of common stock exercisable within
60 days of January&nbsp;25, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(16)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 62,000 shares of common stock owned directly by Dr.&nbsp;Cano and options to purchase 30,000 shares of common stock exercisable within 60
days of January&nbsp;25, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(17)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 68,119 shares of common stock owned directly by Dr.&nbsp;Carson and options to purchase 80,000 shares of common stock exercisable within 60
days of January&nbsp;25, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(18)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of options to purchase 90,000 shares of common stock exercisable within 60 days of January&nbsp;25, 2013. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(19)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 5,000 shares of common stock owned directly by Dr.&nbsp;Kisner and options to purchase 15,000 shares of common stock exercisable within 60
days of January&nbsp;25, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(20)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of 45,000 shares of common stock owned directly by Ms.&nbsp;Phillips and options to purchase 67,500 shares of common stock exercisable within
60 days of January&nbsp;25, 2013. </FONT></P></TD></TR></TABLE> <P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(</SUP><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">21)</SUP>&nbsp;
</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Consists of options to purchase 80,000 shares of common stock exercisable within 60 days of January&nbsp;25, 2013. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(22)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Includes 2,875,136 shares of common stock directly owned by Symphony Capital Partners, L.P. (&#147;Symphony Capital Partners&#148;) and 156,295 shares
held by Symphony Strategic Partners, LLC, 4,282,895 shares of common stock issuable upon exercise of warrants outstanding held by Symphony Capital Partners, 232,822 shares of common stock issuable upon exercise of warrants outstanding held by
Symphony Strategic Partners, LLC, and options to purchase 30,000 shares of common stock exercisable within 60 days of January&nbsp;25, 2013, held by Mark Kessel personally. Mr.&nbsp;Kessel is a Managing Member of Symphony GP LLC, which is the
general partner of Symphony Capital GP, L.P., which is the general partner of Symphony Capital Partners, L.P., and is also a Managing Member of Symphony Strategic Partners LLC. </FONT></P></TD></TR></TABLE>
<P STYLE="font-size:6px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1"><SUP STYLE="vertical-align:baseline; position:relative; bottom:.8ex">(23)</SUP>&nbsp;</FONT></TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="1">Total number of shares includes 4,391,035 shares of common stock in aggregate held as of January&nbsp;25, 2013, by our executive officers and directors
and entities affiliated with such executive officers and directors. Also includes options to purchase 5,258,717 shares of common stock exercisable within 60 days of January&nbsp;25, 2013, 35,000 shares of common stock issuable upon exercise of
warrants outstanding held directly by Dr.&nbsp;Dina and 4,515,717 shares of shares of common stock issuable upon exercise of warrants outstanding held by Symphony Capital Partners and Symphony Strategic Partners LLC. </FONT></P></TD></TR></TABLE>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">63 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>P<SMALL>ERFORMANCE</SMALL> G<SMALL>RAPH</SMALL> </B></FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The chart below compares total stockholder return on an investment of $100 in cash on December&nbsp;31, 2007, for: our common stock, The
NASDAQ Stock Market (U.S.&nbsp;companies), and the NASDAQ Pharmaceutical Preparation Index. All values assume reinvestment of the full amount of all dividends. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">Note:&nbsp;Dynavax management cautions that the stock price performance shown in the graph below should not be considered indicative of potential future stock price performance. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g484784g97e79.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">64 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>OTHER MATTERS</B> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Board knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly
brought before the Annual Meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="100%"></TD></TR>


<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By Order of the Board of Directors</FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-bottom:1px;margin-top:0px;border-bottom:1px solid #000000"><FONT STYLE="font-family:Times New Roman" SIZE="2">&nbsp;</FONT></P></TD></TR>
<TR>
<TD VALIGN="top"> <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Michael S. Ostrach</FONT></P>
<P STYLE="margin-top:0px;margin-bottom:1px"><FONT STYLE="font-family:Times New Roman" SIZE="2">Secretary</FONT></P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">April&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2013 </FONT></P>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A copy of the Company&#146;s Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2012, is available without charge
upon written request to: Secretary, Michael S. Ostrach, Dynavax Technologies Corporation, 2929 Seventh Street, Suite 100, Berkeley, California 94710. </B></FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">65 </FONT></P>



<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:18px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Annex A </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>CERTIFICATE OF AMENDMENT OF </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>AMENDED AND RESTATED CERTIFICATE OF
INCORPORATION OF </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>DYNAVAX TECHNOLOGIES CORPORATION </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>D<SMALL>YNAVAX</SMALL> T<SMALL>ECHNOLOGIES</SMALL> C<SMALL>ORPORATION</SMALL>,</B> a corporation organized and existing under and by
virtue of the General Corporation Law of the State of Delaware (the &#147;Corporation&#148;), hereby certifies that: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>IRST</SMALL>:</B> The name of the Corporation is Dynavax Technologies Corporation. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>S<SMALL>ECOND</SMALL>:</B> The Corporation was originally incorporated under the same name and the original Certificate of
Incorporation was filed with the Secretary of State of the State of Delaware on November&nbsp;6, 2000. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T<SMALL>HIRD</SMALL>:</B> The Board of Directors of the Corporation, acting in accordance with the provisions of Sections&nbsp;141 and
242 of the General Corporation Law of the State of Delaware, adopted resolutions amending its Certificate of Incorporation as follows: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>1. </B>Article&nbsp;IV shall be amended and restated to read in its entirety as follows: </FONT></P> <P STYLE="margin-top:6px;margin-bottom:0px; margin-left:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">&#147;The Corporation is authorized to issue two classes of stock to be designated, respectively, Common Stock and Preferred Stock. The Corporation shall be authorized to issue 350,000,000 shares of
Common Stock at $0.001 par value, and 5,000,000 shares of Preferred Stock at $0.001 par value. The Preferred Stock may be issued from time to time in one or more series pursuant to a resolution or resolutions providing for such issue duly adopted by
the Board of Directors (authority to do so being hereby expressly vested in the Board). The rights, preferences, privileges and restrictions granted to or imposed upon the Preferred Stock or any series of Preferred Stock will be determined or
altered by the Board of Directors. The Board of Directors shall also have the authority to fix or alter the number of shares of any series of Preferred Stock and the designation of any such series of Preferred Stock. The Board of Directors, within
the limits and restrictions stated in any resolution or resolutions of the Board of Directors originally fixing the number of shares constituting any series, may increase or decrease (but not below the number of shares in any such series then
outstanding), the number of shares of any series subsequent to the issue of shares of that series.&#148; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>F<SMALL>OURTH</SMALL>:</B> Thereafter pursuant to a&nbsp;resolution of the Board of Directors, this Certificate of Amendment was
submitted to the stockholders of the Corporation for their approval, and was duly adopted at the Annual Meeting of Stockholders held on <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2013 in accordance with the
provisions of Section&nbsp;242 of the General Corporation Law of the State of Delaware. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-1
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>I<SMALL>N</SMALL> W<SMALL>ITNESS</SMALL> W<SMALL>HEREOF</SMALL>, D<SMALL>YNAVAX</SMALL>
T<SMALL>ECHNOLOGIES</SMALL> C<SMALL>ORPORATION</SMALL></B><SMALL></SMALL> has caused this Certificate of Amendment to be signed by its Vice President this<U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;day
of<U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2013. </FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE">


<TR>
<TD WIDTH="7%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR>
<TD VALIGN="top" COLSPAN="3"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>D<SMALL>YNAVAX</SMALL> T<SMALL>ECHNOLOGIES</SMALL> C<SMALL>ORPORATION</SMALL></B><SMALL></SMALL></FONT></TD></TR>
<TR>
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR>
<TD VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2">By:<U></U></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000"><FONT SIZE="1">&nbsp;</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Jennifer Lew</FONT></TD></TR>
<TR>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT SIZE="1">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Times New Roman" SIZE="2">Vice President, Finance</FONT></TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">A-2
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="right"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>Annex B </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>D<SMALL>YNAVAX</SMALL> T<SMALL>ECHNOLOGIES</SMALL> C<SMALL>ORPORATION</SMALL> </B></FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>2011 E<SMALL>QUITY</SMALL> I<SMALL>NCENTIVE</SMALL> P<SMALL>LAN</SMALL> </B></FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>DOPTED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL> B<SMALL>OARD</SMALL> <SMALL>OF</SMALL> D<SMALL>IRECTORS</SMALL>:
N<SMALL>OVEMBER</SMALL>&nbsp;12, 2010 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>PPROVED</SMALL> <SMALL>BY</SMALL> <SMALL>THE</SMALL>
S<SMALL>TOCKHOLDERS</SMALL>: J<SMALL>ANUARY</SMALL>&nbsp;5, 2011 </B></FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T<SMALL>ERMINATION</SMALL> D<SMALL>ATE</SMALL>:
N<SMALL>OVEMBER</SMALL>&nbsp;11, 2020 </B></FONT></P> <P STYLE="font-size:12px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>1.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>G<SMALL>ENERAL</SMALL>.</B> </FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) Successor to and Continuation of Prior Plans.</B> The Plan is intended as the successor to and continuation of the Dynavax
Technologies Corporation 2004 Stock Incentive Plan (the &#147;<B><I>2004 Plan</I></B>&#148;) and the Dynavax Technologies Corporation 2010 Employment Inducement Award Plan (the &#147;<B><I>2010 Inducement Plan</I></B>&#148;, and the Dynavax
Technologies Corporation 1997 Equity Incentive Plan (the &#147;<B><I>1997 Plan</I></B>,&#148; and together with the 2004 Plan and the 2010 Inducement Plan, the &#147;<B><I>Prior Plans</I></B>&#148;). Following the Effective Date, no additional stock
awards shall be granted under the Prior Plans. Any available shares that, as of the Effective Date, are reserved under the Prior Plans but not subject to stock awards that have been granted under the Prior Plans as of the Effective Date, <I>less</I>
any shares that may be added to the 2004 Plan share reserve on the first business day in 2011 by operation of the evergreen provision in Section&nbsp;3(a) of the 2004 Plan (such number of available shares, the &#147;<B><I>Prior Plans&#146; Available
Reserve</I></B>&#148;) shall become available for issuance pursuant to Stock Awards granted hereunder. From and after the Effective Date, all outstanding stock awards granted under the Prior Plans shall remain subject to the terms of the applicable
Prior Plan; <I>provided, however</I>, any shares subject to outstanding stock awards granted under the Prior Plans that expire or terminate for any reason prior to exercise or settlement or are forfeited because of the failure to meet a contingency
or condition required to vest such shares, to the extent such shares would have otherwise returned to a Prior Plan in accordance with its terms had such Prior Plan been in active existence at such time, (such shares, the &#147;<B><I>Returning
Shares</I></B>&#148;) shall become available for issuance pursuant to Awards granted hereunder as provided in Section&nbsp;3(a) below. All Awards granted on or after the Effective Date of this Plan shall be subject to the terms of this Plan.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) Eligible Award Recipients.</B> The persons eligible to receive Awards are Employees, Directors and Consultants.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) Available Awards.</B> The Plan provides for the grant of the following Awards: (i)&nbsp;Incentive Stock Options,
(ii)&nbsp;Nonstatutory Stock Options, (iii)&nbsp;Stock Appreciation Rights (iv)&nbsp;Restricted Stock Awards, (v)&nbsp;Restricted Stock Unit Awards, (vi)&nbsp;Performance Stock Awards, (vii)&nbsp;Performance Cash Awards, and (viii)&nbsp;Other Stock
Awards. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(d) Purpose.</B> The Company, by means of the Plan, seeks to secure and retain the services of the group of
persons eligible to receive Awards as set forth in Section&nbsp;1(b)1(a), to provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and to provide a means by which such eligible recipients may
be given an opportunity to benefit from increases in value of the Common Stock through the granting of Awards. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>2.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>DMINISTRATION</SMALL>. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(a) Administration by Board.</B> The Board shall administer the Plan unless and until the Board delegates administration of the Plan to a Committee or Committees, as provided in Section&nbsp;2(c).
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) Powers of Board.</B> The Board shall have the power, subject to, and within the limitations of, the express provisions
of the Plan: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) </B>To determine from time to time (A)&nbsp;which of the persons eligible under the Plan shall be granted
Awards; (B)&nbsp;when and how each Award shall be granted; (C)&nbsp;what type or combination of types of Award shall </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-1
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
be granted; (D)&nbsp;the provisions of each Award granted (which need not be identical), including the time or times when a person shall be permitted to receive cash or Common Stock pursuant to a
Stock Award; (E)&nbsp;the number of shares of Common Stock with respect to which a Stock Award shall be granted to each such person; and (F)&nbsp;the Fair Market Value applicable to a Stock Award. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) </B>To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for
its administration. The Board, in the exercise of this power, may correct any defect, omission or inconsistency in the Plan or in any Stock Award Agreement or in the written terms of a Performance Cash Award, in a manner and to the extent it shall
deem necessary or expedient to make the Plan or Award fully effective. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) </B>To settle all controversies regarding the
Plan and Awards granted under it. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iv) </B>To accelerate the time at which an Award may first be exercised or the time
during which an Award or any part thereof will vest in accordance with the Plan, notwithstanding the provisions in the Award stating the time at which it may first be exercised or the time during which it will vest. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(v) </B>To suspend or terminate the Plan at any time. Suspension or termination of the Plan shall not impair rights and obligations
under any Award granted while the Plan is in effect except with the written consent of the affected Participant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(vi)
</B>To amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, by adopting amendments relating to Incentive Stock Options and certain nonqualified deferred compensation under Section&nbsp;409A of the Code
and/or to bring the Plan or Awards granted under the Plan into compliance therewith, subject to the limitations, if any, of applicable law. However, except as provided in Section&nbsp;9(a) relating to Capitalization Adjustments, to the extent
required by applicable law or listing requirements, stockholder approval shall be required for any amendment of the Plan that either (A)&nbsp;materially increases the number of shares of Common Stock available for issuance under the Plan,
(B)&nbsp;materially expands the class of individuals eligible to receive Awards under the Plan, (C)&nbsp;materially increases the benefits accruing to Participants under the Plan or materially reduces the price at which shares of Common Stock may be
issued or purchased under the Plan, (D)&nbsp;materially extends the term of the Plan, or (E)&nbsp;expands the types of Awards available for issuance under the Plan. Except as provided above, rights under any Award granted before amendment of the
Plan shall not be impaired by any amendment of the Plan unless (1)&nbsp;the Company requests the consent of the affected Participant, and (2)&nbsp;such Participant consents in writing. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(vii) </B>To submit any amendment to the Plan for stockholder approval, including, but not limited to, amendments to the Plan intended
to satisfy the requirements of (A)&nbsp;Section 162(m)&nbsp;of the Code regarding the exclusion of performance-based compensation from the limit on corporate deductibility of compensation paid to Covered Employees, (B)&nbsp;Section 422 of the Code
regarding &#147;incentive stock options&#148; or (C)&nbsp;Rule 16b-3. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(viii) </B>To approve forms of Award Agreements for
use under the Plan and to amend the terms of any one or more Awards, including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to any specified limits in the
Plan that are not subject to Board discretion; <I>provided however</I>, that except with respect to amendments that disqualify or impair the status of an Incentive Stock Option, a Participant&#146;s rights under any Award shall not be impaired by
any such amendment unless (A)&nbsp;the Company requests the consent of the affected Participant, and (B)&nbsp;such Participant consents in writing. Notwithstanding the foregoing, subject to the limitations of applicable law, if any, the Board may
amend the terms of any one or more Awards without the affected Participant&#146;s consent if necessary to maintain the qualified status of the Award as an Incentive Stock Option or to bring the Award into compliance with Section&nbsp;409A of the
Code. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-2
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ix) </B>Generally, to exercise such powers and to perform such acts as the Board deems
necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Awards. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(x) </B>To adopt such procedures and sub-plans as are necessary or appropriate to permit participation in the Plan by Employees, Directors or Consultants who are foreign nationals or employed outside
the United States. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) Delegation to Committee.</B> </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) General.</B> The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration
of the Plan is delegated to a Committee, the Committee shall have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to a
subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board shall thereafter be to the Committee or subcommittee), subject, however, to such resolutions, not
inconsistent with the provisions of the Plan, as may be adopted from time to time by the Board. The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the
powers previously delegated. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) Section&nbsp;162(m)&nbsp;and Rule 16b-3 Compliance.</B> The Committee may consist solely
of two or more Outside Directors, in accordance with Section&nbsp;162(m)&nbsp;of the Code, or solely of two or more Non-Employee Directors, in accordance with Rule 16b-3. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(d) Delegation to an Officer. </B>The Board may delegate to one (1)&nbsp;or more Officers the authority to do one or both of the following (i)&nbsp;designate Employees who are providing Continuous
Service to the Company or any of its Subsidiaries who are not Officers to be recipients of Options and Stock Appreciation Rights (and, to the extent permitted by applicable law, other Stock Awards) and the terms thereof, and (ii)&nbsp;determine the
number of shares of Common Stock to be subject to such Stock Awards granted to such Employees; <I>provided, however</I>, that the Board resolutions regarding such delegation shall specify the total number of shares of Common Stock that may be
subject to the Stock Awards granted by such Officer and that such Officer may not grant a Stock Award to himself or herself. Notwithstanding the foregoing, the Board may not delegate authority to an Officer to determine the Fair Market Value
pursuant to Section&nbsp;13(w)(iii) below. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(e) Effect of Board&#146;s Decision.</B> All determinations, interpretations
and constructions made by the Board in good faith shall not be subject to review by any person and shall be final, binding and conclusive on all persons. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(f) Cancellation and Re-Grant of Stock Awards</B>. Neither the Board nor any Committee shall have the authority to: (i)&nbsp;reduce the exercise price of any outstanding Options or Stock Appreciation
Rights under the Plan, or (ii)&nbsp;cancel any outstanding Options or Stock Appreciation Rights that have an exercise price or strike price greater than the current Fair Market Value of the Common Stock in exchange for cash or other Stock Awards
under the Plan, unless the stockholders of the Company have approved such an action within twelve (12)&nbsp;months prior to such an event. Notwithstanding the foregoing, the Board or Committee shall have the authority, without the approval of the
Company&#146;s stockholders, to cancel outstanding Options or Stock Appreciation Rights that have an exercise price or strike price greater than the current Fair Market Value of the Common Stock in exchange only for a nominal cash payment of
consideration as necessary to effect a cancellation of the Award, provided that such cancellation is not treated as a repricing under United States generally accepted accounting principles. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>3.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>S<SMALL>HARES</SMALL> S<SMALL>UBJECT</SMALL> <SMALL>TO</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) Share Reserve. </B>Subject to Section&nbsp;9(a) relating to Capitalization Adjustments, the aggregate number of shares of Common
Stock that may be issued pursuant to Stock Awards from and after the Effective Date shall not </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-3
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
exceed 22,934,429 shares (the &#147;<B><I>Share Reserve</I></B>&#148;), which number is the sum of (i)&nbsp;the number of shares subject to the Prior Plans&#146; Available Reserve, (ii)&nbsp;an
additional Fifteen Million (15,000,000)&nbsp;new shares, plus (iii)&nbsp;an additional number of shares in an amount not to exceed 7,934,429 shares (which number consists of the Returning Shares, if any, as such shares become available from time to
time). For clarity, the limitation in this Section&nbsp;3(a) is a limitation on the number of shares of Common Stock that may be issued pursuant to the Plan. Accordingly, this Section&nbsp;3(a) does not limit the granting of Stock Awards except as
provided in Section&nbsp;7(a). Shares may be issued in connection with a merger or acquisition as permitted by NASDAQ Listing Rule 5635(c)&nbsp;or, if applicable, NYSE Listed Company Manual Section&nbsp;303A.08, AMEX Company Guide Section&nbsp;711
or other applicable rule, and such issuance shall not reduce the number of shares available for issuance under the Plan. Furthermore, if a Stock Award or any portion thereof (i)&nbsp;expires or otherwise terminates without all of the shares covered
by such Stock Award having been issued or (ii)&nbsp;is settled in cash (<I>i.e.</I>, the Participant receives cash rather than stock), such expiration, termination or settlement shall not reduce (or otherwise offset)&nbsp;the number of shares of
Common Stock that may be available for issuance under the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) Reversion of Shares to the Share Reserve. </B>If any
shares of Common Stock issued pursuant to a Stock Award are forfeited back to or repurchased by the Company because of the failure to meet a contingency or condition required to vest such shares in the Participant, then the shares that are forfeited
or repurchased shall revert to and again become available for issuance under the Plan. If any shares subject to a Stock Award are not delivered to a Participant because the Stock Award is exercised or settled through a reduction of shares subject to
the Stock Award (<I>i.e</I>., &#147;net exercised&#148; or &#147;net settled&#148;), or because the shares are withheld to cover applicable tax withholdings as described in Section&nbsp;8(g) below, the number of shares that are not delivered to the
Participant shall not remain available for issuance under the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) Incentive Stock Option Limit. </B>Notwithstanding
anything to the contrary in this Section&nbsp;3 and, subject to the provisions of Section&nbsp;9(a) relating to Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of
Incentive Stock Options shall be Fifty Million (50,000,000)&nbsp;shares of Common Stock. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(d)
Section&nbsp;162(m)&nbsp;Limitation on Annual Grants</B>. Subject to the provisions of Section&nbsp;9(a) relating to Capitalization Adjustments, at such time as the Company may be subject to the applicable provisions of Section&nbsp;162(m)&nbsp;of
the Code, a maximum of Two Million (2,000,000)&nbsp;shares of Common Stock subject to Options, Stock Appreciation Rights and Other Stock Awards whose value is determined by reference to an increase over an exercise or strike price of at least one
hundred percent (100%)&nbsp;of the Fair Market Value on the date the Stock Award is granted may be granted to any Participant during any calendar year. Notwithstanding the foregoing, if any additional Options, Stock Appreciation Rights or Other
Stock Awards whose value is determined by reference to an increase over an exercise or strike price of at least one hundred (100% percent)&nbsp;of the Fair Market Value on the date the Stock Award are granted to any Participant during any calendar
year, compensation attributable to the exercise of such additional Stock Awards shall not satisfy the requirements to be considered &#147;qualified performance-based compensation&#148; under Section&nbsp;162(m)&nbsp;of the Code unless such
additional Stock Awards are approved by the Company&#146;s stockholders. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(e) Source of Shares.</B> The stock issuable
under the Plan shall be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market or otherwise. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>4.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>LIGIBILITY</SMALL>.</B> </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(a) Eligibility for Specific Stock Awards</B>. Incentive Stock Options may be granted only to employees of the Company or a &#147;parent corporation&#148; or &#147;subsidiary corporation&#148; thereof
(as such terms are defined in Sections 424(e)&nbsp;and (f)&nbsp;of the Code). Stock Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants; <I>provided, however</I>, Nonstatutory Stock Options and SARs may
not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &#147;parent&#148; of the Company, as such term is defined in Rule&nbsp;405, unless the stock underlying such Stock Awards is treated as
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-4
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
&#147;service recipient stock&#148; under Section&nbsp;409A of the Code because the Stock Awards are granted pursuant to a corporate transaction (such as a spin off transaction)&nbsp;or unless
such Stock Awards comply with the distribution requirements of Section&nbsp;409A of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) Ten Percent
Stockholders.</B> A Ten Percent Stockholder shall not be granted an Incentive Stock Option unless the exercise price of such Option is at least one hundred ten percent (110%)&nbsp;of the Fair Market Value on the date of grant and the Option is not
exercisable after the expiration of five (5)&nbsp;years from the date of grant. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>5.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>P<SMALL>ROVISIONS</SMALL> <SMALL>RELATING</SMALL> <SMALL>TO</SMALL> O<SMALL>PTIONS</SMALL> <SMALL>AND</SMALL> S<SMALL>TOCK</SMALL> A<SMALL>PPRECIATION</SMALL>
R<SMALL>IGHTS</SMALL>.</B> </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Each Option or SAR shall be in such form and shall contain such terms and conditions
as the Board shall deem appropriate. All Options shall be separately designated Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate certificate or certificates shall be issued for
shares of Common Stock purchased on exercise of each type of Option. If an Option is not specifically designated as an Incentive Stock Option, then the Option shall be a Nonstatutory Stock Option. The provisions of separate Options or SARs need not
be identical; <I>provided, however</I>, that each Option Agreement or Stock Appreciation Right Agreement shall conform to (through incorporation of provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of each
of the following provisions: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) Term.</B> Subject to the provisions of Section&nbsp;4(b) regarding Ten Percent
Stockholders, no Option or SAR shall be exercisable after the expiration of ten (10)&nbsp;years from the date of its grant or such shorter period specified in the Award Agreement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) Exercise Price.</B> Subject to the provisions of Section&nbsp;4(b) regarding Ten Percent Stockholders, the exercise price (or
strike price)&nbsp;of each Option or SAR shall be not less than one hundred percent (100%)&nbsp;of the Fair Market Value of the Common Stock subject to the Option or SAR on the date the Option or SAR is granted. Notwithstanding the foregoing, an
Option or SAR may be granted with an exercise price (or strike price)&nbsp;lower than one hundred percent (100%)&nbsp;of the Fair Market Value of the Common Stock subject to the Option or SAR if such Option or SAR is granted pursuant to an
assumption of or substitution for another option or stock appreciation right pursuant to a Corporate Transaction and in a manner consistent with the provisions of Sections 409A and, if applicable, 424(a)&nbsp;of the Code. Each SAR will be
denominated in shares of Common Stock equivalents. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) Purchase Price for Options.</B> The purchase price of Common Stock
acquired pursuant to the exercise of an Option shall be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment set forth below. The Board shall have the
authority to grant Options that do not permit all of the following methods of payment (or otherwise restrict the ability to use certain methods)&nbsp;and to grant Options that require the consent of the Company to utilize a particular method of
payment. The permitted methods of payment are as follows: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) </B>by cash, check, bank draft or money order payable to the
Company; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) </B>pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that,
prior to the issuance of the stock subject to the Option, results in either the receipt of cash (or check)&nbsp;by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds;
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) </B>by delivery to the Company (either by actual delivery or attestation)&nbsp;of shares of Common Stock;
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iv) </B>if the option is a Nonstatutory Stock Option, by a &#147;net exercise&#148; arrangement pursuant to which the
Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price; <I>provided, however</I>,
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-5
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
that the Company shall accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of
whole shares to be issued; <I>provided, further,</I> that shares of Common Stock will no longer be subject to an Option and will not be exercisable thereafter to the extent that (A)&nbsp;shares issuable upon exercise are reduced to pay the exercise
price pursuant to the &#147;net exercise,&#148; (B)&nbsp;shares are delivered to the Participant as a result of such exercise, and (C)&nbsp;shares are withheld to satisfy tax withholding obligations; or </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(v) </B>in any other form of legal consideration that may be acceptable to the Board and specified in the applicable award agreement.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(d) Exercise and Payment of a SAR.</B> To exercise any outstanding Stock Appreciation Right, the Participant must provide
written notice of exercise to the Company in compliance with the provisions of the Stock Appreciation Right Agreement evidencing such Stock Appreciation Right. The appreciation distribution payable on the exercise of a Stock Appreciation Right will
be not greater than an amount equal to the excess of (A)&nbsp;the aggregate Fair Market Value (on the date of the exercise of the Stock Appreciation Right) of a number of shares of Common Stock equal to the number of Common Stock equivalents in
which the Participant is vested under such Stock Appreciation Right, and with respect to which the Participant is exercising the Stock Appreciation Right on such date, over (B)&nbsp;the strike price that will be determined by the Board at the time
of grant of the Stock Appreciation Right. The appreciation distribution in respect to a Stock Appreciation Right may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined by the Board
and contained in the Stock Appreciation Right Agreement evidencing such Stock Appreciation Right. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(e) Transferability of
Options and SARs.</B> The Board may, in its sole discretion, impose such limitations on the transferability of Options and SARs as the Board shall determine. In the absence of such a determination by the Board to the contrary, the following
restrictions on the transferability of Options and SARs shall apply: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) Restrictions on Transfer.</B> An Option or SAR
shall not be transferable except by will or by the laws of descent and distribution and shall be exercisable during the lifetime of the Participant only by the Participant; <I>provided, however</I>, that the Board may, in its sole discretion, permit
transfer of the Option or SAR in a manner that is not prohibited by applicable tax and securities laws upon the Participant&#146;s request. Except as explicitly provided herein, neither an Option nor a SAR may be transferred for consideration.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) Domestic Relations Orders.</B> Notwithstanding the foregoing, an Option or SAR may be transferred pursuant to a
domestic relations order; <I>provided, however</I>, that if an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) Beneficiary Designation.</B> Notwithstanding the foregoing, the Participant may, by delivering written notice to the Company, in
a form provided by or otherwise satisfactory to the Company and any broker designated by the Company to effect Option exercises, designate a third party who, in the event of the death of the Participant, shall thereafter be entitled to exercise the
Option or SAR and receive the Common Stock or other consideration resulting from such exercise. In the absence of such a designation, the executor or administrator of the Participant&#146;s estate shall be entitled to exercise the Option or SAR and
receive the Common Stock or other consideration resulting from such exercise. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(f) Vesting Generally.</B> The total number
of shares of Common Stock subject to an Option or SAR may vest and therefore become exercisable in periodic installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time or times when it
may or may not be exercised (which may be based on the satisfaction of Performance Goals or other criteria)&nbsp;as the Board may deem appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this
Section&nbsp;5(f) are subject to any Option or SAR provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-6
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(g) Termination of Continuous Service.</B> Except as otherwise provided in the applicable
Award Agreement or other agreement between the Participant and the Company, if a Participant&#146;s Continuous Service terminates (other than for Cause or upon the Participant&#146;s death or Disability), the Participant may exercise his or her
Option or SAR (to the extent that the Participant was entitled to exercise such Award as of the date of termination of Continuous Service) but only within such period of time ending on the earlier of (i)&nbsp;the date three (3)&nbsp;months following
the termination of the Participant&#146;s Continuous Service (or such longer or shorter period specified in the applicable Award Agreement), or (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after
termination of Continuous Service, the Participant does not exercise his or her Option or SAR within the time specified herein or in the Award Agreement (as applicable), the Option or SAR shall terminate. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(h) Extension of Termination Date.</B> If the exercise of an Option or SAR following the termination of the Participant&#146;s
Continuous Service (other than for Cause or upon the Participant&#146;s death or Disability)&nbsp;would be prohibited at any time solely because the issuance of shares of Common Stock would violate the registration requirements under the Securities
Act, then the Option or SAR shall terminate on the earlier of (i)&nbsp;the expiration of a total period of three (3)&nbsp;months (that need not be consecutive)&nbsp;after the termination of the Participant&#146;s Continuous Service during which the
exercise of the Option or SAR would not be in violation of such registration requirements, or (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the applicable Award Agreement. In addition, unless otherwise provided in a
Participant&#146;s Award Agreement, if the sale of any Common Stock received upon exercise of an Option or SAR following the termination of the Participant&#146;s Continuous Service (other than for Cause)&nbsp;would violate the Company&#146;s
insider trading policy, then the Option or SAR shall terminate on the earlier of (i)&nbsp;the expiration of a period equal to the applicable post-termination exercise period after the termination of the Participant&#146;s Continuous Service during
which the sale of the Common Stock received upon exercise of the Option or SAR would not be in violation of the Company&#146;s insider trading policy, or (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the applicable Award
Agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) Disability of Participant.</B> Except as otherwise provided in the applicable Award Agreement or other
agreement between the Participant and the Company, if a Participant&#146;s Continuous Service terminates as a result of the Participant&#146;s Disability, the Participant may exercise his or her Option or SAR (to the extent that the Participant was
entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i)&nbsp;the date twelve (12)&nbsp;months following such termination of Continuous Service (or
such longer or shorter period specified in the Award Agreement), or (ii)&nbsp;the expiration of the term of the Option or SAR as set forth in the Award Agreement. If, after termination of Continuous Service, the Participant does not exercise his or
her Option or SAR within the time specified herein or in the Award Agreement (as applicable), the Option or SAR (as applicable)&nbsp;shall terminate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(j) Death of Participant.</B> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and the Company, if (i)&nbsp;a Participant&#146;s Continuous
Service terminates as a result of the Participant&#146;s death, or (ii)&nbsp;the Participant dies within the period (if any) specified in the Award Agreement after the termination of the Participant&#146;s Continuous Service for a reason other than
death, then the Option or SAR may be exercised (to the extent the Participant was entitled to exercise such Option or SAR as of the date of death) by the Participant&#146;s estate, by a person who acquired the right to exercise the Option or SAR by
bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant&#146;s death, but only within the period ending on the earlier of (i)&nbsp;the date eighteen (18)&nbsp;months following the date of death (or such
longer or shorter period specified in the Award Agreement), or (ii)&nbsp;the expiration of the term of such Option or SAR as set forth in the Award Agreement. If, after the Participant&#146;s death, the Option or SAR is not exercised within the time
specified herein or in the Award Agreement (as applicable), the Option or SAR shall terminate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(k) Termination for
Cause.</B> Except as explicitly provided otherwise in a Participant&#146;s Award Agreement, if a Participant&#146;s Continuous Service is terminated for Cause, the Option or SAR shall terminate upon the date on which the event giving rise to the
termination occurred, and the Participant shall be prohibited from exercising his or her Option or SAR from and after the time of such termination of Continuous Service. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-7
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(l) Non-Exempt Employees</B>. No Option or SAR granted to an Employee who is a non-exempt
employee for purposes of the Fair Labor Standards Act of 1938, as amended, shall be first exercisable for any shares of Common Stock until at least six (6)&nbsp;months following the date of grant of the Option or SAR. Notwithstanding the foregoing,
consistent with the provisions of the Worker Economic Opportunity Act, (i)&nbsp;in the event of the Participant&#146;s death or Disability, (ii)&nbsp;upon a Corporate Transaction in which such Option or SAR is not assumed, continued, or substituted,
(iii)&nbsp;upon a Change in Control, or (iv)&nbsp;upon the Participant&#146;s retirement (as such term may be defined in the Participant&#146;s Award Agreement or in another applicable agreement or in accordance with the Company&#146;s then current
employment policies and guidelines), any such vested Options and SARs may be exercised earlier than six months following the date of grant. The foregoing provision is intended to operate so that any income derived by a non-exempt employee in
connection with the exercise or vesting of an Option or SAR will be exempt from his or her regular rate of pay. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>6.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B></B><B>P<SMALL>ROVISIONS</SMALL> <SMALL>OF</SMALL> S<SMALL>TOCK</SMALL> A<SMALL>WARDS</SMALL> <SMALL>OTHER</SMALL> <SMALL>THAN</SMALL> O<SMALL>PTIONS</SMALL>
<SMALL>AND</SMALL> SAR<SMALL>S</SMALL>.</B> </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) Restricted Stock Awards.</B> Each Restricted Stock Award
Agreement shall be in such form and shall contain such terms and conditions as the Board shall deem appropriate. To the extent consistent with the Company&#146;s Bylaws, at the Board&#146;s election, shares of Common Stock may be (x)&nbsp;held in
book entry form subject to the Company&#146;s instructions until any restrictions relating to the Restricted Stock Award lapse; or (y)&nbsp;evidenced by a certificate, which certificate shall be held in such form and manner as determined by the
Board. The terms and conditions of Restricted Stock Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Award Agreements need not be identical; <I>provided, however</I>, that each Restricted Stock
Award Agreement shall conform to (through incorporation of the provisions hereof by reference in the agreement or otherwise)&nbsp;the substance of each of the following provisions: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) Consideration.</B> A Restricted Stock Award may be awarded in consideration for (A)&nbsp;cash, check, bank draft or money order
payable to the Company, (B)&nbsp;past services to the Company or an Affiliate, or (C)&nbsp;any other form of legal consideration (including future services)&nbsp;that may be acceptable to the Board, in its sole discretion, and permissible under
applicable law. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) Vesting. </B>Shares of Common Stock awarded under the Restricted Stock Award Agreement may be subject
to forfeiture to the Company in accordance with a vesting schedule to be determined by the Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) Termination of
Participant&#146;s Continuous Service.</B> If a Participant&#146;s Continuous Service terminates, the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant that have
not vested as of the date of termination of Continuous Service under the terms of the Restricted Stock Award Agreement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iv) Transferability.</B> Rights to acquire shares of Common Stock under the Restricted Stock Award Agreement shall be transferable by
the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board shall determine in its sole discretion, so long as Common Stock awarded under the Restricted Stock Award Agreement remains
subject to the terms of the Restricted Stock Award Agreement. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(v) Dividends. </B>A Restricted Stock Award Agreement may
provide that any dividends paid on Restricted Stock will be subject to the same vesting and forfeiture restrictions as apply to the shares subject to the Restricted Stock Award to which they relate. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) Restricted Stock Unit Awards. </B>Each Restricted Stock Unit Award Agreement shall be in such form and shall contain such terms
and conditions as the Board shall deem appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Unit Award Agreements need not be
identical; <I>provided, however</I>, that each Restricted </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-8
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Stock Unit Award Agreement shall conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise)&nbsp;the substance of each of the following provisions:
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) Consideration.</B> At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration,
if any, to be paid by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to be paid (if any)&nbsp;by the Participant for each share of Common Stock subject to a Restricted Stock
Unit Award may be paid in any form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) Vesting. </B>At the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions on or conditions to the vesting of the Restricted Stock Unit Award as it, in its sole
discretion, deems appropriate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) Payment</B>. A Restricted Stock Unit Award may be settled by the delivery of shares
of Common Stock, their cash equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iv) Additional Restrictions. </B>At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may
impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent)&nbsp;subject to a Restricted Stock Unit Award to a time after the vesting of such Restricted Stock Unit Award. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(v) Dividend Equivalents. </B>Dividend equivalents may be credited in respect of shares of Common Stock covered by a Restricted Stock
Unit Award, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. At the sole discretion of the Board, such dividend equivalents may be converted into additional shares of Common Stock covered by the Restricted Stock
Unit Award in such manner as determined by the Board. Any additional shares covered by the Restricted Stock Unit Award credited by reason of such dividend equivalents will be subject to all of the same terms and conditions of the underlying
Restricted Stock Unit Award Agreement to which they relate. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(vi) Termination of Participant&#146;s Continuous Service.
</B>Except as otherwise provided in the applicable Restricted Stock Unit Award Agreement, such portion of the Restricted Stock Unit Award that has not vested will be forfeited upon the Participant&#146;s termination of Continuous Service.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) Performance Awards.</B> </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(i) Performance Stock Awards</B>. A Performance Stock Award is a Stock Award that may vest or may be exercised contingent upon the attainment during a Performance Period of certain Performance Goals. A
Performance Stock Award may, but need not, require the completion of a specified period of Continuous Service. The length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and
to what degree such Performance Goals have been attained shall be conclusively determined by the Committee, in its sole discretion. The maximum number of shares covered by an Award that may be granted to any Participant in a calendar year
attributable to Stock Awards described in this Section&nbsp;6(c)(i) (whether the grant, vesting or exercise is contingent upon the attainment during a Performance Period of the Performance Goals)&nbsp;shall not exceed One Million Five Hundred
Thousand (1,500,000)&nbsp;shares of Common Stock. The Board may provide for or, subject to such terms and conditions as the Board may specify, may permit a Participant to elect for, the payment of any Performance Stock Award to be deferred to a
specified date or event. In addition, to the extent permitted by applicable law and the applicable Award Agreement, the Board may determine that cash may be used in payment of Performance Stock Awards. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) Performance Cash Awards</B>. A Performance Cash Award is a cash award that may be paid contingent upon the attainment during a
Performance Period of certain Performance Goals. A Performance Cash </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-9
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Award may also require the completion of a specified period of Continuous Service. At the time of grant of a Performance Cash Award, the length of any Performance Period, the Performance Goals to
be achieved during the Performance Period, and the measure of whether and to what degree such Performance Goals have been attained shall be conclusively determined by the Committee, in its sole discretion. In any calendar year, the Committee may not
grant a Performance Cash Award that has a maximum value that may be paid to any Participant in excess of Five Million dollars ($5,000,000). The Board may provide for or, subject to such terms and conditions as the Board may specify, may permit a
Participant to elect for, the payment of any Performance Cash Award to be deferred to a specified date or event. The Board may specify the form of payment of Performance Cash Awards, which may be cash or other property, or may provide for a
Participant to have the option for his or her Performance Cash Award, or such portion thereof as the Board may specify, to be paid in whole or in part in cash or other property. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) Section&nbsp;162(m)&nbsp;Compliance</B>. Unless otherwise permitted in compliance with the requirements of
Section&nbsp;162(m)&nbsp;of the Code with respect to an Award intended to qualify as &#147;performance-based compensation&#148; thereunder, the Committee shall establish the Performance Goals applicable to, and the formula for calculating the amount
payable under, the Award no later than the earlier of (a)&nbsp;the date ninety (90)&nbsp;days after the commencement of the applicable Performance Period, or (b)&nbsp;the date on which twenty-five percent (25%)&nbsp;of the Performance Period has
elapsed, and in any event at a time when the achievement of the applicable Performance Goals remains substantially uncertain. Prior to the payment of any compensation under an Award intended to qualify as &#147;performance-based compensation&#148;
under Section&nbsp;162(m)&nbsp;of the Code, the Committee shall certify the extent to which any Performance Goals and any other material terms under such Award have been satisfied (other than in cases where such relate solely to the increase in the
value of the Common Stock). Notwithstanding satisfaction of any completion of any Performance Goals, to the extent specified at the time of grant of an Award to &#147;covered employees&#148; within the meaning of Section&nbsp;162(m)&nbsp;of the
Code, the number of shares of Common Stock, Options, cash or other benefits granted, issued, retainable and/or vested under an Award on account of satisfaction of such Performance Goals may be reduced by the Committee on the basis of such further
considerations as the Committee, in its sole discretion, shall determine. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(d) Other Stock Awards</B>. Other forms of Stock
Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof may be granted either alone or in addition to Stock Awards provided for under Section&nbsp;5 and the preceding
provisions of this Section&nbsp;6. Subject to the provisions of the Plan, the Board shall have sole and complete authority to determine the persons to whom and the time or times at which such Other Stock Awards will be granted, the number of shares
of Common Stock (or the cash equivalent thereof)&nbsp;to be granted pursuant to such Other Stock Awards and all other terms and conditions of such Other Stock Awards. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>7.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>OVENANTS</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> C<SMALL>OMPANY</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) Availability of Shares.</B> During the terms of the Stock Awards, the Company shall keep available at all times the number of
shares of Common Stock reasonably required to satisfy such Stock Awards. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) Securities Law Compliance.</B> The Company
shall seek to obtain from each regulatory commission or agency having jurisdiction over the Plan such authority as may be required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise of the Stock Awards; <I>provided,
however</I>, that this undertaking shall not require the Company to register under the Securities Act the Plan, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts, the Company is
unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company shall be relieved from any liability for failure
to issue and sell Common Stock upon exercise of such Stock Awards unless and until such authority is obtained. A Participant shall not be eligible for the grant of a Stock Award or the subsequent issuance of Common Stock pursuant to the Stock Award
if such grant or issuance would be in violation of any applicable securities law. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-10
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) No Obligation to Notify or Minimize Taxes. </B>The Company shall have no duty or
obligation to any Participant to advise such holder as to the time or manner of exercising such Stock Award. Furthermore, the Company shall have no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of
a Stock Award or a possible period in which the Stock Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of a Stock Award to the holder of such Stock Award. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>8.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>M<SMALL>ISCELLANEOUS</SMALL>. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(a) Use of Proceeds from Sales of Common Stock. </B>Proceeds from the sale of shares of Common Stock pursuant to Stock Awards shall constitute general funds of the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) Corporate Action Constituting Grant of Stock Awards.</B> Corporate action constituting a grant by the Company of a Stock Award to
any Participant shall be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Stock Award is communicated to, or actually
received or accepted by, the Participant. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) Stockholder Rights.</B> No Participant shall be deemed to be the holder of,
or to have any of the rights of a holder with respect to, any shares of Common Stock subject to such Stock Award unless and until (i)&nbsp;such Participant has satisfied all requirements for exercise of the Stock Award pursuant to its terms, if
applicable, and (ii)&nbsp;the issuance of the Common Stock subject to such Stock Award has been entered into the books and records of the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(d) No Employment or Other Service Rights.</B> Nothing in the Plan, any Stock Award Agreement or any other instrument executed thereunder or in connection with any Award granted pursuant thereto shall
confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Stock Award was granted or shall affect the right of the Company or an Affiliate to terminate (i)&nbsp;the employment of
an Employee with or without notice and with or without cause, (ii)&nbsp;the service of a Consultant pursuant to the terms of such Consultant&#146;s agreement with the Company or an Affiliate, or (iii)&nbsp;the service of a Director pursuant to the
Bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(e) Incentive Stock Option $100,000 Limitation.</B> To the extent that the aggregate Fair Market Value (determined at the time of
grant)&nbsp;of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and any Affiliates)&nbsp;exceeds one hundred thousand dollars
($100,000), the Options or portions thereof that exceed such limit (according to the order in which they were granted)&nbsp;shall be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of the applicable Option Agreement(s).
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(f) Investment Assurances.</B> The Company may require a Participant, as a condition of exercising or acquiring Common
Stock under any Stock Award, (i)&nbsp;to give written assurances satisfactory to the Company as to the Participant&#146;s knowledge and experience in financial and business matters and/or to employ a purchaser representative reasonably satisfactory
to the Company who is knowledgeable and experienced in financial and business matters and that he or she is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the Stock Award; and
(ii)&nbsp;to give written assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Stock Award for the Participant&#146;s own account and not with any present intention of selling or otherwise
distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, shall be inoperative if (A)&nbsp;the issuance of the shares upon the exercise or acquisition of Common Stock under the Stock Award has
been registered under a then currently effective registration statement under the Securities Act, or (B)&nbsp;as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the
circumstances under the then applicable securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with
applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-11
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(g) Withholding Obligations.</B> Unless prohibited by the terms of a Stock Award
Agreement, the Company may, in its sole discretion, satisfy any federal, state or local tax withholding obligation relating to an Award by any of the following means or by a combination of such means: (i)&nbsp;causing the Participant to tender a
cash payment; (ii)&nbsp;withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Award; <I>provided, however</I>, that no shares of Common Stock are withheld with a
value exceeding the minimum amount of tax required to be withheld by law (or such lesser amount as may be necessary to avoid classification of the Stock Award as a liability for financial accounting purposes); (iii)&nbsp;withholding cash from an
Award settled in cash; (iv)&nbsp;withholding payment from any amounts otherwise payable to the Participant; or (v)&nbsp;by such other method as may be set forth in the Award Agreement. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(h) Electronic Delivery</B>. Any reference herein to a &#147;written&#148; agreement or document shall include any agreement or
document delivered electronically, filed publicly with at www.sec.gov (or any successor website thereto)&nbsp;or posted on the Company&#146;s intranet. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(i) Deferrals.</B> To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or
settlement of all or a portion of any Award may be deferred and may establish programs and procedures for deferral elections to be made by Participants. Deferrals by Participants will be made in accordance with Section&nbsp;409A of the Code.
Consistent with Section&nbsp;409A of the Code, the Board may provide for distributions while a Participant is still an employee or otherwise providing services to the Company. The Board is authorized to make deferrals of Awards and determine when,
and in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant&#146;s termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the
Plan and in accordance with applicable law. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(j) Compliance with Section&nbsp;409A. </B>To the extent that the Board
determines that any Award granted hereunder is subject to Section&nbsp;409A of the Code, the Award Agreement evidencing such Award shall incorporate the terms and conditions necessary to avoid the consequences specified in
Section&nbsp;409A(a)(1)&nbsp;of the Code. To the extent applicable, the Plan and Award Agreements shall be interpreted in accordance with Section&nbsp;409A of the Code. Notwithstanding anything to the contrary in this Plan (and unless the Award
Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded and a Participant holding an Award that constitutes &#147;deferred compensation&#148; under Section&nbsp;409A of the Code is a &#147;specified
employee&#148; for purposes of Section&nbsp;409A of the Code, no distribution or payment of any amount shall be made upon a &#147;separation from service&#148; before a date that is six (6)&nbsp;months following the date of such Participant&#146;s
&#147;separation from service&#148; (as defined in Section&nbsp;409A of the Code without regard to alternative definitions thereunder)&nbsp;or, if earlier, the date of the Participant&#146;s death, unless such distribution or payment can be made in
a manner that complies with Section&nbsp;409A of the Code. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>9.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>A<SMALL>DJUSTMENTS</SMALL> <SMALL>UPON</SMALL> C<SMALL>HANGES</SMALL> <SMALL>IN</SMALL> C<SMALL>OMMON</SMALL> S<SMALL>TOCK</SMALL>; O<SMALL>THER</SMALL>
C<SMALL>ORPORATE</SMALL> E<SMALL>VENTS</SMALL>.</B> </FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) Capitalization Adjustments</B>. In the event of a
Capitalization Adjustment, the Board shall appropriately and proportionately adjust: (i)&nbsp;the class(es)&nbsp;and maximum number of securities subject to the Plan pursuant to Section&nbsp;3(a), (ii)&nbsp;the class(es)&nbsp;and maximum number of
securities that may be issued pursuant to the exercise of Incentive Stock Options pursuant to Section&nbsp;3(c), (iii)&nbsp;the class(es)&nbsp;and maximum number of securities that may be awarded to any person pursuant to Sections 3(d) and 6(c)(i),
and (iv)&nbsp;the class(es)&nbsp;and number of securities and price per share of stock subject to outstanding Stock Awards. The Board shall make such adjustments, and its determination shall be final, binding and conclusive. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) Dissolution or Liquidation</B>. Except as otherwise provided in the Stock Award Agreement, in the event of a dissolution or
liquidation of the Company, all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#146;s right of repurchase)&nbsp;shall terminate
immediately prior to the completion of such dissolution or liquidation, and the shares of Common Stock subject to the Company&#146;s repurchase rights or subject to a </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-12
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Stock Award is providing Continuous Service, <I>provided, however</I>, that
the Board may, in its sole discretion, cause some or all Stock Awards to become fully vested, exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Stock Awards have not previously expired or terminated)&nbsp;before
the dissolution or liquidation is completed but contingent on its completion. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) Corporate Transaction.</B> The following
provisions shall apply to Stock Awards in the event of a Corporate Transaction unless otherwise provided in the instrument evidencing the Stock Award or any other written agreement between the Company or any Affiliate and the holder of the Stock
Award or unless otherwise expressly provided by the Board at the time of grant of a Stock Award. In the event of a Corporate Transaction, then, notwithstanding any other provision of the Plan, the Board shall take one or more of the following
actions with respect to Stock Awards, contingent upon the closing or completion of the Corporate Transaction: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i)
</B>arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#146;s parent company)&nbsp;to assume or continue the Stock Award or to substitute a similar stock award for the Stock Award (including,
but not limited to, an award to acquire the same consideration paid to the stockholders of the Company pursuant to the Corporate Transaction); </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) </B>arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to the Stock Award to the surviving corporation or acquiring
corporation (or the surviving or acquiring corporation&#146;s parent company); </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) </B>accelerate the vesting of the
Stock Award (and, if applicable, the time at which the Stock Award may be exercised)&nbsp;to a date prior to the effective time of such Corporate Transaction as the Board shall determine (or, if the Board shall not determine such a date, to the date
that is five (5)&nbsp;days prior to the effective date of the Corporate Transaction), with such Stock Award terminating if not exercised (if applicable)&nbsp;at or prior to the effective time of the Corporate Transaction; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iv) </B>arrange for the lapse of any reacquisition or repurchase rights held by the Company with respect to the Stock Award;
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(v) </B>cancel or arrange for the cancellation of the Stock Award, to the extent not vested or not exercised prior to the
effective time of the Corporate Transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider appropriate; and </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(vi) </B>make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A)&nbsp;the value of the property the Participant would have received upon the exercise of the
Stock Award immediately prior to the effective time of the Corporate Transaction, over (B)&nbsp;any exercise price payable by such holder in connection with such exercise. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The Board need not take the same action or actions with respect to all Stock Awards or portions thereof or with respect to all Participants. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(d) Change in Control.</B> A Stock Award may be subject to additional acceleration of vesting and exercisability upon or after a
Change in Control as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written agreement between the Company or any Affiliate and the Participant. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(e) Parachute Payments. </B>Unless otherwise provided in an agreement between a Participant and the Company, if any payment or benefit
the Participant would receive pursuant to a Change in Control from the Company or otherwise (&#147;<B><I>Payment</I></B>&#148;) would (i)&nbsp;constitute a &#147;parachute payment&#148; within the meaning of Section&nbsp;280G of the Code, and
(ii)&nbsp;but for this sentence, be subject to the excise tax imposed by Section&nbsp;4999 of </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-13
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
the Code (the &#147;<B><I>Excise Tax</I></B>&#148;), then such Payment shall be equal to the Reduced Amount. The &#147;<B><I>Reduced Amount</I></B>&#148; shall be either (x)&nbsp;the largest
portion of the Payment that would result in no portion of the Payment being subject to the Excise Tax or (y)&nbsp;the largest portion, up to and including the total, of the Payment, whichever amount, after taking into account all applicable federal,
state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate), results in the Participant&#146;s receipt, on an after-tax basis, of the greater amount of the Payment notwithstanding that
all or some portion of the Payment may be subject to the Excise Tax. If a reduction in payments or benefits constituting &#147;parachute payments&#148; is necessary so that the Payment equals the Reduced Amount, reduction shall occur in the
following order: (A)&nbsp;reduction of cash payments; (B)&nbsp;cancellation of accelerated vesting of equity awards other than stock options; (C)&nbsp;cancellation of accelerated vesting of stock options; and (D)&nbsp;reduction of other benefits
paid to Employee. Within any such category of payments and benefits (that is, (A), (B), (C)&nbsp;or (D)), a reduction shall occur first with respect to amounts that are not &#147;deferred compensation&#148; within the meaning of Section&nbsp;409A
and then with respect to amounts that are. In the event that acceleration of compensation from a Participant&#146;s equity awards is to be reduced, such acceleration of vesting shall be canceled, subject to the immediately preceding sentence, in the
reverse order of the date of grant. The accounting firm engaged by the Company for general audit purposes as of the day prior to the effective date of the Change in Control shall perform the foregoing calculations. If the accounting firm so engaged
by the Company is serving as accountant or auditor for the individual, entity or group effecting the Change in Control, the Company shall appoint a nationally recognized accounting firm to make the determinations required hereunder. The Company
shall bear all expenses with respect to the determinations by such accounting firm required to be made hereunder. The accounting firm engaged to make the determinations hereunder shall provide its calculations, together with detailed supporting
documentation, to the Participant and the Company within fifteen (15)&nbsp;calendar days after the date on which the Participant&#146;s right to a Payment is triggered (if requested at that time by the Participant or the Company) or such other time
as reasonably requested by the Participant or the Company. Any good faith determinations of the accounting firm made hereunder shall be final, binding and conclusive upon the Participant and the Company. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>10.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>T<SMALL>ERMINATION</SMALL> <SMALL>OR</SMALL> S<SMALL>USPENSION</SMALL> <SMALL>OF</SMALL> <SMALL>THE</SMALL> P<SMALL>LAN</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) Plan Term.</B> The Board may suspend or terminate the Plan at any time. Unless terminated sooner by the Board, the Plan shall
automatically terminate on the day before the tenth (10th)&nbsp;anniversary of the date the Plan is adopted by the Board. No Awards may be granted under the Plan while the Plan is suspended or after it is terminated. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) No Impairment of Rights.</B> Suspension or termination of the Plan shall not impair rights and obligations under any Award granted
while the Plan is in effect except with the written consent of the affected Participant. </FONT></P> <P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>11.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>E<SMALL>FFECTIVE</SMALL> D<SMALL>ATE</SMALL> <SMALL>OF</SMALL> P<SMALL>LAN</SMALL>. </B></FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">The Plan became effective on January&nbsp;5, 2011, which is the date on which the Company filed a Certificate of Amendment of the
Company&#146;s Sixth Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware following the approval of the Plan by the stockholders of the Company. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>12.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>C<SMALL>HOICE</SMALL> <SMALL>OF</SMALL> L<SMALL>AW</SMALL>. </B></FONT></TD></TR></TABLE> <P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2">The law of the State of Delaware shall govern all questions concerning the construction, validity and interpretation of this Plan, without regard to that state&#146;s conflict of laws rules. </FONT></P>
<P STYLE="font-size:18px;margin-top:0px;margin-bottom:0px">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>13.</B></FONT></TD>
<TD ALIGN="left" VALIGN="top"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>D<SMALL>EFINITIONS</SMALL>. </B>As used in the Plan, the following definitions shall apply to the capitalized terms indicated below: </FONT></TD></TR></TABLE>
<P STYLE="margin-top:6px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(a) </B>&#147;<B><I>Affiliate</I></B>&#148; means, at the time of determination, any &#147;parent&#148; or &#147;subsidiary&#148; of
the Company as such terms are defined in Rule 405 of the Securities Act. The Board shall have the authority to determine the time or times at which &#147;parent&#148; or &#147;subsidiary&#148; status is determined within the foregoing definition.
</FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-14
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(b) </B>&#147;<B><I>Award</I></B>&#148; means a Stock Award or a Performance Cash Award.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(c) </B>&#147;<B><I>Award Agreement</I></B>&#148; means a written agreement between the Company and a Participant
evidencing the terms and conditions of an Award. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(d) </B>&#147;<B><I>Board</I></B>&#148; means the Board of Directors of
the Company. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(e) </B>&#147;<B><I>Capitalization Adjustment</I></B>&#148; means any change that is made in, or other events
that occur with respect to, the Common Stock subject to the Plan or subject to any Stock Award after the Effective Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization,
reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring
transaction, as that term is used in Statement of Financial Accounting Standards No.&nbsp;123 (revised). Notwithstanding the foregoing, the conversion of any convertible securities of the Company shall not be treated as a Capitalization Adjustment.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(f) </B>&#147;<B><I>Cause</I></B>&#148; shall have the meaning ascribed to such term in any written agreement between the
Participant and the Company defining such term and, in the absence of such agreement, such term shall mean, with respect to a Participant, the occurrence of any of the following events: (i)&nbsp;the Participant&#146;s theft, dishonesty, willful
misconduct, breach of fiduciary duty for personal profit, or falsification of any Company or Affiliate documents or records; (ii)&nbsp;the Participant&#146;s material failure to abide by the code of conduct or other policies (including, without
limitation, policies relating to confidentiality and reasonable workplace conduct)&nbsp;of the Company or an Affiliate; (iii)&nbsp;the Participant&#146;s unauthorized use, misappropriation, destruction or diversion of any tangible or intangible
asset or corporate opportunity of a the Company or an Affiliate (including, without limitation, the Participant&#146;s improper use or disclosure of confidential or proprietary information of the Company or an Affiliate); (iv)&nbsp;any intentional
act by the Participant which has a material detrimental effect on the reputation or business of the Company or an Affiliate; (v)&nbsp;the Participant&#146;s repeated failure or inability to perform any reasonable assigned duties after written notice
from the Company or an Affiliate, and a reasonable opportunity to cure, such failure or inability; (vi)&nbsp;any material breach by the Participant of any employment or service agreement between the Participant and the Company or an Affiliate, which
breach is not cured pursuant to the terms of such agreement; or (vii)&nbsp;the Participant&#146;s conviction (including any plea of guilty or nolo contendere)&nbsp;of any criminal act involving fraud, dishonesty, misappropriation or moral turpitude,
or which impairs the Participant&#146;s ability to perform his or her duties. Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such
Participant shall have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(g) </B>&#147;<B><I>Change in Control</I></B>&#148; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) </B>any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than fifty
percent (50%)&nbsp;of the combined voting power of the Company&#146;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control shall not be deemed to occur
(A)&nbsp;on account of the acquisition of securities of the Company directly from the Company, (B)&nbsp;on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires
the Company&#146;s securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, or (C)&nbsp;solely because the level of Ownership held by
any Exchange Act Person (the &#147;<I>Subject Person</I>&#148;)&nbsp;exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the
number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence)&nbsp;as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person
becomes the </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-15
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the
Subject Person over the designated percentage threshold, then a Change in Control shall be deemed to occur; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) </B>there
is consummated a merger, consolidation or similar transaction involving (directly or indirectly)&nbsp;the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company
immediately prior thereto do not Own, directly or indirectly, either (A)&nbsp;outstanding voting securities representing more than fifty percent (50%)&nbsp;of the combined outstanding voting power of the surviving Entity in such merger,
consolidation or similar transaction or (B)&nbsp;more than fifty percent (50%)&nbsp;of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially
the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) </B>there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale,
lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than fifty percent (50%)&nbsp;of the combined voting power of the voting securities of which are Owned
by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition; or </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iv) </B>over a period of twelve (12)&nbsp;months or less, individuals who, on the date the Plan is adopted by the Board, are members
of the Board (the &#147;<B><I>Incumbent Board</I></B>&#148;)&nbsp;cease for any reason to constitute at least a majority of the members of the Board; <I>provided, however</I>, that if the appointment or election (or nomination for election)&nbsp;of
any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member shall, for purposes of this Plan, be considered as a member of the Incumbent Board. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2">Notwithstanding the foregoing or any other provision of this Plan, (A)&nbsp;the term Change in Control shall not include a sale of
assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company, and (B)&nbsp;the definition of Change in Control (or any analogous term)&nbsp;in an individual written agreement between the Company or
any Affiliate and the Participant shall supersede the foregoing definition with respect to Awards subject to such agreement; <I>provided, however</I>, that if no definition of Change in Control or any analogous term is set forth in such an
individual written agreement, the foregoing definition shall apply. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(h) </B>&#147;<B><I>Code</I></B>&#148; means the
Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i)
</B>&#147;<B><I>Committee</I></B>&#148; means a committee of one (1)&nbsp;or more Directors to whom authority has been delegated by the Board in accordance with Section&nbsp;2(c). </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(j) </B>&#147;<B><I>Common Stock</I></B>&#148; means the common stock of the Company. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(k) </B>&#147;<B><I>Company</I></B>&#148; means Dynavax Technologies Corporation, a Delaware corporation. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(l) </B>&#147;<B><I>Consultant</I></B>&#148; means any person, including an advisor, who is (i)&nbsp;engaged by the Company or an
Affiliate to render consulting or advisory services and is compensated for such services, or (ii)&nbsp;serving as a member of the board of directors of an Affiliate and is compensated for such services. However, service solely as a Director, or
payment of a fee for such service, shall not cause a Director to be considered a &#147;Consultant&#148; for purposes of the Plan. Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Form S-8 Registration
Statement under the Securities Act is available to register either the offer or the sale of the Company&#146;s securities to such person. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-16
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(m) </B>&#147;<B><I>Continuous Service</I></B>&#148; means that the Participant&#146;s
service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Consultant
or Director or a change in the entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#146;s service with the Company or an Affiliate, shall not terminate a Participant&#146;s
Continuous Service; <I>provided, however, </I>if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#146;s Continuous Service shall be
considered to have terminated on the date such Entity ceases to qualify as an Affiliate. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#146;s sole discretion, may determine whether Continuous
Service shall be considered interrupted in the case of (i)&nbsp;any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii)&nbsp;transfers between the Company, an
Affiliate, or their successors. Notwithstanding the foregoing, a leave of absence shall be treated as Continuous Service for purposes of vesting in an Award only to such extent as may be provided in the Company&#146;s leave of absence policy, in the
written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(n) </B>&#147;<B><I>Corporate Transaction</I></B>&#148; means the occurrence, in a single transaction or in a series of related
transactions, of any one or more of the following events: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) </B>the consummation of a sale or other disposition of all
or substantially all, as determined by the Board, in its sole discretion, of the consolidated assets of the Company and its Subsidiaries; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) </B>the consummation of a sale or other disposition of at least ninety percent (90%)&nbsp;of the outstanding securities of the Company; </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) </B>the consummation of a merger, consolidation or similar transaction following which the Company is not the surviving
corporation; or </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iv) </B>the consummation of a merger, consolidation or similar transaction following which the Company is
the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property,
whether in the form of securities, cash or otherwise. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(o) </B>&#147;<B><I>Covered Employee</I></B>&#148; shall have the
meaning provided in Section&nbsp;162(m)(3)&nbsp;of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(p) </B>&#147;<B><I>Director</I></B>&#148; means a member of
the Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(q) </B>&#147;<B><I>Disability</I></B>&#148; means, with respect to a Participant, the inability of such
Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not
less than twelve (12)&nbsp;months, as provided in Sections 22(e)(3)&nbsp;and 409A(a)(2)(c)(i)&nbsp;of the Code, and shall be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(r) </B>&#147;<B><I>Effective Date</I></B>&#148; means the effective date of the Plan as set forth in Section&nbsp;11.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(s) </B>&#147;<B><I>Employee</I></B>&#148; means any person employed by the Company or an Affiliate. However, service
solely as a Director, or payment of a fee for such services, shall not cause a Director to be considered an &#147;Employee&#148; for purposes of the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(t) </B>&#147;<B><I>Entity</I></B>&#148; means a corporation, partnership, limited liability company or other entity. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(u) </B>&#147;<B><I>Exchange Act</I></B>&#148; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-17
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(v) </B>&#147;<B><I>Exchange Act Person</I></B>&#148; means any natural person, Entity or
&#147;group&#148; (within the meaning of Section&nbsp;13(d)&nbsp;or 14(d)&nbsp;of the Exchange Act), except that &#147;Exchange Act Person&#148; shall not include (i)&nbsp;the Company or any Subsidiary of the Company, (ii)&nbsp;any employee benefit
plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii)&nbsp;an underwriter temporarily holding securities
pursuant to a registered public offering of such securities, (iv)&nbsp;an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company; or (v)&nbsp;any
natural person, Entity or &#147;group&#148; (within the meaning of Section&nbsp;13(d)&nbsp;or 14(d)&nbsp;of the Exchange Act)&nbsp;that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more
than fifty percent (50%)&nbsp;of the combined voting power of the Company&#146;s then outstanding securities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(w)
</B>&#147;<B><I>Fair Market Value</I></B>&#148; means, as of any date, the value of the Common Stock determined as follows: </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) </B>If the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value of
a share of Common Stock shall be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock)&nbsp;on the
date of determination, as reported in a source the Board deems reliable. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) </B>Unless otherwise provided by the Board,
if there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value shall be the closing selling price on the last preceding date for which such quotation exists. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) </B>In the absence of such markets for the Common Stock, the Fair Market Value shall be determined by the Board in good faith
and in a manner that complies with Sections 409A and 422 of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(x) </B>&#147;<B><I>Incentive Stock
Option</I></B>&#148; means an option granted pursuant to Section&nbsp;5 of the Plan that is intended to be, and qualifies as, an &#147;incentive stock option&#148; within the meaning of Section&nbsp;422 of the Code. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(y) </B>&#147;<B><I>Non-Employee Director</I></B>&#148; means a Director who either (i)&nbsp;is not a current employee or officer of
the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which
disclosure would not be required under Item&nbsp;404(a)&nbsp;of Regulation S-K promulgated pursuant to the Securities Act (&#147;<B><I>Regulation S-K</I></B>&#148;)), does not possess an interest in any other transaction for which disclosure would
be required under Item&nbsp;404(a)&nbsp;of Regulation S-K, and is not engaged in a business relationship for which disclosure would be required pursuant to Item&nbsp;404(b)&nbsp;of Regulation S-K; or (ii)&nbsp;is otherwise considered a
&#147;non-employee director&#148; for purposes of Rule 16b-3. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(z) </B>&#147;<B><I>Nonstatutory Stock Option</I></B>&#148;
means any option granted pursuant to Section&nbsp;5 of the Plan that does not qualify as an Incentive Stock Option. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(aa)
</B>&#147;<B><I>Officer</I></B>&#148; means a person who is an officer of the Company within the meaning of Section&nbsp;16 of the Exchange Act. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(bb) </B>&#147;<B><I>Option</I></B>&#148; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(cc) </B>&#147;<B><I>Option Agreement</I></B>&#148; means a written agreement between the Company and an Optionholder evidencing the
terms and conditions of an Option grant. Each Option Agreement shall be subject to the terms and conditions of the Plan. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(dd) </B>&#147;<B><I>Optionholder</I></B>&#148; means a person to whom an Option is granted pursuant to the Plan or, if applicable,
such other person who holds an outstanding Option. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-18
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ee) </B>&#147;<B><I>Other Stock Award</I></B>&#148; means an award based in whole or in
part by reference to the Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;6(d). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ff)
</B>&#147;<B><I>Other Stock Award Agreement</I></B>&#148; means a written agreement between the Company and a holder of an Other Stock Award evidencing the terms and conditions of an Other Stock Award grant. Each Other Stock Award Agreement shall be
subject to the terms and conditions of the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(gg) </B>&#147;<B><I>Outside Director</I></B>&#148; means a Director who
either (i)&nbsp;is not a current employee of the Company or an &#147;affiliated corporation&#148; (within the meaning of Treasury Regulations promulgated under Section&nbsp;162(m)&nbsp;of the Code), is not a former employee of the Company or an
&#147;affiliated corporation&#148; who receives compensation for prior services (other than benefits under a tax-qualified retirement plan)&nbsp;during the taxable year, has not been an officer of the Company or an &#147;affiliated
corporation,&#148; and does not receive remuneration from the Company or an &#147;affiliated corporation,&#148; either directly or indirectly, in any capacity other than as a Director, or (ii)&nbsp;is otherwise considered an &#147;outside
director&#148; for purposes of Section&nbsp;162(m)&nbsp;of the Code. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(hh) </B>&#147;<B><I>Own,</I></B>&#148;
&#147;<B><I>Owned,</I></B>&#148; &#147;<B><I>Owner,</I></B>&#148; &#147;<B><I>Ownership</I></B>&#148;<B> </B>A person or Entity shall be deemed to &#147;Own,&#148; to have &#147;Owned,&#148; to be the &#147;Owner&#148; of, or to have acquired
&#147;Ownership&#148; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting,
with respect to such securities. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) </B>&#147;<B><I>Participant</I></B>&#148; means a person to whom an Award is granted
pursuant to the Plan or, if applicable, such other person who holds an outstanding Stock Award. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(jj)
</B>&#147;<B><I>Performance Cash Award</I></B>&#148; means an award of cash granted pursuant to the terms and conditions of Section&nbsp;6(c)(ii). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(kk) </B>&#147;<B><I>Performance Criteria</I></B>&#148; means the one or more criteria that the Board shall select for purposes of establishing the Performance Goals for a Performance Period. The
Performance Criteria that shall be used to establish such Performance Goals may be based on any one of, or combination of, the following as determined by the Board: (i)&nbsp;earnings (including earnings per share and net earnings);
(ii)&nbsp;earnings before interest, taxes and depreciation; (iii)&nbsp;earnings before interest, taxes, depreciation and amortization; (iv)&nbsp;total stockholder return; (v)&nbsp;return on equity or average stockholder&#146;s equity;
(vi)&nbsp;return on assets, investment, or capital employed; (vii)&nbsp;stock price; (viii)&nbsp;margin (including gross margin); (ix)&nbsp;income (before or after taxes); (x)&nbsp;operating income; (xi)&nbsp;operating income after taxes;
(xii)&nbsp;pre-tax profit; (xiii)&nbsp;operating cash flow; (xiv)&nbsp;sales or revenue targets; (xv)&nbsp;increases in revenue or product revenue; (xvi)&nbsp;expenses and cost reduction goals; (xvii)&nbsp;improvement in or attainment of working
capital levels; (xiii)&nbsp;economic value added (or an equivalent metric); (xix)&nbsp;market share; (xx)&nbsp;cash flow; (xxi)&nbsp;cash flow per share; (xxii)&nbsp;share price performance; (xxiii)&nbsp;debt reduction; (xxiv)&nbsp;implementation or
completion of projects or processes; (xxv)&nbsp;customer satisfaction; (xxvi)&nbsp;stockholders&#146; equity; (xxvii)&nbsp;capital expenditures; (xxiii)&nbsp;debt levels; (xxix)&nbsp;operating profit or net operating profit; (xxx)&nbsp;workforce
diversity; (xxxi)&nbsp;growth of net income or operating income; (xxxii)&nbsp;billings; (xxxiii)&nbsp;submission to, or approval by, a regulatory body (including, but not limited to the U.S. Food and Drug Administration)&nbsp;of an applicable filing
or a product candidate; and (xxxiv)&nbsp;to the extent that an Award is not intended to comply with Section&nbsp;162(m)&nbsp;of the Code, other measures of performance selected by the Board. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ll) </B>&#147;<B><I>Performance Goals</I></B>&#148; means, for a Performance Period, the one or more goals established by the Board
for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative
to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by the Board (i)&nbsp;in the Award Agreement at the time the Award is granted or (ii)&nbsp;in such other document
setting forth the Performance Goals at the time the Performance Goals are established, the Board shall appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows: (1)&nbsp;to
exclude restructuring and/or </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-19
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="2">
other nonrecurring charges; (2)&nbsp;to exclude exchange rate effects, as applicable, for non-U.S. dollar denominated Performance Goals; (3)&nbsp;to exclude the effects of changes to generally
accepted accounting principles; (4)&nbsp;to exclude the effects of any statutory adjustments to corporate tax rates; (5)&nbsp;to exclude the effects of any &#147;extraordinary items&#148; as determined under generally accepted accounting principles,
(6)&nbsp;to exclude the dilutive effects of acquisitions or joint ventures; (7)&nbsp;to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such
divestiture; (8)&nbsp;to exclude the effect of any change in the outstanding shares of common stock of the Company by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off,
combination or exchange of shares or other similar corporate change, or any distributions to common shareholders other than regular cash dividends; (9)&nbsp;to exclude the effects of stock based compensation and/or the award of bonuses under the
Company&#146;s bonus plans and (10)&nbsp;to exclude the effect of any other unusual, non-recurring gain or loss or other extraordinary item. In addition, the Board retains the discretion to reduce or eliminate the compensation or economic benefit
due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for such Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding
to the degree of achievement as specified in the Stock Award Agreement or the written terms of a Performance Cash Award. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(mm) </B>&#147;<B><I>Performance Period</I></B>&#148; means the period of time selected by the Board over which the attainment of one
or more Performance Goals will be measured for the purpose of determining a Participant&#146;s right to and the payment of a Stock Award or a Performance Cash Award. Performance Periods may be of varying and overlapping duration, at the sole
discretion of the Board. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(nn) </B>&#147;<B><I>Performance Stock Award</I></B>&#148; means a Stock Award granted under the
terms and conditions of Section&nbsp;6(c)(i). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(oo) </B>&#147;<B><I>Plan</I></B>&#148; means this Dynavax Technologies
Corporation 2011 Equity Incentive Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(pp) </B>&#147;<B><I>Resignation for Good Reason</I></B>&#148; means voluntary
termination by a Participant from all positions he or she then holds with the Company, which resignation results in a &#147;separation from service&#148; with the Company within the meaning of Treasury Regulation Section&nbsp;1.409A-1(h), effective
within a period of ninety (90)&nbsp;days after the Participant provides written notice to the Company after the initial occurrence of one of the following actions taken without his or her written consent, which written notice must be provided within
thirty (30)&nbsp;days after the initial occurrence of one of the following actions, and must reasonably specify the particulars of the action; <I>provided, however</I>, that following the receipt of notice by the Company, the Company shall have a
period of thirty (30)&nbsp;days during which to remedy the action giving rise to a Resignation for Good Reason and if such action is materially remedied by the Company during such period, no event giving rise to a right for a Resignation for Good
Reason shall be deemed to have occurred: </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(i) </B>the assignment to the Participant of any duties or responsibilities that
results in a material diminution in the Participant&#146;s employment role in the Company as in effect immediately prior to the date of such actions;<I> provided, however,</I> that mere changes in the Participant&#146;s title or reporting
relationships alone shall not constitute a basis for Resignation for Good Reason; </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ii) </B>a greater than twenty percent
(20%)&nbsp;aggregate reduction by the Company in the Participant&#146;s annual base salary (that is, a material reduction in base compensation), as in effect immediately prior to the date of such actions; <I>provided that</I> an across-the-board
reduction in the salary level of substantially all other individuals in positions similar to the participant&#146;s by the same percentage amount shall not constitute such a salary reduction; or </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:8%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(iii) </B>a non-temporary relocation of the Participant&#146;s business office to a location that increases Participant&#146;s one way
commute by more than thirty-five (35)&nbsp;miles from the location at which the Participant performs duties as of immediately prior to the date of such action. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-20
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(qq) </B>&#147;<B><I>Restricted Stock Award</I></B>&#148; means an award of shares of
Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;6(a). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(rr) </B>&#147;<B><I>Restricted
Stock Award Agreement</I></B>&#148; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement shall be subject
to the terms and conditions of the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(ss) </B>&#147;<B><I>Restricted Stock Unit Award</I></B>&#148; means a right to
receive shares of Common Stock which is granted pursuant to the terms and conditions of Section&nbsp;6(b). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(tt)
</B>&#147;<B><I>Restricted Stock Unit Award Agreement</I></B>&#148; means a written agreement between the Company and a holder of a Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each
Restricted Stock Unit Award Agreement shall be subject to the terms and conditions of the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(uu) </B>&#147;<B><I>Rule
16b-3</I></B>&#148; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(vv) </B>&#147;<B><I>Securities Act</I></B>&#148; means the Securities Act of 1933, as amended. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(ww) </B>&#147;<B><I>Stock Appreciation Right</I></B>&#148; or &#147;<B><I>SAR</I></B>&#148; means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and
conditions of Section&nbsp;5. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(xx) </B>&#147;<B><I>Stock Appreciation Right Agreement</I></B>&#148; means a written
agreement between the Company and a holder of a Stock Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement shall be subject to the terms and conditions of the Plan.
</FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(yy) </B>&#147;<B><I>Stock Award</I></B>&#148; means any right to receive Common Stock granted under the Plan, including
an Incentive Stock Option, a Nonstatutory Stock Option, a Restricted Stock Award, a Restricted Stock Unit Award, a Stock Appreciation Right, a Performance Stock Award or any Other Stock Award. </FONT></P>
<P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(zz) </B>&#147;<B><I>Stock Award Agreement</I></B>&#148; means a written agreement between the Company and a Participant evidencing
the terms and conditions of a Stock Award grant. Each Stock Award Agreement shall be subject to the terms and conditions of the Plan. </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT
STYLE="font-family:Times New Roman" SIZE="2"><B>(aaa) </B>&#147;<B><I>Subsidiary</I></B>&#148; means, with respect to the Company, (i)&nbsp;any corporation of which more than fifty percent (50%)&nbsp;of the outstanding capital stock having ordinary
voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation shall have or might have voting power by reason of the happening of any
contingency)&nbsp;is at the time, directly or indirectly, Owned by the Company, and (ii)&nbsp;any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or
participation in profits or capital contribution)&nbsp;of more than fifty percent (50%). </FONT></P> <P STYLE="margin-top:12px;margin-bottom:0px; text-indent:4%"><FONT STYLE="font-family:Times New Roman" SIZE="2"><B>(bbb) </B>&#147;<B><I>Ten Percent
Stockholder</I></B>&#148; means a person who Owns (or is deemed to Own pursuant to Section&nbsp;424(d)&nbsp;of the Code)&nbsp;stock possessing more than ten percent (10%)&nbsp;of the total combined voting power of all classes of stock of the Company
or any Affiliate. </FONT></P>
 <p STYLE="margin-top:0px;margin-bottom:0px"><FONT SIZE="1">&nbsp;</FONT></P> <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center"><FONT STYLE="font-family:Times New Roman" SIZE="2">B-21
</FONT></P>


<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g484784g12t42.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">VOTE BY INTERNET - www.proxyvote.com Use the Internet to transmit your voting
instructions and for electronic delivery of information up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you access the web site and follow the instructions to obtain your records
and to create an electronic voting instruction form. DYNAVAX TECHNOLOGIES CORPORATION ATTN: JUSTIN BURGESS 2929 SEVENTH STREET, STE 100 BERKELEY, CA 94710 ELECTRONIC DELIVERY OF FUTURE PROXY MATERIALS If you would like to reduce the costs incurred
by our company in mailing proxy materials, you can consent to receiving all future proxy statements, proxy cards and annual reports electronically via e-mail or the Internet. To sign up for electronic delivery, please follow the instructions above
to vote using the Internet and, when prompted, indicate that you agree to receive or access proxy materials electronically in future years. 1 OF Investor Address Line 1 2 VOTE BY PHONE - 1-800-690-6903 Use any touch-tone telephone to transmit your
voting instructions up until 11:59 P.M. Eastern Time the day before the cut-off date or meeting date. Have your proxy card in hand when you call and then follow the instructions. Investor Address Line 2 Investor Address Line 3 1 1 VOTE BY MAIL Mark,
sign and date your proxy card and return it in the postage-paid envelope we have provided or return it to Vote Processing, c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717. Investor Address Line 4 Investor Address Line 5 John Sample 1234 ANYWHERE
STREET ANY CITY, ON A1A 1A1 CONTROL # <FONT STYLE="FONT-FAMILY:WINGDINGS 3">&#103;</FONT> 000000000000 NAME THE COMPANY NAME INC. - COMMON SHARES 123,456,789,012.12345 THE COMPANY NAME INC. - CLASS A 123,456,789,012.12345 THE COMPANY NAME INC. -
CLASS B 123,456,789,012.12345 THE COMPANY NAME INC. - CLASS C 123,456,789,012.12345 THE COMPANY NAME INC. - CLASS D 123,456,789,012.12345 THE COMPANY NAME INC. - CLASS E 123,456,789,012.12345 THE COMPANY NAME INC. - CLASS F 123,456,789,012.12345 THE
COMPANY NAME INC. - 401 K 123,456,789,012.12345 PAGE 1 OF 2 TO VOTE, MARK BLOCKS BELOW IN BLUE OR BLACK INK AS FOLLOWS: KEEP THIS PORTION FOR YOUR RECORDS DETACH AND RETURN THIS PORTION ONLY THIS PROXY CARD IS VALID ONLY WHEN SIGNED AND DATED. The
Board of Directors recommends a vote FOR the listed nominees. 1. Election of Directors For Withhold 01 Dennis Carson, M.D. 02 0000000000 02 Dino Dina, M.D. For Against Abstain 03 Denise Gilbert, Ph.D 4. To ratify the appointment of Ernst &amp; Young
LLP as the Company&#146;s independent registered public accounting firm for fiscal 2013. The Board of Directors recommends a vote FOR Proposals 2, 3 and 4. For Against Abstain 2. To approve an amendment to the Company&#146;s Sixth NOTE: Such other
business as may properly come Amended and Restated Certificate of before the meeting or any adjournment thereof. Incorporation to increase the authorized number of shares of common stock from 250,000,000 to 350,000,000 shares. 3. To amend the
Dynavax Technologies Corporation 2011 Equity Incentive Plan to increase the aggregate number of shares of common stock authorized for issuance under the plan by 10,000,000. For address change/comments, mark here. (see reverse for instructions)
Investor Address Line 1 Investor Address Line 2 R1.0.0.51160 Investor Address Line 3 Investor Address Line 4 Investor Address Line 5 0000174913_1 1 Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor,
administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name, by authorized officer. John
Sample 1234 ANYWHERE STREET ANY CITY, ON A1A 1A1 SHARES CUSIP # JOB # SEQUENCE # Signature [PLEASE SIGN WITHIN BOX] Date Signature (Joint Owners) Date </FONT></P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0px;margin-bottom:0px" ALIGN="center">


<IMG SRC="g484784g67q95.jpg" ALT="LOGO">
 </P> <P STYLE="line-height:0pt;margin-top:0px;margin-bottom:0px"><FONT STYLE="font-family:Times New Roman" SIZE="1" COLOR="#FFFFFF">Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:
The Combined 10k/Proxy Statement is/are available at www.proxyvote.com. DYNAVAX TECHNOLOGIES CORPORATION THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS OF DYNAVAX TECHNOLOGIES CORPORATION FOR THE 2013 ANNUAL MEETING OF STOCKHOLDERS May
29, 2013 The undersigned stockholder of DYNAVAX TECHNOLOGIES CORPORATION, a Delaware corporation (the &#147;Company&#148;), hereby acknowledges receipt of the Notice of Annual Meeting of Stockholders and Proxy Statement, each dated April 26, 2013
and the Company&#146;s Annual Report on Form 10-K for the year ended December 31, 2012 and hereby appoints Dino Dina, M.D. and Jennifer Lew, or either of them, proxies, with full power to each of substitution, on behalf and in the name of the
undersigned, to represent the undersigned at the 2013 Annual Meeting of Stockholders of the Company to be held on May 29, 2013 at 9:00 a.m., Pacific Time, at the Company&#146;s offices at 2929 Seventh Street, Suite 100, Berkeley, California, and at
any postponement or adjournment thereof, and to vote all shares of common stock of the Company which the undersigned would be entitled to vote if then and there personally present, on the matters set on the reverse side. THIS PROXY WILL BE VOTED AS
DIRECTED OR, IF NO CONTRARY DIRECTION IS INDICATED, WILL BE VOTED FOR (1) THE ELECTION OF THE CLASS I DIRECTORS, AND (4) THE RATIFICATION OF THE APPOINTMENT OF ERNST &amp; YOUNG LLP AS THE COMPANY&#146;S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
FOR FISCAL 2013, AND AS SAID PROXIES DEEM ADVISABLE ON SUCH OTHER MATTERS AS MAY PROPERLY COME BEFORE THE MEETING. Address change/comments: R1.0.0.51160 0000174913_2 (If you noted any Address Changes and/or Comments above, please mark corresponding
box on the reverse side.) Continued and to be signed on reverse side </FONT></P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g484784g12t42.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g484784g12t42.jpg
M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D
M``#_X0,B:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B`\
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835`@0V]R92`U+C,M8S`Q,2`V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M
M,30Z-38Z,C<@("`@("`@("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C`O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87`O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;7!-33I$
M;V-U;65N=$E$/2)X;7`N9&ED.D$X,3E&0D5#03<S,#$Q13(X-C0Q0S8R.4$T
M,$1!,$-#(B!X;7!-33I);G-T86YC94E$/2)X;7`N:6ED.D$X,3E&0D5"03<S
M,#$Q13(X-C0Q0S8R.4$T,$1!,$-#(B!X;7`Z0W)E871O<E1O;VP](D-A<F16
M:65W('8R+C`M0C4V8B(^(#QX;7!-33I$97)I=F5D1G)O;2!S=%)E9CII;G-T
M86YC94E$/2)U=6ED.CAC-&0X8C`Y+34U-3<M-#4W.2UA,#$R+3`R,F)C9F9B
M96(Q8B(@<W12968Z9&]C=6UE;G1)1#TB=75I9#HU864T,6%E-2TX93-C+30U
M.3<M8F-D-RTU.3!F-S@T,#<W-6(B+SX@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO
M<F1F.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@`.
M061O8F4`9,`````!_]L`A``!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#`P,#`0$!`0$!`0(!
M`0("`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P/_P``1"`,J`G(#`1$``A$!`Q$!_\0`N@`!``("`P$!`0``
M``````````<(!08"!`D#`0H!`0$!```````````````````!`Q```00"`@`#
M`P,'%0L)!`$5!0(#!`8!!P`($1(3%!4)(187-U>7M]<86#&1(E(C,]-TU)6U
MU396=I:VUG<XF$%1,G*RD[,D575X87$TM"4UN-@90M)35%F!H90F"K'10W,G
M\,'Q8D3%>9E&1TD1`0`!`P4````````````````1(=$B\`%QH2/_V@`,`P$`
M`A$#$0`_`/[^.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X
M#@.`X#@.`X#@.`X#@.!YB:ZZ^Z4V6_MJX;`UR$M]HG=BNP4&6=-2SLB<]"";
M5L@</#\S9=IIN*+$PF8S#:$I0VRTE.,8QC@2+]Z#UA^LG3_\X?\`VZX#[T'K
M#]9.G_YP_P#MUP'WH/6'ZR=/_P`X?_;K@/O0>L/UDZ?_`)P_^W7`?>@]8?K)
MT_\`SA_]NN`^]!ZP_63I_P#G#_[=<!]Z#UA^LG3_`/.'_P!NN`^]!ZP_63I_
M^</_`+=<!]Z#UA^LG3_\X?\`VZX#[T'K#]9.G_YP_P#MUP'WH/6'ZR=/_P`X
M?_;K@/O0>L/UDZ?_`)P_^W7`?>@]8?K)T_\`SA_]NN`^]!ZP_63I_P#G#_[=
M<!]Z#UA^LG3_`/.'_P!NN`^]!ZP_63I_^</_`+=<!]Z#UA^LG3_\X?\`VZX#
M[T'K#]9.G_YP_P#MUP'WH/6'ZR=/_P`X?_;K@/O0>L/UDZ?_`)P_^W7`?>@]
M8?K)T_\`SA_]NN`^]!ZP_63I_P#G#_[=<!]Z#UA^LG3_`/.'_P!NN`^]!ZP_
M63I_^</_`+=<!]Z#UA^LG3_\X?\`VZX#[T'K#]9.G_YP_P#MUP'WH/6'ZR=/
M_P`X?_;K@/O0>L/UDZ?_`)P_^W7`?>@]8?K)T_\`SA_]NN!*G3X9!!:<G5\2
MPJ(%KFZ>R5?!#_:)4IH4##=A-FCQ`F(Y-?DR$0!D!AMAAO*\X:90E"?!*<8P
M%HN`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X
M#@.`X#@.`X#@.`X#@.`X#@4ET'_W%L__`(E.RWVY[=P)RX#@.`X#@.!BA1F$
M9235!R]G`@X4KTSUFO2S[Q#NI9F8:_)*]2/YUX\B_D\V/[F.!E>`X&(/FX-;
M"DCY/+V!XF-F7+S':]=_#.'$-Y])GS(]1?F<Q\GCC@9E:<H6I"O#S(4I.?#Y
M<>*<YQGPS_=QXXX''@.`X&*]\PO?WS;\7O>>`>+#X>E_J_N[))0K&?7\W_2/
M:T_X'A_@_+X_W.!E>`X#@?-YU+#+SZ_'TV&G7E^7'BKR-(4XORX^3Q5Y4Y\,
M<#I!RL0Z'$'(&7<P#8L<8@Y?;]%_,(I#9GQ,O->9?I/9CR$^9/CGRJ\<>.>!
M\Q1F$9]Z^Q9>S[F.$:]-]9KTO^T1?H>U89_)*]6/_K"?*OY/-\OR?)P$$S"(
MD#HR-E[VJN384`EAQKR-XD$`X\[']G<\V?6;S`)M>;/ACP7XI_N>.0RO`<!P
M'`<!P'`U/JI]32T?\0':3_Q(;2X%E.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.
M`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@4ET'_W%L_\`
MXE.RWVY[=P)RX#@.`X#@.!H&OOSJ]?TJW[]D(_`W_@.!'.WOJ7WC_<:_^MQ.
M!)DC_I#_`/\`EG?\M7`^/`<!P(__`/\`;F?Z*4?RW=X$@<!P'`Z9'_NXC_N^
M=_U5W@:MK3ZFVN?X`4O^3(O@=37_`/\`Y_\`TJ7/_P#E?`53]V.VOX45;[6M
M.X$@<!P'`<!P'`<#4^JGU-+1_P`0':3_`,2&TN!93@.`X#@.`X#@.`X#@.`X
M#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X
M%)=!_P#<6S_^)3LM]N>W<"<N`X#@.`X#@:#K]*DM7GS)4GS;3OBT^9.4^9"B
M$?RK3XXQYD*_N9Q\F>!OW`<".]N)4O6-W0A*EK4$7A*$)4M:L^UQ,^"4IQE2
ML^'][@25(_Z0_P#_`)9W_+5P/CP'`<#0/*KZ6LK\JO)]%:$>?RY\GG^>SJO)
MY_#R^?R_+X>/CX?+P-_X#@.!TR/RCB/AXYS[OG?)CY<Y_P!5=_$QC\7/`U?6
MR5)UOKM*DJ2I-!IB5)5C*5)4FM#,*2I*L8RE2<X\,XS\N,\#J4!*D_/[S)4G
MS;2N2T^9.4^9"O=?E6GQQCS(5_<SCY,\#]JJ58N&V%*2I*5V>KY0K*<X2O&-
M;4]&<HSG'@K&%ISC.<?W<9Q^+C@;]P'`<!P'`<!P-3ZJ?4TM'_$!VD_\2&TN
M!93@.`X#@.`X#@.`X#@.`X#@.!%6]2)`/I'<983-EC2@O56PB(TC`D.Q)P\A
M"J)>3#FPY3"D/1I<60TEQMQ"L*0M.,XSC..!5:E]?=;3Z73)\U_;$F;/J%7G
M3)+W8SL<IV3+F`1\F5(=5]+./,X\^ZI2L_W<YX&R?>YZM_O[4_M%]CONL\!]
M[GJW^_M3^T7V.^ZSP'WN>K?[^U/[1?8[[K/`?>YZM_O[4_M%]CONL\!][GJW
M^_M3^T7V.^ZSP'WN>K?[^U/[1?8[[K/`?>YZM_O[4_M%]CONL\!][GJW^_M3
M^T7V.^ZSP'WN>K?[^U/[1?8[[K/`?>YZM_O[4_M%]CONL\!][GJW^_M3^T7V
M.^ZSP'WN>K?[^U/[1?8[[K/`?>YZM_O[4_M%]CONL\!][GJW^_M3^T7V.^ZS
MP'WN>K?[^U/[1?8[[K/`?>YZM_O[4_M%]CONL\!][GJW^_M3^T7V.^ZSP'WN
M>K?[^U/[1?8[[K/`?>YZM_O[4_M%]CONL\!][GJW^_M3^T7V.^ZSP'WN>K?[
M^U/[1?8[[K/`?>YZM_O[4_M%]CONL\!][GJW^_M3^T7V.^ZSP'WN>K?[^U/[
M1?8[[K/`?>YZM_O[4_M%]CONL\!][GJW^_M3^T7V.^ZSP.CK6HC-=]HJ]7ZL
M3O*`5BZ_[),F`UCVCL^^"Y1<!L?4L$.4;'W^XVB)`(081Z8REZ,AEQ34A259
M5CPQ@+T<!P'`<!P*2Z#_`.XMG_\`$IV6^W/;N!.7`<!P'`<!P'`<!P'XGRXX
M#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@4)C5"J7MC0=7N]:!6^M2^X?>^9+K
MUF%0C@25+'%NSKX^3)%DF9,)]^"_GU&5+1E3:_R2?#/R\"?OO6>LWX/.D_L7
MTS]IN`^]9ZS?@\Z3^Q?3/VFX#[UGK-^#SI/[%],_:;@/O6>LWX/.D_L7TS]I
MN!%6^.M'705HG>)47H;3HXF+TQM8D,(P=;U&).'$8%!L,N#/@RV!*'XLV%+9
M0ZTZA25MN)PI.<9QC/`]&:PM;E:KSCBE+6L&)6M:U94M:U0(ZE*4I6<Y4I6<
M^.<Y^7.>!G.`X#@.`X#@.`X$/=A_J`;R_H>V9_(HWP-,H'[@*#_`6F_R:%\#
M;.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X$3B_ZW-$_P"&W</V
MT='<"X'`<!P'`<#PVO7;BA=>K3N*JM=A&@SH[L#O=B?KZ;U#OVQM@C;C)F:S
MV#)`P$U7<P:7;8ES-=CZ<*J+\46THW/LP^*VC+F75H#19/Q*%12=6$.738>)
MIYG:[=@:>^'GL:"YJX]HF')+[DJ.THY/LU!EU2RZ\K:(I>8WZ;\>0))P9<-Z
M4S*;5D-F@?$!7.ZH_?C*VZB%JB3L>E:M!PIO3^0FX62S[#E5:%4LB1<;MY)$
MM#"4JWQ$+?FSX?LV<.>NEOR?*&V:@[M,;RNNH]<Z_P"PX&7>=X5*M;'US62O
M2O8(0F9U58ZA9;0]ME;9+L6PW%UM5R=3EUTL54KT(EG7$'X\[D^`J2&@C?B2
M4X]:[!KZL]D0EFV0"+5H)'UV%Z6W=^X6@A;;/N.F`VJ@,D=E8K9Y#UJT<9@O
M+;=PF*^^/];+:9\=2@UFA?$]B;$L6G*L&O\`;QIK>0TA8:1#M718[5GE5`9<
M%T.3<B$8UVVB3,5_-GC2HZ,Q6Y4M>(;R\,>1*5*#7Z!\7G36P`U<-,]I0=59
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M_B#=/S%G(V.?41]>@:FD2#,^RC+;3Z)/#PAJ.S.9<N9&N&P`@Y6&T*Q[25C)
MQG/JISD,7)[*TV)9;!3)'Q$^G+=NJNQ!VI;#6?HFE*.BMEE2UC`P:1*%H[+*
MF8L+IJGE8JHZ494W('2$+\JFEXP&.:[6ZYD"()Z-\2/I=)#E'K''&3XNK7Y+
M!-^H8$.6=H=ECLPXJ>L'!L$";(PUA?IC9K$W/^J/-O*#:G]ZAHQ*Q")7Q!.G
MT8A4B$079F).J'8^`DV=6[=<([1!][LTB.PC-6H!R>MS*_2:BB)BUJ3B.[Y0
MBIGN]J1TR1$Y^(UU)CL"Z-3MARK)-T@<@T[YO7JZ7;7X%IFV2^QS(-X^BT:Z
M,LSAB7LSQC<%UZ6TRRE2\!-E^VJO5=IE4G9'>_J=2+;!H,[:4ROV73\L43B:
M]'8EYDVV1'E=F&U,AU)'R,M.*\,R$QGLM87AIS*0B^1W"U+$*@0<OXFW1Z*7
MM`VMEZ^/DZ[0Q)*CK?+BP:Y)BH=[.H\V"4J6E&$Y\%MY2YZF$8:=R@+H?11V
M8^OUI_\`LVV7_P`QO`?11V8^OUI_^S;9?_,;P'T4=F/K]:?_`+-ME_\`,;P'
MT4=F/K]:?_LVV7_S&\!]%'9CZ_6G_P"S;9?_`#&\!]%'9CZ_6G_[-ME_\QO`
M?11V8^OUI_\`LVV7_P`QO`?11V8^OUI_^S;9?_,;P'T4=F/K]:?_`+-ME_\`
M,;P'T4=F/K]:?_LVV7_S&\!]%'9CZ_6G_P"S;9?_`#&\!]%'9CZ_6G_[-ME_
M\QO`?11V8^OUI_\`LVV7_P`QO`BR9K8EJJR]4JL:LL6WFY>Z>SMU-'X%?75A
M\PML>A;QV`09'5]PW9'A@\=)LJHS*')\IS+;.%*7G*LXP%F>`X#@.!#_`&'_
M`*O6_P#^@O</VN;+P+557]S%<_W"'_8^/P,]P'`<!P'`<!P'`A[L/]0#>7]#
MVS/Y%&^!IE`_<!0?X"TW^30O@;9P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`
M<!P'`<!P'`B<7_6YHG_#;N'[:.CN!<#@.`X#@.!X_;XU!\.>V[*[#[@W-`M%
M9MNWWJ_U=VCL1JT6>FL5X_UX&!^P=0ME.+UTQ#(4^\#"(*N.CS@SRDYY8`%B
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M=HW?-J!_>]ZJO(?7S-*O\^84L&O*=9SVZ+&`+U^77"ATF0G%)DQT>AK$$@7C
M.^C"4^C*>!\#_1OX/E8B6#KI98L^AU)_5>OQA37Y$Y:JE2);.VM&GM%#=IP$
MH'PX$+:Q36FMV)%BLT9<>3!)!AQ4BZS,PE]8;="ZR_#5U?M#N!KN9LC:0`YM
M/6UNU%OK6A8]8G`)&K7#3VFFK.=J?LE1=,R94:CG*NSB;$G/QHI4DAA#>);Z
M&\A<>5V$^'A9;C3]HS=CZ:LUZUU4?FG1+HXOWT=@53;8^E2)]=JDYJ)(6:;M
M(HP!?(PX6)#K4:5%<E(:;<2K(><XWIA\%&O5ZXZI#FF3;";IKPM9ZZG9UK(%
M)-CTN7V14!$-N>4E1F2#+\NY6.$2ALR'/?V!DEGR25BUH9"5*SU"^%/6OH'[
M)CK$6UP9`:$TJ4U%;;'L.TU.R"]>0=*WG4^M+G,%6'TGU7%ZL'79\V=,87,?
ML@$82EX5+'QEX#%:[ZO_``VM=&SF_MA=@R.U3WTV;/V`',7FZG$P*0_O.Q;\
MLA74L.B-9=5&E&%;-L+9>*[&;+$S$##KK4=]KV?`;*5Z4?#BT:6HY>;M:U@]
MD:2M!`GKM^_;3O%T)"K@2TYJG5D`-8:%[;$G[%"M=<,UFDJ!R4.8E5">]%\<
M3)LJ:H(<U5UZ^$H'UOJ75][V"W?B.F-4;NZEM;%MQP[6L;1B[W=/N[@MC;8T
M@\X48DJ9.RP5H0\]$KXHE.S")^14EW`;5;>BWPH=D4V[62S;#LU\&TVXUN)M
MZ]&=M2BLN=L(U<]C6B)L'8,FSQ\`+"3L,7=EGB9EHC.CIM>,.-0V5I9A*8#<
M=@4[X9UH:O-S);WV=8&;M1:]`O56H6RMA..E!=?W$:%:6L!BEUF"Q-&V+2%]
ML3T6F>JU'7!@BVG,L2V1J'F0Q,+J9\)8E3S5C;V1-+!3<FR?..T3=I6F88N5
MIME-Q\Z['(DRF,D;);-@CK5DKAV(VY@I-*I<@MJP\RUP/1`-WRZJFG3F&ML!
M($,%8$UITF81(&0B,_V-PD[,"IE-IFE:W#%,.RY)AIG(F+%CONO24(COY;#:
MZWW#ZQ7`X%K-7W32SMAL=FFU`&&&S)$DB4-C\1\2\1(J(OJNB6WY;3&"7A[N
M7)<2PE]3RL(R'"X=Q^L-`L-AJ=SW13JY9:K.A#CP0E(FM$8+\\;83#;R8V(2
MUS!T4742K\N6QZL2"V.DYD.->BYY0U2P=ZNNX41NDW`LA6XP-#)URU=W*4#D
MGTR2NU;P=US3PE8>;6Q%/S95PK[T1]]IS$"-G.%.2,(0\IH)%I':3K[LBR#Z
M?1=JU:TV<I"L).&$#R)$N:H/5F`4HP=>PW&RU%KJ8EH&O1B+BD02#!",Y$=?
M;?:4H(^^_P`^IGK+5C=%24&:&.$G;0F:A5>;RW-C1_8%2L9S+S-<%RT&$9PQ
MEA=?\2F'?8,9D<#ZE>]O5(/:H-/D[>"2"<^2?'MRQ<(P7"(*UZS4VEO"5&A@
MZ4/>(E;=>X`P:AE;N"1##\:/EQZ,^V@.ZOO#U/\`/$9C[RHTR81442-A1R7E
M>G8%-@EYDMN26X\2.**9M(I(Z?(=9'DU%(>(K[OM+.5AN(GM!H,W7+A:QNSZ
MS*!4"2#@7"=&E+EM!B5D(Y"`QB5PFY+9B<5L:'!4=`]4OUR[#L%O*I33C20B
M`5\0SJJ<JU9M(;8T0BFT"01Z."9S#9L(L-8:Z[:89(Y#F3HT0;%AA?9WI^<O
MJR-20A9E893+8RL)(G=PNKXUX/'(;QUY#=/1HLP:F0=80E<2<PR]$DRW?#T1
ML=]4IAE*Y*FDYERH\;Q]>0PVX&8K?:+KY;JY.MH#;-0F5T95CUW*$WIZQS8J
MHUF."EF[&49)LPY(T1$A68?(2\^AM#T>8TZUE;:\*X'QU3V;U+NV\W:B:Q+D
M;1*U]6:99;0>8$RH=;@JO).YB1=;Q-(XB356X;+H9!)2!F,EP6XWAF3EN1YF
M4AJ^]_JP]4_X=;7^T!LK@;49#L'(7L,B::@-^LT_[0`-E*^0\S7F\&_>`B3$
MF>@OS_DV_/Y%^&/'&?#'`U3Z-Q?[Z-G_`&4[W^WG`Y)UR+0M"\6?9JLH6E>$
MKVC>EH5E"L*PE:%&\I6C/AX9QGQQG'R9X&_\"'^P_P#5ZW__`$%[A^US9>!:
MJJ_N8KG^X0_['Q^!GN`X#@.`X#@.`X$/=A_J`;R_H>V9_(HWP-,H'[@*#_`6
MF_R:%\#;.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X$3B_ZW-$_
MX;=P_;1T=P+@<!P'`<!P/*'L(8^'T!.;U.[;V,3A6`8(V!;KCK,-<B1&2V>@
MZ^6#M5RJ6NA#Y".[?+)0]?21S<5]K*24>"03[&K#A!;H8_7(_P"&)ID1=4@-
MDU>LQ-BT<WK"Z!#NP)1(NV,76Z\#O/M,],HB::G2X86!%($&IST!LA$RW%<;
M?];"PQ$V@?"TL=?I!N3L^O'(]5-3*M6K*]L`D7(NF+38+M?#8.8J8B7&=DWH
MSNDE'6IQA"Y$H@Q#B+;F,QT-AO)&]?#@VK/)[OL^R*\+F;*I`<Z1E62ZDJJI
M^F5Y6MMC"Y)`"N>PNKO91IT9(3$EM0R+[0J<C#*DMR\)#[T_K;\/.L!P5S"6
M<7D%;@I8K72Y#8$K/O*+70,#0%P+-SWEL&7YT9JY#@I9N4ZO,4JMCS-,R\NY
M6'$9H?X<NUXRMH5^SURP"K`Z_J&98AE]EKB'IEGUU!"`:WB<^\J:Q.:IKB"(
M5Z$Y&6ZF7[6AQYIU.>!J^U;)\.'8MI$'+'N23;;*8%@M)SU4S8I]+%AK@NG[
M2L$^O724)DP@C-9M]9`'8AN9(>C1);\)J,X\W*;:3@)&M],Z@;8L]'O!V/LQ
MP_W?"K9J\F`W=$C,QJ)4Z)MZ1+*-18TZLTV5)"==@7GB3\Y09R-5%Q&DMNSD
M*"M\C77PX!O772\46!VFSK?9MA)Z_P!=#)IX_4+0ARR*!B#CEE7M8[5V`D-F
M'U:BX?\`>SR)\!4+#B&FIKS:^!O(\;T*,ZV,VD-3MEEP>MKKI7W;7U&R[%BL
M3UTVIL4)I2S"5V.WP6GZU<KON2P>D^9GP9&6,J7.0SAAO@=2WP>E=R;Z6,WL
ME>8VOU:W[-:!U$",Q2*9@F;0*HZ)V&YL+88L[)]FGZ_`ZFGCZ_+87(0^86F5
M#G/N.1G%A^MZSZ..:9TMW";#;K,UG9A_4MWJ\$Q=28*P7#9M^MI$I4[OLD-;
MK96:S#O;AJ\3&R#Y.;$BQ6'%1_(E+33:0E3:CW0NX;#F[,VA?H^KMX%M=ZI\
M)#>R<U^^5<4&MC)ZD$:MBI'#E;?N"BU_AQ"$L,Z1>ECI4&/*6Y#Q%Q@(M!U7
MX6`EFROMWH561\`1M;7$P%9+];@L<17*M-O>G+V*##S$MJ7@?-(0CZH+J%.O
M$LHDRX:G6VE+;#X:QT_U2B=?.S\5.V[CVWI\`G6C]YKU1*#AUDHM*U/#D":1
M2*V+R=KS4,92X-8(-9PF5':DOCI<9EE+\=<;`=<R)^&X>,#[OLJRG=076QP'
M[)!JUQV6Z$MD=VZ#JO;!YQ(BJ6:RX@39$>V"'(L'+^(\B;-@I<B/S$0O3#=#
MVJ_AUK#W6_0MCD9XWK;J2KV<\C7^T;6:72`6MJ8&CTS:X<+7I<Y9:\5ZMT$=
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M;H9EZHJU/$/E$L5:K`MD[2S))1%/,)'0B'F(9:B89Q@-LU.6^'!I<N1N=-W%
M69I<GKM^HRYU@V*<N$E.JXLVG5>OU9,$@_-<9K@B."$P03>6O6E0U^LTJ3B2
M[(="$=A:I^%IILQJW5UQ)3`C\^NUZV:YM3!(L1K`:AGZWL)FN$,7"/#E5)VO
M2*-K0P-3*D>U2\#L)D.N^=:9J0GP)J+H+%<.7D1LI,H'UTNV#I,?]+UA)4K6
M,J;L$9<X%5'UITG($Q*I.VM3\/0X<1EQ,PO$=@-K=]#V-H-(@:M^&Z.CU$$,
MN<FX.;U)UC1M.<&[$N%S(S8%/*:ZN%,H\25`FS'P53UVO7H".RZ]Z;<)#B69
M+RGIKBG0Q>V;Y\/+JGKO8E%+[!O;X5B]`TSZ5K^W7.\6'4MJUQ)O&_(I>B!X
MD^2FE-U:U5$V9GR(N%XR7;]WRO4\L:`V&)(:+^&?JHM7]5GEF*Y8-@T?W_*J
MI&V'9]C`C1VJ7FRI^Y%8<R><A66QTX(TR^V[,DN3Y[;;D=G+KZWG@RH"@_"V
MVA<WVJW;*[+L5DVU=U,.M6LJW#O5IWY7-1[,,B:N1*8>BS::4P<JC@O`EUB'
M!*N('Q'&WI#\5\)-&TKI$#V1V!HQ_:53-VG?D;4?6\SKQHY*BFAHVC44I4ZA
M20+L"?*.S[IAN"1DE"T-UJ1'7`CMR,,+&H7P+A:=Z\:WT;*MA.D1SKAR^N0I
MEXL%CL).PF;48AEK2=</EI)!Y;>2Y`M<I[KZV4--YPXAM"$---(0&D;W^K#U
M3_AUM?[0&RN!('`<!P'`A_L/_5ZW_P#T%[A^US9>!:JJ_N8KG^X0_P"Q\?@9
M[@.`X#@.`X#@.!#W8?Z@&\OZ'MF?R*-\#3*!^X"@_P`!:;_)H7P-LX#@.`X#
M@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@1.+_`*W-$_X;=P_;1T=P+@<!
MP'`<!P/*S8@7X<!;9&W*?>MH#!=^M-PP5V9`EW0^&CC;-7*=LH:]ZQ1YEH"$
M:&U[<!5+^/:$M-R9T-M></JC(6$>S5?#!I\<A><[2GV21(J)&$("#[3<+*?!
M4*)M-JWMZUJ]38B*+"8]?V#4B4R($=9]\(CL%%>5R)&<]F#IV&F_"WM\N.:.
M[0>B2M<OU8V0"MW@^^C+X&V4S8@:+F`.8+1C)4,;(!9TWW*M9&(-G(;EN('S
M'FW@[%QTM\-S7TK5]1L-QN!-K;0VK601!@76QFAED%@M<;0L^L]FW)X>VEEM
MH'2*Y9D`7_,AR>KU<XCS%Q4.1`VFQ6CX<FVTUJIRMPSQ$&L7`B?"&(=HLU8"
MVJ?V.VI(V_8ZS*-28K44S77-JT>.LU%<RPD#,A1A\QR-ZRH[P?6\ZQZB=4--
M0-'[AV1L516'0!VZF]D2[E'"["L#W6P'KO6HZ/2I\DG#8:,PP9.!`&@HS;^'
M(LA_S+6^K+ZPZ[>J?AI.1%T)G9S(E>E?>55+0).Q3XLB$B3[09$E8!MTPAMR
M<+,'=\N1,2\^=I_$]K++V?0\Z`LW4[IT\9UCHRSUW9@!S7&D[#8HVL#KMBGI
MC0+%4=-;#&6`697+;:ERI\#4I8R0]FF(2X]%2B8TE:?26H(S=,='[7K<CK$=
MV!F0-=`<VJ;9:Z%V(6#0BM;MUS6-N[%ARN(W*L%#OIW>4,?[3E3L-]$J(H:^
MVXSE_`8D>"^'?6*FF`2MM?>K7:RP53?<21<I!%<>_A]:WZMV^FSI;A0-&87K
M\?;Y8]F,LLG."RRK3"WY;DUKU`^&TK5\.'>`.N_/S:=48IM&#!)]5'13)37=
M8K(<O.H5CBH$YAC0"8S13(^OLRHN'<Y1'+1(BVVTF&&Y8;V;'=/9W7I%(SM=
MZ!JK4QS65L&S!I5N>:HQL=>'PVOQ+`\A7#$D@5*;`JLN$V&F#YTR3/\`4C^A
MYE-(P%7;SK#X8ELN%DGWG?,XC>#%6#5DO/FW1QB0Z`-5:NV-!N%#C5=@`NNR
M*MUZ;F.R6(Z@`3W/.D,H@2%2G%!V`^O/ALNCF=WNE;6+KAO8]RUY&,V\J6<F
ME+IK3:MA>3%A-GV"&S9<R'L*QDH@YEA2ITY13+4QEW.&/1"PX:V]):`:A:Z@
M6UZ)#[5Z,62"6)TL3EU*VZXE7B]$8S`ZR>9;`8T4LW8`EB+AW#"Y"IC$="LO
M(::R$;0BGPS9MKCW*/MX(D].`U=WUY5LL<%B&.T5+#X$1BT>=#CM`2XZ5UI4
ME4.9[/.(*#3,-M.>+G`R&CM=?#_`:OM[M%-.TVA=D1.Q-+X:N)5=6+%(%;V8
M]H&\L5T@6B0K+#FGMI6-G&,39*Y2)Q%A33,7&<L("(18[X5]Y;`VZ?L/$(AJ
MJW$Z#!)W<S+9($6X>U]W'3<GV0X*G#B](N%ND68E+-16FVXL""EQ<D>F(YA`
M3#:=1=!>S)B^[15M4J4B.W816;.@!?RXJF"]A;!,:PJ$:>BOSH.0\I[8Q'5]
M?%8DO-RQ$N1!7F/A$O,A[(:GJRE=`!50WGK\#O<5/!;>C:R5(<`V0Y7R->HF
M@]/#_F#'JA^3,(R2TZHUK4!(X;+QG5>H;5/5+:8?7EC(9*RZ%^&WJZY26+U;
M(8RS7RLC=FE8UHLA%^7L-X<=KUN)79TW[LR6.7"\RJ?%S.%PIN%$V$N>SC\*
M=6M0:A/H'PO$5RT1#NYVB3Y7.HW2]QLUW(GS[4NB#5%-9O-2#H>>&E3-?T5I
M$4BRY#D)$A&?.9;;5EV0L)K(#N@NX[KK89!V5#,'V*O=NNM!K]4LYIH69$U6
MEV[5UB8A,#X:H,YFJ`-SDAK)EIQ(_$PLVTEYR0F.A`0S0BWPV:@KL)U\#V@]
MK)EJPX,6F79&BM+:`V/46U=O6&"YKZZ2Q,61-GT?9VI;&='8F/3E2L1_]5S*
MAMJC,!)`/170AN=2=FJVN6-0KG,<L=/=N^V#1H!9"TJUTFB7]<B';E/^]35X
MNB1PJT0B&7)/MTMR/EJ*K.4(")KA&^%LFT-B"6Q7I$>WF;_6!PP!;SV*3JJ-
ML*@[;.;&;%086&6:92;4S/LDHC,0A\>/-P5M+=A8@+99"3NV`/HJ]>MGVW;N
MP;G$M^OQ`6W;)IU$M)Q;`PLS3<,U^U$:;&CRA=ANTC7\2-$2(\DU1$2N.A\;
M(9?QEP,1J#K]\.4#+8OVM+>Z0=ZP1ZR0+MR;%.LTBIC1D.KBPL8D.+AR)=;6
M#NG8:5+'>61[^"2X?J8>3/B*#+URU_#?B[89WP"W7#-6ZND+!LZJQF[=:#0&
MOSMNQ<8O$2C5MN$ZW-*WTKN:&2*!H^)9%H@1B+PQ'1Y&^!Z0:TV!7ML:YH&T
MZBN4[5-E4JK7ZL.SF$Q9KM>N`.#80KDN,AU]$>2X-(M96C"UX2K.<85G\7@0
M;O?ZL/5/^'6U_M`;*X$@<!P'`<"'^P_]7K?_`/07N'[7-EX%JJK^YBN?[A#_
M`+'Q^!GN`X#@.`X#@.`X$/=A_J`;R_H>V9_(HWP-,H'[@*#_``%IO\FA?`VS
M@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.!$XO\`K<T3_AMW#]M'
M1W`N!P'`<!P'`\DME%_AQV<_V+K6SLS5E:U:[Z(V573I2QC,7<_"`4C;US'5
M,<HK$=*1'E1QL2.M.(D:>3:=@P5O.)<QP,!3*!\,0YB-,BW.#7K$9I!D`218
MKHNKVF7#"R[?,P9,OL+BL0+=4X9Z=,9]!UAV,-GPWY+&67(*N!J_9[6_1C7V
MLZ`/";6NVJ"AN\6[Z.=J:Y^<VQ2(HT5<T[0-GI:FXE/087O$,(!P'GDR&7T-
MYD(C>IEV4P\$Q%-4?#ZW.."@T;,<N3NJNO58=D#ZGM@N&6:UCKW7E@!5:WV6
M*&)!PIPW4*AMV:M3K_ES"386%36DMO0\8#1Z;JSX63ABC,UB_@IEA`W6.`K8
M=>PRYDA*M)2W7JRFA#8MYR>U*@F+6V4CE)$%.(+#P9,3#[&8?IX"<&-H]"NT
M5>:.%]C!;4F9I,C2B#MO)EJX?&Z[VR0U#/),FXQ2.*4$L<TA9Z<IQS*&IT#)
M>%G/I(EMY6%<`%3^$\U<)\6+88EE>R3B[F)&#=TN$^HN^\ZMO2D#8+Y0D1C1
M;0U.!R3BV`Z<D)I![`DKEN0ZW`FI#=2N/AS)U-3M'BM\40=K_7.U=4;Q)#)!
M=!XT>F5<[2#E5JK<S*&GL2RTHU6AQ2#'8DD7@<]4&7'Q[P6]P/E?]*_#=J5R
MF4#85SLE6."ZIK4VXLQLW8HT3,U19[&0.:VU[%/J(>[B.L*B7T`X52+0\J.%
MBC<R9:VXK[ZG`V/LB!Z.UNY44+N':!2&.U%K"HZ+SI0)93BFIP*^;'TY#HLR
MXP@\I)>S2JL>'U^<F&M<B5'C2&YRV%M.)RZ&BG*Y\+S8B+.P;NSQ0+),2:=&
M`RMB70)3CU@JFO\`4^S)DNC2'B@JO3)1X74*::P18EI8(G`$9]ES,MF3EP)?
MU=3^FMGU_OT<)W(+MC=U[(AML;&N8"RN58W2MOG;^"K6KG`!D;*R^$E";Q1H
M\"/*9D/1"%CC$U.>+C\UA(1S4]*_"YD7>REP^P`UELMAKEIKI=!?<MP/Y)UZ
MV4'9:[=%;(%3DB;8)/S1N]AF3):Y4N>.3,;RMYA#<!ML)2$A>A4+7VN;#(VD
MU8*E4NR%J/U*_P!FV/:"[IKL&T>G;5N:YUGER4IL3PF?4YLZ>A2EC!T0;*0O
MT6(SR6PULLCX:EDI]9J\_9M9>KPO5D.E@H<78UK'EF:14=D1+,/#+<@3XM@C
M6E=_I?EB1U9;-SG83[49#GINX2$0O5+X45%HI.M1KK#M`BS7G7+4^*#O]G,E
M9EUMDHHQ4",5\5.A0P[HM_LUB>_F,J*P(48@+6AESV%O(3W8Z;\/FQ=8ZJ5O
M=S'7'0-=NVRCPO9%GOEO(KG7':J[Z5V!82=S9F,%R+)9V[E#*):U^P0D-QR4
M93+4*(^R$2[41\+5<&1L$[<@!B?KR]6`?#9J-I*%3D6Q7/9FT+!;`H$!AYV+
M*!&;GL&R0)#S+7L$7P5%:D,.PF<,AOEPIO24R`WATY%W]&M;)?LT7K;;X)23
M8%F_)$$5R[U^%291V0S&CE\"=X0XHP]&=RW$L)6$TE3TYIB,L,%LC67PTG+'
M<J=;=IQJL>CEK<"=`A]OVZNIUSDY6KX5V[7Z,T+)MPZ:!L@$I87;6F&I,9A?
MK8?7&=CM)9#%;G'_``RK38Z[N"[;`>)6B!2:YFEXJ5QO+AJ)%JAB5J\&:K`$
M,M1!BYT4[8%8?B-HQ*&R8F9LJ(E<9U[`;!)T5\.L_2;=L=_8Q*STO7-Y]X6.
MP2=O7BYCJQL,N'9`6JQX'$2)QJ;9-L@C*,DR>(TIPNQ)Q*B/)\_KY#MT#4OP
MX3-RLFQZ)L@2:+:AN'WQ-K)0]N')5?KLB(B,2C6>6ZLFD2]70N0;>7Y;#BW'
M64^QD)#\1W,98:X5`?#(V<7OX>S6X:1:VG>0!TD]8+\>@@C%PL.=OIB,5_UR
MC*@>:_:=U6%N;'?;BM"["5C17L(DXAL)#NG+7\+_`&#7:'H^V7RL6"NZX#3K
M%4IY$Y90XI:-C1-GLG)GSK%)"C)4^2.IQP_(1A;;0Z'#8,MI8C-Q9*0P92B?
M#`L9T\\/V".:.VPK;MB%*S5-D&*?)?CWU6R@6R:O/@HF@/8A-V68MBB8$B\B
M1E+4Q;#3*(*?9PEV\:SZ`;S-G.P%GNHDXR4;-:PFV.#L<\&J[4BJ4.9:C(Z`
M@?/@Q,*CZXK;A9A2%+A^P,K(0L8S*>D2`C"$_P##5I@.\Z@!WYF2(WO.)IM<
M@1:"3D6`_3K@+L14E+MV?8X08;+O6P7"*52I#L,W*=F0XZ93,=<%L.>O=5_#
M'G"M3T#66RH:9YBX'#FG9->VM;VKC%OI"!2DODP)-<_V\4?F"M-PG!R).&\2
MX4.4N,VZPY(SD/42@4>NZRHE*UO4(TB%4]?U.N4FL1)<Z84EQ:_50\,$&CRB
M9!Z20(R61T%M+DA]QQYY>,K6I2LYSD(%WO\`5AZI_P`.MK_:`V5P-I-GA-;@
M^\C<M4*#A]J-ZR(1">KUG_/Z2/9QD2;*\%>3/Y+R>7'A\N<>..!J'TMZ[_?!
M(_BO<OYN\#DC;.O5K0V@_(RMQ:4(Q\V+CCQ4M6$IQXJKV$X\59_%SG&,<"1.
M!#_8?^KUO_\`H+W#]KFR\"U55_<Q7/\`<(?]CX_`SW`<!P'`<!P'`<"'NP_U
M`-Y?T/;,_D4;X&F4#]P%!_@+3?Y-"^!MG`<!P'`<!P'`<!P'`<!P'`<!P'`<
M!P'`<!P'`<!P'`<")Q?];FB?\-NX?MHZ.X%P.`X#@.`X'DWN$+\.0EL?:<3;
M>QG*I9R!$^8VV"E7RPB*^?6""$BHE^U)%O2`S*JPNC$RE=A.O19JY\"8MIA_
M"%-X#3ZW2OAC&KB1UJV;LJI9$T!B#:?9INS(%9)6G8OT!V3YY5I$^!&;CE;1
MFR40`2FK=892]*:%K0V_-E(E!N%QO/PYQ%<T11XMRG3P>GK>.D:Z'T0G;24(
M>3;&2-T8:MUA<PH7(%,_,B*3)*(34Y@OKA>V+81-;P\''7@?X9VN[7:!E)V&
M#BF]RP;#J0H,]\&9OO95N>I-'/G()=X2X0B#K9*?KXQDY[;@!*E>BF&Y[0Z^
MIP-0FUKX;3=P-Z]LQVVT`EUSO4&NOR;-8[56Q4PC09]F[!O2(!=3SLE`*)8=
MZD6&C"\C7IT]2QPN4]EI:%AVZM0/AF[`F4_3==V:?)$G;1E$.KO6K8H:3:_>
M<?4DO%"M#I(4,:G5N1GK]46LP7G&5JD"F(JUY<F.LR0M&OX>77M](3,V1M,G
M+K0\#`KA,IM.VD"0#-*2<:UM-#294US(V9K)@^\@+Z.$--J2EV0B2]EQU8?A
M3X=?6<M4IM.DAK=[$2)6DX2(JN9>87)6"\0]9Q;D=)ODUSHI,C9G=3BI,K$A
MEUC,O+[R&T+=\4AMFP^D.B]F31$ZPL7EEX/K<'J%O(J_V:(X0UP'&7(!(K!F
M8[.DD2S%DK=^*CRDAYY4V:Q(2M3V)#+#[8?3972C2VT;G,OIQV_B;"]8*Q=A
MRZK?#@`?7=C4^/3!@39->%1G5#Q]R9KNO1`EQ[+;D5X9$]%;&?6?4Z$8S_AC
M]4R$L,\Z"NS<(`N.^+"HO]A<$Q94>N!*RJ:PW)D2)D>;.A@T/376GFUD)+JU
MRLO>#*6@D0YTLU8O3NV-04M9&I0]N:L5J$N<E22-EFB*RJS[0MK1`*U+*05P
M[.*-;C/2A\]+R7(DQR*[X.)B-MY#6#?P[.MYIMUG$78`9F.U.:K+%>V'8@[%
M#5804*M7Q^CL1I&&0,G9(.`TP<6E*\R/#+C7H.J4O(2?GJ%HEW5]5TU+J\V?
MKNGR]FRA0":>,.X=QM^L;-IU\BD9N):)\Z(6K^WCC*4J<\6,R$*;RE33><!&
M$#X>'7D5&B,B<[%"NQFZ]*?E5^^%*SDM:J192]MUS?C0^N-B0I.XZY.G9+PE
MYR+F*E2F\R(\A3#"F@[37P]NN$04%##1UY%1!-J7;I;@W85HC3K,0ES]3G#,
M2U$/;5S3`RPVC25;+3F\K0IXA"6O"THDR6W0XE/AZ]<C.EI6@R$"ZNZ]G7H]
ML*=$3=2K<R6=LM2*40PTMQORPF1TBJEWF4MM1VUMS5>]$+P7\9^0XE_AX];B
MT(5"P-NXG`JO-4[$H)?K$,FD:7FZVS89*GEI#,G.9U?/6RX/R9S6<86][/&1
MA:4,XQD-]LW3O3%MVO-W&7CVS-K+62IV@]$BVTM$K5@FTA6NI=8A&0+3F(DH
M0,.:FKQ-,?'E0N<.\5>+4B6U(#`V/HKU^MQ:ZD;*+MYF!>6=I,D*G.O=G=I8
MKZ;():-M5^N5C,_`P-.NLXW)GRI+:,R$35X4RMM"$-I#1W/AK]8W38VR.C;I
MDX+!R0\2?'MKXWTY4SWBJ6?9A"HD`;!*R7B2GE,QF6!GM*,/XB8>4ZMP-L@]
M".NPO4![1PH&=%T(];*_;G8@XXJ',BR:HL<FM"&Y+$5#1,"&ABVX[<<DW.4Z
MUXJ>6Z[A#J0[U:Z)=;JKK\MJ\?4BDFE'-56G3!025LYPGF70;B0;*&QRY<J6
MN7[8[,92IN7A?M#7EQY5<#44_#>ZKJ)@C4VGSR9<,E4>7.GSHCB;&.DS(A,J
M)-C&AC`5N`;*CHLF5[!&@NY<C)2VMMM3K;@9*)\/KKNW[)@JSL6U-1:.5UQZ
M%KV9;3C;M-(4R]:ZAAL9DD,.PF*Y1-C%A@[,54=3#<CUU97+QF1D.RWT"ZZJ
MA&XY47;[#-M5HAW>WG3UT-SS=MMT,-L8!D\=EX>9:?E2A&TRS#C;3;,?TU,)
M0VA+#>$ALZNF&CY6IV]*&(ERL>OXEUHMV$#;#?+.5EU]W6LVM.TJK@"+Y#VL
M51Q`BJ11+@II6(Q`4Y*8FXD9FRUO!H\_X=W6PFISVX;>)#><J@Q&'+_8E,"Z
M@T7S8A.O!3:I.<0J-7;$M<Z!$3^:,/N*QZJFL^G@,9]X%1!V^Z'N:HWBWU(%
M5RM8L]GUK!<]L$["MU`J5BI>OC)\S,EKEMQ:L%LK^$Q,,N(<=3AQ"FEJ=RX%
M^>!5?>_U8>J?\.MK_:`V5P)"2I2,^*5*3G\3Q3G.,_CX\,\#GZ[_`/\`&=_S
MB_\`\/`>N]_\9W_.+_\`P\#Y<"'^P_\`5ZW_`/T%[A^US9>!:JJ_N8KG^X0_
M['Q^!GN`X#@.`X#@.`X$/=A_J`;R_H>V9_(HWP-,H'[@*#_`6F_R:%\#;.!5
M/97=GK=I_8-CUILB[%*O8*B!#6*S%)=)N+U&!P#4>"30P3V#$"OTZ"4$5<@V
M>*179B'AE=2X2D)1$:<<2$</_$VZ3Q0NR#\K;TJ(/U('EV"_)E4"_L$@P5D5
MJLT/(LAG*XDN48M`W=E8<#8C,NN%<E,(CI4MF0EH-YLW>[JQ3I!*-8]F*'O!
MKA"H)9*:K:YGNZW%-U2>OP4-+S"#R,,NGMEC"#<%>?S.2($$2R5>[($F4V$K
MZJWWK'=9+9(G6Y8N<F:AN)37>Q?:*K8PL:N;!!$RXLY1US3(V#$(VD,L1B1*
MBQ%OJ8@SH$A6<-3HRG`KD.^))U6G$APF45VG691)6U7DKNNE-CTZ+`"Z-L7S
M1W!;RLJPA(+<&EZ[M#;\`D3_`"4=N1#DX1Y\1W5)#X6OXFW32A"R)+8&Q+7K
M]X16%W0I6[UJ+:E0O$*II%;'/-V)RBV&I#[8\'E`=3FYK,AF(XRZPTQX*\\N
M.AP-BC_$-ZC3+&W5H&RR)$C(/9J4&8-H%^G5TI<<WP%KMJFB+3&KKE=*6V49
MLP^8R/8DKDN`YK)3"?87$O9#+WOO;UDUS=;=KJQ7*R2;M3IKH=^O5C66Q[?+
MM%F@^Y%6&G:Y=KE8(P]C7&E1K)`D'QP=V7("1I.'9F&DH>RT'3L7?;KE6#4J
MNDB&REFV=BTC4X\;$T]L-<FR;`V#J5&]*_7*HB4#AX/2X^JWF2A+TL^(KVEB
M/*PW*>0SD)>U+V(U'O`/?K'KFQS2-;UI;+-2[;9#5:L=3K\<U3)!"%:UBS-G
M&"AYT37IXF7'FRXCCK$5^*XAW*,X3Y@@5_XC_4:%"&$BUXNU?&EA<BQ1B-FT
MKN.N#V*>L*H_6[Z1FFJ1!C#:%L:`E2*L7>4B'89:'(L-;DAE]MH-7@_%4Z/3
M70;"]H688_8(9%V'',:DVB.DQS4`CL,0Q1B45RJKDPMBV`EJ@^R("Y0J86=@
M>2+AU;T=+H93_P!3OI6W\[\S-HG!;="U59-PV]TMK#90Y(.LTV,*D6P!+;D5
M=,C&S:\H]!8D5?"/?>9DQB,TPX^XEO(;I8>]N@:S,V3%GL;CF-:H#ZH.VTJ!
MT5L^P`G8.\BP`)J5JKF!5?DP[@2NY*R1D1(@Y4B1A*7EN(0EI>>!K]F^))TU
MIM@)5>T;7EA#,`W9*_&9GT&_LQ+(0J`3:ABR+I115<P-N@T7*TA:PZI@UV3%
M<L(9P6VXN6XPVZ%Y\X4G.4J2I"L?(I"TY2M&?[J5IS\J5IS\F<9^7&>!^<!P
M'`<!P'`<!P'`B<7_`%N:)_PV[A^VCH[@7`X#@.`X#@55LW2_K_;2=Y,F*P84
M4V+88-JL\V%;[2/>D'A@+8M=@3H?L95E`_V<9M0TGTF<)9<S)3EQ"_2;PD-3
M`_#]ZU5B!*@``%N%8D`08.-+A[!N#4T,[7+'K:WB3P!Y);R@S\2SZAK<QMV,
MEMII0IIMMI#&5M*#'0?AT]8!H!NJP0=]CUECV9Y@!C;&Q71#9/YIYHIP\J!(
ML;T:18KC4L)A&)SJ7),UM.5Y6EUQYQP-E"=$^N`";)(0ZQ89$IT:.KT)1*]7
M`FD'3P5YI6QJU1P#<PRZ@13JM;:#`D#H+.$MQD*?:QXMR'4J#N7SI#UZV0?M
MEBM-<L+\J_RY<V^0H%WMHD-<WG1XZ$+Q9!(XM'A$6:K*%-3A",IPD>1\\AK&
M%K7XAL2>I>DFCF;+&`%H9[!YRSL$XUG/)>B'EV/YVH)1FUSW(R'6+!X2&T90
MII.<83Y<H_(\"R+:/3;0WYEK\B$H\[BO,XORXQCS+5_[2U>'CG/]W/`Y\!P'
M`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P*K[W^K#U3_`(=;7^T!LK@2!P'`
M<!P(?[#_`-7K?_\`07N'[7-EX%JJK^YBN?[A#_L?'X&>X#@.`X#@.`X#@0]V
M'^H!O+^A[9G\BC?`TR@?N`H/\!:;_)H7P-LX'@AVROW54'V9[N4G.LBVW=D)
MZ5;6W'MV1;][W*K:X9+AZMHVEV_1=(`B*Q:HE2NVPM"1*VV5+PXTF0VR]$&Y
M;;;)3W$!7/N`)T#K_8&[-B=L>EE.LD4=&U3"["D=:]I]O&IR)&^X&[MT7F:[
M49FI:8+,.]9]7B[#:T/^V,O1(+89J(WC,9G,8/4.K]!>I>\:D1LE_P!(VD#9
M+U806[+I"?VN9**#;PNNI]=>WGP)0.<1+8LFK!T50J`J?`'IA3"!J2S`RDS)
M?D!7^K=S^MW4J]7C6O7"L![[1KQ>P-Q^DN7V$^<=>V?N&SANN`O8%G&&BT.R
MM%CTE6\*R8N!!F<^N5(07*2VVEM/Y4$%ZQCZC["6?2L(9H*LB0EN&]LNMNR1
MUG[:7.6-I6CJ;%D;CVO=+&0$Z5*5^VV`Y.[&K?R:K]D9@/$"HUY@S)AI\T8-
M<TE8.L^_=]]6:%L;K5:K7L[L!K>B;F';3L79>[;K917UBMJ[1DUFQW"UU,29
ML*QNJ(`,_/"X3"#OXORX33*&H_F6&E;57T;ZX=G'.J]?T]L&I5/3Q70X:G[=
M']K;U386O]JAG>I"R]C$Q#E;/5*O'P-'LE,DV,P\0<)&/FTVV\PTAYUYT(:M
M/8+JEM%&XYVQ.I]WAL$XD4[/N>PNV&X:^+#E]C:?N]UW8$G/P=539@JH;>J0
MK8D"U-4<?9YIZU`'QTN'`FO"TLA.[6Z]'3Q4/>GT.&(=>"]T;$2H4@_VIM:/
M6ED!P'1FPK_BMD]'&9AG4%8$:GK-;&BJR--3:_$)1WIGNF*J9(;#TT^'ZO3N
MRJ3V]K%;H4F$"-;E.4O8\^Q[R/;[LNV`AC6`"NUFQV38CD!@1,AV32:PRQKP
M,Y8D+%RVLRB2BB):4A(A/X:'56P#1XFUP=OW2#"I[-&E,W3>NR[0W8*^,9M$
M*J,V:.6-R(99[7XJ[&(5>QZ3;`F,2?\`3:R[E#J`V$3\.[J2`K%IJU?UJZ`;
MLL*HBQ]C#&Y@Z\ZX"Z^MN+YKZO:@NL="#^LZU1;>E$X6.&O(A,NMH2MMQO&4
M9#1G?A3=%Y'O-$G49.3#L<6'!N@]V_7+V;8D,/$K[58C;#DM%6S%Q;IA>M1S
M(CVR4M4(\Y(G^*WY#N5!-+G372?S>9K$).P`PU-]Z]['F.AM@&H1(T>ZM@:+
M7M+CSI!>'W2=6KT?6XB5)&JQB.1(L+DO^9QYWS!%D[X8O34L043.:]LM@DM6
MB':A*3^Q[F8CUA\7MD)N\-7ZFQ.*/)KU-";%#.R8HICPC)C%RD9>%LD'TY"_
M[CBW7''7,^9;BU.+5_?6M65*S_\`5SG@<.`X#@.`X#@.`X#@1.+_`*W-$_X;
M=P_;1T=P+@<!P'`<!P/,.Q_%BZWUC?>[NO<^M[->L_7^QT:I[`.0G=/O#$'-
MAG]*UNO-B*BO;[.XYPC)/?8%+Q5=69$-_P"L)Q*4XTE#@?;;'Q8.LNE^P.Z^
MN]W&;"8L77Z@,[$V598'T82Q$45-U_`V&('5JE+V@QO&[E3<(O"'1E!ZC-@^
M]YC49R2W^:+0'"R?$_JM,*ZK"W+J-W:J!':</:4MABT:OUL!53\:8'E+#L;%
MJ23W)&7-BA::,P;8G`<&QA2!(;1`DR9B7HK(0YKKXY75';>O8MXUIK+LM?BL
MN8??3K>B42@7V[(I%0UE4-MW39OM]'VK8];R:E3*C?0Z"<1BP.V2,7(,B\BL
MDG$Q<AN8KXU71RPDR@RMV*]GU"+_`)H4F6/JD1J(M,F;HF(!N['O(Z/EKU]:
MD=@P[H\CEI.7,0"C3C34B`XPH)?`_$BU(>Z\;K[1YU/V1`Z<T_28FS0]CM&J
MFP#>]=;%XA.;6KMHEZ?8VQEI&V9@9E<>(3DABT9J3$=G1(C,R*XZ$2(^,5UR
M^DG4^F9VN-Y5_;NS[E<M?D=;W*-I.BV?6%PHMTI%+.@;LU=-W@!]A)N+V,&)
MPH],D6Q\B'G(D1D.YSZ?`EXQ\2WKJ#K?4^WSX6QVZWW"J=>O6NB_S:%(AU2I
M6:_:,UI`.[0>?L;**H.CVWL16F93K69K<9I]YU><(9SE05MD_'+ZB,%=AP6J
MANJ2/UEI6P]@+`:7&TH(5.U@%J-CO8ZPUBFV/=X79]G'VZIU[$X;-A@71J8\
M^,N9)AI4]ED-[UI\8GK!M-K5S=>I^[VR^ZK^<U1JD+FK4D^B_P"S:E=:U5KO
M3:E;Z-L:W:WL4JDUVTLVTG/A&Y`=JIPR4UN8XZ*)QH@;/NGXL'6K0]NVU7[O
M6-W/5;34J\56T[@!:]B3]13-PZ^TC/[#G]"@K1)LD";+VGG58UV8QZ\*,`<E
MI]@R43.PJ/@,5;_BW=>J1UQT/V8-TC9V*AV/VB4U+K(#$LO6I\K.L8H1=SCD
MPC=%=AVM(0P\N!K\AAA2;<[+<E>G$]#$M66$AD-G_%;T/K+7T[8BM9=@;S`#
MU??EWL`*B5"D3++7ZAUHW[CK?MRPDHEBV36ASL(%L-25-(BRI,B2.7A]#?CY
MF\!U]@_%IZZZHUU;]@[(HN\J<[03NRZK<Z07K%'Q<:[:-3Z7HV];@"(KB['D
MTYN1&I^PH#+<A)=4',]+R%OH8;]H4&ET#XT?5C9EVZ^Z]JE1VT_:.Q9>SA:K
M'(SM`B!PB34-N?0N;?<.DM\Q@>RH2+9C+L=W7LBZ8F04Y<8]1Q.6L!T]P?&X
MZ?Z2VYV(TM<`FW'KAUL:Q\\7!`_5KHHQ,26T@'D113Y/;(J?584>3V!KZL%[
M?&K`"2CVS$:>^N(ZC`;!3OC(]6;W"H1JO4_?DNJVA%)7?;PQK\(1HV@?I/W)
M:M!ZP>W%;0MT*!$BMA[.IA"*+)U=VSB5CVD%7I3(IUJ:L.X_\8/K%#J9*\$:
M1V&&UD3LX_U\G3YFK6</M]IZ[7G"TSJNT,8LKY23NR;8&LUB"RTRL%.M7@-8
M)K>4C*@S_83XM'5GK'MZS:+VK#VA!V56`O6TT\##U<$7083V>V?*U341U?F-
M6QJ.4)4TU#7-LJ4Y2U`$YQ(8<EYSZ>`Z%H^+/H4/5=QVNHZL[$[<CZ+[*B.K
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ME"\!,W*XL9E"I\R-#="^5>-PK,`!V0:F4D=8`XPW`3.BO09J81:$Q/BIF0I"
M42(<K#$A/J-.8PMM?BE6,9QG@9C@.`X#@.`X%5][_5AZI_PZVO\`:`V5P)`X
M#@.`X$/]A_ZO6_\`^@O</VN;+P+557]S%<_W"'_8^/P,]P'`<!P'`<!P'`A[
ML/\`4`WE_0]LS^11O@:90/W`4'^`M-_DT+X&V<#R4[56OM;G;^W!F@=9[$?I
M&O=6@I4F)*ZUU2PU?;=]V/;*1$M,G2=YF4&URC5^KM26X^5)&')0=F;!BL+`
ME8\2=-BA7FWW+XG1>H[!>@ZMNQ+9H*@:4HEKJQ7K?K10O86\;+2`L39=UTML
M&?K>T5$E40>(!.L%K`>R5#S$&7$L"`P>%&)30OYVH+=JJ#IW34715</R]T6>
M[4-[<)74&MJH8&&),6NP8NQ6\E+2)LX+7R+,=4A^!8"H<B.]B$J'3)HKVJ.0
M9"A]`G?$,DUC7%BB:G+0#5OVIV106K1+KMKVLM=7*[-AP]AUJ\TP`;TAKLH]
M;R](BFJ?&7%)VJ%9[:5A*ED7V<2L-AAM).?$AE?>OUH[KPD.UK=*^NN]E\R>
MO&M:=*U*Y?C#EXN\77]3L.@=7-0JS!K>G259GCY`4Y!(F=AB9:YA-,=EUL)G
MZOU_X@=8VUUCJVP:VTC46=9T*T;KN5@U+J&DV&HW@KJ#;5EL^KJE$UGJ:F5T
M-4QA(E0JF\ZR^Q/9FA9K#*78[KV60RG9@'VD.;I[7Q-.:J.1ZM/ZS.1:988'
M7?11*-;]]C9M&?H;Y:W;%UW?E[P"&RQA2_9USF/FW%K!%J:&;6X),*"N.T8?
MQ,!.TM@U1JJVJRZBD;CI--H-_)]<=17VPDZ!6K$>*7+<1;%"ZOV_YDV0W?M=
M2YK:GP%GB36;X)*PV1*X$IU829K?7';B\,'I;PRY:>/E^^5;AB7X76?K^`ET
MW1X>X;'28W$0>O?4Z",,7,OJX%$4U:QA6PK0<.QO(["2MR`H/7NHSZH-H!4S
MKNER618]^]2VZU7Z2,IABVV>N%#(P[*'UU]FGBIYFYV$(ZJ)-=7#BEO79DXD
M)C/(>P'D.Q;?B@2].BKO()[V:OE8I?<.YD*Y#TMIX3C:IFF5^B0>L58QKTOJ
M!=\HJ+]L"S3Y2`*GU'&P@2<PJ>03[&3D!Z!:X(=AAO3&=83)RPW#LDUK&^6,
M7(NVO7%F)=Z@03+]:!KUG&HO70G)1+ECV6X8V4+#2G%R4(=?=1G#S@4;N&Q_
MBB`C*QL.L;$,!*QK[4%4O9ZFZ=UF:EFBMCJW7B9>-OZ@C3HCC=LVJF[F=D#Y
M`9;:JO61PL?(ECUY7A;P>LFID[$3JG6"=ONC'MMXUU2/I2="MQF@Z]C9K(S-
MWR,;@_ZBF#BS9DX:]G\&/+C'I8PCRXX$@<!P'`<!P'`<!P'`<!P(G%_UN:)_
MPV[A^VCH[@7`X#@.`X#@>)]^T/\`#PV3V,[:5JV.=B`%QM0`_M7LK,$;EW91
M=0",:BA]=R[>RH;=>O@ZNUJX",!ZK)'3@\9HDPX$DOJ]'"?4?#O,=6_A>2]G
MW,2>VY?;]=MF`&-)[2KM^[2[YNPO:TM<=K0XH/?FCMWFBK=M`?ZT2(/E//+/
MQ'8<0@PM&8C,IL)G"Z.^'G5JEKP7)NSQF&T+W%;JK;=B[VV;=;K=VNQU,MU5
MVC:3%]O5O+VN^%+-3JH48;>ERY+PY@=CV7#&&FO`(!D]7/A#6:KF1E;L"JX(
MK3,@W*8U/O;<NJBD82U1M9]>KLX)FT.Y5,H]4-SU;YJ!;1F*]D3=I\>'+EYE
MD8^938:[#TE\(BUFY]XK>JI<@]J#3\G=A'%3DV\:W6J%L#:.KMEO4=<(;8X8
M$@L#L?2(;+8!O,B&`=A38#?L^),^.Z&W4^G?"GK^G^TVGF;0;K6LM@1`NG]L
M!+7NW;!_YMT/%=D66CT?41%Z^6F3J/5U>%W@K+`CZPZ(A#T1B<B.TB..>>8#
M])=;/ABZRV]4(I2_;9I&V=28%7GZ0Y?87L&V7V7]\!;'-@23VR]EO7&8O=,$
MH2TTP^5E&IDZ"&$PXC#SD:"MEK@?0CU)^%9K,7:.M.P+[;"0AN@6SJPNA;<[
M&;UN4#7%!WX!U0;+ZUHI"W7`E$UB,4)JE/(15BY,+YNN+'/MNQ')D=3P8`?H
MSX3.U;1N,F/N-E`!H&N:#U]V;7X^\=MZ_P!/VW6,+4U!U?0W'*>U;1=4,U^#
M1MB`Q<0XN,WA;ZV9#;SF$M25!:/2==^'DJ^ZQ!:6L=<1:P^U=M]E=2T$9:K;
M!'U:_P"TJ;?:+M)VKT@C)BBZM"L0,Q9B>:QB-'C)?D3S$:$G.79.`J40#?""
M[5V3<VVKC*LT9VX"R$^^5&VW3>=$HMD/;.TG0]2D=OU72+5BB4E[=A746W@]
M558!P9%M::(-(3E*GF)#P7PV:;Z(K=ZY$]AV76#`_6[!#?6A&TDL)J4<:;UK
M<Z8W=FH8G"ZV3%GZ5<2S8GVY*T$9BE.04NS&$Y0%/RM#^$V+E;X*NV,F?;[&
M0G=>[5#1MF;LLE=H`/LIM9-BO(<!6)5ADUWKD-NNV2/OZX1Q;`-Z+.QB60;9
MPA'@&V;6T+\,.^SRW9W8LHB4K_9QDR,>(+VCMN#K<Y828ZBT$]::KJ%%GB`A
M&SKR&U_7Z])+!0231:'&9CK6MJ0[EX,'7=%?"OQM.B['USM`E3K5KYRS7ZF0
M=9[ZVS3:/$K]Q*S>V5JJT:K5ZQP*7.H;,J),M$FKX97!#QI[B,Q(S$Q#+@2&
M=L7PN38'=PDY<:+,";<V]4=\[ADR9]P4W9=@4"[U1BMDW3&8^<NUZ!;>M[:%
MC(CN13[=:*Y<95'CDU)"!S&E_A/UDE<C0@?=I8+JG6Z#=+@*UYL[</T2/53/
M8/9%KU%5#5,#7>#K_;M3T-N]@[/J869"*B:<MO,(:AIJ/B$R%@]/Z"^&N``O
M@M5EPK("+<M;[[/#\[/NRF/I*ZJIJ-YC[FNJ#9W#J+Y"4="2[L9)Y3,/R,1\
M&UR7V582$?[UU-\)3L3;RW:3<INHFK;7A]5CDKT_>[]6"%4:$C=@KJJ'@D$B
M*?`%,#:6>DL-KB-R7D0<O^56/16H,VQUJ^%?U_4Y3(0>L:OG6>@:"/6,`,,7
MH&>V##U!N96Z=&VK8$.`ZV8NNX)VV&9<F-)*XD6VR95,B+Q+82\R@([B:L^$
M5*V)>2DS:+5M<V1M?[X&TT"T[HVI;])R=DE#[>WY]G9U\;,D-6CFYQF_,O$(
M:(Z8?G/1X+[253V([H:?.ZQ?!&<K$"5=7J9:ZG9-6W&AUM>U+YLNVCP-4K>L
MJ[4ILBM*NQ"<Y2=A5#3^IH$8`3:S$LT,$,]48]Z2G'5A)P_J7\-_8X+800'N
M#=YT-L.TW_9ARG!^X'9<"V$N$ENV6;<)BN5AC9(-.OIUI9MYIBUQVVH3$U<Z
M3&G-^LG*&PNWJCL;U%K^IIHO6>PZ:"U=UTU]6!A,;&ER\CM<T(`Q+IU?B9D/
M>U^\A@9ZI21/KQ7YR,3![K&75/(5C@9&-W>ZI2QL8O'W945CY=G&4QJ2ZHE"
M:19C3S4,2+FKGP(J!69Y5W`]M^7EB-[S2N%ES$IMQE(82M=].K]BEP8+VR!M
M;FECR*\&C6)R*PLM,</9K34R,L9+*LQ@+YAQAILE*5'@.>UL>5W/J8\`W)'<
M#K2]33FP&-NUJ34:Y;@M#+%XK9:5AJW64>,,5H'$@QQKI(I)LH8U#FC5167F
MI\.4R_'4XTXA>0Z+7=3JM(E*B1-W4R:M,DQ#P_`?GSH#SX*/A\AB*4AP7ALM
MK+F<QH[C3JVYLY*HD=3LI*F<!O-%[%:-V;/@#-?;0J%QFEGB#8ED`301P6:%
MP6R4P@*=82IDD%3!>0XW/84Y"?2M/INKSG&.!-'`JOO?ZL/5/^'6U_M`;*X$
M@<!P'`<"'^P_]7K?_P#07N'[7-EX%JJK^YBN?[A#_L?'X&>X#@.`X#@.`X#@
M0]V'^H!O+^A[9G\BC?`TR@?N`H/\!:;_`":%\#;.!X;=O_AK=F^Q/97;.ZJQ
MM77`6HW0/KVAC*D3MUB$$BFI*\C4TBSTB>XSHZZPJM/+F:M9I"GY3MO`3FCC
M2'@34AM<S@:/=/A$;[L%KV!:*GV#K.M\W*51)`$=391FL(HM?U(%&II^LDR:
M1K^GHM%-NEEUQ3WS+_H#'`#"['FO1H;IC.4!.&F^B'8;3FX@VWAD/KV4EL]G
M=D;A/@D[!M0(=*UW8*ULREZJHX"<$ZU1;/#&Z>JVP&6HP$R3/CGY(J.Y%F#T
M)]+@??1_PT;>!%:M3N6UUR59('8;8^V.P)^@VPFZ_O:D7>MV<D[K@S,A:EU4
M:(4TMMXD*)3@YZ4<D,AP^(2##[$AR+P/2/8`#:>S^ONP:I`*P=-[DV!JV\UH
M0=#F)EAA:WN=F`F!`(W#.CH@B?,6"D2V)*I$1IIYEY*LL>93:%*"AVB>CN\=
M;]C=+;D(6W2NO=4ZEKFW*A"ZT:;7N`M4HL7<%>=E6:Z,VZ_FF4'[N3N8BNM3
M4O`1\5<8(X0B*AR2$V$\&-[.=%.TNX-X[WW)I_LZ`TE+NVB9NG]<X='V^S$X
M3=BK]-#6>(2E!Y%.):Z"JQ6R"X3X8D7?B%#KQIAB.090E890A\-MDQ2+\*GG
MJX,OMDI'5G0X2\T>?=Z)/QH/1J-3JV+$MA(%,;LEEM^UY58-8>8G2R$%8^."
M@2GW68\S+H6#ZP]:[_I[:?9':NQ[P%M9K==J<?'-UZ7:'VI%>'[*V]=ZZ?MS
M-BPU%@W(?5=EC*DQ"&H<'C0-3@MLR'L.90R%U,JRK/BK.59^3'CG.<Y^3'AC
MY<_WL8X'YP'`<!P'`<!P'`<!P'`<!P'`<")Q?];FB?\`#;N'[:.CN!<#@.`X
M#@.!YTD+WTDK6Y]SCA^P10;>EX8MU)O"3@J\66O,FBU=J<8I#G"Y,-JGSVF&
MJV&9>B-2VDNR7F87G3)G-MNA4>C#_A9"@%,H\;;EL8@ZUJNG1X.Y3[+LRKAI
M>S*U*M]&"[50Z\Q$@Q=\5*3H\GBRDI#+2PT5KSD<-LO97D)BGG?AG3J5ID<<
M+I,U/2/NJA:;*')^P'53IA`[4C0>*LO/<COFG+%9*:-C0R1M:(A9R2N/'D/-
M3WTO!F-1]<>AW9,5,/:T(7\ZBM_-P6<B,[`V+"?K-:]Y`;Z!T=)?P14,D4:F
MVJK1G5!($F5'@$X+T9US.?794&/KT;X:E`B6D2,VGENO7O4L.JD!$J\;#+52
MKZT,0T;5PW`]3$D70'+Q.M"BGG=<BRBI>:N,SYY.,14!\[-UE^&L#&SSY"1@
M,FV;2@UD@3%G[B1(F]H4VFR`\7,\:W&+J(3J/K)\K&61D17(X4"2(N+?896I
MUL,M<I_PY=Y[2@PB6R9CU_+(%Z&EUNO'MFUEF:($2AM>5KZUCX<*%$&UF[_3
M*(%.N351HA[!,:RP^Z[F/G@9S;[7P\+7L@P0V;:13MZKNUYY6Q+<<M<J&Y97
M*51Z3>!<IQ(J<"DT@57-(AVK4_%5[OK[XG.2$F"ZM[#@06(UW\*:R28`Q.TC
M)Q!Z3,C3!-@V3MMN!8Z?KNM:NFP!MI055#1G35'K=&K:A\^2MD)GT\9Q+?>?
M?RX&R5#8WPU--V6;V"K&T[1>+]7-<GK`7+RI^R]DW8^.JH'9B&FBZ#(J61;O
M,.G5&RPPX1UV#(D"ASF6(;C49IUL.Q9M5?#@K)PMH:[/6JMFJ4<J=F@R[7,V
M`MD07V,*U;FN6`,>*12`KW94!FCJM$F2YZ<BP?A'CD%I614E\-_V[`^'K*M0
MS7&QMDR:::I`NH=>Y@.%>-BT4-*158H"U:["VTH)6-KQ=_6A'98HI!G29.8X
M@O8(*I+B9,N&A01"Z#^%ZT9&6M.SSDRYE0KYP=*D[$V,%MEAE1;EG;4^V29A
MET'(4=V(=K$DO"7*>9CFHR)LL,TI#DEY0;I'*_#8UH`U91%WS/N'5=M@[KH\
MQ!ZY&_8K6?0QNULC+BA&9$I,*.!#X.S(V83(H:,9<<DX8QZOB'7A:,^'/8ZG
MM.#5[O>45#5+;,RZ1*;L7<D856'+?7[/IHU::M$%N99L$C:-;`E:]-*AT$,3
MTQ9*(SK<A3ZUAHQ*5\-ZRZXVG[F!WVU4/0^J*YN]5HIZC-E22I]:@;%V>#F:
MYPLF0G&3$^%VBL<);4B&SG*2CK#JFO967&@WN"Q\/EB=]'L0_>ACG;BLA!3`
M:#9-@J$T0=$VU:S-?KPHD,E21>IIT_>]N--Q,1WT>TFLN,(<RPS'0@/S7[_P
M\`&QK_+1N$'9%[GI`+JS)#G57#V8O$L)<M=[PT<N,Y.46.Y;.MF_(+A\TI^-
MB.HD"@+4RXY"2\&`N.K?AE0;8=K%]V7;7[@'N,<!?6CE_P!N2)=TOH8#:HT&
M=;9S;7L-U*:RIU[(-/RV5NQ:X+F-+GJ80F*X@)1V#8OA^[EO<*Y']OE1%ULT
M6IKB0PENV5K^4\9UE89$VB;"(U)J.*PW8-6%CZ'HY0C$]E'1RX]Z7C+$P6XL
M-`V)0/AS:[U(5`-6`M`@VG3NYMD5M%8G;!N]G)U2HQZ+:+W?A0UO,YTM(:.Z
M3#3&G)JT,ER#"VVU/9F.I<"(SE`^%>P=JM>V!>MA6>ZUR.F#;;!9[#MCWK&)
MA-8W[,"S[,ERV6'1[I*GPC(,<MGPB$IT9@:A$B;!B(CA-M.N?P\QV\[CL`5N
M\+-*;1UP4UDV-:8N35>%B]M;2(;CV+-,W!^*^'BG#U[WL*1,5*?@9K+,L?!>
M3'R\VE08R-LGX7U)UI9Q]>O;INL/:H.0B02MO[+L)V93*I;MC;X]SL,MPE28
M-A.V$J9G!V'W(TPW'=91"]>.J/XA(0CK'T'[00RELK;QRT#M=6*0,L4L=:K^
M%@03E<O<_94T;,1.5#8E2`-]6^X^_#\SC#T=\>M[T?:XJPBNKCOA5,1?:*U:
MI)!-JI4*"@;&=W$6)E*F3N%`M@%MNNX$2"RUVX]*!2`R/9_7.PY2%04R8SJL
MY#6*#KKIU7]=E-8R.[-FLLT;M;6.]B%T$&)H$\``ZRU&+<UA3`I@$RXU6Q!+
M36O\3AV(SR7C8]N1)'LJC+\B0EZ^:]^'3J/WO5#EN.ZVC:2&K?M`VJVC:T0<
M!BS["G:(!LX0KS4YB>4UK8[TQ91K:9#DZMX)1ISV&H[S*U!I.OK_`/#NZL[)
M!;`I.RL1JZ.U\GJW0!`@5:I=$U'KFFV_:VPCZIEL,Y<&*ID$W528D3)0_F/'
MAUE0H8F1B#(2P'K73[?7K]5PERJD]1.N6.`R3#SW()`8Y)AO^/D6Z/+1().$
M[C*<X4T^RTZA6,X4G&<>'`KYO?ZL/5/^'6U_M`;*X&U&D'UPO+6Y(2(3]9K/
MJV"`0)#_`&;'F]='LPPH(E>NK/E\BO6\J?E\4Y\<>`:E[-MW_;>KOXHW'^??
M`Y(C[;\Z/.;UAE'G3ZF$5*X)7E'FQY\(4J\J2E>4^/AG.,XQG^YG@2#G_D_$
M_N>/`A_L/_5ZW_\`T%[A^US9>!:JJ_N8KG^X0_['Q^!GN`X#@.`X#@.`X$/=
MA_J`;R_H>V9_(HWP*IT*]=A<4.B83UNK+B,4FHX0Y]\<";RMO%=&X;5EO.L%
MY0I2/#.<>.?#/`VOY]]A_P`&NL_VD@/W+N`^??8?\&NL_P!I(#]R[@/GWV'_
M``:ZS_:2`_<NX#Y]]A_P:ZS_`&D@/W+N`^??8?\`!KK/]I(#]R[@/GWV'_!K
MK/\`:2`_<NX#Y]]A_P`&NL_VD@/W+N`^??8?\&NL_P!I(#]R[@/GWV'_``:Z
MS_:2`_<NX#Y]]A_P:ZS_`&D@/W+N`^??8?\`!KK/]I(#]R[@/GWV'_!KK/\`
M:2`_<NX#Y]]A_P`&NL_VD@/W+N`^??8?\&NL_P!I(#]R[@/GWV'_``:ZS_:2
M`_<NX#Y]]A_P:ZS_`&D@/W+N`^??8?\`!KK/]I(#]R[@/GWV'_!KK/\`:2`_
M<NX#Y]]A_P`&NL_VD@/W+N`^??8?\&NL_P!I(#]R[@/GWV'_``:ZS_:2`_<N
MX#Y]]A_P:ZS_`&D@/W+N`^??8?\`!KK/]I(#]R[@/GWV'_!KK/\`:2`_<NX#
MY]]A_P`&NL_VD@/W+N`^??8?\&NL_P!I(#]R[@0WG8O8*!VFH\M/7:L)FIZ[
M[<;;A+[!AGVW8BMG:0P_)5,1KAE+#C#^6TX;RA7J8<SG&<>7Y0LG],G8_P#!
MKJ']H@1]SK@/ID['_@UU#^T0(^YUP'TR=C_P:ZA_:($?<ZX#Z9.Q_P"#74/[
M1`C[G7`R5-WKL2?L^IZWV+IT?1/GM7+P=KYT-L\;>F%2*&[4L$QQ"`Q6*^]#
M]JCVUM;+R5NX\65)4E/BG.0K/NU'PX(-GV=4-R6@2+MDZ7((W\"]9-DPBTEZ
MWS1EPFRQL<$^F1+83(J,>5*<%^=L:AC.'LL)6K"@CVEZ<^&G-LM\%T_!4H[H
M,4)VQ;[C"MVP"]=C(MM[W<U/D"#+927'LKY6SIM<0@T(9>B^#B8;.<.16F8H
M8,\&^$C=VZU+F78.38JX#7D4"V$NFV%8FC19O6+M"K\6*(D*=/6&'8I%64H6
MPETOAU]EN4SZ3[K;@350#W03KW@INC7VXH=8`&14.;:2D.Y6>W@+%4J$&:"#
M&RB)S=BD8K-(QL9J;[0PIKV3VIK+KV(3"&F@B\-JSX>E5U^&);)L:O=MYO79
MZ:5EF2UFJU?VJ0KFY+U9=B3CM5I1)VMDZ%0+D0==J>97F8%1G!Z8JDONMH6&
MQC"7PV%5`;1!NW9T]FMVLAM6*6A;.W#*V*1MNPX$&LV(*S<8)'-UL%BN`:YL
M"Y]3BR'2'HS$,Y@M*;1Z81Y1Y7PGM06YYFGV?PEEV:U97+7&/[:M5/=G:SNW
M6RQ4JN#[&AXB`GV6*=@T-V,*A*?F2X\=>9*%^K+R\$L[TIO0&F74NC9%@-MW
MFT^\+SF@A-I[`B9F!]O%",.^#@M8C6H=61@'<;SA(A8A+>6%6",/ES%M/-P%
MK8"*[[$^$N_3TG3E@$V^M4*ND%*JU;L^R[.HD`T_11V(T.351$V0Y/AN523`
MP)DN(:;/HG,-Q9$IJ>I$@-AP/^%F/I),(2NXV/7'PQ^&9)'+=LP>^F)0@V_:
M,1]L-/.0O9"(J#?+V-AY2MM^;+'S&XWKR1"_9@WFUS?A[[=OS%KL][=FVRQ0
MP=/F.M7J]!\6T-6GFF2=9NU:$DXS\4"Z;;@#;%%/0H,>65C0(4I*Y'H-+#6"
MMT^&_N';];S*DXL-BLEK-6YNYKG6$?3Y%JM\RL:OLE%M2B1&&X*=-F=%`X4P
M',A1V,RH,;S)QF2[AX,B2TM\.BJLU@T2,R24JSTW6P&OO&-JWTH8M5#V)!MT
M73;#,ZQV5,E^NAZ\+.)`X0^TU`B19&,8RZE/B'8;IGPRHU(MFW6RU<@4H3?M
MS4NU&DVO80[$&^[W'6PALVL.!/;F#+,XM5]L39$*,Q&PV+`R([P_#$"+&6R&
MG(UGT?ZX#-E4+;?84Q8:_P!AQ=&N55`%#)AP;5-4T6[7C9^KA6O9-$@OQ85;
M%VDT6E1,MK;CE&8_I^SNMH?]4,W61GPW-7(M&FZ`[[SDW8;3>M]MJX2Y7`R9
M<K=_EA-=5EE#MALC)*6!F8@(;]^"W)./)`DK]=3C3O`[TW4_PY6MF$:;\\"C
M&TB>RQ]9&!!.SMMNF!UZ=L=PO`ZN:]8@%7X@^#2[Q()EGFA./8J\5B^:8J,I
MA*$A'E,G?"\KEW<UY'>,T,]UJM-M-LF;\4V0-'OFP14K3+L-1;+.0F?.MA^;
MU"1,<C/NJP62#3(B>T^>;C@;B5`]!Z[8!FX=@VTWL87V&N.XM@TJQEC-M-42
MN2+'#K.F=AZ_!4\7,0D-,MQ"UQ`LL6V*62(&$X:E(Q+C(PD(P*0/AAV4+=6X
M.XY%7M4NI[1U9%VW>+GL&P$I-3V!INID+^9#E;F5DB;16K)K6RUN,U-E9=A3
MR-;"QV\/S0<)MD)8MYOX8^P:U3(MQV(+=KW7:FLZU`CB-CV-5U!0!JL3:3F&
MZ)R@/-+DQ0"))3/DLLN21;2'%SE,M)SX!U@/5;HC>-5[)W51]:;)V:$9.[!%
MG6XMUMT>PVHEJFY[:KUC>K^;]=JP!*0V;=:["7@3US&V9SBX\EEY?H0D-AL.
MJ:7T-VF.JE/^;$\#9=DT:!>V]9[!MTQZT$:S9!.G+9&5955JYV>H),V6KZ$J
MYEX1@DHAD7#=?=C-LOS<*#08(WX5XO7C<5%H&N:Y-U8*W!./7._/,%JJ`SM"
M$&>&XCD<6%VOUL+,./8+(C8')%)1*7+<;;2]@)UT>.Z:B_I*N>DMKS,Q[;;P
M]%V?,D6RPG6+/>-B$8]"UXV6Q<V)DX@[)LIM^(&EQ5XBRY<MUG+KS<9MJ,$%
M:WHGPY:YJ^ZQJCL>S;"+Z5TO6[5>-B![WLTIMARK]?ZS4+$)M==/19S4Z38:
M<#CADHCA%J<@Q2,6$MI#,]#3X=*J:_\`AR;!G:LB4,YFG'[7M'KG9).N)+]F
M-6NWV/2X,\4TW1"4&;,LD%F)K2)2)H8I+'N28<(<`)`ILM#:);:`NKM;HWUU
MW27MAF_5VTSG+J1:-6`8,V/?P%<E6#YJCZ(0LC58"V.#7XUD-4@3$%2IZ(V)
M2HL9O*%MO8R[D,?)Z#=9I$&KC&ZK:1PVHPY\(=`#;-V,&BS4RRFQ34*0>0,M
M$7-@F5TKMNR/BW9F7ECW"[V6<I\&L-A8G5.K:7I;7]=UCKT8Z(I]69FLB(#\
MZ81=:R2*3C1!Q<N<\^^K,HH2?=\F,I9:\_IM(;:2AM(0SO?ZL/5/^'6U_M`;
M*X$@<!P'`<"'^P_]7K?_`/07N'[7-EX%JJK^YBN?[A#_`+'Q^!GN`X#@.`X#
M@.`X$/=A_J`;R_H>V9_(HWP-,H'[@*#_``%IO\FA?`VS@.`X#@.`X#@.`X#@
M.`X#@.`X#@.`X#@.`X#@.`X#@.!`A/\`K547_ALW%]MG07`GO@.`X#@1(6_K
M,=<?X%=D?]#I3@5,V:/^&E5.PM[N-TM67=ON'+0(V0XW?+.D71_G5K(TY="9
M1$DQ"$MBHE:'88G)@JG/AB!"%'PS%5)8;X&(05^&93:5=`-?N-O-U+<(G6VM
MC8BKD]OV>%2P<C;1WW"`CL)8D0]9.`-EWXJ7."9'LY!B.\^Y.B*@MH92'Y4$
M_"NUV$H,NO6HE$@4RZB]JT7$G.[R!*=<C<?5)^.\)&R`[Q2TD&!]8JLV:*89
MDN#8<N*[)CL,3VU/!^5WK1\,O;,R3K@`:/E$?-8]$9`CMI;'E5$-4QT)VGV2
M6R6BEI=+`S+R#I#LYU,F4T6EL1EDXZ&UL^TM!^E]I?#&.ZW+40N4(2*K21VZ
M*=7*X8<N0LO<H.Q`NM=_7*?4FC\@?*E1K.5L8'YMDBJH#$TQEJ.+<<0XRIX-
M;&5/X;P>,=V-9-RV<7&EVP63IH65=+=#*:LV#K^MZGJ\FV48-452_#9!)4<1
M*?)1F7W7FB3T-"<Q<26$A)%?U3\-'9X$?IJC6AZ4$]YV6GA@]<MNQF1UKF;"
M*55=DCA2\Y+HO8X]TQI&(Y)EQGR4.!)@O..NM..K4H,_O0)\/8'M&2.V9E]S
M8@"L:<U6>`-3[6U'77G3@T5KK-@LI9Z&"GD:H'N[Y*7YBZRF:][7,D,R6XR5
M-!$D$9\)L+4`F1^UE5ZEV$!L2FHDCKWM.JASE0$5%HZ2U]<)PU`EM\75ZH!8
M+`1Q9:94EAM$N-[6F4M<@)0%ZM^'/M\Y7M7#K23LA_Z/)%J31'+CLX81LP+W
MQ=]AP#=F!R\CGRMXJI'<ILS!AOH29'LGL2?9L,9B+;"OQ#87PSK=3G]X^ZMS
MP"FXFK;8[750%AV%2KY8@&T&U[5M=>L3,*XU\;*$./RA!<F"A$W)(-\B+;G,
M142_2<#97]%_#$/4O8&LZ?M.)59EW@RZG8[$5L=N5/F!-@7B&V8*U%=F4,`*
M5<"YQQL`>%H='QI3R)8W*T1,80$N;WOWP_C.]-?5C;02U1[:SJ()6*O;A]?V
M$"UZ$UE?)T+9H!$\P#S`'#40W-1>*2"F,.5Z'(E,O/PHQ"7AP,`*HGPT(/76
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M30-F0U[7*?CYC?F8=1-?^&)N^Q&JCFS_`#U/;^V+.*9K3Y/:F'#EH@1MCSU&
M`0^1#C)&4]F=V%-S(A-&&P3I$HWZ$A;C##;09R^WWX?%!MNH-26\^;DVKK_>
M'6`D:)'O;TF@FLO%][2[I<T"X<-).HOG-!RGYA6/'FB(+\-QJ1F-%R_E`:)&
MU7\*J1()H9N`YM@/69]7GXF7*],CB-*D0J9IA+P8J5QA!RIR"K`]$`L(DNPY
M11$M]B2[A$_RAG]B0?AKWNBUO;Q@L]8*98]PV2J0M@`)]R>CTG8%D&V7:]L)
MV+$M&%4L+)K,2;(>G3HR(B!1%I32L,RH[N0LU3+]U,UWK(BD3L18/66P"FV'
M,![3-ML!L.:;M1LCM:O,![)`B62FFX5DMLGV@1*;CS6/D2RPEMGP2%;06W?A
MOZYV15[:,NYT3*IFMA<P-/DKVJJA0F:U4JKINK'W0DR+Z1+91K4=RA,")Z8C
MTDO3WE$8ZWH6,2N!%N[^K70"KT]3PW?YG1;;L`99K5?0EM-VF?:-4[AI&X$)
M`1"DM9.)&$[&IE8L+K,J!YW2+HKUI:)S[OC("9F[3\.H('.:RS>I5&BFQ>J"
M7MSIO8@.:$@:AS&W/JFRXL[[65:\)A"I;$B&DH\/FSIC7LRF7\^5I812'8Z"
M=5M2V:_1S&Z+[K+;TS<6D!(MJ#M<[*UX%'T(2$V[KZ,"L"AINFDW(.BF<$R)
M)+!B<4A-IRZMY7Y,)\T@$^']G=E>DZCN#1;;H,=9[I3*Q*MEZ>=IXN6S=8]X
MK8.MV-QB!7)GO'9)@D7KCJ&R<25/3(?C---1O2"0AOQ'^II(-4C&+V2A8M*J
MIB3#(54]'73V[53XMY<F7`JF&[68`NH`)\5=@F1I\N($7,C8ENMXD,Y6&>7\
M0?IZF,B6C<\"5'RSAZ2X/J6P"7NM7IWR0]#/('U.2Y72D.!JZQ3),.?B/*BP
M`LN6ZVB,RMW`;76NY77:[[/`ZAHE^9N]S/&;@"2U51A4L'$S:0,*$R[YDZU$
M2+AAY604^)!()<<@3R$"3$8>6_'>;0'PWO\`5AZI_P`.MK_:`V5P)`X#@.`X
M$/\`8?\`J];_`/Z"]P_:YLO`M55?W,5S_<(?]CX_`SW`<!P'`<!P'`<"'NP_
MU`-Y?T/;,_D4;X&F4#]P%!_@+3?Y-"^!MG`@D]MBU"NS&I]"P:$,)5K9.I]M
M;-(;&>N4F`1K3^J[#KBM/5UBD)J$V,=2<F[4%J3,4:A>SMID>++F4-X="(M>
M]^^O>QZG(NX]6R:S6HQ?1T-9&^Z](U1M==[&W$CK[46S,9DRY#;.K[)<@TN"
MZ6>4UF#F.IZ0RW'4T\X'QS\0?K.FU]<*6HW=$V#M37P-NU1$S0S&/"HV^QKJ
M5'M-O3E6)5;!7<\G#8Y[TI'E9S[3+Q%BI6\D,P2[LZI;K/;DY7*_L:UE>F8&
MYF=EU*-7H(4^?=I0ZSSI\*EQCAB+(DL3%U*7B-,(,CV)<7TYL7VF&ZR\X'WL
M?=34U'K.J+%L`!M&FR-I:^8VI)KLRE8+&=6Z]R=IE6GW/:^0)4B/KM:&6;8(
MF*X]%>GR%(E9D)8]!B6Y'"3Z9OJGWW:^T-0U\!L?)G4)B56K?;R%%(PM8*M<
M`)1;(0J82^9>='$['"`;($RE1U(9]5IU[T%.JB2L,A%W<CN)0^F%/U=<;Y#B
M$(>S=WT74##,NUAZE[J'6)),G;KJW)-(<:-_,6JAI,_W2QA,PHXE$9A27',*
MP&NWSO/KJD=AQ^C'@=D<!A'-S,;>W#.#DX6NM?$--:+@;[/5\67:BR\VRS0Z
M@;'OSHS3;3<>/*5EEV0_'D,-!K%4^(9135?V3;C>I]W`A59WSK/0VOZBSKR>
M1W%L4]M+15&W=6YR=<XEL>YVB`VVO(CX]N=2J+&0ZXIIYQR.R$O9[EZ)QV0I
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M1:G;(`&R*6Y&(SJI9YK4&8T\B*MQW*EQ<26&W7D!W.R&[+CH^)IXG6M:P;Z$
MO^_-/Z@O9LC=(]49US7]L[#J^MX5I@#<"3).ZG??ELC^S#64Q(_I,ONR9;&$
MM(>"R.?DSG'][/`_.`X#@.`X#@.`X$"$_P"M51?^&S<7VV=!<">^`X'YGQ\,
M^'AX^&?+X_B>;PSY?'P^7P\?Q?\`DX$,T")V(19Y<K:QC2DBI>Y9,8>+UJ*O
M<,Q@ZHC%>BD2$NVS9S#D-L:AYE;32D?FBTJ\,^'`[A;^LQUQ_@5V1_T.E.!6
MW=0#X8HV_;@"[F(@8EQL1=BR[(J$PCLA*)9RP5,J+FV017@2<QYLN57O5?)R
MA:'D0GF$29&6'\>HH,K0-0=$-SW?8&KM>KN-KFTBK4"S72>!V'LV/23LYZYV
MX/7;7'(0;)$!7:]CS.JIXV09B,R?2AQ\CDR,H0Y&:#4[B6^&50[!KZ\$SK19
MPW8HX*M.5RU;`M`&A$8NA@5O*6TA5A1>4Q4&S.GP(!9HEB%Z\M.8C\SQ\)<A
M`9VDG?AD:CMKB*;L>O"B*)1+79>N1+YL<[4#4R0NS!IAJT5W)`E4[%$%1R9D
M3BS36GQ\!E$J'[8W[*M#(88]J;X96O+I8*9:3<IF^U=R'2K)".7K<EDL<UN^
M5K45%KNN<$Y!`K,L;0ZN&*6V/"07WW!#,V&_Z3*9;CCP:X:C?"6<;0J58@*2
M)P)7`0R<+);8F6-D93KX1V742H/$-J;/@+.6K<B'!19IM.;1"*CXD9Z=#Q!9
M2':*7#X>8;8.L+#6=T+K2=?,=BZC2I].^<4P;2K/NRMVZ^;0VK)O9B$4B^[P
MP?5YF)#F8<D!QY61F.K&9#K+:0V)V!T)WWV.;]NMAS=UO[$NCCHFG1RUN7K2
MES]-4Y$><X9!QI0<#7[Q(%5ER)/BD67+!B.\Y#?9:A/+3D-?L>I/A>4VZP*%
M=3"JI;=2,3QT-@ML_9@_`6$)JEE,0'R!X38\CQBAM7+%V!+<Z3&ER?26EII]
MYEA:0R_6FP_#@U]9,VO43LRA6!P]9=3H8LDNYL3S9T1:R]*L-B*5"?,GD`N5
M%:^F"X6+PAK45AZ'%7[.IUEC@1QASX1F5OAY)WT:U6*M&<COE+'N.)2ZNI49
M[6M@'C&9LYI`*^$`.M&Y=D;PPU/>$"T&)N?9DNR\AMU["_#-I.TH'7_8]7,R
M3$U`4F+,65[99VA5L'8ZJ:@5"NBKP^7DC`5!%@9TM(^%%=P%!N/8>5[*M3;O
M`E@]9^@^^MRVY9`G-M]\@Z<V>*OTB`O98ZNUN@ZPC@(-TA66'%P.%!SN06\(
MKL)S+&)9(9+]6*MUIMM7`P;8_P"&B+I-DZ]HMU6Q2;)9A1,G6V;A=G144UC"
MHE6K0VR0I>8P?PBP'\"@[,QMQ^+"E.,M.-Q9*V@R&QM4?#O09JFQKX78$RMF
M7FV5RH65=]V4-#/[&F[#P,/OPIT,JV(JAEO8DE,%,AY4.*N:MAG&5K3&P@(L
MDJ^%23EPR[5_D0Y5,J51$A$B;EO04NJHIPK4M:U]<`8N&^Q[%L%0<73&01MI
MG)8K'8AKANR$+<4L,O-J/PR'P6X+L$LLF[)U+KDALW8SE#V?M:X6.9K'%5*2
M;7#&NBK++(7NLW844DMV&##>FLD9\WR$/"4I'@&[0ZA\.7,1K9@XI$0.ZVG=
M527),.Q;.5$`E:Y95U+4JTUQ$AS-L;;O(=T4.>AQ9J91:#+'X<<6B;&R$=$J
M=\*JWW^T7MS8,+-VM=VLL.T$`^V=LA/+,-KN'ST25C"CL&"'UH==VJ:BD"$A
M#5==<+YB9DX4W%:9#+U<+\+4_("."RU3.P*S-9V#4D&;C<9H>MQ0H_:%.B4,
M'7"YC+X"F`8%]/28-27!9$9]YM3H<5U349U@-U@A/ATE>M<JHP;0)L>AJ+LF
M$.D1X5MOYHC\^B=;;!AP,)`Z4_<[&R=H1]#0]B$W)CD`KR94?U6O]9X&2G9^
M'Q(T9%LYVR#[AIG2.]E['E[`,&MC7.'(W;#R0,D[0=N'F(S=F80W8GUD5N/$
MPZ6,9:?PEJ-A#01+(UQ\+&0N"#>N,29.@&X];%&W=D[3+2FG12*X#$RA]NE%
M9T:33M<P:/$`,F427`M=0A\<[*8>DR6G0V2\VOX8VVR8VY6#:HN2_5]926O,
M`V#M&NP!-&UW7K_7Q)JTB`!`?%9G!*YM4^V!E%FO:R+!A2X.925LJP&-M^DO
MAITC7<&D$2L/7H?>.NHI>L%IYJ]O.IKE3BB@@.Z/,67!(+7TU\S:QK323$>/
M$>*S(T-;+CKK<=08VJ?^GR.TC6]<[-[`SMB#*O<#F\BFP-B6&]U(R<MNV7Y9
M@L2.&/3"JD1I<;;D&,X)D/ON0VS(AN2C#\V`I\)RJ$3H;JH[?.P]1-C`Q%<A
MAN_%(1.\D\_.7<&R3M-A^]*AX3IOS[L]^'2@;47$/WBTJ.B+AEM.&L9"NYY[
MX30_4X1V07'&-?01%U:K(T67VR2?L$*'KND6>PUN`Q[1B09>NNMJL&R.B/K_
M`/M@@2$X@^T8EJRX&Q0B_P`,(*$(@XEKBE)[L64)*`W;5L.5;YB_HLW[72B9
MWM)!A49(>@[$O8\A/<=8@BI3,EF4^Q,&IQ&#(5"[?#5T9L2,[3[,U6#].NE_
ME87$*7UX54KB2R#KANCXK$A]R9(1<7-Q^\A<*..EP9?D?F,.)3!0IL+:[T6A
MW;W5!QM6%MN7C:JT+3GQ2I"^O^RE)5C/]W"DY\>!(?`<!P'`A_L/_5ZW_P#T
M%[A^US9>!:JJ_N8KG^X0_P"Q\?@9[@.`X#@.`X#@.!#W8?Z@&\OZ'MF?R*-\
M#3*!^X"@_P`!:;_)H7P-LX%/;C#J3O?#KTW(T@)/;"EZ$WB>K78)[8IX4:UU
M6J=9==@K/0H.N(XUX#8HMR+;/#NN2WY;.4>@I:T+5$C>(0#1ML_#OVIINY@X
M.JY0C2]UIW7715R`7[4MIJ(&T:3V]<;C0NO4J:P5>PYG2DV[ESL*(8RXS[ND
M.//NY;:RR_D,N1[)?#_F[1Z6N31TJ/LO9U*K*^K4Z%3KD`E!=8G;&S5-<XL4
M83+&-1->V*S0VL`8I6,1@QW$XG99B-X7)P';B[4Z:UF!\0'8=%T^?M%HTU4M
M@1>T@5JJ$G[!L</66=AG++1*T/NYYR(JL%BB3S_L2&!`B:J>X2:9D1Y;<IX,
M5;[7T5`Z^ZLYVKI*T`Q0_742_P"LJC:Z9<+*=T?JQ-MUM#F&-O/P[";7$UL,
MV`:K"GXY>69AN2V8DWV12!ZWX@6IUEM#4A;<6]]7:^I]S&6ZN7P@3W%;\Z]L
M(W75AVHQ3-5^]XS6PWDN`#EVC46QUCU&$*:RY$1X,^HJ)+PT$)=_-S]=-"T[
M5%L[#:[JNQ1FP]FM]<AD2SF`85L%4MX!I0_<A^.Y8%IBDX0[7=;>=G#HN,$R
M3328L1QMQ[QR$4[`V+TNJ?=6,/(Z,@$;\P'WK6MU=AS-;LR->TF-KCK$$O%[
MK;LR2S/J%XN!/2S@0<=PW&Q.6$PPRY(E^PJC,!I^E-R=+J-1[\0JW5C8>N:=
M1^W.F0.N*A%UG?K!N#8&[;/UIUW=]:WV)KPQ+F6863@:[.H$"L.3)$9H,.8Q
MCT<>$5@+)O[KZ;.=W:#K]V'-8[?W#75?DAB::Y<Q"V:R;JUVM5-KFPT)DP`[
M5E54!IYX<@V-??$LK=B^T0WIC$>0$+!-D_#I9ZW[_P!E`=<V0?IH=M6M5S<6
M&*_L$3=3.P!1P16J6^F8_;8ETJPBM$"+#$/VLB`AUN)ZF)#(^/ZF%!Z.ZIB4
M>'K?6L/5P6%5];LTFH-Z\KPT7@+``4O(2!FK"H8;'A[K8'!U,MXC_+EKR^7.
M<YQG.0IWJ-C1E6T/OGLSJ[0!:ONV4EV;BWFCU\I<K?)V`3UCN/:]2MSX^M>\
M)PB&J_VL`0,2T!QK,A#9%WQ2^XCP6&G&]S=+A-<ZMC=D:QPXYM3K5I0G2<5;
M7]MM]"USI0GL#2"*$-.V=<,1*K-$#;H,U!L>N;"9GY>88D.QVFF)>&0DS0^W
MNG=J[0]E=<Z0BKB;\K1$M+WM)@B;0/K)T\"LD*NW64,5((/4Y5B%7&4Q&./1
M80^61G9P\I4U+;CZ`R/=3:4W6=5U=B#JJB;NFV+;U*]PZJ/VBTBMB7&YU*P!
MKA46])5FK4.[9L]ZK!`2HZ[**."0(*(*5,(S&8OG>9"Z3J<(==0E>'$H<6E+
MB?#P<PE6<87CPRK'@K&/'\7/`^?`<!P'`<!P'`<"!"?]:JB_\-FXOMLZ"X$]
M\!P'`YJ:<0E*EMK2E7^"I2%)2KY/'\CG.,8S\F>!$);^LQUQ_@5V1_T.E.!4
MS9D?X9M2[!WRWW.RX=V^L[:1.RWF[U;4"J3\Z-:&7+L4)M2#4$*@7%K@],:?
M@?F=($$",)CT8RY+*.!WM?;.^'WH`N/O>H-D7KV4U*HM2(@ZIC:5\JXD*8N]
MTK@:EFQ)<46&ZWB5G86U2]B+"$J&&X;GFE2F,Q&6VN!CDE?A7#V"=DASDBUW
M:20,NOC@>\8Q:S3MAUC9S!*&!&,`\E2I)FH=I23DH:.8<D!1QD2M]F-'CB,M
M!\0%9^&`$@6V*'F*;$M"+W()QJ],V98PPBLVNR3QAR'`G4U@M`AN6PP.E$H`
MY3ZB[T=3LF.SB*WGT@ZU>NO0'8.]]E;1L-XME@)%K10MX4X[93!MK5#3\/6N
MIIHF=J@4#*R(4Z?8*[I87/EIE06IY1I+L5*'6_6:R$@5C6OP^J%N-.H&))>-
MMQDU2*C`@&[3LVQ2&V:>BFVW5M7?LBY9($`#@V:6/A`(!&7%<D(@N1VD/J>=
M]8*Q!*I\-H9K+:>;G'W/80E*WCL;5<6FVI>RI5GA-%K=NBG.U'7%+'$'YB-<
M%_9+2XRO*&9)-D-@E*Q[0S&7@)[B/_#LUI:JI<*[N"RU2VB:F/V`()@S6S"D
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M%TGT/H8^4MVJ`9D#:"@NQ"9)`O:K1:(,N'80U"!.12@8P8=A$HD,?K`$AO&?
M(\K,-;BW<OR9+KP1M5/AJ=9:]0J919PBT&F:C4Q@)<]%QLH%!FR",VQX7LN8
M)!%88UK8(&5?#.11)*,R!S,Q+3:LHC1O1#=;/T(ZV7*K:SIUCK5D+!=323DZ
MIHG7NW393DZQWX#M(Q,L4N:6DO6>1-V!6()%Q4[+WJY:5&<PJ&_(CNA&6M/A
MH:3J5(LM9OY^\;BL-IGT^5.OEL-RXAT?&UJU48VM(0&-!DK'"$TV)2(*65I0
MK+OB^VK&(KN(R`G"L=+^O5-'[9$UJG2A`K=57+U"\CXE@.--/A[$/>@6/(IY
M,[$P.1/J?5)DRF74R,R_S9"T+SG.0[-4Z?:+IHVQBA($\]#LY6A%):2URM)=
M8]&LMA3ML4P,`<G%7E`:Z)V.7G%_88OIQG9$]Y"TJ9RAI`:/'^'QU<AQY,*#
M3#@T=.EVE)`:'O-P"0B=5NDF!/M&M2K08S`R4UF9)"HLA\-(RY%<5'0A6,L^
M+60[8;H)U?"Q:G&:HDZ;\RK/KNX`7R%ILC[[)O5)6X%Z,Y+],DRR0A"G;S/:
M=BO(7'GQU-HE(?PTC.`S8'I3H*J:T3JBJ@K%6*Q#MHF[UZ57;G90UGIY^O#F
M0E=D5*T#R+!L(T#K[/N]A#;V?/#<=;=R[ZKF5AQ/=(NN-@TI#Z]/TN>/U./L
MQ2V#ZV'M=H&JAE32#L<HEDFP6]YYA2H5FG,X96ZI+&'L.,^F^TRZV&N1?A]]
M:(3,.%#!7J(*'LEA<`)%VSLR,$AU*S2O>=UH$44Q:&X<>A[`._\`:!X8A*6"
MTO"<R/.VVVV@,>GX<_5E,"K#456SM1J8-L`JNXCW^WPUP8U@#2:ZYE*H96/A
M;D$!*5#;\<>5]A+>):9.6F\I#M&N@6A3R=9@YS%N^CK5^J[)J<5K6/<+'%KA
MT)8;;3+JB5;'8Q-HA87`M@I,63!CR'%1(SV?%MM"4)1@.[;N@'6&]NFL6NFG
M2XP]&@L3ZZY?+K'K>'8;-'2Z0AAHAV/#@E"D[5]9GS)#6$NR"=?A2U9]H0XX
MX&UT/J5K.G"MBP)^)UED[/W_``.QME(2'GQ;R[W7#E1-4S$?W?)2^F"`>H8Q
MU]M;JT$I_MDN0G*YSZ<A')GX;_4H].`3R5$.N.5L16@8YEK8%X8C9'TZDUK7
M=:;D--'DY<=&5.J1(^5IRE4E2<N2,NN>12`SH+H)UCKJ3"(%,*J2<CW&--Q(
MMMD<SAK80*Q@KQZ*T$6EI=LZ+>3E25JRI:9LQ3K66_(TEL-._P#3)ZA^P7`>
MFE6=+5Z9>B6)S.QKRZ]*'O2`;RAWYL<=:5$]&N1&L^HAQQ>&O56M4G.7^!(^
MXQL(+L[J$''-*8'B;7LP;`96_(E+9A0.O&QHL5I<F6Z_*D*;8:3C*W5K<7G'
MBI6<YSG@2-+FPH#7M$^;#@1_.EOVB=+CPV/47X^1OUI+C37J+\N?#'CXY\/D
MX&-^<]8_?/6OXP!_U;P/W%EK*LX2FS5M2E9QA*<'Q&<YSG/AC&,8F>.<YS^)
MC@9K@0_V'_J];_\`Z"]P_:YLO`M55?W,5S_<(?\`8^/P,]P'`<!P'`<!P'`A
M[L/]0#>7]#VS/Y%&^!IE`_<!0?X"TW^30O@;9P*?7&+3W.^'7IJ3I9)W8TO0
MF\3=6WW]*-@#N:]JU2LVN@MMHB-61TYKUG1<3&R`CJICZDY1Z'J+QE4&-P*_
M4;9'PY=JZ:N==%ZYE0-+WJF]=M`7`'>=6[$IH>SZ;VK<;E1NNKKB3J8TWZ("
M-Z-'84`^TZRF%+6\\Z\VC##W`S1'L1\/:3M#I>_+4H=LK9-*K,;JK*'U_8-7
M?C:Q+6-FJZWBV&`&E"(7T>'K5#:378AZ-/@-R/":AJ,C+DG`=J+LOI96A_Q`
M=ETG5UEN5BU%4MA#.U8EBL6LL=O8:JM;#-6G754'WLR\,579Y7)]W(Z$V*$R
M%SG""&G8LEJ4Z&+M]CZ("M?]6E;5U/<`HB+KJ)<M8U:YU;9]@L>H]48MNMV)
M<_=KT<Z;ELZM&[")U;,EFS2BXQ<UF%+]G4W"4]%"U.LMFZ<);AWOJW7E:N`^
MZ@KZ0-[ELBM>V\?K\[M)BF:K:,,,[&FQ5U(Y=(E$L%6]6)&?2I43PRVE:HTO
MT@A+OYMGK7I6G:IM/9#75=V.)O\`LQOKH&AV$L&$MU^N;S#RAFW+*UD_*CQ)
MT(3KVN//S8L7'O>6PUB/!6VZ]GS!%.P+UTEJ_=*.+*Z98*;%]T;VKVZ-[&1%
MY1JVBQZ%UA!V[8(4@]-:G:UN]X-:1]R#3_HL>]<A,1D/OR<0U1V`T_2VWND-
M'I%])5?K=LR@4NB=N=,A]?U]>NMQ6O<&P]XV#K1KRX:QO`_7-AR1OP^8.UJ;
M:#B6WGI$)`<:QE.&D^6.R%DW]R]+U=W*#1W'7XO<.\:ZKTD(\V,OP;,JL%:M
M=K/2P>P8")0^K+M/S-'GWQ:#XUZ:+C9>CX>B.R6&'@A8'L'X<<?KAO[9P&I6
MJ!I9&U:Q6]PDHX_<0RYG=@BCH>JTE,4Q)M$6_`Q-?)$8\.(C)$,/`15.(D-0
M8^74Y#T<U0/HXS6^M1FK0L2KZVATFH1M=UZ`+>"0P%+2$@8JPJ,&DI1*%M#P
MV66\1W<8=:\OE7^2QG/`IWJ-G0]3T/OCLGK'1]I"1[$1[-Q[Q01-AV/>EW4I
MK?<>UZM=G@=,25L`@/G8%P!$BTE(`0S*0T1<\6WUHRE0:<;VWTE&USJV+V3K
MS#3NT^M.E)E`8K=(V#<J-K_24[8.D'*`-/7!@6*56*.&W.3I[,&25BPY[K[3
M#SS#33<M+02;HC:W3:Q]H.RNN='.I9[`5\D7([XC#V+G$K1,Z)LL(%=R(F).
M(.T)%B'W.9'CV"0-A09<\@K#KJYGE6\D(_\`B.3`U)J>G=RF=`"-U,4#9<&N
MRK'.VONS4+NE@&R"5;@6C8YFU:<I]HCC=7AA-?S.M,RQNP0L>*-CMJ4ZY(2C
M`>D3V,8>=QA7GQZB_!?E2GSX\V?!?E1E2$^;'R^&,YQC^YP/GP'`<!P'`<!P
M'`@8@A;G:RB);0I:L];-Q^"4)RI6?#;&@LY\,8QG/R8X$[(<;<R[AMQMS+#[
MT5_#;B%Y9DQU^G(C/81G/I2&%X\JT*\%(S\F<8X')W*6&VWGU)9:>?:C,NO*
MPTV[)?7Z;$=I:\I2Y(><QY4(QG*E*^3&,YX'%W#F6G<,O)CO9:=PS(6WAU$=
M[+:L-/K:S\CJ&7/!64Y^16,>'`\_NLZZ\O9^6JV(C@#\2M'L;6L:>RU;W!%W
M.;RX/:BV0)5!5XLQ1#<8OAZ>HG,'!'1[#^(&&E)<RAH+4EOZS'7'^!79'_0Z
M4X'?MO1OK!>B]\,6O6C1=W91B18;?`<L-HC!2%AG`)=:)'6`T(S&'#RQ09,S
MF0^PVVM<EM$CQP^GU,AT)/1#K9+8>C/UBUY8EQPF"+#6T-E18Q8Q7B,,B+MQ
M:'$M3$(C=H^(#43WLZVJ=[N3B'ZF(O@UP,RCI5UP19Q]M^8DM10/F(Z#8<N%
MT6%`S8]7"4R85"`%6#(468L%;K(V,5ELL)?)^P-.25..X6M8:J[\/CJLJ%[L
MBT4^,%Y6%ENBA.RME#A,LU6CDBP5JSDA46V('%K17IDQYJ'/E-/2&(;F8R5>
MAA*$ACV/AY]:P[.N!U1JTRJA->7K4=Y0,9-G3SAQ_1(\E'U:'FDK24-38@P%
M.F-/R5,*3()ML9CR7'&77<*";'NL^EG[\8V<[3\JNQZU4^ZE3'OVQ8Q)LM#9
M>8JI'V#!7`UGW8T^K'I(92R]X^+B5YQC@1V>Z+=:;(?EV4E2SB"<Z<=,RDCM
MA[#$CG[%8#&Q3LNTO"!MHBBW;-"(;8/YA35LJ?@M3\M,*;;:92V&+@_#\ZJP
M(MIBM4`N^FVB1P(@\2V%L,N_`$`3E#LE6'5UPK:)OS:B4XUK$"^(;@X80/R-
M;PUA.%.X<#.W[IAI39DO4L.YAGC5'TYK_9VOJU1)LB3)@3AVUJE"H5CDG34B
M0[82+J:@S)CMXS(2KVF5[6I>9+$=;8:]CX?'555B`VR50C)"P5UJ`F`1(;!V
M!*6[*&N&'(Q(DPNR^RDR*<'9*,N/H7CTUX3C&,)3X!-6LNONL-/V&]6B@BBP
MHSLJQ3;5=I$NSV,T@\:F>DE$F4R:*3VTI'-H4W$2C"4QFG%H1X(SA.`FK@.`
MX#@.`X#@.`X#@.`X#@.`X#@.`X#@57WO]6'JG_#K:_V@-E<#=)PX:58]E*CA
MY2+ZB'?92<&*0B^JWX^F[[/,9>9]5OS9\JO+XX\<^'`PWS*I7[RZ=_%4!^UW
M`_<4REIRE2:93TJ3G"DJ35@*5)4G.,I4E6!^,I4G./'&<?+C/`V3@0_V'_J]
M;_\`Z"]P_:YLO`M55?W,5S_<(?\`8^/P,]P'`<!P'`<!P'`A[L/]0#>7]#VS
M/Y%&^!IE`_<!0?X"TW^30O@;9P*AW!K7JN]/7^/-T[:#FVYFBMV&:5O&'LJ8
M*JU#I=7L=`%7BDE-:)N$&'8IUL.7P`XB2H+,3E2&W%O(R/:RV$%TBT?#7VQI
MZY4^L!0\W3=^J>@^M=M#':/N2HC+-KF]VNWU/KJ'8=M8H&87K\U>3YN"$L\%
MU$-!-3WB02XRVI`9^=N7X=[^R>GA1^U5H3L:[U```ZG/"\[-J2C&NG+"S6*"
M&GP0F`X.9K\G;XS;%9C6QET=)(YP[`1E;BG%!SBW7HU61O>_;%4JQ>\SM=53
M80+MR@96-L7<D>!4_P"D(G=]7U>)<,R:^5&,&5V),D+6W&1C$R2^\\EIIQ+^
M0QEIG]`V]?\`5Y[9]8L`8!\P81O3P38H7?KMHJ6K7;9KG+N=VHF.$#T'5$+8
M<JJ(E?2"\_7,E4C7,Y5AMIQ`6=UOLG1,G<&\-4ZY]O9V:/NL^V[J0S3+_#K\
M[8K-0U=!+NN7LL%;H)FUP:2:JGM,`80<>9B2(Z\LXSZRDA#_`'IO'6+6]2U?
M8.S>MH6RPMWV*GKS784OW:YBO0-\B7PFRK4^P7,"(K0`%0Z_(E%I47+AB/`8
M6D?X/.Y2L(LOECZ)5SN7``F]=Q3&XRPG=X7:VRBC6R4:GU_#I_6JOGMDL6Z6
M80YH^RWFQZ)2#''DQ\NV-H&J`L@I3#;>$!I.F=K?#YIE%OINJZQNU'UWK;M?
MJ")6)QVE]CK=?[_ODCUQU]9M76ZO4"SAS>Y\."]4'(@<2P_#>'+%#6G64XC*
M9\H66=V7TH7W)H87-I"QNX.P==@)56@19VPQ,FU4^;6;G8:7&MHF*]"UT3LO
MS+B6"6$8L,99R*.;E^S8:3X)R$+@[+\-B-UXW=LBOO$(VC3VT*H!VO=(;_8Z
M/8+5L:";$U"@#:Y:'IC>S#$*$7)1Q8ED!*]U1DNKC82VUEY&0]"]6AJ17]=Z
MY`ZM#Q:WK<33*F.UV"A#"(6&$I<<-!;JHV.'+L1BXMJ$&PPC$>6VB4UY?*\G
M#F%8X%0-3(ZY4S1V]^QNMM7WH'6S<_LJWL&E?.7;5]^<A77VWMJ5O8SM<US`
M/;!%5M%]OH<J14JLA6I7LY'+CK.<H6TD-9+W_HM'K_601LFMB@LG9W7'3:-6
M`X=?VE<JY5=)+ONE2&OA1B\UT#[CK-*";DE4V'#+'UBE2B'LF%Y2AQYO@2;I
M*]],R/93L71-'6(*OL,.($SF_*N&)7U(Y)J/8(8RXFAX(K*SK-!UBX38[%EE
MUZ.W*65>1@@M;ZLYR'6[B$>N&)F@JAV%`0[4QL?:7S2KX0UL@_0:;&#YAQ25
MQL^QQPVQA:]?J(*D1`\!0,U'(PBALP,@I9PN9YN!=A?G\Z_4\<+\RO/C.,8S
MA7CGS8SC&,8QX9_N?W.!PX#@.`X#@.`X#@57V71:GLGL-4:A=Q&#E<(=<MK2
M)@W)`L+]9X?N+K],AK]M"3QA%OT9+25>"'DX5X>"L9QXXX$WZ\UK1M45Y54U
MZ`16Z\LG.,J&MD3)1*BA/TLSYF9)TB4G>I+RPG*\>KY/-CQ\/'.<Y#43?7G3
M5CO\;:1NDMS[]#*!C46PJL5O85'*UY$9L+.:%1+#'!)>@(AMX3_JOE7Y?%>%
M9RK.0F?/R^/C\OCX^/\`>SX_BX\/Q/#/`C<)J#6-9M+MSK=(K=>LCRI&72`(
M.-#J6B6'A`Y+&4#HD9/LCT(>TI37YVJ1C+V<9<SE7`QA;^LQUQ_@5V1_T.E.
M!"6U_BI=?=/6Z]:]LM.W*2V#0-@6K7):C5JJUTM9IQD0.T0[2)PB"NXQ&W0F
MZ;!V9I`2IRI#D9N66-91+S"8B37XX:#-^+SKF`9"@G^K?;!L@M[?@K8++P[K
MY&=T];.L0'%PW94+['D]A6I$\I5Z+.&'(DJNH/"CH\S#]V2Y<C+[#`?4;\8C
MKR1Z6*[S_,2_L:K?VI0]1BPZ=A=4BAN=8MBSJ<.`325O`]D2VE:2*BR[K&21
MQ8K6(FC/2<]ICM_F7JA(NB_B@:/["7K2.N*+K_=S%M[`:VKV[=?PSE1K[`]W
M1Q>MG")K;Y.P"[>7KT>F4FYAF:D34S*D2W+`8%>PL3!Q&,06$#4[X[/2&Q7:
MZU&T2+GJ470]QKTK8=D;.)Z<$ZQ$V/!7?(%B;9K8$VY8&M>MSCO7DS'C"[,T
M%L<E$X;):&KB2_7;#MN_&\ZNHHF-M,ZO[)3=.YIL0K]*\*C4A^G9VB1ZRX[:
MC.NS:?I*397]O$=1.LY;=;'+J?OB2T.4;3)7Y,!QF?'#ZCO6#4M?I]?V5=G-
MSVU=/II1!?0^N@SI*/0^N-^G-/3-U[NUBJ47'Q>SH(<Z$A(EV/!>`4C)'JS$
MPIT/2W=>^:#HC5NW-L6I9ZQ"=*4LC>;K5M<@"&P-AI&01CY2-#&TBMMS#<DD
M888S[-AQMECR^+SKK4=MUYL*K[?^)MUOTI]ZSFWIN4A/:_W*[4<`X=7(R:3$
M.B:"9AO[`'*ML8FU,2.V2.E9'A63118]N;/:C.08,J0V$<ZN^+[UGVG;]9TJ
M%4]QU4ML0R(#$WKA7Z9`&ZP5>`4"SZ<(;%F#+\81%&[KKQ2-*!N"L%514NX0
M72,<2M*0TS9?QO\`IEK`SN,82;V`>@:2V:O5MKLE<5JUX+++AP%\LMY+B6R^
MT0QM`&D#=:ET97.API%AG,MPZ\R8E/M-*"81'Q5^JI'5_9+<)&;<*M1NM0F=
M:2Q"RBP<*3LZD(G[`"@+GJ>#'LDR0:$W&PZM/01T<E@232[`R[+BQ8SK3RPA
M:'\;WJ=/L0BEQ*EMZ9>K13:T=I-/&IT\:*WBZ6RQ4:L!M3UB4$W"1"R[1(([
M%&8R9=E,4O"_:X_OOVV!-BL!;3KQWRU1V5V3$UM2*GLT-(.=>=<]GJ99[>%K
M@ZLWC56R%QH4&>"R,M9D_#)@CS[@R=')P('C,BOYC*DL(2^L+N<!P'`<!P'`
M<!P'`<!P'`<!P'`<"J^]_JP]4_X=;7^T!LK@;4:#1CL+V"5*,PVO6:?]8$=+
MUZ?YFO/A*/>(29!G>@KS_DF_4\B_#'FQGPQP-3^C4+^^#97V5MB_SEX').M@
MR%)7@_LC.4*2O&%[4V&M&<I5A6,+0JR90M&<X^5.<9QG'R9QX<"0.!#_`&'_
M`*O6_P#^@O</VN;+P+557]S%<_W"'_8^/P,]P'`<!P'`<!P'`A[L/]0#>7]#
MVS/Y%&^!IE`_<!0?X"TW^30O@;9P*?7!JD9[X=>D2M?[2);3?T)O(E3-FB-L
M2@VIZI2`5FUS`V!5+7J3%X'P[6>M%AM=8=8EJ`3\85&CN*D->P)\@5]HZ_AH
M[5TQ=:)3Y&9^H;]2^N_5VS1YT?>M/=)4D]<+F"ZT1`1RR0@%F'B">PK(8C`;
MF*?::R9;SCWGAZ(UEH,_-O'PY'MG],3^+J`![$/4>MTWJ8@(2V/68MJUC`L+
M5=UW7S`P:S"!$J-(N3"6:SBSH1&G$G,^Q*>]=>'`^\4QT5K$/O\`[A!1+9L*
M56J;?ZWW#3$A;DO<R?6*<WL65=-8U&,?2H068&D9%ABN#ZZ^MH:\M32G(L1M
MCTPQUO9Z%SM?]79.UIFQ(`63K>'C6$;8Q#L/'N<G3DFW:U=>%]BLR,KL3NHV
M-A+J3,Q>P5I`^\LP$9>4T[X.!:76.P="?3#OC56MR,_Z4_GZ0OV[AOS>V`@,
MO8:*7JH,6<:MQH.BA2CL"DD:GF2+$3W%QH\QEY3"<NO+X$(=_I_4X%3=4%>V
M>L\;2KEHV:C152%KS%?:JLS>HB0`N>QG(A$T&BP&:-2`<J=(-1,K.A8;;RQ>
M4R'E86$7["E=$1'<Z)6;("-G]L6,;OF+M@N4LVV4:'HB@W5^NO;8*W>`4DHT
M68V-;]`L`QQU453MBCB7(<F;AM+F75AINF=C?#ZJM*OUH##-M"Z'K'MSIAX#
M;-A)[.["V!L#?*>LVNB6IC0"I6T:;W/(&B-/%H0<8/D0%BY$$:F4VVMIQMU0
M65>M?2-WNQ1GTW49&[A[%US79-=!PCE\@-7BHN5>ZF:*]:03/HZ\GVIND,6"
M2%:,)09]V1Y"VV\HCM9;"%`6?ANQNNO8&^`+=;$Z1OVTZL+W%L%JP]B7S]NV
M-&,":A1@U>/SD.W6XP'R<^.)AM",3QT]+RH\G+^/4Q@/1?4U?H]5UIK.KZL@
M>Y];5^CT\-KH9ELTUD;2H`,?'JD1;5EQ\XVEQ@R&$J20QB:G.,X?QAS"L<"G
MNH6M`T70N^=\T$'NB-KTL2[/YN&MC^P=N;'%X+T_<FV0>TWM?:TBG;_`I+=]
MV#`+SDJK8QM],.>E;C*,-J:;#3S)WH:BM]70>RH::[*V'UGTF'U(`CN;:M`@
M%I&-L/1QW7D$Y>:N,>KX>N"=QM4R`T>L#XY4^:['9<=RW*=:4$H:(-]+D=F^
MRE6T5;1\GL)@J6L6^Z4./WF0(''G;'$9O)P*!,KS08YARZS8[=F=`>9;1=]*
M)GIO.J2H-*^(,0T4@7HRN[]ZQU#?M0MNS&(N+M?V&Q-+T"_7S%-LL*X6'8V:
M+=%4)BRV,>,AM8>=#CC#D?V29,PPK+:@]%7\*2^\E?CYTNN)5YD>GGS87G&?
M%O\`_%Y\<?X/]S\3@?+@.`X#@.`X#@.!`A/^M51?^&S<7VV=!<">^`X#@.!$
MA;^LQUQ_@5V1_P!#I3@5>WE5?AO'+MV"VGO?6&(Q_;CHOJ-O/9!9^RC4$1N@
M02]^4WV.36K4V3KTT$4(Q70IL#'BV9X]%&MH7YX,!;`9_6^H?AHDV9FIJ,D9
M8"NM*-N^ZV>(8N^W+%?Y@+LG5@36^[?L"W6\[.NVQ+I:JW9!39R67G$CP?VV
M$TYF&XY&1D(BK@'X4971D#K`*VKL$KJU-UJ.PPD8UOOMY.ME#NVM#,^!2V0F
MW+%<G-AZI)58GI8@Y#!LFA>6V@DZ2F+EE$EW(3A19OP^^J9K1L2@CIU6P!T'
MM&BZ=L8J+MJ]#9.LOIGH#E_JS!%QRSD;I=[;M>4/))<>;(G2F(\N6AY<?UUK
M#(PBWPY0-*U("%'*=-J%'VW=]T:E@!B%XM?J;-MA?<P:\6\6V,47(VV)B7?;
MD[*];VP8/A9?F>5F)#;?8"H]<T+\(2W:7+[M#:DM;]`IM.IFH+'KY!_?/_8\
M:VT*!U2I]ME:?BW5VKF]BR-3&TUV)L:'#FGL@T.^B95B.O+8;'(U#\'F;L,=
M:01V5KF]&]I["V][\UCMKLOI5B5;ML?03!O%SLA"AVFH`8FN=HR:A17F)!);
M53/2G(\B%F0[.><?"W%DWIT-)4>S;3>>HTRF]H2A;1>V=IUFG2Q!"PIJ>G[[
M9GQNY[B,$B+<'#UK5=?(X@2RSK?L<69']D4AJ4TM058+CO@ZWNUT0B?KNM!A
M?7KVOZ_6K<YFQU+-_8JS5`%UJL[6E!2(\WLX'KL_K2J#)4#8K$F&,L`P9$6C
M$ST6U!JM*I_P::];-9CA-8'^QUZH66[U^S;`(;@+:^F!3PV(#8#;>QL@U+B'
MV8%,F0OF=$N\)X;"!RXB:^I#3["%AD3&H?@ME9-Y@$!=8JT*TQH-ANU0A&-[
M:PIH0?65WN?(U],HHZ;6*GKF';7Z>?F$Z$B$-^=;\!V3)%S76FW4AO9C5GPF
M18"/`+ZHIURIO;-&T-B`S<NHWS9<!DF+,0-?V>O:SDR&;!8]*VM=GWC*'!:S
M5&@TY@N4(M08C,Q3Z<AKAO0WPGP]FUY6BM8LY0CLO3`F7JN\Q;GV-N+,P%=-
MHM;"CVNBWP9:31.N[QM6Q`N;-/L\%Z);)&8+L^9/]-MY?`W[3-\^%9HJX2-D
MZJNX.I&1^L)&O42B!S<\ZK:ZU[21J&"M4%5ZXNSJ?J68?B:&:?FQ&(PLE:9%
M<:DN)G/H2ZH+9Y[T=6,&H-=SM2.V;(LA'HL*55+S`0G-BC4^6*9(3R%8BC`L
ME;.P@/M#<UZ.N#DS"Q)PSF2UA09.I]Q]!6JB.[(S;9-:J#=MN-):+6P&8"1B
M)ZB54E=K$D,^[#<8,#TU8-,F1)4=3C,]N,YB,IU>/+P.<#NAU>),%I$7<-<]
M()!][$<R8IV"IH&X?IE8A6-AN<)C.SJN8-["#,CBC&'1Y+$Y+D5YYI#BT!E9
MO;/KL*JE<NYO:`:O5>W4T9L*ME++!/5O!>E&)S`\=8XL,Z)'D/=TA^4TOS*:
M2I$=YM]>$L.(<4$:J^()U=18R-<<NIIA\4W66YDJ31;M&Q[[MMA/5$538@=\
M"BT3K\S:J^Z.F`FH"BL&6\RA]A&7,>`;V![A]<K;BR8J&S!-H=J^LRVW2.1<
M0L@>[1`0BNFC)6"?(#X5<FO!H5N%XGQFYBI(UV>RW+;86K.,!A1W>?JL6?@P
MQNV1\TF5LK]1$B(]?M[I4P<C+.L2$AH":_F08#,3*P1C**QL.B<2H3S/M/JM
MJ3@.I0N^'5G8=;CV@3LUH,/77JU92#=QKMHI[X*#:7-<1H3!IP^&A#XLX=.V
MY7(Y%M#[F!SI5GVA3:<Y5@,=$[_]8)UB=KT:Z&/%H'6#K9292+F,@DD7&7<H
M%:#5Z*3!0SEHM1F927T110Z'*(2\2X:V&G42FU9#NK[^=0$(EN?3:`<;B."8
M^%QPUNDI($#+=3=C!@2H]>=Q8[!#;O0?,\</]IG"\$6?;&F/-P)*V#V<T1JM
MPJQ?=BB@$D+)K,(A#7"-D)S<ZYB3YNJP6((D7/ESIQ\95Y[D5EA#CKN8^483
MYU(2H.4CLWH:(!KUFE;*!1@EJKKEK!S9#9)G,H''NE2US,DO17("9@Z0.O=Z
M%"9462VS*BSI>&GFT*0[A`0.2^(]U9C(2Z'M%CM,=RKM6UB2'IQZ#'D09.''
MX8YEZU1:XVFPD!.&R<6"YEM^6'?:GL8<BN)=R$F[7[;:UT\5W`(LX#9Y"5I/
M2,/?=K56=?&C<<I39I8\'Q"ISS26DV@]!D5]UR>F/XPAD=Q#DR2PGU,MAA-Q
M]T]3Z/LK5<N(RZ^7&O[)L6:<C"!T,'%%U^,7D,AXDFP&0C]BLUC4"EH'1!;4
MW#Z6%NJ6AA"W4A-NH-L5K=-)8O%6;F18>#MKJI080D!9<X):*-9RU.M8.7-K
M9>P5R>\(L(22Q[1`G3(;^$86R\M"L*X$3;W^K#U3_AUM?[0&RN!M9D?,)P_9
M8)TK77_6;=]XAF@STSR(\WFC^0\(-P/1>\V/-GT/4QY<>52?E\0U7YG6/ZZ]
M_P#_`+!UG]SO@<DT^Q)4E6=JWU>$J2K*%0=:^5>$JQG*%>37B5^5>,>&?#.,
M^&?DSC/R\#?>!#_8?^KUO_\`H+W#]KFR\"U55_<Q7/\`<(?]CX_`SW`<!P'`
M<!P'`<"'NP_U`-Y?T/;,_D4;X&F4#]P%!_@+3?Y-"^!MG`K!L,#JX/VGZP;!
M/,[+>W!:86W-,ZLD@[W98&N!@=-'G[>OL>YZ_:L$*I&LGHFNXF6I;P^;+Q.@
M0/E;0PE:`I-<K%\-X)UOV4)`#3VP-/&PG5'J=L812YNY/G5'U99MN':/H6VT
M9Y,1J^V,*"N-X-$0EGIN)LPO*@.>[IDB3$:PV$M2S'P\)NUNHQ^'9Q\*_0M3
M:M@=:I543L^'6BFEK%8L5S2PBVS0X==,8J\V]P_8@,:T/PI"CCN8J<*>D*9<
M"3=C:@Z[]=Z;VZ[$FM?WN[8V3K"QXWJ)A'+1>;!=*!':LTDE2ZV&+'6HH@2K
MYXDE>*'HS8V&\K_6(\&(VA@(/*,](+-J?J">W5)O-7%VD'`UEJ%%UVG<+W+N
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M=7(<";J!TZT/K8?"@`0]T*K@;=IF](Y>\;2V)?[$K9>NZ`,U71R\BP6ZQEBL
MD96M>A88N,-6[D?AB.A2FE.^9Q0;H]UXU.]OEGLM@!.C[?Q7A]9GG(=@-1A)
M\<&A&1@&18ZPW,P"-%J^-L4V/"ENLY>:9?\`+G*O28RT$<#>D?7P/2=N4(<'
MN\<-O.S"+;LT@O9]ZEV6PEP"&&`N';#.-29V1\*&QB.Y&=]9J?'4I$W$K&>!
M8J@TJLZPI-,UU1AN0M.U]60%.J(A4V>34*KM8&QA(6`HB6E3B<]42!#;1EZ0
M\Z\YG'F6I2LYSP(MUMULUIJ=&PX=/E[*^;^S9=VGGZ79-L[!MU%$S-CV:QW&
M\2*+4+$>(!*`Y8[';2$A_(EJ+_TC*$^5"4)2&.*]3="&A%.!$J7(?%T'55(T
MG5(V+/9FLC=:ZYNE"V%3P"WF2K;TYT7;M9!969C^7);Z8BFG7%M//(6&?U]U
MWU-JS8NSMI44!."6O<!>?8+RC%@-3*]*/F2*3-B-B*U-F/B`!*T&4XF$7(C;
M>),GQ7X)RI?F#,;7TO0]VC@@+8[5E+U<.79,RZ<-NEIK-0N;L9Z+*B"]D`*V
M5%P]A5B+-A-/X$E/:!SCJ<^JRXA2T*"5UK6XM;CBLK6XI2UJS^*I:LY4I6?^
M7.<^/`X\!P'`<!P/S*DI_P`)24_)X_DE)3\GCC'C\N<?)XY\/^?@?GG1\OYH
MW\F,9S^:(^3&?#PSG\E\F,^..`\Z/E_-&_D\,Y_-$?)C/AX9S^2^3Q\>!`I+
M.,]JJ+C"DYSCK9N+QPE259QX[9T%X>.,9SX>/`GS@.`X#@1(6_K,=<?X%=D?
M]#I3@5OD2^INX>TFV=1%J+L--QDF+Z)L4V%LEMNJ-W(+J_7BKE=HNNJUL:0>
MHI,UK\J,$IL4L'!C$TMO1%.9S.RF<&@]+R?0W:,U&N-$Z@V74HV_.HY.\V\-
M9"D^*.!4&=8!&E[-1;0J%?C,L%MHJH/%7-7!R[E<2*W+1-2J0A4@--@@N@H*
MF=GJM"!F-35RA6+9-9OFRRUZB;6.C;G%=W-HX_:'=3@;U>[T*A2&=S6U<!PN
M!ABU-36Y'I(PS$2V$E6K9/PW"832]=5<K>]7-)@C&H]?;)H<[;H0;KQBEUFJ
MV##<C8-72(]J/S8U.'P1TR(Y,E32,A8]K.79KK+H8&O1/A3K.!54>U6<=))S
M@@:G%:0<[+#JU3E$8@!PB'JEI!);K6NH)6/OR&Q:O2F0DMNVI+!5;3SR$(#=
M[D$ZB:JL.R=4;`Z^GJ50]?ZXTPLON8O:0D\2&HY*P7`+K)51)0KR7VL$FH-4
M4OB4F-`CO/(A-^TY>0XTG(:7%)?"9!U^S3#-A<B!YL2O48\ULG._8<M^KU6S
M0[""I3`N\08I5^BZVG=>LH?C1V5#Z\/#R6YN8\=^1ZX;'?"'P_*;-%=&]A5?
M8+-0`DOG5DH4B[*(:\C2K728-0CJ-[&'39&7*],IFTTBWI,ES`<;AU'M;\=[
MV=U0=%^J?#),ZU+;RKQF99H-0F3=?N6VKS=GVF]F#Y&KP+<Q7HE6:;D'+C[\
M",0+%'::@NC9L*,U.\RAZ'5\#6M<0?A</T&+1#]D+G2?T2:J>O+>VC&UIMY/
MU@32\72E*M11V3,'G"#5?UJZS&:%2Y3&<B<P(>5^1MI0;'<A'PSZR1W;J[<,
M>QB2U8O@&/?"VR"FWCI#9U[S0(9`.>K-PQ--O['N@D'VO2PJ)#?>.0')##RX
MC<:'!D(#X3-P_#DO->C![*>NU6JG6J<='4'8_O':PR,_#(B:=MAS95:N].>E
MNK'V&P`HZZV1(.QGSID/)8#MR4I6VZ&_%;!\.\C7;`=&9+6-/3/31<.9HE51
MM>-;:[KM`:R4XF+>IDA8<Q;+$)Q(+BY+CJ9!087=E,RW&)N%X2$*ZOD_"EA4
MM`B/+/ZY5?KY!$O@=A']Q5RYOVBOS]A:T"V-$M\DI4&K^V6TM$:.0Y*`*),I
M#+LAN2TAEH)P9UU\./6$XWJ!27`\FJS+,@W&>F;>E!VS@RG:YW-=![-L:2]5
MII\-3M`@#)$;"F*>&L0T(4PQ[;Z4@,%);Z+&^O\`K=ML[8J+I:)V8QL4;5['
M7;P;/G++UILQM!*4V$,0;%::YJKV_3SIHP5]!H2[769BYKK$:=+SP(@U:/\`
MAY;N'[.-9U?ORIU/4ARCTV38;F5W/!^>PX_LB&#U3JRA!0EG+V^\T*/;-4@I
M5?K,6&[$CNR(;;,;UY$IG(;W;-[_``U-LU/KHW?QQR:D'K47`UI430G84`M1
M=5;ZI(#7!,_:Y,*6R%77`]/L0[WP3>G37*VXXS+6N/+0AU(;4``_#7B@:;V&
M&68C8(+>P<+&W"19-U6D^2V;K@X?W&8M-S`*7.LT@U6?2FFC)4M"3&B@64N2
MW$#&V?*&@TJG]"]*ILFX4;CV!+T3NFI[4T#0]?/`-I3Z`%`9AU@=O*744B:M
M(LDT:75J>*_*M2U>SN^B\]DA)RXAU`9(\5^$_+:$!S=U'Q54R/3[!&K;YS<4
M`FI^LWXT=KM7FUIQ+14M=A%ZW"Z\]751W+%$R2:P]&;8\N,!IL$W\*LT&%5:
M6]<<TFG6`G'#2)1'>18%L,;@30=GD9\Q0"27?V!IR(%T@%,.32>'`$=FON*>
M4VC$CU0EX/KCX=EB@6BTCK%?[$]J%_7(65:9-Q[$F;+`,$+2?"Z1-Z\(SI$@
MU=RZK,2DCZ>2K7O)+[B68\%;N$M)X$&MVCX4UDUK2:Q)$W<*,V"+AG\524_M
MT?81=7W/*U"'LMUO!%158[%<>^8=8DVB8_-E8%J4J1,PS(D2%*";MR:^Z-[Z
MT3<^TP:S7:53]5U<9)(VW5]WO-8+`6=`-$Y3+GS7.'*Z.AWH)4C!$>P3*1VB
M$<<3]=I]&<1I"`PMPNGPR["/K-5N%MD1JWJ6YVK6-1.A;IL@O6[V5B,:G[&6
M]DC<]=&CD6^L2;>V$*2$'I2I<VPC7\):=4I?KAM@ZB?#3V7M1G508T.L.R6X
M$\>W4Q=QV;Y"2=>5-C6SD1#K,]L(7,`*AKQU$5EMYR6]$8E36DNMN.OJ"0;W
MV"Z#721=C5OV(-*(O&C7=<7HS$C;(P&9U!<:S.O<4.=+!A:0]2FV<-8I.1V7
MG89:;-]6#%RN;'<C-AN3HCJUV2V59J&BS7>[VO5,&3FTU>!9=PB:;4W9\^V4
MT0_*S%=%45BW!R$0TD(XT]DO%RR[)CY\L=IUH+.:QUC3-/4L70*"*4(K8E\M
M-98=ERB$N43/F)]@/%B)"<Z_,GDS)PG(E2'7%YRIUW/AX)\$X"%=[_5AZI_P
MZVO]H#97`D#@.`X#@0_V'_J];_\`Z"]P_:YLO`M55?W,5S_<(?\`8^/P,]P'
M`<!P'`<!P'`A[L/]0#>7]#VS/Y%&^!IE`_<!0?X"TW^30O@;9P*2VQ.EV?B`
MZ.9-T+<<G=)K3VQ3%(V+[V-L]=1,>CP)PHF/G5R39F@)O<*:AL@JRU+A!9;D
M(-/4U,DM*?A(R%0J\>ZQ:LUKVPL&.NNZQRNG%LT';[]4++NVBVJ74:CHVP&-
MUZ0KU&MS6WSU.J%7T_)3-,NZ\?(QR\)LFRP_#D8(0VUA,>M:YU(,Q>G=:':S
MN%7-;AT+J*U:[J9G8(\C-USK+K==A6_]10+Z7!WHY7S)Z+MJX,1XJ14PPZ<D
MXE-*6]!@REM!=[>[U)C:5VN2V3.LXR@A:%9;+;B5(/GJK=8`:KCGK)(FTZQ5
M8F&L0FU1EBDK'.0Y3#RI>&T85X*SC(>26Q)_PQAM+Z01[S7=SQ@Q?5]T[`=>
MVEE[>P:GI@[FT[N:^U[:\M=G1F7MJ=N8B-/3!DQWU),D,7CI>S&:=AR`R.Z*
M'T(6=^(+6,UC=5+V]6]-;_?[,VT-'L)9^C5#?\W)4A<0$`I:6*W)?VV[>"1>
MHIC9;4J,&)8S[$N!Z60W6\;C^'MJ/6\@1:+OLIL!1^PVXMKP=O+VN1D7>Y=@
M]!:F`[&N-F![@(7J$3O1JT:SMK5<%0,/K8-14O"<14,MI5D)@KELZL#.]?8D
MK6:+?86^J=KF#;-W6J/8*,U0I,7.H*-98):'KR1L;Z19]K>UA[F%J*Q*VD/Y
MV,17).)'G<6'V'_$]Z[%M"`.P@T%LMVMV3;E7TE!K,WZ(P=B9O-SUHQN"NHG
M60_MX7IZ,'FZ]F,2UR<VK*HTI[$!]ML@AV*V'H>*?45ABY:([T-16&/EHAS%
M1<R8F2,=F0B),<A29L',B-E[R.*8>>8RM.<MN+1X*R%((W?[59/KMMKM``UO
MO.Q:RTV6-PK&@75Z0FRE@U9<E-66UUT:2V./'J'UA4%Y)461F#;.+=;]&6*9
M?6VVH-IL?=36%+W7I7K]=ZGLVH;*WC6J?80@PL,I,AFHRKX?M%6K%8NS8:_%
M2_OZ2?IL^/*=!0SHH;AM#LR8Q'<2[P--8^(?I%_6'8S<.*]L%%#ZRVDE3+L0
MS)U"]/-V$3M(KIV=#`!HNVY!.NMHN@ASRNV]NK-N#U)EISECSJ0&^%NW(,4G
MK6IK3>ZCZ>TAV56Z*_5,:7LHVN&(0.QVV2Q=CHK<\BOXBII%0*&D2@4H]$=@
M05I0XJ4MJ.X%M58\,YQXX5X9SCS)\?!7AGP\<>.,9\,_\W`_.`X#@.`X#@.!
M2#;#E?\`IY!MFK'H,.KYW4Y*H^W`D0J1Q`SIK:KN9+BI5NKV%4]4]"$I8RWY
M,E?2<]7*DX;R$<5QRDY>U1ZMXZ:8PYNO>3<OVJH"G,(@M+W-["X<PK9:,2JV
MYZ;/NQE?IML85#\JU^FGSA\*B[25/::]:\=.DX=V5O%$WVVHBWL-QFI&S?8%
MG\+V6U[8$<PVU[M;7EI+&,Q_*ISR)\P2=UC]Q+/U]T6:TT8F9H>W$3L:P#1!
MIJ(UC<H/$3%IE,6:P/3($AI&,C4K1'PTRE24Y<QC"L!=_@.`_P#VYSGY,8QC
M\7.<_P!S&.!PPZUE24)=:4M;6)"$)<0I:X^<HQB0A.%94MC.7$X\^/%/Y+'R
M_+C@1.6_K,=<?X%=D?\`0Z4X&!G=@>EVM[-LZH/WR)4[4=V@\K8B(L#8L>87
MV(@/7I-@1&.QA3C!"(!K8<>Y8,#9"QH8>I"R/LS3_F<")]46?X;.I[.*+:L.
M!Z%<#L9YMAI"]LA[#-#PQ>J:J64:"V%ELA'KL`-K*GJ)O3H[<2-'D0)TI:$'
M&Y!`.W?J;T&/#VQMUM%K,5O<Q>Z[E&5F)?\`?1&K^\46(F2M^PPX2OEGQ^OH
M9RQF)C#,U"!T0G((+C0LNKD(;4%<3\[X0HBD7.Z1&B-N@5ZHLF",&K.[]/61
M`K7P#9L`55AR9$EI0<G4F*/8I:!\J1#R#D"\D9/L:(K4EH+.SQG0:E;"CZ/L
M$1`N]$B8<=&$D"NRCDH@1MZ^M\&#+-'(1`O'#9,FZ?KN`F46DQ$2B>(S+:UN
MS7L2`Z>T=X]![^YV%C;O>F"ETJ<'UIN#YSBMBCF)X;3=DLI,&6#RZG[3$*52
ML'MA$'91"`O"X69R4E/13[.G`13M&[_"Y6#L-W+YDV@E2#U@)-M4?&WT7240
MDVS:B;63I[\64&S-I\VT$K6/*&HLI-;;6I^')F-X;:;0$N]D;'T&IQ/<FS-Q
M>R'+K5]?D!.PJ>-*VQZS$JO5W:`8E#AE";,BQ,N6]B57?-*::;]HB^AA;^8Z
M'/*&DJN'PQ@6NT:0:O"0U>]\1K:,J8X]O`=L*MV.(1?U/`K=;='+9V93;9"1
M!D`F:K"7$*H&8DHQ!]E6^I08@IH[X:E2"ZXV'"L(>@4PW.U9O45-G'[@0"V^
MKZ?V$S8*3$99N[QEJMAP.U]D19YAF&U")J]L=8(93"<DHP$G.T[X?78R_G"[
MLE=GV+>+H!3,&3K#N"M'*SM!JMRUC)XFGE9H56I=DR*EU@<1*?BPA)-^!7O3
MDY4W(\LD(JO[_P`+;(:>9L2E$A=AEV$(L=");H'A=GFJ^`Q[LBY?D3Q%2NCR
M&Y__`-IY27*7`46F+=$2_:W'7.!)\"S]#QFN+%LFP,SM<TSN79;M1K`Q:)MX
MAQ#]B)WT[3K5C#0`L:!:XD6R]$WY"I\9\9[5.GMO*=Q(6G"0C"*=^&.3,Z/+
M5*(5M%K)7#7FO->/UW&Y(UE&MV^S1+'5GKHZ;EA98G7MH*;.8+X?-*1#LC,A
ME<5)#T64(#'W"\_#4VKLO>0+9S-\I9P*5N<J^&K*7W9K"CRSPF+N+3VR)E1(
MU^Q"J\(/6ZFZ)L$(D[$1`F6T)%QAO,_ROI9"3:F-^&UN>1`U92'!-@+(Q<[C
M$;KSFU@MB7$/-V4GL*A/WB*@68D0YD"Z%T%:&^14IJ)*D-.C$-MY2V$3!NQ?
MP[$Z)P9`4^_!06T,4ZZ/485'N-:V.+F5-&=K4XT)(NVH2Q7K51U31A*1'!F/
M>=>>+C43FHV9#2>!E*YK'X2JB2X@N56V9,$:!JS,8_>]P1!Y`)():TK(J2-^
M=)UD=:P=WDT*O1%%V,S(MBC15>,F2PY+RL,U>KA\/FFS-?=5;B'V/"`QXP[8
M%<LBL;FP!%"]FTNY1G/?NT(Y9%E:JUCH<(D--1)3ZQ48:ZEDDEEGPR@)(?MG
MP\S&E?;8!FH%],Z,-':'(6+.VF&-HOTBQ52C>?#)"`2G@#@<DJ5"E,>U1I,3
M.%CEN)PGP"%;3.^%KEFWG6X!<X9L2(%YLU:IL+>>+=#-8W)"K,.\2JJS[NG4
M[8$+9`)#+4I]J"9S!&K2SA<%I2<AM\%'PP9L*??V)L:9&LD:=16W9,S>2YYY
MJ[ZM54G`56K<I6#!B;?M=W7P@Y%Q79)IXFF3#4_,>0[D(PT<3Z$TL7O"K3]M
M[1/"+K?J\UZNP,7.MSJ@-U)8K-;Z*YJI%2$@[#2M=:C*P9I9FR1&QXL+B-AY
MY^+AA7@&<H.MOA*V.RU>K4EN,9L=R>=I%8KT@]OZ9(/1Q[.M9Q.9[`>G+1-K
M=BCU*NMS+!*PH::2W[.J8_Z\EMP/1<#UMU%7=8FM-P`)9[6]B!$*X:K96XW$
MPW/%%52<3VW"),[*+MR7V)/H>NW(0^B.TTTE6$-(PD-6M?3?KC=MFQ=P6;7B
M25_C68;<%ELV:WQH<^PAXM<A"IA8#$/L`"S$"-5(*419$9R)GTU94TK+CF5!
M]]6=/^O&DS56/ZLU^FGSZ;1@VNP:8%DMC\'%;KP^2)#9+#R!V9#L)V"*F.QL
M%2"))-QES.%OJ\,9P$=5GX?76H-6(E<.5&3;O/,OQ.SOS2Y8",NY+8UVNVP3
M#]MJ53G`JD;8`6?895ZNM283N*XE].!^6%-H7@)MT[UUU)H9VU2]9U\F+)7F
M3'FW$R;M]RNANRSXI6R&VYY8Q<SY\C)FY*6XBZISU,*5[1Y<_D$-I0$W\"J^
M]_JP]4_X=;7^T!LK@2!P'`<!P(?[#_U>M_\`]!>X?M<V7@6JJO[F*Y_N$/\`
ML?'X&>X#@.`X#@.`X#@0]V'^H!O+^A[9G\BC?`TR@?N`H/\``6F_R:%\#;.!
M6*XW/2WWXO6S7EA=LN-_,:XWC<]2+AQ'LTF)6S+%;!W>#;2>,YB,6.PCZH](
M!1',>>3'!E7D9\(RL9#STZZ[JZ85SJ9LXIICL3VXJND*J_3MH7F_D7ZD.NG7
M\?L#=.S*=9K&2G2:"ZZ-$1KO2#96^S3D,]*P#RV6<?>8<];`6NUUTSZ>;(IG
M3S:@;3AP=(T4$U]<]`';DZ<#;3$`AK=BL50AWY3Y%\@4;FD+Q,.28$_.7,$9
MGG7AI7G8P&T["V)IOLKJ+M#1;3KO<EHTYKN/:Q&PY\*K1Q-9W1&U!:22]GT3
M5YN:;89N<8?9]=SJ\<AS,"FI[6766G'(DC$G@4OO^H.D1O3W3(!+ZW]F"^MM
M\2HD;KG6:-%J,![4,K8.SJ_W7KH$S'<OPE-"9%RM:KECX\)TI&AU6%.$+RM+
MR&70MP_/ZU]@=W]T.N\F!L27L[8.IQFM>T(IV+,"B0.MX`0_6];%1!M*UL!'
MMG@-PEYU6G1<OO$FQ4U[*([@QQO(8&K_``O.G--TM6NOM?HAR-JZHQNP$:O!
M9MF=+RQV.RP637MCR&21>#->3-AAI/H`G\8PZ'0VWAK*L-IQP-**F^KM/[5]
MCB#]@W_#M=IUY:P>VV(,``]HFV6#6W6VH%+/1*R:<`JN/TT57KTD09S!;(Q0
MZ\94XE3LMF4RR&H];-*='.SO6L%4NL9O;51TS2-EZFWE2UU]\+69])V'8>NU
M4FPG:^%ME4M`44\7IM^4_;1,L8I+=TEE7<MM2<N*R'K"*AJ@0A8U,B637`AP
M!Z99)3+\\BJ''9BIE$5QV(D=^=-RUYWU-M--J<4K*4(QG"<!Y`Q9W3:N=2?B
M%7P%![2[MHA:W;%UAV484Y*N.Z[>]JRKM51WYC$2BPL:91A="E8D#;>:E^K,
M#M^V$B3^&&\I"QVTA?54WW#ZE7&Z1+C'[,[`J#Q/0=M!-*9A5JKZI@6V]E0-
MC-M-NIKL'98;:IH3*@.*<8LS#;D;P0["9>0&*V3U+TEJGKEVD#3W^QUUUGLI
MX_LNRZUH3]8M-V@V6=M*?N62UI@?$I(V>HP5V08R\E)^84@18N,8D.QX+3SF
M`^T#8O7:)6_AJ3K4;VT<)[5LD"X]8RMFC`I=A:L6P=%6IEF9N=^E#0]2#B6J
MAM_YOMN18S<%-A*"XS>5J<2XH++:^WW6]C;@WGI<;5-A`+#H5.OGCINX5QJO
MUJZ0=C8NC(DUKE]XB\7L%=A$Z`3A.D'X<.-)D,95#5)8SA[(3EP'`<!P'`<!
MP*=;$M;0#>X%AS96I*3G%ZID_P!CV&(40G)3G1^VX7OM;F+[4O\`[7E*<]D2
MWZ>/"<M*O:/D]%0:35]C1D/Z?\=\]:6?9][;^EYR]6UYQ`3,7N_RDR7_`.>5
MCU!!3VK'L:/%CR>TL?FKWE_-0^=+V)';>T9_^?GK=&]EVAOZ1G,FNYS@9B7(
MVIG$TIX[GC><<5]H_P!43XQO+A]K\T?\/S0-WZZ6-LX5J<=%]UM<<P*+N5>8
M5$&Y@SPF)FZPKB73J_GG:?6C%O+EV%CT8?D;PKY7O'S\"Y'`<#BXC#C;C>?'
MRN-N-JSC\7"7$91G./'QQXXPK@07K#00/5,JN*"W2_&0]1I#-(KE9LI(02#"
M&E(%H*F83Z`K!]J6<R'9<=AYG*%,/Y<<CQ65+^0,V6_K,=<?X%=D?]#I3@?>
M'TBT4NZW:_6P4=OQZY7NZWA#%ML]@G5ZKKV#48U(MX"K55LDS6A(2R5^-ALD
MAN+APBM+;DE3JV65(#5[#\/?KT6"6".+'6@7<#=$O^NVMC%KK<KO;1U<V?5%
M4>[QO:+E8"[!=)VJ,#8KS<Y,AASYO`UN(6H*.]G#?[ATSZ^WJM4ZH6*J&7*_
M2=9-:<&CP]XNU7;*:UC0Q\6!4K7\V#X?YW"1CXJ/+BMD?:$QIS?KM^5Q2\J#
M3$?#SZILT\[1XU%L$(-9RYHW8)(_9FRQQ\I-L\&]#+8T]9H%LC'F1ML&;+.1
MR,-F0W$DL3LH4WX,Q\-!+9CK#I(]?BVSRE.S(NQQVF/$S"3UC83(<U_:=;W.
MIYP.CEFAC.!=CU(`D>"&4X>Q!RV[YVWGT.!H&R.B?6';*26+QK^8167+7LT0
M>AW2\!GWYVS5)^?><.B+%"4PU8FL9;6AORX80O/H>DKP5@.B6Z"=6S`L:(?H
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M&@J-?*]LT$`M2KS72DBP8/F-E;$/2+%:7Q6P`*+==V#%GF0[Q:H0':9Z#%GE
M6Y<B+#(99:4A#,?#(:*6^'+U*.OC'B]"L1!L*K#82#)VCM!P8$%,&!A\560@
MW-O]B#5&OEQ#+P\5%0U`BYPK"&O*I2<AMMQZ-]9[Y5:!2;+0ILJL:R(60G3Q
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M.]".J<P?D66U>D_!1*6Y`8L%KN9KW(-P$GUX?5Z^X0L+[H.F`!)20V,#QE-C
MAJW<N1VFW?!>`W^^]6M([-N12^W6IR2]C-4=[79-U-EM`\?)JS\8W"=BJ##3
M$02B:N#8I;&9:64RO2<PGU/!"/*&N0^EO7&#K&P:<8H3J=;V0[&/SZS\Y[7B
M-'DP&41A<$3)0:1.#A1$5O#46%&=;CM(QX83^+P,99^B_6>X6-RUG*.4?.+F
M64HW*C7J]P$0S=K(S2I<^.CPK&PP-,KG$7EH>CI;RGQ1CPSZ+'I!TR70KK(3
MG`"3E.L<.94Z_4P-6<$[,V4)17'Z*("@:=;`\<?:X\>)L"MAZV.CQ#V$9*M-
MPFL>O\F?$/@YT!ZN.29,S-)L.)DU*HTV9C9NS53IPB8/)#+%7)TY=N7-G5N[
MQ#4SW]!><7',N25N2TNN>56`RZNC?6CWE2RK%$GPY>OIE,GU7$*ZW>-&'R]=
MM,(H\A4)%A]CDR*R[$:<BN.(4XE:,X4I2''4.!:^+'3$C1XJ7'WDQF&8Z793
M[DF2ZEEM+>')$EY2G9#Z\)\5K5G*EJSG.<^.>!]^`X#@.`X%5][_`%8>J?\`
M#K:_V@-E<"0.`X#@.!#_`&'_`*O6_P#^@O</VN;+P+557]S%<_W"'_8^/P,]
MP'`<!P'`<!P'`A[L/]0#>7]#VS/Y%&^!IE`_<!0?X"TW^30O@;9P*TV;J5I:
MW=A:KVG.!R\C>%%>IR*9<6BV&7JP#IPC8H7YGAV<1%9C5&W1-J&EGH?GS[R?
M?:<RMO+#?@$=4/X?'6W6E1WY2J<(MPT)V7TY2M'[:2JTJ??+U.AT&U:S#EQF
M5#L11%RFU&W/LD"#;*DSG8\=UQKSMKRX%U(D=N%%B1&,K]*%%C1&,K5YG/2B
M,-QV<K7X8\SGIMX\<^&/'/R\"N0CJ]4:\(WU7`%_W&'K._LWEXE6(UT&R*]J
M\CL\G9K!L8SIH43K!"+52USL]P(DI;I#!A+<A_#<=#,9"(Z0S->ZYT8!2>N%
M&=,7:QP>K12NE]9&K&:&/V.7,JFN;=JD'FXS!($,..M1*5=)<?*68D/U'&V'
M59RI"O4#9WM8QQ-GW#LJC$<!-I[9I--JKIT_%59*L(GZS%7>'KDNJJ-/B'I\
M81/O4I^?%]N:]XMH0UAQCY5<#AHW6133FI:/K4[M'8V[+!5Q*F+%MK;)G!R_
MW^PSIDDH<L1N0TAJ$/9EDYKN(0V(A$(5`2S#CI])A.<A%5AZ;:<L^S;YM$M(
MOCA#882Z03%18M26-?CK3L35PG2=UVG7Z\D6J6.V8?U,!A@W)BYC\%N,TMUN
M&B3(DO/!M77_`*Q:CZQQ]EP]1"RP:#MF_1=FVZ"1+K*0\6]FAT[7TN:$CJ88
M;"Q#`VD1ILR.UCTG2TF7*3A&9&4)"P7BO'CEMQ;+GAGTWFLIPZROPSA+K65)
M6G#K2OR2<YQG&,XQXXSP*=:PZ(=<]-ZOW)I[7%?/UNB[]H4:B;3@1C^7)=D>
MQ2#NOCFP7)CL%7I;/N=?/*R:+>129\F+&=RPC+6<*#8K?TXT5>]KZPWA9@9F
M=M'2P[60C5%KP:]*;0ANL3A\XS#K^,0\HCLWY-DD0+3A?G]\#4M1_P`QPWA7
M`LN2@QRHTD*E^I[(6'3Q<O#2_3=]D)1'H4G#3F<*\CF6'U>57AGPS\OAG@5`
MM/0KKK<X77^)9`UF(O=6Z'1J%H4JY848+ZY:U]9=<6D);PDOW9E#5^ER]4!8
MLXEZ?A)',.QO20AYSQ"R`S7%9$;/OVW82)Z;ALFK:YIUERY+PL3[EU;,OLZJ
M(&C_`$4JA24/[()^T.9=<P\G+.,81Z><J#>^`X#@.`X#@.!3K8=RQ6][@6/I
M6UW0?+>Z82]AN5>=,2T^.C]MP<'E/-W>K_\`8Z\N>Q8:]/&<2G$K]?Y/24&E
M5?:.&W]09QV,T>S[+O7?LWQ>I4C.!WMJ]WYR6G^&VF?5&E\3/&,WC+.6_:VO
MS5WR?F@?&F;/])[1OAV(T@Q['M'?LG'M%-D9P-]MD;4S[P)>&VV/4AE?:?&,
MC&8_DQ(;\5N^7\F&[]=+/\X"U4C_`$B4>[^[J-N1SV&I!7!4P)[=NH*[B09=
M7;;+B2V8\GGBIPU%])M&?E=\?-P+D\!P'`<")"W]9CKC_`KLC_H=*<"$]K_%
M2Z]Z>MUYU[9:AN4CL&@;`M>N2U'K54KY:S3C0<=HAZDS1$%5PBH>";HL'9FD
M!*G*?7&;EEC7DE^Q,1)LB.&@S?B\:X@&`H-_JYVP;(+=WV+V`P\,Z^QG=/6O
MK$"3;]V4^_,2>PC4B:5JU%G##D2374'A1T<9A^[)<R1E]A@/J-^,/UX(]+%=
MY_F+L!C53VU*)J,6'3L'JD4-SK%L6;3QP":1MP#LD7TM214:7=8R".+%:P\T
M9Z3F94=K\R]4)$T7\4#1W82\Z1UQ1*!NYBV]@-;UW=FOX1RHU^/`=T<8K9TD
M:V^3L`NWEZ]'I=)N05JI$ULRI$MRPEQ7L+$P<1C$%A"%=^.7TRLIRPUV&)W)
M%*U&I]Q;?:HT^JU-A0"!TPMT>G6V#.PW>WE*,;9FR<2*+':PYDU&QGVC,%[P
M:R$^ZH^)SU[W'?\`K[K:J`]H1[)V,H])NM60:KH&#'JCEQJW9NR2J;?\-6J7
M,!7:C3>I=M#'8;#,QN&8;CLMNO(6ZZR'HMP'`<!P'`<!P'`<!P'`<!P'`<!P
M'`<!P'`<!P'`<"J^]_JP]4_X=;7^T!LK@2!P'`<!P(?[#_U>M_\`]!>X?M<V
M7@6JJO[F*Y_N$/\`L?'X&>X#@.`X#@.`X#@0]V'^H!O+^A[9G\BC?`TR@?N`
MH/\``6F_R:&<#;.!^^&?[V>!^<!X?_I_S?B_C<!P'`<!X?\`U_EX#@.`\/'\
M3Y>`X#@?OAG'XN,_B^'_`-7'XN/^?'`_.`\/_K?B_P#)P'`<!P'`<!P'`T$W
MK6NG3[%GDR;3`,Q94*>S(!6^Q@66R(\.5K\0C[$+(1H>9S8(W*B9<RC.5,O9
MQGQSA.<!B8^GJM$R+5&+[#9R$-&[$(RC9-T_[/.V3)C)XI'\QA7^M%<V"=ZN
M5>9.?:G/#&/''@'&)INJ0,AU0RNPH^:^2-F`F4;(N?\`V:4L:B2CTZ-YRZL>
MN448E9=RKS8_-U>&,?)X!'@*O1:-V'IM2`D+"NN2=!;?.9%&K"6L+$<LC;>F
MW%S83AF3,D0W)+A^6I[#:\)=4YC*L9\B/*%F>`X#@.!$A;^LQUQ_@5V1_P!#
MI3@4+W18?AQW'L!V#C;7Z]VLUMW;^P-4]&MRV=IPA$F6*FT6GO\`8>A;/#N5
M^^0R5>J&O[0ZF(W8PK$*W-6D9`;:0Y[$->:#X`;3\)0(&U=1JM$.VH6=M>X=
M<MV";)W[9+%+O7;`-M"K;+8V;>KM/?N^RMN[L):=*@8\:9,-W&1,88S$9;C)
M0^@)IVEUSZ"Z%TE5^INPB.X&*59CZ]OZUK9'?_:BUWT6=Z\#ZG8(1>E;:Q?S
M>P-:B*$D.)6PU'-#1K+J_D1G+KWF#IZ?V3\,KKZ5UC`U=+GU0KK'5A[3M`E-
MUS?]FA1-57?8:K7<BR[47#&PUNK)'9NNI$DK<Y<R:R@A!D^N23ZCN'`AS975
MGX,>K]LV*G[!U8/8VJ3G@+78ZBU`[!W&=L-TM>*J6@"9%<`Y/#MG"B=NMPG!
M`(ADA#>:F)9F1\QL.H2'1AZ"^$C:+=8(-%J]UHH^F4D_VA<VQIK9/8W1=)HP
M4`7V(\;C:RNFNKK1O=3$:1VDM;DX%4_$?#4:E0Y;#,A+$5(7+_\`4>ZO5JN,
MM2R&S(AB*5N53K]%+ZZV"K8]ESK2_E]8&GXXPZ,:).$4D*W,FN1";S!O`^,[
M(D1D*PK&0F^K=Q>M-TK!VZ5C;(`K5:S<P=!/G68QEL<*L=GS#Q6<3'WQC6&0
MEC]X,9@E<_\`9<O#R<MR%>/`P0KO1U8,J<3"VDVG&`%CM<5R;4+Z-:+UFG!+
M4>ME@`.D:M%181%:BT<NQ.?A9?;C$1[T%S.)N,,9#*O=RNNT:KT:Z/W4JS5]
MCE+2,IQAS7FRDQB;-)DYC6RQRL9J&'@=&!>'JOV">F*$3&_-\2LLYPYD-9QW
M\ZG)%2;!+VB\*K<,1(/S;.=H6R0%9@!XL.09D$"%@-5"`(@,L5.&_85^L\A2
M:NPZ:SC`IM<O`;U![9]?B`2U6%G8"&1U'K3EMMZ2%;MPLG70J9J!\514(2`1
M#,4F8ENH0.@98]O)^=.8K+V%8SD-,(]\>K@>Q0*>8V`8$6\I""38%2*:RVJ.
MM$A!XX`KD6/BOS*4R6:GP3-G@LD(ZV4NB\/^>6EAMMU2`_!W>?KU+UUL_;L\
M]9J_K'55Q#TTW;CU"NL!HFZ=US1=H"["$`9!+M<FISJOL"$ZP1=@,QY+>%/L
MJ<C*:><#6+7\1KJG6JG<K5"NE@MV:>*L!A(*JZ[V#.-6J!5\79LX4I:)-9A0
M+)5Q$[71F+./1WU`!K\)6)DUC"F\J"1MB]S>M>I;<4HVQ=EQZK8@Q6O!";1&
MN6_W7%*68&JSCHGSA8`/5Y]<6M820(9:E+2*A.M/3,L(=:RL-1K7?WK-8ZA5
M;<JTV<&JY65BF!:D7US?EWEVWR\T14.N*JP6NF"*R4V/LX`^UZ6'&5L$VUX7
MY4/9:#L%^]W7>%I*P[_#V"PVB@5E]F//;&4BXC;7-<G:]C;3"-@JA9P8$^85
M:*(0B$!+B&$QB$>6TMI[*<Y4D-KLO;W1E*O(G7EPLQ$!9SL&I$1L!VIW`@IB
M%<2(0*,FV5T0`GQ*2.:.6<9">E&'849J5/:;6XE7F\`C\M\0+KS6=N7G4-UF
MW*BR]>NDHUAO%LI%@':U9EBXM6F/)5<VHDH7`@26;=%1%G3<Q(,N5A<9EU<C
M"6UAN?W['695$JFR6-CJG4^YV&U58,1%TZ^%Y+!FB#3!N\-V$.+K$PS485-!
MU^9.*3"L>%#@PF,O/.I;RE2@PD[OMU9AS(XIK8LLF;)Y-JKH,52+Y+(VZ$#B
M$9;IVHXQ6D1;'3R61,ED>>BNN`R#[#B&);F6G/(&#C?$6ZFK'JD$;\="&8]'
MK.Q"5*(ZVV2]>QE5L]0(WM))RIB*H3+$8]?JX:;+,.P6Y;`EF&ZN2MM"<*R&
MZB^[W5<W7]EV@/N.OE0FHDX<O,@=!/SI,)A<PP-9DA1<40\5M\:24KI"(RX'
M8GI>E0GVD94XVI.`P97OSU7#DQP,AL^.+-$8"RV!MBKMOJCL(:.N@^AVK)5V
MR5X8P(+4BP3_`$3`V4IDB/6RZE]EO+:_*'['[W]<6=>63:MIM!K7]%KVU26H
M&R=[IUJK90U:!=5C764\-J,T0FY,C$5=R1/RY,'Q5MP(3\I:$QD8=4'>'=[.
MJA11/$;:\9IH8N=CVLC5;R('EF1]G)4QZ=6")6LPX-M%OVH)/@QI8QR7&F/#
MI?H+<3&?4@--&_$?ZE&B68P78KYH1[B<.)L06M60S%RW&8F%R#.0@L5+M[48
M73(:K'*(K')$L5Y29ZY6&%85P,_CX@O3_"Q*)&YA8[)\^W7P*C%<N@-!W+IR
M=6460*LQ6X*2VOE60:_`^<L?+E?]K:4U[9YO#&0W:Z=PNM>NYEJ&W;;`"N$Z
M3B6JTC",8RT1$-PG<M//OP4C%278RL^533K:5MO-N(6WE2'$*4$:6_9-)V[;
M.F^Q-='H]FI]BN^Y5"C$9F7&2ZZ+TGM<*5B2(<^/$GP2`HR-D1)4=]IMZ/)8
M6VM*5)SC`3QP'`<!P(?[#_U>M_\`]!>X?M<V7@6JJO[F*Y_N$/\`L?'X&>X#
M@.`X#@.`X#@0]V'^H!O+^A[9G\BC?`@:NF7Q#6O7G7);@P=ULDV*4.:=REJ2
M\&8UXZA[#*U88S,3%6ZTVXK_``<.YQXXQG/`W%>Q!J//XCI^?(UJUW/@N-\N
M-K%5B1&,?FGXHMY'GD?ED_G?FSP-2KQ(K)N5=AND9SC$C9'8$>ZRY)>6R[$#
MRTH$Q7&\JRE<86G.<,(SCRLX_P`'&.!LD.^Q+*'<R/B3X+Q36,^]1'G7&?-%
MBNO3A3,=2V%Y5B<U)8]3SH\48QX>&?'@:B[;9,K7P^&P^19+A8?79XD5S*SA
MTA\]#M1<D^#Z'/:5JE1DO-R?4_/L/9Q^2PK/`D7-W@^]<BO89GJ_2`K7OJ^9
MCT_>2:5B[^W^'G\WL7L&?1\OYYZOR^'E^7@:Y4[._'8'P9J)A)^P;'V^(8EN
MR5+]WQZV=NA2*TOU4N*7&1##IBLMIRG#6/+X?D4^7@8&S[`>,T`W)'1"`.6_
MK:BWR-,;FY2_#1;S;\9(U#S#;#B9,!`M6''<9QAS#N,83CPSXAM`RR*&F+<Q
M/S-FH([PQ2A2/5\Z!B2-1K<R.A"'E>#0]AYMY>6F_E\[N<XQXYSP.K&M2CEH
MH<^'[=$&3`NY6Y(UQ['EDR:C8ZL`3(?;:5EAU3;\60MC.?%3:'\X^3.58X&/
M3?$9(NW/R$OF_P#0!$V+@'E]'JX0LG,+9QZ?J>Q8)Y'IPQEWQ\OR>'F\O`[]
MWM*G@MJ@C<SQ\ZN&]4-2)K;^&<O-6NRU:;EJ.MA>'D-Y'2EL/X5X87A:L?*G
M.>!]\6502S;*<G9FS83%WUA7!\1#WBB`Y;@M0$(5';>5AMB,DD9Q(>2CPRO\
MEG&,KS\H9=B\0IT^.):A36Y$\SL.O,O*6QEMJ5K["D$)*O*OS^C-5\K.,8\R
M?_;QC@1A4[C+#!?G&9DDRT01UZU3:9D;,M3KTN=)7<%$IR,RG/1R1(IC-X<>
M7GS.>FGS9SX8X&[7JR+6!NT,:J</G5.X:_`R9K3WHJ?66-Z_+NJBK95AUN.\
M,L6([B5^&5_D\>&4*QXA]7K&LY9M>>[E38$5[8>R*M/BJ>PEN<NJ5^[C%J?;
M85E#T11,1B0RE7CE'@G.<85CY`_$7Z(?"+]@B$(,@SKJ[VZ"^MUG"H;5=F-`
M5MK6PO*TRU39Z'6U(_(I2C/CG"O#'`ZL38$4%58"R48B0DA]546Z$9*7F5N3
MVCJ\!/)AR0YYUSLS8BWG%K_(J2O\7*O'@=XM8E3;'5A\+,R'@/NYFEE\>KY&
MBN&=='#[B,H:5^;#W%$(^?3<QXY=8\V<?(G/`P--O&!M$J"BZ2)6=*H-XN3\
MU<A#SKT:DSH>9T=UV0OU7)<MLRTEE6<^1/IYPK./DX':1<\#"U_L$M)"2(BU
MS3D^(*2^G*HF;;).PE*8;=7B,RZX[+84_E/AZF&?[N<)X'>BV18:P7]!#,V<
MPK:='J(UE+OF0/59JAKZ(UEI#RO*Q";)%%R'4(\,J4M:L8RI6?$.2K*HV<U?
M)@9FPH<O9%[KL^(M[&,3L5:N[($O)DH95EI^(X5`)DM(7X^7RMYSC"T_(&N5
M$F5F1=&X>)3GEF;%LB,1<=E/N9(-0Q=\7":FYRK.93<-R(TIM*_-A&6DYQX>
M7'@&=SMD/@$L][I*>SHH);866/4B>MD:'.)!/P/'U/3]M=D+\Z5>/IX1^+G&
M>!GZZ_+<N&TH;TA]]D;8:S'ALN..+:AM/4"L2WVHS:LY3';>EOK=4E.,84M>
M59^7.<\"/"+;B^U5%PEM:L_>V;B^1*59S]5G07][&?[W`G[V>1_\![_-+_\`
M=X#V>1_\![_-+_\`=X#V>1_\![_-+_\`=X#V>1_\![_-+_\`=X$0F&W$=F>N
M/G0M'_VE=D/\).4_BLZ5\/Q<8_%\,\"JFQ3GPRK!;>PIK=%.P%LVOSMKJ>V#
M=JK^T\-&8+4FBE;0<!$*RHB-.U>'/G!_;W(*O.)6M&)C<5$C'K!\\0?A,U@>
M*J4HG2DL7F\C;?`]\6;;!<C*ORK)M>DCKG)/DR<TE7BPJV7.R-I*/28B1<XA
M'E>JPM8Q[@21NNR]"+06%:L[!VHW=K!JBW3*O$B6MO<TM<FWV1-/LDT5DC6A
M<(!?9]7@V@#.DJ:5/^:\.1%DR%0VU9=4%>Z'5/ANT3.SK?,V59=BYM$:-71M
M/V#)N]=S0*!>Y]WOHFAT2KOA*;(!4HJQ8R1AF0XUZ61#\6?ZV&9+4N6&\O;5
M^&!9]_&]J6F7$`;/AW>MM#+Y=)NRZK6;*;)U+2Q<?>ZV+FDH=;:J,H5#I,7-
MHE#X88DZB`AF7)2^VIX,]K^9\.J!2MG7<)4[%7M?OK*=52\"PB-VR8-C`$=6
MU#:MD'TK5,UTJ;&A#%#0R;+&(P6!+ELBY1>4\MA"IS@8AW6_PN(E>&[GFMSI
M%>L=[V74Q^RR=I['%6;->*T-VU9]FW)RRSB\MZPMUX2FWS)-U==?'0V(\E31
M%"8Z/3#%-VKX<.P]5[5ZP4^TF:SJBU5\7?KNY&%[!DUV?5J^6N!.UT2N$;F.
M-+ITJJBM*$V)X6&P.E`HBVUP6F9"VUMAMU=K/PT>P5XE5&O0R)VVW=1\[%82
MOL11X$H?8X.PC5H`4XY,56:\&JFP!UJLI>=7A$F..L3$F417$E(1ZZ`UP[=^
MA]WU_I&\&8VR:_IG36U+;I&N#(K-X$T*00M^I&-GG9MYF0IF"-LTNU3("EO2
MI4E\!,?RIB4S(1A*4AL]VK?P]FJK3[-8==$2VKK`/O.KR&2+FPQE0KTS1VN;
M<0/T_:^LK:>"3XEP?UO035==P7"NDR`AET)-4J#,3&?#2:_L?X?=!@[%'V^9
M;(S796'50.S@UW`6YQ.OJII/2MC"A*Z>N(^.ZAZ'JQK4)<%)L,$N:G,7IM<%
MPCF<AI#(8F[2_AU:>E:CWY7M9E]GR=@L[.N]8N,?9Y14B5,UC(H<+9,\B(W-
MM:LO6_:1,Q7!426+5%GV,P0%.,R&E/(=2L-N5/\`A<S]7E-9S21%6NBML1<Y
M+9Z5V3CONV^NT\OI\`)$7`VIJP1BDV@ZSGUZMUR#.0LP+$/L"8<EMMS@8FRD
MOA*NCF:.;*"Q;E;!,4INNP)V_*]<XP6]F#I,MKK,0,Z/NLQXJ3W;*Q9*]X.2
MHZ#3+)6,TVF,AL).V#M#X>=RLC]PL\YPV=B[5))>L]9';D]_2=KT/YEZ3FU\
M!$IL-NPVEN2U8AX2;$#L3!$U3/DEI<<;\R0[>FM;_#OV/M`9(T_#Q:+O28`_
M9U;<C6#=3E/BQL&JAAJVU)PT3:UP?F#2E1!BYCD#,N1!2(C#)6&D1?9D!CSE
MB^'O"JV=5YKTHU1SMMATF9`"!MK$8LT[K"ACM!5Y-94QGYQ[#:8&AA]-@.U1
M)G$TQE+6/4E(D.H#";8V[T?"[1U(JP4Z3>R&\M9ZL77ME0[K%RR5UZ4VMK@/
MKW+`H_L,-=+M+C7H8$(SL"19$E&B1%OR_%.76W`^Q^]_#)V#C86P[0Y'L439
M0"OW*[2SE4WKD1:0\*'K4V-3!KTT(R-E34!3%6+SA0Z)[8H41AD9D?,.6F0Z
M$9VW9/PXSSVH=:,V?9!RD:Z%7G:=.75YNY3-,V4FY4.X`[/5"]^;7-LVPQ7S
M-GEY!F)B<^!'Q(+\<TXRVRJ)P/K*._"NDGC8PP$**'TQ^E7A@B_%WD9HTN.Y
M9ME214&F#ALDG#*ZDU59]>%I:\P86:%79DKS1G6GY$A.`R(_J%\/3LG4;S,Z
M_P!WL]?D4V3,JU[N^JM@7J7:H];(5.PC[%5XLB[R3SC=:V#5[5->63$-)P<R
MYES$J4UEYMP.%)$],=QT&KZ;K>F]H:UC]L"NQ`T+#'K.%]2%:K5'-JF(<DC.
ML1^-H*TVNOGGIT,2*;B$7TS5RL,(9RB3@(M?NOPLL;%@NW+3MM$FIFS^RVMK
M0>O)FTE0@X]U_)#<W&^;!'.[,..VC.ZB(L9@&1=A%3ML?=;9E-X>]I;2%@!%
MI^&2=H\+7PFSS3]43L1O9C)S!7L.<GCKW*H@&(7M\[;,ER8="1J]KRZC1MBD
M2"[`ZOP2\>"4S$]J0RL->/;<^%<U`UE:$-5ZVB8>Q:Q/#%H4&_20NN#-?,[B
MN`2X;&D'7AXFE5R'-VU;B,7!O+2#+!%:H<><TQ'2R&P:XIOPS]K.PM>:C@NW
MRQ5N@F"@JNU^Q[NC68-21\BS44G0WS98R*=JL(@W%)@':P0FPL21WJQ78JH?
MCC@0CIPQ\.6"BOMQ*9MB5.I)"!<Q>P[-.MLXP+J=RJ9;?$B*(12[7*GM:AI]
MGL3E7G586/2&C6SPCY'.YPY,R%SJZ'Z`]MK.>M-='4':MMV;1R,@Z98C69@L
M7I4BH:\$/3W'GT#7!"'JG;J]B%(1B-)5A:'8JO5C/+:#:MATT!K^]=/*?5X\
MN*""73;K,!D@7+GI_A(T5M&;)>FF3TXF9)2I,N2XXX](?=<6M><Y5P)HX#@.
M`X$/]A_ZO6__`.@O</VN;+P+557]S%<_W"'_`&/C\#/<!P'`<!P'`<!P,4=!
MBK,#,UL[#00"6`41!F(#BW6VYPHM#>@$(;CC#C3[:),20M&5(6E>,*\<9QGY
M>!7>-U!TO$BQ84=W<S46%`:%Q6<=FNRN4,#666F&X+?FVUG.(B66$)]/Q\N<
M(QXXSX8X'U^](TYG\61N;_\`A\?UF>R?XD17GB8^JS^)$7\K7_P\_*GPSP.2
M>I6GDJ2M,K="5I6ZZE:>S791*TNR/ED.I7C;.%)<D9_/%8^5?_M>/`XIZD:<
M1C"42-S(QAGV;&$=F>R:,8C9SE68^,)VSC&(_FSG/D_P?'/XG`?>CZ;\,I]?
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M8=<SG;6<K=8RVGR*SXJ1Y<>&<>&.`QU)T[A6%8D[G2I*WG$JQV:[*84ER1_T
MAQ*L;9PK#DC_`/&*Q\J__:\>!Q^]&TUY,M^MN3TU,(BJ;^^8[)>FJ*UYO2BJ
M1]+'ES&:\ZO*WX>1/FSX8^7/`Y*ZDZ=5ZOFD[G5ZRT./>;LUV45ZSK7IX:=>
M\VV<^JXUAE'E4KQRGR)\,_D<>`?N.I6GDJ0I,K="5-N.O-J3V:[*84AY_P`_
MKO(5C;.,H>?]17G7CP4OS9\<Y\<\#BGJ1IQ.,83(W,G"6G&$X3V9[)IPEAU6
M%NL)QC;.,89=7C&5HQ^15G'CG&<\!GJ/IM2<H4_N52<LHCY2KLQV2RG,=I65
M-1\ISMG.,QVE9\4H_P`%.?EQC'`Y?>E:>\WG]JW1Y_7]J\_WS?93S^U>GZ/M
M/F^EKS>T^C^0]3_#\GY'Q\/DX''[T?3>$I1A_<N$(:=80C'9CLEA"&'\IR^P
MA&-L^5++^48\Z,8\J_#'CC/AC@,]2-.*PO"I&YE8<2RAS"NS/9/.'$1\^,="
M\9VSG"T1U?*WC/CA&?\`!\.!^YZE:>5E2E2MT*4MUN0M2NS?93.5R&<(PS(7
MG.VLY4^SAI.$+S^23A./#./#'@#'4K3R?)E,K="<M.N/M93V;[*8RT^]ZGK/
M-YQMK&6WGO67YU8\%+\ZO'.?'/B!/4K3J/2\DG<Z/0RM3'D[-=E$^@IS"L.*
M8\NV<>BIS#BL*RGPRK"L^/XN>!P^]%TSY/3]7<?I^BJ/Z?WR_9'R>SK5AQ<?
MR?2QY?9UN8\V4>'ERKY<X\>!]L=3=0I4XM,W=:5NJ2IU:>SO99*W5)0EM*G5
MXVWA3BDMIPG&59SG"<8Q^)C@8B3TLZ^SS,2P%0VQCAJ`*G@X!(_O[L`=DP!!
M6:,(DX$)9?9\S$2//G!HCKV&\)]14=OQ\?+C@=O[S?KY^]>V?9@W-]T#@/O-
M^OG[U[9]F#<WW0.`^\WZ^?O7MGV8-S?=`X#[S?KY^]>V?9@W-]T#@;;1.MNF
MM;6F/=:E5B$:T0Q)4'!+F+I>[8]`%G'Q<@Q&'LVVS'(L#))T+$]9QEM#JTL)
M3E7EQX<#SWV,WT:VGLO=-"VKJU]MK76Q;(&M)N%LPR_=SVP-M#=10#$6JZGU
MI<9^WY\?8>;:%$1U11:4O.X<0PVVEWSN!IM:VG\*&0!JVUI,&=KD@<(#-T1)
M!05N826D6653=054Y7/?HA,L'9BHBNA*K\YZO`FS6XDEA4LA$3)Q.>X$F,%O
MARR[[:MNE;U+VM<K_L8;=PP)>=GW5P2?NU:$:P@@M?ZIKX^3'PW>6-3(8DM,
M"GI)EU+:92GFUQ,9#2"M@^%8!J[UMCP3.QG:I1=HR:O)@QM_;!M5_KY+7=2;
MV/7:.9FY)3-C/TS7NM0HHDTS)EIHT""F++4+;S)QD-NV/KOH7HYOKU>[CJ>X
MI%[YN(ZKB+)(MUTL(6BAC6JXAD0$V3[UODF*'T7$$ZR!@\"F6Y5='2<0LNQF
MH?M,E`=[1L'JANF#'T!5M0[M$^V,A>Q-B=LVP;XFP50%?-05VEZXN,O9C>RB
M5D]T;4U80DU(>+'$G6UPPAN!)CM)@R<*#/AK%U>N%$TSIX1UJV([4K5L;N+K
M'7U!.#<@`5?M5-KF^*[M,);7YUPPQ7AVTP+UEB@X,A3ZVHA#"UQH&(V?9@A`
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M<]A01UT^Y'&C6X$*$S<[U$'L2X<RUS@=HQ`BV5J(N]U.1>"V0I]2,F`^)BDP
MY+.&V<-AAYG0'JQ/%VX-+H1J0/OJ(_SS:=V5LUQRSS4-#8Y(R<D.6]4@H?LT
M<1&08G/J7*+>EYI2W5*6I09:O]&>KU8M7SV$:TRU:,'85B:+RK?>"$A@@,(!
MRHMMG$ZR2&DCA<X#%5&BY3F.RAOTD(PUG*.!KFE>C&N-#[,-;#HUSV7'@2(L
M$+4]?O61*Z31*DR]-)%*@#'9BJ>>#V"PRT$9JWG%3)<N,T[(>>>]5UT-L5TI
MZYYDV":W3C<::>DYEL2X>Q=CQ'Z<_B_1MI-KUDJ/;&TZMPQL2*DNA->P-2F6
MI?ACR+4C(=H_TTZ[V1FD02-)G-!J!3:[KX)71=TO`:MS:943XRU5FOVD$*L4
M0;<88>RAX\YO)1N6ZN0E2G%K]1S"@UP[T'ZKV/V7!374]QH=#JT41&8OVQ(D
M,)*IP:F5L,?"0XUJ:BB;:NLZ\"#99=A""4^`-:8DO.H\^%AQK703JE47A[@'
M6LV''#U0K2`(MS8.RIH.O5H_43E(L<"O@YUODB0SUD`V6?[QDQV6Y<Z9)7,>
M=7+\'L!'.Q?AH]?;HU!9K4_8VK48(-,'$TN]V%YHQ0%N6N24U1!8LLX['IVO
M"Q"[$Y;XP*B#"?E2LK?9>\C.&PLKK7K?JW3[4D=K8>:JM;G(L*9]0B64Y+K,
MG!]`AAMMD>3FS5B8==B"<L"8L%R+$'M2Y&&VL>IC*0[-0ZZZFI+]<G!@1:47
MJMM-7D58+'<;E;;([:SU(QK4@9,V"SGBQ>Q2<4!MH0QB>])1&@QV4-81Z+>4
MA&!WH7U-LA*Q&3&H1LLO:Y7MYPG[_MK4V2226V4>CDVG6CZ/8B4$WMLY*COL
M8;<8??CJ1E.8,'V8,G)Z4=;I8R*(DT2<["9(SR,Y.;Q?4OV)!FLT6HV$-;I2
M+,F3;*K:0>LP""H@@J0+).BV'9+#CF%*4&N2OA^=4)X4+7">MR)2OA861N`I
M'8>R90LV+902:$BK="<MV8]R%UAHS+P(CE$RV1693JHJ6EN+5D-ZI74?0]`N
MM0V+7:H5^>=%!&*]6#9J[7>R/#H5@=(.&G_9S]A)0Y!0D@J^T[*<;4^IE26\
MJ\C36$!KKW1;JPX-9%-:KBPH\45:0T)X=9+A!G0!]RW2*[#'6H,^-8&Y<9;F
MX0L4S'6E?FA*:]FCY:B*5'4'/4/374VC;46M&MG+'6O;A.I:C`$#RSJH0[7F
MEJY9`=,H<F:0P1.6$4J7;Y\V=)(2Y$^:[[*VX]EF%&;0';WO]6'JG_#K:_V@
M-E<"0.`X#@.!#_8?^KUO_P#H+W#]KFR\"U55_<Q7/]PA_P!CX_`SW`<!P'`<
M!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<
M!P*]&>K>FCQ:XF"(FWX>OEA'W&QP8&UMK"`+ET$+J[P>[AZV)NL$!5[H'E4L
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MF,N0VS(J[E&LTP.S#?2\VS`<PE/Y-*5X#8]?ZAUSJQB#&H598KS(W7^O-60D
MM3BLW+-"U3&-P]?U[SE)\UQQFN1K'-2AY>527O7SEYQW.$Y2'41I/5[7NSTJ
MG';R&NU_V.+6V0,-N0KMM&';X%\L#+B".',2K#$OI="T9SEEGVU664-J0WE`
M8XCU]TX5K-=IL^CP'JS4]66;2=<$IG&6&16KKB"`UFR5&.[')-2<PR8*L0(^
M7EK5*;3&3EMU"LJ4H)3'B80K+V(*9#+3J(;28BILUZ#$9@1&H,9@;`?D.0Q;
M"8[*?,B.AI+B_%:L97G*LADN`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@57
MWO\`5AZI_P`.MK_:`V5P)`X#@.`X$/\`8?\`J];_`/Z"]P_:YLO`M55?W,5S
M_<(?]CX_`SW`<!P'`<!P(>V_MEW5;%':'T:Q[#/["N;E*KU=K1&I")&9T:F7
M"]SI\XG=;%60L0?$!4F7X_ZPIYQ]3:$-J\RE)".OI[VO^"ELK[)?7C[K?`?3
MWM?\%+97V2^O'W6^`^GO:_X*6ROLE]>/NM\!]/>U_P`%+97V2^O'W6^`^GO:
M_P""ELK[)?7C[K?`?3WM?\%+97V2^O'W6^`^GO:_X*6ROLE]>/NM\!]/>U_P
M4ME?9+Z\?=;X#Z>]K_@I;*^R7UX^ZWP'T][7_!2V5]DOKQ]UO@/I[VO^"ELK
M[)?7C[K?`?3WM?\`!2V5]DOKQ]UO@/I[VO\`@I;*^R7UX^ZWP'T][7_!2V5]
MDOKQ]UO@/I[VO^"ELK[)?7C[K?`?3WM?\%+97V2^O'W6^`^GO:_X*6ROLE]>
M/NM\!]/>U_P4ME?9+Z\?=;X#Z>]K_@I;*^R7UX^ZWP'T][7_``4ME?9+Z\?=
M;X#Z>]K_`(*6ROLE]>/NM\!]/>U_P4ME?9+Z\?=;X#Z>]K_@I;*^R7UX^ZWP
M'T][7_!2V5]DOKQ]UO@/I[VO^"ELK[)?7C[K?`?3WM?\%+97V2^O'W6^`^GO
M:_X*6ROLE]>/NM\!]/>U_P`%+97V2^O'W6^`^GO:_P""ELK[)?7C[K?`?3WM
M?\%+97V2^O'W6^`^GO:_X*6ROLE]>/NM\!]/>U_P4ME?9+Z\?=;X#Z>]K_@I
M;*^R7UX^ZWP'T][7_!2V5]DOKQ]UO@/I[VO^"ELK[)?7C[K?`?3WM?\`!2V5
M]DOKQ]UO@:?([7[%;O#6O&.IFU)%E<ISM[RUG8_7EF"FO-'FJWEWVY>VLMYE
M9*O83Z7A_@?+X_W.!L'WP>Y_P0-D?9:ZX_=9X#[X/<_X(&R/LM=<?NL\!]\'
MN?\`!`V1]EKKC]UG@/O@]S_@@;(^RUUQ^ZSP'WP>Y_P0-D?9:ZX_=9X#[X/<
M_P""!LC[+77'[K/`??![G_!`V1]EKKC]UG@/O@]S_@@;(^RUUQ^ZSP'WP>Y_
MP0-D?9:ZX_=9X#[X/<_X(&R/LM=<?NL\!]\'N?\`!`V1]EKKC]UG@/O@]S_@
M@;(^RUUQ^ZSP'WP>Y_P0-D?9:ZX_=9X#[X/<_P""!LC[+77'[K/`??![G_!`
MV1]EKKC]UG@/O@]S_@@;(^RUUQ^ZSP'WP>Y_P0-D?9:ZX_=9X#[X/<_X(&R/
MLM=<?NL\!]\'N?\`!`V1]EKKC]UG@/O@]S_@@;(^RUUQ^ZSP'WP>Y_P0-D?9
M:ZX_=9X#[X/<_P""!LC[+77'[K/`??![G_!`V1]EKKC]UG@/O@]S_@@;(^RU
MUQ^ZSP'WP>Y_P0-D?9:ZX_=9X#[X/<_X(&R/LM=<?NL\!]\'N?\`!`V1]EKK
MC]UG@/O@]S_@@;(^RUUQ^ZSP(0VIL'L3;+KI6V`NG]VD,:VL]S+F1\[=77,9
M)F0K-K*VTJ+[L?\`I+FL.2&")]IQQ+GIXPRE64Y4K&$9#+?31V1_`;OO]HGK
M+_/W@/IH[(_@-WW^T3UE_G[P'TT=D?P&[[_:)ZR_S]X#Z:.R/X#=]_M$]9?Y
M^\"$^R^^]]A>MO8<L?Z5WX0"':)V_+-%L;ZZX%,BQ+6O+&HB2]VP+VN>0]AA
M^=WT6$J>=\GE0E2LXQD/6"M(].N5]OQPKR!!2/-C&<85Y8#"?'&,XQG&,^']
MWY>!F^`X#@.`X#@5?[#?NXZJ_P!.UF_\,W83@;QP'`<!P'`<!P'`<!P'`<!P
M'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<"!5?UKV/\`A;F_;I'\">N`
MX#@.`X#@.`X#@/#^[_<_$\>!JQ^Y`:U,@#B:B[I`G%G3H<$+6['9)2X0QZ#'
MG2W6:\*)KBQF)!..CSNX1A2W<83XY\?`,1])E:_^0OGV+ME?S4X#Z3*U_P#(
M7S[%VROYJ<!])E:_^0OGV+ME?S4X#Z3*U_\`(7S[%VROYJ<!])E:_P#D+Y]B
M[97\U.`^DRM?_(7S[%VROYJ<!])E:_\`D+Y]B[97\U.`^DRM?_(7S[%VROYJ
M<!])E:_^0OGV+ME?S4X&RU^Q";1`=)!G93D9@A.%243AA,--BD1KN&9T.6-,
M0X!&*\PYG'CA;2<*QG&4^.,XSP,WP'`<!P'`<!P'`<!P'`<"K7>7^I-W#_X6
MNP'VJ+9P+ZU[_N`'_N<9_P!28X&8X#@.`X#@.!5_L-^[CJK_`$[6;_PS=A.!
MO'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!
MP(%5_6O8_P"%N;]ND?P.IMG9&QAFP];Z>U(,I#MXO]<V!=73VQU6!VJA:SKO
MYN1IL9H96'(Q<N=-%;3%::PE]IJ)'0Z^OU/!#:@BPQO??!<N9K&OJCI=FR:R
MT56MS[5Q9+=8[#62I"RN6I,*D:VL=6CPFUCU,TJ<M9^:TZPPIUEO,92L.JP$
M(W?XB\JL2K%*9U]!BU@GH74.T-6'3DD@EF=L'9@%RW?1;=%Q'FFHLZ95HLQ\
M2[&]+VIX<^WG*E*0G@2S9]\]@*A;^R@LD,TB0`=?M/IVXWF!"V!&-V2)8P&P
M2M/"*>E'7!L.3`DTMM)1[R80\V^OV?#:L8S@([J'=[89JH7\NNFT>U3PLO1=
M1JQH*.V5KVK,;8WC88@"+0+R-V)#59XS-1B%81:22@(7&EP9"$,?FBT*X$G/
M]D=J4[8$?3NP:SKR??(>Y]!T@F?I:[1'J92A;U'725#-#1)N2\:"7`!.I,AA
MR+)?E1GFE-OISX+\B0E[LWO9/7?7L.X^XFSL\M;JS4AT&68KP2(T^:)L)F2Y
MCMBL5:P\B.';DK;3'=6I+^&U/8;C8=>0&WZ*V),VYI_76S"(V"%FWBMQ;`\+
M'SX9*%`Q.>?S'CM3H!$M'=RB*E'J8]=3C;GF0XEMQ*FD!JAC?1,26)BD==>S
M1E`TA+@(+@]>UF8%*)B/K821$2W[]$>E#)F$>HPXMII2VU8SE*<Y\,!3SMCV
MMV#K"OU+=U1U=OVCNZ^/M"['5=H5(*&UEM2LW&3!'R:H1D#+R7GC+M%F1VI(
M&?%A29#+J7FE-K9=<QP+FT&YO[#-:OO,BHVR@/VG3MP+NTV\06AMKKZI%KUW
M_J)F&R\\AI[P3YV\^*5+96A2D-J5E"0T'M9N.[:IBT6+3YX\!\YA^ZRY.T%1
ML0K%@.ZMTS:=B@`26"/C!1FT&Q#;;V5?FZH<=]#&4.*PX@*\N]P=S-V.1,^:
MT+*6$SQRM59$J]ZH1"Z:L=C/G4HCC_M_*,WQ[W1E'C[-[#G#>$^U?FG`Q$;M
MIN5T7&$N'P&$RS(7*MKHK@?`V(V0Z9RNQTNLX@*\:]E]J[QT0T.+3E_`EST<
MJS*\)'`RHGN#N:?8J],D5B$UB8G7HV9JQL0I)2<FV=0K%V#+6J-/<RH^RB#=
MQC8QE"<YC)A-N-K2J2K#B0Q5=[:[F+BZ\+EG`+:+*7TRJ7M%BN"$#ZTC8G5B
MT;VL%81!=PL`J0-ME?CPHKDE*WVQT[#;N5R/3>R&3J?<'<Q\[KJ7.K@^+@XS
MU\@E-:L!\H(GD[:Z[["V]:;4-G/J<-PV0MDK$>-#;;5F,U$8D-OX<>7A;88N
ME]M]S6,;31\\J$83>2?6-PCL6+7A3<*A8W5J2_[&M]63$>2Z$=E!2].APX+D
M]+DAE@GY7\NN^DO(9"D=P=SV<MJ240!C(6;)$ZJQB]#C!DHF6_&]:1M&QW&U
M!I4E;I<=&`2:9%<@-LJS'99:DID8=RM*F@FOJ+OK8>Y7BS5U<&SV7-0Z2VDU
M,%BV!;5;L.T4W=5@UXYB+G/M#==;K49;&9/FG(2ZOUUK\R/*%F-??B7_`/I6
MO'^G@<"0.`X#@.`X#@.`X#@.`X#@5:[R_P!2;N'_`,+78#[5%LX%]:]_W`#_
M`-SC/^I,<#,<!P'`<!P'`J_V&_=QU5_IVLW_`(9NPG`WC@.`X#@.`X#@.`X#
M@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X$"J_K7L?\+<W[=(_
M@;=LO3NN=OQ!$38%><++K\J9,`DQQNP5>P!72</(\JV+LE4*A#T.(8'J]"8P
MB1AB4UC"74*PE/@&BV?JEH"V0:T,(Z^9&C:G4&]>"H%2L%II$1_7C3N'TT$\
MS4389-FIV9'F<S`(>TL9<<<5G'BZYE09FV]<-(WD?:A-IUZ(*#+I$UU!/C\/
MDH41R+J54C.N4"V!\V*@`NJ)ENHCK@XCK4TO*',K1^1X&S&M2:\L4O9$XS74
M396W*8-U[L1W)`HSFQ4\1#.#QX=:8\UI`],>'99J/6BX9?5ZWBI><I1E(8$U
MU[TW8LV/WW1H)!%PHE7UM:&')Q=N,<J=(DYF4QF>Q'(,H6<J<G\D.+)\I6)X
M8PW(3C&,8#6?O3]%9K,NK.58Y(C$+F$V&1/2=@[!?OA&Z5F"\+KAZ=L1RSYN
M\B2!&R%QX:,S_1CM*SA",>.?$-M+:'U;8:,&UQ9*_.M%1`39Y$7#M%HM-C)-
M3R8T\(E2I%B-F9UAGO)'668VSE^4Y[/ZB,M>3+364!)XL6-"#8`</`B"Q0R(
MQ!'CX$=J+#AQ(S>&V6&&&4H;0A*4_P!S'BK/CG/CG.<\#O\``CJV:KI=YM^O
MKI;1[IR?JZ87,4L7.?2]6QEF+QXT+YW/!%M*8G6</`96R.DNJ5B"F2\II.'5
MX<2'.R0+4U<05IKP86?;B5BS5^?$(V1=>?:>,&*J4BS&'LA#3<MK"`+J'$YP
MVI*EISC*L>/@'2).70U&3#-:DI1F&E]F4F&7OD$G$3*CJRJ/)3&G4"0RF0PK
M.<H7A/G3XY\,X\<\#EZ]V]Z9.?1+2_?BHGN]1OY^P??"A_G]7V!13Z/_`&_,
M+U/R7I>IZ?C\OAP,=[N/^ZU`OH/UO[C7+]O4$^=@7W.J?ES#V9RA?T<^P9FY
M=QYO5]/U/'Y?'@9#+UUR4;.9U+2\G&HBA[1KY^P??#4!2_45!:*?,#VYN%ES
M/CEK#F&_'Y?#@=#W?8/=<@)]"&N/<DN6J?+"_.T-[HE3UN(>5.DC/HY]A?FJ
M=;2K+JV\N>*<9\?DQP.^IVZ*)1S2M24I1F'$5`AF,WR#DM$@+SG*X,0EG7_M
ML:$K*L^+2%I;SXY^3Y<\#HY@6'(Z:'SI'7/N<G*7.)"?G<']UD9SCC;KDV>.
M^CKV.9,6ZTA677$*<RI.,^/CC'`[N5W-1"$65J*D**C8JX(TIF]P,DQL%U.4
MN0A\_.O_`&N##6G.<9::6AO.,YQX?+G@?L!VZ"<2DB=24H4F?+=(3DB[Y!')
MG$'_``]>=,Q"U^QB5->\N/,ZYYG%>'RYX&9HHHT+@'G3\2"/(GKG9;+[`.)K
M,,0HI>0PJ)'417`&>T2,-,>9?E92E.5>&,Y\/'(;KP'`<!P'`<!P'`<!P'`<
M"K7>7^I-W#_X6NP'VJ+9P+ZU[_N`'_N<9_U)C@9C@.`X#@.`X%7^PW[N.JO]
M.UF_\,W83@;QP'`A+8>_]?:NV5J;5UP>(P#>Y_G4Q32B8\=0!)2K1QSWN8O-
M<E-/02!]XFU''>#2VGI6<-*6A2T>8-#1W!U3Y.MJWXEKBY[/Q(Y"EX>&PE)J
MP^<X-@"Y^P'6"+K(*&6L)F(*C.-*DI<(2$-^/AXJP&C7;O\`:7H3>X\&@>P7
M9NE-GU[59X5!$!G2%A+V+)WT3=3;>.LM3JT,169ZIC[ZHSK&(ROS//R>(2?4
M.S`&[[/L&L@5$N*UU>]6/7IFV2S.LH@9@W5HN)120P`>OJ=A31?@M"6WF0R\
M*ROQ\,(2M20LGP'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'
M`<"!5?UKV/\`A;F_;I'\">N`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X
M#@.`X#@.`X#@.`X#@5:[R_U)NX?_``M=@/M46S@7UKW_`'`#_P!SC/\`J3'`
MS'`<!P'`<!P*O]AOW<=5?Z=K-_X9NPG`WC@.!77=G6RG[X,"R%Q(D6H0O76Q
M:"R/'LLMOL2KT0IAD=<AA;+J98FR4@U2(LL<MI.?%_Y59QA/AD($>^'K2B56
MA`C^T=B$2]8T_K?4NN[&-ER*TFEHUJ1D6:!:9%=$&4!K@2)WE3!AV,22Y%9?
MB-);QCR^IP.I??AW4W85IM%P,;+LK!BVKVW**8B5\6F`HKM)494<HJ(HAY7Y
M%(]8G@?A>?R22SN%93Y,>8)>H_5]ZA;>M&T!5VK,R+;=D6C8I(44TK29EQC/
M6N*F-/`B-LN3<VT6*92VG#?IHQ^0RM&4^5Q7`MEP'`<!P'`<!P'`<!P'`<!P
M'`<!P'`<!P'`<!P'`<!P'`<!P'`<"!5?UKV/^%N;]ND?P)ZX#@.`X#@.`X#@
M.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.!5KO+_4F[A_\+78#[5%
MLX%]:]_W`#_W.,_ZDQP,QP'`<!P'`<"K_8;]W'57^G:S?^&;L)P-XX#@5L["
M[6VIJE>NGZ'3]=6H9>[_`%'5[B[E;+/7)XVU7@F_`"RVV`=7/1Y->C-Q\KE.
M9<3)2K.,-M+Q\O`AZ\]VH^O+%LJAV*K#%7^BWC0M,%BAKMQF@K+]+3%(59BF
M;*U55"@;54D6F1B$U-=8>(-Q494E"G?+@-BT]VALVU-O6K7S@"A!@]8V!M:E
M*0U,VG+N<J-K8R5"LFL/N:Y9U@CWN[`0\N/[_P`O--+4G"5.IPC(;H[N7:A_
M:%YJVL]852STG4ETIE#V*7/WUVKV^:9M(4%92TFC"7@K]=D#Z8`LL1Y[!&?%
M=).^HS&QA24Y6&EN=HKDDI-N*-<5Q?7T;V`9ZZR[7\[R*=GJL"[O$UD_>8]-
MS7_<&:?&O\Q,3V51%))<3&96$XQX-9"!V?B-E79@\!G4PE-LE=E,ZADB<6V<
MIB-JO-EAU!G;B'O<_JN27K',Q"Q`RG#'M*<I];Y.!(=%[QO']H6"HV.KTN)4
MJZ;[!0+$5JUJL1BX:\!Z&?-Y<N&RP<ZJP:\&K]SBA<I@J8)NO>U/M-X0O&59
M2&,A=\R\KK:3W;]$&9-XKNVJ-KL_J(19<%2B1.PW0!JKEA!*-"7B<;+4.RQI
M;,)3:4Y(I=B*6G*,JP&WJ[LB\U"T[C@5>+8="T;;N*+;;O6IY$J?@4,OK^HV
MFK[+A5QD=GV]I5EMK`LI`PO#T)"TO84K*'D)#;MH=C=@ZCZY5'=5IT]F3=K#
M9J"+)ZB#&Y,PR''WL_[,T.8G^[\>\KL)K[B%NPTM)862\\=+GDQAS(:0>[O0
M/HAV-L_7]8"7N0.W.'T_IH.S:/=4':DH_5JE<!Q687E1/)7<M@SDUZ2UY7<,
M8'^52L+4K"0Q-Z[]@*A8]:KBU.(5UKLGKC-WA`N:C;T:?#L,@%;3%2H3@M,%
MV,M5CE4^0/R_ZN'6YJDHPVK/`TZ%WVO)$5IUUS7>O*F;V3K*YWPY%M!S:IH=
M7BM.VD3UG(K`]6N-9W,S,4ZZ/S)5*E18K"/!3>%95Y/,%N=M;KGZO)ZN%_-X
M>8<V`%VR3GR,DID1D3(UCJ0MLI#4).8*GID8Q,%^R94ZEEQEE?J>7*\>3@5<
MIWQ$@UEI$NWS==2!Q"N=?R&U+Q2DFU)L=?V`Q=JI3PVOL9EP&HV`=I9N8\G!
M,.X3A0Z6V[Z6<>;&`NGK4SN(@Y81^X*)2JD1&+$OAB-`NTNW`#D(E$>=FQ78
MYD,`L0@K79C/L[RWHWLDW"TNQEYQA:$!O[1P"\?Q5$'@>;1F$@GFM8,#LV%`
MMQU+"2BP>)/O5(S+RL)]HRUZ/FSX>;QX%9]<;VV1L*4N\LZTJ\3KZ^<V<#B6
MQ%Y>5LH?%UA-L`F3;3-*EA8@B2&L9FKRV(T&!/D$HK:FGGD93ES#81R%[;[`
M0!H=YNVJJL"HF[==;&OVFW@MY)&K+'<I&O">TA`#9XY^MCQPV1;::+6^F0*D
M3&H,C&6',+SE+G`B^B_$4)W4GJ<*C5(J"3MNM]H6S9C.+7-?3KJVT8%LBP5V
MH1/^R$+,-6P9K=^5E]W#"V8DAM:4+\<>(??6OQ%7;T=T<%):Q@A,WBK;"/[A
M7%LDPD_JR?4!%\L0,.)C*%Q\V-VU5V@29S>7\Q5)8<1G&%>.,Y"31?;'8L()
M4K9L'5-3KU;V]I[9&W-/Y`7LD>+LXU_0?I,8J6SH\FN#(@PC8*<XB0F6*=FQ
MHSZ7&%84K"%J#8>MW;N'V'/AJ]&J.*L3QIB+L&\")I)YXY2;TFY_-8E19D)<
M1A+X[(]V.4@S\Y0J9!F,KPWC"O'`7,X#@.`X#@.`X#@.`X#@0*K^M>Q_PMS?
MMTC^!RW+V$J.E"-/!&*]=K?9;RQ:)X"M404+)F)`FE0X,^T$DMFC@"-*<'QR
M3'I08SL@E-6ORQX[N<9\`Q%G[4ZIJ479<HPNQL9U97-7V@_!>$QQY@@-VXVA
MVKL@@I<B.*2B<1"\8)1GVH[L)7BE6%*QG&`R<GLGK&+M39NG5R#:[CJ;7<G9
M5G](6E0:4''C(1DL'`E%2TH)VD*)*P9$N%E#?HM3V%97X+SY0BAKO7JE%9(V
M4M3-N5[$>B4G9@<(9K=:29MU(V!;0M'KANMY'7,B(\KEBL$1IYF?+@OM(=\_
MDRE*O`-KL?;&KU0)52!O6FVHA^\6L]4JA1,0*#(M1^76*^FS'9\1^+L)^J(@
MQ!><X;:<)HG2GT^DQ'<5G'B%CZX=AVBO`K*.CE(D"P"!YJ'%."IP(U%C$HK4
MMF,7"DV8Y$2380[A#\9]"7&7,92K'CC@9G@.`X#@.`X#@8>PE)8,$7,0*^9M
MDX;!>E0ZQ7<0<G3\I'@F.*%9*3!PU$N6ZK"<+D/LLMX\5+5A.,\"FI3M5?V>
MK-,[("]94WU"X^PEK?7+!L&4+A`O<Q4V$#U.L28``L8NMWO)X:P*%1XT5+2I
MTG"UY]+&/$)/?W7=1N^-;:L/:Z&!*MM.I&3M>.R;-,^=<`E7:M!L)B":$.`H
M]83EDE)>%MP(I2086Y$=F^SXAI4M`<MP=BQ6KMD:;U=#"XLMCV?>JM7SZL$F
MA\/7E3M,^:'&VHVXI#JG99HU#7&&0O!"I7L\EW*D-L*SD(4SW:DC5=DB=FHP
M8."T@&N1NK!WS%Q&;!V$-J]WQ0XI_P!SV"ABZZS4"QI2,*("B1?,7#S6'6L*
M<2G(6.T;M0MM_6LNVNCJM%LT`[;JO+$`BEG>#,':W+<B1HI--JJM7N-;DR<J
M95*ASAC<N*ASS82ZE3>5!7`EVSVK7-<;`O%EUCK9M-5W37=)`RU<OERL50-&
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M;9%WJ4DN5`-'#5518GPP9F7;-=OOMP3F(B7X2);B<-N>.%H2'2KN\;S:[IV+
MI`C4$J&<TV(I\RCBK+:1(.;LM^VQ[;F#.G2V\DQE-KDZ36<+B.OK=E9A.>L\
MRVI26L!$)'MMLB'U_([SA:JI9L=5-@6RIVB8.O5A53[$"K)N+7X-LU<8^9CL
M\P'M95]YE@@39@!X&(+\B5*Q%\KO`EX[V4!CNQ%`T&*$8,_.(1:"5TM[1./[
MOI9$53'+N`JD=B.F1@]938-G,MYIM:418;T=?F6J2VG@8OJUV(.=@A=MGV.J
MU^B$@#X!^/3XQ2X/7,>%LD4A-$SKH#N%)IK@A9&+$2J*[`42@2<I>2B1G+6<
M9"U?`<!P'`<"K7>7^I-W#_X6NP'VJ+9P+ZU[_N`'_N<9_P!28X&8X#@.`X#@
M.!5_L-^[CJK_`$[6;_PS=A.!O'`<"LW8N^:>JZM;#MNB-DSVVMC4NW4612*+
M>;/"<V,!*2$TT1*(5(9.CK+3YZU^B+>5A<U&/D0K&.!I5IE=9"@[>Y.S*N,2
M.5V3UO);DCO0[>,FP[](:UY)TG%;&^RHE#OD4%21CLH\C3GJ(EX2K#F,!UM5
M(TL/W#;!NM279UV=&VSLYJV#TIVW(Z\Q]G3)Q,EL!J<_('_1TVI!B<ZZWXO^
MDF6MKT\^?*/$,7M-GJ6]O)QN[MWYVZ*L.K5;`:JJ-HN:=5<42(JM-KWDBKI5
MKWYRI=Q%R,R5_-,-8C9D?F6&>!CI+?47&_W67YNQ_?GTXPI4\?A>S/O8U=G<
M-L/0O>2TL9U=]+BI:6E^BI[#.2WDRM'MWAP(ID_^G:'GE[M)EV9DO6=Q#.O!
M*5E%Z<*,[-1N.5O>`';@IB9?EC%;&B.OJ)H0J%F"UF*IST4^'`G<2=ZOVV)=
M^J$5=_AAMD;0V]73S9$-?0%;M^QT64E>=L4P!LV4-9!S9&)K4QQV!'E^"AZ7
M6V_%O&<<#2(IGH8C75M['5QZ)5-7!]I:P&6R;3!)FI5>!L;3=Z;^89I^EAAL
M1MM,<Y96ER"2(_HDA3C3CJUL(2K`;=BN]0JU4MN:5ALD@E&VIOF!4]C1A:K"
MQ6HNVMKA*O>`L,?9([:H%6KMHB*&^QOL.(&8ER$QDK2X[A&0WW8^W^NUDTV-
MW->[`3:U!3-MU(L*N*!]@'0UW6C;"8"5L_$Q'B>V%Z:U<V?#,Q*%#Y49M;OG
M4QCSY"(R5#Z-ZVKFT;H9!15T'0FV[3?[W7R8\K:J(/V=MNHU%<R8(I,B&0%V
MQ$ZNV0?[HCPV9$>&]-<]F2E>5>4,/8-5=$X9;2NMC:":OI4K[=RTT.P5L[U9
M=JU)N9/?L-F"18;4+KP>$:L4ER/"?6TEP>[F"A.6L81@-8"GNF]A$ZDM^KK#
MV:;>/U[<5=UZ_H]&Z(UP*U<9LE-PV@T8&546Z;4)A7RSM/M.2VTHPAQO#6<H
M3C@6XV-`TZ;SHN7L7%L;GFY-DHNL4$46."<>*;'U-8AED@VR+EA$V&7E4&!/
M]5PBEMR-.3G.?!_.,9"OU%B]#;=%%W:MK@%`^TNL]IUF0(FEGXP4QH[K\X!$
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M.?5<<3E02'*U%U2U!J@[N4L3N<G4D#4)X(!D&KE>K>*U_J;9T*)#*`=1U><]
M*GUG%EB$(T5EB*PN>E'I1F_(A/I<":-5:ATH)-P-Z:Q&>!.]:?UW2F;+')37
MHUDUU7!H^31Y4V$\K#+YID0U&:7-6G$IQEI#;F?R'A@)\X#@.`X#@.`X#@.`
MX#@0*K^M>Q_PMS?MTC^!@NR'7V;OX6&%-VVNAQT")8(!&OW?6%?VI52/OZ-&
MCQK)!&E9X0I7+W551U+%DX<Y&$8><0\TZG*?*$46+H70+.*O,0Y8,6(]9J!H
MJAUR^6ZI![->:4C2<*/!</C[#-D(GOE[RW&PJ<II<3TU9_%=X'U>Z/C7+).V
M"C;-UQLD_==QV>V&Y&),NJF0VYZV8J!VKPJ$Z;P)!^[:ZX'89GLNJD.^X8^7
M,9PKRH#67OAZT\91K%0J';1M-#7C7&H:G?(F-=""XRS773MA`&Q6QUCEF8*H
MCEJBAW8AL1ZSD*=[1A_*DOH6MT-T/]23A[7D&AJM^F8$&%:3AZ16('5ZEQ]1
M'HIX-%%JP>UCFSO>-K"2X^98\W")PY#2U>DXVZWP+/:KH;6K=:4/6S!XS:&:
M+5A-8;L=A=P\:-)%QTL8GD%X4M*77?#P0WA2L--82WA6<)\<AOO`<!P'`<!P
M'`QQ<X'K`HC8[`6&@00*&^5+FS$Q@>*%#X2,O29Q";*6W'C18Z$^*E+SC'_U
M>!YX7.+TV(=>M`'I5@W)"U!7B=ONNG".NYVTXEGA/#/G(4M5Y+?-6"[8H8VH
MPE$I>)\]+21\9Q2V\X4K&.!+$&-UQE=C:HE)K8A7:#@INP4ELT1V//U23/Q]
M7183MGKTLBWBCD-GYU*20Y+=C/\`M"H<E;RT8DK<5P.%\U/UEKB^NXG>K8NY
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MS*K62DUC18(>X,C$\35H@QVD,X2IE.<(2$SFK#HPGV`#UI^S8QNZL:7OZXHX
M"2FH35=6GYM/DV&<34.PX.#DI+D,;(%J=SB7Z"%.L)RWGS9"*.K=6Z\2:@9I
M^B;7NUL!5K+1[/+K]TM6T!!87[0J7;ZK.%#[DT/(XHFQVI#TR4EE'LA]OS>T
M84K&<<#-V`SUANDSMVAZVE)4B)1ZE4NRI.GEK'C(>OB15LBB`0(A7F9#S5BC
MP'B46<R)]69AYS##N,._D<!!I5CIM&T37!INT=A6]95RPWVCS8<XKN_-HJ`Z
M*%#A-DZ^VE":AY*UG5PVNYAMRX9)MF%%CR$JBJ3EU6<A8BSZ_P"J$?L#I]LQ
M5*7"WT8@7&P:[P*#MQS!D2#J+``P;L,T?&QZ\`)7&D,#)$]Y.67F_"*KU&U>
M4.OU93HDA&NMETM(VB>P056@I6Y;38V1)E%@%<8+0Z:#IMEV'$CJL%(KD=R5
MB(J`Y)93E_*W75K=2K(6RX#@.`X#@5:[R_U)NX?_``M=@/M46S@7UKW_`'`#
M_P!SC/\`J3'`S'`<!P'`<!P*O]AOW<=5?Z=K-_X9NPG`WC@.!$&XM:3-G0];
M181J$%51-TZUVM*5-8>DX)0:&2E3Y0:,EAQO+$TBF1A+3R_%MO./%6,\"M^S
M>DP?9%RV_L&63KR;A?-CZ,NE+/2XIU<FEB=5?,G!\)*8B$V(!*3:45A_$=[+
M.4L>U)\WCY>!F-;=8K)KW>MTVCE6G#,"X[6V)L+WR\/V,QM$0)OF92\5V&XS
M:$4)YT>EU+67G1R_.SE><>"_*K`;K*TQMH%L^\675^V:W3:;N"[4V_[`&EJ0
MNQ7J(5J`4#7#T*@%I!=NNM"KI7:U$CR_>(Z4X-SEUV/G*EIP@-'?ZO7YTC/H
M3>PJ<WH$IV!;[(R@>:T95MMLDB^1-G2*-&.^^?FWFJOW^&E[!-<3)!N%G,;R
MYSX.X""S_P`.<V;N9FW8VD!88+V"S6]P+D"35"S<2N]INQ@=A=RF9C"R`;6Y
MF?7E9Q\JWWDNI\&D^7@3HUT[A0A^Z[$)-C\[HOMUWG:==WTG,N)$#JO&YG9L
M)$P=2%'<U^+:P]?)OQG"4.*Q)DK5^>83E7B&E0.AJZW6[=K@!LA9_65QG];S
M,VO[$$0"<YHKHFRA4%8:/FT,`!I(*XZXKL(/Z3D94E,B,EQ]U].5<#.U7I6J
MKZ.[2:-Q>(MB#;R(G%:^G62!,GR]?5]%(!5&@B#CF7\R#DG7GS?B>RRV%-N^
MA$85C*74^;@37LK0D"_:2INE(:ZZ-!U@SI9R7!DB%/UT@`U;9JP8+UQ(B.I&
M&H]C&@W8J$*\4MYD8RO"L>/B%:Z_T.-A`4S7J-SE$:VD]BX&Z$+BP6G[_%J5
M(HHRM:EU[[VL$0[7ICE**AH3KLJ9#DMR80^.CTO5\R\!K%R^'U<[-K^B46'N
M<?`EZGIMXH6M;9)!D';`+`'-IUJV51PGF*_&CO$`.OALZORU1T-M/YDMN-I0
MVE3?`R9#H85B1]=0PI;4A\/KX]V#EPJSL$/?6P#H;<EN`V"OQV':58P)9HI3
MQH/$1U67\QY"G5*2C'@GP"V5QU"9N3'7=;I>N!I>F+P*N1F*,A%G0Y=,'6MN
MHK@:LXG3'R4**W)LJ'F%S77W,1V,I<4IQ7FX%2*1\.4?5W!T"5L''S7-=9KI
MI'8U>!C9,1@G?;J%KE:*;<IR93[K(J66`UB"DA&?2OVN1"9=SGS+=SD+6TBH
M=D08TK\ZMM:PM!&$#I]2IPH7KPP$J$%%<GMXLEKM&,V4C99ESLH-66,1(LQ@
M5`>;;4EI>,K\0EPE5,D+B!MR+9=Q[0&"1@?,\<=9C4<_B?A]*9]G`Y'NN%"@
M_#WC&=3(9PTI"<^57A\H05`TSMBI[-MQ;7NUZW6M:[,VH+W)>`,ZDN&=BI)Q
MQ@$/:ZS53\DQFNL5.Z-5N-Z\B4->G#<+>3&7XJ;4V$>C>ON_PNN-P:B!['U*
M,J6RS.Z2HBRQZW>LWVM9W);BQZ9A;N#>0$EX*,/2H[:VV4*4]AM?CCPSP-?:
MZ4&*I3=JZ^J&P*Y:*!>"&J+-$K&\*<,M8Q);7@QBM6`2?S5X54CCJ[9*H##-
MQ2`EN(:%S1N)&'G5+5E08PSTUV%.U!1J!.NNK[=,K%LV">CCM@!]ADJY4XMY
M<:54Q6JK]&N#>YZPO6K3>6H"E%W/>C#[C;^$I0QZ831>NNMKO>JM%ZD.;?.+
MA:Y.44YLF\JBQ%WK8D[7(AUZO2(;AB,="0Y3]Z9ADY62$><EQJ)A"DK<5E?`
MD3K]JHOI'5XK5A&T9MXVI%[+&IA9^-F,48H<\Y,+54(=\J&HLDP`@S\Q''HS
M;49UMIO+;:,?D<!-/`<!P'`<!P'`<!P'`<"!5?UKV/\`A;F_;I'\">N`X#@.
M`X#@.`X#@.`X#@.!\W8\66C,>=$C3XCJF_7AS([,J-(0AQ#N&WH\A#C+J?.C
M&<84G./'&,_BXX%%+'U>V\]UNUGU]I^RM?1A0`J75M3-E!V]P#M&N3+*:L$"
MBO8K9L2='5P@0*H07:1*0Z098]F\^&774J"49NE]CF-\:XVD7M]$B5K604E%
M#"ZS4BPJWK@'Z;BNG]=R)KIEX#(UE(MJ4G(ZE1T$6GHT>+Y_(WEQ01Y<NL%\
MW#9=(;EMNR"%$VC12&M"MIJU>@U\M11\:GV`G8S<.E>^!1\T$.6&7,83(>]X
M/Q'O9VTO)>PRPI(:Q.Z/DSCN_(4RUTRK`]OT:Z5"'$UW6K$)4;,6O8:=C#+[
MM(:1LDX>8M-8E-)'MK'98S)BR)2\N-9=0RT$U:*U;L?2HVKU/,JEF:P=OVSK
MK=X0!@W!K6OPYZ%'F5"F:GC&C4DDP!C6!G.7426WDYQ)D+1B/C",+#1[1U7L
M1_1+.MY=KJANUS-T$=W;!G648;^96SB1&XFK'(KEI2+G1K2.#-CIH^*R_&D8
M>9]TQT8QECQ1P--.](#1Z!UZ!$[X$EQ=64[7U/OMFQ!N`:WW"%K6]B-AB!XV
M(&L\:IE0+<P5[-%C'84YP6A:IC3BW\Y3P-LW?UZVKV`CX(SK'2:.=4/W]IN<
MV^'+%H4[1^W2@.)!,CVH9MQ479<4-5H[S:'7507G'U8<;9\/32$WD=2/)W)1
M]JU^<%@)IVI-AZZ2*F#GE339>TR]?/`3A*?"4RJ5$#1J,W'DI5YI"VG$);4G
M"<8X$=:)T]O/5PJY2;I>=4WC85\V,"MUPV!%K5WBDK,.9>5#LH\JU.L3S4.<
M(KK;(ZL1H2(XP0TSX/,.Y6XI8;4_J"Z`[AV%O.LK35:M:-M4;7H"AKFUY^7`
MH]FID*Y1GK2:&PEL-&VYL^U9F-M-I1EQ]E7K97YU<"!I75+<,SKA&T3F]Z?]
MH-&[&1O5D=J5\)O6@K8'HA<3MAHQ/MKE@<W,"N;3QC#SSJA<Y_++/I,,L(3P
M-[,=39\[L-4=_0]P6UR4+R4:M(0X,JY)!&"[K3.OQ8D!.;`,E!@=UUZ1.GQ'
M):VE/2Y#D;+#SJW<AF>L?78SH5R\.$2U):A6>+218RFZP"6"N4,5BE#2(V1;
M\!;":./P[C=L3D*))CN8C(1$81A3RDY<R%K>`X#@.`X%6N\O]2;N'_PM=@/M
M46S@7UKW_<`/_<XS_J3'`S'`<!P'`<!P*O\`8;]W'57^G:S?^&;L)P-XX#@4
M[[<:3!;61I.>_K6%>BP??&J8)^6H3[QF0-4O'9LJ\Q"+B<I4W4'6_(N>A7YD
MK'AE7`K7MG2V[G;!V230(I`7KB9N3J"\`H(^A.D)%RK=(8U1%+$Z9:4'H:@(
M&D,AG4S6F8,E&40W4J4GQSX!FM):X(@>U.S;/;-?V"-/+=AMSG*Q8YO6\F2:
M<K9U4W%=.1>Q"K`B&%`R8JU^C&P.6C"5>AA6/6PK`;1<=?R<]A[\>OO7_96X
M+&?V-I\OH/9-4*.AJ_K>A`1=<C'QK]Z9-Q/HUQ6;+%*DBL-4?.;*Q+0SC#^'
M,I;#09&LKCG:,_/T3;%=[)O=P(-[$=C4#9J:)%Z\HNL`CB)F^X*8%1*E&U*T
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M,5];4PB^PE&5-JS@-7V-4^VDH+UMV&-UI>2.Z>N&I]ET<K&ALS9`^V6*)>:O
MJEB=%FH2PR<BV[71-^PPW\MX]=J&Z[A*<H5C`:I"ZVWNF5K05,L>OKF:K>O3
M/;L01FD-&%NP4?*35_J*Z(9G4IL^#<6W:QHZ3+'$52,X;9\WE3G#GR!Z.WJK
M'2A;I1*JU8.H`T^TGYEB88K<JLHJH21UYO->%Y/UI3[RZI'4;FQHC<%U;GLD
MAQ#'F4I.%9"@FF=&]NJJ'HE'8A6J$S'Z=;\?UI<SCT@>2UIM3;`^E^OJ2US'
M<_\`9$\#<0,B:#DN_DF89'*,9Q[+G.`N;UVA5'7B3A2G]6MT:CA_-35=8M2R
M<&7B1;[RX4=$E)$2@I/E$G'ZODCF6:NN%8Q-AKS^:/I8\>!;Z7(O;=U%PX0>
MH/ZZ6(F.'#TBP&&;I%L"%R,0(8BN-`7P<\*^A+679+Q%AYO*E>5E?EQY@HT"
MH$@?V,/F+WH+9%ZV:2[(1[A0-[B23HBF5'1_N<;'"17[LV;0@<%IT-F5"(4Y
M47_MF4[ES+;N'?52&'U5==J47J0?UG7=0;K9WK6ZULF#6D'-='Q]<D66W[*/
M0JQ/@VR7A0Z=&$QK7'+/*3G.&X,1Y?XC6<<"(86E=K5+KG:>NE]H&Q'0&N]T
M:ZNE.+4-MO?8F=13\9XZ98.@S<6IO[IJ]<OT2:L[7F41YK<<I&6UZB8^,J#7
MKUJB^'M":*B']+WZ#+IL;?D`#4A>L;+M"CR&S1K":/BWZCF7]O9NIC%P$MXD
M@",0RYFE^9R+A3*%-)0%C.T5*O=UU-U&03UT7DS:_=*P8VC4X=)+]@V*DTG3
MEG%SHM@J[1L:3OT$;9IC$3+ST[U%R,HD+<<6G.5!/'3.MVRG]>ZK6KD"-UXF
M+/[`0/@V*.^,*O5F7>3Y"L$7*Q*G$Y%&AS@\MI44`N3(R(BX;8]17EX%H^`X
M#@.`X#@.`X#@.`X$"J_K7L?\+<W[=(_@3UP'`<!P'`<!P'`<!P'`<!P,0?")
ML@0K7UF3M>;-0W1KIRKD?=%C%LR?*AZ4$+>C(4,(I:\V&Y"496UE7F1X+PE6
M`\G+MKBPPND6@-7'-(;5N%VQ)NU=RZ,K]MMQ+2T$H:MK$_9YVJC2T*3:+F,K
MA!M591-<RM!:0B7ZK6&G%J"?%4^?CM]J"W576.TXV0=3)AMBWVTC94419JD0
MU-"BURQ3[O@]-C3"P(T/8$R*<Y%BJP9?DE<HRI&'W`U[=4C>>XKUU4V9K"E&
M#6C1.Q-57F..39LU*QO%2!DS'LQG9E56()/LUJKUIIM$-?M"X[#TIYYQ#BEL
M9;"'5ZCW1'G=T$4"DW)RT['H&U9CU\L])71;6NYE-IXG@]?Z_LT.Y$A&PZS8
M==8><B2(RHZH7I16E/,//K8;"U?5B1\T-?@-5W.BF*O#V!L?<XW7\.119]+:
M*T`=$^<"CMQHTHK.^C)1Z#(EM,CVL-1G,MH4AEA3_@H*S'.NTP;UT-D*]J(U
M42.TNR]?M]NHH"HD;3G7^H*19;!7J9&F:=;FLN;$%1ZU`CSR(C#B%SI9ER8O
M*L1T)P&`.Z:WD_&Z9K%U&]1;V#U=I>N2DGQQRT1]3E*;MH'8;B:1L2#88T*G
M6BP4-,B.<9,1'FY0E"!\=QYY.6>!*_<J#9=VQP9+7U#V-;PP`=V4UJ"@!@TY
M$RK=C84ZK`=7;!D,1)K>1P(1/$E/8;"M7LT%*U+7EK+OAP)\*ZZL<#MC2]ES
M'=@6('(ZW[4KMME,$"$^K5TXS/U9@>#IXR'[+'#&[5@>4FHRWYILZ3A6<.X2
MTTAL(MZ8QE4<)LZQ/:5W)JJ/=MC408(U(4I5C5%IX-$)RJ!;&Z5.%)<RW&R;
M#.2UYL&,I;9?=;PKUO2R\X&<<UR0IUU[S&;!5=P[2IU\UYK$@/&PS1J39]A3
MTB=B)L.O]<E1KXQX-&&9(0AK4>#F.@?&<2I>5*RXM85;,ZO+DNG\2O)T;N9O
M8IJ_[*MU/K(G71T<%TO=S*A!D71JK6IMGB%ZQ1B$=K`4/<U,.I$3<S2*40\N
MI2H+(V^N]ER'<G2]_F4ER1K&MC+N`!9`7UF:&K44UJE*C]@N8=X2PA^V3;P_
M[)`>D2O0E183++2F5NONJ#AT*U[9M<0=FA2=+L8<'(^84QFZ7VB/ZYV%<;LL
M:;<OT"P!562R0CT*L$7V<1C<5Q,::N8\AMR0VTEW@>@_`<!P'`<"K7>7^I-W
M#_X6NP'VJ+9P+ZU[_N`'_N<9_P!28X&8X#@.`X#@.!5_L-^[CJK_`$[6;_PS
M=A.!O'`<"I_:.P[:J7T2$-:[.CT>+<MOZZU(;'2=?U>X)6W?C,J([9HTPZI,
MB.0$1F,):BI_U=[.?%?R\"`ME]GMV4`]O6HCPQ*SL:YVCU=I(O9S%?HL6L5Z
M#L>/K=N[-VX3(L$,Y**VF18)BX68,"6S`S);3A:$M^.`W[3FT=XWW>FR1IDI
M9,ZUIN\]N:^@L#J7IYFF9!TMU^,$'$;)(MS.W%&TNK;PZZP'<9<>PG&7/24X
MM(=PWM^_S=O;6BXW3K/3M.TOLK4="12+S5H!)S94/8`BL%Y1D@?<*Q;0*?LL
MJR+%US`IK+*9L)2I'K8RXE`:<_V"VV@L3V/B\U%JL"^X$3K)CKBY517SEF`'
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ME^.%9QC`0(1[RVT]IO<UPJTT=4+A.W_2]%:@'VNI22+^N#A.ATPYL.-=@`Z)
M+)VAW6A1-B7+REEQ3B8J,)QEOR\#&WGOO;Z\+ZO;6A*$M:PM>H[G;-]5]8-#
MY>#:P)L/K144=.<PDB"2#VF8:8=8\N,N,N8PO&.!@Z?V7[96<#HL&1,/+OUJ
M?[.Q]@IUSKS4\HHN9IZY50`$CCQNSK/5*L/@C&C3[4Q2)?M3[F$*PA7@KRA>
MV^[%NU/.]4@+!!EQ6SK4?KU_=)APR2!)L-I"Y75'IM"Y,P4$(?.<$RX]B`\[
M'\J5M-K6UG"LA0[5G?/=9.O!&KM7!4Z_`>KN\M^G`@\%[(+V:)$BJE8-+6ZO
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M`&K2[+7[9"1<(*]4U+:,BKUN;?957D.PQ\0HXQ&F214M:/.OR8R'Y9>S6\R>
MJM5'*'=8$PYB'O1S;#PO75#8VHQ,U(:;"-RG-/7>]P0TZMU>9E3-P57"<N1A
M[TUCLI9=QY0LIL?<UEFU'J[B@72NU1/9&P`!;^WI5;3-#5X7-UF7V`W)K]:M
M<J-$8-764+1"%,%5N8C^LK"T/.I2G(33IBPD++KX=/+;"I>U2<,M9@$Z^4$=
MD373LFNV$D&7G(Q,N=$A&X&(>(Y)$5U</$YIW+'@WE*<!*?`<!P'`<!P'`<!
MP'`<"!5?UKV/^%N;]ND?P)ZX#@.`X#@.`X#@.`X#@.`X&(L"K&@&653X80A:
MO8G<5Z%9)TT97Y!9?@B(DU/&Q)Q",-0M7G=RPRXZI*?*G&,YQG`>=Y7L%N=S
MJ!IS:D78U.!;>NLBQAXXIJ@P#4K;&P6S%K#4VCT\*2+P!%9!R)XEN0;(2%K5
M`"1WGO69<QEW(3%.VML@)V3U-3"MVHI*A;$'&ZS8JJ#$B)OS0V0'UE&N\8!B
MR1#A"VNV`^N//),*G0887YO(:3A2I;B%.!K?8;MBG5^X]":GK!&O08=KO6OO
MI(/%H,J=#^85S+$:\*!4AR'&>'2S,R5!7)ER&W%8'1&FDI3ER2GR!$Q7M;NB
MF??.&+2_!??K%#V=?]$TR/6J*5K3M2IVU6=:Q[&2O%/O!4R1(AWI3#D\66C"
MU*RXO"7,>BYY0MEURO\`9=CZ]-L6T_E[959ONQ-9DYA2LU,$7'G:Z^PMJ.H5
M5[#8*C8GAD`A$?>D"Y6(<M/EPMME25XX%69FZ^Q(O4AVW0=F";R_;NR8'2>F
MB4#5].`6RQ@`I<U6KV8KX668117SEAL0&?D/[YEL0&1HY3KCGK2&V\!A#';?
M>4('UGNL90,M7;]KO39VT)J=+]ZB;G=+YMH1KFZABDPB1C6#6`L"()8D!Y#<
M=;9$QA<=*W6T8;R$U]P]\7W4+P:%K$]5PB!VM-[[;,3B84?8HEF?TPW476=:
M,H<F1FA+EGDV=[,V0QG)!GTD^GY597G(2*_L?:V.S]/U](:IX?6-OT3?;V!A
M>6;-L\FTUN9K9A1"V3)#,)H,+%2[?(BM0H:UJ?::4^^ZE2FVV@P_579]\V'!
MV,2NM^J6Q::+MH:OZ]V2#KHVC1+A,0,S&O/N(`R5GNR*1!N;:X-=GR58F%6F
M75>+Z4H>6'3%[1V^]>NWE7MMEU;0(FKJ;0;+K@Y,A3R]6I`:TB[[,<M.PIDE
MP%./R4PZVQ.FQ6UL1(JL>SLK6G"W70@XUO\`WW"ZNN[>@;%J#1X4>V%:ZOD[
M2*G`M.U](U9\=)#VT]2GK-#;I\>!7GWS!V**CR#GNG,3T([$I[*%!(EA[?MH
M[;ZRTD#G!(M&EB[(U=91,>18-VFV2M;8OU2@5)^?%88'UH=%=CID3EKQZ\V5
MEA7D1&>5D,]T_P!O;2V.F]!=TEVGK^%&:^N"*Z.K=&A5\%4=BCS9*MO@;=0K
M?;AMRA$FAJT>I*5#FLYC>?+.4/I5P+J<!P'`<!P*M=Y?ZDW</_A:[`?:HMG`
MOK7O^X`?^YQG_4F.!F.`X#@.`X#@5?[#?NXZJ_T[6;_PS=A.!O'`<"LW8O9T
MO72];(?T6WM\98]C4P#7)KMOJ(%->VF6*2(E'<:@V6')>9DM/(6\@HUE*87C
M^+XYX$0WKLUH6KE]M5._:\J,;80V_=>Q=DH)(W29-CV79KM'HCU>L0^,\UA^
MSHU*Z7CHS+RT[E.!?GCJ0G"/*'2UYL/1=P[.VL*"Z_Z?#;(K.UMB5@GLB3=-
M3P]KSK%5&IZ#UR@T1$1&QY\<TG*\>U)5E:F7''%JRA"^!(EENE6LF\Y.0?5Q
M6WS.FK'4:5:]RPX.OWK-KH[;($`[&AU,>=2FW6*)4@U@C3RKT)YC`]F2K+&'
MG$.)P&GN[6U-C<#NUU=:ASH8;N&/U^D=K,1:%D]%V(HS'U_B0R%RU\^G:A$M
M<M`%9S#F'D.YSA+68V,KX$-L=M^MBGQODZSPV[-*[&)Z\X%8&TGWC#A1K]&M
M,;:*YB1_[C$[*G))(CXQB1@TK+V,^O\`DN!*52[-::MML+Z2/Z<`UVC';GOM
MB7(?/:_L88@;TL=,6/8-KO>N!V$'JR.-D`+Y1@E/CN-29?IY<7AQU"E!CB7;
MO2AG1Y'M5:-&&GIXW9>N*#9ZX8"A"&S!>&3@ZQ:SM;ZEQ5O$88D);(]F#L(_
MUAI$Q6&,I>RK.0W*=O[142I;+,OZS!O:-F[P50-S7F'&KLRESV;K2:E9HVZ;
MB(CPLY/TZR+LHX?/DN^I)8RMM][S,XSY`S^QNQ-4"=7QG8/8&F+%-J#YZBDP
MVN",842MF!9*]"X&O[@D.]'7'AF&F51#D0?X9FQ?S)O"DR,?D0UN=V`T:%K6
MW-VT[4T"W%M<;2K<2I3:8/KN;3N/9.XZ#09(8]22#<1+T:QV^NW6,-?D2%*E
M+CQ7<.*RWCRX#7KAO+J^/,Z)&F--5@S4.S%$N6QTW.2!JJP==A371%\-1;</
MF0EOS)ULN<"&J2IO/E49C-./>9Q*<X"&2'9_K?L2CZ@L5DZIZ\<:V03WL:#A
M]PVC45)&50K4;.#8O$Z98KA`2$^<%^*&69BVF?+(D+:6IW*U(\<!>,U;Z'6%
M=8`TO6P9>;P3G"-=L"7:\2$ZMD#]/66TON@2,6.J$^/=JHN0(9?&>FAYB3C*
M?S!64Y"MVJ>X/6>R5VA7T-J^/28];TSO$E+S[F`)L&GJ9J---,6'7T>)!B,R
MG1%V%6@>2&-P\M09C.6U93G*OR(3=I()63XZPA"O3X3HH$;S3]D1VE#-;%JQ
M=);LW)BORR;U,91'A;"J,^"Q+=@26W%0%N-.,/K^7.`MAEQS.%8RM64J5YE)
MRO/@I7Y;*?'Y5?\`+P*@#;G5[COR6=K'5_YX/4J_KTL=[)PH5`79*Q:H(YA1
MG$0;+2B^2Z34\D6X!`LR\GV9QQ:6F7&4+5P.KJH+U?LVH)>_XVB=:4`"3&7$
M_:%RJA5<S6QNO;@5G$9IB;`'M,3DI-TI!5OS8SY9#;2\_FB,*X$9V3L;I*]]
M=S6^;OU^C$'KE>:KJC8E$V9%J8^8*,CR*ETR9MZWFX;X>OU0&)-,$XI.6E:8
M#)-M+?@MW@:YL[<77T3J+K_$LO5&B&*Y;F[K.HE$LQ?3`77M-=I[B&R4&K7P
M@])UR5.7G$CU046'(9]_LY4MQ3>4K3@+,;QO%>'T[4U/FZ,B;;C[OL0JE@-6
M6%ZG`Q,"2Q2B]ZBLG&['&)UN%@*.KCC*$-84EJ0E.&E^7&%9#?M$W2I7G6@D
MA3*AG7@H`3L=$G:\5!#CLT2QT4[.K=CJB8U>4L"ID85@N>D]#5F/(:6EU/\`
MAYQ@)?X#@.`X#@.`X#@.`X#@0*K^M>Q_PMS?MTC^!/7`<!P'`<!P'`<!P'`<
M!P'`PUB/1:L"+V2;%,SH@2"Z0>A5T/.L!^;AGP\D0*#&-/$"I.2ZI*&6&DY4
MM:L?+C'CG`4'N6PM+V/JOKK<I7J&)O6M((B\VO-&/PM:1A>GJ\%DF_G1.F/6
M+&`<8W8)8G,>)`'M+=)$I"8^7$^.7<A*H^X:TA=E*+6F^OL0#<+WK"3*I>WE
MCJ0Q9%U*O50.1FB)8..IZY@*L&@D60N)<K#;7O%I4!+66DI7D,Q<;CI_1#O6
M[0Z:>_8%6"^5.MZWK\2+%(M:_<C294,1L@M)EMY9#,CC$K,:&\WAN1(ER%MQ
ML82V[Y`A.N=B>N\.;VZLL#2E0"!-;Q;>C;%J$S]633^VG`-FF5&9!+TF%):M
M#`RPG%2$-2C+;8Z0M2EN+\R\JR$UZ(8UC?=>Z_V+1=65NDIUL3V6Q0JE3+#2
M"M=@FB#4NNV&0&L-+<<`R4V5I*F_5>]G>:<=4J4SA;:%8"$;#OFA1]*[$';`
MZIC0^OM=;3JVII%,-6?5Y'5[ER.S<EBTV5:(C;U2JP:BFR#22I-:%X8+2_01
MG+^'<)#F7[%=?H9KKD:):`B1G7-<ZRNE7-G!%%"'-&U+:US@:XI`^N")V4DR
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M;6P%?%";-B!DR`@S0<J./E$W$0I*'EO,8]#.%NA`)/9&@PFA&[8]TVJSM)U_
MNNVURTTL>UJ5^M4O8-<)BJV2L-/(J2R&OAVSE)4<</:%,>N2F1W(SZFLL?*%
ML+9N/7,+L%JG39&O/';Z0!7FRP;,H?$=@:I'L5.61FQR)"0A;PPQ=:^/DHQ#
MC*PZJ"PIQ['HJ;\X1YTVV?JG:=3N)W3^H*KJ2LYL,24^Q6C6N9LFS32<60^T
M8/@Z(\N?5Y^8#+2FXI9ME_T7\8:3Y4K\`N+P'`<!P'`JUWE_J3=P_P#A:[`?
M:HMG`OK7O^X`?^YQG_4F.!F.`X#@.`X#@5?[#?NXZJ_T[6;_`,,W83@;QP'`
MK9V%LVA(2]=A]T;:K^M)5?V!4-NU6,5.#@\DV2H)1]T?'4DA&DXDB)$U]3;Z
M6O(^KP\$+3GY>!HMKUWUQN4?=-A)[0@-1M@;!Z\W"ZF&"U>\*E8*\S0Y6IQ`
MZ9*&//"XFP8PX8O#3^7'9B)_YBI'J(\`Z&O8&EZOOBV!J=VC<F6ZQ[9V!;[)
MHQ/T73__`+>#_M4RW5]4W-(5?X38U<?+N8R"R'&<,>56<IRM*@[>P:CH2%O!
M,(OV(.ZON.T3]#M=GTN"V,#J\':5DJGLD"E$RL9P<Y;!$@LR#C0W61Y(<@^S
M#0RM#W@O"@PSVNNO"MXKUTOL),;G3]MQ=VR>JB;=3T5^9MU$MBY,D%1/<WST
M:1)-QFSRJX@FEAV6GVC$?T\Y3D(KC]>.EB#L+8K>]V79CE_BZKB$<W*J9@R=
MJC]\8WS\S$-X%82J\+L/D$N1\>#^0R<-X_-?S;@2U7:'U4MH;<?7>C[4JTR]
M;*.[7D[$DU@C3/IB;CVV[RSVQ*H@BV(21<$"94UX6XTM+[L*&K.%JPXG#F`Q
M@C2O444`D[!HNR!-6U-9MI:4GX;#7,:2UQ)VGI:YR!U8@QBMAR8D8+6$IEH$
M2BYE^5UJ(RTTEI:?-D,Q7]"]:ZEK?<G66N7_`"(!;YV7?*Q/KJ#X=PU6KQ8J
ML'+%]:4Q,F"MIB6`JD!B7"'2D29#,/./#SMI3A(2WL:9I78FJA<\]LX(-UN`
MV1KR0S=X)X0R%7<=9['"J#5Y\S.9?%.8F70&T,E(3X94XI;2%H7\J0@!WJWU
M*IP?8:S-UP/U7K[?!?=^S*84MD(51J/>"=&@"A=?L,V"V.-5^N546<8)BH>)
MC;C#LIG\FIG#3>`PUQZ@]62X>B:4-;5,"6+'4]@Q=.U-JU5YDPND'MB5O=)1
MJB.2QDB:3#U)X"F/$=RMY30>6ZEU3BLH<2&*G5?J2$'ZYO=9[;0:`/0>[`3J
M'9A);5Q\4=3LFW!36RP0Z/;*;91$R!4#`^)%94TQA^(VK"''%J5XY"U]B`ZV
M/*ZY'[-LQ4J94R96P:U-/S``_.SB)#4EF$%);T:&+B0):54@C-+Y;',Q&VL,
M^?"<,IRWD*_43K-U$3-HM@`WB!;(Q7JC9M5)QFT@W`^U=&M>[`IG8!IX=&AM
MR)E=B.,#UEHKD9N.TXVAW'BTUY`WS15;UO8X5D):I[8W_;\X>U1*D]8?GS4+
M2]3*I3R630FHQ@T"LP@*6;3"P['FFI4)\L4AKSEN;XMI6D+.2Z)2IUU&;'EU
M<0_?`@B97PUK<86HR,!3UR')@F)(R[Y40I"I3F5)RG.<^?/R\"KR*GH:)V)=
M`"NPQP#=2^PH>W#76T)L0(-!V/9T8/'>P<("&!N+?AXF/ALSYH!DHU#(*:Q)
M>B+1E7F#'4WK+3+#I8SKFO\`8?8]UT+<H-@$LA83NM5`VA,N_OV&VCQ=F#TF
M$>=CRR,8@)EY>F.Y1$DR$8REQ*%H#!-ZLZQ5;6UPV=K/?$K46I[O:J9:8MNI
M=Z$DZ&/N=+:)4A:H'SJC6>#;V+<SG`TL$)X(Q)CD%GTV&W&<*P&GG-<=6ZOI
MC70-KMH_0Z-<,;-7`M*;1K&=6MOQ]G&O>VP)$RH'*F4UNRD>:D?ZG,@"X/S;
M4M3+;C7G6E03;N2BZ9IFOM!P+!NN=H4/I@^$;U'<\&*O(GR"@G7QFH#QCDFZ
M@[(+L#S]1FR75>,=2UY1EW&<8QP)=T/7=>UK6`2/J^RO7:J&"%DM6;S**,&I
M]VL5GL)(M:[42*18L&'*(%;"_(RYAAAAAKRX;;;0A"<8"8.`X#@.`X#@.`X#
M@.`X$"J_K7L?\+<W[=(_@3UP'`<!P'`<!P'`<!P'`<!P.2'/15A[S)1AG\U4
MM:L-MH2UCSJ6XM64I0VA*<Y4K.<8QC&<YSX<#SOO.LNNF>OVB`,CM+.U]J6H
M7"<?U[=8MDUNZ+V%9VS1TN/63S::R:K-I8J)B1,DQ4)B9C1G6$R7?%3"'$A+
MJJEJPUV,K#Y;L":M>RJ0-^>M=TR2MU4D(%F)U!53)U\A#X@A%EBQSE8(N37Q
MC,G`I4F5F?B+X*1G@86X]:]1&7]+VG>MN>G;A#6?6(F/L3YT3JG,VE:Z;-.&
MJO37`L.8-"D,394^4XAN)"8GJ2AQ;:FL+<3D-7?U7UIO5LWP!LV_'=@'(FN;
MU1[C6"=SIC9'1FO[#<6;Q;$./C!$`C'2+N$:*\S,/.35#VXK4?&?3\^%A)6D
M:M5P8$#>=7;Q^?U"EW?:^S-M6YZ35YT79UI/C&H$U\EFO!1H:M-4\B*0^IB$
MB%AG$7RNMNY=4I(11B+U0.:(B5^O=E@2*WJ79T#9KFU!UKI9HB%V7;+3:;2,
MFVB(2%$*N=?L9"PSVV8,J`[B2VC"D)]1G"\!]"FD.K;GWJU,([BA+"U8!7H^
MGJ@2L.ORSFUX(6PB;:%-#3I`%*LC#A&P0H_K.`9HZ.38SB#Y5-^#?`SV^-2:
MW/#02^Q&_9%.(';3M:F`3.3-3K3EEUKMXH/D$M(N*-A%LRH#84/`CYGQVF)\
M7+?FQ)\5^HL)Y/5N@O;GI99RY)`;,K^G]D5NIU**1$HDIHQTM35'[<@1-CR)
MBD58H"'ML2%JQ$2IU274.9_P0A?K%KS7@2BFP6F.T%IVL!B;%'V(V>CE-96`
MBP=01>/6D.;+`ZA%?*IV5F3XDIL[,B>_&2C,.4TE*<X#=[34]93CO9TBC<4R
MDV>V:XH8';1<)9:^-)Z@K0(%:VZ]8XTR;$>35"!0&5G.^T3LN>5#276DM^7"
MLA7=Z@]=D]<J%KYWN.6AZ=+3+/KL$=9M.J`XJ\5XX.CA#NK9,*)3X==>6';:
M6\U/Q#:-BY<IV0N5A;OFR$Y&^N'7AC>6MK^Z\_6=KKF64A70\6\FHLK8DH;K
M^!39DUT')+O>\'J=4HL967H33/R);]JRZCP1D./6JOZ<BE]E6'7&\5[YM,A%
M+I=SL4FP5,R0K06B1#<"DU$@W3A(:`F5`:F3E.S)33A"<[E2G7,^3&,!:[@.
M`X#@.!5KO+_4F[A_\+78#[5%LX%]:]_W`#_W.,_ZDQP,QP'`<!P'`<"K_8;]
MW'57^G:S?^&;L)P-XX#@09OC75DV/`U-'K30]QRF=@=2[)-^\)>(:4UBF%ID
MTXJ&K++WM1%+#R?1C_D?5SXX\V.!5K;74C8E[N._;@+/EH3EXVSUPMU,K42_
M2!%+/5_67T>8N4N]5E$!V+)-#\5N9D:EQ2LN*0SG&4\#<=0Z?W'K[>&Q;`6!
MV*11;GO#:M_@DAF^VF*3&KEX>?D"Y)32BJLM<\^WX-X=S@BC*7\I=\<^GY<A
MFB6J-Q`MJ;7G5.F:<O5'W?L?5M_,6K9<^7(GZ^:I`2L5\L#51D`Y*K@Y'C5C
M$RMOLDH21Q"6I;R<>GYG`T1[KUN-4XEK)NNT=>NBO;J-V<5O5RV9^>\,2WL,
M?LEVM*I/N'WB_?V7X603!%)'$'W0KS9SC.,LY"MD?H'O-N[P2[CE+Q5(NSH>
MZD@DV+&5M[*5V%BD")U'^H>7Y>OT)"4Y^1622LQ_Q?R?`L%"ZD;("U#8EJ@V
M,D0W,U<^S1K15<G6P3$UAK][?EGL$!-Y:7"K48VNR-4:P+DO,RYDQIJ7A3;2
M$JRE20T:+T5OHO6=KZ[$9E-NVF3^UNO.PF'1K+^OG(HFL/#`>YP[5<R3L<B&
M1(`*S"*QI;<W.2!:5)7E+*\\#:174W<GWM'9/65Q/B;9MFU[-)W[36Q6#CX4
MHHQ6ZW2J_JZ_DS,9AN55+LTBIX5/<;\_BZM[/BIM[*<A/.[NN`V]=;ZQUZJ=
M<"LU(6>TK"(5E^>L8-S0:;=:T4ND-F<E"WW)\JOP9BFU_GTF4OS97A:\JX%8
M1_3WL+(IMMU)9+C3C=:NG9>OWJP7^Q,*M$NS:9U=KVLAM=#+;2$R@:[!8;(=
MIXN.;C9G,-K1%=D*<5AW",AJMZZ;]G3E'TW!"FJ:O8O7S75]US0KM(L"HB2T
M>1L:LCZ87DQ51I4@4LGI!)&/,94Z\J+-;;9RMS#F'.!E1'3C<NNH^H8%*#RY
M(C697L_`3%H.[6]0V1%9VE=:L6H#S%G56C>'&W`(!>24+T<9;D*1C*U>7Y0N
M'LW5]\OKO6TG#@Q(4K6Y6W%KM#,6ALM/@YL.B;OK^*RR=1`81:B"+/8(Z9$I
M+4?#S?J2/+C_``.!2.B?#]VQ6P$Z@+M8(30K!T[M>L&XGO*06<UUO#8*Z!+V
M#!&(0TV^9UI9S]+635EM2%,N3Y;:$>#J<<"]5!8WK!>L%DM6F]*U@LL9K.G!
M@5-MZY9PH)"37XUI.';Z[4Q,?%9!#2+DBO`/85OHRTXVN0VJ1CR!-$H1;%W8
M6;AW9$6DPQ$N&4H2JF+DN&S#JW\PSV+B[+28%)AH<;QF&TRMIWT_%2L>;/@%
M8:'JK<%#V`1!MT[3]CUB8['6W?DC:EF(RB5Z@0K;F21<KXJE>XVU1=B`I\C$
M"`>P5S%9$HQCT?/^9<"/*9K?M)6.L5IZ\P*)4*U8W*U?*W6=GL;7@$HJ%;`O
MI61*,?-MBN1"(V2$I]IERFL9E.*7-AH:QX9=PI`:B/ZC;9HFL[CJ,6/I6QJB
M*V]KO;FK'*]8S>B+&`DQ`?N^YLT":,)6;.O+F!."XY0;+EOSQI%1"<AYIO+F
M,I#`V;J_V/(:UH$7W%6R^R@M=W97F[+7MI#*+:JG#V/;<'*\&V!-:H$C6&\*
M=+'MM9MT=^NLR"I)KUVLJ]1S*@L5V$TYMB]5'K<W5VV3=JU+=!%CNJZ?=V],
MRIF(^K++324FCV#W08;KR'3QA"VH^(W@F!E36/+C\0+):RA6$;0JT.M0\J+/
MP83L4A#.W=&R#*5-3)/H.D[PV,#HL4R3&RAQ3OLS64>;#><9RCQR&]\!P'`<
M!P'`<!P'`<!P(%5_6O8_X6YOVZ1_`GK@.`X#@.`X#@.`X#@.`X#@8D]7@%M"
MDZQ:A,0[6CL58XZ%(-J=@%1CRD9DP9K*5H]>+(2GRN-YSY5I\4J\4YSC(>>%
MAZ_;W&=3]0Z%J5#U^?,0/GA6MI/KN8:L$@NL[$7L4@Q5]8VLA5SK0,C?`)9H
M5-FLQ,*A#LO(;3EQ32FPF"3JO9D_L-IZZ1J-1:AK_58@NR@N/M[IAT@(L.KX
M]6F51VEO`67&KX$L$2-%C6AN2I*JU$]G\OB\MC`:!L[2>]=Z7;K9O&-.J]+<
MHEEUM:).H[B((EY>N'89LB2O]@&V",;K\<X<-BL0H>8SXUF3B,REM#K'FD(=
M#3275#<Y@?V;J0Q^%1JEM:F;'BP(T[9I*]CKKLNU[0S?`ESAQIE>B$-7C,@$
MNCBD5/KI=D3/,EIYN,AUP+':!"[:UJ+KU/OE:E$H]WV1M:PRGW;HJ[$]3TER
M)'+U(+:KDL-'SL,T5)I=C*ENNH?1[2VCSR$LJR@(EMG7+:1K2N([@T--V_9.
MQC.\]CH!VUJJG)@X98S+%;!ZZV7[M?;J)VIT-H/!'R<L8:9C,2F$Y0J0I>0C
MDMTYVU-#];*_#^;X275=<:>HNW[)5K0,&5UB%J3;(?:`T8Q32%,EE#/LJXLA
M,2>(("79))Y2IC>(WAP)$[*:EW'V%908K-(!"I7S9[-=?Y0:UVE0YJ!5]DD:
MP'KNZQKSP)2YK+42I*DK%I:;E+:DHPP\XG'G4$T3='J'=C*MN>OURO36(^B]
MA4"]DY,EJ)8+I9)CNMH]'AD\R&)7KB,AZC+86M6?0A^KG/IKRZO.0TCK;1MY
MZ^A7VR;%U71!VRM@7BBY,?-/9`Q50A:]"QW:X+$4\,/J$"/60.HJ@E#0X8OV
MB2:D.O.+D,Y7C"`R+.C3]"MW;.V:ZUUK<S&V[3]?.TFGV*5'CUNX[&#1KR]:
MY>QF),.9Y1Y([9(TA]UWUURVD*0GR>5'@$&%>O>^RO6,KJ^5K6DR]E;'LVP3
M>S[*1VU$R0=N-OP)*,[%8GCJ1&"RZ*4.P$135.1'0ET#"8B8<D^9S.0DJQ=<
M-SD.UFN-^)OE'-A*^-L->FPI=9*"2M+J\W6:ZYFOU9Z/978<F'9KI+E$7'6X
M3+\1QY"G?:6X[#2`V3J+IO9.FX-P"VN&BL4A4"C"Z/1%;$D[5=$E:^,)Q;K9
MH-MG!@T^#7;;+D15PA+J5+B>SN.*2RMY3?`N/P'`<!P'`JUWE_J3=P_^%KL!
M]JBV<"^M>_[@!_[G&?\`4F.!F.`X#@.`X#@5?[#?NXZJ_P!.UF_\,W83@;QP
M'`IQV[K$XDC2901:MIUR45WQJC7!UK7NPKI4(<RCV\]-39L$H%7)0XRY:F6D
MI21<3Z\1'R(<3C/`K7MFT=@ZT?[)AJ2:GKUU4-R=/ZW#*E;=?G]B!!)./J>,
M;B4=#`V<.+BC_M+^3[\B<RM]3\E;V'%*5XAE])W$@1[6[-%6_97FFPNP^YP=
M6IAO<.[(YU=?@*G-UD<'U*V+7J"=6(\=*UQG7I:5>DC+J4^JVWC@;5<[6F/V
M+O4#9FP.PE4M,#8NHH77"F:I;LC]=MFO"(JN*LD_-:CC9-#N<:?:WR\>TOF5
MJ>$C8Z5-98REE2PT*1>K:G:LY&=A;81VC;[>PJJ&TPV0MF=:2>MJ[M`AXE)I
M7L6:-)UZ_J!;Q=^R+5[8@NGP]H2[C#/`J]$V?V:7:A5(S=-NJ!M=CXNZ7+,L
MC8O5DZY(]B8F@VM1OSL_FZJHP0;D$<C\Y]GQ#SA?E]/Y>!8RG&]_4OZ5^R!`
MY:I%#UQ>NV,2=7CFS;M<I&U'8ERL-4TW1:]ILB#4`HT4%9_8<1R<*:MR5$3A
M.&_(ZKRAIX^S]HHNAK!HT_;=M4C?X3?/7.56]@W?TI=E?J.YK$-]N=*2*V8/
M#2E)`7\<9'NQ/:U^4%B.U(;;\?)P-\%;/WR>T)V.WV\JX4?;.A]_V&VC]8FY
M9V?52$2GZ_HH:\:BE!XSF/?FMK`3>)R!*XZ5>A(6Q+9\'/4\0F;>55W%3>KF
MKZ;2=NW'.XCVWM+#R6V)DDE,G2;'>+LS./R2,)MU:HVOTD)WLRA>/")'#-I8
MRGRISXA6J1N7L)LW5%_I0X/N*H[EV]VOLE+2#ITE&;EJBEZYH%(/;-^8!4\6
M!A!]>9L(YR.,=5-C1Y#!52D94XO*<AKNT>R&_$XT'MZO-[`BDP77ZP@-M:N@
M-EFQ4S;92[$-#SYQ<(SA<&25JVR)T(C&>SA2FX2<N-JRWX*X&K1K9M``%Z]5
MC8^X[/':@57M()M-EV+N'=VMH5FLE)WW'J]:G&+5J\<7L90VV!9?P/9DM^SJ
M@Y6I"OR",9#T8VK9+#"M75!JHV`ZNNGP.Z7C+P@H;F#[!%&]>"I>K3#$Z1A$
MPNEHRAJ7"D3DXD.2O*[G&'\YX'GMK_:/<:/3AE3F$-B6"\!^C=FV32[G'8(D
MI-\B7BQZI*BBTD9-1(9*[KU6(DV(4A$E#DI]4>.ZE*LR%)R'H#H&^Z?%,W9^
MD[4W7=*`NP:WK\$YMQRY6.OLWJVM.#$`J1:+<+3<)Q4H1>C>_(CN5#14YQM+
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M`D38SA`2Q$E>&'<HX&%VQMF]*U/UXN;NP=Q5B2C2=G*LTFQ6^^TRY[!M(FX-
MCP]BJ.SJ31I%?V'M1X8-3[I`6D`U#+BI[$MYG#KK^<!<+L\WM"X7#JE6:$[9
M1BKIG9Y&T@7MD7K3T>2D9K44;@0KE:]8P2)<=.#D7%Y;CH94PY,PMO'@G/`N
MP`'N"0(,4ZN0X\,#C(#SDLM//2EO1(3+#RI!TM_VJ:=RZC/C+D^$B1^>.8PM
M6<<#+<!P'`<!P'`<!P'`<!P(%5_6O8_X6YOVZ1_`GK@.`X#@.`X#@.`X#@.`
MX#@8@^/,E@A077;!\TSI&&[#%6?`F&=4`ER/*V@JV&(K0/)/Q$YRIMI_/HY<
M\,KPI.,IR'DS=]F%@71_K_*N&VMO@=IVZ9=*_7;)&LMAKRYMH2=MHZ+L+<M@
M!AYMC54-;PDLELP6$H;*2TQX?L[S;B4("?E724SW`T^'KVS=C6[WI428W:%2
M7\Z85<S"7J>#8*CL.#4)H:%2(6N2$^(N2^6AO/E\60@F#ES#*'(Z`Q>^MW;+
M)['ZO3]3B]B3]$F]EZM*E[Y01L.4)VIBW&C`IZDS9$TN*+"`-?%0%S)3+\5#
M<^2^VEQ;:(V<.A!ZMC;K&S^Z*JG;+G?[O&U_M6U5Z2"/[+?#Z<?&[4]QB:(Y
MKBWUN&,K]U12,.SP\H2V\Y)BP7GTM/-.LNN!;;J?L."?UD.J=EM!B22L^Q=N
MTO7U@G6VX6G&PP=91[UDV37MQM4"/;%UP>(ENYAN$GG93*XCOI2'DH1Y0JT=
M=NP#KB;V"(V;N*`$V=V7`!*\[?\`9NQ)D*BZ8J5F/TY$B[7MER;L&E5R^O@W
MR94B,\)"')L",G"6$K4H,$>V+OQJ-TR(C+EL(A;+?J[2^8=2-ES]5L96V.;8
M!P-G6>Z56#7I%:V?$LFMI;K+D:;+8DA8362;C;:EY=X$Q=V=M&O3KDK65_N8
M<$/!]AQ00AKY^PCW3'9_7[M2&ZRUR<R.AX?+^J3>*(0*DI4/)N(7YL.I0G.`
MG$M*V&+[94I9^_GF*$=ZW[6,S*A"'1X%2I!ZM3]5-2SDE^.U+Q8K'F43(OL/
M3<+Q&C(PQ'9\N'E.A%?3#;M;+!-GV>1MJ\V2C$]DT6I4(-M<G9[+L,3,+0UU
MV,:M,V>%CM@B.YK.RX18#0_$<%CI;PKV;+JVD!G7#=HJ5W[SYVCM[8^*6`UU
MJ^T!K%51$<>2UV'/"MBOS1.J`T:$4@N6*%&B1(^).6Y,V<0RAY[*5*;2V%63
M&S2#W3R%;1V\-I#KD0OVR3NHAD"T[*+DPV(:A!D%I.WWIJO/S[]LX#6W58#0
M"K_N4F<G+BK5-CQL92%E+?M3>7WY.EPRZ7M2N:@]VW@3#@,AASU;OYF1JC%H
MF6ZW2AAER3AJFG7F1[([,3&6'(\F0UAYQYII`<.A%GMAJ#LT5:[A9-H3!GS!
M*2MES+3L(U59QVQC#<T]2@U?V*&"DJ/8J7(;0@L.C-^@TF1&0XAEYM3?`]".
M`X#@.`X%6N\O]2;N'_PM=@/M46S@7UKW_<`/_<XS_J3'`S'`<!P'`<!P*O\`
M8;]W'57^G:S?^&;L)P-XX#@5A[(;"W)KA6L9>LINL6QUZV92-3$8][KEL,3H
MA>_%9$&%8(DFNVRO1\B13$?Q>B+;6\^O/Y%U&/DX$)[`[CW?79_;M)F5'WU8
MM=;"ZZT@18P='O$C7KK&UH]!^>DNU6-B?)'5:8U)L\S(:,_*;6I&(Z7,/JRI
M2PW;56_MP;$W7?J9*&P(6O:5N#9^N$/P=.[5F,2Q-#6^Q`ER]QXLB]:C3<Q[
M#?K17(7CA6/22G"W$9P&Q6_<&Y9>S]GT_5Z-1":SHP/K,O?']LD[$(<M[NR&
MIA7,(-8!DR.'H@D/7X&<))SXQ)$DDKT?20A"E9#1KQV9VT#<W3L0"%UX[I3K
M_MH'J2VULO\`.3.T;?F1)I4:SV.OFHA%JL`5#Y5X84*&R(,I11$9:E/-9=;\
M`KQLCXB6TZ45W%4H=-HLNV4_>LFJT)F7\X\0C.F*V6N=?O5N-L-F&WU6,"3J
M3<;&6%M1?.18PIKY?#(3A7^U^SR'8*V460!K9'7=,W3LG75LD"Z3LN$9H6NZ
M%4WK#]*]AV?*E2M6R6$2VT0WQ"$L3LY>2IM./DQD-"I'?FW7OK=V'VD$`:]D
M;(U6NLV"E5*`=DE*^7HNT)8C&M\VQ^$65*&VA4:5*AFF$O,XB3V,8RA"?R.0
MD"L]P+WL:M[MN6O:<'E-:(1J4K9:,8049NC$.0(+S]^T1]Y)&/$A[!H+X.:@
M5XM8C2%Q<(<0O$A#B0D56^]AHZG[-[*O5L`)E(IMVV;J2JD6R25JUY&@KFZZ
M=V(IHGYU'K.+;00G,PUQVXK,M#&/%QM:\A$0#OHLA4=\VVP5P=6UZ,TE1;#9
M:@1D2F#8;>!T]>JB7UL;DO3,0\AL64`-R->;0VIT>13(RXI*TY2&ND>^=R'Z
M5T/LUH1KPH7.;GL^K>P#`,J1,UFM0-<,%)E_L&O2X\NZB9%;K8])4>_(<ELK
M@NX\V%?B\#7@O?'<UJK[Y<!5*I%6=[/L:EI:A]-V#L*?+U<8U:;V75+0[3ZK
M8H1^PV@F,@15J;A.-L(C/J7AKP1G/`MQ==R7^A]?:ULPB/%S+F6N.KJ\5@E*
M;<*##1$ONV`%)F/.TJR%Y-M`$8(4SEUIJ9*<SF2A+BL9:5A'`@P-W=M,O=LC
M2IRJ!@Q*;VR):EII16"CD6[ZC".VH/9K&)_[0RG&P:;9041D@UG.6/9R4=U+
M.$K\<!,FAMP[FVRBA[&/HU$-U3MP;=)]-K,(K88>V:]'KY)^*%;ENDIDH+?I
MA&'%<<,QX,4?D(M2<>9].%>(6&MMZI=!9$2+Q:P-28/G(=8!NV`BP-06L9'S
M^P`QZI"D^TDYGI*]-E/Y)7ESX?B<"NF].U8[4^W=*Z7'.5J6;OMZI0_8+MBL
M$86W1:'<2Q`$)*1(#DZ)))6`X:@NXC(PE;$:/%==?\/.QAP-1U3VGVEL*UV@
M1\P@!QDO2MGWG4%="F9H`^\QK#=I+2,RNWL_894L$S,/R8S13$R.PPW#94]'
MRR^MM*EAW'^SUT']%V^T<X+6F[BQ3(]D)5^,V9EU5E]5^:K!&+#81,;-3(S,
M#*W&L8=PZ\\E.?#'CY.!)_6S==BWQ7;G?YH\=5Z^UL`_4ZM2G6"T?8U6CU-_
MW?+3MQD@^AD3=2[JDS6QL>,VF!`?9PIY]:\J2%BO,K&,XQG.,*\/-CQSX*\,
M^./'']WPSP/S@.`X#@.`X#@.`X#@.`X$"J_K7L?\+<W[=(_@3UP'`<!P'`<!
MP'`<!P'`<!P,/89ID:"+3Z[7UVP]$A.NAJR@K"!9.$?D3%'*-$L*@BFGW%8]
M20ZE:6D8RK"5YQA.0I!/[.;I5U0USOP(,U9"NEF2<2<K)3-U+(L-FC&K"`IN
MM-6``;[)ZR6J]6`6Q!;?>D)3"94[,4PXA"FT!+)#;NU0._=5Z\LX"FC=?;7`
M'6XBVW+"Y9*_<Z_2XUHGUV?:7'FZD2L,LGB<S'!QHWM*A<)9+VGP\6,!JVY>
MS%<T7L[1FB*O"IT:9;+?1PESC%3$&O0==:WMA*>`"2QPSVR$],,FBT!U,9O"
M5QXT:*\](_/&,.!&I'N1L>IN=DB5YJ`D'$UA5KS;]14DE5-@UZUWNO538$;7
MHZX/V4@_+KAVNOSIL5R6V,8:F1VY;/D2I*L9X%C=$W@UN.B2+39(=7<V92+7
M?Z*\IFJ6FMXJEC'J1`Q"+U:TRIE@K!.2/DQ<SHS,Z4AR,[CT)*DN9PD*Y3>S
M/8(+K2XW*</U-992=^@=%:[+4JK[!GXMBXLZ<#V-80NO';3)L]Y>#60?(@#!
MT&='>FI'RY6<^BVG"@QQSNYL,(/Z\V>93:M'K&TJ%JVUV9^$U<++%L%BV)L<
M5KVPT_7]L#)S7P!+7T,H@Q+P;P[F4A>(:?*XE3N0EGL]O&T]=7!PC6=5IKCO
MS%W9O>WXL3)9B(2KFK'*V4LHL-@)*A.-7"YS[=EQLC)S(9CY;RI;+OGQA(;U
MG<-]=[&5G4S%(&0*%:=-6_8]>LL\YZQ^SV"O2*`VS!;&P$N-5H%`7=<Q'G)3
M;\N3(;6XTVVRVGUPX]<=K[0VBO9K%_A4B9%I%H'UH->-9?.95%LA3W,F5?JZ
M"EV5Z1*LC>M#ZO=4HS&].$0D87A++*VG&\!BJ]N;;EAO/9NDXI5)JI+4-?I1
M?6+=HMK^!QIFW0KH^S8]B'Q#4J-70LO%8;F>S16G'X4)64ONY>4K#(1"3[-]
M@(W6V=O897-<%TUJUV]4DKD-L*(&V=JRN$XL$#LBD@%D7#51J9]+DJ5*,DY<
MJ&,%P_;T-267T)2$@&^W`*-V@U[U]KKM6)B2XVPN;!L*['#43&V9%"^?U-I]
M4%-3&GRLTB(RU(D25L+95B;&88QE]3F&P[_5C>NQMR,72)MD*&I5TKR*J:1K
MMFI7FJ6:N5FYQR\P'/L.;C+EQ3[1=`U2&)@WTV/6C2$.(2K"<<"VO`<!P'`<
M"K7>7^I-W#_X6NP'VJ+9P+ZU[_N`'_N<9_U)C@9C@.`X#@.`X%7^PW[N.JO]
M.UF_\,W83@;QP'`UJSTZL7-H$S:!#!AJLVH#=P*'WI3.!MKK#[DD"9:S%?8R
MZ^-?=4I*'/.RK.?R:%8X&L%]-ZQ/_//)BHPIV=AV&F6NZ^I+*H]_V+7>1&:4
M4DX9GM>SO`,@(?I)8])MST,>HE?BKS!A1'7W4@"]SME!:V3&7`I93%Q)3(EW
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MY1(T&T3)3[!!N7#6:A1&VG4Q7&$80GP3A/CGQ#!&=!::/Y)9)Z\`Y29I@C7I
M9H>F8%CDJ;7S\:T`P<R,&E0([[8H]$1(8>4G,E&?,C#GIK6A09R!J?7`LCM`
MN-J(R`1W2ZA_:<F(J6QFZ2$!'Z[[43:1)PPQ*<#27&7'8Z65N^?*UY4Y^3X'
M;F:VHT_7#FHIE=BOZW=J#5!<JBI$_$-5/8&-!V0>92):2>(Z!C*6<+]?UO+C
MQ\_F^7@:F2Z^:6,6`Y:26NP<L[9R6NS%EF+610W82>IG%/:[F&X+4Y`\FY6'
M%8RWAYI:7_(CU\.^FCRA\#/7/1]@?.R"^N`<K-F*ECIV.VZ3A#YY@]07]7&B
M.1D"?&'1I)2@25C7\LM-X6WX.9QZZ4NX##RNJV@)86-7LZZC0A,(W6[)!9#V
M*X`94`[4*1'UM6R<$H%L$`I"D"Z+%0-3Z3R$N,XRIS"W%*7D-XSJ#7;E%':U
ME`'R5*%%A!R"),V"S&Y#98#98UO#3GCA<S-L$QP=9(;4EO#TIQ&/32WG&6L>
M3@=)S1FHWBU?/.T42X;JNS+)N2N%5O$<S@^S+@AQ%GM4*1[;YT/FTNY]>-GQ
MA*RE.<,XRA&4AB0O6_1E=LYZY`M;!!-FLD&S#B).%),->RQ+IE2K@FN0<$\C
M:<_:7%97/>$,P7I3GY-:LJ^7@2V+$#0PD4#'Q<-BP@^`+%QY#KY!R-"%Q6H4
M%O,L@Y*FR7F8S*4Y>=<6\O./,M:E9SG(:Q:]9:\O4X"3M],KM@)U<^&M`$F0
M&QUDAQRO.//!9B)Z$HEOLP'9"U)CNK7&4K/BIM6<8\`Q=,TUK#7MIM=UIE0@
M@;/=7'W+"38EE).'\3"\NP3XXV#/GRAU?A$[#/?(2HX]J*S)G/*?=2IW/FX'
M+.G=9*UBC3.:E#SK!N$T/14/;"F(283)I-B:8Q,Q.P5\J#2,2,9]?S>;'AX^
M7\CP,Z&H=1KMJNMU!A&!EFV-(#S;P2BR)J460@`'^Z1).<.5)4+05CC,)CKE
M-,MR'VD(2ZM?D1X!MW`<!P'`<!P'`<!P'`<!P'`@57]:]C_A;F_;I'\">N`X
M#@.`X#@.`X#@.`X#@.!^I5E*L*3GP4G.%8S_`'LXSXXS_P#4SP(!LO5W0UNJ
M='HQZ@(D576LXN3H@J%9[F%^;)$ZJ6HK/@3P=B&DU2Y7O!_&'''G%-H>6E&4
MI4K&0V&'H;4<"_Q=HQ*7#;O<*!'@1#CA([)2RJ)76ZA'+^Z))5T*Y9D51I(U
M194?)-R#C+2G\ISGQ#KC]!ZM8K6NZV:J\"X*U=(KI"J6&TL-D[.P7JKLB0%)
MRSBL8(3E0Y$MQ:6'G'(WRXPI"O+C/`^,'KGI`?*ODQC78AUS98DR`N3,^69*
M0)X&QDI!JP@QHPD3E#ZP(/')3D^9'%MPVGYRO75C+J4J2';JVC-?4:51GJ9!
M(UV+0S%UL4.$P;,D<G[!?1>!1XS<"9H@2+VD@XUCU$NS7WW$O(;5A6,-)3P/
MI/T1J8EK\7JZ33V44@"8Q8@(R$6/C9X&PX+$3N#X2R#RL6RBS6"I>4[[4S+0
M]_K#B/-Y%93P.IGKSI;VC7;Z:`,91J@:,#T.!%G&X@80,"$6#(2)+!QBC0>Q
M("G(Z)\3)-B8J/.3[0C.'O%>0Q9CK3J&UC&15YKKUW9BWB[7R$Z=+FD/Q)^P
M"^2]C!)='$H;DJF35(99=#R%/#Y#,=O#K2O+C&`E`I2*H9LD"WD@[3]F%U:R
MTH<8;DSHDJ%5[@\+D6,3&Q#E,,M-DGPL17JX1Z[.6$^DM'R^(1G0^L^D=8`L
MUBA4M^N5_P!_UBS(%1[A>I<1@U39CI"N2(B25FFJA184Q];CD1K*(<O*LXD-
M.X^3@;=8]0ZWMR-CMV*K1R*=O5P-4=DY]X%X:[76Z_'(1!`B8Y`(17(D6)%+
M26L^RY86ZV\I+BEXSX8".WNI77B340E$DZZ3*JM=)ER@<9+MEYEN15V`?#$G
MQ:B<FS.EY58.BA[$:8(>?<%R&&DH7'SC@2:3U5K,Q9JW<R5#JLFU5')3YNG/
M<\-F</P9#?-\BA2X[;2)[;H7'LS:9.'DL-_G6$9^7@=#6NF=9:?9,,ZYJK%<
MP>6.R5=]Y&S,M^,%C.0P0EF:?)%9D*OU^&^MH>.86W"A-N*2RTC"L^(2=P'`
M<!P'`JUWE_J3=P_^%KL!]JBV<"^M>_[@!_[G&?\`4F.!F.`X#@.`X#@1-MK4
M8W;42HMRK7<Z25HUL5<JW9*)."0C<(J[5;12Y;*_G"`LHF3`FU^X36G&W(BE
M>9:5H4E2<9X$9_>SFOPGNR?ZZZ?^XSP'WLYK\)[LG^NNG_N,\!][.:_">[)_
MKKI_[C/`?>SFOPGNR?ZZZ?\`N,\!][.:_">[)_KKI_[C/`?>SFOPGNR?ZZZ?
M^XSP'WLYK\)[LG^NNG_N,\!][.:_">[)_KKI_P"XSP'WLYK\)[LG^NNG_N,\
M!][.:_">[)_KKI_[C/`?>SFOPGNR?ZZZ?^XSP'WLYK\)[LG^NNG_`+C/`?>S
MFOPGNR?ZZZ?^XSP'WLYK\)[LG^NNG_N,\!][.:_">[)_KKI_[C/`?>SFOPGN
MR?ZZZ?\`N,\!][.:_">[)_KKI_[C/`?>SFOPGNR?ZZZ?^XSP'WLYK\)[LG^N
MNG_N,\!][.:_">[)_KKI_P"XSP'WLYK\)[LG^NNG_N,\!][.:_">[)_KKI_[
MC/`?>SFOPGNR?ZZZ?^XSP'WLYK\)[LG^NNG_`+C/`?>SFOPGNR?ZZZ?^XSP'
MWLYK\)[LG^NNG_N,\!][.:_">[)_KKI_[C/`?>SFOPGNR?ZZZ?\`N,\!][.:
M_">[)_KKI_[C/`?>SFOPGNR?ZZZ?^XSP'WLYK\)[LG^NNG_N,\!][.:_">[)
M_KKI_P"XSP'WLYK\)[LG^NNG_N,\!][.:_">[)_KKI_[C/`?>SFOPGNR?ZZZ
M?^XSP'WLYK\)[LG^NNG_`+C/`A\!KN=K[MA+CS=E;$V/[PZR/99?V#*J4E\2
MF)M\4I;0O-4J%2;2W,7,\7O72_G.6T>7*/!7F"SO`<"O<+L=5)6Z;?I=\%8(
M4RDPRLX]<7%#GZR-C!:95+U,EET1Y"R(0:\'MC;463);2W*F17VD?*C&5!U*
MWV7JMU!ZMG4VNGR]BVT3O@D'3YSXP&1`2-7KE(V`NY$)#\F$$16W&&FU(;Q)
M??=F,);;5A:EH#8Q&[11;:D74F`;L,^O7M=V',FNV.NRX#,*R2;-#BBA6!LJ
M8JR3(4FJR/:7HJO9D-N-K2M6,JPD)LX#@.`X$=C=CCR6T[3J=(8U$,52DU>]
MOEY>!Z0Q01:S!X'`;$YCSI$];\:;7).'_798PGPQY<*QGS<"14X\V<8\<8\<
M^'CGQ\,8_NYSX8SGPQP*ARNW8"#3P.PYM%/-TF]4_;=RUJ3:,"WB=JB:BKIB
MVSX18-Z#:JD_:ZV"DS!:UOS$80C")7L[JDMY"QE"MC=ZIX&W,Q&H+)Z"W/:B
M,S7R"6&GL>9MM<N0,#NN/)3GP<Q[.E*5XSA*EI\%Y#;^`X'R?6ZVP^XQ'<EO
MMLO.,Q&EM-NRWD-J6U%:<?6VPVY(<QA"5+4E"<J\59QCQSP-#UU>9-\'6&7+
MK!"L/URXG::ZB5+9)CC+X#$-$LQ7"[$>(V6"XFR7(2GL-(3B;#D-IRM+>'%!
M(/`<!P'`<!P'`<!P'`<!P'`<!P'`KQVZ'QB_5'LR(F87F&7T%MX3,PVOTW,Q
M"=!/096&W,8SEMS+#ZO*K^YGY>!>>)&:A18T-C"L,Q([,9G"E>96&F&TM-X4
MK/RJ5Y$X\<_W>!V.`X#@.!\79,=E24O/LM*7CQ2EUU#:E8PI*<Y3A:L9SCS+
MQCY/[N<?W^!R0ZTXE2D.MK2E:VE*0M*DI<;7EIQM6<9SC"VW$Y2K'XN%8\,_
M+P.+DF.SGRNOLM*\CCG@XZA&?3:\F77/!2L9\C>'$^;/XF/-CQ_%QP.*9D12
MFTIE1U*=4M#24OM94XMO\\0WC"O%:F__`&L8^7']W@=C@<%N-MH6XXXA#;:<
MK6M:DI0A&/'.5+4K.,)3CPS\N?D^3@,+1GRYPM&<+_P/!6,^?Q3E>/+\OY+\
MACQ^3^Y\O`)<;6I:4N(4IM6$.)2I.5-JRG"L)7C&<Y2K*<XSX9^7PSP/FN5%
M:P\IR3';3&\F)"EO-HPQE>$J1A[*E8PUYTKQG'F\/'&<<#D[(881EQ]YIE"<
M94I;KB&T)3A249SE2U8QC&%KQC_GSC']W@<E.-HRA*UH0IQ7D;PI24Y<7X95
MY48SG&5*\J<Y\,?+X8X'%#S+JG$-NM.+:5Y'4H<0M32_ESY7$ISG*%>&/Q,^
M&>!^H>:<\_INMN>FM;:_(M*_(XWX8<;7Y<Y\JT9SCQQGY<>/`9=:2I"%.-I6
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M2KPSX9\N<9_$SP/W+S*<MX4ZUC+OYUC+B<9=_$_.\9S^3_PL?B>/XO`Y96A.
M,Y4I*<8_%SE6,8QX^'AXYSGPQX^/`_<YQC\7.,>&,YSXYQCY,?BY_P";'`^6
M),?+&)6'V<Q5-X=3)PZC+"FE8QE+F'L*]/+:L9\<9\?#/`-R([N?!I]ES/IM
MO>#;J%Y])W*TM.^"59SZ;JFU82K\164Y\/Q.!S<<;:0MUUQ#;;25+<<<4E"&
MT)QYE*6M6<)0E*?ESG/R8QP/Q;S33:GG'6VV4(4XMU:TH;0VA.5+6IQ6<)2A
M*<9SG.<^&,8X'/&<*QA2<X4E6,92K&<9QG&<>.,XSCY,XSC@?O`<!P'`UNY%
M90*H6HW!]+VT-6SA6'ZR,N,^U#QDJ7']5O"D96UZK./-CQQXX^3QQP/(D+W`
M[(-]N)'6XI?=0D8-8+5^UESZ*W[+(M5"L*M?-QM:AA3)G*QVXPRK>])+KS)?
MC,"FVI+<7&5Y3P/9K@.`X#@4JV\3,TCL:%O#NO=G6ZKD]$&*>DGKJDDKMB!8
M6=C5\[B`5CBEYD#\R1B%.,K<3AMS#:\85YD^&0^/T[Q?K+]F_L#6[@/IWB_6
M7[-_8&MW`T5RVT!U&PFU]?\`LYEO:I`<4V`W]"NP,-V.6*"B:Y$]I;Q+\D>-
MD$$CQ766<-LOLI5AQ*O4<\P:WC&H69KY,7UR[.UTH[<"%^BDZMIS8E<F!K69
MKL*I'B5>4)F1F03-BKP]J.1B1D-PIWE]1YE;OY/@?>E2M7:Z(!R5)T!VLK[P
M2D@==Q(T/5>T5C9%/J[YJ57A147))OP#"A$NQ3767Y+;DA+DC*O/GP3X!*_T
M[Q?K+]F_L#6[@/IWB_67[-_8&MW`?3O%^LOV;^P-;N`^G>+]9?LW]@:W<#7F
M=F5./;"%Z9T'V4;MQ6N"JB0.8T5=\R95;"$RAD4)6TI_,1+$(F:E/)4EO#F5
M/9PI64X3C`;%C?$9.<*3ICLYC*<XSC.-#6[QQG&?'&<?\N,\"'\-:5Q'(0L]
M8.QK@T@%N=<P(>TMLIX,)!;%RXJ^#*P(=*+'5*-;5.J]M]V-Q%.85E.,I3GR
M\"68V[Q\.+$A1M*=FVHL")%@1&<:(N*\,0X4=N+%82IQ2UY0Q':2G'CG.?#'
MRYSP/M].\7ZR_9O[`UNX#Z=XOUE^S?V!K=P.#N\H3S3K#NENSBFGVG6'4IT3
M<FU*:>;4VXE+C2D.MJ4A6<84E25)_%QG&?EX&GT2YT#6(+YLT'KOV3K(#VMV
M=@7%TEL*9'1*?;99=<:66GD'V4J:CHQZ:%I;QY?'"<9SG.0W/Z=XOUE^S?V!
MK=P'T[Q?K+]F_L#6[@/IWB_67[-_8&MW`?3O%^LOV;^P-;N`^G>+]9?LW]@:
MW<!].\7ZR_9O[`UNX#Z=XOUE^S?V!K=P'T[Q?K+]F_L#6[@/IWB_67[-_8&M
MW`?3O%^LOV;^P-;N`^G>+]9?LW]@:W<!].\7ZR_9O[`UNX#Z=XOUE^S?V!K=
MP'T[Q?K+]F_L#6[@/IWB_67[-_8&MW`?3O%^LOV;^P-;N!%>\]DDK_I7;=$K
M.D>R<FQW36]TJ@"/,TE9AT1XS8*_/%#6Y9"8MJ)`BKF2D8<>=4EMI'BI6<8Q
MG@>E_`<!P'`<"H':CK&'["&NOY=^I:^+E-5[8G6J58K?70YHN`KDS5.SJXTY
M6U$A<]QZ7#OQT"3Q$]1AE;HYM_*L.QVN!7#K'TIN%?Z^=@--[4$5_6X_<M'J
M-!R"H=B79(T>TU[2X76UVWPR0Q`#MM7+9-R'Y.9<4W[Q>7#C2Y[N9[SZ&@@N
MF=!=]V':E'V'V"K&H[O:-@G]>[,WM;_?J[((HA0"O<,':FF*/6[!6V9%BUSM
M>H6FK!%M^6'"E1!3RR$?*H8]#P;5U]Z'WG1>[^K5JQK'73M3UIU3U'J:SR:>
MWJ.-'K.VJR7VR2V'<H\>U:I(W=>+'\]X2\$:P6`D";[2_>/KM(;1P+O=AM3W
M#M3UEA:\(Q3NH[-=+1H>RV5@/<685NUW'INY==[#LLBLW$/#FPE7"M#:R^\,
M>PPN*^09:0\C+*W$\#RA$?"^[4PJW\V57R@M`"\.D:!G""4J7=YX;0&IMZ4;
M=NOMAD7[I",4K8MW38!MK<F`28#$:8FW/-2YLAEO#20L#T5Z.=BNMFX$7+9A
M.F7&DR6[+78-6C6-]Z%JTVB@:U#S=VZN&M5D0-@-[L+T^>.FU9QIM%+`X%0`
MTE,-LFQ-",H_2#M;1^R-OWG4JG3["(QV<L.WWZX]L.IU>?L6O%-L['MM66,F
M@-9AIS9&N5"^+C3OGJ2L<M#S;44,^/'I?:D!E)'1W?L_83NQ[)IK5=Q$1-@7
MBX;4U><V%!?A=NXNP-D;3O%":V-(EU.4"S-ZS";V,@BFS;$^.\L8MF%EB)'@
MY4&#_P#3T[#C*WM(3:ZU2-M!KU?Y%[I%5'[%!L/Z+`#]NW^S0]+U")MO4=WU
MKM?69J%<(-@DL6H,P]+*193<MW*XE==&!-7:?ISV&W'4^E,<%!U[F[Z3UP0`
M720(,"0M.JNRI>-$3A=BKB[I2+W=FZ*')ZV)LJD5V8!NS<%]M$(K%4](7P-#
MT'U([,:!.:HL\#4E6L1BA;IWU9[QF#?M4U1=X`[9'7R#7K`*)5G5E9,G%5SW
MS%4\U<)18RG+[F&IJD(RA00XKX>7>H!">+Z3+Z=T[;Y6CR6C-E>WV4A9QN\R
M381,R[[B+.,U;SA[;V(L\`9%)%7D.6`;#'^TN.NR,,H0'H#VMZOW/9NP.N4K
M7M"I9<5JW5'9VAR+M93,`<<IDS9FCWM=T1(2,L//*SH<PWY$D7(\B,J+&\7$
MI?5^9\"!*MT8[$5;HCV"ZRV`_7]B6L]L/5+FK"4RPQITP_I_5]/ZU5P.!NY"
M]U2QUQZYQ0FJ"(AY1$:5%%LL,2IK2TS)+"0TVF]/>WM%U[L;6\:H4TW'ONL]
M.0ZT<SM:",33"FDMY;MVX"I%D'#*.'$J?.UJU@@KTRMC1]?@RLO)@C8HR+&C
M\"3^I_4;=NK^W%^WUM&CUER+M1HY9HA,38-96>3JZ9;;3MBY$Z0\7.ZOQM>2
M^-S=X8[UJ_81X*7G#SKL-S&,*6$-;\^&]V"W1MTX7"R]8TB.YN39VP"VX3\&
MN;0F[6K5WD`"VI*U>M476I%0%E$==\5S(F,-,KD1DQ)>7!*XSCKZT!*':;I1
MN_;G7[IKKVD@PT2S:2U\4JMA@&=A5^PXJUJE:;A4:M'V;U?M:6PI8QU9M,+#
MLDT)A@KGB)G,D5+'35>*`QIKJEW-O>D:9H5;="UE(U%NS:G8$3M#-S*W*%L"
M\#=F[#VGH`9`KHYRNGJV('W>TBBI!PG)FIB*#-L*C3T.*QD(Z,=`NSMHIM%A
M#:CJ+6>P:=;[=;MP7&!L`H6^_(<+UG<$B=3=J/P*F./B*7LJ?>XH,R7Q*<L<
M.%.GI82N%$89G!=[M_U]ON[#G5HC3M7T.>[K6;N><=)V(V(A2M:?/WK9L75=
M>C5;'N*<^40S=KB-DR/8UP\-1Q"7D86ZAA&`H/I?X;G;W56P=:GC]]IVQ=?Z
M>(4X/'H!NU&7T[EUI6*_U;K5,%[&+RPV)[-QTHC6)0N)D)=D#SYJNBUDFO"<
MX[!"UO:7J=V*V[O6X;<JY&GD:A+TU8>LT+6$BY6:A%;5J/8U'LAC8IIS80V!
M9AU.L4K;SE;]F:S7"JLPJVEQ3^&I#L-8=>1TUVK?.F-*Z[V(;1*+(@=F*-L&
M0&%B-:S(PC3]=[!CMES(9VLP=>OZ(-W^568SRID`=5XU4D3W?*U#;1G*N!!E
MTZ![ZKVTUVO5E3H)*'0MI:\V"#LR+0"UX>VYKBJ73JB;#:()@ZM31M<I8G7^
M-)'9\%AJ,BOL2Y,7,&,PH@1]F"7]A:/[07LQN]LIH^H&*1N#=77'?ABG&-N@
MYXJP`=4T/1];OF@K,)E5M0PBW8R&MIKK+[GJ!"&%,MS$MLO/^4*CTSX;?=:N
MTV#K>^V'7FQ]&U4W<[_4=0@KJT)LX.WV,S0[3'9A7&_:SNE2N@V#FXW$*@!:
MA,ZKS!U6#-2&$,FB7LH>P_5K7^R]<:]HE7V.+!""-<U'2*P^/I!Y7S`&DPQR
M[*]T`J8D9$AAB0RMS1C<^?#<;'3G<88AQ(L2&RA06DX#@.`X'2)CHA<:0$D&
MLO0"D*6.FLX6XUEV)-8<C26L.-*0ZWEQEU6/,G.%8\?'&<9X%7QW2KKP,D5J
M0S3YSZZAL=6W@'MMFL$U<39CKD5R7<W),@@N9,-$?86425O..)D--I;6E2,8
M3P+6\!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<"$=I]AM6Z;L-,J-Y,SHM
MJV+%+OT*NBPA8X8N$H+8J+6)H<!"%Q9+L\U@EL0:YB,G'G3"Q)F+\D6'*>:"
M#ZQW\TK<H.J)];KNXRC6\)AO&KFFM7'FY-JKU='U@H9O,=A_+2H5,A0KB/5F
M7)]%:\O9PAI64+PD-YU'V^U/O&J7*TZY@[%+.4JL5:[3*I,UY9`MT-T^^AR!
M[7MEJH`O%ANV$3?!@J2L8MA>5.KCK;<2VXG*>!I=+^(!UYO(>LDQTF^"IUVA
MT(E2JK9M?V$!<;:-V?+V'`H1`#79\=$V9$LDS5IE#2LX3Z66&\O>DEYK*PSF
MN.[FEMJEM/!J?$V9+G;KUO7-M5I$G6-NB^X*!=9%IBT2QWY&1ZWZ4.NC]+))
MA/34(90IEM,E<=4F+AX,-?._G7S7.PSVK+&]L'-T%6MO7@,<*UO:BL?8>S'`
M-$LZM:ZY(PX*X-GNC`'9(B6Y%2XVA$=YUW+GIQ):F`C]WXI'558,W91+^UK*
M!!@;)9'"==U#>"+<\31*Y2[9LIP=']V,S7)6L@FP13AV,ZTU(B.2%-)0XZP^
MAL)3/=V]3U<T<K%AJ^Y!-H!TO45R56Y6J[+[X++WI9R],UE3@,=EEULM?3]F
MKI.*X,;7ZD+`V4])4RPRIW@=[17>+K5V2L#]6T]?7;0>AR342>-=KEB"RAT@
M!4-77@DT08-C![T++8+<`7RY<2G"Y>9<7&<R($QMD-$?^(OUYBCGS<F%MMJN
MH-WX7%L2-36^6*)B]3&#@7;-U@9@PY4U5%UD_7WG3!)QEIIEAQA3>'<OM)4$
MDZS[B::VY](S=(7=2<S6M;)7*<,51+&V2M51'6>^TI-BU_#3"<<N<$G;M9&A
MT-N'YI4B1$QY6O(\PIT(L)?$RZB0&Y9&+>3]BJHH6(-GK[5:);K%0JX)L$`&
M^`GG;6,$OC(+!@Y8X@)O\DI3=@R\/>PU(B2TL!N3_?#KRQM&/J3WO;GK(LQK
M6ODB$>B6=ZL5TSN-=9C:M@6`^@?F(.7=B=P'PHB_!;3<M_R/K9\N<X#K;7[\
M=>M+6V]TV_3KQ`):^RF$5FC]?V<P%)V95&`[*32:\5'0I$8M;E4:RQ"*8N,H
M0IE:DX<RZVM"0^Q/O1IL(^4BF:_N0?)!QJ]&.M?1#=""`EXN>!KM%U,4EAQY
M*!$VE>(QT<Z,%*=_-\$X2%.H=E,-K#0,_$ZZL^2:M,W9KGLA'%6;;1J>[>T3
MME-0@,\GJ&'%4,3)^E`$S86$S1;J&O1=0\WZBELN)2$NZF[G:1W??7M=ZW?O
M1LV.A/YLLI_6]T$B*/986):B&O\`8$PJ'B.4:^CDCY"7H!1N+X/L.1L.*E)R
MSP+6\!P'`<!P*H[H[#;9U=<6JS2>E?8OL`&<"P2B[WJNR=9Q-89G2Y,YA^ON
M1=N=@-96O)4<W$;=>6D:J'E$EO#;ZUX<2@.SI'L!M7:MI(5^\=->PO7D5#!O
MEH]SVQ8NMQ>NDYS,V#%;KD*/I_?6T;*@O)8EN2$+?@,PL,QG,*?2YEM"PB27
MW&["1IDR,S\,;N=.9C2Y49F=&NO1Y,:<RP^XRU.C(E=O8\I$:8VC#C>'6VW<
M(5C"T)5XIP$Q,;ZVB]I"9M9SI[O^->8QK`MGKN]8>NBMLSX62\8;FP12[&]7
MM/)%8AOJG>1VTM2_9F5)]'U\H94$,-]RNPRW&T*^%_W2;2MQ"%.+NW1G*&TJ
M5A*G%X1W!4O*&\9\<^7&5>&/DQG/R<"9MW;[VEJHZ#$4;IYV`[#P"H3)6=9-
M3V'KF(#UV=[8]&^;I9G<.]M7&GBV66\/^>'$E0_26G'K^IYD8##Z>[&[>V7=
MF*K<NC_9/1`-X81G.;"V=9NKQ2IQI4)+*HPAZ)JKL/LBX*GE<N9PPI`M<=.4
M9]5UO'ESD-'L7;G?82PGPHWX;7<"U#@YLJ*'V@'<NEK`2RP1\^1$B6`,P>[8
M!CK(HU'93)C(FPXDQ++J</,M.>9M(2E7=\[1-:<N.S273_?U5N=9(N0@VA3=
M@ZZO[0OD9&`_E*U@J!WH9U/%@N^\GO*DK91K^/87O%O'F8]8(25W-[$I2I6/
MA==UEY2G.<(3=^BV%+SC'CA*<J[B)3YE?B8\<XQP)NV_OG:.M8E'D4[J!OW>
MKMK#R"9V%K*P]=A<G74UEH8XV!MJMJ;SUS&F$Y*I[J$+#.%8F%0W?,\G&6<N
MAJNJ^S.YM@WL)4K7T-[/Z9`E<$,SMD;#M/5$C4*][$-ESH^"T/6W9*_71[)2
M3'1$8]C$RO*^^C+OIM86X@,->.UF\ZI<;-607P[^V>Q`P$S,&"[Y4K=T[AU>
MWPHR\)9/`(MQ[2U:UQQ<]/Y)I!$;!EXQ^>,HS\G`D&A;ZVC;]=;%NI_I]O\`
MUI8Z5'?>KFJ[C8>NDV[[4<9%J(-Q:/.I6];;0X+\F4G$-&3YD*WB1G&5*2SX
MNX"%,]S.Q'AX_P#I=]U<_)^)B[]%_'/_`"?+W#QCQX$V;)WSM&CTK7%IK73_
M`']MDW=QZ)EEU]1+#UU@6O5$A8J"04+O,O8&]*349\UN7+<A94`*&F/:(SF<
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M8Q'>A-L+P%L)9S+LIO*4J1AU;81K4NV>][%::W7R_P`.3MU211LX+$DKE9+A
MTSDUZIP"$QF+*L9V-6.U=ALCX@,RYF1(0/@39BFD*PRPZYY49#:]N=DMPZXO
M1&IU#HOV8WB!A0QDF-L;6MGZLC*B5>GQ$2)4"%#VCV,UW<VY0AY66)&7Q3+2
MG$YRRMU'@O(;!I7?6T=I3[-#N_3_`'_U]C@@S1063VK8.NI:';YKCSK2P`!&
MHMZ;.FQRK*&\.*619@Q,H7CRO95YDX"$\=S.Q&<8S_Z7?=7'_)F[]%_''_)G
MP[AYQP)L*;YVC`TF"VI%Z?[^,7@N8P,G]>A]AZZM[7K</)`I#]^F"Q'>D'4#
MPS$>`U*\D*T2Y?HS&L>CZN'FV@B(7W![`$"@R!+^&=W)#19Y*!!E&2%TZ2.#
MP\:9+9C2"Q!L;VXGDG((QEQ3[R8S#\A3;:L--N+\J,A)VZ>PNV=77!FM4GI9
MV+[`!W0D(JN]:KLG6<368\Z5)GL/UYV+MSL!K*U9+#VHC;SJT#50\MR6\-OK
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M`F?=V^]I:J.`A5'Z>=@.PT$N$R5GV+4]AZYB!-;G8EN1L5XPSN#>VKC#Q;+*
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MVEO374.84DKGNMH4&=*Q,*AN^9Y*<LY=#5-6=FMS[`O8.I6KH7V@TT!+>W^W
M;(V%:>J!&H5WV,;+G1\EX>M^RE\NCWO.3&1$9]C$RO*^^C+OIM86X@,1>>U>
M\JG<K-6`7P\.V6Q@H$Q*&B[[4;=T\AU>WPX^4X:.@(MR[256V1QDW&?%M)$;
M!EXQC\FRCY.!(%`WUM&XZ\V+<[!T^W_K*Q4F,^_6]77.P]=)MUVJZR+<(-PZ
M/.I&];?18,B3+1B$C)\P%;Q(7C*E)9\7<!"F>YG8CP\?_2[[JY^3\3%WZ+^.
M?^3Y>X>,>/`FS9&^=H4BD:XM=:Z?[^VN=N\!N99==T:P==8%LU1(6*A$%#;S
M,OV]*73I\QJ7*7"5D`4-,^T1UYPYEG+;JPT.@=J-X7"Z5JK6#X>O:_680Z3;
M@$]@7*V]0)M5J45;3KBC!Z)2.T%NMT@>TIO"%)'C)TGS+QX-9QYLX#N;-[/;
MIHEZL%2J_07M)MX"&>B-#]CT&U=2Q]0LZ)(Z'->D!8>Q.R]&N;#4&3)7$=Q.
M%0UY?87E"5M9;<6&XZGWQM#8@38!6V]0=^Z3G4T0T2KU>V/8.NQ(KL^8Y#+2
M5`Z6[K+>>P1$(DR\.984HY*#Q<NS6<X>RC#RV@A%/<WL2I*59^%UW61E2<9R
MA5WZ+94C.<>.4JRGN(I/F3^)GPSG'`FRV;ZVC7=2T;8HGI]O^ZVZV2F8YW2-
M<L/72-LC7+3L4E(7,MQ.S;UK^L)D>.[!:97@-82KF7);64I4C#JVPC2J=M-\
M6&T5P`6^'%V[I0HV<%B25QL5PZ92:_5()":S%E6(Y'K7:P_8WQ`9AU4B0B!`
MFS%--JPRPZYY49#;=N]DMPZWO,^IT_HQV8WD"APADJ/L;6EGZLC*B3?GQ</R
MA\*'M'L7KNY(EB'<^C(R^*994YCQ96ZC\EP,_I3?6T=IDK)!N_3[?_7R,#"M
M%!A;:UAZZ%H-MFN/K94`!-ZAWIL\A'*LMHPXI9!B#$\BL8P]E7BG`0I]^9V(
M_P#HO.ZF/^3Y[]%__P!7</..!,Y3?FTQ^E`&THO3KL"8NY@YD40Z^#[#UR;V
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M/SQLX?);ER&&0HEK[KR9JB=!UL/T*^(`#'Z-MI&;031D5\'\C``QKA&I`$T2
MM<"+>9J;&3'0J1`D9L>(3]Q3AIWTIKBEX;X'H@(5GHL*KVBNMGP^MY[7I(BI
M5AR?LO3TOJ35XEK-P8&0+LB[O7[=NG+18[^F"(9=GD'1&67_`%T>F\K.%H;"
M#=$]<JQL>ZT'%JZ==J^NAW16M=3A=5;JW(>Z=VJ8,QI$ULERJ!`,K6.QMN6*
M+8+`O=12472Z.BAR,87';<RVIOTI(0M6Z1L6J2.M,=71;XEML']4`5/J^OD'
M;A\,/UC3&NLF(59-3K`)WB"M=<D$`Y)N$89KTH%#L@^%%9*QI&$O8="QMOTR
M%/ZQOW9$?TN['UKLOLO>E/V8Z$KTKIP_VDHYVAIH=9KA8'<K#LLCIJ;K1H5K
M"#+>!D;&4]=B;(2J+AU:6F`J+KWKJ&HJ;J+J_P`,WXA=9?W)0+QI_;5Q<V-\
M/-PW<:ALT93PI&?<"L?L9*)D95*G5E9D0\TTX[`EDR3;;3L63B$D+=]MJ#>&
M=^62Z570_=W<$ZT4S0KX2X:)/='Q5"UC9M#W^_7*CRJ\.WO>Z+>2=PBD;L9]
M[-%F#`"<,.X90C#K2,Q@U+HKUOJNO][#KJ.Z<]QNO1BNZRV.`<OF\MB]7;)3
M+FB^&]3SB`TZ(TON+8-E(7.*1H;A`3-<@1HT1!0RTM[R2(D=H(5+:D7#`8J-
M-^&;WWI2VRF\H5MOE'M?PX(-IVY4=_'3A':E7O!4IV'<=*@[7@KY84[,6+8!
M3#+&8\IA_#JEA:_KEK6%U9U=?-VZ>Z9=F@%QV2;BPKQU>=L/5#&PK,;B7FVD
M6MQSR@S;(_5CIMT1<EQ9$A5O]ME@QL%M^(Y-C^985)*ZBE6`?$IJ_AM?$/`Z
M^,>^1.PJ9`V%\/&)6-A@#^^K3V+A#;8J)V2<.B1M.VK=R4^,Y7W1LZ1$>7&E
MN3$JSC(29?NIH'0FZ:+L2M]7^YW;O;E9S0[F)[*TVT=+Q!.ND:>\2JN:5Z&Q
M;YI69#39-816:]868`7W<3".,/8>P7;S,:#M/=7ZKW$V_MT]M#IEVWZM6?<U
M/+C;_NFWV#I<;%V.JMUK4]2@:>E0*9LK>1LK7L$-7!['!B$0\F$R4A3?/);C
M3WX4D(YE4+:0GYPUT+TS^);#`2;13K8]%I%E^%S3J>5VAJ&578NL=QBJR'W#
M7X0Q\'"H8-<<$F%#KDSW9&>GB5R\OK<#.C^D%*CZ?MF^P_6+NE4>Q-ANTIVU
MUR'9^E3_`&6V&T0M>K[/+,%#4VYFNOLREXV9K<=>&!LDRRN"1;G-18K,28L:
M\'4UI6;_`*WVY3-MP?A_?$@/'*B0NQJ.U;+Q\-:;DA;MI8LJMDVLW:Q78(9L
M%P;;C-Q(&I=9C$V:BT:<1-B"F'F&,(#WC3G*DI5E.49RG&<I5X>9.<X\<ISY
M<J3XX_$^3.<<#]X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@=,CD@D?/
M4);AO%4PY61C)%Y^,/=(887F$W/D1F)4EB&N3Y<.K;:<6E&<Y2E6<8QD/!J5
M\7G<VK*6>OG830&NH(,1VN[*=26F-&VS=&X#SUPZTZ4W[LHY:%UD7HMFQKJ]
MJLVHH`Z.MB(][L'$I)">MEJ&I*PFD=\1GL":);$S6.LU3N\6O?#1TCWQH=2J
M>S3DG8]\NV[T7`>$TFR,F4&.#9:A6'799O!*+,FS9K+T),8>Y)=6P@+E](>R
M97M-H].QK'$HPNVB;S>-?VT'1)FS$QP)ZF&W1[HNRU7=&L=/[:UM<TP5L.D:
MY8`$0@,<>QCSR&5LR'0JKVN^(WL#KYW:U#U.I6CQ6UV+]3M-W,PF`>V$C9TL
M5M;?)G2YN50JY5]57*ENP]3AQ#MJ.2;,>K4!0>.^EN2EUO'B%,^NGQKM[=I*
MQ7ANJNLFI9.S=C[,$:^UT4-[?V>!TW`*1=`;?[);(IFPK&;T(+N$;8VOM?ZN
M'IRD$)-UXDJX#),<IEEF6E(31K?XM&WM[74;K/2/5ZL6'8=FZ15#X@M,K9_=
M@T7(L6F=@:YK,VG:R2Q$K<TO`W<3W/-*5UQM^&@%'"Q8)M4S*2;,-L/1?I;V
M><[CZ5C]B0]((4G56P;$7E:)585RXUQN>I1[<(:)V#;ZU,@PWJ21M5ABDW(8
MI2I#K8A$.0Z[AV2MA@(PW+VLW;7^UHWKCI#3FN;]!INL-3;JWE8MB;=E:P)0
MJ%N/<-LU$`'ZJAXI5C"66W@\:_.&9;)6>*BR&XT6`P[F3.PXP'F5??C\U\5K
MK?5VI^O=9>EJ'NC#Z\"3]MV=;B5),Z/-4_=!BJ]B+'G4>K-FWRL(LMIZ^V@8
M@&V#FR8D:.S/D.(CN*RD+3:>^)UMF\[[UY0-A]91.L=<;!OVD=$R94C:$XSN
M+7>_=Q]&QG=QBNVVAM4&+52%)"AO>-:?)0SV)[1**U(<@)8>=Q'#U.V]:+%1
M]4[*NE0%A3=HJ%$MEGKX:QDIX8`5+``<XK!'&"PL8:(C!TV1$2VZ^Q#E.M(5
ME26EYQY<AY,#?B=[N1"^'O9;EH37-'UYW!U-HW9M\V>8O.VYNM**;[`V:NB*
MAI\%?JYHL_6@.QH0*TQ)L1R^O4T+:2*O=`J:J7E2FP]BK=+L8^J6>?3A,$_;
MH5>-2ZL"*$5B!AJQQALEX&)(EFXTUP9!)$T-,O2$LNJ9;7E>$*RGRY#P+O\`
M\>:N5'KF2[)"]*CR]4AD^KM)9'$MG#JU)?VML#49WL;VUU\J<7"LQ$E^I^C`
M^'W64^>2;L:\BL-17O3RX'J+JCM(>W13NWYRE5.L)*=>-M7[5E`60M,]ZL;'
M^;FG-;;2K%G,%AH"5-KPFPO;$;CNXB1R2V8S.'V_64OTL!YNY^,%N$/K[K!M
M:R=<=;+INS.GNG^YV]8P/<5G<LFOM=;MW32=4``^K81#5,>!LBTU,=?X98G&
M)/U]N7F+(BPW5N984X'NG:[&/IU7LEN+)DJ%58`8L9-,-KVB6H>#'2"<Q,5C
MS(]:3F-%5Y$>./,KPQXX\>!_//+^.S<]:QM1D=]=:*K6P>W*YH_=WO\`U[MH
MS<A6MNL_9#0_8';-#N>P'2NMJPZW;-=6#1ONZZ,1$/"X@DBLK$EOMQ'&%!?7
MK]WTVMV0ZJ[[WKKS0(DALG3Z:*[7-0)O\G&-BOV/JQUX[-E*]!L[E6:2)L+C
M&Z9@(7AR*Y&D3($9U]QAN0YA@++]-.R<GMYI`5V)@4N32]9[,-&#6BL%WYJ+
M3<=*I6Q$I6R+6!G#1S].)W[T))**)5F0[%$OPU/N)D./,,A4W?7Q0JMHCLE=
M.JIVM5]6WIEGZCA^OU7FVHA"([J$]B]BCZ!>##:&:W,CU_.IUJFR_24Z]DHB
M+Y&\H5AWT@I&$^.Y9MD5C7TO5O7/SV2[$.KE>FQ;8*[(2XPBR[]UOV[V)8FJ
M_5]?==;AM+:E;J#/6!B+`,U8$5&%_?3KZ7VF![Z\A:'4OQ7YMW[OP.C%OTVQ
M4[]+VJU28-G18+$R&M=/'])8O9ZZW6K!;12ZW9&"5#V-,B50L#*,02`^(8&S
MI&&GI*H38>B7:[;E]T3U\V7M?5^JR>Z[]410Z16]9AUEO>-CED3PD-(=8B5X
M+9;.80`@$7B;HX0-(&23,)<4?&?F/,-+#S^I_P`2C8EF)]&5,4/2AVJ=EF.U
MC6W+)3]@;5<F:U*=4QYXI9AM6IUYTK0[E)L1.."7&G`;1!K!FNE_6@2VG%QU
M.K"NH_XWA^LT'5^R=N:9U7%";(V)U;)G*[JK=%DO&P-(]9>TVBMP[Y%[7VW6
M#FIJ@V@QK.FZMQ.+)#R2(>?`]Y.19B713K+P?FOOC/;:V)2MX;1']=:C"I.C
M>HH7LH5C8*;]-.6`T=Z5USME$J4?:('K[.T%5X22%G9"(P9L\(U+CMJF1QSJ
MG8[#H>H_3KLO=NP$+<]7VMKZM:XV]U^V<(UIL`51+F3V!KXPJU:DUGNZGV6F
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ML\XII+=NB:_N:S[PK8\A1M8V>M;`K0>)I(E"#$&Y<)1*;(CNJ;:B+P_D-,UG
M\5KLIMW4NOM@TWKIJF/8-W]E:;U^U+7;Q9>RFO:NS\XW-\/S;#:-FV?K#%JM
MNC18&EL)2]0LVZ$S)G^62\RE+.9`>LO4_L&)[6];=,=BPE>(U&#MVAAK>NJ%
M94<A.K1&6TI@T`<)Q&V8A=H.9C/QVIK2&VYC3:7TH0ES"<!87@.!_.MJOI3V
MQKFP^M5DM&J;BUK"AUD,)V+K&9L76^UY,W=8T1KYBZ[\2+MV\:[6*Z(V+-&/
M(8?%$"1F,L8[/=$-223B%A-]KZ4=EZI,(R>NHVOT/-;[-;-[.BTOW<HRSL%N
MGR:J,T=I^5B#:&,Q:O9JS:;DE^&22L)`>]F6^QES+:V@U&;U`[@3]=U$)K8'
M:M'6\'J:ZUW=9TKN`5?7>Q^W2+VA5%;O";<NY&+26;Y*J!N2S8?]3/+3E29L
M*)G+"7`G_O%H+N'M_9-EMFF9CL2EB>OU^T$&J$'8\RF%;C]\%1M@B-C7P?-B
M6(6&`&M=VJ)0I@J5.8R49]SD?=[S.)2L/A`>B^H_=ZM=A6;/M1LT;*!MMZX<
MKG86/N"+@%G1^LK/MB#=1]@H$:R^_"%G[#ZXFUQ,X2H*^)C&9#TQR4PX-B9<
M#']J.D_;Z[[RV]L>GQI=EH=]V[3B8VM5>QUH98UT:LSNG\LS$O,*Y[-J=5VC
MKTR%UO<FA56??KZQ)S.7W9$J*8<S$">B?4.ZUJRD-SZVU(1&6D?3^B1>!51=
MJJU6M1HSJ7>EEM?9*GP13&R".M*^=MVL8`.)Y,FE!"*V&(:B&66EO("DP+X>
M/Q!&S-3.2;N2K!HELRGVMZQ5C9"&[#17:O*ZVW&%]*1:1;I;6[-61"E%.CVJ
MW%A1'(,UJ6K_`+1@&U*BAZ/2NK>P=H]-NI-!W33!A/=6O;'UH/[0%*NKY.(%
M0*V#1B6^Q$*W-$8N;4*=ID8M!SA:UY*Q?S/R94[Y>!5;'3[MO`+5UV[B+!N.
MMP=]=>K96Z]`N]-#IUE1*-W)[+[+NK,IPU?PB+?"QI*\5^.M*LO2IS3K8[+"
MT15I:"R>D-$[]I[O=<9*IQH!$VA7;F[1+1:-CB#ESM6QCI_;\J-)'6"KVET2
M0I\(58A"11HU7JI:X4;+(R:B?'&19#(4NL_P[.UM1I#-?I1JPW"Z634=`32C
MU6V`YK37O6';X)RJP=QO!:B9V8<,O1=WZ\KON^7.A2CV"!^3.<?9&09RW$A/
M'7+H1LRB7S2)[;E="VB?JW;&R#A6RAK"X-ITNESM+TZ)JY--UN_:C+U8CA[_
M``WUE!DF400Y<,%#<=U,,DPVR%?9W2GMQ.TP,J=<U=<Z5<TU_9D'6TM6\JQ"
MSI"SF>T.R-B6BP'YE<V62P<1N?KL>#5&$Y`=+/P<PE0I;8^%X2<A;?6_7/ME
M7.H&Y-0[1FE=F7;&\=9*`O1MC,M67='6S747KN#/`IUBF%A4.MWC9^M-?'1)
M9B5-A0YQJ9)?=D-1YRI&`I>QTG^(K6\;`FUZ=9IM)NDG89RO:HF;RB/V#6D4
M#KVIB]%4^L&R-IR%\RP)@C5C+>228+)&K#YJ'W8\A<M8>J-.TYL>P]K8.^#D
M;9-!U20H,JW2-*6BZ58A$"=D&<OZI;N,\;2+9;1#N"&CX[:408A&4"1+>]N6
MTDMYW4A>_@.`X#@.!\7Y$>*VIZ2^S'93X>9U]U#+:?'Y,>9;BDIQXY_Y>!C_
M`'^"_P!M"?UQA_HW`>_P7^VA/ZXP_P!&X#W^"_VT)_7&'^C<![_!?[:$_KC#
M_1N`]_@O]M"?UQA_HW`>_P`%_MH3^N,/]&X#W^"_VT)_7&'^C<![_!?[:$_K
MC#_1N`]_@O\`;0G]<8?Z-P'O\%_MH3^N,/\`1N`]_@O]M"?UQA_HW`>_P7^V
MA/ZXP_T;@/?X+_;0G]<8?Z-P'O\`!?[:$_KC#_1N`]_@O]M"?UQA_HW`>_P7
M^VA/ZXP_T;@/?X+_`&T)_7&'^C<![_!?[:$_KC#_`$;@/?X+_;0G]<8?Z-P*
MXR.LG5.4R['D4*DNLO[-VON1UM1F;X+V;O*GW*@;8M^?`SC."-VIVPC,"4G'
MY@EJ>YEI#:\(4D-`?Z*=&Y9:WF9VJ:>2DWW0-=ZMVV$4N5J*5\QH.H1(4.JZ
MX<JQ"V2:S%%UM,!MV#(8B-3XLM3DEM],AYUU83EI;5&C>O--<H6H!P:JUV4?
M-VPMZ]J*V@_9+99).)9ZU6ZXV\X?N%QLY=Y*,2")6?,F.-M-MY<\C;:4AL#-
M1U.QLTAN1F+7$;-*T0/K(A;\%4^\95$K]@.VD/6W&\SLPL0H%@LLZ4A6&L.Y
M<DJQE>4X3C`5-._#J^'W8:[%JL[2])AB(`#6M9@9KMVN-1+#Q.H!5VKVNTC[
M'5+D%L4$C7JML<Z%]N:E(G3`11\9*>?@+]GP$H5#J?T_H%MKM[I.L==U6X5&
MT/6^LV`%/>'$0A5[4@31&(8]V,60EBK1M15H:"C@\8]R1H8^+Z41#D=E:`E_
M5U-U)I77M1U1JV'6Z;KRAAHU>J-7&E<.P`8:)YLQH$5R?/ES%M->?/AEQU:O
ME^7/`B3<75;J5O\`V!2-I;@U]2[M>]>,0XE9.SCY.#_J`NQP[D#&6,8'.C@]
MW$5NYCF#0J(;CD(PHPTF=$0S+QZW`TFN]"^@E1(5`I5]`Z9`3*,"K5;`9$L,
M08ZQ-0%7$'7F[%!8((@W.9!$;".1U2S+<^6^T6E8>=<]9?B'WU7T:Z/Z4V/7
MMMZTU73J_L*I54#3*K8'[A:+#FM`JO0!NJ0/N$59[69""#0W5XB-7$%(\9LH
MH&UB"J0J-E360L[>P^O-ETJV:[NDL>5J%XKIBIV@7'LLH*Z2`'X#XPO`06`E
M!AD?[9`DN-Y=BR&7T85XH6G/R\"I\+H%T/'XTFB-J6H^EUXKM6J&J(TF\W*;
M$#5*AVU-]U_5K##FW&1%V)6]>7="2]=@V1!>*!))3('HCNIPK`7;]_@O]M"?
MUQA_HW`IVUT:Z'-QFH#NA=+3Q;-ZW1LU`0S!@G`&=@]AGT/[CN#@`S,G!GCU
MT]/TW)"V%+B1U*9B>@RM2,A@*A\/WHS0"UA,4FAYJTFUU"?1;#$";NW`/!%:
MZ3UN*U%,;D5EC9B*Y@PK70.$,043%2491%:=;D)?;2[@/F+^'GT"#YT5B)IR
MFNL=:JZ/J&EH!2\7(V*J-7"W%C8->`21!JY3Q=L$U:[PXY00P:9(H$38L=R'
MAA4=CTPO&\9KLAEV/(*A7V'VULOL/3H+K+S+J<H<:=;6ZI#C;B%9PI.<9QG&
M?#/`H[4/AY?#[HH`A5JWH[7$>ODUV%$L62L1^Q1LB;/JZWZ3(U*-\X[.6<@T
M"+J>_&@(VN,*;`AQY.0W`B1O4SG@;)K3I/TSTYL:-M75])ATJXQ1`D&E07:^
MR&:M('@M9@].B/>.OG;Z[K\M.'ZUK(\4W+E"WI>&83*_4]9M+F`L3K*IZITU
MKREZHUC&KE0UYKNMB:A2JL.*I=@5^M`H;4`2)B.3ITN8N/!ALI;3EUUQ><8^
M56<_+P(QNW6OJELC:(_==ZUOK:S[8$.ZI?%7XHMAZQC'='VVU7K5*Q\U,Y&8
M>:;;+N5FQ_3PGU')JTO>HC"$I")SWP_NAUBKE=JTW5-9@":A`U>+JJZSL.]T
MPU78.F!&R0&L6`MGJ%W!V4;\TPFX+-%96U+0MY@R^A_+N,IPD)`JW4_J+3;E
M1MB@-?4YF_ZVLEDM]*NY&R&#UL"V:XZCJ>B+8:^<)^P$RQ&=9=3T0.'GJENO
M^UMCV7G/-)3ZV0EC;=!TWO?7ECU3MH=6[I0+6U`0;K\\NJ(EUX05@G@A*"2%
M$(!<*;`'Q<6>/(0I$>:/GQF9$=UIYI"TA`P+I/TPK)[1=G`T$,-/];9FPB>G
M"C.R+VJ16C.VIDTAM*P%?6NSC=ZLFQYY*0^<)6!)2>5>?<7)=<4M6<AA:%T`
MZ#:R2^BEZ4UR-:?,QC*69I\W8&(:1](V7K<36Q4>QV0LR&U\!HVX[2-&UB(E
MBNC8YV9[+!:4[E7`P0KX<'P_`29\<'J8(%$%]5C])FJN(VOLX923NL!.HV=$
M"ZL?HL+8;%..M#M1QF0;$J7!>G-166E)>P\VVXD+)Z,TYH#K725Z\TD!K5&J
ML@V0LQ**Q8)ILJ=LA5N)'(6*SV>RF#5HM)^5$'QHZII&9*D^RQ6&,+PTRTA`
M:;M'JQU#W7;"M\VOJ[6=\NY</KX"Y;K"XW,LHP5JNWE+_0(U8-^\$$:<JNW,
MS))(=$N0GGI*\*>4YY$82$263X<GP]+6-8%EM(4)J/&":@KC4@%;[952V`FA
M:_?:GJ,>X>JUO#&WFJ95=H'QC*ER%+D#R;L:1EYG"$("Z=6BZ_I%9KM+IR*G
M5ZC408FLU:L@5"A0.O5T#`8%A0889#4S#'"A0V*VQ'8:0EMIIM*4XQC&,<"H
MUAZ#="K=?-D[,MFE]=VBY;>)12^PB-BL!PW!.D6"5#*2I+5=)V236P>;!)U?
M7T&4CHD1!V*)CQB.)4='I9"2*EUAZET$M6S=(UKKFI3:=M:Y[OJ;==D8$#*W
MM38E$GZSNUO!@X)%D*,EV2DE94*2PS'1$5F2Z_AK$AQ;N0@Q/PU?A]HJ).@H
MUDA%+)6T/>T5E&\]T)#@;8!G6LB,,TJ&G:6&Z`^U)O!;U$`_=[4AN<XT\AQO
M.$8"V].UYI?7KM5511M;J,.C:Z'ZFIX*NF'!-4K>O1+\&0+K0BGPB3-5A1QR
MAK"&'D0\26F6\-)<PUG*,A)?O\%_MH3^N,/]&X#W^"_VT)_7&'^C<![_``7^
MVA/ZXP_T;@/?X+_;0G]<8?Z-P'O\%_MH3^N,/]&X#W^"_P!M"?UQA_HW`>_P
M7^VA/ZXP_P!&X#W^"_VT)_7&'^C<![_!?[:$_KC#_1N`]_@O]M"?UQA_HW`>
M_P`%_MH3^N,/]&X#W^"_VT)_7&'^C<![_!?[:$_KC#_1N`]_@O\`;0G]<8?Z
M-P'O\%_MH3^N,/\`1N`]_@O]M"?UQA_HW`>_P7^VA/ZXP_T;@/?X+_;0G]<8
M?Z-P.S&)#IJU-PR$*6M*?,I$:4P^M*?'P\RDM.+SA/C_`'>!W>`X#@.`X$#V
M(-`N^WFJU9&UD*^"I*#D8.IYYN"^4F%50E2I;32T9?6VQC&$8SGPQX?WO'&0
MVGZ%]6_O+$?C2?U1P'T+ZM_>6(_&D_JC@/H7U;^\L1^-)_5'`?0OJW]Y8C\:
M3^J.`^A?5O[RQ'XTG]4<!]"^K?WEB/QI/ZHX#Z%]6_O+$?C2?U1P'T+ZM_>6
M(_&D_JC@/H7U;^\L1^-)_5'`?0OJW]Y8C\:3^J.`^A?5O[RQ'XTG]4<!]"^K
M?WEB/QI/ZHX#Z%]6_O+$?C2?U1P'T+ZM_>6(_&D_JC@/H7U;^\L1^-)_5'`?
M0OJW]Y8C\:3^J.`^A?5O[RQ'XTG]4<!]"^K?WEB/QI/ZHX#Z%]6_O+$?C2?U
M1P'T+ZM_>6(_&D_JC@/H7U;^\L1^-)_5'`?0OJW]Y8C\:3^J.`^A?5O[RQ'X
MTG]4<!]"^K?WEB/QI/ZHX#Z%]6_O+$?C2?U1P'T+ZM_>6(_&D_JC@/H7U;^\
ML1^-)_5'`?0OJW]Y8C\:3^J.`^A?5O[RQ'XTG]4<!]"^K?WEB/QI/ZHX#Z%]
M6_O+$?C2?U1P'T+ZM_>6(_&D_JC@/H7U;^\L1^-)_5'`?0OJW]Y8C\:3^J.`
M^A?5O[RQ'XTG]4<!]"^K?WEB/QI/ZHX#Z%]6_O+$?C2?U1P'T+ZM_>6(_&D_
MJC@/H7U;^\L1^-)_5'`?0OJW]Y8C\:3^J.`^A?5O[RQ'XTG]4<!]"^K?WEB/
MQI/ZHX#Z%]6_O+$?C2?U1P'T+ZM_>6(_&D_JC@/H7U;^\L1^-)_5'`?0OJW]
MY8C\:3^J.`^A?5O[RQ'XTG]4<!]"^K?WEB/QI/ZHX#Z%]6_O+$?C2?U1P'T+
MZM_>6(_&D_JC@/H7U;^\L1^-)_5'`?0OJW]Y8C\:3^J.`^A?5O[RQ'XTG]4<
M!]"^K?WEB/QI/ZHX#Z%]6_O+$?C2?U1P'T+ZM_>6(_&D_JC@0MV/I5/UWH#<
M][J%8!#;34=972PUTB_`239'FA8&=+&SG!Q!;\"?B)+;0YZ+Z%LN>7RK2I.<
MXR$3O=9;"T\ZUCL!<\X;=<;QG.J.NOCG"%93C.?#5&,>.?#@?/[VBQ?7_N7V
M*.NWW*>!$-S"Z]UY8G:C<^WMA"V=@6--R0>-*::,3X@DRZ18$3YJ`&CBS<)@
MF\(E88]52%.^SN93C.$YSP-8]\:8_#,M/]GG77_EXX#WQIC\,RT_V>==?^7C
M@/?&F/PS+3_9YUU_Y>.`]\:8_#,M/]GG77_EXX')!?2RWHK&>Z9V.N;.'#(S
MD_1&K1D14\M/C"QD9T@2T!$'Q53B4QEAM3SK:,NNIQE6/'@6$5UFLB%*0K?U
MS2I*LI4G.J.NV,X4G/AG&?\`\U/XN,XX'Y][18OK_P!R^Q1UV^Y3P'WM%B^O
M_<OL4==ON4\!][18OK_W+[%'7;[E/`?>T6+Z_P#<OL4==ON4\!][18OK_P!R
M^Q1UV^Y3P'WM%B^O_<OL4==ON4\"+K[5KMHNWZ0-C=N6"THM>S"%2(C"E'U5
M7&6XC.L-AW5B9'(42F5DM[4V3IL=K+;C[D9R.\ZE;2LY2I`>L:<^9*5?B>9.
M,_CX\>!RX#@.`X$-Q/J\EOZ,X'\H%<"9.`X#@.`X#@.`X#@.`X#@.`X#@.`X
M#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X
M#@.`X%;NXG]5+L7_`$-;"_DR1X&XR_\`I4G],/?Z17`Z_`@FBO/,]CNQ>6G7
M6L_,3K5CQ;<6C\5K=GC_`(.<?B^7'XW`L![=-_\`G)7_`-D._P#O\![=-_\`
MG)7_`-D._P#O\![=-_\`G)7_`-D._P#O\![=-_\`G)7_`-D._P#O\"O/:^5)
M<Z^;`2Y(?<3[7KG\BMYQ>/EVU0DY^12LX^5*LX_YL\"PLS_IDO\`3+_^E5P.
MMP'`<!P'`<"H7;#_`+RZU?T[E/M`;QX'I$W^=M_XB?\`)QP.?`<!P'`AN)]7
MDM_1G`_E`K@3)P/.ON-V_P!R=8+HG%?U%KG8&L('6W?/8(V4G[,M=<V-E6@Y
M-!@FZD!J$#5UD`$W[%*VJ$Q!D.F(^?!N9A;6%(CX?#:M/?$-T'NO=,/K]6H&
MS`^T%`K62-A+51WQL:GGJ3;+74;'0K66@SR@X=<8<VDD9"$MN/CGXK.,M3%N
MN(:4%?+#\5$-KWM-O[K]L/3UHR%UG/A`=6FZ"U9K'<]R6B%3-5WBZ``-?L-/
MIU!G2JI6]G9)3<";45=%#QBE$VX3\\6Q,"5X/Q/>NM@M9&DT<'MS8EE:M&K:
MS71])I$0KF\8VY3-D7NM'JP](L$%AH)``ZCL.2?O10R;!?'Y;7'SEUCU`WWK
M-W7J?9F?NLB#I]FINO-6"M:V6OVZYL8'3K[2]CT>5?1EYA5YE,I\569H)IN1
M`R\[F:^P[XOQXKR5,X".*%\1(%N?:'6RB:>U'?RH'=I7;:+I;+NT-I;VJ@FL
M]:T398>9/KBYY(B:E;(K>VJJ3$X94EE`HMA3ZVYK;L)H/W<W>VSZ?[*6'3:]
M-QK=2`^NHYB)9:_>,)V.4V-.U)V%W;!K,+79.NP`#]4>IG74I'<*YL;3[)69
M$:5$RTYEY(=(_P#%%T72J>2MENJ.VG8-<J.C3%A+U&E9-UA^X;^K%-MM$US5
MB9$F#('+.0`W)N;X.0XT9F+&=]=YI_TF'`SQ;XC.O'VP4O7.J-R[,#GM\ZBT
M1!L@\$!JE?GDMHV694B5E%2;K804^0+UO88#D$U'E1H4Q,SRI9;=9RJ0D,E7
M?B.:.N-[%:WJ%3W/9[6>V.6H(2&)U^A3!40#?/1B6V(LR6;B1TZK9>J!M*9K
MF6R#J@\A+<)2EQ,20E?2G;_46^M(7'?U)Q:HM(H<V]0+/!L81L5;Q<G7T'WH
M;CD*NW/F$!1!T4MJ2S!FXC$$MOMX?896K*,!71?Q6NM,&8$%V"N[NJQFPZAB
M[I&A3NM'4$<U:PN6/.N!\Q`XP2CCK%M>%59D@%'?<;9\N&V9[T&4ZW'4&.VS
M\6WK#I`?8)^RJYO"ON5<55WC8Y6MT2R$.VV(KK4<1UAAN*?=CR=@4N)M^N$"
M[#3JX"(!-*XLN6XV^TT$9"OCH=&S$XH-A_39F<.FB(L>-G5,]QXZQ/AS2I4B
M!:C$Y#D^)4P@R5,(MYPB7Z4=3<5F3(4TRX&\[&^++I>LPK=`I>O]IW"]5F\J
MJ;%=(5Q%<$E:\-VI,U#9MK-6'VLHAG6@*Y!YT'VC,?))^4TWA$+T'<2$A;30
MO;O4?8G5MZV[1UV,75M<6.VUFW1;F*C5NR!IU.$03Y-96OO$I$\!AX(38E-Q
MR6(4YMIW'KL,J_(\#$:_[I:BV3UC/=L:^/O;>M:HF]*M0R?7&$7.OIUI8B==
MO"Y@:"5GCY;`!8:3,6]#FR6'8#>7FEN>.$Y"N=Z^*_HFNTW8MJI=!W!LQ=)U
MO;=A@V0M<$A@FPUU$,(N<NKU6TG3T4?[XF:LL0VY1W7T-PY%9GM/,O.S//!2
M%G-1=P=2[IW1MK0=4CW*'L/2L<8J\,G:Y[*!9)2HHITV`%V2!-)AR1JG33<6
M(2;0[AI3[GFAN2V$K>2'GN0^*KL\5\ZBLCKO6W*X!V]V%KL9V;<=LU&<0U)U
M<OYBC[0M@(I<=`AZ3L/8!C"!SX`15RI@*\^]*B3C4%^+A+H6E^'EW>/]X=7[
M+V*3U;$H::%LF508,8'8+$79//,TVJW)Z(MB_P!%U:>&'0[=K9AR'/8G@,_/
MIS!9.=!?0_@(,"_&!U=$%T"X;:T_M+45`V!UZ;WFP<)QQ-JGU:7[RWOZ%+M<
M&J32$6+,L];T1.G`I$:1*Q-<?PQ);A*3A2P]*-(;BJF_M65+;E)C6"#6[A%G
MNQ!]J#N@;&,EB#!&OF19@6XX^AB:,-B9$=2V77XK_I^K'>>86VZL)6X#@.`X
M#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@5N[B?U4NQ?]#6
MPOY,D>!N,O\`Z5)_3#W^D5P.OP($I/\`6.[%_P`!.M/^AW;P)[X#@.`X%?.U
M?]7W8'Z;UQ]MR@<"QDS_`*9+_3+_`/I5<#&SFI+\&>Q#D^Q39$":Q"G>DE_V
M&:_%=:ASO07X(D>QR5I=]-7Y%?D\N?DSP/Y_,?#R^.[C'R__`'0!`SG^_P#^
MGGH_'_UO>W`_?_3R^.Y_]/\`P/\`^WIH_P#;;@/_`$\OCN?_`$_\#_\`MZ:/
M_;;@5AVM_P"L)T*[;_#&";R^+!]]=JCMIW3I^A;UKF'U*TSJ%"ZRZS$*F,2+
M(,BGC2VB<1_+'A$5!?:SX+0_^*G@?U59_%S_`,^>!4/M:GSE>LZ/,E'GWR23
MYE9\$I\V@=XX\RL_W$X\?EX$P:D[4S=F;,QKI[6!*OI4W:LNR,EB<^QU'YL2
ML1F,;0K<NGA1]+58D_\`0,1RI7UG%)3C\CG+B0N'P'`<!P(;B?5Y+?T9P/Y0
M*X$R<"C78<P05V(U!KR7KS5.SZMLWKYVKA2*U=:JA=FED:M]#YG%6A7R:1("
M@]"V"Y(BQC@]\',2^[`AR<N9Q&PRH/.:?WYUGKZ#G9-(ZBZYE]H)/PY)/<D3
M=EM5:D1+3)N5>D;[V3K]94%"N%JK0U9$N5.D'2$Q#D^8IW+/M/JNS$AI'8CN
M7TQ;-=QIA3HKI>];2A5K6D6Y;,N\73L_6^V;%)U\!O\`6'KQL,_&&2Y^O`_N
MD6S6RDC\QMDF!'CPLQW?9/$+M;1VGHOJUK#2/9Q'5"@V#8^[I`6\VXIKZO4B
MD&Q!.O=?=H[:N%]R5,1<S9TVN45BSQH$?,A4U]PP\QZR<2Y+N0J?0/BF=4=)
M[.IFL-2=-5Z^<[%=DC^L#Y?7&-4@8*2X\M01D2W;%B5U49Q%UBHV0E)JLR<J
M.5IQI,>0G\W:SP-@&=ZM.]7*75RKW2(#7FM?O=@BE@;T4(H`EO5\Z?V(WEI9
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MU6;28MEDO96Q`:<`%&B-UN,%@9;+7-)PH#,R38;*.C(9G2UKR_*;3Y7%*QP.
M_4-/ZHU_4BU!HVMJ/3Z0?D&)1RHUJKA@M<+R+`PF(;>)!Q\./`FK)PT)8>]1
M"O.PA#6?S-"4X#`F^NN@[+*B3K%I?5QV9`US.U!"DEZ+6R#T759**[!G:ZCN
M2QSJFJ9*@R'65#L>$7+3SB/)Y7%X4&HO]-NI4J%[ND]9M#OP/FE4Z%[&[JFD
MKC9I5$-1K)3*IEG(7*,@*O8(+$V#%\/1C2F&W4)PMM&<!\&.EO4*,A]J/UAT
M(PW)?&RI"&M44AM+\@.09*"W7<("X]14$A'0ZWX^/E5C^]G.,AL![JSUIM#\
M239-!:=/2(%@C6R$^8UU4R+L6SPSEHLT4^PY*%.J:+Q['=C$]#^,X<Q,)R7O
M'U'EJR&XU+36I*%6+!2:3K*AU2G6R66G6BJ@*H#%5ZQ2CL)H88=-AX<)J`4R
M1%QVXCN'VUI5$:0QX>DA*,!RJ.GM44"B2=74C6]'J>MIC)J/,H=?K`<549C%
MDS(S86I=?AQ&A<E!U4MW,S"VE>TJ=7ESS94KQ#46^K_6YF1,E,Z%T^U)(ZH8
MT3/?:UU4VW9FEHL!H5&U1)6@5C+VO6!;#<9(A7C!Q':0WZ?D0E.`VBDZ6U%K
M8T7LFO\`65&IEBL`>MU\\>K58#AS)H)3QS0BK"BI.#$9FSX(`6PB/%;=6M+3
M2$I3\B<>`=`]H#1MI'U,39=/:SL`NAWV1M.DCC-)KA.%4ME2S12R2[[7(TP<
M\T&M\JP')DUTA'PW*<E2G75+RM:LY#8*3JS6NM5$E:]H-0H^3$6O02WS4KPH
M!@E$J0=JOUB/.P,BQL2FZ^!8;A0\+\WL\1M#2/!M"4X#1(O5WK;"A/#8NA=0
ML#I#I9YX>C7M6Q!6LZ]=))GQB9%YCX;)/[&L"GD83A"\FIOCC_67O.$I4ZF5
M+7E7"4FB5H'3JA6X+8T!6:T+AA@8>`VI2TQ1PR`RQ$BM>HM2\X0G'F6K*L^*
MLYSD-EX#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@5
MN[B?U4NQ?]#6POY,D>!N,O\`Z5)_3#W^D5P.OP($I/\`6.[%_P`!.M/^AW;P
M)[X#@.`X%?.U?]7W8'Z;UQ]MR@<"QDS_`*9+_3+_`/I5<#K<!P'`<#P,^,]_
M6K^`Q_\`U2ZO_)P9P/?3/XN?^?/_`-_@5%[5K2V7ZRK4G"THWV16I&?#P6E.
M@MX9RG/CC./!6,>'`F[4ND-TT2P4N3:NP9J_5*M0+D]-#%QQ/)HV5N$AEUH8
M0,.V)\>0J=85'0^)Q*@/F(#F7(Z)^83F8^`MGP'`<!P(;B?5Y+?T9P/Y0*X$
MR<#Y+88<=:?6RTM]A+J&7EMH4ZRA_P`F'DM.9QE;:7O33YL8SC"O+CQ_$QP.
MA@(%PYA[`@7A[`SW)AW`^)AS`;S>?W1A?I>;`SS_`"^S^/I>/R^7@=?%8K:6
M'8J:\#3%?C#(3\;`F!AAZ&%SXAHCK.(_IN1A.?\`HS><92Q_[&$\#(OCX$II
MMB3!AR&&4K0TR_&9>::0MAR*M+;;B%(0E<9U3><8QC&6U93^)G..!T\U\#EQ
M+N0@C+J)D@BAW(V%EQ!"6XT[+GI7Z/F3,E.LH4X[C/G6I"<YSG.,<#[Y$B\Y
MRK(T?E6597G.8<?.<J5(>EJ5G.6_'S*E27'<Y_%RXXI7XJLYR'617*\VTAE`
M$,AEL0NOH:0+@I:0!<\OG"(;PQA*1"_)CQC8QZ.?#'Y'@=]B#"BJPN-#BQUI
MBQH*5,1VF5)A0\NYB0\*;0G.(L7+Z\MM_P"`CSJ\N,>.>!VN`X#@.`X#@.`X
M#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X
M#@.`X%;NXG]5+L7_`$-;"_DR1X&XR_\`I4G],/?Z17`Z_`@2D_UCNQ?\!.M/
M^AW;P)[X#@.`X%?.U?\`5]V!^F]<?;<H'`L9,_Z9+_3+_P#I5<#K<!P'`<#P
M,^,]_6K^`Q__`%2ZO_)P9P/?3/XN?^?/_P!_@5"[7XRHGUI2G&<J5O@GC&,8
M\<YSG0&\<8QC']W.<\"Y=3WGJ"ZV>71ZGL6K'[6/1.]<*.)M/R7?=#R8I;,!
M>/".5P*DY\DGV5;WLZOD<\O`EG@.`X#@0W$^KR6_HS@?R@5P)DX%3MA!-T,]
MMM#W*O6:\2M%P=1[X#[)U\):`HIF;JN7K@EK^U%\XB-6<M:),:.2@#6,RU#X
M[>)"O1P\]ZN`L\%)^^@PDQ[O)B?>PR`3]U&HN()D9[?%:E>[RT+#CV(9.%ZO
MIOM>=7INI4GQSX>/`\PKU7>Q!;9_=>,*7NEI^2_K(QH*2%.[B!UI`@&`TC))
MQ:J7C[*8U`A4FVQ3GM@Z*"A%9;?MJ"$B7#>PSD,L7VSWZC[$V8/<UC#A:[%;
M@B!::6K%$^>E@=H*4;"4`DQQY2Z4L38(-T]TUC!>>@@C%=67E)<4UAI:H`;Y
M2<=K(\>G(L!>T6TS7.U?8F%;8Y^LBZ<,,:@E@]SD]'OPRU<G18I*H0,KJT=$
MI34K*G9JFY4?$J%A;0:CJ39'?8[9-=/WRBCQM-R8!P[NV1U_&KITI$/MLQ[5
M)RS'V";Q6(NM[!F;'@.(]K]]C8L:8K&$R?%8;KV+LG;U^Y;)HVG0DL;4Y^@+
MR]3+H*K@HA+';#<HE]?"'(5D*6-B.W;QNPH->&PP#HMQB5!)2)V9./9\I:#L
M=@ZGLT!U6UM5`,_?-QL`$YIH?L$EJ>TV`?N^Q`8)`:S<9P^R,66&<]XS).,.
MS%.$<M99]3$A2XWJIR&NU-KN_"BP0!4I!C6(]?M(#;+>"]9CVT77*BGKBP1V
MQ,"!85O!@W5IW6$5!3,8:99SDDI7LSO@EW`:U2-K]]Y]Z3`V)K2%6J:O>1@"
MB=4:)\[9K=0CGXD,$+GO%[I4(K-+*5!UXF_;(^9>(DQK$?#;KB\1<!B:Q>>^
MU7JVKP$@`8V!:HR]RPM@V"U:]#06S)T/<#J*RW*F!K)7AM?K,*DJBS@DV"P0
M19)&$PE*BN>;/`FC7]J[?C]T:<J&Q!0RU:YL&E7S^S;D$HC=2C5K:4F6:(K%
MO.O6X\PB`+82/%1XK+BYJEN*?6W*:6])@!>3@.`X#@.`X#@.`X#@.`X#@.!_
M.91K5\9#1>NM;@1U$,;>N%KI^Z=DV!Z\BCFP7%70E+V8\'IE]NUIW)A[6+^O
M@8&J2``<'`2&M,PS*@L-P?1<>2'O[K:/=(FO:1'V.8A6#8#55`INQL8#361I
M.U>[8V3TP?7DD2^`D)XEES+47VN3EEOP3EUS.,KR'A-5Z+\4)CLT-JY@UO23
MH=O<+'7Z3;9EV%*B+TOJ79,/M`%[(OK8-X,K+;DI$Y_4!%_"<D'W&,(=:0RE
M,CD:81-):X/D?%^A?,PY'A79%@HM#$;+KU#,U6.<UZ_*_P#3Z(N%-.6LRG;$
M:UWXZ7[9BW@V5V$J0G"YLB.22\\VZVM%7SUS9-0N]?%,UI#V'&AT$C;:O;=I
M;DNHDL3IB-A;"T]4"O:;9D<&`K@8AN"OQML1)VL)P.4&&9>"I"`E9RGULQ?9
ME$PW:+:"_P`5@A9V`\O7%UJP'9G8OK=?[J]2"C=N;IT0&/\`A_R=L:VJ-H=V
M6$<U[HZ(B'M!^5)8B&/?<N%,A99\)GK2U5PZN_H"X9'`<!P'`<!P'`<!P'`<
M!P'`<!P'`<!P'`<!P'`K=W$_JI=B_P"AK87\F2/`W&7_`-*D_IA[_2*X'7X$
M"4G^L=V+_@)UI_T.[>!/?`<!P'`KYVK_`*ONP/TWKC[;E`X%C)G_`$R7^F7_
M`/2JX'6X#@.`X'A=\8*GVVS]G_@<D:U5K'8H%1^)K6C]KG`@9,O$K`)NNCL.
M&K#)'Q9#(40WEM7FDR<M,I\N?%7R9X'NEG\7/_/G@5&[59\"_67.5*1X;\(9
M\Z<>*D>&@MX?DDXQ\N5)_%QC@:5UC<DO]BE@UTZLQ':8ULC!&KP[J9+BM'>W
M$<,14Z^A3]^;``$L6W#GHSLBZC6/8TNJ2KT$^,1P/57@.`X#@0W$^KR6_HS@
M?R@5P)DX&(DV`##,C*[+-B(M@-1Y\P,"DDH;!DM$%88R4E#!CKR9L^.-Q*:S
M(6TA:6?43Y\X\V/$.]#F0R,2-/'RHTZ#-8:E0YL-]J5$EQGT)<8D1I+"ELOL
M/-JPI"TJRE2<XSC/AP,..MU4,'3]7$V>O%++5?=^+171QH;-.UOWM&]L%^_Q
M$:2Z0#^\HF?5C^T-M^LW^21XI^7@;#P.I$GP9^)&8,V)-Q#EOP)>8DAF1B+.
MC9PF3"D>BM?H2XZE8PMM7@M&<_+C'`Z$ZR5T66"`"9X*..V7)!-<"SBD&(6/
MY$QTS"N`@V0^W,*Y&Q%X=D>@AST6\X4OP3GQX&:X#@.!A!-EKA[,G`,^$-9A
MH:<EX$E8)',5#[DIEE<G$-][T$/.P7DIRKPPI3*\8^5"O`/C5[;5+N&8L5+L
MU>M]?E.268IVKFAI\-)>AON19;3!,3)EPGG(LEI3;B4KSE#B<I5X9QG'`V'@
M.`X#@.`X#@.`X#@.`X#@.`X%.-J_$)Z1Z.V"2U5MOL_J"@;!!^Z?G#6;%:X<
M295_?L2.0%8M;Z?4@U;,P9,9EX]X.QO+#>;D*\&5I7D+ALO-2&FGV'6WV'VT
M/,O,K2XT\TXG"VW6G$94AQMQ"L92K&<XSC/CC@?3@1IMW<FJM!T0ML[=&P*K
MK+7X1T?&)VNX%XH80Q,+SF!8@>A^2M.91,N3E-1XD5G#DB2^XEMM"EJQC@:5
MH7M5US[0PK+.Z^[DHNV&:9,'0+:S4C#<PA6I)B/(E!\&Q3J6"@QDPQ#?5$=>
M90U*]G=PTI>6G,)"P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P*W=
MQ/ZJ78O^AK87\F2/`W&7_P!*D_IA[_2*X'7X$&V/3AXAL"Q[#IVYKWK8A;J_
M3J_8A(&MZLL0>>BC.6=0,BW\^Z+9B4*=Z5KDMO8:D)9<2E&<(2K"LJ#K_15M
MK\*O:'V->NGW(^`^BK;7X5>T/L:]=/N1\!]%6VOPJ]H?8UZZ?<CX#Z*MM?A5
M[0^QKUT^Y'P,'9-!72Z"'*W<>RNTCU8F$0$XP#Q2-#!TEV:]815ECCGB8?5<
M,K#BRIP=I+JX[K3WI95Y%H5X*P%F77,NN..J\,*<6MQ6,?B8RM659\/'Q^3Q
MSP.'`<!P'`^B'76\+PVXXWAU/D<PA:DX<1^47A.<86G_`),_)P/GP*C]JL^4
MQUD5Y_3\N_"&?4\/-Y/#06\,^?R_^UY?Q?#^[P-/ZSU"P#=_#VR.K+,%$51K
M9F!80G-MV`^C/?4Y7II'V`Q#8KVQ\WQA>4MYA2)7L3;F5(\&TYS@/5#@.`X#
M@0W$^KR6_HS@?R@5P)DX%-]K]9BNR^PE,V7(DU%^BPPU6&VR$5CSUVYIBFC]
MYCU`*TMJ([`<`;'C;N7'.^M(C*1%$-MI;D^T>,8)LT!K9_3>C-.ZCDOC9+^L
M-94>@./AF7(PAS-0K8X#A0J,ZVRY''>6!C##>4)RAKRX\,>'AP//;<?1C?EX
MV1N:^ZZV;4=5R[59I1>KV"H%K%7MA70!:H.BX]GIFP[?#J<UZH!:])TUZXK(
MYLVN4N<K#F(J,NH<#/E.E78N6J<XQV:N.9,Z/>S$F8[LS:\-<F_RV^P#.L[#
MF&.*,P!PBJXV#4W)`J(VT,=<KF,YC.X:C^(2,2ZO;KA6[6Y:E;<>#U^K]G=B
M;@LH67<;XN"<UW>[`%,N4\@+;]5=GFP(D<C&A1I,Z(/&KGI4CUXC;@^0&X[U
MT%LN[;/?V'KJ1J7$XEI^=KV,7V4+LLX_K*R")%Q-U6Y:T>K;L.7!+&35J:8(
MRVIPV6/9'1Y#"I3B4L)"$:?TV["0=7;`"W'?=J*[%)ZPF4+7!,1N?;$033%D
M=J[:N$YYR4_#R/FDW*-:ZX!;-20$Z<RV"QE#.&L):6'1QTX[1F)(1FV=CYK@
MQNKZZ$VQ57V#N6ONV/-9"ZW@DJ_&A,'\^XH$$W3C)-)J-+29L#EIDQR&&H\9
MM+H>@&KH.Q`M=@UW8<@68G5P#3`S%MA$9DV?<I\*G!&;98"\>9$CK@2)=N3-
M])/F<4['PAQ?E6K*<!37J/TBE]3)&U?FM.K<R/O$V-L6PGG25ED28QQ;VVB1
M\I7&Y\=]J+&DD[<'3%&I5'A,-HG.)\CBT)<#>.F?7G977&B1ZQ9OHPP^;GUY
M^V#Z"^>0!&(I&FM;ZF"$@&2%>"+,V"X2=>^]C<B3&@X;7-PPWB1F/[0^%W>`
MX#@.`X#@.`X#@.`X#@.`X#@?SW7G>=#T+3?BX]?-IB=K#-M[^VYV!M&FZF#T
M'O*_,[2`;;ZMZKI>O9M1LE#US9ZB938+2(DBL-8G^I%FQ7&)*65(SC`>V'7B
MO&ZCH#1M3LL%T98ZQI[6=>/C7UMN/CS86E!!I6"\XRMUIQV).C.-J4E2DYRG
MQQG./EX$P\#S>^)4Y(`5+JIM&4$LY:D:2[MZ0VIM*;4ZE9KR3JNO10F_5XE;
MGZM31)ZTDA04Q9H"I2H4*2N*RM4AQ*66G7$!K'63:-3[']]-][[U%&NA;4,3
MJ1UPT^N]6;6.R=9"R>R0&X>S5U-U<*SLZI4XE8I5?J]S%R9CT)B1&BX(LMK=
M2ZOR<#U(X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.!J&P*.!V91K?K
MNTMS':W>*V9JIU`^=(&$,BCH]\;-S!(Q%MRH$U+$A66GFU86TYC"L?+C@09G
MJ[%S\N=]]GLYS\N<_3&1QXY_NY\,#<8X#[UV+]?OL]]F,C^UO`?>NQ?K]]GO
MLQD?VMX#[UV+]?OL]]F,C^UO`?>NQ?K]]GOLQD?VMX#[UV+]?OL]]F,C^UO`
M?>NQ?K]]GOLQD?VMX#[UV+]?OL]]F,C^UO`?>NQ?K]]GOLQD?VMX#[UV+]?O
ML]]F,C^UO`?>NQ?K]]GOLQD?VMX#[UV+]?OL]]F,C^UO`?>NQ?K]]GOLQD?V
MMX#[UV+]?OL]]F,C^UO`?>NQ?K]]GOLQD?VMX$<;+ZU5VOC`MX([)W3=B5$L
M40S68%_V22L5<'&2\2=39)9T.J/%CRY3->LTYEO+N5I;]?*\)\^$JP%=>J]6
MAC>R+$EK7]S#^P-;1Q%1,$LP+)2/>1#+CR=V6=O0FOI%V79_E4(]6X6KRNY0
M[_K&48FM!ZY\!P'`<"&XGU>2W]&<#^4"N!,G`<!P'`<!P'`<!P'`<!P'`<!P
M'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P
M'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P(CWAX_1R4\,HQGWC7_#+OYWC/
MOT?\KG_[G]__`).!YR]5&`R.R;68D.XM/(:VI[,F0S7F[[#]0IYIGWS$D:`'
M')BY*_E`^W2Y/YOEO.?,O&%X#UVX#@.`X$-Q/J\EOZ,X'\H%<"9.!6S9O94+
MK38PS6RZ-=K:4(`AQ-R96$UM<>,9M,+9,G7521&,6`3/EFK_`"]2'(<5QMO,
M*'):8]L?CM2$NI"0M,[2';GUT%V&+$$`48M,L@QP61EAR3D>?5+09J)54,Q7
MB!8`=#R28)YV`0@R7XLZ$MI]M7E<QC`5^.]V:55K[M.E66BWL/!UQ->&C[IE
MD(5K=TGB%Z>CVN/`C@BY6R5IBKS-YU]+\LS`@0%M///)?]*.ZI(;T3[B=;0T
MVQCBNSH4&94[+)J9UF0`MR/9"PXG<@YI]AS-?](E7ZT0UV=06+Q5/"1"1,I<
MV2PVRM6`[>[.QPC2%NUC6C%*MMD@;`45DF;+7'*[D?KVOC+AK#7ZK+8H!8V,
M,E!R[;M\*PMH3'GS&XZWW_1RAG.%!CA7<#1$UNLH)VR17B5O;NDH((+URU,S
MLP:/9[552;Q=*0645N=(*4Z:TQ`)9B$'9368J&52L9:X$RZWV32=N4X9?M>'
M6K'5"[Y>)")MPR0USVT`9(5TX/F##$,>6&$1!T5)B28\EAE]E]A:%IQG'`K_
M`%+N1K^X]M=A].Q]5V#%V#K6N3K2;M!`%&CZ\FBHP'39V'@+8L$5K)3R7TP)
MC)C)9P_'>"3LR$M-*AN2@VC5'9(+M/9NR]8MTNV56?0B5CC!3AUVNR`FPQ=.
MN!'7]L,UOW(;*$QJ`-P&*C.QRL>#(<:D1WV4N-N+](+(\!P'`<!P'`<!P'`<
M!P'`<!P'`<!P/+'8G>GL;%E=L+9I3JYK'8>ENG5HM]/V/9[[V6-:PV-:36M=
M6U3;.P4T'7PKK]LBO/PX@6V-0A3I.R#\D9[*_63"CY2\H/2*A7(5L6BTO8()
MN8T#O=3KER#-$66XY!L59P\,V.;G,-/2&F9B(<Y&'4)<6E*\9QA6<8\<AMG`
MJUVR[$'.N].U[)IFOX.SMD[BW-0M$ZRJ1NXKU[5)%SO>2LMHE<[M'K%W(UNK
MA05?GRWWH84K+=6RVPU'4IWSH#4NOW8_<%TW1LOKQV%TO2=1[2HFL];;D%/:
MPW"3W11;1K[95FV12X2E'3^JM.G0=I"V75\]$F$L4_&7%?CO-2EJ4ZTT%TN`
MX#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`
MX#@.!$F\,>.NBF/*E?B1K^/*O/@A7B='_D59^7P3G^[_`,G`\[.K5Q25[&0X
M>=GW8]'(-;1R.21,N$C-[]V3\MOJVQ4L]@-B?1\JKX^07A5-J?J+2AK_`%?S
M^Q.AZW<!P'`<"&XGU>2W]&<#^4"N!,G`@K9W6_4NWS2[%=PQN29<J!BD.3@=
MTN=36X$+A[8!0\I%7/"&LG@`V^&TABGE]XAG"LEV$\PZYE?`W_6^OZ]JJBUC
M7-348^;%/%LA`#1X\7LQ.()BJ7["/<-'ID\I)BCHZDQXR''5)CQFVV4>5MM"
M<!%<WJGH\G:=FW`G62Q(SMMC,:X8GW6[2A.&'T4M)1-9`NV!06EJL*]<@G"B
MQ$>$LDZ*C*DY<RTGP#H6CI]U\N,B3+/4B4]+FS3LR;)AVZYBGYC=KLVQ;9;A
M4ET78(:WJ_;B>VK"V4'YS[%/@DUQ'FU1D---AO6QM$ZUVO:->6^\B"90OK"=
M+(59N+:+.%#N.3#-3LBHME`A"X\+<AC%FH84DS$+,3(K,\9'>2WA:/'@:98>
MHW7^TCYHLY15S(4]L\U*;19[=$<6FRVVXWHRI$F$=CR67)5IOI65A:%I4UF3
MY$92VVTA`;?JS15"TN/#@]=)L(2M`X%MC1*P]:3Q@(]/O-UE7^RV&=',SI[L
MVPS;)/DK1)6YG,=B2XPUA#.4H2'VD:+UH_:3EV0&(P+98G+$Z4/B;/9PY)3M
MK$:O`GW8<@88BJ&N3Q&FZZQE4;TLH1`SY/+F1)RZ&)JG7+5-*M5[NM<%V"#9
MMBV:#:K&37>KO+4W-@VIZ\.#*]'F6!^+4JL8MDJ1.*"!B(@TL[)=Q,8?0O*>
M!.?`<!P'`<!P'`<!P'`<!P'`<!P'`<#Q^V+U0[P!,=V]::'G=5#.G^Z-SV!=
MYEMVW8]N@-E:P(;<T[3-26^#&I]-H]CJ]ZAUW-2R3&J69"KF>T8B/>AZ?M3@
M>I&L:1'UGK77NMXL]XK%U_1JG2(Q20RB-()1ZH`'@69[\=M;C;#TQN!AQ2$J
M4E*E9QC.<8\>!O/`IYW/T/L?>%-U//T^8I`W:.B=_P"N.P%)&[*R>CT&W$J.
MT>$3ZA:2]7B$[%7()@!:IF62$2$0<BS&F5*BO-^=&0U'KGI?LFUV'VOV;[/.
MZ/"6RX:<U-HJJ430QN^VVNCZQK6Y[:OTNTV&V;!JU()23QTQM9<9N#&%HCQ(
MP]*\R'UOY2R%\>`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`
MX#@0+VFW?CK3ULWOV$S6EW/Z%=3WK9R:DV2=#N65=,KL\Z@&@JP)/2!ZB:X6
M&<.MP9CB//XH8=5X(4%*0OQ8-,,EZE0+MK[;T#;-G/TG7L2LU37MNF@SFVK'
MG5J;;KVI3MD@M37?,W5*=T5IZPNV*N5G,2,2\Z&W%1IJ(P>J'`H5W0[\ZZZ7
M77JA2[M!&SY79_=XO5B99*Z!:>W2JK*E!Z^6V,ADPRZY;T@;M=ZR/>$Q,MRE
M1B[LS"\-0G4J"OQGXSW52'591^*-V:.>E'D5NN8MM5'AHQ+YP485>=<7QX?$
ML1*VNZNO\&S!T1R,(9,F0G"K")\.(O*L)#(#OC#=<)3D<,NF;G?M$@T(K`]N
M-3!HRI68V27M,*J77+I:K-7P;5><OVG#5;@N%'!L\L;]EBP(DIV2C'`]".OV
MW(V_M%Z=WE"JU@I$'<.LZ3LR#4;4H:NQ5Z#=ZZ/L<(686'FD1BYL:*11A2F7
MEH5^+\F<Y3@/)XQ\;?4PZ_;HJT'7!.TAM!]IRFC+M+H%LKUZM<_6%?TGV)OE
MIW9!J4%T9D)'JFQNL=K#30\Z5B4H,.2586[F;#B.!)!#XS'7*%(MA)K7FZ)=
M!I5$V3<S=T6*H8:1[7K?;-.U/(J;-*LE_"W"#:++(N<8P*'$XHXG,#+9D(B9
M]JCX<"5M*_$TTAN+<-:TB+'7!^QWBR7(34K:*K!%6MW(XF=O.53AARPFLB"@
MVWV^G]>;,23%;@/Q6O=RD*DX]6-ZX7!WO]30U^G`7[-P.!)L,0*B29!**,'Q
MB)!#7M\^/"C,S9WD3CR>V2FVTOR?)_<\ZE>'`R?`<!P'`AN)]7DM_1G`_E`K
M@3)P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'
M`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`UVW5&KWZKGZ3=Z
M\'ME0M0F<!LM9L`^,6!G@I-A<4@*+#)K;T2>/FQG%-NM.)4A:%9QG&<9X$8O
M=9^O4G9I7=$C2FL7]M')E7(E]CO4P$Y<B!&E8CIJA&0?7"415/!(A1TL/^?#
MJ418Z<JSAAG"`G#@1K==-:FV3)FS-@ZWI-UED:>4U_.D6BMBCCTFCFRH@Z8J
M;JR,:0I0`H:`0);\;\Z=DPF'%8RMEO*0I_J_X6W2C6:KK)D:8J&RBEXVE8-M
MSRNS*A0C#P:PV$>`%/#:N,!U&MUT``APJQ!\C3,+VB1)CHE2WI,O&'\!/RNH
M75M1"NE,]?M28GU,N//5V0BC`&U"S`BR6.Y"2#"&X26U2!=QMQ,M&RM*L,%)
MKLM&$R%>IP)>H5!I6K:;7=>:YJX6E46HC60U7J=<@LBP-?$1\JS&%B!L9*(T
M`?&PO.&F6TI;;3X)3C"<8Q@()MO2'I[?!=?"73K)H^SB*I";'5L<:UM5I\0)
M`:+FSR88YE\:I,:-DS9B<E2$_D5NDI:E8S[2]YPZ9SHETTLT=<:Q=8M)G&G2
M]L/O>]=?U^<[(,WHC7"MO(R7Y,-Q^3)/S:@*S(RXI7F;&QF\>#;+:$A(E8ZV
M=?:49%V&H:5UC63H,FV:#%P5+`#"(LNU!O@QHE`EPX+3T2:V/VE9&$N(SA6&
MCLY/CX2GL*#N;W^IH:_3@+]FX'`EUO\`.V_\1/\`DXX'/@.`X#@0W$^KR6_H
MS@?R@5P)DX%`NQ6VMPT_>M;JM5/6BOTR918I)Q`#5;FP(Y"))";R?V;<W'V*
MV7GOG=/8JE/EC!4:4Q[RD&\Q78L]4J.VR$[=4[A?+YH:DV?93[DVX2Y%PA32
MRX/L"+"-!WFR@JU9XK?S:I6)D"S5D;#GQYJ0@5!!B0F4B!#0\F,V%`-J=N^R
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M0,L)$I[AU]\\H[KE.O=@Q/A-MYPB#`]HC0F'H[CF0_1'>'LG:+0NHA.KS0J9
M.KFH'@YFUE+="">\]E6G5=>F6R:S#J<@XG7T-C81&1'P[%ASL9K<EN1Z*EOX
M@!:75.X+TJY=A`.[I50"Q:-N'7--UVQ70-MB.OUO95.URW6)!`D5;>C6-!S9
M-EG#8\^(VRPVY&=;?2UEE7E#2^UQOM`WL?1%6ZY3Y0J(7A;&L=_)/QJDNJ1X
M=0-:GQ`:N+MBHMQ,SADP&>--,"P4@(7GS%-+1.9:CNYP&H:][#[Q+=3+V=V-
M7_FQV%`ZG,3JHX`K1\C&M=I8ZS4?<T0VR$)U2)#B%AQV[9&2QZXZHCI4:^PP
ME7RQFPFWJ!>+QL#3^#UUL!JZMHM]K'4O8=EJ,6B6+8=#AS\8`6PS5X`"J#84
MEY;C\1M^**&Q2,:(U-:CH;D)RH+2<!P'`<!P'`<!P'`<!P'`<!P/!>]5W:&Z
MZ[\43?\`,[4=I]=6KJWM+=U,TE5=1;9>HNL:P(TSUPUKL2IJ):]BAI0&XS9U
MS/S)A1PRB?@BE[V=S'LJ&V$![):(MQC8&C]-7RQ.1W;!=M4Z[MQUV(PF+%=,
M62H!S)-R-&1G*(\=<V:O*$8^1"<XQC\3@2MP//GXB%DO,*H]:]<4K85SU?'W
M_P!P-.:3O5OUP49KU_BZ_/C;M9K`/J-I7#G2:J3,NT^/%<GQ$)FM0WGDL.-.
M+2Z@-6ZT@K=I#NIN_K7C=6[=OZQ;ZP:"WH#;WU?I&T+35[Q;]J=A=?VEL!<"
ML*.?:KAH'KL0M0Z0](CQY;"W8^&<OO8<#TOX#@.`X#@><=$[,[OE]\.S.L-G
M:[O%`ZTZ\U1IE6G[04UXXL%=[L>O9^M7"UQ+X&D&GBR;(1/"QT`3Z;"AL0*]
M.DH;Q+SE`>CG`\R:?O'L#K*T4^E6UN\[J;V)V%V_4F['=JR%KY,%1*ON\)J^
MJB:JUJG5-7KK\B!1"[]SFSCWHMS!`>:J.^K"L>RA8G=&[=H:ZN5@A5G78VP4
M2DZ)MFW[.>DYN4HZ3+BE&H(2CU$-6:N98(DI$R`U)E>9[,C$16<-L*4I+B0J
MK3>VG9F_U?:5CS2JW3),?J=9-EZMJ3]4NKQ\[M.A;.W51[4Z.,2HDX.2"E0=
M*`$A\!,:7(838(+F,SH[GG>#;]H=C=^:;M.]MGFZZNX:8UU1^MS-1UX)"/#[
M(6-[4(G1%Q-J.*"OO6&RB[.Z)BI@Q'&(48<XXM;&)'E4L+&;OV%MFA#^O)$%
M&JD)NT;LUU3MW.SQ-BL8T%3+,$/L&7`,\3F,X*D+N;8V##)3VO8V\R4>NE.%
M^.`IE0^YO:@7/T]1]@:`<L96[;$&@CE_AH,@!D:HV(C5T"FY(Q^NCV8>P!HB
MPSI\J.REV`J+7Y./,CSK?CA,7<GN7<^L5EKHNMZK=O@F9K_8=VL99]BU1!P5
MFKT^X'1DATV*!%!K0Z,6J[+!-"$R933)%A7D:4Y'Q*"'V?B#[8DG#`"%IT(3
M?#5409F3X,?:>8\($>M]_KL'>Q*$JBKF0=*,"J8P25$5XV)^.20IEI32,/NA
M);?9GLA(!RK/!U!#]NLM(ZQ%J?5C$>UQ!`,AM*Q[9"[#DG9D>J_.-]P''I<2
M>VTM+*VQ\^`B3'@OJ?<>"';KWJ[/T4+8CD;10>^$B6W]=#ZW0H(G8X4W2-/7
MGKA7-K+,6@I&KIYNR&(=[?(@TR8\6'$]KB2&',-.M8;P&ZU3N[V*M-C(P%]8
M7*\%";,.UXNX:(691AFJ"=C:VH28R8XNNSX+-R2/O:S;F'7DQ<CX_P"13A&%
M/\"Q&F]R[;)]7+;L[859&VW<M$9W,DO0**"L=:R6L6NS5J9!TT>)/(*&F2QF
M"*AM)<0B0E]<E+K*7$K3A01_I+<O83<>X-7D"L4+4]-N:GW$5L<,+7+![-?;
MM6MJ"Z-3[(*/7(!`-BJ:9JZW"HV"MJ!/>4MQQQ4J,EE:@TBU=@=]UWLYV%I=
M=6W:6@3^A:YIW6=@E,AZJY$V<3T[7;;L8D@!HTC=R`BE$[H4F2R"+C(BY;AN
M0LC(V6\SVPZ>S^ZO8?6:+M(D=>1YV!7;<@**DA'K[-DD0P*US*K9IK$'YIM-
M%BM@DL-.@8C$EI<AA['D]KE*CPI(6QZ\;%V-=8FZ&-GM@T'Z'O3:%1!"Z[7K
M"!DLZ[%F5OZY>*LV%U>"I@Y4GXTOVR&K$.2V^A2/+GS8P%>NDFXM]=B]`[B5
ML*=:*#MP;L#8=8J=KL&LX(.`!&&PH^PZW)`!!`:+@7B-38-ACQBV'XB$Q3\$
M@%=?G+'N$901>![D=GJ;5:'.V1IQ-LM%WU81W1915=$7:,Q2XQ56Q3.*C6\0
MZ)G,\#J(%2!D$TZ5=0>($K/#<88PC*&'`[IWOSN2#$,6F'H\7!UPZ?*5JNW2
MQXV1!8'Q8QZLLP-E6\<S25D6J#)K=AS(]&&TZ0<>9SA&/3\ZFPL%=.R1D9UX
MZT]@'_)4`NQS.A3^S,0Q1"SP:W2ME`XY.PQEKR%658&P9A-ACV[,6.\VGP4K
M#6<JQ@*S6?L!V:VA:*OK70%IDL7X;OKL`-N[DJN5X%7:_K,`?+OZ4GWF9;=9
MVK)&D%JM[*XIL%F`=-MY3Z!*.OU'>!ZY<!P'`_GIU>=[$0^I_2COX3[A=C[1
ML7?FW.F2]C:FL1+5C_7R57^TF]M=ZYOE/"Z_'ZJ&E:^"`UG83Z03D<LDA!D0
MHSKDF0K#_KA_0MP'`\Q^Q4?96ZN\6L.L`C?^YM#:VC]5-H;[,2M#%:;6+A:[
ML(VYJS7@*(?LEKI%X?Q60P.RSW&X4)$/UI<C#CZW<--)0$B_#XNFPK)K7<]/
MV-?[)M(CHSM9V!T17;_=D`LWJQTC7MNPS4G[K-K(6M@S%C@BB"8CLUF!%5+;
MCMN.I4^IUUP+Y\"#^S=_/ZHZV]A-I53,--IUKH_;%_K2B$;VR`D_3J$?L0?,
MZ)YV_:H>"(YOU6_,GSH\4^./'QX'E[1@VZ]%S_AO[8?[?=F-R/=J=F4W76XJ
M'N8UJ\_KD@-V)U7W-N*>5K0.K:JII&G&PEZU_`='+@36X[,3+L5QEUESRI#V
MRX$/[W^IH:_3@+]FX'`EUO\`.V_\1/\`DXX'/@.`X#@0W$^KR6_HS@?R@5P)
MDX#@.`X#@.`X#@.!P6VAS&$N(0XG"T.8PM.%8PMM:7&UXPK&<86VXG"DY_%Q
MG&,X^7@<^`X#@.`X#@.`X#@.`X#@.`X#@.`X%%]H?#GZR;;MFQ+98X^ZP6-P
M2<S=N4[6G9WL=J35^T)S]:%TLM.O6K-9;2JFO[#.LM."1!9=YX=ETM!CH:EJ
M>QCY0NR*%#00L:$"P(8H.'@0Q0D6/CM1(`T:/CMQ(,"#$82AF+#AQ64-M-H3
MA*$)QC&,8QP._P`"'=Y:%UGV+I+5!VD*,3A$&QU^Y@"M7M]NU[=:?<ZI.21K
M=PI%_H)NMW6F6<-*PKT9HV?&?])QQE2E,NNMK#3-#=3-/==#-RM-$QLFP76_
MP*V&M5^W%NC;N^+Y/KM/>.2JM58UPW+=;P>$5,%.LY*5'&0GX\+$N>^_EM3K
MBE\"RO`<!P'`<!P'`\KM<[U[]'-FU"#;=)/B==$=XG*Z><ET1X6>AZTDUNIR
M()5\A\[)@&!#J1Z6:0_*]5QLDU$9S!DSG,-L$`F#M9CLXBUF6-.'+<Q6#_5'
ML$)KPJL5*"3:A]AXN*U-UB<GVIJ5&,UZ;[N=GX@-J6S!E/1U,Y=2^ZUP.AIO
M8G=B?V#9HNV*%66-/C*U<X\C8$"N%0S]JG@+I9@E=ML?&"QD17)-C&#H#ON5
M<M]]467F6VG#6<>F$8;0^^%'VS>I8;0]I7FR#ME5<K356"LCMEZ-":Z'KIA'
M7EBU;K2=:@6"6VJY91LKVN0/7"F0%OS)TYUS#`A&0B=OLU\24-;&0%\U%6@4
MFY;2EUO6@D+KF<:24;'4C;ML15IQ].RO96P,TA5!$>;:%,M-CQ[CTG$9>7,9
M9"5:ON/X@]GM!UF7K(92*F*V7+8B3[7KUU$DA1YMSTK6<17G6;XS$B,U,':[
M:74285-9G,@F\MN.->+CX2IJRV;FW]UA?WA:!(MBW&==[FCTS4,<>BPZUO4:
M6)C5VI$K>"63RW>PMN+U%XP'2S.C-.@;(AC*\KSEW@;7596]+=U`M5U)5)K7
M_:>RZMNL=W,2L-#C9*SUC-L@Z]6Y!1,%&O0+Q$L/P693PZ=$01SE3`^1E<=D
M(<VML'O2&5>HU/IV':B^&AAZ^1#:_EVN[5!$6F=?))&V#XR[^-?V$:*VN_7"
M$U"_U)45%?Q(\[V8[J9007%[#_$1I<FITJSZVB,RRIRK4FF+>I!>YV6X%A&D
M]BV_,<Z9S9P`5J/<C%-&.GS33\MNMJFRF7,>=.%,A+P';/Q&2A\]DKJJGA!(
M+8]F0P*;K!>>L[51^Q==`!%:C62:;"QL1)E#/E"Z+!%BS677(CB<(\6'(_`B
MBN;@^)S!.GY"=5)-0+$]>["G%MHI<2V&LH;1%&Q$U]6@\&VF(PZF`]FCIZ1Q
M.22C-VR0Z^IC.,N)6H+=:<+=JW=["V]Q3R.=?/ZTV-7FX(37,,54R=YINZ[%
M#K]X*&&C!TM52-MU,Z*?C0G7\P)><O*9REU"V\!U]YW/N;7<;[/ZJK]9-!JP
M4U=7M4UEVD%2)LH'.IHDW9^R%$A]@(3;4_4(Y$S'BAH@AMQUR,G./76CTW0K
MW6>P_;/9FP]B:N=A!AMIUWGKS8+75:;5IF&:XDIMB@P[N`^?D:^OOD<6+7CQ
M@F_%=CPI0E,7+*L3F?/AT)1%WGN@<V2'^<@@S4J'4>XIVL$EUK6T69$V!U_+
M4'8L.GN$,$RY`^.%A[LS7_>AR"VY%0N=[2AYR,Q)9B!BM4[*^(I;P$4C=->4
M.GGQ0?=5C(5E^I&,,VBR5@'J=6N=4Q["3M09BO#S5PL]HB)L"(L]B=`",2&5
M*1E;\D,5J38O>R[[%ZRL[:ILZG519NR&MB.5>CEA@P^+;I_8$0VS?"9@["FT
MC`,W'IKD04Z+=R9DS\2FEI0PK#`=[<FWMZ6#=.X]5C]/#MRZ0HA74\:[56=J
M9-GC.U(RK4-IL,P80(6?,&_7A,`Z:<C@VAB50F8$>7YG'$H:D!&U#G]Y;/6K
MV$MU3O-66R>TE?JW#"CB5!71R/SAT.^>UW33(B^3XEWUVX"=M^"8EV,F();'
MXBO>U8DH6H+,6NT=J:A<;%&"B"=@JQCLJJ-`/0J*JXS(VK)&HM7$J\$B5Q_8
M58A!Z]*ODDX*(6),B.Q`7!S(>BY=DN/Y"^/`<!P/.ZG_``Q.N%)/TB8+L?8N
M=0=:74)L#7>A+!V4W&?Z]TNQ5(ZFT4;W'J0G:WZT@)K^RLLSP0QY+P\9(BQL
MLLI3&82V'HCP'`JKO_I]K#L-::A?SMEW)K78U(`V&HAMB:'W%?=,7*12[5/!
MF#M+.EJ,8&8L57F&ZU`G(BS6WTQI<5+C&6\K=]0)!T'H+7G6[7Z==:V9L;@R
M18K-<K`?NELL-]O-SNUT,23ULN5UNMK(%+#9K(>*RUN/2)+ZO(C"&6DMLM-M
MH":>!@[/6@-SK=AI]J%0SU7M@,M6K(#(M8?'F0)V!(%F!4YG.<8>AD1\IQEU
M/_M(7G'`I+J?X<^C-2776USB7?LIL)&F7I$O3]+W+V5W!M?7.LR3E3,4*"8J
MU(N5H)!$F@5&L,\2.ERT2I$*',=])275^IP+[<"'][_4T-?IP%^S<#@2ZW^=
MM_XB?\G'`Y\!P'`<"&XGU>2W]&<#^4"N!,G`T$[M;5U6L42GV;9-!KEMGP?>
M<&K';C71%BFC<)FK]X1`A`C')R8/D&2<^JAK+?A'<SX_F:O`-^X&O#[=5"QX
M[515GKQ.T59`]=FK8\T-FGJX@NQF4*6=#QI+A`0@G&3ER/F0VWAYO'F1YL?+
MP-AX'39(#Y,N;`CSH;\\;[-DC"9DLNRX'MC:GHGML9"U/1?:FDY4WYTI\Z<9
MRGQQP.N0.!1,H1!*&!8V;8)RQ@&&0(1(<HV2;A2B+@\1'D/-NDIS8^$\^IIG
M"W,,LK7G'E0K.`Q[MRJ#%@DU-ZU5MFU0@.;3,K+IP8W8(E8Q(7#S8Y(9<K!%
M@#B6VIKVQ;>(_J)RGS^;&<<#.1)<0A$BSX$J/-@S8[,N',B/-R8DN));2]'E
M19#*ELR(\AE>%H6C.4K3G&<9SC/`^REI1C&5J2G&5)1C*LX3C*EYPE"<>.<>
M*E*SX8Q^+G/`Y<!P'`<!P.G/(#Q41V>4G0QL%C+>'IL^2S#B,Y>=0PSAV1(6
MVRWEU]U*$^.<>9:L8Q\N<<#N<!P.*E)0E2UJ2A"$Y4I:LX2E*4X\<J4K/AC"
M<8_%SG@<N!',7<.I)I(@&A;2US++B;..I!45%N]9D$AES+NS6!-1(06B:Y4.
MSE'QLA$>`XE,M]<=S"&U90KP#8JO<JA>($DK2K76[@+ADIH:62JYP78($4P-
M6EHB*DS!,J7'8)#W%82^PI6'6E9QA2<9X&R<!P'`<!P'`<!P'`<!P'`<!P'`
M<!P/*JA@?B5KMI23=B>(=??M=OE5""S:-2R8`61."U)`5S8DJ/491:T:E'D8
MYSV2('CC;&Z[(C9>3%;SA4(.P0K'Q%W`E715[`=&E6M?6=F4J\6G1YEQNYY%
M;(]L<N:JW0H$6=++GGZMFG*$^:&*B1YOOI3JEX:6&*MFL/B#[*JFWTDKW:*'
MF\A-NCZ53J[;]8""U(@RV"Q[5+,&W@*[)E1;BT21!$3)N"$F(W%4YXY5XYD\
M":]@ZS[/E;):S>M;I:J="NP#KTWEZ>1UC*ME9S4A.YOI'`,//UT^$;<FDB=:
M7)<1F<RY*D35P76V\Y\`Z_36T]E+!L'?8OL`Y;9#55:H(T;)*UX.$H:KJL_M
MOYVM:H=B52O&IU<CTIJIIEN39)-IV>IQ^&_[._C+@?&A]<=LT@N-L+%I/EBQ
M3N-OC;]U783U;+I):SM]0VI6=:QO54";DI156)-:;'0F7$.P&<NM+RMA&6DA
MIX'7GQ!@.T>JTA_;4^T:S%T"OR.SD*P8T^VX:V.6?F.W.&,9`T,'/;``4R$I
M%)%N1TI0VA*UO>&<Y"1>PFE]UV'=*-R:P.V##U7T2_1ZN"B6*JPF(5@/[8J9
M38!2HCK6'(AAFRCFI1Y`>++$,J&LS/94R4I9PXK@2%UPJ79`=+.6+L+?B1:8
MY7Z.#K]-@JHBZK$5'HU/?M5CF/5^IC#DFY/W=LHS)=S.P,<2I:HL1MC,?#81
MN1ZY[-:V5O#8PJUV221OO9?JQ<*]%)'JY+%L:5U<C5&+U4XL.8"=?#A4RTVJ
M:W!2ZF2[/0Q(9<0ZZM3H:55:]W^C6E6+>9(EJBQOVUD1[@BRZD`&9FNYDVN/
M5!FQ-2*A9HK.K`0QDO&F,0/+:R3K\1U$>!EMW@<NO^K.V)"\ZQV/V-8@KL=*
MO>XHZ9BC5/FF1^K;SJG7J1U=?G4Z+`@GQS6WQQ=R/A;3;J8;45Y;$?P2PT'+
MMGI?<&U-SBY=$UR9Q7@^H2"']E"]DB@N;>:D$C\8GHHN"GVX?/J]+LE-G3L2
MR$$7*R7.D`ZI;\6*#RXH-&SU:W&UKS9`\S7[%9TW?K_K^A"J'%VVTZJD%0.Y
M-M68"-K$6TD9-`>+:IH-S"-N(?PT&L\@*W&F/O,(;5@/0S3\*ZAJ36:[?Q3#
M5GKE+H(<[9(IS)V+;;'#J`IFSSXLN:I5A=CPSS;[*'R6,292<8=S_A9X$J<!
MP'`_,8QC.<XQC&<_+G.,?+GPQX8\<_W?#&.!^\!P'`<!P'`<!P'`<!P'`<!P
M(?WO]30U^G`7[-P.!+K?YVW_`(B?\G'`Y\!P'`<"&XGU>2W]&<#^4"N!,G`\
MCN^>IM';ZWQ6M/SMDZ3IO8O8?3[L[J37X*X-^R;*)/[F(:[EU*SU@Q$$22,:
M)6QVF;AZ>&)*""<+E+AM+2B8I`;OHGJ3VGU=VD9V1:^T5GO/7X35]G5VN:M.
M;#OMJGPAAS:=]L.OA5A;N,,O\]"%?I1X2AZRSBN3K,D7[!A4F#G#N0K#MGX:
M_:,WVK[0=AM5;>H],$[IDA'8`F-L79U!M5G#MU72@!RK&KSK&G`[UJ.$!/ZN
M=-*EASE@S958B#GHXR)[;F4&V2>M_837^VAYCLSW7)XU1M+?F@ZT$$UC;>\]
M=EKV=":_WG5(M9BQJ]/C1-<'=L7*TU";,"AR[`$E,KN?!+:GV8B@LETGZJ;P
MT"KL&;V[M(9<KOMSZ/F(MYB7#8&R"\@G0:1,J<R^'/I1;\*_,LY9_P![)JXU
M;E?!9<5"AYS'1A2@K1TDZY2MHE^M'8>P=G:GV@QUQM/9(5"LE2W+MK9(@>=V
M'2M4U!:89FUE<N6,@2(UPY9I#)=I<<,Q;VQP93HB+`=4&4WIUM";>^(N<\-K
M:1`6<UUP]X1*U!M%J"=HL#6M9=C-)O!QTVM1@\VM:A*$=Y1;#,EPC*B*RM9B
M>2$E*,2T!G+]T0[6&M47H13NU5JJVT9M2ZTTVD2A6WMO5BCB*KJZDZ]$;=",
M"@_M0FED=FW*K3B+=A'A)9E#+_LZEH9DRV5!KIOJ'N^UW0Y2+UO\+LS855W#
MUH[0T4<5WUV`IIZRU#5NPI:2\>TU&JN.T;4XID=B0&@R*T'F1K'/AMSBS+;^
M?*R&UZ5ZY;FL6^KJY=NXA'8M:U/V*MMDV#KF@;QW'!+0C-BJ7SYUC`O8T6<%
MQ*:[[CNE=E2->174TR,-&193+#_O>:SD+'=9=!=C]5]8]AZFVQNUW8.U3A+9
M[E'V4[:[M9#%?'6H5ABIY,6ZPL0#$HL%-K>F>>!`@1X;3C;##+CC*I4@*M6+
MH9W)B&JSG7'<>\BZN+ZMYUP8%VG<.X;%,,;OF1;0_=+/-)FLV`_*#;).'8KR
M#S)*">I:!K20L?#64QV@C_;W0/XA-^!'QM$[A2=2OEZ#JT$.Q7M[=EB:JX_6
M;=JHN?I4`X:FS#DF"*'TVPNM7AQ>+A:W+6Z/+I9'0V$Y"*P_PS_BB#Y!J3+^
M(K:)C9@I69KX_P"F'=3J,8#+D,(D#)A@0:9K2Q*Y+93,6)$S%/28*(1#&(\A
MQYL)HVI\.ON!?E'Q:^T$FR4RW[31?3M0N>VMX8#1'&]W7:]BR@Z`/5+A/C:M
MK?%;!1*0M#-.E2F7ICK2'H<5V0%TNK&A^RNG=";7U[M/=,?9FR+%:]@F-9W8
M]9;]=I5;%V&MC(5;BVFR&'*V9(*@VF-*GK8$Q1+42-)2PRIV0AR:^&*TCUN[
M%U+I39]![-WH2,[Q(,;454MO"KU?K+.J4NQV,W8]9M9NME8&7LY!HKLR'%<Q
M*\SLB#&S'4I;:O#(5)NGP[NW>SJML^F['[/NV05L_K%9*,>6G:&\AHV7N.V5
M,#(EB(-.&$80"J:Q`[HB%+&.L<!7SM]S%$5QYEP5$0VZ%P>MW7_LGKCL+O/:
M.V-TRK;K+8@"DQ->:F:O=MN0?7,D2%"Q)XF*BUUL1C":V^/DQF3C+J9UI;F*
MFE(K$Q.,<"D-Z^$G;S`(>R"O5`,G+'OSLSL&[_2")Q.$42N]@]H'KB$OFEW0
M5/@'$;CU"$EM9#X,2'6\$I\_+1.*SE'J!:_X;O2.T]'J5M.G6FUUN]R-@7*K
M7=BTB671Y9#L36E1IY.IEAT4#7@4@352E;=0%)-QTE"`I]K!53\YAR7)#TBX
M#@.`X#@1=JC=FI-Z5V5;M/;"JVQZQ#L1NIOGZH49*BOG%6W6V#PIF:QG+$J0
M*?=2A[+65H2K/AX^.,\"3TJ2M.%(4E2<X\<*3G"DYQ_?QG'CC..!IVQ-BT/4
M=&M6S=HW"N:_UY1PLVQW&ZVXM"`UFL@1S67IQ<V8(NL0AP^(UCQ6ZZM*4X_N
M\#9VR$!Z.B6U-B.17&8\AN2B0RIA<>9C&8CZ7<+RA34G"L>FKQ\%^/R>/`Q0
M.UUZQPIA$.39E0X!>R@ICZVWX>&"E/-3:[9(ZD3FHSBD"C`YYE;N,995Y/.A
M2D*2K(=H18`-@P24!-B#:0Q>?7S&1!*$2P*/"UI;)A"683SV()<<XM*7XSOE
M>9SG&%IQG/`BV_=B]%ZN.&:O?]JTNL6FO4.)M(U5B!F/FSC]<3[;&H4.\OUV
M-E\U\UW[I,;&)FI8RQ[:O#7F\WCC@2@4L=>!OBXIH\%#R3A2*#"QBA2"/?,&
MIS$^5"#BV9;[+A`I,BBY3C4=K"W7&XSJDISAM><!U8-NKA,Z9K<$HS(,U^&`
MGEHB6Y"$1HEIP14`>;F.,H@R\$L"9'DPRXXI/I_DL)\R?$-CX#@.`X#@.`X#
M@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.!#^]_J:&OTX"_
M9N!P)=;_`#MO_$3_`)..!SX#@.`X$-Q/J\EOZ,X'\H%<"9.!13?70Z@=@-J7
MK;UHL]CBV<YUW;T=0HT4G:6J[KFQH@;_`!"=P*J8VWB:G=KH-#[^GQQ+A2`N
M2#PT\Y`E,.375("H&^/A,H-O12^B[;2ZQ'&U#2="':S/:[:<I*Q=/V_2[7L!
M@\X-LXU)W4MJ#0"9XI1LQF/?MP6F<\7:RXM/`UTG\%QLA3+K3_OFC:G+32:+
M5XMFEZY??LB)M1DZDEQ56Z:QLN(Q?:10WM3I1KZM3&FQ]/B&R4:2HTS)4G@6
M6K'PZ9@7:>[-F&-ZSK"[N/;_`%9VR^,QKP8#R-F=7]PR-JBHQ-P19&`QXS:H
M3S8)XHV.'O,0(D=2VY*F_+D)AZ;=0'>HP/<8&/LN3?X.U-K']GCX<^M*%Q*D
MZ>B1H\D9F7/L=HL]G>EO1DO2I,XFI*EY\D9F(SA+6`^W5;KYN+KI6QM4MFTZ
M%M^58KELW8&X]D1]9&=;VN\V:T(KC5/DL`L;&O@(8JNP!K@OTXRXHV*!@C($
M"%$:AX]0-NL/7@U9.UNN^Q\S9'I`-9Z_N%1`:XC5"*S/64O2(D6S3)UZ0;3B
M;5R480-D9&/"')K),7'>8)-1E284@*D;\^%\'["]H36_[KMAJ143XJK`C&G9
M6M(,X2=!5A--D1P5I.(M<%BU"&C=6D3HB)XQ]V&X7EMI<4SEMM(;CTM^'GCJ
M)L6T["D[:;V@4L>L@FMI1>=K[%=O5B2+NUFO3EIV;>7+K9I6PK$Q+M+@H:ZN
M+!]W5^#"A>+^8^7G`W_K!TK?ZJ73L!9ZANVY7R!V+WFQNNXCMHUNH%"XZ3(J
M3P.P"!-FIH^BR9T\N9;A/-$RK!%Z(+'L#\-.93[7P+T<!P'`<!P'`<!P'`<!
MP'`<!P'`<#PD,?!$!/U?7%1KO8VS`H5-UCL.BDCLZJ'+-;8YJ^2=ISB-AU.:
M,;2<SIH%;W]G^R7$`.1('V,.%@0V,C/34\H/:G75$KFKZ#2];U`9`#5:AU8%
M4:^+%PVQX^")KXR,+@QXD)G*FXS*(\9/@C&5>']W.<_+D(([C]7HO<33*]$'
M-@V'7M'L%UI![8;]4%`"1ZUU.EGXUMQ28;UHAEP`J,=L8@?F8_*'$VG8++T;
M,96)'J-AX>E?@F;ZMVR=@TPMOP2QJ^=UXK^J7.P%JUW7+7M;:<UD)UGJL"LG
M*[#M<&9'J=!`]=O;1SZB`R8+L965*@J>8(2VF0L3>_@@A;O"MDLCV&GEKI9A
M-K`8MMEU^7FS6J_;7>QQ2?7YDD'M>NG)P%=MWJ-,R8.)S4(E.I\!,UF1'<RR
MT'I/T]ZI0NI59VG5AUAK]FC;+W%8=R220?7`#6Y!P_<:_58MK<L4.JR_FX8(
M3[,$ES&'X<$6Q%@R6(28^<1</NA3'M9\)A79W<.XMX/=E[75;1MNCR--/U&?
MKNLW#5@W1;M("PDZ^G5QTH!M1^6[M<*FUR):CT>`]ZJX6!R%Y]NX$/B?@E)"
MRH)L=OJFQ[*#FZTLM7E2^N8BR@*I>:,C<XW)NJ5RY[(LN*E6JS5MS/":=6A4
MJ$!`Q`@UR?&,R6WWWPZM,^!D,``*\+/]F"EBF5`HJR4MYK5WNX70[6S?S5\#
M'*0*D[*+*KS]8</2(8W+3_JQ&E>=M:<_D<![Y\!P'`<!P'`<!P'`<!P'`<!P
M'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`A_>_P!30U^G`7[-P.!+K?YV
MW_B)_P`G'`Y\!P'`<"&XGU>2W]&<#^4"N!,G`KOL3L2*UMNW2>EBU!OQ%>\9
MIL,`V`)8K#M+#6(16K/;FP!:/+LT.Z3YDH#32$AYX6((0Q;2&5SWHJ)#*E!8
MC@5.+]M*O3=D;;I6RZC8]>5?5`RAD5[-*SJV<`W)S8[Q=JM#*K6*B7/[#?(J
M36R;LE#XEG$>/!6\K/I>*\!,%_W5JW5U0%7^\W$<$I1N6*AC+,AJ>6$2<F8K
ML\?-S+"1"2(X98]A<ER>[Y(+$9&7774-X\W`CT?V^ZXE"`@5"V>-=GG;+.J0
MUA8:T1_4+P"8,(ZY(=D@V6!X.2:LT"'%*R%-"YLN6VS'D.N9\O`Q[7=/K$\'
M!V'&U1[0.R"3)\(5E5^X0H,\`#AO3GS[<B97F&VP12-&=R*FN91&-K9<0/7*
M6VM*0W`%V8T-9M@C-5`-H5@KL`S%L$T56HDB0Y+(,5<S9@!KV61F-B`\]')4
MLOAMK#WJR6!DI]A+C##CJ0QM_P"U>@=76@G2KWL*,!M8D<-*2`2@-J(3Y,0M
M/##(>`[0D%/Q8)F)MC'I>C0,R9,5,UA;S;:'4*R&WWC>&J=;T41LVYW,<(H)
MY0CW5:D1R143*8.0'2HTAZX:$04P'<%,+EN374HB1XJ%//.-MIRK`0Z/[X]0
MBA!8J'OBF*(-WE.MW(LCWO"<;N"IK@SW>OVT7'2B%@DWB.HAG.!R9#S+>7\+
M?92X&*/=_.KX8)4[!%OSIX=;CXT/%4*KMC0^('3X(`RJWV.*4%#I`&H,UZT0
M"#,V2EM!*++:S`]J6XA"@[HKOWT\.081$1OFH$(Q"MDK9#3&9/+EOA!4LG"D
MN)'>Y\$$D7G`DU<6`IK$^='B//QV766EN)"3-9]C-7;?N5FI%!GV`Q/JM.HU
MYGEWJ=:A56D@]@OV2*";&V0L)A"YAF/*JDUF=`PM,R$^RMIUM+K3Z&@P!/MK
MHVOS=JP[18S-41IR_!=:V\C8J7<1PM^SG*".V:PBLSU`ULVH6.I4]9`C,@^M
M'&0XDB5*4S$;]H4$@7_<5,UL8U0$L7SAD2]SWUO7%)=KM6/VB"JQ/52RW)IP
MY.`CY\:OA5!JK*5F;*4W'2K&,J5AO#CC80KK3O5UEV>+U7)%['A`CNX'(4&I
MTNTPB(6U8.3`U5-M@R4&1$S'A/NQ[L)1%E9=R.)ND8R8,B3[0SYPWJ[=B:W0
M]A$Z67KEE<`U*D0+[LS9<=RN-TW6@4]BZXJF+#&F'XMM)R+&_KXDPTD2,(Y9
M?S%0[A/M2,X#2U=[>IN#;U91N(2_96`M?/+K<2OW*;8,P[07%5\'#:"1*X^4
M?L,P\:CPE"4-**,2U+9=CH<:=2@,D8[K=70+SD<EMT,VZD)7K*SB,(M!%!"O
MV@)FR"C0=T:"EM&QJ`./:YCT-3Z!K&<*F98QG'B&_"M\4"UN)8UW,D[*DQK"
M`!6"/36437:FP=M%IJ&3MBQ,<@IAB1!JE$T3,)RN2TW%RYAI2%M*6&0I6[=;
M[+IUGOFMSSE]KE3)64*1D5@46FR)AJI-9<,"@,1V%'>L,K"_!N.J'AYF4ZK"
M&G%Y\?`(/U5W8UCLVN56QNBC]/8M%4VE=DLDY%;M#8ZNZD6"^=3L@MKHY<@;
MYN&U86/7"M25'8#R'694)EUI2>!Q-=[^OHZ$<*"2ENN(0%3M.;"S9*E1+87J
MQVE[PVO,U!3#M/LK8I`>Y)=L0YZ1[.,=E2I@].'H+<OQ\N`M55;37[O6:_<J
MF5C'*Q:@PVPU\Q#ROV4F&+Q&IXZ<QAU#;R$28KZ5>5:4K3X^"DX5C.,!G^`X
M'EGL7O?V$@R^UMHTOU2H6RM+]/;/;:ALJWW3LO+U=?[&;UOJZJ[8V"W0==0M
M#[#"SX@\':VH8QTE8Q?O$@RYAU,./Y)"@](:'<1.Q*-3-@`$3&P5ZJE=N(5!
M!E$:>@39Q$,V.1.CMNOML3$PYR,.H2M:4K\<85G&/'@;7P*M]L.Q)CKK3=?S
M*AKUC:.Q]O[DH>B]8TTG<$Z^K4ZZWO)26S-M]XQ7+E+K%8#`@$^7(D1@Q64M
M3*&6HRU.X4D-2Z^]D]M7G<VRNO78'2%4TUM.AZUUON(9]'>XI.[*/:->[*LN
MQJ;`?Q8BFK]0F@MG#V76!!N5`=$NL*C/1WFI3F5NM,A='@.!Y&V?XC.]0FOM
MH=E!G4VF%^H>IMJ;-H%BOLCLF^,W>1KNFMTFM%[%NX'26-&3JJ_F):ZP2EC1
MDF[Q7R`V,A:W8TAY,=(>N7`<#R<V'\8'KY1-O;5T+!UWN:];=U%:K[7+!2JL
M+HL><1@:TUS4MOVVW@IEKOM:%RZO&UH=)D([SC[3TR36B4!II4Y,=A\.X1^*
ME4Q%K$U@QU_V77V;3OX%U^HUGM>R^LU2JUT/6'407>XL\')V/=XU3,`CJVV!
M9T,=);9.SY91$&/!<ELR&F@]*5W4/FO6BR06#A:)4EV>.1@#J^96;ESZEF6V
M5'`Q$F'%FG)3LB&MJ)F,EQJ:O*?06XE:59"M>M.\&C;WKD?L0^>B:UC38K\]
MT39S]3.OP1R$7I^/+E&=?'[C66UR(NM3>7(JIJ9\.0-?BRF&)3?HY#;]>]L-
M.[+V>:U)7BIF/;Q@D2<'QC]9/UYFPCR09DU);&*,CX3L4V"9=RB>)G(AEXV6
MEK5&]%.7.!^;%[;Z+UC.LP<_9BI*P4\W0@%AK=1J%MMYV%.V);:53`WH00`6
M=DJV-+[%"9*XAJD.BF2D14E#:I<5+P:O%[T=9FU62-9MBQ*(2JVT[!J(F,N,
M$D)E.64%<+[3D$![GL;T,E5B,K6Q>3@HPZY!A1X;V)SD5UA]MH)AKN\-<W.K
MWNWTLS(LX;7<RTC+!)AB"X]A9:FYGLV`<'FG8(H><R/(#)$-R1$>>B(F,.L*
M=PXTXE`1A4NZO6VVT`5L9.R!U?"3ZT(M!&-:890$6K$(P(,&V(]H'SH+;P:6
MV-K\U_.'?!"XS.)#:EQWF'70R#G;S1;30DFJTS$UDSKA6SX%E=K-JCPY5>7?
M`&M8$>"/D`VC9,W/M]BCQ,0(T9V8RXZSAYIOVF-EX,7*[Q]3H;15U[=]2\0M
M?J=G(1V&S,J<@5=Y-6B5I,8=%%/3R!>;)O`9#HZ.VZ1AJ*Q/:&&O:&O,$S4G
M;VM]C6"]U:D6J'8CFLRL`'>8<*.02V`,$HBIT88].D0V!\N:B.C/K-QW7E1E
M_D'L-K_(\".F>V_761;8U#:V<+5<IFP7=6Q:UD58TEW[HRRS(7!:AK#)<4)]
M*0C."W_="LJ\,2<Y^3@9K8/9;1>JK]5=7;"V*'J]]NPR29JU<GQBRY1@;$<E
MM/26)$0=)@-?FT%U"$.NH<=<1Y4)4K.,9#Y4#LYH?:,X.+HFQQ!XL??DQA8=
M,0P.,NR(/SQ209D""PV`2'NC7]?&6)*9#368TF`XP[Y7LH0H.M;^TVA*$<N-
M:MNP8H@]0U!6K*,4#M$R2S-L3]%C!Q(G`\'+19STR1LZNH]WB\S)K:CD+"VD
M^TM>8,49[@];Z],*#S&SH,*>&FC1Y*$H%;'I4:21`F+,O'L\<`\Z\R""5^<\
M9=;PMH#F(ZV25%<0I&`#^XG6DP42$![9!6$NO8"]7M#:Y"/V*9(N;3!.4]!C
M1P@B>Y)%QXH2>ZZ4;PH4TV/EJ5)PF+(RV';I'9S7-GCB(EB?=U[<#=QO%''T
M>R/PI9J>:H>V2^FR>1<@`^5%E8<FV"TJ;4R]E;,22T[(0RG*O*&VW??6I-<'
MWZQ=;E$!&8=3EWB?'>'&I4<96(C1IY)$J2'C98P4X336R.!T:0\U**+@2$0V
MWUL.)2$/S._'4$>1GAYV\:S#,"ZT,MDX3*@65@HR*,3H0L='P.=!IF.V.05G
MMP\AD(47;F86PN,EYIU"`M-7;"#MU?!6NL%8)VMV<,,L->-C'T2AI@&:A,$A
M)4?*;SEN3!(0)+;S3B<Y2MM>,X^3/`S'`<!P'`<!P'`<!P'`<!P'`A_>_P!3
M0U^G`7[-P.!+K?YVW_B)_P`G'`Y\!P'`<"&XGU>2W]&<#^4"N!,G`@:V=;]:
M7/>5`[%F%7AC:&M*9:]?U6:$V3?0%;:JEV?BS+,-*4@/88=/..$YHZ&^J1+A
M.R</#XBL.8S&9\@30'&,A!`L-'D$9<<2.@C&)9@G/-%Y3,",U%:D%#)21+)E
MB+R&L*?DR777WW<J6XM2U9SD/(/L?VFZ>!]Q=GM?;MJ5K3)H#'6Z*6M^M+C8
M)]ZLEB)1[4Y`&AJ[3R@:PT7Z/QNPXL>;.9DHP5C69UAS&4,.)4&8VGV/Z![W
MJ$#5=FK.Q[A1M7&6FQ@FG@KG7PT,2`UILCYQD&9H,R!=D56F4FHV"&18<<Q*
M:=C(S%8=6Y#=<"NM#L_2ZK;,H0VW3-UJBUJZ%_FN>/S;O,@[O&W(KI^^@=BV
M4)&)Y6,T7K2RI`L!`ZL21F')OMRQT=#,M;87=U-'ZW[=HT[;,K5%PI]+ZMCX
M^O:H-M!JR,N635E&U14]BTTW:J>LM@;8XHT+>G901HQDC(BN.*E8<:D/N(;"
M&M.;:^'[43NM[GJ_7>R@177>LA&GZ9*9%V8A&0Y7IFRZ95]7SU_.@K#M^SG7
MZ]9(L2?)7.;D)?4XZ15[1'<4&)WI8]`"])@OB06G1\Q.Q+H2IHX@&N&Q=JP!
MM.02/5FHR9QT=KZM7F>RL(.UX,<FLCJY*PER%E2O(A4N2L,S?M_]&ML:C#Z?
MVS3=E0JQID[K&AE:A"7;(HZE64Y5+3KF972U_"G1,`B*HB(ID`7ES9C:')S*
M%Q,2'GX#CH:X+JO0:JRQ=KM&@]AZ\+SNVMPTS7Y9*S%#$H[;ZGM1NCNVO&1F
MP"3N=;6>]EH678B4J=4YZ2WXGL\93J`Q[EM^'Z5K>H)^TM8[7U3,V+6K7)8J
M4RR764["H>EQP#30R=LW.O+J6@E*VS"UF+2):?S-4Q-0N8MMI;DF2L-DH^I^
MJ`;1=VWG4^LMCJ12HW(SIH10K7L"X!RIXN+VHU0*1-NTU9$OD(TZ>L&'<R%(
M)N"A<Q[+?M'@A'`E&G;_`.M^C=@6ZOR:K<PF[J=KVI5;8]&U@1N6TJ5)*GMG
M")M=J-?)3FP@VRV]NT]@HDF+-E#QS[8T\IEQQ"8DJ/##A?"6E=BO=A"%TT;N
M@4P/W_UVH=S>*7@I519FU;/UIKBAM7(7!J%WE%*U'8UCN2/5[0PQ&:66'Y0Q
M(;>9RX['#>36Z`FQ;/D%;M/VVK5W3_=*FZ4UC;!UO<`S,W"'1G795\=BU*6E
M\;2"(VV/@HT%W,EHC%GY3-;BMN+PR$+AR_1`%8^N%Y&:GV6'LUG,@PFCI<MH
M^/G&X0JCZEK6KI3T8E<6UDZ?;`]=J2`ZI*76FR#>'B*(;OMR\!MS&S^J79V^
M:&C[#I&UZMMCL=U]KELBT24=M(P;`I5D$[).4%K9*-?6U=.E6(>R.M<JL$G4
MR'A4C*W4/0I;\-*PA#LSK3IQK&3MJ;6->[FF;MU-2A.S)-@I%QNXXU;R>GI=
M*W.8I,'89FXQ6(.PCU=D0R9@O^2GIA%7YK;TF:EQC(72I_0_K<K`VZE=3/UV
MW&:%!KAH#'O]XGB:]#(ZZA:_,UL:A1QF+EIFNM>QJD):0XMQ&9&,I>6I>0G'
M26AZQI!6TY0%WVLEMO:1O:%DEXAI@M-RIHD%6`@:%']HEK;A`ZK6(+*UJ=RJ
M9/\`:IRTI>ENXX'<UWH#5FK0NP0%-`2X0S:5C-VJ\HG'[`8E&S-@%Q`A%]PB
M4)RR$=*A$!F.C#3J,I0WC/CY_%60U&M]2]+580X+'#+=)D2(>PH4RS'-D["L
M5VGXV>"K=6MLLA=3EEGV><5>K5.%0(DQV4J4/CCV<1G&E)\V0_:_U)T758M=
M&UVKDPX*J5JBT\#6H=NMJ*W`K&K=E_2SJX(T#4:6/Q`UO;UN8"-X1X0!KJQ[
M?A!SAC`372J;7=>5&MT6I0<C*Q4@\``!'*E2YJH0H:PB-#C9F3WY,V3EIEO&
M/.ZXM:OQ<YSG@;1P'`\?=A]5>\`)ON_K+1/WJ=AU%W1NFPKN]<MM7C;M4V/K
M"?MW35+U);(#5'IVKKA6;U$K3E343'+R>"KGID8B/8C9;]J6'J3K"D,ZSUIK
MS6\8@Z6CZ^HU2I#!5]A$5\FS5``\"T0>BMN/-QG9J(&'%-I6O",J\,9SC'CP
M-YX%.^Z&B=D[NIVI2.GB='A[0T1V!UMV`IHC9<@\-H5QGT=H^((5"S'ZN+/6
M&L1"P&U2U,D8HTDN-,:9RJ*\WE:>!J/77379-/8O:_9SLXWHZM6>WZ9U+HFI
MT+1%HOM\`PZWK:Z;;O\`-M=BM^P:-K<@X;.%]K*BM0(PG#$2,/PXJ2^M_P`C
M`7RX#@>)EOZ3]W2.D=S=*Z_.ZK9ZV[?W!NFUJW,8N&W&-X5J@[[[#6??EIA)
MU%"UG)H1NWU55UG"!Z\V^'"FX98EO)8\7(N0]L^`X'@KOL%\-->U]XVOL+HO
M8=7V8-V#;:%%OM-LVU(-AVZ-*AZ3:-DIIYVCVBMSFAT8/:G8!X/ZC;2P\Z="
M8]J;(RHJ@ERQ%^L-@OEU,7/5VXM40]<=J(!"@WG5NQM@5*QV.QB>LNL*U>=G
M31.MK0%>JND@6EL@!<H6^MQB5#:PXX.3*6XTD++#>X/7F?(J>MB4;;Z<=B+I
ML*M5>/;0]HE+-07;4)I)T[!ENEYIBNZW>NEQC!AN6O9TP_/ZC3$<>SF4@*[[
M\U7UATD9L`(KHG<&SY=9ZU[U[&%[66W->"8JYYH0]RH.5R^ES5\)6VW7S(C8
M\F&`(2H!)P.W*1F.M"TI6R$K:$V9U`L6\@%&I`_:6=W#1UCL1"9L.3?CIL/:
M!$$KKBT@+V?.V`\T[=F`]>DX7ZSC\%;+25,2%+4TC(1/N7?70$!MSL;7+V+V
MRQL@)+J(ZZ+KWT@0HDFUS"VG;`-F:E>&V."&$71TI6JD0(S1Z8#\E=>86^XZ
MIC&'`Q4FY=$=RW.IQJ5J+96U3#G8BM4!^TC)%DK;((S>3W92_E+FX1LEG`RI
M537<Y-YB'(32$$<Y?PE43,5`]60LA![,:"UK4I>M[#3[A4JI/V1O*@DH+40C
M8(@"$)VA6*M=;5<3#4YUP0$.W/=8Q;&8;T[+;!1"F\);9>PP$=:YU=TGLVI#
M&Y8U3W'6*IHV`>59'[O==MP+A*&`M:13XDS8FD78B8O*P^L;@PJMO2GI4R!'
MDH:CX9?;2AL-HTB-ZG70A3M-Z_U/M&*O6M0*RI:#L*RP1^M'9?8,K<"57NQA
MRR.1_G=/WKH*9)PS&S.83@9Y$.H@RV$2`AG9X/X>NM+IM?21;6>QG[0:IM+!
MV>NTF=:9V+@/D$M5BV80KT+DQC)IMN55$%GYV(B9<%I&/5?0U,PD+5]6275N
MP[!VM9=!P#^+@2KNNF=C3"[MJ<;'@QV+*.UH&S'LA&6D7F>"AOEH4=M"5K$S
MXLE7E;D,IX%'2A?H*`L-G:HFJMFW;859[-44T>KZ;7><CF;./V56`L':9,BJ
MS&Q3-!IU@OK#C:'&_;</^5A<9MEQU?`EC=MXZ7;0-"-D]B-;7M-LK8O;=2>F
M#9EQ;31:QKW:&RZ!%C6IZI6`6-A&+M;J84BB\Q?;O&;CRXDI8PU(4'5U^0ZE
MZ!VV;O%!K6UI[&F].;!J#C`NIE[".JK%M[(;!D7N84M)P_(GV*T[+W#29D8-
M$;3Y![,=_P`GH1I_A@(Z>[0="/ILW-L"XO;F.WZ4=U7L".!,!+;%"5:SBI/7
M&M@Z;0QC-B;JJ+K-ONM*X\8>\&$R<P'&)$ER"UXNA]-D6#J'M6TB[33Z#V$/
M$;'O+7B3L>K$[-1X5P"[=D672]KR#^<-XK'S5HLFR[71)N,*"V-E&IWIHD1Y
M&,ONLA<E_5VANLFT-&PJ'I*T2BNXMVW.`')U,QC-:UJ<*:NV3;#IB>%-6@?$
M@51X./*H;@CHKZ([DMQQMG"D-(R%/:AV9ZB6>\=7-GV,)L/7-SKOTX;0%:ND
M58S890"]=@:U1K];;X9L:)C[TVF&1^VFTB$,1$LN2#+;[K,)`]2(X2ML_?\`
MTNNMK"E=HUW=`:T[)T1[\E5Q<6_US!77+Z-H/:U5<JQ5+(T)<M)=$"RR:@_*
M;7,&RGTY4]!G.0D\#2:-HOJ1O'?#U4#=<KFY!SI$)L2S[?N.PKA"L(ZYPMIV
MZBQJRZ$=LQ,FYM&O7W7!N29,2%H<<(LJ>;>F)>4\H/72N5\14J\!JM?B>P`:
MR&&5\+!]>1*S#$AH3`X=%S)F.R)<C,>'&0CU'7%N+\/%2LJSG.0S/`<!P'`<
M!P'`<!P'`<!P'`A_>_U-#7Z<!?LW`X$NM_G;?^(G_)QP.?`<!P'`AN)]7DM_
M1G`_E`K@3)P'`<#R9WC;]7!=P;IJ-YT5IC=P.CD]0&Z;2!]5`C[X(O.^16Q;
M5?K)?;19K04#/M%V=(Q)<9;8<?)<]%I"E2<MMN(#7)'97J*'%6&U0.LM2R*,
MG_FZMK)#4\&QDP3&O-H";7)/5-\Q[PJD^53:T?'!@\E*'[?@BE,3*\RI.60[
MKNY.L=)ET6V$.GP"LLW_`''LZP5<E&5KE=K,$M>;"H.IB^P!-5'R5&C]B*VR
MRP788&)A^?@<-3+4VV]':80&4U5V:Z^YUO9:31^L`6N:C*Z_V_M'<XR":U=]
M'4&C!*%K\L9DEG89-T/<9]DJFP@PV=#:QEL6J+,A27$X@MH?#2=<[?TQ>JS>
M(5'ZBZG$4J!UMVKN2`+.DP31FQ;$H&T=ZZ<OE4]QY"QWR8QR4%+RE&UOL2EI
M.J]I;C/2E*P$A&>V>EJ6.JVB`_7*'9AU8#:RDT>EB':$&K44Z8KVL;4VAFKD
M2<]^G5\((W!`7#(R$/,3I;!"(SE;T;&9`;OLT)H"M:ET;=:;UFU,>J&_MF=<
M*^:%W!(:GP:Y4[@,<&UNPS\I&&H$TE6QI=,%`W&4LSE3WF5+<P\O#H;)I5_K
M)V>M6R'\:!J\0UKC9N+U@F;@5@N_-M!6P%`2+C(9&/R7JE>Y9_3J)A$3-0T0
MCKABYTA.9"V5-!!<C=^B:A\U25YZI!G9(BR]BCAN36!]5*QJ',3ORZZ;.L"`
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M6L%F8ZBS50:3I(IAQV,.Q[N19D-ML-)>?2L-L.=H-=XV)L`[L[K/KX[-NFM]
M=441?Q)RE2QUJ:V'1=+6"PZSO-Q.R&(J*+#([:C978G&6AK@J)C#C2E--I6%
MAH/=@G<:#8]CTK4AR#3*]:.OM<79+67KV'ISVZ6--GR:(-4&&,DG'*K5MRP,
M^H])CLRI3,CT<N-MLYEA@[?\1"N4NP&Q$S5YZR#8/86;H`-8J)9@=H&G2%=%
M2"=Y+NXPR/<`S:;+CK%/CIF4*?-QY<1E]7L;[J0W[17;W&X0'8V^/U>,+INF
MY<*57(,`R)+V@M7EZL"[$D9LZ!Y:</K]K<616RX)?]GE#5)PU)3Y\96H(7/_
M`!1-?5*HFS=JUC:0]H""X9'YA_.>F23!=<ZG[$O3<<#*24;CE,0:]1&E374)
MPW#?)M(7G*$9<4$<5;XM0(LFW'2FH+`S7&@E7DTL*,-5PC>D6,N137YXJ[!A
MAHO(&U9)EQ"V[&Q&4.9:5Z*\.2?!"@O9U^[(.]@YAN2%UC9JK4`@&A37+193
M-9R_)L=ZUO0MI-U=JNB2)$DWD/6]A1$/37,ICN2F74M84CTW'`L]P'`<!P'`
M<!P'`<!P'`<"$#?6K0%D)7(R>T]KTJ7V%-$D;L4F5D:Z0LL\(U'8&32DS+'M
M#\IB-$:94OS84ZRTAMS*D)PG`;`<TIJ*S99S8-;4LQ[/=8.QF?>%?&R?)>AH
MR`$@VK&'&,XR9CAQ<:)A[/BK,9A#>?%"<8X'-W3.J'I%(E.Z\J*I&MIL\C0G
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M:HS32HA(-,E/NLN,Y;REV5(5\JI#V7`S)#3FJRKDA^?K^I29$H@4+/2708]<
MA14V>JUI+$_54QE?M\^RT<-/==_PURQ<5W.?.RC.`T;2/635.A=8G=25(6^7
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MV#A]NH!TNHN@Z<^3'6%O/LN<(G#B4A4AC&,>FT]A*TIPI",I`"ZO:9&P`;-B
MJ(S9!H$1V85CV[8@D`=LLB=N"Q6"T;#7(=C!A@AJ)82MGF^:)'AL0VFG<H;:
M0GQ\0V:MZ!TG3Z]*JE7U91@=;G08@V<&'UX>S!G08%F-W.''G-89S[8ABW64
M@3QEWS9]NFOOYSEQQ:LA@9/5?K?+?.RW]'ZR5,LS"XYZ<BHB&9Y-M<^$5\9,
MYF,W+R\@F-CR4.)7AQ#["'$JPI.,X#/3-`:2G#90>1JRC9&341FY$-FO#XK2
MDP[&-M\++?LK+*HZX5I#1"+*F\I4U,C-NHSA:$YP&[6>E5.Z8`8M=?&'LU6R
MC;C6ED8R7W05I#MRF1QX4]GP=A$HT:<^SAQO.,J8?=:5XMN+2H(_7UST,MX/
M(5J'7WK`&<1PZTU@6C,",FJ@Z0W%9PB.E.8K-3K`V"VTK"FVV!\;"<8RPUE(
M9$YHG35FECIUAUC23,H33I>O1SI&OCY68E(G0)HJ15FT.LJ;R&]V$Y4=MG.,
MI:9ER$-^5+[N%AW1NG-4A@LBN"=>U(:#ETV+KV4,A!(4:+*I$)\Q+BU>2AII
M.7P[4RPSWO27G.,O3'G,^*W5JR$E<!P'`<!P'`<!P'`<!P'`<!P(?WO]30U^
MG`7[-P.!+K?YVW_B)_R<<#GP'`<!P(;B?5Y+?T9P/Y0*X$R<!P'`\NM\;MW!
M\Z>R%'TUJ6K5O8@)C7$$!M0I3RU@*OM3[AJ"L+/66.Y3'P!6-/K6T3;E6RW-
M+(CJJI',Z,EO"V4!/_9O8SW7NGZ]L834@;9LJT;8UY6;GZ0;Q,-18HV8J-;H
M`T!6Y:CMH&O`XT4;'0AI]M3R?8FI#K;,%X*1A.SNRAM@Z\O[<ZX"+3LZ/LF-
M2Z_<AH:V0T"=?;DLNM81ZQC8"*?`K8*\!F"D><78QE[.(8>2MA:6%3I,4)"E
M=M-W4Z!I<?*ZB51*]NZ>NNTI(^N%3;(&O12%=(7"-KZ8\]0(Q>19XDMA+MI;
M;#N)2B6AYMI:_,G@3W4=RN$.GP3L-%TF#%6L?63$:)2?<$R$,K4:5<U5*P$F
ME#`18PG7K<6!@[-=%,3FB`>/ZT1<QM3#S@=3K[;MM[:W$4MMTJE:IFL'^M6C
M3X.I,U-39I^\VJU[3;*OD[.>K,$U.%@AU.9?$P4N0<PX)AIR5#3)?SZ81OL_
MM]=@"=CUQ.AZ]8Q=.VCBA0:L2@;$D/-"`$&]EJ[)L,:-K`E6L%-MSZ$-9I+0
MZ1-:2_8!ZIF6<X:Q)"O`+XD/86'=HP&/T9>%CK%N">(/3Q<ZXQ"4@!DRD,JT
MRFTZR9&S;?*APL>?#TKV1><-_P"M^GCS<"P&M.WFUKW9J*Q*ZV!1E>)V<*.M
M-@;^>;<@:JW6NG0FV@#)G7HA;IG7MDN,MFSJE>SL)*`9V8Z\X5YV0VGLCO/8
MFJ+5=]*Z<TE5R2W^IVS=AT8XJL'#8!Z\U<;=R8RBV"GUD*RARKREC,-I2V^I
MN9/+HC95'D.QV9X1G=>U)4"8)`8'7[6MJ"KUAK1AZ_-@+:FGLUJP0=3/.7VQ
M,Q]?D5)Z_CW]AD84*+&>F%&9=7G)>C-,8=?B!.W4K<][V3L+?8/8.KU4)\-9
M6)E%M$BOR!+NSZ#F1.ACY<"2[6ZY.=#4![&`S:#+$0^M6,R7X,2,_%4^&G5V
M]]AF-OW\:0U[K^UP[SVGLE`K;\T+,JHZGZ8U[IX):OG(0+1*62+7*Y6^2PL<
MTZ0G)&(E^FAAUIEGV=80U1.^6X2&PM/T0;U)B"Z?M&^QQMXLPS-V&0*FNW$:
M,HQB1!DZU@QB%OI1.Z31]HS+7%C++").6GU8]1+(;WVWV$=UCM"G:\TC9ZI0
M+@C2>T[6+#DM-125,K89JMV\?\Y(MB"T*YVHI;G+4R+DP@`*&XPR*"%99:--
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M56`[""ZE"V*QD6#BWFB)!P;E,HC,1"E-/!<K1]COU^ZS7V_$`(2_[)KH[8K.
MI+1;]71:W*N,E%(%S8R"%3&A0<J/`:OF)-?>:AQXSDV((;\?4=SEU8:WH??!
MC8U^UOK^S:3H\J/>]"5LO=+L`K!J#%ER#%/A6:S2&QQ:KK$-:L1<'I%;7"F$
M\E&[`RM#L3#:<JP'HS$@08"%-P8<2$VKT?,B)'9C(5[/&8A1_,EE"$Y]"'&;
M:1^5:;2G'@E.,8#M\!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'
M`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P(?WO\`4T-?IP%^S<#@2ZW^=M_X
MB?\`)QP.?`<!P'`AN)]7DM_1G`_E`K@3)P'`<#R>[.0.RI#8NZHNM"/8T;1Y
M%8U[*==`!3Y:%\[`%JJQ*`)UFJF;,U^>;IM_!KD"S,FNS8)T*XP1DE43(\@;
MF*$P=>[%OFOW[:!+=839L448+4\&V&(KD6NL"+I9]GWL77V=638V5XD4$!J4
MA54'R*<(C^\&7Y+_`/KOO!7`J=$9[Z^VCL1OIQP1^<,+`]1J1G-?3OI-BUAF
M^R++AI_+*NK:Z8FS8#-J\0OK^;V5&)>1N>!8S5U@["C>MFRZW)@[E<W%9Z]L
M%W2LK8T+$VW0+(#TA1WCF#9><MZ$*;F[YDV+YMXGJQ">AXCIC>`_$?'`KZAK
MN?[0OW>CLGBK^ZBZ@:2$N9FPXZXYN^S,E(QO,^1DKGM7FN*K?N=;V<V'$3"<
M)7B1B=P+>62V=HZ)TI`66H5V=:^P0T/5O,"M((A:++,%/V2*PZT>%@9#<V3=
MTTIQ&);F,/(;*>=R0GTTNN("N=OVS\0W6P/9<ZLZQ*[#E';V?LFMQ!"@OF2-
M2%NV;:3T;7U@G![_`"VR(4I"KX)F%/AM99%M%$H<=RPK!".$O6O9?>\(1UQ*
M"4*FV03=]^[!`V$>FD60?*U]JBN[*S5:$R3E1+185SY%]UZU(L#MADMBQL&0
MPVRMM")+3>0F7JOM#>=RHD3/8;7I6KW^7=+>&9D"Z>3KU;=`A8`PE!-.PRY.
M:9#CILJ;(@1534-.2'X:L->TL>B0F!;7@.`X#@.`X'!QIMYM;3S:'6G4*0XT
MXA*VW$*QX*0M"L92M"L9\,XSCPSC@<^!\W&FG?)ZK;;GIN)=;]1"5^1U'RH<
M1YL9\KB,_B9Q\N.!].`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X
M#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@0_O?ZFAK].`OV;@<"7
M6_SMO_$3_DXX'/@.`X#@0W$^KR6_HS@?R@5P)DX&,?-AHQ:`!DEQD<X5BSIH
ML,_/BM%B4(9F,DE+@#G'4S)D4>J:SA]QM"D-9=1Y\X\R?$,GP-7'7>EE[$6J
M`FWU<G;`#6'SM7''Q,VQ!6598PEXL$C2W20YI6937@IYI&,^HG\MCQ#:.`X'
M7D2XL7T/:I,>-[3(;B1O:'FV?:)3WF]*,QZBD^K(=\N?*A/BI7AGPQP/R3,B
M0F\O3)4:(RE3*5.R7VF&TJD/(C,)RXZI"<*?D.I;1CQ_)+5A./'.<8X'9X&&
M&6.O&Y9D>&.ABT^NSDC+!"&%(,^6")+8;E('F8T5]UX7.5&=2YAI]*',MJPK
MP\,XSP,SP'`Q9LX%K0J:=L9@6`"#&?:"1DV0B"A0^/A249?FD9SS$2(SA:\8
M\SBTI\<XQX_+P`0X%LHJ$=KA@6?"$V?:!ID(0B%11"/E2D8?A$8+S\26SE:,
MX\S:U)\<9QX_)P.Y'EQ9>'<Q9,>3AB0]$?S'>;>PS*CJ\DB,[EM2L-R&%_(M
M&?!2<_)G&.!TR!L*)D"HA4N+&2SL[(L)&($(D.09)XC2)N1PIF2ZVX0G8AQ'
M7?19PMSTFUJ\/*G.<!E.!UHDR(0CMS($J--B/85EF5$?:DQW<(6IM66WV5+:
M<PE:,ISX9SX9QG'`^!4L*!#9IDX3'AA`V,Y,(E2LR,.&CXC*?.]*FSI;C,6+
M&:3CQ4MQ24IQ^+G@=QEYJ0TT^PZV^P^VAYEYE:7&GFG$X6VZTXC*D.-N(5C*
M58SG&<9\<<#Z<!P.JJ;"1(C1%RXJ)4UM]V'&5(:3(EM1<-9DN1F<KPX^W'P^
MCU,HQG"/.GQ\/''`[7`<!P'`J-M+OSTGTCL&5JG;W:G1&M]CC\"%%:;<-E5@
M&<")/L,2@N3\.:0:4!P2A26I#7MF6/-&=0]^=+2O(6V;<0ZA#K2T.-N(2XVX
MVK"T.(7C"D+0M.<I4A2<^.,X^3..!SX$=[5VYJ[1E&,;,W)L&GZOU\`S"09N
M5Z/C:U71[Q*:P-&1GR961&C>V$R4IJ/&9PK+LA]U#;:5+5A.0TO1?:'KIV<'
MV$IUZW9K7<D*I3H0VTN:]MHBRN5N:3CNRQC!R*/DNRA62<:.XN-E]"$R$M+R
MWE7D7X!/'`<"H9GO]TBKVUW=&'.UNA1.W8]JAT65K^=LRK1[%$NQ!^/$A4^9
M$<(X3#M$F=,9CI@.J1*S)=0SY/56E&0MYP'`<!P'`<!P'`<!P'`<!P'`<!P'
M`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P(?WO\`4T-?IP%^S<#@2ZW^=M_X
MB?\`)QP.?`<!P'`AN)]7DM_1G`_E`K@3)P*2[HZY7;87;+K%OJN0M2P0^B_G
MG/,V0I&+,[:)>_J'L.EMT.%*C`R0PE1C"KVB7YW9D%T)+B.OMQR2IB41`N2'
M67<$"G+!'&PSRQL%9N('FR20B*75&:42CBB,V`*F3QK$S*TL//18SKK6$J4T
MVK.48#RO[%AZ,-V)V:LM2WMI_5]\)ANOK5X8<NYS65M:%59^WQY0ZWW^B#'K
MI7F2DW8U=G-9'YE/O8C1HLQ#,2<AQ027V=?MU]T[5-=ZG[4:UJFT*7L76=!O
MU]);$)46?,V-::.ANC`48H[A+";==[1;01>-6ID9]@I!E(2E&/.P[P*D-:$[
M5Z;O.IJ_LGOC*:GWW;Q`O6*E+V/LLL5L^&RE27-BP,F:C9'RP82-<R+>"/8@
M!$X/>TYDL2&F<.!8BN=.NQ,"WZ)EVS<BK_3]77FE7:=%M&U-LE"4`H`HH8?<
M"C$0I&(Q-DSKK=G"C\=H_(:9KD=2'1^4N2'H[(;CNSKQ'[!;3.VFJWD(X+V5
MH'4=8)PT;/OU?L`JL5'?L7:,*RUZH`<NCVF;D+1/@L'6\C"8V;#1AAYW#SV8
MX8F@43;O5JXVO>O9KM&LKH:MZQ&UA]BP6^R$PX&:N;0P`.07&&*V\Y+G0YXV
M8\JQN$W"A&0?<8ELJ2RE]01=8>I/8.N[0LU\UR<"4Z5M#>C8R8=U<3+13A[2
M.R-A7Z[;/L^Z7YX^I,P+10:):'QU+3$6=>@6!,:0AY")"FHP;H=ZI]O_`'W7
M7JSV%4@-G;0#8=K06VKN#WFB%$V<7/GP0#S,E!SE>,:PDQP/N)YIH8VXTEYG
M,?+;BI(8"-H[M'(F:%DP>TM<O<&'?-CRSDIG:.S@:-CTX,['JU3ID5ZMQ3X4
MA)<U%36E6*:ZEJ7"N$HF2AO+6[A.`M;KK16RH?46?H'=-[';@V03HM^I]BV-
M85D2L*\3[(HZ@99#HXQ&DNC/49)1U/CV$OQ8/I^E&\6D-XP'GI<:U8-9['OU
M);[C4JIUG6FE=-1B6AXNS;MK$-7ZO4TZ.;MX1]RCTF0:UX)L#4$D0=MX26X:
M@1+<AN5!1"PAY03:KI#V`AN6A=?WR8K#%T,['NED&@MN;E'05WHW5-ACM>DA
MV6I>9`V&%L]A#3BR65->^71F'YJ9KZ4>8-]@==MO#B+1?<&WZR=B1^R&I-A5
M>19+99"3+\P/>KRZ\^#A62"T-U_:+@$N@2LPJR#SD/A0-+[3GKDI#20AR#H?
MNA2M@]?QA6]7780!S8HZ==R`#<FQ<5RIA@L/6J+_`&ZS$C,T46M[FX,5\])8
MJ,V*X"JSIG+(A]:VDJ<#,+ZJ=G"<.EB=?]GB8NKT+3-WTZ6%@MC6\(Y](S3F
MUX.#3Y&?2K5-/%).+57D.F)B_>(636<2&&YRI3R<A9,QHC;5AZJ:_P!5VPW2
M=@;3II?5MD/)M)6U/Z^V/)UOL,'<EU>UGC(VW6A\<=&A$1GB#XZ:KVQ*9.8.
M6\>RX"+8W5+L#-M.&RNW8U4UDZ1ULLA2M3[#VO01*:=61]2:FZ^I0`"^*CZK
MK=3R"(PH+@2<U(L<(QYR:F'83"5!IL7KCW'LA6XFD;:)4@9*W=L2?7JZ5W!L
M\E/^;3&SMQ9H.TW78C$J-!]QTLY76X6NVW%50W#%LK)O,/J4TV'>F:7W"NS=
M?0-/[.0I1<9N"_W7<S!#>6V2IZZ0@6SZ1-M=.JXO,TP&4*KNK7I-?E!'&!<<
M3-G1Y#*FG%/K=#:J9U$VW3-1:AHU8V#'J-IU/U[WAI")88NQ=F7!B<8N+%<9
MU_L!"K*RW*8+09P!<R1ZF'I@;$GV.#*D,-)SD-MT?UX[`4/9(:\7G<)$V!81
M81LB@+V9LR\!`E0)1"$FM5&$[<FH[5M)4XM(C,_.<C&8.E(T3#DA:5.K8X%\
M>`X#@?SQWOL'JO0M,^+WU[V\_<J]N#>^W>P=EU'16M1[7M<S:U>VQU5U13->
M3:7.JE'/@[0S9K&)D"&6X\EQ;<V*Y%=2VXVI&`]N>NP`W5>OVBZO98,@98ZW
MIS60`^-EY2J4/-AZ4$'%8,E25N)5(B3H[C:\X4K&5)S\N>!,?`\U_B83$UFH
M]4-I%QIR50-+=X-%[/VH7!5H_;5TZ@"Q=]`S+B4"5<89..@PAZQC\RGV8KV(
M:'/:'?(RTXZ@-8ZP[:H?93OUO_>^E)1RUZCA]1>MFI)>P9-'N].`3]E`=Q=G
M;D6J8V3=JY6W;"4K]6N(R5+S#1(:A-DF$NK0MU*,AZG\!P/YC]@[HU\*Z"=K
M>A1"/>/OOKKV([AA:MI1G4.UI]BLYG;G>/9^Q-8$Q!>%2)-6)!K/2;8+,QC#
M9!0YJ`[[0Y(;0RZIL/Z<.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@
M.`X#@.`X#@.`X#@.`X#@.!#^]_J:&OTX"_9N!P)=;_.V_P#$3_DXX'/@.`X#
M@0W$^KR6_HS@?R@5P)DX#@.!YC;PTT.L^V-PWJY]KM)U)^LCJ22I`2QUL9&F
MZ``2X,6NF/GLB;MT2.."-I3S,F0Z0DP0TR3.P&9]I>C"H\9X,XWJ+K/68EOK
MZ=\:I@)8VQU(OF4F35$68J=CTQ"UJBH,%)#MAB._.K:U?UJMIJ<M$62ZQ.=R
MTW(;1E*PW??E3I.T=LZ'O`?L1KJBF-76[86KG@\BTEFR]ALE\51,F*=7Y%.V
M[K[V;9@5JJ-9C#"\.Q0_5EH<D"G5--<"F.DM!4.O;*J%3(=I]#%(I6VV:Z@Z
M#4!@V;"W3JO2]9UV#L!%F$WLDF(JYF-:Y\]5TPZDRV4<><D)9B8S)2@):MW5
MRK`]+2=E:TV?JPR0$=**WUOK.V9S=;KZ%E=;&LE=2["$[@:M$@75J]7KT\B9
M.'/)*QI*X45MI2%-*2\$V;#KFNG>G3>DQ/8S4U1P[1JA6F-N70F&L5>G3H;M
M*,%+,1'-WZH>]95M2<BRL>0NQC#IN*]YG$.M(="MN=%Z$V#9]B["J?9;5:G8
M^\"S>Q@-[KHPS3IFP"MPV\FN0KD`F[`K+QT\"A;%].C3W7DM^T!8<V(B0SY6
M4AG-=]"Z!.O=Y/BNQT?99ZN[<L%MEM*=^=I^C7(MM+7VR?&T+Q?R3`O8<<52
M9(%^8S"$O2!<Q"51TICY;=#L5O5_5J@_>PZ83LO6!I):]]J*5JRNZIJ@F#)N
MM2OM?MK.S:D2(U>R$8XMVD8.QW+`18S'8D$HD3"H<9_+>$!U`G7K7'4K9]`W
MGN#MG(/G]8ZC*N7B';%R8%BN;I$W?F;3M!JN"[JXV-JA,ILQ#A=A0HE$8>"#
MWO:&/9<90$IWK3G6NVF.S][*;YI<>T[SU1+Q&.S]BL3:]J76M[U71]1O7833
MY5^;I?LML77(3J[&B(/DD6761^9BV$HPH(/V3U&U-?\`:NZ-I7/MMK7`&^X@
M/*K+T2IQ8-6G7;6.RJGJ(X<(IV%%@&C8S&QTDZW,?AQY,M`UCT',JRE]H+S=
ME=7TC9>M:10[U:->BB<7:>G+#0R&TPPBR`SVR=?7,);0`;%;,&P;YXK:,`9$
M3$>%.:GY1(<4VI?E4E01+U$AZL'E.S^VJ5N(9?*=.VE<Z_:+#[HQ7`(@_KZZ
M[%LEUGV&US+"3'7<]7)5[<K\FP-MC8N`59&1<,Y1"P^Z$36OKQUY).#S379_
M7E,BB)VP]OU(F!-TP+(IU=WMOK6M_P`VZF%&[>U%!Q)[M3DUN(;9:]":X==S
MCS94N+(#"0^N77673;`&+]E=%CC@/0%CTZ)LNL_FE1&-2.[9*2L0]EUB"]LB
MRR:G8[9%MT:,_(Q,:?,NS5Y;DH1-2S@--&_#L!7B25"5[M-5;(S2]:'=,6.J
M5T#.)9KD\O<%VI\!8)0;<BK6/K(*P"EX'U\A+<S"PTMA*_9F\QN!+G7;6FG=
M%=B8IN7VWK.SKYMNC-Z?K%1=)CHA(W8]-4?58N]0APZO6V546$U:+2&B#`9@
M1&DA%'IR,/.)?7YPT*Y==^L4*.8V6K>NH!P!K878+LW0)E"KE;(6I!DL=U[=
MMFW`"[6K;*F7JW4-_6T^'@F*A(F1H,_$=Y.7&%+D!<;IIU^&==]:V"M!]HO;
M;@V.]%K*BU+DS9*'7XPP-49J)3LFTVN-)LDB=5G9!N3%<B,RC#TES,5ES+GF
M"W/`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<
M!P'`<!P'`<!P'`<!P'`<!P'`A_>_U-#7Z<!?LW`X$NM_G;?^(G_)QP.?`<!P
M'`AN)]7DM_1G`_E`K@3)P'`<#QO[4:(TE=-S[5)@>Q,BJ=F2X<+&$5V^M19M
M&IL&R,:V`SI8`?(U\8C'WU#0`_.8KSA6-#D%<J?:8<E0I$8(DTXUUMU7M_-V
MO.RC5AH%,W'4=9ZKE)U:5&U8':A^A=\;Q+VVU'S=.9)6&J6&I[_)$43H<HO%
M#/H9<S-AC5>@V&1D=<NK(O9%"AZ0W]$&3;!V1?'W4>0$.6:VFF`.S-?;A>H]
M+<AZ_FO2!D6V4MI2+5)?3F-'=<<27=8C28KX2+1-0=.:91`U?,;JVY"KVVA_
M<BB$B&P!4>`FZ5>?2QM"WS`L-JC:XA#J#*K0/K0T>0N1*$EHBH,G,K"FW'(R
M0E?6AKI[(UMIGJ#KS8!?80S:=N*6H62""!;,I!>IW.Z[Q,3+TE%9#5^L+)6S
M5I0>L:Y!:*/*9=QECQ;D2FPKCMOK)T\Q?K_I#8=\[`!:GK:F4;:-HE*"UO.O
MA9_:MRH5;JPT$23K2?8[G=+BOK^,82,'^W1(S$5[#;:)+KN&0D"G=$NF&Y<'
MZ-4]NWG8GT>$`$C#L5FH2P]7@6.MV601KS1J/K:)5+RFWUW9<B6]F<X8GC69
ML1R.N*RXVEX+?ZPV/UMUI!(ZT&GU@9-O[$[<UU!@'1\B%9[?M"V6PKLZX#8T
M44*B%FQ@TCL1U$:;,:82B"IAY3[C;[,E\(6Z_!>F]!BZ\MU%WK/ML>M%K8Y5
M39G(F+$,1R%?U)UUBQTH$4BNQ)PD&"JE8%0IT9"/>+SGMCS\M<AQ[(:MMJ;T
M2["[-$[6L&_IXLE"U<0KQ$6'B>X19.K5@]M`HZ,O#ABB.%72$$E4[0J/7R<C
M#JW1,AZ'#PXW(6\&-I/7#I=<MUB18+>-NLMV>I`RV!=2&9`.,P/JT;:>J=LO
M(77R]"'DQS^;'JL.J4'DK;G1(4A]QR.CUF7F0U[>/7;H6U:-PV>Z;I/4<]L"
M_>]CK@)D5,-T^U5:.XBU(J!+%!/6@&MIC.9+S[,C/NEII:F5LQ,/MJ"6=Z[7
MZ9[TO(G7]ZW).J\S6%EJP)D]$6.CUR]3-E&;:#+4`>8.`S*)L=@EJ!Q!8\+3
M$]S.)0VR58=7*;2$]U.M:(W7U^VG2:+;3UEUO;KCN`B>LPN!,;),6B[W\]L^
MQO5CVZLM0[%#!6>R+1!RB&2AR$1\1GLRU)?2H/-P[7NAN^FQ<G8NZ-PA!6R-
M'U;?\<[>:A5-:#CD>6BR1B=LF-.ZO%JKEE74^O4KU@#S,0([`8S-%Q'I/K26
MPD"M]`>D@76)_L/5MT;`CZ^FTXQ)F;$0_3"4(9680EZE6Q+@>?K24I4V.#BD
M!+\67!=ECI3KN6FF9S#*F0L/I.P=;=%VVY/TV9<45(AIB->G+R0;A%P$L##[
M"[M*%*^R$%0$;*1?JWL?<!$;+BSQJY2T(C1_%<YF9YPT30VE.H-I*/5#3F\[
M)<7F36P-I208Y0:."E4G=FM*6!N%5KV(=)#`AE>DUFU5TE)4`7%)P)Y&.\^X
MUF;EMT).8^'/JY`2T`).P=DS86P:*?U_LE3D?6<=VZA"=5/TL(M?L>NX[52E
M56NV22TSD`D4B>YA#A!,M?GRL+@:DUD#TUKNLZOJTLI)J=+B/AJE'+OL2I(*
MJM39+E<JC$IF/&7)$U`,ZR+@+?\`5EJA1&O:'GW_`%'G`D?@.`X#@.`X#@.`
MX#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`
MX#@.`X#@0_O?ZFAK].`OV;@<"76_SMO_`!$_Y..!SX#@.`X$-Q/J\EOZ,X'\
MH%<"9.`X#@>-.PB_2(YM/L1<]WTW:NO[F-MY:D$KW$M>R8HL^-J#5&?Q:-?F
M*Z2',U]Z8=U\!!N,14MNX+RX\)K+BB;^7`L=MS3NE]:B=>H8U+<K17]N;+US
MJ4N*QLDN"%Z[B7[4<CK2NY21Q`XY,7-5K9Z(#E,#FW9<J5[/)<4TXTY,0&F=
M8Y^DL578G8&'J<S23&L0\K9D&$QL2R;`5C76S=05[;-?&!DF6Q$(#Z%1-Y8Q
M6F65C`9%4C$)]UI_UUA5NT;DU&LH9(7?0MB1FH5K;&OMDU$/ORUEZ(1(]MQN
MV-Z2ZO%!RJQ!%VBO;-S6)6;`94T,E5]]R)&CM3(<3*F0M+1=?:EUMK&D=@:;
MJLI`V?2;Q(TV'I+NY+I(I4[;A'=ETZT*+68[F"Y!LPN#;-D&TQ3\NO.SXX&=
MG+,)"T,1FP@VT]I*%NJ)//\`T!D73.WA(`=4"S.[K%1#BSG5V$_M.R>U':[6
MGI6M7J//V,337BHW,MZS*SE$I$*,MOP#U*T53];U77@:=JNO.U>IWF``O,4.
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M-;.S3MUR967:7>;F@)'=LE7*T^R/A*^T<0&`R+"',O\`MCD1EI3\C*7\Y]5"
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MF*U(JTT`=<A2ZVNL3)WSTMRSDZ(]LEK;\V>1-O&72),V5V0UDI-ER5NNSG7'
M&W\N,.N-*#,:AZPZ8T5[B^C.L2P7S;`%ZP']HL=B-9C!3@[60DC$7DT4GYD*
M=@:?K[>''/.ZCV)6<*PI]_+@3_P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<
M!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<"'][_4T-?I
MP%^S<#@2ZW^=M_XB?\G'`Y\!P'`<"&XGU>2W]&<#^4"N!,G`<!P*Y6_JAHJX
MR;#-ET4,*FW:^:^V%L*:%%AF)FPC&L[8'O-6AVR5-&3WY(INUUT?-D(C*BOR
M'(;>%N^3SI4$Z&ZZ"LC0]@^)@&&11D38AK1",W)1!.@9K1$*6C)<PK#4\7/9
M0\PYC\DVXG&<?+C@1[7]#Z@J;4&+5M?URN01]JL%U:&A(*1PQ^S6BN3ZB<)3
MAT;+<,A[96B3D+#3R%L-1TMH;0E++6$!@!_5OKH*8%11^E]=QHX2OVNJBVD5
MH>I$6NWA$]JV",8<:7ZL,VP6EM.I<\W@Q+?;3E+;SJ5!E<]>]+Y`/5/.NZ[F
MJ/TF'KMRKYC*^;^:E`+R3\4?@5ZGLB9+1R6N9B7A/MGM6<.^KZF/-P,3.ZM=
M<R48[#FZ5UT_%LHZIB#<=59'):GC*-'APZI!6AMI&&HP:$.CL-I;\F%,,-MK
M\R$)3@)D%@0H1XJ^(&0QSIR;&(EE1&4L^W388857HLAY*/!&5QP8.)%1X8QA
M+,="<8\,<#+\!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'
M`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P(?WO\`
M4T-?IP%^S<#@2ZW^=M_XB?\`)QP.?`<!P'`AN)]7DM_1G`_E`K@3)P'`<!P'
M`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'
M`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<"'][_4T-
M?IP%^S<#@2ZW^=M_XB?\G'`Y\!P'`<"&XGU>2W]&<#^4"N!,G`<!P'`<!P'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P(?WO]30U^G`7
M[-P.!+K?YVW_`(B?\G'`Y\!P'`\I_B!$!(>Z51\O&J\B78ZDU3*M],=2)675
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M91Y<+=?<0TTG*U)0C"G',I0GS+5C&/'/RYSC'`^O`<!G.,8SG.?#&/ESG/R8
MQC'XN<YX#@.`X'63-AKAI(HEQ5CU1L3$SDOM*AJB9;];$I,K"\L9C99_)^?S
M>7R_+X^'`^Z%H=0AUI:'&W$)6VXA6%H6A>,*0M"TYRE2%)SXXSCY,XX'+@.`
MX#@.`X#@.`X#@.`X#@.`X#@5,+]].D]?VLYHPYVOZ^B=PLVB%2'];D-KTR+;
M8US(NQX\"HRA#I=,F-9Y<J6RRW`<PF4I]U#>&_46E.0MGP'`I#2MX]D]C5N+
M=*SK?0D"NF"5F9"1K#MK9#9SW:"M1RM1WRK(O24\?'G2TAO5<:9?>;:4OR)<
M7A.%J#:OGWVO_>)UK^R[MC[@W`?/OM?^\3K7]EW;'W!N`^??:_\`>)UK^R[M
MC[@W`?/OM?\`O$ZU_9=VQ]P;@/GWVO\`WB=:_LN[8^X-P'S[[7_O$ZU_9=VQ
M]P;@/GWVO_>)UK^R[MC[@W`?/OM?^\3K7]EW;'W!N`^??:_]XG6O[+NV/N#<
M!\^^U_[Q.M?V7=L?<&X#Y]]K_P!XG6O[+NV/N#<!\^^U_P"\3K7]EW;'W!N`
M^??:_P#>)UK^R[MC[@W`?/OM?^\3K7]EW;'W!N`^??:_]XG6O[+NV/N#<!\^
M^U_[Q.M?V7=L?<&X#Y]]K_WB=:_LN[8^X-P'S[[7_O$ZU_9=VQ]P;@/GWVO_
M`'B=:_LN[8^X-P'S[[7_`+Q.M?V7=L?<&X#Y]]K_`-XG6O[+NV/N#<!\^^U_
M[Q.M?V7=L?<&X#Y]]K_WB=:_LN[8^X-P'S[[7_O$ZU_9=VQ]P;@/GWVO_>)U
MK^R[MC[@W`?/OM?^\3K7]EW;'W!N`^??:_\`>)UK^R[MC[@W`?/OM?\`O$ZU
M_9=VQ]P;@/GWVO\`WB=:_LN[8^X-P'S[[7_O$ZU_9=VQ]P;@/GWVO_>)UK^R
M[MC[@W`?/OM?^\3K7]EW;'W!N`^??:_]XG6O[+NV/N#<#N4S;NXL[;J6MMG4
MG5PV!=J;L*RB#FO;_;[+*AS=?D*!%DCR8JSZTIK6(I*/>L+0^U)6MM<;RY;5
MA?F0$D;W^IH:_3@+]FX'`EUO\[;_`,1/^3C@<^`X#@5!WP*=*;(KB$4KMY<$
MIH1K.6=#[4AZSUTRK%A$XPNQ27]Q:G<E7QO#GEAHPX\E8]U]7@K+7F:"2:ZC
MT]QJ;RP1BY1J(&C,8O+Q/+1_*70GT"D],TEB:1:\/*^]B1(PX[A2O47X^;(3
MKP*&;ZZZF;QO,EL^N;4'T"^F>NI74FH(GE!J(+O,67L(]/L4A^=4RMH%PP4"
MS17&)H`C#F174N..MNX2PE0;GH'1FU:3;)MPVMLBPV)#-3A@*72XNV-F6ZM4
MUJ1>]J6`D,*YLV1$?91`94+)60S%F-0G#<S`'+RL1E.N8>"!-Z=9NWVR-E;L
M+5W;8:%J6^56/6P6MD;9VU2DE8Z8E)B^SD9U?!&5ZS?9?B''I,^NJ6X6:?9B
MR8_IR)+B`QNL>D^\0.S0E@NVU9*ZH+8UF`./TK<&W`1VXTK70O?<D)5&`PN'
M7H&OJX`.;%K,;W8)(>RG6J^[/G>61)<CNA]*9U>[M@3=%)V+LU)M?N'L$2OE
MH02OEM0%L&MY[5>8F#<5833PJLNS8\":J#6W">0(.5(PXER:RIR-P)ZTWIOL
M;3^KMYU7=]OH+;E*P=BP:/M%RQ6>YDZ^Y8!C\>HE3ECL`\5-*EPQ=Y4E:X8T
M?%9;\C;$5.6\Y6%6"_7G<@38,S%;W*`I&Y-GZ]2'&:TE=@][V]!&@T@1LV&1
M5-LY"#"M)\J`.[#!*BVZ7$:*1%1O1:7AG'LD@-6N76WO-0=..&G-Q7S;E\C!
MV@EGJ-(W'L\9-N(Z-6M'@:O!KYW+0692IP^UU2REB1X9&;+3&RGED^NU*EXC
MA-.H-!=D'#=['[=W>ULD46N?7TT6J1:SSC&*</HQ-G8Y02V#<K+<`.6E*@"0
M[BHA.;&/Q$.D9/HR5Y;6`SH3M0S.`0L;Y&@RY';%F*Q2LK=&T,S+9B0>A6T?
M:!])E"4@6GP6N@1,*K6\/S53#$MTLJ3E^&VG`0'3^C?Q%04O7SL_NT2<^:S5
MG]Z2I.R]KVS$Z?8(=?BQ"$\/8A*!UR;!.09;T:*45AAM3N,(\GJ.9P&T(Z@=
MD25#N&OMH]J)I@H<TW>*L9!S-W;+)>[*C:Z5V*!N%I2!HFGSRC,>]6^G2D&W
M8;91N)7Y$)$E2&TMR@M#1-==BJULLWMH591%GUT2ZX5FOT[3L_;M[M`=G98<
M55U#'0YP_6!,6,%(9@3O;;$1CDC13,QIW+43P?:=#+]Y=:;;VKK*EUG3>[<:
M(LWTJUR1*L_STM-%</0)(2SAHM-8+5)B01ER#-A+07&X;F,,R'(^/Q7$MIR$
M6:WZR]J\;5G67<>])9+73FS6;PW4*-MK;PU4N(/![2@0H*VL,AW1@663.U:5
M*`-3W`CC@9[Q:RRYF.Z&[:#ZU;AUMU&N77+8FQ1.P+1.H]@IM5O+DHHF(R./
M:X@5T8$EALB8@^O@J(4]49`0,BH1,$0X\V2S[SDSLN!`;O3+N0)=A`J;VG/A
MZ($UG?Z/5!:]F7QXB`F&@5[@UN<2*%:V?.VR3'*600]'GR"#,VNHK[2(.7FG
ME,8"QP71?8&E]AS5_K>VR5ATL/U*JK4+5%UV-<BD=%IBBQS,%FWR3H"Y&"V9
M%ABR"+UI<*2C26IF868KS#+?`N[P'`<!P'`<!P'`<!P'`<!P'`<#^8C8.[-7
MBN@/;#H@2<L:>X=T[%]PPU9T8WK'8TVZ6@_MGO-LS8>KB(9V)4)`<L.M-,M`
M@U#+M2UP$#W$R52$-LN+;#^G?@.!1SJ]]06A?IG8/VU+UP)[X#@.!^9P]E*L
M1V%RI'D7[/%;6TVY*?PG.68K;DAQJ.VY(<\$)4XM#:<JQE2DI\<X"F%=[Y:(
M=T-J/L%M&18]$UG=>;AFDUR_B<V:V.LT5FR$[/-(QM/.;+%01H:KU.<:FRU2
MO91XIA;\IQG"',)"=4;YTTY<DZ\;V-7%W59_-837L.R_;%%TZO:W5G&'<Q,0
MO=6-5OH->\?5]V^S+PCU_7SZ7`BH3WIZBG]8%-S`=[54[K4/=@VMYMB##;<4
MD*O-E@CRM8K@^LPJV_;C,RTA2L:>+7"@2(Y(<^B5&<=CY]3@;\_V*UDQO:C]
M<\/6Z3LG8NJB>Y:JN%0+G,IDBD"S`X(Z^3O,<*Y6@!21*)MY;C3GXZO#RH6I
M#[\5E\-;A]QNL9"FWO8,';P293M;/5-NWFHP6XNIB,7ZRJIM"+!1R:WDO<ZY
M>[8TX."E0D<D,*RV76XK[N6G/*$Z5"VUV^U6O7:HDL&:O:A,0X`*8B$!^9PR
M<WZD=YP>6B#RH]_P\4N1Y3#$AEQ*D.-H6G*<!78)W,T:4-]I110R3J$#J):Z
MW4]H6:R#L>Y"LBT1/1@$J(R#?-'K1"1=8TZJ^BB$B?(LPU^'&CO9RRIT(D.?
M$KZZU_2`S=LYRS^A9KALNITBA(`'<W>U,ZNWXWUW/VB0/]R?_:)6572;"\9-
MC2*;C.D8T)]2)SF&>!9.1V9T%$N.W*'*V@#A6'0X4_8]NX)0+&)!T8'50E;L
MUFGE;:3"Q*B]FO5JY"2$Z/%GR)42(2CN.MI2YC/`U"'W5ZKD:'1]F#MR@B-,
MV1>"FM*40'`[I/)FK\!:(2;!5%5.)6'KB)+5V"*D22"9P^*B#$:R^^I#.4K4
M$HP-U:M*[<LFAQEOBS]M4X)!L-JJ$06??57QA.$.)C_>E@0)S5(I*:*+Q9;4
M!4_V]<20A[#/I9\W`[=_V>`UP2U4*.12LF1M_:HK4-:6,9C/-0[*7J-VN<:8
M95(E1E1PR!=#F(6XUAYW#[C6,-Y2I2D!A"&Z:T/WU5NO:HTM=NM&K;IMAN:X
MF5#'Q0--/U*O.Q8KDH<B"?F2Y-JPX\F%+<>&-LHS+:;3+BJ6$7"N]?48WK*S
M;C&[PKSVMJC)ID0W8WP5X'.Y>V0MIG72@==)U6':[;&O[[N6PCXB#.8*N-NH
MC+<4R]A`6/IEOJNQ*G5KY1;"*M=*NX$1::C:0LI,L+8:X>A,D0YH;+3C&'H)
M"#(0XA6<8SC"O!6,*QG&`B?36^8VXK?OZG)UW>M?3]![*%:\FJO204>1=8QR
MEA;L&O%?&!BI66*K!H>8Q[&V2S&(NLH2^Y'92\A&`GO@.`X#@.`X#@.`X#@.
M`X#@11+_`*S^@OZ,.R?[*=?.!+^]_J:&OTX"_9N!P)=;_.V_\1/^3C@<^`X#
M@42[.5[7!K8(C&P[[L*?6TT^,6M^C*CKN[[#!V(;6U7MFJ6VV.T"NV`M3!4*
MQ6IZ1A^5AJ*0F!8JDYRH>O*0E'4Z6DW&IICG)%G83U[HJ6;)++1C\JPM85"P
MV<DG8:&XAJ061X2%RVDI;DJ<RXG&$JQC@6<X%:=WZ8-;1LPYZ%.CPPI71_8+
M2YR8Y*),S*\K;\6@/B[6+:$$0920Z.D45<5Y,0A`F>G-PIF0UE"EX"D;WPOS
M\J$RQ+[)V=;S.D@VHVTQ`)(.,98!VKYPM"&0H.Z"Q*M<'(*40BXEUAR7/5ZD
MG,UMYW/E"XQ3JV)L.@-0Z"M%C=LH'6Q#4<@_).PR!EB_#-8D14^97S,,N?G3
M7`UH;&^S.M3)A!*8R_3>Q)3YL+"ODGX=SDFY;1M/TXVR,C8VX:KL#$9B,:4_
M$H4<O=6=@ZFG^K<E")8FVZUO\VH0)T6%"D!A$:$K"9+D1K"0RVG/A\BM<683
M8+?L@CM-L!L;8^RA,2T#C$E6;-<AU3@`[5,41MY6`W>*XY6W)+A*)%BXDR9&
M'&V8[C7G6&K:C^'09UC<-!VB5OHV>AZ/*W69#KC`8Z&%R8=H(22+<<<ZU>Y<
M]4^:N6MDS--NGI)>+AMIU?BUAQ06%W;U,";>O-DV0P6"@;>:TFWIE@G*I[!A
M]8=G8HO83HX[/8+!RQBC6'(YP48"MR(N)PV=)1B0UESQP'?ZY]5PFAB)VR2S
MC=WNANNTFJ(M4P2]!(AZS4Z=6:^[5`[DHP:?AU)\Q7O;8L%+GA%;4TTXN0ZS
MF2X&C;>Z2!=J/[*<1;V:W'V%L-S9V(<.KH>9$6YOK;<-#C3OE8.#FR)P6?L4
M*TM3%);>Q.$L(QX.8;E-!JE0Z'?-?88_8LZ[U>WD@7:FQ=CZS%M>N5FUUUB[
M4VX4RXA11TI;IUE8LY&/:VID8JN8[&@R1<=#,%$7"([08N1\/N4-JFK:70-O
MO4`55Z.*JNQ2P6ISDVF]6`46%6!6QPQEFZ1,5J\&C8]3LZ;-;-N/(4C"5)4W
MYU!L%6Z)!@TUPB2SIQV2=Z[7OKQ;6J[I5(.%FO6:W'+<$55&B%WL,P.'@R[%
M(]YC9;Y!HD]A#K:XGAE&0P9KX?>++<!QNQ[209K[`G48PX&FU"8^1N,#6KFE
M,3Z?:"C]S>@$]:E\Z==(1`ZH/C!-V4G*<?E(>4PL,12^B-UULW<$0-LN77Z0
M3/53!9PB)EBR`OZ`K73#9R\/&R]DMI>><,#*GEJ$.C.1!T1]U"TM)5EYQ8>G
M/`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`HYU>^H+0OTSL'[:EZX$]\!P
M'`Z\MER1#FQV<D,/2(4QAK(E],4MAUZ,ZVWD3*6MI$4KA:L>S.Y6C#;_`)59
M4G&/'`>2M"5\/6%TWZYE-@V+8>J]%F1/8"G:2A]G]E%F-D/!=F56_4G;XN84
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M/BE24JQG&`\R@.O/ATR"7>$>P+F:TE:T,"ZYVRV>0-'*`Y8K&<V-.[%5O:#.
MP8)!LG=+71-RD9\0/8?R<\.<'/A8J5-QVV5!`ET)?#&<ZRZYV+9;3M=VE?2%
MORIT*$UN>V1]M=@),GN)`?VVFPROG*S-V'1;'V1&C3V$EWXK;"Y$:)G$?,M8
MYX/1(G-Z;F"'<#0AF]T$M-NC=\OO;F@%KG,:2-%E-7T*DWPU8794F&S40T36
M;=?7+Q&D,Y',38\M?I9E(<6%<3=`^'%;NKNJJ$8W)&(]?">SCD.BEXVT2@\C
M>=CLX+JLE;+3`PR`8D&`42))7)SF'`GU]B)B6F1!4W[3D+(PZ9U@G=T#-WBW
M%9/MC6-=/!R=,Q=C$M%3I9X36TR5.U=M'NV&\3"M#96(,B2ZEE$E)%F&T[,<
MEO!FNT%8U/=H.CZ?M(KLVOS;'V"K`_4ECU+;#%'MM?VZWK_:$\02S:`<J--%
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M6BVN-8G8.*)>+I'H92=4-9XDJKQ=`DW[MD0B#T3RS,92%N^`X#@.`X#@.`X#
M@.`X#@.!%$O^L_H+^C#LG^RG7S@2_O?ZFAK].`OV;@<"76_SMO\`Q$_Y..!S
MX#@.!Y[]Q3E-'VH+#L6L01:<Y0BSS%ULM_VGK2-88+I%YI[5X2?JNB79^\EE
M/-XEN`RR41<IEM*88DY>D^B$Z:Q5YKU7%8#3JYA6@Z6KYO$Q8X(2`^+T3/N8
M@%$(;$B)PO\`.'8L5*8\=Q&6V\80E..!93@.`X#@.`X#@.`X#@.`X#@.`X#@
M.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@4<ZO?4%H7Z9V#]M2]<">^`X#@
M?"4A]R),;BN3V93D.6W&>$YC8+,R%QW4L.B<S4.PL%6W<X5&]=*F?7PGU$Y1
MXXR'D+0QO0O'3'K7,V1M7:&O=*S`O8JBZ3(]I+E4Z3L\J)VW3]A:^VB-GJ`#
MDB9>!E,(F9H]Q*/,,A->VR59::7X!:Z!I_J-&['1]BMV@3,W,WK-CJA\S9-[
MCO#)46+KJ-L1S+]-:PRI>TI6C4-.O&D.(>73_+C'E9\%\"KE;T9\-<)TTMNL
MJCONNPNMCFS:N*-7X)9]0/SX%T!`0H.C4-9>-K!\;8R,2J,P<BI!`64L,J-E
MDFT0>7AJ:D+2M$^M@/M/ULUX/VK;XF_J]UGL<;6%0:-%[&,VIU^<(4^'(<O=
MA+@C\>U3VCU7'E8LO!6"5F2(SS[SLAEQ;3@0E3]:_#]K>J=O."^P$4]K"DS^
MOM0NMF,;@#EH.F:QHC<*[WU[U0&,1145(JB"-ID)4<:N3@E.,NRGHGO&2II&
M&`](JK;*S>*Z!N]+-A;14;4.B6&MV$!)8G`3@@DG$J(1&2HN?0D0Y:%^.,I\
M,^/CC/@K&<8#RUKVGOA\O%N]T6`<MFMR])L`,=V[VF7L*J2F=>96T)_9VD;@
MC7.=!6-M-FUKM0K.'"B^678\&:.?!.19.(_IJ"";LW\.%_K)K_95BW;NI-/G
M7[L+2ZU+8V=4F=K]FG37=099-MCR$9\1[NMM-,]DPHXO'>@MA)$>%)9@^HRF
M:N`Z'HH8@].K++[G=?CFQZ0:);+1L*\=KZ%,OT2,5J82R:HUYKZ^$9KOG@RJ
M/7XFN1U?D2%J>\T'$V/+=4E$ECQ"M!33/P\S75K4-%=[!P1^D'MNV`C0[]6+
M;JNG';OM1]LRS91S1.IZR"PPMP#P8TGUR`46"L(5F)F2J?'SAQ]86>'Z_P"N
M+O=NR;$@;.E2^SX[6^`]@U7#MH1J.*J!`/6HS9"P5\8!BV4RXD/'@2X<,T7G
MQAOMN9\.''5,]H6&>[25;7=UB:'K%ZNFTM>G2O8JJM:>N&H)H4;:PVW6M=[4
MDBW)$ZQ5VV!(X&32F3S,G,D?(1E;C6,82O*58#\F$=4,]H-)Z[+6"RV3>E*Z
M[;A*5Z83L=:]I<UW8#^G*_=#]R!M.!RANR6LS5ACC$\6+]W1%Q9>)'LN9$1I
MT*;HU/\`#)V'UTN/NG>E8L&DZ<"ZJ4(QL(?LRL6:-1I'6YV<OKG)C*,UT]7"
MAV>_:W$(9F"BH^R9>])$5WRJ1@/3#4(RB`-8ZR$ZMGA2FM1-)J<37Y8(X$E5
M\K3XXB%BO%1KM7AP*[)'$QOIOI6/CL1'$N>++:$9PG`47Z'%=:BMF=RM.:XB
M=A8,O5&Y%$=HPMRV?1%KJ\?:.W9]EV69=I9;4\V?<9ILJ,,19A+-K>?(1![X
MV'YT.QGHS`>DG`<!P'`<!P'`<!P'`<!P'`BB7_6?T%_1AV3_`&4Z^<"7][_4
MT-?IP%^S<#@2ZW^=M_XB?\G'`Y\!P'`IUV(W58->W8!58&R=-TP,?J,Y^0,O
M6L-K;-MA>QRRR1]?$"!VOK)7!^&[1%8G,#X+CCA8O/AK9@1Y.4O>@$BTYIIC
M:L1AAAJ*RSI>MM,Q6!4T"Q&:;(LH;89!DE+(AFF48PE,20K+\?&/37G*DYX%
M@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#@.`X#
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M!"UNCTE^QQM7+`&C@JK1(6!DTB.(6AYK#)!HBM>&I*0M(T1ZW@>T_6S7\'<U
MFB[_``'6BR0-;4=5A=LK.X.O[A"G1Y$Z[&S0`ZNU$6K#5(!:-.C%1Y6<_'D/
MO+DQE.MY"%*?J7H56]4[<]@[$Q+#K*D3NOE'N5H,;BIQ$?I&K=>]Q.;"T%J&
M&='!X,4/40VSBDF/$=)8(E3"I;D51%];3?HAZ0U6T5BYUX#<J29`V:H6<=%L
M%:/UJ7$(5PX')X]LB$A$T>M4.6/F(<\R5MJ\,^.?[OCP/+6N:2Z!/&.]T47<
M+GKTY4+""B=OMGF[,W3F<7]S:$_M-1-OLV\Z*57CQW6>R3$R`-)I8>&Q'Q\@
M'(BRE1E(R$&W4;\.F5UFH6S+%V%W(U2R%]["4<$78V/K9K:?:%^P=U!=QVV(
M]ADUW(>W5,KV3`0"D1\&P$EL"WVX?JM(F*AN!Z(F0/4"TRNYW7XWLBD'"^U4
M[#NO:>AO;##,6*F`K;JC7FN+Q/D^DY#*4*M,:_"@9+SCZ\^R9EL2GEX;D1\<
M"LY30W0`IU:U#1\]C!073&=NGSE%V?4K;HZCF;QM,BV8AV.&/L%3UB$#@[H.
MA-2$/$:\.!V,6W%4\Y.:_-G%A9T?K?KU]^W8]E0=KR7NRT?7&!5AU!"M]5C-
M0ZE+#UH>T8L]8$@(=UL*HXJ)!D0&3I4C&%YF9F0XT?VM+B@V#M'5:!=8FAZY
M=+]L_65BG]BJK]#=RU(Y7&;0,VZQKO:CPM$IZWU*\5MH#+I*#S<C,L:\CU%-
M83E"\I5@.,V;JIOL]I.@F+19++OBD==MPD0+T^P4],A_7EE/:<`72S7>NQ%!
M2Q"Q6DW4AKD.:)$H%1W(TY+WLV78C2PING2/PUM@]=+BR'WY5K!I:E@NJE",
M['&[4U_:AM`F=8G)[O7Z2MXM7CU-G'B#UL<2Y&)"R0^P^OAMN(K.,IX'I;J0
M)1JOJ[6M>UA*#D];@Z/5!U"G@<@'`)6H10T-``D*54H0NKN#R@W#;[:AL:-!
M4ESQ8;;;RE.`K]UVJVM"&V.Q.UJU>=J[,O4.TXZ^62V;+(U!X<-"ZR-';2JC
MZUATVNU9$NDU"_7DV,64+,2BLHJ-EQ?;'V825*"X'`<!P'`<!P'`<!P'`<!P
M'`BB7_6?T%_1AV3_`&4Z^<"7][_4T-?IP%^S<#@2ZW^=M_XB?\G'`Y\!P'`A
MW8G7[3.V30NQ[$U\"M!X+'C1A1B:F6R1@LPI$Z5!2Q+@RHKR5P)).2N.OQRM
MA4EW+>4^HOS!U!$.,/W=+@0VL,0X.JA,.*RE2E89C1C?HL-84M2EJPVTC&/'
M.<YSX?+G@3;P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<
M!P'`<!P'`<!P*.=7OJ"T+],[!^VI>N!/?`<!P/A*]?V29[*_.BRO8Y?LTH6P
MS**19'L[OHR1<63&FQI1..YX+CM.,/MN/)2E3;B<Y1D/)W7&N>DEFZ===4V'
M?NP(.DH8/L)0-,7GLF;I6C+]8QV\JK?=2WT2\/M5#UJU+(#@=C*Y"^04R^G"
M$2'?:F<9\X6D@];^M43L,QMO%D1,V<WJV/U>51Y-["*"RI4>E1R;Q1ZGQFXY
MG&\9>F&&XSTYMYN3\T/!:(Z&/!_@5GKW3SHA4>GMMU%6=Z58+H7Z1*]).;<@
M6SK.VY7[30A`>D52JE+XSKQ%*?LU6"#8<2,0*1Y%N:?0U(20P\EM>`LTTGKU
M7>S/76H1=]3(&_ZKUQL5>H>LB%[!'SVZM"N3Z>B4:M:;`)*G[;,B6:GP2K9,
M7/@$Y[S$IYU4F&F2E`1!4NN'36KZRVD.C[]9/:_JLS0E!M%F-;CUA(':-J_6
M';:MI:8TO(L(L6-%UH56-@&9#3F;#F789Z)V8[TU:TL*;#T-KYFO'PPBPU(@
M`-U<W"C&:^6K$L<1K)<213B;#(!)X=UT9.%3FWO4:=CK4TXE7F2K/CX\#R_J
MW7/HH2.=X1U8V3;JO;0EC"1NX=[)6UJL8K^RT;(E=O-?;2(6:Y5YJCR#.M;3
M8GL0"#*)`")&BO"2##[L5]"0AJYT#X?D[K93=DV#M%M"-KU5YW]0VKLU>]3H
MO?9DA;>Y8_96V:J.'/TMT5>0L[LC4XQ&$_380R6D)^9MO^R25(4'H07UGU?M
MN>W^C3%VJ)\MO5=\M/8^CM;%JN;I4`M]U=1=5VR1F'`?:LM`J[U-J`A[#\U&
M6T/K;?<<4VME&`K05ZI]*)W5_5%`QV%#5S4<3:I>WTS<-.NO6^AS+QL>S^]A
M!1->O55H`>HC+J\SE^,V1JK`JQM9CK\TM2O7\X63A:?T>QW/.[CB;6D8[`2-
M<9&FM-P;I0H'GJ3XRO@6;1::4'"P=E6J)!ABHN1SQZ>1@BY$EQV&AC+Z<8#,
M]GJ?1+S#T8`MVS=AZCLZ^PE7EZ7N.L&:T_9FMOQM?;0]UC5(N5&V)4\"I](<
M/^OD@-RQA2$>5UMWT_,'UEHU=]\AI:K&KC8K+O>B:`V\\$1()U3U9>O[8;T^
M%NENV`$$QQ4F,>LQVG#5#)$(=#%N.,$DH0C"$-("H[W57H'<^OUM"C]Y5HOJ
M2G5_J_1S&R8.W]06<!K:=U&61D:9FF"I(6;UO'/97;E9)PSL.5!*ID-X3$;\
MR?$/1K5-3J=!USKFE:Y6.52*E3JN!I#X9NOLBI%<&"H<<'.&-52`+JJ8<Z&A
M#[?NV+''YPYXL-(:RE.`H[T:J_4-.R.U^Q.JM2V!6Y)G83>L]LOGSTV=0)]X
MU7=MJ1S_`-'@&==K3-`+=NM@-2B.),89F1F2P_&82P]G*P]&.`X#@.`X#@.`
MX#@.`X#@.!%$O^L_H+^C#LG^RG7S@2_O?ZFAK].`OV;@<"76_P`[;_Q$_P"3
MC@<^`X#@1#?-I'*=9!U;#:4V]LM9`!-/K-T2/KIJN#L0B$0<H.1+7S8U&;;/
M2,S$/,QFTNY<CI6O"O!MSRAC`<U)'=<N<EIR/[3JT<XN,\Y$>?B/8L"T284E
MR!)FP52H,A"V7?2>=;PZA6$K5C'CP)QX%%]HV'LX4[:5W7^L2A`!IH;J(19]
MA'/=="?%P)-FF[C!OR1SMA`E[05O\&;7`3X:+$5[E82F2LLR^V]';4$!Q^_6
MUZD.J`"VZ7)%";?5+4VW+)L(N^[7X).]W4#7<%7E54.$FSQM.%V4JJ&2F)99
MBC)N<HD+BQT+?0&M_P#J=[)73[19$=82B9PNBZ/N(T8Y99[46"WM$?77[`]>
M3$ZLCX5.@5HJ=5"CXE^D_/4REUA+K>96807)[#=F;+I'5>I]E0]6S;`]?;A1
MP-FJSY&:T;IXZT`B)DCF+#%!"TRS6`=+@H@-#XK7M<E][QCM2'$)C.A"%Q[H
M;(U5+!#;50`I259NQ]]U<Q*('30.&NM#-MZOUU4(=-]AU_+]]VXT&V>DNQ$G
M*CL.L!"*<3W/*VY@)HUOV4V!9^N>S]RVG3$V!=M<5DC9(^KZJ6*&Y=Q<QIRI
M;@#@*Z0,UFNSG2\MNWM@W<9@JQ@I$>\F%8\$8"MXOXB-YD#!Q`MHMH5#F:,N
M.U7K%'L-@.UABQ5S8QV@`Z?@H`II,>[\]1`U-KAR$RLI8KL6<](]-N.B0Z&*
M^_\`-R7#6)2VU+5U'U_81-:TQ;YX;91+8DV:/K-GNNHQ^RKC.@`J"T,9UV(K
MM\+-02>2F)29E>G.N0ULQI&&0F&_]F-FZ<L.V)#U8+[9KLK>FGM9ZRA-L00O
MNB1NK6`1NFPHQ4-6D>^ZE+W83@C99"5AZ2*AE79#KKS<7TL!*7:3LT3Z[D-,
MP!5$?O+VT-A"*G-98=,17A@B99*G7B1&`[!!%1\DD-:MF"&(CS[+ST.!)6TA
MQMJ0]&#\ZX]B;SO[1MPV/C6,:MW^O&;K7!E%?/37`ID_7Q<4B&AL7&0"B19(
MZ?*(M0I$Z*S(;C2&WD.H:E,R(4<*Q#OB/V<U`J]L%Z"*XI-QH6-F@_>)2QQK
MBO7TJ=?GF;[-!L4>6/@5:OU^AMN&LN3,2X,RP#&L,K0[AQ86>Z[=A;YOH\<F
M9UL(J>LQ=="SQUDF6.PNV6QE;$]+EBUC*[-I(D:BNI`Q,.N2%$,R,O/MIPSA
M.,JR%==R]^=DZB;VK+E:$;*0:G8K$(H"XIVV.OW&/3K!8@Q-HMEF@+&U\O9T
M`,9"-XE/L27)#;6'')#D>/(".`_Q-=O$C,P9(ZCG(D7Z<XFL1!--NG-PR%:E
ME[@.B%I+YRFU]B-:SC=90H<-C*G-R5NK2E[/D1Z@6,C]K;R+O>EZD2I?O\7N
MK=G8W7<LZ/5)8G:Z@ZIV49H52A^XAX8J\9<G017MQ*:ZYAJ!X.+?]*)G#[(2
MA7-\G8O4A_?5D%-%[!7J'9S9"+`B$VH-EG5&66%(,Q(H8:;(0@MH4)201EF.
M^F/$DX5\J$95P*.B?BC6@D,F3)FI*=7'A[.O8!Q5@O5J8BTF;=[UK:E-7*]O
M0=<SXX?7$]V^N."7HSTR9/<A81Z:&7%R60^]M^)[L>M"=ADW^K-B&.5"IT,\
M)'GSA)@B7+6>C`KN^%F#QU7GSPK!W)*8,`2YK41$^>,=9RGVQ:('`M;&[![7
M.#!AB72`-"`67L^%TQ5R*S!0Z>=J(JZV(-8K%9Q)6J@!@"3<6ZNW"$(C2"2$
MN&&EY<RIM'J!KNG.V%YVS8*4@C2V**W+[$[6T38JQEV8;Q.%UC4]DV4`NPJQ
MR105IU4"35VQ\]AA*\1GR&6)2&)C?L[0?O8CLQN?1NW#K=>U2[M?5HS3H$\L
M&!<)1;P[L*?"[$GF(U=Q'K9,:8A$8VIQ\&8W(F1EP53F7FFWE.>DL(Z']ZMT
M$-6W3:K?705D%2*#23LAMC8$N7*/'KYM*PZ^AF`;K-3S6'-8U@!7%68L467]
M1D3(QG"/*UEYP,:UW_W`67@>#ZV--'Y@.F$6`QRVV9EVNNG:M2+1,GV^4*UV
M4@,5P^BVS(]9DP7I;A1VO3_71%RA:&0]&M?7H?L*LCSD-B0,G/"Z[*-@Y:'O
M;:V4L53`7!H+-6]&C(?F0Q5DBJ6I"?+XK\,X2K"DI#QVU3W_`.V=HLPPF8T)
M8\U"D4P97-CUJP5LI5;-L&VLW;4M2E[0U0[&J\]J8Q9?I+S(@@I3L-AIF#)P
MZ^A:,*2%C]&]Z=K;<*:KP5Z[_-&O74I"%68DNW3BT\"\?E6J&'6,C0*L\)FX
M!3:TJ(<1*G1'H<K"T81YDX1P),WSV=V)0-J6_3E-UTT3FHZT7G;U/N;DPM):
M?NE;BV1^/6R8D=5S6!0W+8-M+9![#T9^9+;CX3E_R1I`1-:^]6S@NV(>FJQJ
M*MV&QSJ_5)<!5@N-F#G?,3&Z+GE[<=#!M:E!\:DH5N1^)'D19*WG"8"4RXRP
ME?F8#*$NX>Z!8:P6Z%IE)J+,F4,X"K)$N:%J!T8GU3L?82T,/38&OYTR=<HY
M^IOUYEA>%15S9D=>76%>:)D)OZR]G2._3.[A12H#JHO4UI'A6X8\R8-'4,$X
MY62V*N`J96`N`=T&M#$JE0X+I2+E,AO+4ESQ^4*UZ4^(G<-L;"U34INC'@0'
M8U\NU->L\8M8Y[D1L+2JA=@!*&!D4V`55"RS:EP2S[Z&FQ4V`ZB;B$M6&TAZ
MH\!P'`<"CG5[Z@M"_3.P?MJ7K@3WP'`<#YO)DJ8?1"EN#YJV'D0R#3+$AT?+
M6TM,6>U'EH=B2'83^4NI;=2MI:D82M*DYSC(>5H?K)U@(=9=::TO?90P>H>B
M#W:[KD!V7LK.JM9D9-SVD%V=UWV-57\3JI5ZK+LU/?L!F.&>@14JG/1\+5F7
M'4OU`D.KZEZHDNYFP"479A%[>&HM&5S5]XTR6L5=#P$Q3&L:Y#;[#P`N6(MM
MGW1W2AB#5YUBBO8%PH&<Q<H0^C*L!&VI?AZ]6B74H]U\TGN<?;*%/V)5[#C;
M5`3IRXV`6>UI5`=/J8]VPU4=)%*N55J8V$A!IIV&?97Z3B'F6,XC*"?EQ]/U
M#MMUVJL?:&S']W:\Z]2-9N`%4:==0UWU;:I+4RL$-Q[(A462'U[;;#:](SIP
MR6DF$<-2A\V.EM:7&V\A"E8ZM=0:5J7902=V:`E==M%.N>L"-J,7S1PH/K$#
MU<V_*W%J33ALT*@#:_.L2+85FQR4VP^M8RD23AM2TN-)<R%^PVT-'0GJ%5JY
ML73<'-X'XGZLJ("[4:&FYA%.374R-<`!A9I5D#Y<B2/!P4T^SYFG/#/F2KP"
M@-9Z;=8SD/N0:`;8VD$FW&_G*SV2NMK/B_<X[<>K=RI[5`]A1QU[@D*&,':R
M,WYJ*TPS%8K9$)YF9\=]W#KZ@^TCX<&G=GZLUV.!]@KX<"-XVL3)[&J4/2)J
M%MVL;Q[)`.V%LA,8@46?2*T,7MNKPU0)U78@R&!;:XWJK<].0R%JSW4O4MHK
MO:FMGHL^8QV\F;"=V298:#0;4&&[-U30=168!3;+'%8)CQ#@#7`V4AN2J3A4
MYO"G<.-MM-H"OY'X:NK9F@]?Z&'7ZVU)BA;)LNTV=B4FK:[K-ZFVNW0B(L\7
M&3(=<4U3C\H414QDB-RV](3A29R9K#KK"@GZ#U<K8[M:;[8Q+I;(MDL%/54C
M%%'Q:V*J!S_L*O5R,9MDD:(C&[B1"C:VS[L<(/.R1ZW'$-R,Q,,1&`VC?>DG
MMW"-?1QFRK7J6T:NVD$VY3+K4`E+L9"#9`E8N513%F`]@`+)6B0J:%O,U+B'
M(WJH<PVMM:5(^4,HYIP7.V1JG;9RPF#-\U7K'8NL62RH%?&-6R'M![6LNSGC
M\,4*BM1":2&L8K\2/`S&@1U3)*<,Y3Z6&PI]/^&!HF7I^=IR-9;Q`#NU;J?7
MA9-J/4E.BR'3Q\W*UK99(5D#%"'IU@D'GLGH\IK+$O"498]F6E+F`O5K#7]=
MU)KB@:NJ<5F+5M<U"NTL!%8A0!;#8FMC(PR(EH:(CPA8Y"VH_F]"*TU'9\WE
M:0E&$XP$?:QT*+UULK;6W9EM-W2^;>:K`8K/(`J55A8"D44K="])IP<-1ZZ`
M:)9"2[^3R^8+N$C4_P!5"79.&FFV4A//`<!P'`<!P'`<!P'`<!P'`BB7_6?T
M%_1AV3_93KYP)?WO]30U^G`7[-P.!+K?YVW_`(B?\G'`Y\!P'`KIMJZ]A@]I
M'A-.:KIUM#9#P9AJS76VF:[$A3"<PXWG`^*'KIMXHW7HP%O,V.E29;ZB\7,=
M"DLR.!@=,P%#K@(2X*+@9!74R;9.`'\LJ-5\I>[P4O)>ODE1V(K690$K8WH>
M?!M.?!C'F\5>.<A:G@42[+[.[4!MJ5G66AZ+*E5VVZTOKI#9+U!(V$94KH]0
MMJRZ9-:L.+##K4>8'O%6K[#PTK'8:EM'49;>=QA[V0(^C;,[=B4H/>%BL\`C
MU3T*5@"Y_7"V0W1NWU;((@>PMP)AHAL=8';-5Z*1BEHM'6[$DF_9\-"W%J0_
ME8=L?M'OL9HTVRKHU'JU@EV6A5H/4INJ+@4(CP\G402]7"_E'4;4A)DL3KI.
MD`F!B6V<AWV\-/R93[3N%A&TGM?W@$S"WSIT;2JK[^VWJW4VN`)0?;6"4^=M
MABZA8!QDD2G"Q-P&4B1"#6JP-"'9$@>!P4BO89DQ<K:#T2)C:1LE*;0_KX=;
M+1JFR69JE*N-=9@SAMQ!*]F7+K),W"4N!%(SH;'HD8_YBOTVWDYSEI&4AYW5
M'LI\1(A7Z:1,]:@KILI2]Y%K*'8J5Z!L"[Q5=?I.:7ICLVR$ADB'%OFQO>("
M:03&EQ8\81%F(=]$S'>:#:JEV*[J/"X).XZ;7&>BU,8=6(`:7V9-S;!R-EFQ
MMKL&)Y6P`"=$LH378N*]$I\D3.-E9D_#T7"V<9;9#H,[J[MQV+M;IM/+QX]E
MI.BSU.IRNOUP/?1I')V:]!-IDG1@:T0[!=[9'CQ`KDBLNSH9.&U/Q-:0N+&D
M)6%C-;'=HVN),NW9S7]6$M@-G44?JNC"M?%#-BI%F,#0=4=NB[8_9;#$.(0<
MOT^%[S@#1S(X;&?>4ZMM3JDAVNT^UM]ZTG:=CZ-UA-V1FTWX6.O*&ZN7.#QE
M5S8ZF,*HF&PY1A5,DK`G"$^.0EPY4!/NM:75(5EMJ2%':+NGXAIO:]<JUMTV
MR>U'L^\HB;1EVO2ET!Q=?U\O1M.UPY5*TT1ODJ&NJU2RSK(ITE+;GQ+%F*_*
MC^C&>1P);IMC[FA*10*"+HH6NAXG7X57I,EO6]C;GUW9:]<[](,$1R6;W&AB
MZ[6CVMZB+8!8;RZWBRH1B<G.&/`,??\`:G>EP;>ZE3:9/J^`W7;4E[JM[A:L
ML5Y.1;_'+ZW?VE4R#!L[$&W.QS@)$\U"&#4RR/F'KR]Z+_LOMX;KNC=/<VE4
M'<%WU_K:%=2,+9<>JZ9HHW3MWG')U1'4!VUJN%P<;OK9:1"NEIP@&VN,)C8#
M/+1[0G*<OOQ@Z6=I]SZM*/#TU.7?9<KM#;!8]<S41V!!%Z>*)`$]9U2`6&6&
M$+<$DQ4^8B9>'G)<2OR868Y.'E]U*4A9#1!Z\PJ53U;C!!`U_P!OG[$=>`T7
M6IRHBJQ(>#R#<D;<\S;);''#GLPIWUBTEV$F=)=;9PPASPRX$1=@=E=F]66J
M+3.NNGPUAIPG44J75X7S`L10"Y81U8V@XR/=L->LH$16(=,*52IPXP#,?VZP
MLV1W$)YKV%Y;02EML/<Z;I8V>%5BE;!VU(/ZR,6L\&U$1+12)$%<:A`?V?&U
M4/M)&T6L[K*K#DEA@MDTZ0=?$,,Q7L+PTC@4Z/WGX@4_WP7@0)8.S8):3V)7
MZ']$1@K3`0%?5JZF=H:](6,7:A^;EDOOL6V+S$R2CD@\EV([X2(SK'J!O--V
M;W9VK<)E2NNFZ%KJJHWS!A,EK1KVZW6,#U]6!NUKB)**5)L-+"&S,XO0J<Y"
M/#Y3\,;/L"V5,>V1$MH"Q.]*CLNR;DZHSZ46DA:C7=B78EM*2/KN9TV976];
MG9@$-+L[!0=.KE<*W`?!1-CHPZR4=Q':?3EM&6W`IE==G=]:X!TU!K]'-FCX
MAN]6JV9BZWMA5G8Q<#]\)':KM@*HNRH^N*YAL-3YT(?+7*DG5FVXL"4U[&YG
M(2`[NSM[?Q>]HHK71Z@I:UQN<GI!F?I2\QRUBP%,VQC6YXU9)U[`9J]LL`T?
M"@IJZH+9I;LE)1*HS"DL(#*6;=/<]_=%PUI1-5L"J1'BZL&US9=PUA;3@D5,
M-V;3PZ\'5S!UZ"#+U`@5J[6*8VVU+&OPWZ\I,IM*<*4^$N:<WML:QW3=P/8H
M`9FM:NV\`TA6K/1@Q(@Q>+0==Q8Y-@1'CF#Z@M=JU7NE=$%L/*SF!8!YCUG$
MLMH0V'T[";CVG1=P]>];ZV`L6&/LS%M(VF!\SK&?EN!:M?\`1=:+N9M08Z+'
M:U&B*=LPR5=*D(\UER4-BQ6T>J^E#H5F8VKW=U4WKBG!=1V'9%7B5K?Y.PVJ
MV#;9<-A%IE8NFW<ZY!8F,S8`]HBFHA*T[#]]D(;EE04]"/)3(0MS`8*'V=^(
M2L&S*^]RCSB3NIKR60TK6^P@GH7&O;CLU8$'"T<D23*9AEM3#8)N'7(;4NQ3
MYK^64QFF74.LA,.R-@6G4?6L?VI,Z[UIKOL):*]K07MVXR:.1,2:X*)D!$$F
M\_67B5.OEIQ`;1&0R"60C3VEX:2OU%0\-*##`]O]QY-=B78-KB+9I&R+#UNC
M01SU<L,(/2:]MW305FV6MF%+MZW7Z[J/;I),\^EKR27`B9#.$^U,8D.A*?32
M;M&4[OG&Q]#TG1C?TO'9(&+3ZR4KSUJ:?F$&'S)^9.@Q!]S(N0(<)[WX-6]`
MF^U*;;RE3"DX"'=97#M[2'J=1-B`+?LMW;.SKY(LM]52[8.;IE<F;TMP%^$F
M6%M$D?K,""TO$$S0*UN,)D//Y<9]9[UN!+O7T3NV&4ZUS=@3=D/XSU6NH3:K
M-I)$94'.R@MQTXJF3[+#DKS'3?IH6?8L+F93B3,80[ZJEX:1Y0O!P'`<"CG5
M[Z@M"_3.P?MJ7K@3WP'`<#6+OB%FDW/WE9BE*'?-"S^\+F"D)BG*=!]QS_:[
M8$DKA$D1S%;C^:;%7F-)PE]A&<M._P"`H/&&VTOK58>B6M=KS-J=G+7KWYT]
MM+S<-X0NN\8M=5C-WR=O5SMC;MLZ>)T&.*U0`@0YQM#$QP3%G!G([26692GW
MHDD)O^BOK#([Q1=:CG]VQMWVW6I[8@*0QKY4^A3=51NL=5ZL+GN;8=#R9'N6
M"&DPE1<DI#29EM==CM9=6AQE`6+Z5:FTKKN@&+)H6P';#0;HSKZF#YQ0,.!"
MYK76.A"^LL2P5F*.%BFIHBT1M9>V8GI;S&(^;$B)GV-;'`Q>QJ-J0[WUZT&#
MVZ;`!W<(U]?;EK#2XNN5F/BY56G,DJU>)4O9K%1S=!]*F.;*C/E:G(.I%GYP
M6#/9B8<%2W%!YK4WKC\/?8>@=SRF.Y%^V!K+;-KT/L"Z[/-!1T9-29Q;]U]>
M==2+01+4U$$<V2V#(/P#Y(JW%;&S1:)$A`Z%E'B&_5?KAUFBWW3UT#]CS*-*
M5'3O6"QAZO)UK'9N=]:V;WZV+M_KV==LQ2@-EZ33+7N\Q#%PT`EPB$D=%SF=
MAJ(_'E\"<-I0^H5FU%WKJ5RW]=,ZFWDQ:=Z;-"AZ;.EE-73ZGLB-H>_6.C.B
M*6_8[A');ITFB&H%*:)NOR(;R(J5P9C>>!,NK-L=9NHVH>OVI2!^WTT7=F[I
M(J&;1H?:6OY:I;FSA4&ZVC8=452\+TJ(F;-VT,BYEV7`V([+-1E9D.J?RZH+
M*TW>VNM@;%V+JVIOVXG9]4&)M<O,]W6^PAM#&64;%`3B58@[.*5F'KNPV0?#
MM$%UZ".)RI+;;V5*1C#;GD#EMW>^K=$Q*K,V=8"(?Y[GY-:JT$)4;E>31@B.
M"$;.<?8`44!9#;8:LU<1*)%2"XZ80V!'6](=;1CQR&&D=DM3Q-Q6G0\J9=8V
MQ:50E;1LR']5;/;I8[7^(T^0W:$[.54<:WG#Y*Q$R,SB.5=<>G0Y$5"52&7&
MTA'H_O/UI+ZQ#;;"VJ[&JM8+[7]8!Q(C2FZB&R9M\ME':V=5Z\WJ*/0%[1]6
MQ:VD,V"%(R(]DE!GVI;;JF7$*R$G1^P6M)FV8VD(3EYF;%=J-8O)"!%U5LV1
M7ZM7;I#LL^J.WJ\-5-5*HA0\S3R28X\N0ASUO15->CAU2$J#]TMV"UIV!AW*
M=K1V[OQJ!<"=!M*KIJO9NKW(5P!OR(AT#$C[*J=4?,S`,R,IF=F&E]N(]E*'
M5)4M.,A-7`<!P'`<!P'`<!P'`<!P'`<!P(HE_P!9_07]&'9/]E.OG`E_>_U-
M#7Z<!?LW`X$NM_G;?^(G_)QP.?`<!P/-CN@P9=V?KI0S6F;5ZP".*<,678N]
MZ9K^0-+6V.FQQ9$G5_A1:><IPN(DFX:L;C+C\*2J'!1)=RMI(6>H,M4_9(J<
ML&3K*YNCJI+76S2UNF:\J3,CO*!EG''7UN$Q.5^@^I2UYRZVK.59_%X%B>!6
M"_TO;)+L-4+(`M^Q1NJY^B]L40^,K!B@,UFN;$)%ZD4IE[+@K6,E&9IIH9%(
M1H$N$D@S&D(;1*BIBO/J<"LR=+=AK'2;)7K,4N-F%WKX=U!UK!K\.X:\;UJ"
M['U\-<,6$LQ[`X-LT*QV&><$+@&A\F0+6W">R\XSAB#XA.&G8';2#V`V"SM"
M<.<Z^QZ/7(FMXD:+57W\'8]=UTT^_)-Q3+UTDGL'VK3[T3-AX'N-.#U0WLY2
MZG(5/V+9_B!O[!W',I16KLT>F;<HSM2ASK/UW?S`JK1#:(VP#)Y\DM!:@"+'
M6Y-5DO.E!D\_&?=DQXK,IM;KJ@NEV'9[,KN&B7-`OL8K"+I,:W)#E?,R+#>J
MDOW/'BSYI:RH(&XL8+'7.DXCAA\N7/>2VPI<5*L26PIR>"_$:V'0;;7;'`LU
M5F6?5=UJ05BMV'0`YR#>)6G`M>DV*\%8SQ,C'#E-B8GD:K\W)3,R-*>S[WS'
MAX89;#T$TXC:X<$U6-IY*6<K`,;+]GV).>I3+Y>LP=EGH6LFS@VI,A8F+,8U
MLL?,DN0Q<6(AQ"TNI:D9RWP*T]@8G;8_L]TGJ&H6.K5N@U0M76K/7KIJR:6V
M<,OUFTV;E2*!6;\^[6P5YI;=,+Q)*[5!;@H@2<J'29#\M2(P:X>I/>J*!N<^
MLVJ)"O\`8+#5[.Y,%9UM(#NO!>I9V+/IP5BU!'DPJ.0[0"@\?S26L&<BY+ZO
M:T,9RZT%B^O(+:%;&[I$W^PVNTEE[UVR;I9FYG::>&M4JT'G[%1`->^9Z(A<
M17*R")1H:H!>.P0BO-.I:RY$]F=4%""PWXO*\U1-9.5V,.E"[(BX9M"-'2+0
M-L$6H!_99`E089BNR0!;9,TJH$C.%26:Y#'I*^2:Y*\0W8@#^*!"M=K%"+@*
M(4Z)0MD#Z)8IX?3<@V4L[CE_S2C=M<2L+$AV5B4_6\P&XH=89P>Q+010B2O"
MU!:.@B>S0'LC81=IL16Z]<(VI0\2N66QHUB,./;'A20")DV;%I@889-%#;3I
M)<IS,$$*@I9:2PQ*4]A48*T[2HW?ZW;-V-FM6@O7Z16-A9O6CSHF;I\8ZB/!
MT/O`%!I4D"3@V-=CK)S8YNN((RCWHR<>JK,:+'Q&]Y<#(3)/Q(H$NQ2(HM@R
MR1LAD8/@L3-*LQ0KA,X8<#V:M+G/0I:M25ZGQQ3>8Y9V5;G#;T_*V)$/V5;8
M<2.H.S-9DZ9J-3]^!]3U[L?L/85KC`+;1V6(-*QVMD[#JS-U(6J:[9G-?(TI
M+>3!%UU[$QLAY8L]KV1.&TA(?8R5W91N`<[H"2#FZI<TW89#0%MW7,4R:V.D
M;?FW'5&+G.40'/Q9TRHN!7HX\@(R[B<V4PTTZRYP(9%4CX@]]K5?K.T+!<JH
M7<*Z;F3+33"N@1XX*&J6]J.=M)@A&;''S$_;DFEA2#KT=A,BF2!3J&,QGYRE
ML9"=]SS^VPSJCK-VE&`XSLVI&K8=U2[*UD/@V"RN#V6K>`B$;;);I8O-@/I]
M/VB"Q.=9;4I4.%)SA,=01)V#.=IM/Y,D*62NI!K8W:42NLIJ0"DW"RO5@[JK
M5(\37)B2-2D`QVMA-\&V*+.<?9BV18Z+&=CR%JRXXX$\ZVSVDJFI=TSMN&';
M%=H=:D6374Q`^ERYL8RO7#$\I7X8NE"8<&<,"7QEYJ`W*CR);[2L86[(3E.>
M!5(*]\40X%H1D//P,#E=37XEF+=P^E'K\S>"-%L\BFM;02(GB:R+*-W1T0L.
M@##E06HN'&C:$*PXK@2U;1/>85=I$*@W*P[$U,YIZG);MRU=?A5WE6_Z0:].
MO)*G9>!#ZV:OY?6\@I'">\QXBIP7VHKDA<U3KGI!&-JC_$^$Z_LI2.;ASK@5
MKL2!`@CB&AA$"F%QX'2/NX\-E6(,Q`*3#5CE71!QB?*S%5AIO(_,9M,1$@):
M&:%VV_`L)(F!C#+&9[4]7M[-QP]DBP8$/(:L:+@]@2H]F$6Q&AM$R`BUHE0L
M9\I3#SB\-O9DX4X$B]7;YN*UP[X1V@I%F2)W9>=:56;'AUNNS1FKJ2@O$$;2
MM(E]@&8ARMD%!",JA-,.8RT_#E16\P5+D<#1-K5S;NPNW.A[I2C56L'7\#KN
MS5FX4]C8D:,_LBM[A2=#;`L\*LPBONVR#M:3*M3WVI4E&7D-D)S$!7G>?2L-
MJT!IC9-%/]=C5LBR&I%2Z<1]0;,E.V=)=R1?@IK6$RO19R$DI23T@?&@G_3)
M8P]Y</.)R]GUDX4$7[0UYW,'7[=YG6YDV:UUL2YI*1J<E_3!*>#`AJ?U=!09
MVKVMEBY`R!9C\X/=\RHMA??"I1&P\W'CRGH[SX:;M/3?<=VC[C8I:2$*U[ES
M0EW1W6%IHPJ5*/?>U3ZA;25/=V1+R+J5=<W1#%Y*.,)B&G`S;CT!7M7Y)029
MJFO]_"UXCM[EO,:MTR+N6[%Y[E)"ZH1@AKP>/EO4JLBY))FXEY%&-D/9$+=>
MB#;0VE,I+SC6%,O(#>]1L]Q_O8]L1-H/L_?'-Q]HL:J+NYURWF=*<K7J:Z)R
MQ->1/I`-MJV/+:;B2Y9-/LK+;LI[P=5'8"LE81\56+1&Z[:W&IUVEU\K*S?Q
M['7^6V((0ZEO=I@=+KZ258@DCY:XDJ*Y!2PAH;B-`>Q*E1O&3B0%F^LU;[,"
M[Y8+)OTG=);-PTII?_L.1:-;GM?T_9577;Q>PX(R'6Q``[!LEC;E#B4EV-'?
M"O8<6TE_*X[6,A=C@.!1SJ]]06A?IG8/VU+UP)[X#@.!]65J:>:=3X84TXAQ
M.5*PA.,MJPO&5+SE.$)QG'CG.<X\/Q>!Y`7:J=3[GUMZP#`7<X&`T\:W5OS=
MNL+%8*E5]AT7L#81D_>.]+G7+!1[/#A@;9`TTZX?/#HLIK*D2JVQ+RQ(E1VL
MX"?2M:TALON/2[D7["C3.QZU33];H^G*]3:Q5[NH7L#2TTH:GF]GB1#6T+'K
MB50[/)L$""[+C`X!Z4T[ZSD^)%CLAGM3ZFZ\_#5T[?\`+FS;V(T\7V,(/CD;
M2M]UV?)ICY.JT;5]1UCK]AW%GN)B)F-3XJ8<&*Q+GR775Y4E:6\*2&LV[6?7
M6X]Y=`[BF;DN\?L;.H@.]:%J`5^W9HYK26O@>R15_;5!AP%Z[*";FUOQQZ?.
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M]E=;S%>U[5==`B`RI;UT.;N]JA:9CA5`![6M+/5A%5,5Z1$0['2:F+DQF)S&
M'X@7CU-U.$:9["]AMZAK7'G2.PUHGVRU5J9K6D0K"*.2A].%8B8VR.;;N]@K
M`QFG)5$%3?-&CO2G%ISXI1P-2[VZUU=M#7&N@&VM[2-``IFZ*+6ZQ:(0*GE#
M)?9=YDNU;7P2DG;(#*&M<;2R<EX=K=F!21Y`1.0I;JWHBGV%AL;CVD;OVXW1
M0!FRB,K?Q'J55J!>]<01DUZ/4=8RKO=B(.VJL#XG`-RX3BNU\>H-5.<DM0UP
MY+D9MJ0AQP*::N^']U9V5U%J>HNNFY!UATE4>QK.V*@?D:ZH&U*TULK4E2)Z
M$V%5K!7+@.9'W,1(N`LK/<:)9=<$D%ICCW<#(T%EL)L:UMI@3\1FKV3&Z!,G
MLN5ZSUEDKJQ_2]:+$IVL-2YM-85:@>T$"ER=/IL17:ZG9(.)/;629C(]%A<9
MIUS`;_4]R=6>O.GNRFX'=WCB>K*AV4WU8=QVO$0D;S1MNG+DS+OVKH06LAII
M\X5K)Z<U#C18429+D^HG*<N_*K`7/A3(Q&#!)0G</PB4*(1A/IPI*7X4^.U+
MB/I2K&%I2]'>2K&,XQG'C\N,9X'9X#@.`X#@.`X#@.`X#@.`X#@11+_K/Z"_
MHP[)_LIU\X$O[W^IH:_3@+]FX'`EUO\`.V_\1/\`DXX'/@.`X'G=V\T#C>]X
MCL%.OH38P"M:^#)EW&$4JXG91.$=NA&58-=55C8M4/ZRM`U$2KQ9,J"6EB'6
M%3T/PYT9_&%*"SM>]+Z9%^SC%A6/HC">B'=9BQW1+7O=/IC'(\!V1!87`1X-
M90RXMI.4>"%93C&>!.G`J?L_4FY;AV%UQ<:_L&6(TG`H%WJ&S*,U>+@`68E6
M$-8X8XP!#52**2W:(I`A`4T7D%E+'L17,Q8S<K+4G`4M+:>[5!]A:TH9#8=O
MK^LZ7UZU8,V-MB#M>W436PUFD-T`7L$"/BC\PF)MDM;@(S-8LCV8)V&Q,Q'6
MEF)A+^`]*=,@MDU.B5.I;*+#;09K5,JPF?<F#A8N6L]BAQYD8_,*)*AA[^6T
MML1%-2W'Y$J<XX\M]+2DXRZ%1;;U`.[$M&YW;%7J$`K=Y[A]>NP@Z36;K;1Y
MBYU74=.U373,+8D:O5BJ96:>G4"2_"'O33(YU4AEQUYIUK&4AO>_A.T]KGNL
MEKT!N"JUVDQ=E#"]GFLWNSB6[^('6FGGR-=#1:O!+UR\QBNOJI:H3L(FE+*'
MI#3K;K>6W%I#-[\U3O\`O%WB&-5[%;J87&L;=61RG+O;JTW2K\4@'F8-X=IU
M>#D`&U?>&)\&,A@T_'17U0?;H27I#JD<"O1_0':<#K>\&_G_`':W7=RLT"LZ
MWUY7.PFUX\"NPYG8.XV2\"2U]E019:RSHNGK`#!8NDX?*L/H!WWVF&GE?ZR'
M>A=7^WD\E"A6KL,4S6WX.M(5EEUS:VS!1DA7@MHTS/L],#(A"!;E?)BP%/MT
M=-RB2V+#:_G2A)%,+V1IUL-<M_7#L).VP5+73;8:?3R&]M+6[0>NI6^=PUV2
M6D:H.;`LQ\2^^W#??'F">H,I>F#HBB8XK-`NORF&TJS*0$I6WKEV,38IDS6^
MV4UX,4W[:-EY:?OM[CRA8*Q(U&_&D$&<#"B;VT&34[2.:J1!]NO^RV2.\V\U
MD9%80$GZCT]NR@:.V%0;#M^<:OYD!%9I.PCMDLE^FU.QO:-H-8.&Y1*X,H)S
M(F-TBCI^/&SYF$1)S:$(83_JS(:!UAUK?AUVR>V'O*1>5`=<U^75=>5O>=[V
M(%K`R]7?<1@>7L\TRT%5M:&9ITD5%#V(W%=E.J#O)80VB.EY\(RWAK'MK9=C
M=D;#3]AJUMK9H=58E:*V7;^Q:Z()5]%=U&2M+E=#U0;(C:US590*QO\`S@A/
M+(D9L]4.1']BQES(9B/U*WL2U5`9V1M4UL7;XW;W7C9&5YW;MVKTJ8+T\C7;
MUA`#5`6(35859#(D_.<4P'=01>FL>VX4E#6(@:J;Z\]LY]XABZ?VPD1'A.Q*
M_LW8E33LRT2C;%>L6RMZSPST9DO6K"@/444IP*,B5M$>,",/@92',M9C8?DA
MU]F:"W:%`]?:0_V2;9-VV+M^E[-&['V_L4R,VU<MD49V#&B5>M2ATJ:;8KL,
M=(?@PE/0PP1K+TGW;)=<RML-88U7M")IU4G3&['=KG0VH>Q.N=5LU_<]\('#
M421?M*JK[`*YD\2G8\RD2:^9'S3[*GB4**0B,QW)+#+3+`>B^EPVU*E7P].V
M*Y!/Y%U]V:NXMVPI99N2I.VV>3%I*Y9X2./6*'2:>H7#18)_IS3*T*>D,-O9
M7XA3LOU\[![4NW83-J,M0M?3]M4TEK8)<[K9;-!*P*1=]"WX-90E2D!Y8+5\
M:L1Z?8X,%0EYY\U-+9?FIC^S,JR&J6SK-WYE%;])K?9&*N/8=]HOE963V)>0
M[5:H$,_=RX@*,#@:?B-`AQ@!P.$GUU]XF&*)#XF*4U(==4X&8K?6GNZ/OU"+
ME>Q\A^C5S?5VNYL`G8-K(&#FNSAW6Y40)L!`C3%"K-'B!Z]81#%=9A!A8^,<
M;D-/KFQ_:>!9/9FI=SVSL;JZ\5W8,H3I(52[95MGT1%ZN(')I9T39X<8J!`U
M2(*;S:F)I,>I@M*,9R/:B+S'BHD^E)P%-8^A^W6-I:NU7BZW^'0JOHC3X*Z[
M&`[0O-4I+OS.?T\,O-2KPL/B.X3MMO\`FQ9I3%CS['8&FB>(KN&(F&I'`NA8
M]-;/M758'J(U>4S-N#JI0H1"]_.*S1(A6UU&>"GRRI,M!8CFC4(JX*7[2W+C
MN-D<.*3+:<0XYC(932^K-JT*_P"T;%==BD+A6;Q--%`@,C:[/8FZY.D[EW/9
M`[08>>82/JXJ#J.TU0,J(-RW&S)#.9RVORID/A78?U6WAKLQ*E:CN0<9"O\`
MV"V?LO:RB^R-C*F3:Y>-[ZAV"((1%3@UG69/`]5:]+55(A3HX:TT?<2W)PQA
MU+H25K#K`7H!_0A7S4QF/J*?VA3*0(8DL/8`[NOLJUU8,`Q[HC(9ABH:F$S6
M%9890\RGTL.X2E7`_-TZ?[#V[85M.T.^8@U8M1*R(K\#Z6-AZ_R%DB34V;=Z
MJBNU(`3#>U;0&/-1V[QZRK#5L)SF!&<\J<J"#K1U[[7A-?96C9ESV1LJPW?K
M[7LQ1>]]I4.KA=<U^OT<=LCVTL&@KEAWI%H%$ILPW#%R39F(YCU\M>U/QV@V
MRN=9NTDNYPE['["'BM*;MU0+VMVJ;+V'5#-\&`JKL*.YB"(!0Q$35C$<X9`Q
MY(H-/5"L+0QPA.=1)5[.Z&NU#J[VFSL\-L/9^R1MI8J?9*;LNG`1NX]P,#*_
M1K'K79FOK"VV-D#FX1',6;90Q.+5YN9(3.(<IAM^(F0OU`F;0.F>S-#ZX[$U
MYL_>#]PW586K<BG[0F&)ML;K1,I1Q((2=9R2K=?EQ86+O#EGDB<MRF1N)OL;
M#RV&FT(#L]?M%;DI]K8MVW=FV0[%%5!0:H42%M[8]S`5N81V%M@V18LDZQQ`
M"MKS!]'LE;&Q3IR*X1]04KRM,>1+KX7.X#@.!1SJ]]06A?IG8/VU+UP)[X#@
M.!IVQ:N0O&O+]2!5DE4TG=*1;*A`M\"$T2GU659P!`&U8QX]^1$8FSPBI_M+
M#:W6T*=;3C*L8X'F1<_A'ZMM/7R'ULA;BV@(HU1L6[;3J0X1S'ME]U8:W#KF
M-589`3:S!!$HO,H=V5-L,5;Z48F,D'13J4Q?%Q87G`==ZH`WJ`WZP]%>MH'K
M$$ZOMY]P#V9LFK!+O$O#!59_#SA)I*YL7TO=_P"2CIPK+GGRK'AP._O_`$^6
MW)5*M!J][SK.^:\V74-MZ[N[M5BWH6&N-/07@QTGZ7,,5UNS`B02PSXK\=)"
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MI9;9UU>V17J@)%R2.R=U]E:EV-VN=&U]PW+8K]0MR`Y:HK`>U2TIKQQ>5RW9
M<9#S@>JLA[,B0_(RGR9?>=>RG&?-A.75J7E.,^&/'P\WAX^'`IOW$Z?!.X]9
MI=3LVR;SKP51"EMMX9=#D*@3WMC$:?/JE!MI.8W.AN3QVN7#,Z<D0OQBEGI"
M4/K;0UCS!*=CT[,-[;E;H@W:4#N3G7.Z:%A.1@$23#'$K?;P5U1LEMEP@UZQ
M$*9`,^F.5X,NM^"5/I\N.!H/4#J=6^FVN3FJ*3>+I<Z7/LXZUAFKY.>,G:^0
M^C^DTVS,I/R9DJ42@64S35&DLK2VB`^0=CM84TE"N!+![5L<WNG5&Z4FGH)3
M5--W#48(-(YB1!-?2X[K%Y\I/EJDLOLN5[.LF$M-)0O$A,I>%+;\B?,%3].?
M#]KFF=)=D=("MO[!M(GLU1R`JX'KDVV;*`]E6O6]AUUL;9];;DE%H@Q[HT5A
MS4`$+;AC71_IM/K2^M2`O@!%(`@0(%MY<EL""#`VY+B$MKDMAQL4:B0MI*E)
M:6^F-A>4XSG"<Y\,9S^+P,KP'`<!P'`<!P'`<!P'`<!P'`BB7_6?T%_1AV3_
M`&4Z^<"7][_4T-?IP%^S<#@2ZW^=M_XB?\G'`Y\!P'`\R.\9;7U?V%2BM_I6
MNY&7Z(8$U:S[/@;5M8:VF'SK$M_65>J^MU/0PMF3F+&D8,$6'7?2G^C%;>3B
M6E(60K1TA$V&+EO5%-:GNZ9J*)M/E%6G,U>0^N/*?`J(P8LN--<!O*S$RMM/
MIN9:RM.?#..!,OSR)?[%@_KS(_:7@4'[":"VEN[>"[N$LU8U]7(NC7*8-.JC
M%+):6KG-SMX3+&Q8R204;&I,\9?(,DXP]$?67Q!CL-NL*8]3`1X`Z$#4ZBV7
MK;8!JL[$+WC2)+2U>L)P#.F#*$*GWC;EV2D36BLXE'=`L*V&*@J@M.Q,NQJS
M$_-481'1%#Y[4Z-V/9C-UF1MDC*.<OLR/.LD:J0+*.JI2*.A:-A@*;.&PST(
MBNAU/Z*"+@R&U(97%=-^9"D^G(]K#9;5TOEEJ>D2`NT</>G=_"=U%=F%&[#8
M3QF-7XYJ#6@)B).-9AV!^LQ3;BXF2OM\),CS.HCLR5(E,AE]7=0\:F=JTL$9
M$/.5'83^RH<>-#E#5231?3]_UE=&8TMQ<U0IZ^D[;!*D7DX4AYP2RAUMQ6&W
M6@R.DNOFP*9TVMO7>X'P$2W[,US-KALK4EG(=<H!FP:BK>MRN*Q`DE#!*<M)
M(*\;(2D$F<DSI";+;]##Z<)"O^U?AY7/81$DP$W7!I%.=`['K`*N"JV8Q)KE
M:OVP;]>8]3BE8%A&+?JM;^=L%J-#\C;+;HAM;2&L91AL)1T-U+V;UYN)+8%?
MVVS?#[>HX&M*V*N[MR37QZX;E+BQVYD:+89#+]4##J@X^/B>@J7&)%IKB9.$
M.N(>">NV6GS/9FJ4BLPB59I\FFWV7<8I@V/,6G,9R?K;8FMT$P<47/JD@/<Z
MPG8&3`4AF0^U#*#F%*8<Q^20'#J[0[WJ`3M1VW+60)W?:ER+5"$2MCIZ11M3
MQ2DR-K2G9G,PY4&:J!$?E$E>16%-Y*>SN*4MG.<!5?5_1S:%!E"6C.[*[;*Y
M+N\&RWZM/4PW!&'@<"5KTK)K]>@IM3H>OJMAVGSY)A3\2=&DI-/(PSY\.//@
M'=`90RNT\>+ME*K!RDZ:U]HP>1IU1+U\,4H.NJ[N0,W7#(.&?:=<K>PI^RA\
MZS0&I2$S71;V&W$+D,NQ0DH/TW@1]?[=K-@)@K);-FZG%ZO"7*9`)K;UI"'#
M'U1(]/$D9I5Z%6:_:,Q)HF$W*:?B-"X*%R77HZ'\!J6Y>F%VW'8]W6"1>J13
M).U;_KRS0)]+`VX`5Q4=>U2T5D11[ZZ(LPS%K=A%KE,LK!>,Y`GK/L0<N9]G
M@0VXX3UUWT:;T1>MWW&2>#VYW;KP!""*8Q<5<5,`;5M:SQRM\L9"=88URMN&
M=H8&(F,1!K#8X/$1Z&?EP@(RTYT[:UR=U;9+<3J&PRNJK3?SH9Z56I4;+C%X
MU)4=3E)+#IN=:)8ZSVY5358;1-;<RR9.DI;N&&O/E2P[0[J!"KNJ-=ZRIA0!
M2%T'K5L?KQ[]JX58?)EB]E]?6!@S)A"\CWV@T$M3)BI(Q,GSR6S<KTI,=U2G
M5AH$[HR<.6^98SFQ1;0,OK^A48CKNKPKE7:$+%52^4JUEJ=4P'SPGL#-8FAM
M4?CMC)69C[$LD^_ZV6E9C9#T9KY<S7L*$00U7ATP6*`B*?7QBR$&0!ABH;L.
M1%DSEL28DZ%EEN.B(TS%B^S-M*2I3OF3E`;)\\B7^Q8/Z\R/VEX#YY$O]BP?
MUYD?M+P'SR)?[%@_KS(_:7@/GD2_V+!_7F1^TO`?/(E_L6#^O,C]I>`^>1+_
M`&+!_7F1^TO`?/(E_L6#^O,C]I>`^>1+_8L']>9'[2\!\\B7^Q8/Z\R/VEX#
MYY$O]BP?UYD?M+P'SR)?[%@_KS(_:7@/GD2_V+!_7F1^TO`?/(E_L6#^O,C]
MI>`^>1+_`&+!_7F1^TO`?/(E_L6#^O,C]I>`^>1+_8L']>9'[2\#]Q<B7CCQ
M"P?#Q^7P,O\`CX?W?#_L7\7@4AHE([5ZVJ\.DU\AUD+@0I*T.AIYYC<$<TZ-
M.VP[98C91D6YD?B?&;,X:=RSG+:UHRI/E3G"<!MWCW"_*]3OQMW_`*)P'CW"
M_*]3OQMW_HG`>/<+\KU._&W?^B<!X]PORO4[\;=_Z)P'CW"_*]3OQMW_`*)P
M'CW"_*]3OQMW_HG`>/<+\KU._&W?^B<!X]PORO4[\;=_Z)P'CW"_*]3OQMW_
M`*)P'CW"_*]3OQMW_HG`>/<+\KU._&W?^B<!X]PORO4[\;=_Z)P'CW"_*]3O
MQMW_`*)P'CW"_*]3OQMW_HG`>/<+\KU._&W?^B<!X]PORO4[\;=_Z)P'CW"_
M*]3OQMW_`*)P'CW"_*]3OQMW_HG`>/<+\KU._&W?^B<!X]PORO4[\;=_Z)P'
MCW"_*]3OQMW_`*)P'CW"_*]3OQMW_HG`>/<+\KU._&W?^B<!X]PORO4[\;=_
MZ)P'CW"_*]3OQMW_`*)P'CW"_*]3OQMW_HG`>/<+\KU._&W?^B<!X]PORO4[
M\;=_Z)P'CW"_*]3OQMW_`*)P'CW"_*]3OQMW_HG`>/<+\KU._&W?^B<!X]PO
MRO4[\;=_Z)P'CW"_*]3OQMW_`*)P/O3ZSOES;U.V3LV1I-8JD4S8U;&!=<?2
M&P1($-@D->R7)I"=;6Y45B",CT7*<-M-J<=<DXSXIPC/F"6MP62:1H)6(\,B
MQFW)8;.7FB;LA:?(6AN8\&5C(V%>;*/#_#QX>/C\OXG`L:W^=M_XB?\`)QP.
M?`<!P/*_OD69JVP@!9ZZ#M2_.C59:H)M9>E1MH1MI>0Y+DJU#`KS]<L?S!GL
M^\<25'\I:;D))(:6E_V1.&@L)3Q_NBU5D5\WWJG[LT?01_S5DF?G%(K/L4*!
M&^;[]@\[GOUX-Z7LRIGF5[4IO+GCGS>/`F3@:G9[0]7Y%?@PJ^3LA2R3Y\$?
M`&3`D#*,#!$PU-DRI9XF+AMLMQ(>4I2E:G%N*QC"?#QS@,9\ZKG]::R_QLUK
M_._@/G5<_K367^-FM?YW\!\ZKG]::R_QLUK_`#OX#YU7/ZTUE_C9K7^=_`?.
MJY_6FLO\;-:_SOX#YU7/ZTUE_C9K7^=_`?.JY_6FLO\`&S6O\[^`^=5S^M-9
M?XV:U_G?P'SJN?UIK+_&S6O\[^`^=5S^M-9?XV:U_G?P'SJN?UIK+_&S6O\`
M._@/G5<_K367^-FM?YW\!\ZKG]::R_QLUK_._@/G5<_K367^-FM?YW\!\ZKG
M]::R_P`;-:_SOX#YU7/ZTUE_C9K7^=_`?.JY_6FLO\;-:_SOX#YU7/ZTUE_C
M9K7^=_`Q3.PK-(-$@#>IK7[P%#0Q:7A5GUKACV,[(-18&6GOGCGU'<N@)'G3
MX8\F/+GQSYOD#*_.JY_6FLO\;-:_SOX#YU7/ZTUE_C9K7^=_`?.JY_6FLO\`
M&S6O\[^!U)]VM@V!/)2M36C$4;`FD966[3K5;F(T",[+D9;1\\,>=S#+*O*G
MQQXY^3@;\.G,E!HTI&PXF,4'0"<9+J<(=3'(1&9C"7484M*'4M/XPK&,YQA7
MCX9S^+P.YP'`<!P'`<!P'`<!P'`CZ1=BRS1\.#H-@L**W.A#"!.,:I@N(N?,
M!"+#AB*P;L8\@ZAB`;8PIS+*49<RK"?'"?'(<OG5<_K367^-FM?YW\!\ZKG]
M::R_QLUK_._@/G5<_K367^-FM?YW\!\ZKG]::R_QLUK_`#OX#YU7/ZTUE_C9
MK7^=_`?.JY_6FLO\;-:_SOX#YU7/ZTUE_C9K7^=_`?.JY_6FLO\`&S6O\[^`
M^=5S^M-9?XV:U_G?P'SJN?UIK+_&S6O\[^`^=5S^M-9?XV:U_G?P'SJN?UIK
M+_&S6O\`._@/G5<_K367^-FM?YW\!\ZKG]::R_QLUK_._@/G5<_K367^-FM?
MYW\!\ZKG]::R_P`;-:_SOX#YU7/ZTUE_C9K7^=_`Y(L]T<6A"=363S+4E"?&
MV:UQCQ5G&,>.?G?_`'\\#"U_8UDLP,781>IK7D<8B(FPLR;/K5A_+#BEI3ZK
M/SQ7Z:_%&?D\<\#,?.JY_6FLO\;-:_SOX#YU7/ZTUE_C9K7^=_`?.JY_6FLO
M\;-:_P`[^`C74LDV`#'*$?KJ;'+GCQQ.4:IA.'B=`!E+`J/)9!V,@0:P]`#O
M^1>&5(PYA.%93A7CP-_X#@.`X#@0EV&NFP*#JPK8-6AQ1Z]+-58,%%%,193D
MA!L_!'E700&6?JR;C:80AU]\<$00B.E)+:64+\<^7(5,K'<B\8*:S$&:[+O\
MHN.[&C[R-UWJBY"+\'M.I"5(9KC)_7-I+LDZ+-C#;5YS\/+Y*,AQQE464MI>
M,\#3XGQ`"\0OU!@6%S74*/M+7VNKEO?#ST@<4$N[B,YJ-%1KT>^4=7AD6<9<
M(%4/>U*:$Y2KS)\?-P-@`=M-R$]_$-:XA5J:)1NS=FOV`<C6EDKS+&O]2BB,
MTA<1FX)US76;7:PLI,+$X!%%YEK:DY7CTT)RXD.GK[LKVDMV@).V45T;/LQV
MFZ_*4X&3TJ1U]69QFZ64-!F)H]J/[B?A[=*00$J2\+#-8#/F)"64H>3E>&U!
M;OK7M`YM6@$R5JG#)ELJ]WLU*L34.F6C7)4=+#+B28<&WZ_MKTXE3[>D418<
MEQ&IA"%G#B'8\EQMSP2&_;3_`'$D?TV(_9.+P+4-_G;?^(G_`"<<#GP'`<""
MMEZ$!;(L#EIQ;KM23DVFR=?'9M/=J3N+%3)$V41P")1KI4;C$B(CS)\E:)(]
M$*;_`*PK"GE82WAL-$C5X34MGM50!&S"!5C5=7KP6&I^1*5$$A5,#1T94F6Z
M_*D98AQD)RXZM;B_#Q4K.<YSP)(X&@6C]V^IO]\W;^0!K@;_`,!P'`<!P'`<
M!P'`<!P'`<!P'`<!P'`T`9]5&[?P&UI^S6T>!O\`P'`<#7K?^X^X?P2L_P"P
M4_@?E/\`W'4[^"-7_8(?P-BX#@.`X#@.`X#@.`X#@:!4/W3[8_AR(^U;KG@;
M_P`!P'`<!P'`<!P'`<!P'`<!P'`<!P/O%_Z3'_\`R[7^D3P(OTY]2J@?P<C?
MZ:1P))X#@.!H%M_=7J7^&=@^U;L#@;_P'`<!P'`A?L1+U<,TO?3.Y:PW<M>`
MQD8P8K68>)LTK/B$X2:Y%"-^TPG(]B?L;T5N`^V_'7'E+0O#K>,95@*[`"-,
MTV`KQ>P]1B6GRX+856U-5V6[,!M,:9&[-60&(LYT==Q\^7@],P2B1OG*S,2J
M>EV,TEMYQ*D+X&AWC8O7#5%+VE3HG7<"JMO[E$]7K/`-68)3Z&8^8VM@]CK1
M*TWZRONP*-5AP*2T-%(?6AQ9!*4H5A;F7,!E[?N31U;J)DT4Z^3,YJ5$JO=+
MW-*-@XQ%B];/O,[6TJ0R=A%20^-9UON/.S"3,MX9,'O9QX*0O..!QTU7^H]J
MU[N];V@@M,KNLWTT;9P`?89VX*J\)'"@&PH+].)4HS81I9`IM<21CW4PR2%S
M8V4^#:D>.0F3IW?]4WK79M&G=9E=7U8%8H6)HLM!,,22MDLU5`VPT1D$3<1J
M>=)Q7"Z(<N4Z_)<<=CX5A?HJ8RH)QVG^XDC^FQ'[)Q>!:AO\[;_Q$_Y..!SX
M#@.`X%:3?U<37\!1?[(<#;N!H%H_=OJ;_?-V_D`:X&_\!P'`<!P'`<!P'`<!
MP'`<!P'`<!P'`T`9]5&[?P&UI^S6T>!O_`<!P->M_P"X^X?P2L_[!3^!^4_]
MQU._@C5_V"'\#8N`X#@?F5)3CQ4I*<9SA.,J5A.,J5GP2G&<YQXJ5GY,8_%S
MG@?GG1ZN6/4;]=+6'U1_41Z^&,Y\N'\L>;U<,Y5GPPOP\N<_W>!^(<;=\^&G
M6G<M^'J8:=;<RWXY\N//A"E91^2^3Y?#Y>!RRI*<XPI:$YS^)A2TIRKY<)_(
MXSG&<_DLXQ\G]W/AP/W@.`X#@:!4/W3[8_AR(^U;KG@;_P`!P'`<!P'`<!P'
M`<!P'`<!P'`<!P/O%_Z3'_\`R[7^D3P(OTY]2J@?P<C?Z:1P))X#@.!H%M_=
M7J7^&=@^U;L#@;_P'`_<8\<XQ\GR_P!_.,8_^KG/AC&/^7/`K:/[<]?"8BYG
MXEZD^XZ)69MV,EI5/NL&`1I@XUFN3K93I,VO,-WRNQ3_`(0UR@^9K>'U)Q^(
MI.<AFG^R>I(54E7,J2MX(-'/B:K$CV'5VS:_8[#93S3CX<'3ZB9J4&SW$C/:
M9<4E`R)*PG#:\KRG"59P&")[#Z^]C*CC5LBQNG16X`^P0R0C<"RURQ1W=:K$
MOW>+-;FC(12E6ZCSI\&1AF<B-+;?RVMM#F,?*%9'IW7FS59^ME-]]D=L6?:`
M_4VZ:Y?HM.N-SLU4%4NR2T:HLX4'3-6+I%5BL6.ORO:,3Q2'BKB753?4QE&4
MAL@>MZ2+"2-8K?9;8N-B$^TUKKETNT:'7Y!>S;[-U"3$/4:\Z_(T9[6LVKJI
MM:_U%J4(P,9S!0_&D>OC*E!%,2N]',:_O=/@[:O+%.`=>8M%,EI-?,^P'-9Z
MVW!)OEANU%*3*(V&OZF[[8%1"&0:9@]B,^AIB.VWY%\"[3+^G-MZ>V32P8\O
MKO7<\":KMD4_KBPZ5;$0K$,?5-+!(5NJ]6C.K:CJROVIAEYE+R4I<SE7Y'(8
MCJG7M!UVBGH_7PEDS6YEK>+'2;BR:GUEK$)&6X4.6DBVQAI@-4K*/C1T(;PM
MJ.A#3^52&W/`);VG^XDC^FQ'[)Q>!:AO\[;_`,1/^3C@<^`X#@.!6DW]7$U_
M`47^R'`V[@4M[VR#@73H*W5?L)>NM5HKVR:J.K]ZUUJS6NXK-8"=\Q-HD/74
M6F[;B2:.C%MFG6?"?*7%S#7&3X/MX<5A04DB5GL@Y$LQ`Q\<+9--A4JOZUL%
MS>O_`$QZ4T9ZG_2TR2?I8"V#K/2AA:MVN>D8O"QLV.Q*0M:4X3E7FPD.UBM;
MNS[[\G_W0&A[-;$!SYY,?KAT!DN"@EAP%4!*2VX];=<1#-(L@U456,9]=)&(
MI&,XDL9<#E6*EV"N5GM5.K'QX;.9L-,(4P6=A1.H_2%329^PZQ%N5*8&$%4I
M(X[FQUJ8B5%5!=D)<1YL8SYDJQ@/QRL;P;284O\`^Z`,>6O#0Q@[E'6[H&Y[
MH%V/`Y8":0PU6EYC,FFC$-R+YOR3S,MEQ.,MNMJ4&UW+1W=BE-ZY<F?&%WD9
M3M6]UW7U-56.CO2PZT0*V0&=L\0HY)BTW$5FM1:U6IL]^=ZBFDQF?,CSY4A*
M@@C2ASL9OFV`:)3OC%]E!EPLU0>V$$`V_P"'MU$KLJ?0%!`EB#W-I]^B/0/<
MEF$'FG8'B][0YEIU#C32V\IR'3I%I[$7:OZ>M"/C%=E*T$WY=FZ/J:99_A_=
M.(N+5+?IK]WC',M"J:8>!5B4.3'B-RR28><E2,*#E&),MAM88VCW7LQL8OK`
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MC$]EBIVEN6)BWT6N=`.F1N]UI^J7O5^MC[)BNQ*EEZ*J%;]P!(Z597E$A#KS
MK*G&F'5I"1]>">RVT;+L2GT_XT^[IEEU1.VT+V$(E=#NH$"562FD[2)J-]@3
M42=?HPX_%)G8;D/+67&R$20A^.IQOQS@(4KFX=U6FOUZPBOC&=I7(QI^,Z2B
M9^'1U(=ETNL3H6L)X^_75<.BRAP:CS&MSU=/MJ)#ZF'"N$OMM>R3_90EFD1^
MT.Q5TU=1^,+V3)C;ILIW3<0X[\/;J.-$A=JP:"7V">H-F>)T"'(#6.IQ`,T6
M894TK`RP1'ADA3<MEUM`6=^\_P"_W_TPNX?[%/2W^8_`?>?]_O\`Z87</]BG
MI;_,?@5OW)K_`+2]>[6`E7_XO_8Z/*OE;*$"MB`=`>I5G`4^A:Q.5X:8N=\?
M#T"7BK5&N&=OPDRR"FE(9:F9>>\L>.ZZT'?CC-U3;=5:*.^/L6+66Z8NV:[#
M$=4^C)6-,SKJ"$)W!+Y6!39`D<H2,L<*5_K#[6'XK^'V?49QE>`EJG]=>YFP
MP,:U4+XV&P+I6ICTJ-%/U?J!T?-B7I,%[,>9&1-@4U]C$F(\GRN-YSA:,^'C
MC'CCQ#9_O/\`O]_],+N'^Q3TM_F/P.K.Z9]^",&<.D_&$W$J,1A2Q\E*>E?2
MY.51IL=R+(1A2:/A2<J9=5CQQG&<>/CCY>!Z6!AV`X8,'P^N7@.'%",2W&T-
M.R\"Q\>![6ZTU^9,N2O9_44A/Y%.59QCY,8X&1X#@.!3SLO(N]N/ZTU-7M5W
MLM$<VWH+8_TD"V(<FA0Q-)V?'/WL79B"93,FLS@@`*A]GUT*23S+0U'PI:%X
MP%<0>JKDQLVOI<TY>XW8F'V_G;%LG9EV`E--):!=NA,H[#^D#WOG$^OD-5/Q
MZZS4?0\T>:CS981AO#^0T+JOIK9M/WQK>P3]7VT'D9;.R2M@%B.JT:ZAQ:[<
M"]IF5`J8VLW8Y;^ZTRU*@I'BG1[2(6)7K87C,1.5A,^R-5;YN?>"G6V$/L_T
M0U,IK^2@G(N2!M92/JX@M;3;,,6G7Q%64RK:2'X1'5.5F3-@/-^LVEW"X(>E
M&?Q<_P#/_P`W_P!;Y?#@?G`<!P/*WMH%W&"[!5$?K+OWO#KWG?+4>2,T]K'J
M;H3?4"')IC=)H=JV60L6PZN8N;`A3M@!-SHL54K$!O*YB8Z(C4V0R$4PZUOZ
M2)`G)?QY#H09;;7;J93I=@ZM="A#=P.4FTKI9YFL*E5E*2[3-CPW%0IK.<J?
MD,M9PEUU#>0YC*[NPVR'D!O_`+H$088L,@G$`NBNM_0,B@S*#1&)Y..-S"K3
M_M;L:#):>PE'CEUMUM3?GPXCS!SI54[`["H];V/5/CQV2=3;:`!V<$8E=2NC
MPA,D'9'RD,'.>B%Z7!G04DIP*=';2^TVO,B%(;\/.RXE(92MZ][$W*76H%1^
M/7/M$ZYNE6:A$`=8^A):1:'0BG4%6P#4*KO**JAJ8<\?1\^%X;5E'FPE6<!N
M3?7#O"]>9.NF/C';F?M,&G1+V2B,](>F2XXRNDSDVO!7R$S%%]GC2CI,1/Q#
M8SGU7FQTE>,80WXY""!TS<Y;7,G9D#X\%P>#P*16-@$PCG4;HO%N0>OW..-?
MJ^356F52.4#3S&3,-MMB4EE2'I;*%^3+K?F#/W@;NG7&;6W;_C[%ADRBV.K5
M*ZBFNJ71LD;J=AN5I'TNOC;$%&4R85$.RK&48CNY?90B+Y_._EM'Y+@-XUGM
M3UZA@2.Q/C)[^0-,B+%;9Q*N]!^H-D@U#6]-57$7;:]UD#*`ZBO:WIJ[@+]X
MDG/-Z*9R%I0M"'5-AF)%1WI$,AZ[(_\`N@!ML]8B?N8`'^]T^'ZHB;*Y,-5[
MV`7%375.S9/O]]N%E*,9\);B&L_DUI3D/U%/WP[*%PF_C]+<FF[#+J8:&CK;
MT"5*+66`\-8G!1T?%;R[,G1'34+#B6\*2G$QC.<^#S>5!D@6KNU%KG4J)4?C
M>[!MT784NWBZD=JW3OI$?KA0[1A,:P6"NX-C*9)@L'FJZ\X09C.*2N3"BOO-
M^9"/'(2M]Y_W^_\`IA=P_P!BGI;_`#'X#[S_`+_?_3"[A_L4]+?YC\!]Y_W^
M_P#IA=P_V*>EO\Q^`^\_[_?_`$PNX?[%/2W^8_`?>?\`?[_Z87</]BGI;_,?
M@/O/^_W_`-,+N'^Q3TM_F/P.2.H/?]"DK3\8;<.%(5A2<_>4]+,^"DYQG&?#
M-&\,_+C@5`%1]V4JUV?3IGXUNZ=8MZRFV.K13^QNC?3RL4*QDJ-FK*N86F7T
MW2,!K,8J2[T,S,B8?3,RW)RZTVZRR^XT&^"AFZS*+F]#^/J71$H%YAZVM1"?
MU3Z-#!D"Z$04*RCP[!(C38L$G[:$G8D-/Q7'HRVFGE8<\K#V4!8'[S_O]C__
M`+"[A_L4]+?YC\!]Y_W^_P#IA=P_V*>EO\Q^!)6F^L?:6D;.K%XW-\0S8O9&
MHUAJPNL:NL?6SKAJ\3,-&J\2KL(X]:]85H1:VG@<<L^XW'2[F.^I7@ZG.,8S
M@+T\!P'R_+X*RC/AG&%IPE2D9SC.,+PE>,H5E&?E\,_)GP\,_)P/+U'2#;;M
M4W14$W+5]2#[%U1:J$T#I#FR(U'MMP/6P6?@[+L%`,2R%=U7-'#X+[#L"J(R
MQ)?FN.9SA*&TX"4(_6S:T$#4"-<5J.E[!U9M./LVBQF;;NG8E+L+TRBV"@6,
M;;YNPY,VS@77@Y[*X#HO#K,>0SA;C*_,O&0U&G=:.R];LR=PD+'I0WNW.Q-O
M6`^F0Y<1FM+6#VWKS7-05+&1AH=T_4C%8D:_CY5'6B:T1\77,NL>HA+88X7T
MDO=.-:SG@Y^LKW&HFB-;:G?^=]LW-KQ_-@I-FM-F)6,>SJ^2A!`43D63"&8A
M%U[#26,>./R:_,&5B=%B\3;E7VM&NP@>^YV`V;L_:@(>R3;@WNH6>3=I.OVF
M59C8S%V#06KS/B)EJPEAV'+6WY\X::QD,M+ZO[_(:"/];INT-5JUV(TL6U#K
MMZ'4#T:PG5.2Q**O8]BDY#TW-?<KH$7F,_&`X<;(R7E/N91A*&DAO8_KU=).
M@]S:>GQM;4^=L8.^+#3JW9]F[.%,/SAK8^61.HW2P?DL*90PCT6(;:FDY\7$
M^F_A+F`WWK!H!KKI02U0]^1S\PY<K%:YLN(!K8&(S@C.=9$PV&J[7J[[2J-7
MX\1#RI#;GEDI=PQZ<?TVTA)>T_W$D?TV(_9.+P+4-_G;?^(G_)QP.?`<!P'`
MJM?2::QMN4=GQ)KXF=6H(?+X^.N8]%E-N>V(6]%:QEU3#J<>7"L8SCQ\?[V>
M!P^E&J_E+!_%TG^@\"--NN4G;]%(T0A8=AU2*0EC9CA2M5800?=P-DXD*%&*
M_>ZG<Z/;*R6;\S,\67%3H4II7CEM+B&G$!5JX=<J%`UZ``Z/N-UIM]H]<T%5
M*%<+H)*V%FOC.OOTJ1*S/2Q%!.,*.D1&YS\>5EZ%,&Y:>:;8@QL--.-!@Q?2
M_KQ#UK0Z%(NN[V2-,C0G)5JKT&*'=L1A=9T)6[$LB'FUDU`D5L^SUX"*4+D^
MU-)2[(2M;OBSEH-RB=9=)!ZP)J-9V-V`K0BO#=%M5U4(;4"$T)9>OE(@:QI5
MYB/G-9E&WK$2UN-;$%&'VW1#Z/&2S"CR_!_`<B'5CK+-TJ-T:U)VK%KH._4O
M9@$\L6,*V49<:)JBO:4#D'4FJ<1K)J/(U]741I+$\;);<??<>1Z:DL>B$LV8
M%55`NMM;H$V6`#===@T.P#(!RH')39.F4[65UU4JOQ5A&AK0\W[BM^)$5_#.
M(:9$7"%,I:7^0"-*YUNZ^:Z'Z.AZ8*[(T?*T2#LM<$F=:T/7D(G?AMS#T@':
MW]I8/ZML`ZTGST+7HW+Q5J/#)86ES*'TI7A*0C&M]%.J0"HUVF/G-TEQM!KT
M4#JF>T"I5'.ZJF0K'1K3&O%5+:KU?0GBNS$%]:`5*L![!@DX@8VE;BO,YE09
M.I]->OM.VJ#W4/OVZB.QPY(C-?.V#7FDS#1I@B_KQUU,X7)T1[M%65Y&LAV)
M5H$-C;<26X^[,*/NJ:4R$Q[4U'JC;6T!&UC=YW0',UT*6'5L4#!U9P762I:E
MVVA/V.N$+%KVP6\,X\"N4ER8(9*8K9:='BR2`Z4ZSG+@0=+Z.=6RL37`VP6C
M>UB$:W':L:B"RPRH*9LA_3E+&ZTI]LL<J)K&(101EZV"P@AF`->'`S<>!%>E
MP7);")'`W4UU(ZD6/KC0NJAP=M4GIW6]YL%]K8J3,-*-9G6`AL@ED*4/8&8F
M$*V&>V=,1!85A+S;<*#AQYW+"LNAF:SUXT?6:]LNH)NF\S=6V<)Z\AB`8Y#!
MO8`1.LPBHA->N5\F/H8TTN60@4F%[W<(R2.9;GJ+:]#*_D#`[!ZG]:+Y,V.9
MC$=JT*V;6)W,E=+M1ZU48]K*8O.S]3[:)#WR=CUS9$SAPNS:9$,C43&Y*X,!
MR4RA7B_YT!O=#T9UUUUM79>YZ]C9OSZV]3+U2-@29;$K(PY`V!M:T[@+F,BX
M86''C6:#8KA*A0YC?@I`=J+$<2[B*RM(0+3>AW5VB!&0M<N6_(+<D,,J-K?B
M!M?!V;SK\+'U@V*HQ\!7-1A*I"@-RM/`I$LF,@0+"5=;DXGD)+<IQ&`E:KZ-
MUUK2=K&)K*TWN+3ZOOG/8&\B;T/L%L*6.\OZJN]!LUD`$$0X/NVU[7M%R59K
M;*E+>C3S/M4MB.R_-?5D+F?2C5?RE@_BZ3_0>`^E&J_E+!_%TG^@\"MN_-7:
M=[%S*^[=;)N,&-%U&_Z\/@Z-'9!0[]KW9Q"AE+E2[5/FU8P?AB2TO6XQ*W@L
MP3/]G]=GVCTWU)X$'UCIGUPJ]?-5QB\=A"D*VQ;P$O3Y=`&1.N]/V3J"F:1O
M%2/2V=?1W41K!3=>!GG247,<XDI%7)3-3A]UI068T)6M3==Z(]0J;)NI.%-L
MA6V%2QNI#(10H<+11@YZ5*CT^KU4$C+0P)$CIRW#2XM+&%.+6O.<\":OI1JO
MY2P?Q=)_H/`?2C5?RE@_BZ3_`$'@/I1JOY2P?Q=)_H/`?2C5?RE@_BZ3_0>`
M^E&J_E+!_%TG^@\!]*-5_*6#^+I/]!X#Z4:K^4L'\72GZ%P'THU;\I8/XNE/
MT+@/I1JOY2P?Q=)_H/`?2C5?RE@_BZ3_`$'@/I1JOY2P?Q=)_H/`?2C5?RE@
M_BZ3_0>`^E&J_E+!_%TG^@\!]*-5_*6#^+I/]!X%=M\Z[U/V'?I/SRLNV!0J
MF%XA=5=K80/[GL$@>?`68=)E*LM-LI6K6(84KC*8IVMR@A^/#D2HZ)N&G\X2
M%>]U=7ZCL@V!^9NP+32*J9NUOLVYV9=3(F+'<@ES['5?LZ6JM>?=%.BA8[%^
MK[K,57DC38<>5A2Y<M#:XCX9UGJ%UJB[(U[LJ'9-[19NMYVE2@:LIS">J,LG
MH*NT&JT`A-%R*8Y)C3G0NN8#)1^"_#?(-Y4CSMM):;;#[2NJ>BB$&@B26Q^P
ML\-KZIUBA#Q;L"H--&J3KPG;R>JZY89D76+!&3'UO\^B3,1^,]%ED&W6\DG9
MJVDKX&\D-!]<R&V=1;CRW?V+-IRGZTI(*&BNC)0@P)TYFSNZS?+I)5.<5&DJ
MS+N)![+P:4*S+4ZA+V%MM(1@-NN==$6>_7"ZU[9VU=92;K1-:5D@6H`%J/;!
M9[4ESN5EJA@:_9Z_:JH2!%A.PRHTR))BYD66UB.M.$K2I6`A:K]0^L-/IY_7
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M.,K>0IH)*T+UFZT==3'ORAYV3(G-4ZQ:\@J-`0W^I4<\/U^)C@LN@J6#E%70
M`O6H]F+.GN2YKN%OJDNOY6CTP^VJ-$:FTPG4H6HV?8Q"GZMV/?-MQA=F`^K+
M=N5HU6]IT".`0ZV#K-3I](K]4,DY+@P>.8:DEI"9&$HRM_"PN+]*-5_*6#^+
MI/\`0>`^E&J_E+!_%TG^@\!]*-5_*6#^+I/]!X#Z4:K^4L'\72?Z#P'THU7\
MI8/XND_T'@/I1JOY2P?Q=)_H/`?2C5?RE@_BZ3_0>!0;9W3[KOMFSV>TV>_=
MBF'S]]M^Q!H0.H'!K-1.;'#@`.RF0PE6O7G#8Z[BZQ!0^U8'C.(2F,*A>S>9
MS"PZMGZ7]9K761U-*6C=[M9"2@\X$)DAJ>68$2X^C!77*UOM8.ZT*(GYV#JT
M'#8((FIDM1)['M(U$++CK;@7^C[)I\2/&B1F#S,:)&CQ(S*:Z4\K4:*RAAAI
M/BUX^5MIO&,?\W`^OTHU7\I8/XND_P!!X#Z4:K^4L'\72?Z#P'THU7\I8/XN
MD_T'@/I1JOY2P?Q=)_H/`?2C5?RE@_BZ3_0>`^E&J_E+!_%TG^@\!]*-5_*6
M#^+I/]!X#Z4:K^4L'\72?Z#P'THU7\I8/XND_P!!X#Z4:K^4L'\72?Z#P'TH
MU7\I8/XND_T'@/I1JOY2P?Q=)_H/`?2C5?RE@_BZ3_0>!KEGM$&[P8M3KT,P
M^2-EQ,9#LP5,@0XB$SV'%R)#\A&,>5.$_B8_Y<\"YR<>5*4_B^7&,?C8\.!^
M\!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`
M<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`
?<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P'`<!P/_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g484784g67q95.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g484784g67q95.jpg
M_]C_X0`817AI9@``24DJ``@``````````````/_L`!%$=6-K>0`!``0```!D
M``#_X0,B:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+P`\/WAP86-K970@
M8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"(_/B`\
M>#IX;7!M971A('AM;&YS.G@](F%D;V)E.FYS.FUE=&$O(B!X.GAM<'1K/2)!
M9&]B92!835`@0V]R92`U+C,M8S`Q,2`V-BXQ-#4V-C$L(#(P,3(O,#(O,#8M
M,30Z-38Z,C<@("`@("`@("(^(#QR9&8Z4D1&('AM;&YS.G)D9CTB:'1T<#HO
M+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN=&%X+6YS(R(^(#QR9&8Z
M1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B('AM;&YS.GAM<$U-/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C`O;6TO(B!X;6QN<SIS=%)E9CTB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87`O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;7!-33I$
M;V-U;65N=$E$/2)X;7`N9&ED.D(T1C4V1#8R03<S,#$Q13(Y.#<S1D$U-3%#
M-#0X13%$(B!X;7!-33I);G-T86YC94E$/2)X;7`N:6ED.D(T1C4V1#8Q03<S
M,#$Q13(Y.#<S1D$U-3%#-#0X13%$(B!X;7`Z0W)E871O<E1O;VP](D-A<F16
M:65W('8R+C`M0C4V8B(^(#QX;7!-33I$97)I=F5D1G)O;2!S=%)E9CII;G-T
M86YC94E$/2)U=6ED.CAC-&0X8C`Y+34U-3<M-#4W.2UA,#$R+3`R,F)C9F9B
M96(Q8B(@<W12968Z9&]C=6UE;G1)1#TB=75I9#HU864T,6%E-2TX93-C+30U
M.3<M8F-D-RTU.3!F-S@T,#<W-6(B+SX@/"]R9&8Z1&5S8W)I<'1I;VX^(#PO
M<F1F.E)$1CX@/"]X.GAM<&UE=&$^(#P_>'!A8VME="!E;F0](G(B/S[_[@`.
M061O8F4`9,`````!_]L`A``!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`@("`@("`@("`@(#`P,#`P,#`P,#`0$!`0$!`0(!
M`0("`@$"`@,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P/_P``1"`,J`G(#`1$``A$!`Q$!_\0`P0`!``("`@,!````
M``````````8'!0@$"@(#"0$!`0`#`0$!```````````````#!`8'`@40``$#
M!`$`!`<)"0T$"`8`!P4#!`8``0('"!$2$PD4%197EQA8(=15E=77N-@:-5:6
MUA=W>)@*,2(CD[1U-K<X&3EY.E$D-%E!<;)S="6U=F$R,[,G-Y&!H4)$)L<1
M`0`"`@(!`P,"!0,%```````!`@,$$042(1,&,0<((A1!43(C%6%2,W%")#07
M_]H`#`,!``(1`Q$`/P#O\4"@4"@4"@4"@^6VE^-^BI]K].:3?68*52R13O=#
MTY(#+LZY)$W26[MCL4E7*V)=.V79,V:26%K6MC@GACCC:V.-K6"T_5!XP^9.
M'_QA_P"6J!ZH/&'S)P_^,/\`RU0/5!XP^9.'_P`8?^6J!ZH/&'S)P_\`C#_R
MU0/5!XP^9.'_`,8?^6J!ZH/&'S)P_P#C#_RU0/5!XP^9.'_QA_Y:H'J@\8?,
MG#_XP_\`+5`]4'C#YDX?_&'_`):H'J@\8?,G#_XP_P#+5`]4'C#YDX?_`!A_
MY:H'J@\8?,G#_P",/_+5`]4'C#YDX?\`QA_Y:H'J@\8?,G#_`.,/_+5`]4'C
M#YDX?_&'_EJ@>J#QA\R</_C#_P`M4#U0>,/F3A_\8?\`EJ@>J#QA\R</_C#_
M`,M4#U0>,/F3A_\`&'_EJ@>J#QA\R</_`(P_\M4#U0>,/F3A_P#&'_EJ@>J#
MQA\R</\`XP_\M4#U0>,/F3A_\8?^6J!ZH/&'S)P_^,/_`"U0/5!XP^9.'_QA
M_P"6J!ZH/&'S)P_^,/\`RU0/5!XP^9.'_P`8?^6J!ZH/&'S)P_\`C#_RU0>]
MKP_XOYN6^&6DX??'-=''*U\SU^FV2F-KVZ+FKVO[E_\`IH++X6860XRZP:89
MKY-QR$J%,L7#ER\4;C1,YDPT8SQ</%G#E1%B/:I(I]?/*^*:>-NGW*#:2@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4&D7&K_\`3('_`-X[L_KYV?07K0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*#DL_\`C&G_`(E#_P"[C05[PR_LW:]_\3.OZQI=0;0T"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@TBXU?_ID#_P"\=V?U\[/H+UH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%!R6?_`!C3_P`2A_\`=QH*]X9?V;M>_P#B9U_6-+J#:&@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4&D7&K_],@?_`'CNS^OG9]!>M`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H.2S_XQI_XE#_[N-!7O#+^S=KW_`,3.OZQI=0;0T"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@^:6K=":.G
M#/9$HFFGM92V2DN1')O`C())"(X:-/L!^_\`8HUA@[)D1SAXXQ9#F:3=*V>=
M[)HI888]&.-K6"S/58XS>SWI;T9P_P"2*!ZK'&;V>]+>C.'_`"10/58XS>SW
MI;T9P_Y(H'JL<9O9[TMZ,X?\D4&-U/K;7FL^6.3'7,&B<#8FN-CQX890^/BX
MXT*O&&UFK=B[(MA+9JB\=,T'2N"2BF.6>&"F6.-[6O>U!EN-7_Z9`_\`O'=G
M]?.SZ"]:!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0<EG_P`8T_\`
M$H?_`'<:"O>&7]F[7O\`XF=?UC2Z@VAH%`H%`H%`H%`H%`H%`H%`H%`H%`H%
M`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%!I7H7^BT[_2*Y3_`$C=G4%V4"@4
M"@JF/?VNQWZ,9?\`K;'4%'Z9W'!H!`$H9,D]A@I,`G&XT"HQ726\"'8Y/=T;
M#+,E47X?7!$6^:/1I%%=%=NNJBLDICGAEEAE:]PM+UDM0?"<^]`W(+YJZ!ZR
M6H/A.?>@;D%\U=`]9+4'PG/O0-R"^:N@>LEJ#X3GWH&Y!?-70/62U!\)S[T#
M<@OFKH'K):@^$Y]Z!N07S5T#UDM0?"<^]`W(+YJZ!ZR6H/A.?>@;D%\U=`]9
M+4'PG/O0-R"^:N@>LEJ#X3GWH&Y!?-70/62U!\)S[T#<@OFKH'K):@^$Y]Z!
MN07S5T#UDM0?"<^]`W(+YJZ!ZR6H/A.?>@;D%\U=`]9+4'PG/O0-R"^:N@>L
MEJ#X3GWH&Y!?-70/62U!\)S[T#<@OFKH'K):@^$Y]Z!N07S5T#UDM0?"<^]`
MW(+YJZ!ZR6H/A.?>@;D%\U=`]9+4'PG/O0-R"^:N@>LEJ#X3GWH&Y!?-70/6
M2U!\)S[T#<@OFKH'K):@^$Y]Z!N07S5T#UDM0?"<^]`W(+YJZ!ZR6H/A.?>@
M;D%\U=`]9+4'PG/O0-R"^:N@>LEJ#X3GWH&Y!?-70>YMR5T\FX04R*3[JIK)
M9Y?_`('Y`V]S'/'*_NY:LMC;W+?]-[6H)YPY:OF?&_6V!`:6$.'"4I)8,#H@
MH`+),RTWDI0:H]"FV8\N-4=#GB2UDG*"*V.*ENMAC?W*#9J@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4&E>A?Z+3O\`
M2*Y3_2-V=0790*!0*"J8]_:['?HQE_ZVQU!M]0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0:5Z%_HM._TBN4_TC=G4%V4"@4"@JF/?VNQ
MWZ,9?^ML=0;?4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4&E>A?Z+3O\`2*Y3_2-V=0790*!0*"J8]_:['?HQE_ZVQU!M]0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0:5Z%_HM._TBN4_TC=G4%V4
M"@4"@JF/?VNQWZ,9?^ML=0;?4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4&E>A?Z+3O\`2*Y3_2-V=0790*!0*"J8]_:['?HQE_ZVQU!M
M]0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0:5Z%_HM._T
MBN4_TC=G4%V4"@4"@JF/?VNQWZ,9?^ML=0;?4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4&E>A?Z+3O\`2*Y3_2-V=0790*!0*"J8]_:[
M'?HQE_ZVQU!M]0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0:5Z%_HM._TBN4_TC=G4%V4"@4"@JF/?VNQWZ,9?^ML=0;?4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4&E>A?Z+3O\`2*Y3_2-V=079
M0*!0*"J8]_:['?HQE_ZVQU!M]0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0:5Z%_HM._TBN4_TC=G4%V4"@4"@JF/?VNQWZ,9?^ML=0;?
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4&E>A?Z+3O\`
M2*Y3_2-V=0790*!0*"J8]_:['?HQE_ZVQU!M]0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0:5Z%_HM._TBN4_TC=G4%V4"@4"@JF/?VNQ
MWZ,9?^ML=0;?4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4&E>A?Z+3O\`2*Y3_2-V=0790*!0*"J8]_:['?HQE_ZVQU!M]0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0:5Z%_HM._TBN4_TC=G4%V4
M"@4"@JF/?VNQWZ,9?^ML=0;?4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4&E>A?Z+3O\`2*Y3_2-V=0790*!0*"J8]_:['?HQE_ZVQU!M
M]0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0:5Z%_HM._T
MBN4_TC=G4%V4"@4"@JF/?VNQWZ,9?^ML=0;?4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4&E>A?Z+3O\`2*Y3_2-V=0790*!0*"J8]_:[
M'?HQE_ZVQU!M]0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0:5Z%_HM._TBN4_TC=G4%V4"@4"@JF/?VNQWZ,9?^ML=0;?4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4&E>A?Z+3O\`2*Y3_2-V=079
M0*!0*"J8]_:['?HQE_ZVQU!M]0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0:5Z%_HM._TBN4_TC=G4%V4"@4"@JF/?VNQWZ,9?^ML=0;?
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4&E>A?Z+3O\`
M2*Y3_2-V=0790*!0*"J8]_:['?HQE_ZVQU!M]0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0:5Z%_HM._TBN4_TC=G4%V4"@4"@JF/?VNQ
MWZ,9?^ML=0;?4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4&E>A?Z+3O\`2*Y3_2-V=0790*!0*"J8]_:['?HQE_ZVQU!M]0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0:5Z%_HM._TBN4_TC=G4%V4
M"@4"@JF/?VNQWZ,9?^ML=0;?4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4&E>A?Z+3O\`2*Y3_2-V=0790*!0*"J8]_:['?HQE_ZVQU!M
M]0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0:5Z%_HM._T
MBN4_TC=G4%V4"@4"@JF/?VNQWZ,9?^ML=0;?4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4&E>A?Z+3O\`2*Y3_2-V=0790*!0*"J8]_:[
M'?HQE_ZVQU!M]0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0:V..*>KE"1TDQ,;FC]Y'(Y%+20V+<@MWQ@#:02PR]D,C?#X^#GS$.)L6.$
M7#I1)JBBC95;*^.&-K]%!X>JIKS[\^0WZS_(3YR*!ZJFO/OSY#?K/\A/G(H'
MJJ:\^_/D-^L_R$^<B@>JIKS[\^0WZS_(3YR*"6Z_T'K_`%M*'\U"+STQ*2$>
M2BF9B>;3V3L=PTCR9/(S<6+3G4ID#82@N3RLLM=M@EFMEACU\KVQQM8+IH%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%!UZ^>6[>9FJN\NC07CD<D@Z.;*T5P0U#=S
M(X9,]G::A)#=7/'94!VELKR`&R"-QIW/8UK;-LLJ[S>-5DV*"-G*N+;JWL&D
M[WO7>\^UYI`G/=I7UDT(275.H),`DF'%;8PYAK:3W[T4%P7F#4I$D-B%B^R2
M>P=/O\IHB%:*#GZ+U3%(?91M=/+()O*.],[QT1``Y(>."Y,&+;E<^T/N#+A5
MO,\/[Q6;:@VW'(AH#2@#6X62(&..#W>$2)OE[%WBSG$EDU\8B\<&#=UAD$M6
MY-]Y/*ME<5MV[9VH4U'I13O6.2&AI)I+6W&R6%GS'4>K(AR3C>O(]MB5BY6_
M>;)2VM,(N*#"G:`T2)L6>CGZ6:ZR:76"LN/7>==Y]R/V!#]1QQ_'X@RV=M[7
M343N^;<+9G'%X=`)QQ1Y5;5FH-_JYSMH@*3(ZXW!HX4`16=2%99F\?J,2>3A
MUT)T&Z_=3<DN7?(+DSM"7\GYC(@`[:O=^<`-Z0C0*VKI9$X'$YG+8O.&6\RV
MOCD@>OL6"PC8"%D#`U510EGF49X+WZ@Y*^0?'3C#R7[V?1L`XGWDD;W[R(D<
M5X-\[^5.HRTHPV>>8;.>31EKGR;T;OV/6(>5NP=I<;)R)-O@S-93(H:BY9BS
M&*-W>6>-@W$-\R^=^Q-G<=32&Z)%*..<;WMRKU8-W9!N,6V-*0WF.R=<%&>Q
MX$.EFO2<A=2.#6B>[WIR%BC*+E$:^+L<737+%^QSH,]ICO(>?XB#L!N4-=+;
M,@O"[6LITQPX><5.1.P)5R4<W[O6+;R4W,0Y1.)J[:PIG;D:N^AC@:7L0?J+
MC+BG"JATDW=8!<;'E5S1Y"=S#WDNSI>>;O=L133.[AVA=EZ&ANU]2;`*/TM"
MB9%V;:,$Q0LL+G\'V07?#&;V-NWB6>#9!/)1,FW>X6#2L9OOG]P@)\E1(P/-
MM=EW<EX-QG*(S"?\H.<NFM9:)F@'9KW9W/F![0WGEA*G:LJFUQ4%D,2Q9CQ\
M-(LT")!%VBX1<9A>)_O6N\#C.R..@39:.K]:+S$KW8L?(P`%QOW=)A&^PW+C
M:[>*;[V=#=HRI:+JZ8S@K*[<<,C,A$^-&SQ[U%[.%70[.X136O>C=YGN^2F]
M>0'(3&[[`Y`\.(CK_:FP^%DXBJFK8?OB?\DH1O$+(]4N-L$L3CK2S;6,>6OX
M9(FSUB0?9I%%4\7&"2`45OSFKW@DWG\_-R`W.EICJOCWWB4?DO&B"Z6Y%Z@C
M>K93">3W&;7^CKS&=QN;L&.[Y1LK4@YQ,01,&Y9+#FQAY9KGDP==6X;;[L[R
M7O1M3F]\2Z-PF%3^$M]E]YKJ_6$"MQWGMC&O@'$:9PEOJ?<AZ3")I=[L]$U$
M)"6>*!6C`=Y0H"DDARUW2F>>07)$.7G+ODGW;/?"F(1MW.7[JXWDM[ZPXU;B
MU/H>6:EF<P91?B9J?;$:.A]3R$N5DXJ?2.13=^B/<HY^XHLV=L4<D[(89!J]
MHWEIWC&L9CL7:$#E!OEQKC8_)F+ZPCNMYCJ#8X<Q/7%^YZB.^P<^US(RDNR1
MU-$#F_-=-PRH1`.HR<&#I+)9S8@NGU`WNX(=X?R:E?"3E;RDY5!HS,\-%1'&
M<1%OK75&U]?R\\=:Z:83R=:7*P"3`,\GLGA^Q7%P#!0.Y(K9V7P:D+)D6KFZ
M@?.7B;R0[S#AAK[>`K>,"Y12R6A(;Q=[PJ6@-_-`^XI1-]=E3(G7_>6:FT*9
M@>S]CC(>P@#UTTE6O8ZX=LRB*.2K?(.W25O>X;"E>\F[PZ';KX(0"9QA%,MN
M);C%)^1&MT^+LS;QJ.Z^Y:;AV`)?8BMV)3M3)N>XW0->+B2]T@F#-H>[50DZ
M5L0;-6X:DZ4YN\X-6:=EVPUWNX(I,MFZ;[K6)1A"0Z=V_P`@H=KV72_6G+@]
MLOQ?'-@[,8KPLA*ST0!C2ALF0,.E"3MDU6:NGCAEV03#CAW@_>`'N4,4F)+&
M29G>3S#NJW,HXG&M#;T+1-=CM70UD.8$DU'LAZ>PB''EMH%XNYD9E@]1=+J.
M6>*!%3-1=#*X0KC3O/G?*I#I#.V6Y`9O:D3X+#6R1FV^I)'=6R@YW</>,2F3
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M%7P]'%LP:)W52'(X]"%@N6!D.]>XAR0?H`9)`>VD(AQHYU<Y+:U)([8Y.&3Z
ML=VT$8\9.!$'Y3;.*PR<F';81,4FRDF.#'IIPDUS0;,KI8I+IA0\A[U+O)Q7
M'^<374+$-R;V("G.D1NI\1G"K=>L6V\C>Q-*;0F7)_2R,`.R1:3Q]_PD6C3"
M2K2.SK%J5QOC%7>%S2]EJ#>_BWS<Y7[2YM1#B(0D,9V%"AL$9<R3F_T]2/M=
M);+X8[.TE"@&DA@^*/R:N4&VB7Y6$I2B0;+XY.VH*)YHJ(X+***V#X8=XEL'
MO+Q&W>]BUCIV9\LVT#Y$;+V&^U?,H9(MF-;<?`W`#C+J[D=(QNH20YU@YA0[
MD>]V`A'>H$NBF6=LG"-NNK92U@V<Y:=XIWBTN]=[1NE3.R(='X?QOY`OH;+A
M/%J?1/;&K9YQQDW'N[5M%Y=C.Y*1V&_VWK>52LFF34:#G+YBV3(B6*"*?\*%
MGROO2N\X8/.<-X9'M=2%OI#5FVB^H`)?C_MT;*S8N&E-/B^/?(9GBS'N8U,(
MIR7&3$B8=`\R`Y9FV722%754%$\<PR?*/FKS_P")$HY;1$,?*3C<@B8Z$C<0
MVH`XI;0G6LMJ24?P@EVVRP`3`G.[7\-TLUG&T1@T&UQ#9E79#/MVMDERBEGR
M(4?/>\@[Q#3GY7]SP@=(;A-K<B=:3$G"S.G-P;D,#QQ+NW.$FQD=1<;(V:)Q
M_7@\6:VQ*I0@I'G<C`F31?%1,6XS?)DLJ#Z0]ZO,.8`_>?=^[`XX7VT7&0_6
M/-;D,9XUQT7.P+#<^W-*\>AL_P!)ZRVRM!9<(=YMSLM=YC$0+U1\U</L\\,4
M7:W4QL%&:CYW]Y'NV<:2U+KK8$&.0S8W**)Z^=\R2G"K9\$CK^%*\1]G;[W%
M!6FE)O/0[X<?U7LR#,8JA)%2F`_P@VFR<H+DA[O!<.#WGL_YM!.=$SU[J??.
MTH="97!^ZP+Z7A`#7<X?0I.2$.\>0AV_9`K)H>:")%&L8A.;!::#%'C10U&3
M;=DXR29MNU4".E>\N[TH'LC2&JU87K6ZJ6V][ZM)['DVAMN"8IRDDVIN=!OC
MPQB8=I#?+YWILJ3X^C$)A@JCXQ17=/TWV*E@S1YC07#WU,[YI3K;FO=*<*(Q
MRB?2#CCH>?<UI,8X]R$##`IW;XJ0,([QAU?M4G*MAZT83G5<A<1:9+R>,#EC
MI)VWLPS\4KXY87H('->\ZY^'3\WWAIL$'4XXN-K0?6^M-42/CC.%-CK1O:O=
M;$.8#78)N<YR,<JF[USOL8C&EF%P/@ZRJ[EDX6Q<60Q3#FZU[RKGYKTOK%?D
M\SCYK6KK9W`.0;BV1!^,&S0F$'U1R\XA[[V!.(;Y-AC>PS"ZNN.0\%BP5(VF
MGFX2N;Q:/6Z:BR5\0J>"=[!S^F,LX$QN01,L/7W;!M!M^2D-=\49Y#F@M'?C
M?>(\[LN*;64FZKT(XUZ;C,88W9W!MV(@F\4:OG+IPZ0P;!Z>1AWF\1[H3N3I
M%JZ;\BF/(IF2T+M7;#T9(-AH3[8#K3W"O=>\3D&W2YQ=8G)"&V3-M?,A!9F=
MR51?O7R::^.:V6%KAJ-J_GGWI&FQ&^]M-FL]$-N57)(/O0<?Y$0G<&W(3QEA
M.V^)#7D1H_C@!@X;%\1B0612&1,(J^S'(9Y-GHYPQ;I>-G;:^`;>[\Y[][%L
M(QSQTM'HN!TE((7Q;Y"D83$(/J[<)/;`A2'<5(ELN!;PTMLE6.)")0ZV1MXV
M3C8YL1P$.&>&*6#1',X,=MG`9_7_`"ZY_D3%X9I2>M'5MD[ODX=QR'GN@=I3
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MJL[>+M\7#AKD@QS43P9-U&[@-G.[\Y8<M^0.R]N`-V1F'`60.)DS"\11!R,/
M(-+[,;[#D$9&ZHD+KQ)B.>L745')O,\G[VYI95OF_;)J"W[6Z`:E:[W@:UYI
M,-L6&G^7>P>\6#::EY#E/KR7-MVSW64,V"E83ALV1[>TT5R3AX.+:OD&;QWK
MH1`,0Q"3C6J;43F[&N'*^(962<U>>;P'.7FH)I#YY$-5PS>$^@^Z2'&268">
M4K'7<IXKBXP/:QA&5A+@!?C/;LQ!/2(53+$YG&,7HRS?#!Q:X1*2<J.:L`Y-
M2UH5V4[,RB!B#FK()![Z"GJT0Y:G@')5NVC@`0Q!GG,0UC.S.NY<HS=&FV2R
MF39A@5OC@-'$4,@L+77*_G<S=J'Q`(84@\+V7JJ`H:7=ZKEN1W9/Y7I+NX>:
M)X;4D,L>E0.0!X"`*LU;-W#)K91?%SUF[AOBU"!:\[P3FS,=:#2.QI-!]71>
M02:)LYKO89H^?3AUI:4GM,["F9C1IW7@UD%;-7V>S`(8`T<K/7)L3F]S%DL,
M"ST4YS#;'9&.]S'=#\<9.$V;NN([>#Z6X:RR:/HMD\:[-GQ>^.J<9C&IF2D(
M@S/AK4Z\?.%SUFRK$XO@FJW<.\4E'>"H:5<I9SOD=-.6%X'*^0ZO)07(.86$
MA@X:3[>&P89Q1#\=%2'&LY$!37MM:Q5P2VAY+X"9`&:V-N3S\XCDJXR2(()A
M/]S[0Y5\E-2L6C]C.8SM#5\ZU7&MUZKC$DV5I"-,-G[>Y\Z@UE^1;/8NMDBD
MJD.NH+I"%R:ZTU'8/?'`"1MCZ35LB\19HA89^W/_`(C.)4!U\0"EQ!+6W*KE
M%&]*,W>Z.6K.-I:>C_%^$0/1D;W-M):+;/-(SV32V43%\.2'HO%%.N*!I)=%
MU\@B)WGSRY#CP^&O)8(WE!_RSO869WZPXQ3L(PQXTYPO3TAVKRS0AS,GFF_Q
MXKSZ6.XJH+:YY-Y=F5Z44[.(Z6NJ&_O%7?O(+:NY>16M-AB6J`OBL4D6LI45
M8Q;$(OM+8,OE+[8^HC<-?OB>0-(8.XMDHB]*)VS\'4/2E1*^:>+'+&@^+$<V
M3OD)!)FVA.[-[IRIE'M,2S:^[L"7(UU)(+B-Y?\`'89L`1RKXX;N;32':7WD
MOKXY(^WPU]*U`;L`,.]H)3#(BET0M>9<[.76RMW/X"-GTAUSJX#OG4\H.2$?
MIE]')5KZ&PCGSJW2TBU]-VZ3Z1L`<:G&K9AD4+(F2;LJX&MK$LVXT2]\%L%A
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MU]HE7`Y/`&O69LDT>NGIHPHYL\#D56KQODLK@FW1?7N%4M.;?(B3:D<[UN]V
M-''VMAD2T4O*BVKPK>#&9EN/D`1;R+;CE`?-5M3D(%$M0ZX!6$[`NN["87DZ
MKS`/ABZR%6"'`.?O>&RK2[K;R(J/"F,7@G'</+VV>F)"'18/MJ<D.06I=F;X
M(OY7V+\6(UUKK4@8S8;F*P8L%SBA`ECB,3P;XA]H^&&R]G;?XVZYV%N!M'T9
MT=M*4W;V+LC0T+(0@B9R$)$9:U''AHIXS4EL3&LB2UD4LAV:SG-1@JLQS;JY
MAM'0*!0*!0*!0*!0:J[NYD:7X^;$UWK392TR'F=FE(B$`%Q\*.DHDW,[`E^$
M`@H@C)D6^(VY:3S-5-@FU:Y.G#.ZR3A[@U:*IN,@UUW3S+X1[,U(Q<;$C\JV
M_KVXSC]O/Q`.UM)SB84@3DDFV9J-]);XIL!T0EL/D6C'A1PS+.F2H]V.;HJ8
MW<.VC=P'F)[SC3YN0X.H^R(375;J`;`V`QF\'#S4R?<M(T/X=%8B(1@SJ'#R
M"[J8"^7@]VN\[?`:&;-+9/%T[>&78AP8GWK/'Z7;#"A!HF>JZOD4!UO)F^WF
ML*EK^.PZ43G?^Y.-Q.);<S9@5A.MF\>VAJG`;8FZ?JM':S[-;'JCVJC[(,IH
M?O1N.^W2.EH.>?KPC;.W`L(\(B^.#PY%XCL+8,/=3^*ZJ*3CQ>+:*3,W#FEW
M[9*[9-/)-1!-3-)PY;(K!G^2?>3:/XW%MK0LT!V-(MEZZU7M'8P*)LH:;&CM
MEE-5:A+;N.0:&RA\QNS?E;P$.N\S?IHJBDK(+HV<*/6ZK2P6[/.96F]2PN+3
M7;*TG@#.4:I'[<29%(L9=O601S(-=14D'<)#6KK/*3Q^0;3#(O6.%KKI)+Y+
M=7LDE<L.F_;_`.T7SC[GS%/AFOAVLT[M-6:3FQ8[5RY-7;W,<WC):OCCOAT=
MGQR3,5G)C]OGSM2+4MK?UM+_`-B9K'CY?29](M6L_3^/-H]/Y3RQ.'/+C1C)
M7,5?S1\&(H;=?:60<&8Z9'B2<H'1F?29R:%EE6O@3V!6QU<>'XGL<_%F9<=F
MRLK=?-+'/16_';[JSU5.WU]#'GUK=+3M)KBS8KY*8+Y]/!7%DQQ;SKN?^?J9
MIU)CWXULU<\T]NMYK%_EM'S]N;3%O<\/6)XF8BT\Q/\`M_3:/+Z<QQ]6'!=X
M3QGD#6/9-)#*FI>3Q(W,142*0:2CI?=D$VO&M+9AW8!PQQ>,945GTO'H,!BO
M4>/6J_A26&3?#-3&[V/XT_=;K<VS&;6T[Z6INXM;)L8]O!?6\LO7Y^T]RN:M
M_&^OCT];-?-GKSCQ9*>S>T99K6?-.XT;Q7BUO*U9F(FLQ/I>*<<?SFTQQ'UF
M/7Z)Q.^8>F=<;86T_*,YPW/#K:XM(I&RU_*B6O(@MM\J;C^KFTMGK(<M'`+B
M<26/KC6>*RUNJ\S1Q6NEBNEGG\#X]]D?G/RCX=7YMU$=?;KLO[WV<%MS7IN[
M,=;CQ9M^VMJ6O&?-75P9J9\LUKZXXO./SG'>M9<O9:V'8_;9//SCQYGQF:QY
MS,5YMQQ'E,<1_KQS]5;0[O%N.\XM#'`=MMIN)FS77A!K(3&H9P'CL>&[E)V"
MZ2)3<P^%I-(:QW(5RP1`9D,D.ULLBJYLV0<(*J:GN_QB^YO03O8]Z_2VW-"^
M[2V'%V6IDS9K]9C]WM::N*F2;;-^LQ\VW(PQ;Q\;TQ>[DQY*5@Q]UI9?&:^Y
MXV\?6:6B(B\\4FT\?I\Y_IY_TYXB8:[OI[W7F[]SQGE+*-9!C&U8`\=CFVYI
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M/4I[F7+CFT5ODPX(B<^;'CL_R^GX5O\`K\K<\5\9\N8M%/'Q^L6FT\1$_P`(
MF?I$RK)7O/\`0S68'P3\#L9C'AD.UR2#2)Y$2@\A(]F3S8>XM<$-'HQ0NW&E
M0VQX6:TJ8\9(/\FZ2&+)YDIDFBTNLKK*?B7]Q<W2:W8:^QU>3LLN]NTRX:[.
M.],&CJ:76[M.UG8QVOCRZ6UB[36]B^&+VO.7!%8M?-%*0?YW4C)-)B\4BM9B
M>)];6M>OAQ/$Q:LTGGG^4_PCE:&U][\5ML\80AZ:@U-\Z0Y-MKZ\CVM16O#&
MPRVW%SHP^\*0A'7R(Y8@N1%BHL5<$4W*;>PS$4X4642R0Z;<TUOLG\]R?-^T
M^`]ABU>N[CI,5LV_DW-G#KZNI@K;#2,^79O?V_:RWV->F"U)O.:V?#&.+><+
MD]CJQK4VJ3:^/)/%(K$S:T^L\1$>O,1$\\_3B>6O>F.3W=Y\5M=R6-:9B,GU
M1J,8I.Y^:D;/3VTF<?E>QPD&0V)LR/O9+(@RTEE^]`D'%=J2&O\`)8S;Q4L/
MQZ[H:X:-M?@_%O[M[6SK]=K8>KR=UL[&#'&K3LM*^>F+:VHTM7=R5IFM6O7[
M&S-,>+<\YPS7+@SS:NOGPY<D$]WH5B;S-XQQ$SY>%HCFM?*U8]/ZXKZS7Z^D
MQ]8F(V9U7S>TKMS8[?5`-EM&.S1P^G`*S&?:JFL)9I2_7+4*6ET'5+'!;<;Y
M6#(O)!YBS;%7+!88[Q434RS3632^%\O^P7SSX7\7M\Q[#)U&ST-<>IE\]/L-
M7:M.MNVRX];;C'BR6O\`M\FQ@S:WG-8FN?'-;5BML=KR:_::NQG_`&](R5R\
MVC]5+5]:\3->9CCF(F)X_E/_`%;?UQ-](H%`H%`H*A$Z#TX$W5*^1HS7L?;[
MRFT,"ZZDNSLT%G,J?0./N[$!<1;OG:Z^(J/ID<,'*S5GBW2=.4DU5[**))Y8
MA;U`H%`H*A@^@]-ZWV-M?;T(U['H_L_>3R.OMLSMJ@LM)IQG$!RPF+-2Y5XN
MY<XBH\R<K69LD;I,VZCA=3!*RBZN>86]0*!0*!0*!0*!0*!0*!0*!0*!0:R&
M>&7%B0[_`!G*8YHR`$^0`=44[8;-=B;JG,"H`"0BT?D2[>ZWBA]+([&"KD:.
M+KME";`>OFW;KIHY7PH-FZ!0*!0*!0*!0*!0*!0*""P'6<$U>R/CX%&V,<;R
MJ7R*?2;)KFZ<.C\RE;NSP](2[]\X=/R!%[G@FG;)53*R#5!%NE;!!%)/`)U0
M*!0*!0*!0*!0*!0*!0*!0*!0*#2'>O`+1_(/<<>WA-"6Q1DP`XZALHWBLG9"
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MVT6EGXB*S40XD1^2/%=?E=;NW,M>`3\*'%D"@4PH\=M;M+-E3+=F\PP2S:)8
MUU?[9?=7LOMEA[3%U=,\V[77Q8<LTS4Q^-,.SAVJ6IYZ^>:YHR8:TC+6:VC!
MDV,/$USV4=S1IN32;\?HF9CF)GZQ-?7UCTXGZ?SB)_@H.0=V/K23QB'Q`P8$
MKAH-I*/:`!]E'9<@04@,8G$3V&-=%26.U+NB<S5DL1QR<F,[V=N6Y,FEG>]G
MZU[]:ZW\L/E74]MO=WHX,U=[L._S=QEYS:TTC<SZFQI7KCI_C_''JQ@V9BFM
M']NE\&I>OKK8U"_18,F.N.TQXTQ1CCTG^F+1:.9\_6W,>L_6>;?SE/"'`^-E
M-P_ET>&HIGL"VTHCN'!=.#R5$(E-(/K<OJ\#DD$3VIBW3!V#&<B#AC;+L7!]
MLV)9?[PAA>L[K?D1VNI\)_\`GV#!N1\;_P`1L];,3M8)RSJ[6]CW\W.6>O\`
M*<ONXHPTR\>5-.^75C^UDM":>II;9_=S-?>]R+_TSQY5K-8]//Z<3SQ_NB+?
M6$$(<`YU+-VRK9\_Y!DI/'BP'0K%.%YQ\DR`S`[HPM.Y)'9!M$"+E8M@??!9
M1*&A!A=FJS1578)8O47"2*:=]#K?D=\?Z;X%I_$_C?QK%J=GAV.WO.U[U+9M
M;%VV/4P9L.AFR:^2^&F7!KY,.;W*Y+5IFO."^*][60SU&7)M6SYLTVI,8_T\
M3Q,XYM,3:(F.>)F)CCCZ>L3PRB7=UB&JD"P';4+"0\$B&DH:M%1@8RA%-A,N
M-ZJ3O1A;:`96>.,91(->$FZ+I%9'-B@24;HI$D7K9%)OA4O^3>[FKV-MKI\.
M;=['=[39C8OEQ3L:=N[B:]MCT,L:D?M\.[2;8[5M&6V"+Y+ZM\&7)?);U_AJ
MQX>.28K2M*\1$\6]O_CFT>7K-9]?X<^GE$Q'"L97W7_A,1`ZOB,\C*6N#>[-
M9;HVZC+`,\,G3TJUSFX)2&;A5L=F7Q<['Y"N;6%[%?/5K-9`*?/<\D+.%U+K
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M26RJ1BSNQWTDW-+4WJKIHJ'>CI`Y:*CLDDVEFVBT_P`M>ZT[98IU.&=/+?)'
ML1FC%BIJY-/1T9Z_%&OKX,F+2I@ZSKIQ5QY*[.+-IXLU-J+VS>[%;HL=N/[D
M^4<>O',^46M;SGF9B;<WOSS'$Q:8\?IQ:)?A,9*P:"P)#><A`,]6/(R9U=)(
M]'W3*::^E4<&3`&ZF`$\ZF#]-X>F8*>%&)Q,HW(C'C1QV23-OCC:LCI??O1T
M_D'8?(LGQ_6V<_;TSXM_!FS5MJ[FOGR:V6NMFPUUJ37#JY=3!EU+8+X<^+)3
MSOGRS,I[=7:V*F&,MHC',368C]59B)CF)Y^MHM,6YYB8_A"KWG=@1,BP,`B6
MV9B6BAAO+'.4..N9M(@`^;SZ&*P"=[;9J2#9920NMIS"-/'F+T@_?O6EGA-\
M\0:(NWBZV6NP?EIW.MLX.PU>FT</<8+:]?W.*NKAS7U=/:C<U.NM&'1QX:]?
MK9ZXIQ8<.'%DG'@U\&3-DPX,=(@GHL=HFELEIQSSZ3Y3'E:OC:_K:9\YCGF9
MF8YF9B(F9E>X7B.Z!;)9;593H)>5,ME;&VLG=6$&U!MY3M2%QV`2W&[.^RNG
MQ7>.1AM9FCU^LW<==3+-2V5L;<\W_O1B['XMD^'Y^OV/\/DZK2Z^>-K%%_V_
M7[6;<U_U?L?^3W\^2<EN.+T\:Q6O',VZ]=-,\;$7CW(O:_\`3/'-ZQ6?^[Z<
M1'#;>.AU@(E`6N<-R-5%P07R+R%9BN67L_(NR&#=94<P&-+MQR;JS9O;%''+
M%LBG;.^>=LL\N$/ILW0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0:<;WW]R9UG.
M$8YJ/@?M#DA%%`(\FIL.'[LXTZ^$(%W3H@B\C>0';6TH=*LW@Q!JBMFXQ9W:
M*8NL<4U,LL%+8AR-![YY)[/F)`!N#@SLWC3&6L?=%&<[F6Z.-^Q!9,RB_'-F
M\81":AV?,Y*W>O&CI9SBY6:X,\,&N6&2ME,T\<@IE[RZYPMWKUNU[IW>Y!JW
M>NV[4@ER?X0H)$&J#A1)L_20=;Y2=()/D<,5<<%<,%<,<[6SQQRM>U@NYIO3
MD:OH$CM!QPBV4RW"TD%A;+C.IN/CHM,R@>YADPO)T-B-]F*:@;,L1CA5_P"#
M+&DWG9-\D^S[;+##(**PY?<Y\L\,<NZ4WUACEGCCEG?E'P<RMACEE:V6=\<=
M^7RRMA:_3T6]V_1[E!>N_=Z<C=82"/"M/\(ME<EPQ6/^-3,GANY..FNV47,^
M&K-O)AZ-V]LR&&23WP5/%QX2S079]12V/:=>U\;!@](\AN46QI^TB^U>`&UN
M/4.7%E7KG9DLWGQ?G@5B_9))YCPZL=U9M>6S!9P94SRP35399((WPO=7/"U[
M7N$`D_*[FF&DTC#@>ZTW?,`0D\8&!)</Y*\,!+"5"&!%RT&25B*/;Q'G1C,Z
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MO2:9DK%2#=)DGX&Q7NDHXQ44ZJ6.>>(878'*+F)%IQ+(W#N[+W/LV*`SKX;'
M=B!>1?#Z.")J);9VQ:R(:`F&Z0LK#M"&/[[!N19MG:=O<S3QO061KG>G(V6Z
MSVC,)MPBV5JJ=PQHLO`=1G=R<=9,?W"Y3$JODF4>E,*V6=@T35<$<,65LSY`
M<GBKG93+*R-KYV"A[\P.=/1T_P!TCOJ]^C]SUI>#7N__``__`'[T4%];1WGR
M+AD`U9*(#PDV3N*830;@\V!K./[CX[1,UIM]D('OLQ,AD4]V7'H?+5TR3I9C
M=4`](H75:Y*6S['-//(*[UQR>Y@2V>12,S;NTMRZJB)LNDPD.R#G(CB%)P\+
M&J)*YJ'",?A6YSLM+MD%,,<+HCV;ES>^=KVPO:U[V#F[7Y*\M81L*2Q77G=Q
M[?W3#`[EFB"VA'.0'$V(!):@N,8O'+MA&]@[AC<R%X,7[E5GEB^8M\\U&^2F
M%LDL\,\@G&G-Y<BI^`V63V9PFV3H<Q$`:1*#1J4;BX[S9YMHKFQ,N<XZ!(ZT
MV7*1$6=I.A[5O=P<6'M+YO\`#*RE\$ELDPH/#F#SJRPQRR[I#?>&5\<;Y87Y
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M&U@$`)E(\8F.X^.NPF\S,9.,TLXR.::DV7,GXAZFCC96[@@FV9WQRZ+*=:U[
M4%#6Y@<Z;VM>_=([ZM>]O=MZTO!J_1?_`&=-M^WM07R5WIR,9:#C^SQ_"/91
MG;Y0]<88XTM]Q\=6DRC(CQD69^4KW8;_`&6WU"19W8L6SOP=F:6=]F^PP[/M
M4UL<`I85RVYNO2HMD0[J3>@8>])CV9`RXY.<)G;<.Q=/$4'A=PT8;W</W:`Q
MLIDOFDW3474Q3OBGAEG?'&X6UOC?O)C6<V0CFH^".T.2,55`,"BVPH?NOC5K
MX2V,.G9%!Y&LP.V]I0Z4J/!K=HBMFXP:79J8NL<4U,L\%+8A[=![ZY*;.F3Z
M/[?X+[.XU1AM'W91I/9ENCC=L,61,H/AS9O&$0FHMGS.3-WKUH[7<XN56N#/
M#!KEAFIBIFGCD%-ON7/.%L_?MFG=/;V(M&SYXV:$D>3_``B;HDFC=RJBV(HM
MW>^$7;=)^AABKBFKA@KACG;'/''*U[6"[6>].1CC01/:#KA%LIAN!F?L+8<9
MU=Q\=5YF8#W+L&%Y,WV(VV8KJ!JRQ&N5GW@ZYI-YV3;)/L^VS3PR"B<>7_.>
M^6-K]TIOK&U\L;997Y2<'+VQQOE:U\[VMOR][VQM?IZ+>[?H]R@O;?F].1NL
M#T<&:@X1;*Y+""T?N4-R2&[DXZZ\9Q4SX8HWM&'P_;VRX87)O;M<,7'A+)%=
MGU,[8]IU[7QL&"TER'Y1[%V`RB^U.[^VMQ[AS@:5>.MFRS>G%Z=A1[YDA@H/
M$JQS5NV);,%US*N5TTU4F6:"-\>E7/#&]KT$#E/*WFB%D\D#1_NMMW3("(/F
M!8.8#N2G#$2/E8=@1<M!DE8"C^\!QX8R/,DL'23=\W0>(8*VP63P4QRQL%M1
M7>?(PWI&>;&D'"/94,VK&22C2(\>B.X^.I>6;(8XIA<L"P>>1_99+5D?05S(
M.L;)%R[->UV&=[X6LJC=0*%SY@\ZL<,LL>Z0WVIECCE?'"W*7@SC?/*UKWMA
M;++?ML;7RO[G3>]K4%][IWGR+UX-UV[U=PEV3O\`?2L"N3F@J*[BX[09?5I=
M-N(52C9QUL_9<48R5XX6?N4K.`JCYICDQSODI;%1&^80[4?)+EC.MAQV*['[
MNG;ND(65S(8FMHR7?O%&9!(MBU%O7K+-]&]<[?DTS)6*$&Z3/"S)BO=-1QBH
MIU4L<\\0P^P>4/,.+3F61N&]V9N?9\3!FW@Z.[%"\BN'\;$344WRQLVD(T!,
M=TA)6':/K7O?!`BS;.L.C]^GC06/K;>G(R7:VVC+IQPCV5J><PMDLX@.ICNX
M^.LH.[B=)B%WR3"/2B$;,/0B)JKD4L&-LS[\<EBHI92^5D;99V"A[\P.=/1T
M_P!TCOJ]^C]SUI>#7N__``__`'[T4%\[/WGR,ANOM62F!<(]E;?F4T')NY_K
M`!N/CK%#>FWN0AB^S%R*1SO9<?ALM72).56-U0#XBC=5ODI;+L<L,\@KK77)
M_F#+)W%(U->[0W+JN)&S"#"0['.<B.(4F#PL:I@KDJ=(Q^%[G.2TNU;988XW
M0'LW+G*^=KXX7M:_0&1VQR4Y:0?84EBNN^[DV_NJ&"%V20/:$;W_`,3H>$EB
M+@6Q>NG+"-[#W!&YD+P'OW*K//%\Q;YJ*-\E,+9)9X9Y!-M-;RY%[`![));-
MX2[)T*5B`-(E!X]*=Q<=YN[VR6S9F7"D=`O]9[*E0J+NT7(]JA=P<68-+Y/\
M,K*7P26RP"@\.8/.K+#'++ND-]IY98XWRPOREX,Y7PRO:U[X7RQW[?&]\;^Y
MTVO>U!?,PWIR,`Z7U]L*-<(ME3G:$I>I-IEH$9N/CJ%E6L&N;4LLH0-3F2;+
M&:PDB*+ABW1NF&+/5;Y/<,K8WQ36O@%4Q'E5S/.RR,`Y)W7>[8/'3,@#BSTU
M)\DN&AD;$`S]^@U)28@'CF[R<A*L@3-7-RJV8-G#Q;!.^"*>:E\<;A-=U<B>
M4VO-A$HKJWN^MK\@(:T8"7+'9\4WKQ<@H0L\?-++D1J$;VAMF)S)JL%<7[!1
M1=BFBME;K)99X?OJ"1:%WGR,V:7E#';W"/97&P<%`8%`!N8[CXZ[";3$QDYN
MCG&1[/4>RYD1$O4T+66NX?I-V=\;]6RG6]R@H:W,#G3T>[W26^K7_P!GK2\&
MK_\`_?*"]"V]^2#'0T;V:.X.[,-[=+R/,2<XVMMS<<6<QB83%V<0QE;_`&$1
MV<VU&48*-AS1>S5B9</;8D4\;I==)?%,*?"<L^;1$V%'%>ZIWE'A1`P+8%)`
M[Y-<*7[0`->OV[9^==,!>]791\U#M%<W*B+5)5RK@E?!+#-2^.-PLW>7(/D_
MK>>*1G4_`;:?(J(X!AA##9,1WAQC@(94F\R=6?@<8]M;:L0EV+H19!.ZB^3*
MS97MK=EGGU<^@,EH7>_)#9LD/"-O<'-F<;`8R-+%Q$KF.YN..PF$D.)OV;9*
M)LQFH]G3(V/?N&CA5S9T[018XX(989*V4RPQR"CK\O\`G/;+*UNZ3WUE:V65
ML<O6DX-VMEC:][6RM:^_.FULK6Z>B_NVH+S?[VY'MM!B-G-.#VRR.WW\CR$D
MN-2.Y>.3>9`PEB9)GC*G.PW>S4=0O6.;!H@[\&;&E7MDW>.%TNUP4PQ"F!O+
M?F\[)#6;[NHMZB6+LBP:/BR_)WA(Z0$LG+M%!V47:L=[KOG2`UNIDOFD@FHL
MICA?%/'+.]K7"UMZ<@.3FM9UY-:EX%;2Y&1+Q(-(_E&B&[N,T`$>-7:KW!]'
MO)_;&TX?+/"Q2;=+-1?P/P56SC&R:F5\<[8AS]`[WY(;0EQ0%N'@YLSC/'&4
M>7*CYO,]S<<=BC#)E(@/:HQ=N&U!LV:2-H]<LW2SJSEPV398X-<L,E;*9IXY
M!2*W+WG*FNNFEW2^^%TDUUDTG&'*+@]A@X235RP2<8)J[[P53P73QMG;'.UL
M\;9=&5K7Z;4%V+;XY))Z$:[.2X,[-7V\M)\@SCC7CN?C?A,F8&Q%PTM+U-AJ
M;/QU$J/R9)8.O!$S.3_LU;8=EVELL;!3#+ESSA</F+9UW3V]A[1R]:-W9!7D
M_P`(ETAS5=RDDY(+(-=\JNETF*&>2N2:6&:N>.%\<,<LKVM<+BWUOODMK*:M
M(]J'@IL_DG%UX^R*.-@0[=7&S7HID9</2+=U&%`6W-H0V4+/1[5H@XS<IM,F
M:F#K''!3+/!3'$&A=]\EMFS1W'MO<%-G\;(N@`>E&\_F.ZN-FPA3TPW>#F[6
M,I@]1[0F4H1>D&KI9?!RHTQ9X8M<L<U,<\T\<@IMUR[YQHNG2+?NF][O&Z+I
MRBW>)\H>$"2;QNDMFF@\32<;Y3<(INDL;*8X*8XJ8VRZ,K6RM>U!=F.]N2%]
M!9;/OP=V9CN"TD\48\:/RS<<KS+,'XWQ8^5=MB6V;^2&S#Q;>[[P6YKP[L[=
MGV7;?O*"D4.7G.51=!-7NF-\-TE5T4EG&?*+@\I@V245PP5<YII;ZS54P;IY
M7SOCA:^>5L>C&U[]%J"Z=][YY)ZQF`\!J#@QL[DK&G4>:%7D[ANZ.-VO!@PR
MN^(MG$76"[=V?#9*Y>LFC1%SDY1:YL\\'6.&"MU,%,<0]&B-_<F=ES=6.;<X
M'[1XWQ3`"0)I[#F&[.-.P1"Q=JY'HLXWB!U+M*8RK!X30=++8.,F=FB>+;+%
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MKH#TR:Z_&.@>MAQ9]I70'IDUU^,=`];#BS[2N@/3)KK\8Z!ZV'%GVE=`>F37
M7XQT#UL.+/M*Z`],FNOQCH'K8<6?:5T!Z9-=?C'0/6PXL^TKH#TR:Z_&.@>M
MAQ9]I70'IDUU^,=`];#BS[2N@/3)KK\8Z!ZV'%GVE=`>F377XQT#UL.+/M*Z
M`],FNOQCH'K8<6?:5T!Z9-=?C'0/6PXL^TKH#TR:Z_&.@>MAQ9]I70'IDUU^
M,=`];#BS[2N@/3)KK\8Z!ZV'%GVE=`>F377XQT#UL.+/M*Z`],FNOQCH'K8<
M6?:5T!Z9-=?C'0/6PXL^TKH#TR:Z_&.@>MAQ9]I70'IDUU^,=`];#BS[2N@/
M3)KK\8Z!ZV'%GVE=`>F377XQT#UL.+/M*Z`],FNOQCH'K8<6?:5T!Z9-=?C'
M0/6PXL^TKH#TR:Z_&.@>MAQ9]I70'IDUU^,=`];#BS[2N@/3)KK\8Z!ZV'%G
MVE=`>F377XQT#UL.+/M*Z`],FNOQCH'K8<6?:5T!Z9-=?C'0/6PXL^TKH#TR
M:Z_&.@>MAQ9]I70'IDUU^,=`];#BS[2N@/3)KK\8Z!ZV'%GVE=`>F377XQT#
MUL.+/M*Z`],FNOQCH'K8<6?:5T!Z9-=?C'0/6PXL^TKH#TR:Z_&.@>MAQ9]I
M70'IDUU^,=`];#BS[2N@/3)KK\8Z!ZV'%GVE=`>F377XQT#UL.+/M*Z`],FN
MOQCH'K8<6?:5T!Z9-=?C'0/6PXL^TKH#TR:Z_&.@>MAQ9]I70'IDUU^,=`];
M#BS[2N@/3)KK\8Z!ZV'%GVE=`>F377XQT#UL.+/M*Z`],FNOQCH'K8<6?:5T
M!Z9-=?C'0/6PXL^TKH#TR:Z_&.@>MAQ9]I70'IDUU^,=`];#BS[2N@/3)KK\
M8Z!ZV'%GVE=`>F377XQT#UL.+/M*Z`],FNOQCH'K8<6?:5T!Z9-=?C'0/6PX
ML^TKH#TR:Z_&.@>MAQ9]I70'IDUU^,=`];#BS[2N@/3)KK\8Z!ZV'%GVE=`>
MF377XQT#UL.+/M*Z`],FNOQCH'K8<6?:5T!Z9-=?C'0/6PXL^TKH#TR:Z_&.
M@>MAQ9]I70'IDUU^,=`];#BS[2N@/3)KK\8Z!ZV'%GVE=`>F377XQT#UL.+/
MM*Z`],FNOQCH'K8<6?:5T!Z9-=?C'0/6PXL^TKH#TR:Z_&.@>MAQ9]I70'ID
MUU^,=`];#BS[2N@/3)KK\8Z!ZV'%GVE=`>F377XQT#UL.+/M*Z`],FNOQCH'
MK8<6?:5T!Z9-=?C'03&%[MTSL@BN'UWMS6,]+-FV3UR+A<]BLI(MV>&>">;M
M=D#+/G*3;%13'&ZF6-L+7RM;IZ;T%G4"@4"@4'4KY_ZXU;S?[_2%\4>8T%VE
MO_BCQZ[NS'D1"N.T!2FKV-$=US7<;J!/Y_.0D(+B"9/!E&%<$$5,EDTTU6[=
M/+I34736#8G^YW[D'_E)[)]&F_\`YP:!_<[]R#_RD]D^C3?_`,X-`_N=^Y!_
MY2>R?1IO_P"<&@?W._<@_P#*3V3Z--__`#@T#^YW[D'_`)2>R?1IO_YP:!_<
M[]R#_P`I/9/HTW_\X-`_N=^Y!_Y2>R?1IO\`^<&@?W._<@_\I/9/HTW_`/.#
M0/[G?N0?^4GLGT:;_P#G!H']SOW(/_*3V3Z--_\`S@T#^YW[D'_E)[)]&F__
M`)P:!_<[]R#_`,I/9/HTW_\`.#0/[G?N0?\`E)[)]&F__G!H']SOW(/_`"D]
MD^C3?_S@T'[;N=NY!O>UK=TGLGIO>UK?_C7?]O=O[G[M]@]%J"Y-9]PSW&6V
M80#G\4X`P+`&>L0Q;H'7^Y0)IFZ$%7P,L/*AR4\1>CWXXN,7053SQ]S-._1>
M^-[7N$[^SI]RK[`>K/PFVO\`.#0/LZ?<J^P'JS\)MK_.#0/LZ?<J^P'JS\)M
MK_.#0/LZ?<J^P'JS\)MK_.#0/LZ?<J^P'JS\)MK_`#@T#[.GW*OL!ZL_";:_
MS@T#[.GW*OL!ZL_";:_S@T#[.GW*OL!ZL_";:_S@T#[.GW*OL!ZL_";:_P`X
M-`^SI]RK[`>K/PFVO\X-`^SI]RK[`>K/PFVO\X-`^SI]RK[`>K/PFVO\X-!2
M@_N9OV<LM*CL&%\?>(I*:Q:5,(-)H@PWM(7DGCLU*NG[`7$#H%OMQ0H)DY%^
M+=((,'"2;I5=NJGCA?-/+&P!G<S_`+.4:$NCP?C_`,0RH-BQ-E'QD=O@\]%L
MAD:B`;8,C(NW[?;JC5LP`0*1CCCU;//%-J'?MGJM\6RZ2F099GW)/[/.129K
MC^,O%E^@15`(CUF6YY4Z2?JRN%N]DQ=-DHAM=3!UG)-=L%S["V%\O#`J"CY+
MKML,E;!Q1'<K_L[4@RAV`'CAQ0-Y;$%10[K[$/NV3$[SH'.['\H29AMF6V5_
M*<3+\8H4N,<L>W1?V&NKH99V;K=0*_>=U=^S$CB!D2_UMP79%8[(<XB?&.N3
M#IN1"2M+P^ZL9+,5=SXNAT@2Q%.<LF2V&#G'%NIE?#HPRO8+`'=RO^SLF)&>
MAPGCCQ.)RZ+'L(K)HL/W?)7DBCLG4$'I!A'#@1OMI0D*.Y@HJ4>V:+I)N+M!
MKI7J=FW6RP#B?W,W[.5<20/VX_\`$.X(2R+$BIG'?)[(4-'@([%I>=?/R%MO
M7:-&8:)SD(4=J*9XX-QQABY4OBB[;YJ!F@7<A?L]DHC9.8QKC!Q=D$1"1-E/
M34I";DEA6.AX,2P-J#IF5-,=K+C1T4?X1DE=$BLI@T5L/<WQ4OV"O4"-->YU
M_9O7K37#]GHGAV[8[B(/!&I'C;?QM9KM`J/(I"'XS7JZ>W\DIF08EUTVBR(Z
M[E1)TIBEE:RF5L;AA[]TM^S/VS-I_DCX37SC(!C*I';'D<1R\01DHD%7&2$S
M?'<E[#`I)&2CLV[E;J(K8D&U\,LK+I=<)P6[DG]GG`)ZV6.\9>+(9'<S@>TU
M`J5W/*QZ6U719)@N*;:X4=[71PFZY)$JUR;XC+N<EL7*5\+7[3#K!""/=*_L
MT`@4:.E=1\)1H2-S!37LA,/^1Q!H,!3U)D3)*PDP^7W*FU&RQ(<$>N,ARV6#
MO%!FNI=/J(J7Q#DNNZ)_9JV-IW=[IGA:TMJVPZ^S+N>1!1"VO;&'Z`D3Y;W4
MW'C:+>,RKI-JW\.[#MG"F*6'3GE;&X91EW-G[.,2E.4'':"X@OYIA%4IUG$F
M6^3SJ2X0I>.-IBA+\@:&WLR6,86B+U$K@_NEX+D-5P=6S[#/%2X8%YW2O[,^
M/>1@>_U)PE9/IM#&&QX:T=\CB#=Q+=>%6*Q,9/(TDKN7#,[#"`UOFX1*-;*L
M54<;YXJWQ]V@D['N8?V=`F;,QH;QYXD/Y''9L/UI(`#/>DA<F@FQBUC&0J`E
MA:.W,WPZ:$[1TAX.+6PP?+>`.>HE?L%>J%H`?V?'N.92##R:,<'-+2.-R(6P
M.1^0`9OLLN#.!2K5)\+,!RP_8[A@3%DF2^"S=P@IFDLEGCGAE?&]KT&6^SI]
MRK[`>K/PFVO\X-`^SI]RK[`>K/PFVO\`.#0/LZ?<J^P'JS\)MK_.#0/LZ?<J
M^P'JS\)MK_.#0/LZ?<J^P'JS\)MK_.#0/LZ?<J^P'JS\)MK_`#@T#[.GW*OL
M!ZL_";:_S@T#[.GW*OL!ZL_";:_S@T#[.GW*OL!ZL_";:_S@T#[.GW*OL!ZL
M_";:_P`X-`^SI]RK[`>K/PFVO\X-`^SI]RK[`>K/PFVO\X-`^SI]RK[`>K/P
MFVO\X-`^SI]RK[`>K/PFVO\`.#0/LZ?<J^P'JS\)MK_.#0/LZ?<J^P'JS\)M
MK_.#0/LZ?<J^P'JS\)MK_.#0/LZ?<J^P'JS\)MK_`#@T#[.GW*OL!ZL_";:_
MS@T#[.GW*OL!ZL_";:_S@T#[.GW*OL!ZL_";:_S@T#[.GW*OL!ZL_";:_P`X
M-`^SI]RK[`>K/PFVO\X-`^SI]RK[`>K/PFVO\X-`^SI]RK[`>K/PFVO\X-`^
MSI]RK[`>K/PFVO\`.#0/LZ?<J^P'JS\)MK_.#0?(3OM>ZWX/=V7PO;]X!P$T
MQAQ8Y2\9=ZZ#DL`V+K*:["15?-I1M.-0>01:4BCLK-"C<8,"9$IX2WS1QR6Q
M3['//)LLX16#N.,5\G3)FZSQQQS<M6Z^6./3U<<EDL%,L<>F][]6U\O<H.50
M*!0*#K9(_P"J/VE_DU17Z3S:@^\M`H%`H%`H%`H%`H%`H%`H/<W_`.(0_P"^
M2_[>-!`>&_\`9]C'_N[<7]=&P:#:"@TZC_/_`(?R;.;8#-UADLM<I;)6FMC<
M?FD8\08Z=!MY-M--S>2QH39=Q`0#Q!V421[55H@X1RSQM99/K!+('S)XP;0V
M.VU'KW<\/E^Q70TR4PC`-9\\=)-@!J1@"B+UW@QL-'E$24/*=1DX63>KMV"[
MA)+-NGDK8*?R[T3@-@/L4SY*PW!EX8];*J9BYC@HT9#AF)I[*2#;*-6=#M?H
M"+Y.O*5?!./Y()J9V>7Q24OB$U?=X)PL%NYNS*\D=8BOR;F6H&:D"IK,:"!/
M74I<02[E:1/FR`!T#'SQKF!?$V[E4:..]4<Z71>YX(9!((WS7XK2]$XM'=U1
M(CG%X1--DREE:Q9J6BT#U\(AQ^6RJ3A7HUL7CH<:$V`%=IJO4$+/&Y)%1MVV
M.738/*.<U>*<L![>D\?WK`W\8T*'>2';DF\8K-8Y"P8Q$HJ6*OCSULV$O6(9
M0(\;OE&BSC%D]:JM5^S<IY)6##H\].("SW70Z^^(:T(;69XOH2Q)V,B7;M!:
M2E(4PQ.-R@IFM#')J:`W@8<@:L/7)%VBS)K@LZ3S2L&3F'-OBE`H_')1+-W0
MX2'F.OH?M.'J=<F^?2V!3]U9G#9!%PPT<\-2%.0*];)!!FW6=71256R2LDDK
MG@$&D'>1\(8P3P%%^047Q64&2@S@]&B)@=`W$PB,#)K,25Y,"C9*.8LHM$3;
M$D_4NZMBT9/6ZJE\<%TKYA(PO/3B4=E6O(.VW`P'RS:V+*\"!R:+3J'/#ERT
MA,Q,`FIY6Q<(D'6E4GC[T>&3?9-<S+QODDQLXSZ+7#RE//?AK")=+X+,.1>L
MXS)H&9$1V5LS9NXYF*D!F50N$)`O';E!,$^,BY7L8"Q*M6SE9<*L8:>,,6UE
MT[W#Y&;DXT<'B0K9C[>/,L4Y@/+[#F!$]%^#ZW29-=>.=L\J(%MC>4E>R\7@
M4>FGFJ]YQJ/,Q9PFL`'QR][VOEDLZNO8(%-.&?=W[=W)N3=\,YERW50_9I'<
M4.V>#B,)<1G79^"Q'6FNA$]AD(4E$6QA;ISK'3?%64B%#`IN011!%7C-=%5-
MHR3H)B,X-<*RYA[K:-\])2M)==Z4!\-G@Q!O%U9#'[\L%-@.N,$C*8M0[$9E
MN$)Q5W!+==Q$GBV3;6`&.US;8+,T4<0F&C.(_$W6.YP.VXMS/.D!O=?E=^#!
MB<SUE%@D'T[K;:$LG)WDKK2;;,5B$9CDI\7/W";(:Y$.F7D0U#8MTVUTW3W!
MR'.V#`.'W)3<4-/ZIY?)M=K;,Y6R_DM$HRSUEM"09LI`RXYZTX?RB'305`Y#
MJ^:P-B&PC;`EFK("8?"[TG@FN@NU53ZX0-OH3@M,'L@TQ+>:I\K#=$;KVK*&
M6OEM=%]0R:"&6T!Y6[=V;$)'NL&$AVR9N4!B-VFY1>Z9E-"T=%-,EF;K,@Y)
M/PIV"]W;W?BSK8VX(#S8G>"W'>#IRC:$X\@7R^IA)K13#C/E"=BR-F=!9Z_F
M)+5R_%=-`RP8KN%R8DHN/<]CDR9KI!/`&D.&JPK9$1Q[Q8+F#YYYD06V`Q#4
M[`!*R.\@&_\`94P;2H2Q)K-!NB8RPWYO1J*\FI4#<C"W0U%*.7#H@JJN'A,=
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M#!M>P*&;^T1#(Z[D46:A,-L3N#33DXM>2'<,W@P@Y0:#"HY)`B]P?!8>N],]
MW`06UY(M0\L;.>5I/D$]VSJO8H[5.P)(-BQC!U&)&_@V/&%\@O$M6:/>#-VA
M'U[-$(LW7\9!RN!&ZC9HXQ"EF?#ONT`8-D_@7/V>HKSPL1XRK2@%#SL^;2)/
M:''V#Z@D0."1L1&WT#ANP]B1<,0>Q&:A!:-E`1XF+89$0R=TD0O-2"]W#']'
MD=<X<]+%X/"]<<K^+<4))Q)O)I!'X9RIV,"Y!)9"&<+C+5*71#6C?C5(T`AL
M4/PC:@5@]3LOAB+RZ`PR'=Z<">1&,IBWKTJS.(\50ZIZ//HDA%8E?26M69O:
MFYF,C,;D&8M1DXF^M=@;-9GTI=9S;,&H$;6>MK/'Q%V\#Z@\4^47#?7.F.+'
M&_7_`"&:[1(`8#$-#PAPTB4LSF$I=ZAB>LXD^/2R*!XTLY@*;YI,8^05<$T6
M`WP8\T716R;.$5<@NK/GEQ`0FLKUX\WU"1DNA$O;023C#.94*B-E+F7#M?Y#
ML"Q88S#$$1\[,L0KYTU<+-!Y5^T:.E45W3=-0.,`Y_\`#*4,#!(#R*UP1:QX
M03D!ZZ9-PDX#`@^H!>_GQDHR<-$7K`7;3!IK)$5U4\4G(I6RJ.2EK96L$D"<
MT.+$D:1]^#WA!B+.5L=>E(ZY1?KXI%Q6UM=RO;6OBK3)5JGUA4FUO!#9A)S?
MH039B'N2N:=VJUL`Q44YU<0YRXTTSB._8!('O(<$&D^CF(U^Z6?[3`G'IX>W
M)PQCX'B[,MQ[J,/K$^SPOD'P0OF_LVPRPRR"+$.\8X;##TBBSO;ZMI+%)^MJ
MLY'VVN-L/C3?8C8`2ECF(M1;&"N7I4PVB8E8LHFTP7LF*[-YE>S99%50)V#Y
MI<6)+-2FNP6[862F8>8)0%X#0</>W4F&;:9.%@8URHRP8FG(U379UL^R9JKI
M#R`ETS<Y).TLD;!%1_>%\)2@0O(A_);5KH,!8D")AZF=O:P]L-A^N9\M9RAD
MWQ<XNG,2V[&7C1OU+KO[&VJ;;!592R=!-XOS#XP3*'378$>W;!'<.UK"TMA;
M%/.BF0EI`8DH6G(!0E-,3"+!Q%W#$]K,^Q=LWV"#YD\$N$7"*:N'5N$4&\^.
M'I?R"P'[YAR[O9)XC&(P+NF;1.)'!$C"0XHREH%P)2,Z\\`EDE&C%59`@+1P
M?DFB%\^T<H8YA@F?>.<*"(V5&V&^X\^`0D:$)262,P4U<QAA>39Q!.-!DI*C
M&<P1*6R-:?A4QX1JX7,/52;?!%MGFI:U!MQ$)=&Y]%8[-X<8:'XI+`P^01XT
MQOG=H3$%6R;Q@\1LK@DLGBLW5QO?!3#!3"_3CGCCE:]K!(Z!0*!0*!0*!0*!
M0*!0*!0*!0==[]J=_P`&#D%^<OC+](;7%!V$`_W)%_S<R_DR5!D:!0*!0=;)
M'_5'[2_R:HK])YM0?>6@4"@4"@4"@4"@4"@4"@4'N;_\0A_WR7_;QH(#PW_L
M^QC_`-W;B_KHV#0;04'S3W!W4G%7>V,Q2V<SEDH;S&6<CYWFU*.(D2;1R9<F
MH-#X#+)/%42L.?XB#L.%PIJXC3J_:+#7BBRBF3C'+'#`,EJ'NR=(Z5WI!]]Q
M*<;=6D<"0V2D*"$BT&P#DL=HR39$ID#*2&0VOP\_D,6:&-H$'+*/.C2D=;$$
M&A"S&Y%&[O,*K+=RCP;)ZYUWKM&)GP]]9C)?<)-Q"D10GQ.<2;&,Y"MK2<\X
MASI(_/H"YBB&83)9"XI%)=TU<,7+)TNVS#GRWN>N-L_C\C@DYGF]I)JV0#9C
M$T=892^+`8S'=9;,W*.Y![5U4!)Q6#`IM:&[(VZ`$D7ZCPL\+MF8AL-8/F8[
MMVRP;%#>">I6K7D`L5/3J2RWD]QSUQQHW+L4TXB-IS*HGK.$SZ!B98X+"X>-
M;9STN*V*]6(.54%6*CI)"Z+1!).Z605OKONR-*ZTPY$I`M@;B60Y)ZXMK"8-
MW1/7C=F+"61*(8&6PX-K84+FLT2;ELFN)B8H29[XJ11&Y9Y#L+M<@@D:[H?C
M[&`PF,,]E;X6B*J<$1V1#E)'`6T6VXSU-NB7;]U`&D(@;K9BE`HMJK8LU>Y!
M0T%O$Q*8NR(Y=NNS2Q2H.2-[J370_P#)`7RY%\E'.P^/.O8?J[0FTK.]&,)A
MJN'08<9``F8ID+T:RA,D>WB<F*"7+DZ(*J.&K_-2_0Z3;N$0EA7NN]!&P<Y!
ME9EN@E^4*-\FHU)3!68!"Y]ZERPU'KG36SRS@J5B;U<@=3CFL6+M@Y=^$7Q)
MKN5G-G6"F*288B*]UGJ.,R'7!B^UMLO0^OT]5).X$.!<?H'`YUCHO=<BY"Z@
M\J06LM&PM1C>&;8DJQ/*X1</<ODDE@3\,PMGBH'"V;W1W&+<<F+D=E&]J2V"
M/MJ2S<XK2Q4W$%]7QF?;,V5"=I;C?C6N4&O+R@S;1^$V1)L"Q@DT8M"Q+`5@
M.S<XJ(A&9)W-?&:2::XPZ-7G&ZDHEQ2#[-CT!+/#&NI1-BXG;$TB<[DRQZ7S
M36<D+#I<S-0QEXMD@+(-(V&/:YIONW5R6H.)_<L\2R,/*Z\F+V73V"/IAN*=
MLHW)8OH;"S"4;KA>W8/(S9`V#TL'D4V.1X?N4BY!$9"[+$13UJT437O9-7!8
M.<T[GC0H$^E.87N;DU#]F92D/-BL_0V#&):Z.RF);*%;+@!5Y"]BP.9:O&^0
M+H;F+'(C`3!!02[73=X.G&6#G`-@A/=X\=V&G>1NGR(XR=PY8')])]Z;'7M&
M06T9C)-@&2<B<F%9+#HS&VJ"T6.%5'`-+P3)L,O;'#!/)+K89!C-3=W-HK6>
M]5>3AXG,=S[_`'J$H5*;/VVAKTD9=2*5*PILZEXL?$H!#H_#3X^+:\$`6OB%
MF+:8"&M\%$%%U5EU`U!Y8ZE[MV;;!WIKWD:>V&6Q8R?8W)[=CMSKPQ,=-ZGD
M4UX/.-!9VE<XQU5)X#!I&RT##5)+&AY!]8QX\Q;N4+JW=L&2X:OQ)YW7.K!^
M^>-+O<_(F/+\X1,WU#LJ!3CCTPAVU]=/MO'87#\W4N.+\:XYM<(Y)D=^`L@.
M$P<F!:;`XBX1;W98*J)!6FNAW=&-XF7SAO(KE;F.(+.C>[8;'--OQF>P]0A)
M8)Y,LY/+=60GC6R8ZWXY00UG<OF=A@Z+-.S,O&Y!VX6(W3S#!D],]R(1B^]1
MA?=G)B3Q?0X$R?V+D4MLK9.!/8K,S).+!3D'K5P0UM*WI_:"L_F2#=NA%>H$
M=OFK)9H'4&W7Q<!M9?'NW-73/D-K?<NY>1<N"3[4T^UQ(Y#LJ!/0&DX1J+GQ
M-9[O>8.M>;5UMJ"$11P%W++@QHHS,.B9;,<C'LD&:S1!KDFH&`@6P^Z:U+O:
M*[^V_N_;LYY,IAMKFAS[E5J,G'-F**Q'7?%PHC(DM=(Z)UQA%Y5'=,1").8F
ML,&#G9H6]+NN@@\Q?*-0WCGO=(Z"V;)9=(9MLK>A=L>V'LC9D6CB9W7@X+J^
M1;CV-#]I[4QA:H_6C8X^9S650$3VMCSPTJR:M.Q9*-K**W4",Q/N7^*NO)1K
MT_KLS.HH)UH3D9*,P50!HZ7PYE><"M*#Y^D/;3S3DG-1Q>8/=%C2&;P2^'D!
MCL@0Q&+L6RR+=L&PL#X`:_A$/U;`W6W-]3F*Z0V7J38&H@\WED5?,=?B=&Q5
M_"];ZT",P\'",U(4,CY#+!ZX<IN)&86PP6?%'"N%LK!K@>[DSB'-X\"B.SCN
MY-GQ>$PL;JW6H67R>)61UKJ.-0+=<#@FN(L[CT$`DEF.OL-ZE"@HP27(2>Q0
M>,R<$W"#/P=0+?BO=@Z+!E.0Q&13/:\^0Y/Z5+:)VP'.$8%&!1R*2`.T"&S+
ME+5VOM?N3,VR8M;HC2Q54BYC[)51B)NR896:V#,:R[M?0\%W<)Y)3$U.]\[T
M$IGLD]C;HQUV7)9E"8?2T8"2)J+B.O89'8_(X3%-$AQPQX*9L%;IN7ZSN[IT
M[R7Q"+RGNL-"SW+D*SGLTVQ,HQR"C/)**+PLV[USG&]9#^6DOA\\WBYUZFUU
MLV).B<CE6OPKEHO(W,@N*L/PP:62QS5LH$3V[W.'$G<FYIKO4V0VY%YOLC,Z
MPG]]?35A#ATJA,@A.G->.==/;"XY@39Q<=$M.X,QRS-TV,#49&;P;/4TWB6#
M8/!UW.7%A=!HV1E.^&:(O26]^/07J[-N0=B-9[\G,QEI=LB6-A"AI_*(`!V?
M+XM%3CURZ+"(U+BB&2Z[E9)VB$KU_P!U5H76&T=3;3ANQ.03-]H&:[)F&BXR
M5V;Y3QG63?>)]_(M^1%CY3A#$CED:W.[?6P*WD)$P29IMT;BW;!3#M,@E&[^
M[:TSO$V0DQF63H&>?\DO6DLX1$:?FXAKL6_'./\`&&[).);;U5L2(NHYAKZ-
MMW*6#EBN];F+Y.476&/41P#`.^ZRX_'A["(3J5[5V3I\!M4EMZ'Z$GA*"'--
MQ"3'R>W)')4!\5_)^V<FV)V6[H+$KJF79-^QS09-6+EJP;6:9!2,<[BSAA$B
MPN3QTUNP1,@\08Q1C,&,SC:!GPF,>K^YUE,7J&$(L#)S#49GCD&?`'#EFJAC
MF_(MGB#Q@X2:(!9S?NGM/)X;E:.=S[_("^2<;>"^1PYT1U(E?<,L6FVTMCC=
MGD";#43(Q!IK')MM=V]'I15P"!HXCV"&0Y1NBJDN'@5[I?29X^1FIO<7(E]L
M.<2T9+MX3]"3Z]"R+?#J.S.$SB(#IFD`UB*!P]A"R.OQ[09G"F<5>(C,G+91
M=6SE7*X1"&]S#QQ@(':<6C.P-GIQW;T?C0&6,CD3XT2Y\NE%6.L!XU-<_+./
MAHZ>CCA#4XWPN.EW!&-.<E7&60_KYIY)!]*=':C!:$U#KO3,9.2^21_6L5%Q
M(0=GIY632\FQ%(]B@Y.FE$6N#IU?'W+8I(H-D$[8I())(X8)XA:M`H%`H%`H
M%`H%`H%`H%`H%`H.N]^U._X,'(+\Y?&7Z0VN*#L(!_N2+_FYE_)DJ#(T"@4"
M@ZV2/^J/VE_DU17Z3S:@^\M`H%`H%`H%`H%`H%`H%`H/<W_XA#_ODO\`MXT$
M!X;_`-GV,?\`N[<7]=&P:#:"@4"@4"@4"@4"@]2ZN#=%9=3K=1%)17/JVZV7
M43POGEU<?^G+HQ]RU!\FH7WRG&*>ZZCNTH]!MY/HD9A\PVH:<#PNKI$[U]H_
M7Z\#9S3=,_;1+;<A\21../\`8C!%P)2R<S*UTW*F(3)%LJK8)QHOO4M"<D(7
MR2FNGX'N67->+X?(Y-Q+$?JY4D<9)EIR-<,XT]0VNO&!TG:M=>OB*H&1$0![
M`4NR=79=D^:75"MI!WV/#J'QM0M-6&U8C*<(*#V;AJHL*UXXV6X@$DX[3OD\
M&EK<0#V:7"J!7&M(`XP56N1M9F5=M6CGL<\ELD`V%)]X;J4)I+4G(`K`MN8:
M[VYL!EK]J_"#M=SCR,7(R_&"L)#,"6OME2R,K!GTD610;M@A`T<<Y*]"(]3-
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MPPY"3".C.5(31&PXM")=IH=%Y]NF2<G]K!=86VI`,N38!Z3!1+?<E-H15S(6
M;/,.Q>HXI88#4<>P#A9\F^Y9?C"&E)E$=TW9:^@>EH.Z@\X;R4NX.ZVXR:[Y
M4%];"F.#.9%G,W%141C)HV]3;*.7RK\Z"0=X]DY:N<`LL]H+NS=CZC9&9QQY
MY-[BV3,=^F^,#77,KV>SV7R;)[M@++7>RK1M6<_EV+004ZU1`N+8UVV>JRYL
M@,#CWS552[PF];NP^CO'OO.^.O)^2;.`ZA%;*/--4:R#[3D9S,)%\57@@W`H
M1L1J$!:\:3-[N@C),!$\;-,D\HPDTS*MG+-)PHNGABH%9@^^#X\'8;KG9#?6
M.^T=<[!![MDKF;9C=./1>O0G'>)93_;CK80X-NHI)QCV)P:V))4>Q8$2>5\K
MLK-O&::S),+#C'>9ZLELZ::C$:3Y,*;M0<8/IKI:T!A[S8.L]?JC=5&$=LS-
M$5L8C&UX&N-W1'\\,`I(P<NHX<(^+O"&#Y)L%5CN^SX.$H22V=:03)AK(/-)
MGJTKL$L+BPR+L=OZ^U'L/=<PU*H[>3))PK.`D+U]?#--))1EF4,#V*;G-SD\
M39A.V/>P<:7IV(B_)W<C0)L6=B]6ZUG3R&A$X=L'92DTU=`IA"8ZNG+U3J!7
M6<@VNSQ,KD&#$>NF.)W%.2>3%3&X>G=_>P\=N/DFVU'=BPO=#1IJ>4/X%E+F
M0"`YQ">;$#Q_3DN.P6&$R&RAKID8"1/>(<DLYD3<`)4:H/KH/%LVBF%!!U>^
M@XN-Y\8UHM!=[NY@"T^_W81#12/:TV64M$6&IW.Y5,V`+5>V)Q(S#92)HHH>
M.F;-Q%DB[UJP6*ING":=P^AW'K>D.Y*Z<A.[H`B1;1*>,B#T0W*O(N0((X##
M)($Z3<OH5))A%'=[/1:E\5&!-XWSPOC>RE^F]K!<]`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%!UWOVIW_!@Y!?G+XR_2&UQ0=A`/]R1?\W,OY,E09&@4
M"@4'6R1_U1^TO\FJ*_2>;4'WEH%`H%`H%`H%`H%`H%`H%![F_P#Q"'_?)?\`
M;QH(#PW_`+/L8_\`=VXOZZ-@T&T%`H%`H%`H%`H%!X*I)K)*(JXVS253S24P
MOT]&2:F-\<\;]'1?HRQOT4&JLJX.\49M'-1Q&4:7C96-:+C#2#:R#9O9"V9A
M8$TO&L[:]+8,C+;*9Z]>K0P2J\`G+DA#]8:V5<MU5$4\L0DL(XG<=];X2M*"
MZM!QA&=:^8ZMF2`QT:2;R:"#"DV,#09IOF440?Y#GNQC?@[M3&[U%`AFA@MB
MABFG@$/D?`_B/+8L^A4ATE&R,8(L8X-=BLB$E;X*,XAIF1<>XTE@Y:'&[U#(
M-IJ6$02.::F"F+9UDI?*Z]L%<0R9?AAQXD(O40B1166R)#1$[?[,U4^D&X]T
MG)!%YN3:D1[TWG*"NPG<E/\`;"B[ME9L3=O6F#!TLUQ2Q;JYIY!B`G`KB%&X
M4RUV#T9%1L-'+;*78A6[J0VP;*[=B5X#/;I/,S.9&V)6#XI"&V/;=46-:MFS
M"S9)JVP2#BF.[[X82*,P>'R/CQ`)'']:1&10G7[21-B1YQ#1$OE`B;RDC'2I
M8B\+"YI(9B!:%'DC27QD+A^C9?-[=3+++((T\[LK@402/(/N,.MG:,JA*.N9
M.FY;EUL)'#FT)V%KAL).VS+96+9M8/M4\-2=..T>)-WUNJK;)!MDB%*\L.-?
M!/BWH7D!RGE'$T+M%GK>)I;4/:[:K$3F$Q>Z\?#92*"Q^)2PX[@S-]():&'D
M7J%FB38V;:-7Q'%T\016P#0+07,[ND8OCL<I`M,;*UO%Y1*Y9QF$`(D5V))8
M=N&)C-(P"3*E@FGHU/'T=:`G8"7I1,,Y\3XO6V8ZS1!1LT["U!:TK$]V]"M?
M:&W-Q]XA3#84'VSO0]$83-.-T^/:NGCTZ`-[/B3V8ZS8`]J0;8VT1QO&<RY]
M:X3M63B+8DR;U9)DW;=J%H\3IGQ)VOPZVMR8UCQMV)'1L$VQ(=ARK1FSMP'A
M8Z.;MT;L!7=K>1BG.V]EL=6:R1:38[:1$B.%@[)-QFXN]37[#J9AI2)Y#]VJ
M<$S&3&^[1FB+J"Q]M._%DD$1XJ=<$=Y@-4Z4WHV?B#<PN^C\6"P3E6$N_<$$
MDVAT2Y4=,VN;MHVQN'TAX\ZSX=[U8<E^*:''(G"!W'?DBQDYE4KLPR=EDQG4
MAB*%XIR%C6WH]L`AM5O(#T307"Y$<R^+ULV:.0N;B_@SUDW#?6`<<=%ZKA,K
MUMKO5T2B.OYP@U:RJ&!QUD(T89LM=Q?4S9BL'RSS8HL<-=0L6*N@E@FEFV:8
MWRQOGDIGF%<13@OQ-A@5I'PVEHZY%MG&QG2R4G(R6;N#*^VX0+UIL;*4D9H<
MD!*882G78-D"6P*JO,$Q#-!HE9-!%/#$(JP[N+A0.81X>AH8"MC&91>7,2!&
M13DN?)$\FL.8782V3%I0]D4[B7B[7<>;>(#;H@#LU`CD?!.R8M<$@SC#@+P]
M%/D"(S144'NT(L[AO69NY$V1<`'L9VA"W2#]HD:P:$B"D1W1)QGA[C!5_BQ+
M9HV6LFFABD&`*]V]PF,.CCYYH8&D[/M1*"ZXN23L'F(=!R4",HGX=XEE0^T!
MF)$MJZ/.29P'8<8,+!VV;YRXNG:]!ZG_`';?"\L[E!$SIYP<*3%@Q9G3!W9N
MWS9K)R/1UZV3D8DP5GSPG&YT[;:GC:;R1#56AU^F&;8N7:N.'1<)$1X"\233
M?),_J-"2O5'CE^XD<IF>Q)/-7KQYKA34CM<A/#\N(S0CDZUYDF.4LN_4QSLT
M:+7M=PS:K(A?.IM0ZZT9"&&NM61I"*Q$>1D!G`?@_+&'KX[+#Q*4RF0G#T@?
ME9#(Y')9(8=/R!`@Z<O7CMQFJLKGGE>]!9-`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%!UWOVIW_!@Y!?G+XR_2&UQ0=A`/\`<D7_`#<R_DR5!D:!0*!0
M=;)'_5'[2_R:HK])YM0?>6@4"@4"@4"@4"@4"@4"@4'N;_\`$(?]\E_V\:"`
M\-_[/L8_]W;B_KHV#0;04"@4"@4"@4"@4"@4"@4"@4"@4&!E$6C,V`%(I,H^
M%E48-MO`S,>D0QF9"%6G:8*^#$19!%PR>M^U3QRZBF&6/3C:_1[E!0)#AAQ3
M=X-U6''[449-C,7JD:EL1UY$8U,(84>#A@M.1PR2B@[<I&9,,0!L,F;]KFFX
M:+,&ZB>6.2*=\0]H?AOQ<#PC0NO+:*UL7B_&`$+CN@VTFBPN3OM7#Q0D4$2S
MBA<\W?E!Q%Z."-L'KK%7PA]=*V3C-3*][W#E,N(7%T=$I%KUAH+5#/6\NA26
MNI+K-M"02&M#4*3D4BEN<?(:]29XPYPR>2.6$';GK,KYN57.5U;YVMC:P9`-
MQ4XRQU$^@#X_::%)RN.16(2BS'6\10SDD5@JR;B&1T^K@)LJ9#15='#,>W<9
M*)-,D\+IVQZF/0$[@NI-6:O=S)_K;7$&@+[8DH?3:?/(;%0<:=368D\\U",H
ME*X=BS5/'WRJF6:KMU=5=3//+++*]\LKW"PJ!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*#KO?M3O^#!R"_.7QE^D-KB@["`?[DB_YN9?R
M9*@R-`H%`H.MDC_JC]I?Y-45^D\VH/O+0*!0*!0*!0*!0*!0*!0*#W-_^(0_
M[Y+_`+>-!`>&_P#9]C'_`+NW%_71L&@V@H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%!UWO
MVIW_``8.07YR^,OTAM<4'80#_<D7_-S+^3)4&1H%`H%!UBY(7DX7]J`V6ZBN
MNI'LM^IW.T0;K!8P9A`1\T:J<FT[Y$UG,[D\4%*-4EL<$KX).,U[Y*XWLG?"
MV>6(?:KRZW/[)FW/P_XX_//0/+K<_LF;<_#_`(X_//0/+K<_LF;<_#_CC\\]
M`\NMS^R9MS\/^./SST#RZW/[)FW/P_XX_//0/+K<_LF;<_#_`(X_//0/+K<_
MLF;<_#_CC\\]`\NMS^R9MS\/^./SST#RZW/[)FW/P_XX_//0/+K<_LF;<_#_
M`(X_//0/+K<_LF;<_#_CC\\]`\NMS^R9MS\/^./SST#RZW/[)FW/P_XX_//0
M/+K<_LF;<_#_`(X_//0>Q&>;FP52SRXF;=ZN"F&5^B?\<.GHQRM>_1_^9_W>
MBU!8W%V(RN#Z0B<>FX/.-2?$G.S1./JD119</:5["E<J8CW1$&\(AW3UL.-(
MXK7:N%T+*VRM@IG:ULKAL!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*#KO?M3O^#!R"_.7
MQE^D-KB@["`?[DB_YN9?R9*@R-`H%`H.NM$O]4YM?_)DB/TJ!]!V*:!0*!0>
M%E4\LKX64POG;IZ<+9XWRMU>KUNG&U^FW1UK=/\`UVH/.@4"@_+7M>W3:]KV
M_P!MO=M0?M`H%`H%!^7O;&U[Y7MC:W[M[WM:UO\`KO?W*#\Z^%\KXVSQOEC>
MULL>M;K8WRM>^-KVZ>FU\K6Z;?[:#RM>U_=M?I_ZO_A[E_\`^M!^=-O]MOW>
MC_\`G_L_ZZ!UK?N=-NGIZ.CIM^[>W3:W_7>U!ZO"6_1:_;H]%\L<;7[7#HOE
MET]7&U^M_P#-ET>Y;_IH/;;+'+IZ+VOU;]7+HO:_5RZ+7Z+]'[E^B]`RRMC:
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MG&]LK=-[=-KVO;IM>]KVZ;?]-KVZ+_\`QH/V@\<<\,KY6QRQROA?JYVQRM>^
M&71:_1E:U^G&_1?I]V@\J!0*!0*#\Z;=-[=-NFW1>]NGW;6OT]%[V_Z.GHH/
MWIZ/W?\`JH%!^7RM:]K7O:U\K]&-KWM:^5^B]^BW^V_1;IH/V@4"@4"@4"@4
M"@4"@4'Y>]K?NWM;W;6]WW/=O?HM;_KO>]!^T'YTVO>]K7M>]NCIMTVZ;=/[
MG3;]VW3T4'[0*#\M>U_=M>U[>[;IM[O[E^B__P#"]`O>V-KWRO;&UOW;WO:U
MK?\`7>_N4'[0*!0*#\Z;=/1TVZ>CIZ.GW>C]SIZ/W>CIH/V@_+7M?IZ+VOT7
MZ+]%^GHOT6OT7_V7Z+VH/V@4"@4'7>_:G?\`!@Y!?G+XR_2&UQ0=A`/]R1?\
MW,OY,E09&@4"@4'76B7^J<VO_DR1'Z5`^@[%-`H%`H/G1O3@TXV1M66;8@!R
M.ZQED@4UJ00F,6:NHM/DC4#B.^Q#EXZED=9HEEDC1S8\=6<X76RL[:`\D5[9
MXV1PN',U[H;FC$89MA.4\E66R-@2':<!F\!=F5W@6*LHY&I\E)95#UVP>)^,
M(2&F\/QQ`+,F5B[1O@VLZ3M91TX3H*+.<(N:9^`I1,_RT=RU>1#&[?834Q+9
MZ.#OCR)F9^`R"/JL![E\Q"A(V5%)+QNV*`N0N6F6;_/'+#!7,,@GP]YZ^29A
M,AS4.%YRD0L]C#_.32,%&<G*TKC9,NYD`Z.1D<]4!&Q09S?$&DIG<39\JQ'D
MD&^6*^`15+B_SY-;4<14AO"51?6@@#+R+G8L6V(]BH.7$SP:.*0:'Q?7T=>.
M3$9\A9HF5($"[C!NZ*MW5VBV3E%-"^02N_#?FZ:6NAL3ECAL(,YW)%YT\$."
MIZ*BD`T=V7$)T@['"HS%VU[8-8Y'G$?M$7#EQ'G&3K`K==%VG=',)#LCB5S`
ME.WY-/@_(FUX>ELIS*H-"W.Q-G11\RA9L%83+(!D<B`U,=$Q9=@R2'L%F@Q^
M2"J.W)9%ZJ\Q10Q",$>%O-(X0B9"2<HQ,E(11V]5)EB#V8ML=@`C\!\C2L*6
MCK-IB'UFQ%77R4N6"Y+$Y`LWP<O^SNLX;YA[5N#W+1("'U^.Y3+K0,*+B0H/
MY0F9<=>!AD=$]<P%>`G;7(=.,91,;M"34B2=X/(VU"I,&..;5^ZQ1"/C.$7.
MQB7,/F',%U%Q\HRE+Z0C@DKEI=RZDQ;7$<@N4L<')#%EBQ!R?>Q])^@T24'I
MP[)%-(6JXPR4Z0V"W1Q.W/MK:HU=;<CM'0K&3:5D#K7SN53>ZY</JZ9Z[E+V
M$%!#?+Q8_P#&A2'O2JLA</5B9)1_84]1R8)]K<(/(N"LYDLIW2=;F8)`"TI<
M[ODL`V;!GIQOLU[/9Y(H?+M.R&=+7C0]JTPT-(8EBH/3NY/XNTULD<<&S7-T
MU=A#9=W<&PTI=)K:BW$R@.K]AFI&TFD0)8R&2NQD:-:+@VA4)3"E"3ARS8;+
MSAC.1)%%'-E6A=RZ&/ULL7C);-T&<:\#=XL@7DFWWT+L'0UP[A[,O<45Q/IS
MA`6^T!'-Q*MDU,0N<J$\.R%A6;*R5F2\P:HD,K]E;*@D6CN$FV=4;?U1.#>T
M(W+H9IJ+/=2`(PJW.,W,KU^P:S1MK79LN2:X-05]YZLC)YO$!JJ;95DI&G1?
M-1:[AXS3'!B"?=_/@NQ87,X"!TVB*";@WIL0W'K!HA&$G;'9TJUH<B*J=S>B
MMO#W)F&#H2[:XW0;"GB=GMK-"3?#M+9AQ$^!NV'`L6'93Z#ZL=@8W-(V5V%J
MQJ_7V%NLK(=;SV$)[)VVM.X[(X_C*3CZ6MWA+!)J0)I+(*YIFUL<F[=J$6C?
M=U;;B!0,OCLF&;%@C)Q-9@>TIL%:7+0>6SJ:[@&S,\'=EE&Y]9CK:11@(,>*
MC5AA%LQEHSPQ-LNU>N&^(6)&>'N[H_"97KDD3U3,8@9GFM]I)AC4BFR4=-VA
MHR%C'O'Z01=U$3N*>G6S&.Y-1;[-^143;LV6+H0X2LLA<(<1X![B4P31%S'4
M[9R19&,$I`]&&R133T=,!MEBW&C-/8$PY`DPU.W2G2*3)VU*1]ZUL@KFX:/F
M^2#!N&`1[O#:J6JY9KY9QJ,@7([**SMA*73\2FH<R?D=NN!><D9)\=<[E;1S
M#8S92[&6J[!1=7:9XLUA#JS0DU#8O9G$W8\WE^1IO(M=+O2VJXE!&VT2S&7-
M=AZ1.1R-3L(=D&C10HE;!CC.W4N177Q6.LLFF37_`'GQMCV";<*#D7=P368D
M$Y#X[U5JI,.R=+QG4NMPN!;60XZD_P!%K.W;,O*H5:3PIWLECJTBF6-Q5(!)
M!&;UJLT?.G*+IR[#/#N[C(Q.,AU1Q2![.DSQ&2H3N$[-'-0&HBI(RUEF$;GC
M-AKZ$CWYG8&O'LL<Y-BYQL2.D6SA1'(JSS3:N6X0]SW86P5K2@.KOG%^(W"(
ME\,W3)UX\#'S]S$#NTHS/GKL`9%1AN4F,AV$"BC<(7\L21O$$@NY4"K(XN7*
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M0E1`#(]<-2[%L.P2:G[O4\'K-9XBP>9(XAS@'#OFX!/R!$1RX9Q:%J10T#C+
M,$C(7JK8W(Y>&)OY4_C1E!:-,C@Z/%)-=HJRNFED4=CE5D<TF-L,@YCCB=SS
M+3<D3(<S+B(N0BC5*Z<;6EZ3I+8"423<(2-K&WJB@<;'Q&SW;MQB*:NTFY0#
M@V9O;*=GEU@GR7'/F0CIO3\/QY-*N-B1(K/G,REI,Y('/A*DC=KJP,W<L)CT
M?)[*1U:CGEBG'S:#0:>LXMB_<7LT2NJ%5%.*_.I%H"P8<C#3L@0DHT?9LWV_
ML'`%K*)MH3O%5\:(&WPMO(]LD?RE&X@310>L\<W>#&X=?-`1BHMF&5<\3><Z
M\=F"&?+59:1OH_F'C"MY=L8>,QD;^1ZX4E>R7JP9$>_!/Y1'8\;S'1UK9V%B
M+HG9`?=9"^2N`18!PJYQQMB;L,Y8-$3\A)-#+^18GIMVR,Q=]N2,3]1BJ*61
M+CAY%\\:M80KFE&7*+SPK*[99NDA<+<E_%;?Y;1[#4A#<,@G#]:33B]Y62F<
ME0D84?+^.$J@@0RZF7A(^6.[1#>)RYY%-NMDNU9*I^"VZ[)NA8(?KSAIRXUW
M,=1+`^5))EJN+2_*7S[6N!PX52+/2LU=222,AQB0Q\JZ*Q5[',_$R05:P]JF
MH[6*)J(O4\.T"W-D\.E'.S?+G4P;5`Y,\NN<?N9^SE)=WJ_:CV=LIF:WOK80
M/<7;%Y[)$&B+-XU4>@TL\1K'KNE&F+EBX"I1G$#F:NABY.\O)0.?,&"*($6#
MGT\(C&)%"';":NWYLH1'#R$O3/[/?QV1Y(O$+8#639R#;]<=AC9R%=#^*G>5
M&XA`LE.5+?7IK%D9>R\4[FLVF)MB7.P01&W^-I!BQ5#%DWQ]-V728]CFRC#W
M+'`4X52OU\0V'B'&':!38Y2-;WE1K<''R'L5)=!@LQ.*&WY?9*NSY05A-U2;
MDKE(B[36&KA01HK<O=+!X=>.'%LG6-KYX!R"O'+>6PN/.F]>%9LYUML/4IY2
M0CI6#F9C(JOGCHW8$8BK90R#:H.TO)&<S]HT=HY9NT"0X$HIGFIB\LA8*>0X
M@<^E8S-4#7-XV1EI!Q)G<9),"A2/"K.#,SUB25ZS,1%D;Q)D3@<>D(=NV2P,
MHQAR7P?#K*+8]&`?D6XI\U-=O[X#^0)4XE--HQAQ,B@^1N%TW,7D'A7Y6YP4
M"FF``1"I.QCZ:K<*E&6SI,A(735^[;MTT5.H%@S?CIS;.[RV!.0G(P.RU&</
MQQY&-3H2?8L;Q;CPHXHS;N'AH0U>OHZL/)$D"#L<(42'R:XW!J^NBBY542"`
M1/A;S/B4$C<:9\O'F9B%QB/PX.Z9%96%CQV-MA>S4I`Q*QIHU7&1\PY;GHN$
M&EV*:CT6TCMRJ-L23EQ@N$H*\0^7LB!M(Z<Y:*+Q[,8)>N8^\8$SZK&5B9:/
ME`=/RM?XLSDI`QI-@BUZ[Y-%<W@VMF\P3R<K6L%/2#ASS];0Z*OR?)LGM28:
M^>&9:.01F14&7=&L(IL``]$1^V8.*QLDYV0I+6RC=X;<)*P.[6Z8I9QAGCDF
M'C%.)_>4E8@1*F>61:(R(XTCY"/00S."QQI!<64G9%F\*E4B!QQX;EN`(2U6
M2?%F!EH_DV+[-HY603;(.KALUO'C;RVG.Q?+#5'*\SJT2ZG0HFL`:9.G8@5%
MQD!@P=G9A&B@P\!)*-)J+D3]V'7Q2;'$3B/A+U/,>VM8*.-\3.?V2!`BRY2Y
MW;L-<,6(.!-Y7()2W5G(*0X'UWS@_/8YB^-$Y>]:)O6Q1=T-RCRM\!B"2@Y.
MZV06+K+B]RN`0S9KR3[K=.=A[&USI\`+P=;3V0;\B58#/IG)Y;"V\R<C\R.'
MEY&Y:L/4F+-I@=&*./X!%=(>QRN$&D/=];GD>E93#BN[\R.TY]NUEM"9[`SE
M>P1N9$'AQIMH=&,JNF2F;PBWB[Y7Q@S;*HX,'RK5-RNFB[5SRP"THIQ;Y4L)
M?M[":\G2$YU9+]1;)UQ`84:=OGUH\M)7:[6$N9+X8#4('BT7#7RS=2#QEXS(
M9N\VRZ*J;=%?(*-'=WQRBBPJ20*(<H%&6N2H4="XW_YW.A<KB\+$ZNUS!63:
M0$!^:RFT"[4?'C<>9.'[EBJ/%OV9G%14ZSR47#+/N'//%*$WB\6Y8-XL^Q0%
M6;EQ,KFJ*[$0W*NG;J"L$G48(#$UDWKBQ969N&;H^7RQN(<H)L<LE\@N?;W%
M#?&W-FA71[>"CO3;.0:0D9R'9F),(M)$-7R_6\J-11[$0#=C%D43AZ'D#.1C
M%:[IYD2Q#N&WBU''.@B4PX8<D"VV=I;/BW)A[$\-VFR3J;`X^J7BZT>#:^`2
M&/\`'<?#9"";XE\L1J)-%S*DG.6*)%SU^RZ4L>S5#\]67G8%;YYQ[E8S,$I`
MA;.2YS$M,'(\0?=[/1EY&01!DT&J7:#48,"8QQL"2S8,<$7CUQBHDI?*SH(X
M"X*\B)1HW=.MM];X'3:7[2=Z62#R]@2F#UU$@>JMX2#;*;)(R63:G7[MDU.6
M;#UU;W6OFW3Q6S[+'"V(1`;P5YRQM:1.X7S(90QW.;;+F\OPC8QVU#K[EV<$
MS7E4@1#$P9O)V#)RIQA@+_WEJXB+$:W48XN%5G"-!F0'!SF$.(DB+OEH>P?%
MF9,L2-H3::.I"0F&.F1$-A[9R^L$$MDHG$]@1L<0=-VJ+9"0MT<U7[2[A9QB
ML$DUYI?G6>UMND---BFXI*RFUXF]ARI_:)'MY9$X\+Q1F9$=)8':1$]*@]@2
M%;$BU$B++6'X-+LK))-7&=[!N5Q=TD:T-K8G%95+<I[,9%L;8^Q9=-E/#\%Y
M.<G<L(G,R2[1^Y=W&9X#UFZ&+)#.[-DFCB@VM9!-.U@V-H%`H%!UWOVIW_!@
MY!?G+XR_2&UQ0=A`/]R1?\W,OY,E09&@4"@4'76B7^J<VO\`Y,D1^E0/H.Q3
M0*!0*#0+9W/N):>V9)X7/=?2@=&`$B`1QG-6;E-]8W@]>Z]:RN4CQG@*`HE%
M-?);`P4,8#"I*0#[,5?#!+7!=BH[#'RWO,N.D2`F)`_2G[5I#SL$!;)N9A)P
M'AK)U/)JTB@IG,%G+1;%L<<#%'!EJQ0LNH\'-;WQRQS52QS#W(=Y'HIO:1LI
M*&V/%9'&2<WQ(@R$,+.TTHA#-GRC42NR%38YNY$IP=:<1NPY=UBIGFR>NL$\
M\,D\<EZ".C>],XXY&8T)D;6=QE*7`H,2CI+.('S+0T0DQF=QV5MQ.`@8X<OP
M.LCT!=LRQ;##P:[B_P#`8J86LIF%Q0OG7H.<-9XZ8/9>&MKO5@;<QQM+8B2B
MSYYKZ0!VQ\.=C[$QX,Z.M78@DR4NJACD@BH^1054P<V512"MFO>=\92X+,S&
M+[*DJCH0^=1H<.US(^VE\B$BH\:.P6/.,VW@;N5QL;*6:Y!/KV;H(99J8*JV
M2SZ`]DK[P2.1"1`$".M)0^A[G3.L]U2TY'_'DBDD3B^S`6Q#C5[Y*A8>]%D`
M\:QU]DB1<+&6+JZS]#%HT=97OC029?O#^.C,T-C;Y78K.1'C9*/1D&MK>3*$
M925#H;`7)(1])JU<8/[-;:BF&/6ZV-E+Q8AV?7M9M=R&6G7-.&`(_JV:PJ/O
M=@:\V0<E#5?8*#U<-%8Y&8A)Q<2)3%X_Q#F+X1TD6*X^+RS_`!&1I5+"V3DL
MT\)8V=A3']Z]QG;-`:AIAL:/OW@EE)Y4))Q?#-UK^'J@S1\O*)-F.?OT,VD:
M8C6OAC=IDY>Y9%&MD$5_X>Z(35EWF/%]YFUSNZV8R'7;I+F3I'54S9@XE?$J
M#"E$9205'=F,S`/Y,/L\RQLJE9-XFJEFJE>^=@P&'>E<:BH),U#QNVI?FXSB
M[9LP9:T/B,U2<P+%FL?#7(2),2)3*%`$<)FT,+K]FH,'J7MGV^:*"@7]NOF-
MHGC].(WKO9,A+#Y3)XP9F#)H,C1HRU9`!&+W!-Z;),&BK`,F9?CEFC+)PIA@
MHY3OCGDGC>V5PHEUWG?'E>-QZ8Q(7LV;1<H>R`G"P*!F\L(P\'PV43B5#W"6
M;>]RQ^$Q^-V=$V3.ZM\&CK!9%1:V.>-@G>V>?&E-0S-O%#:$K*,48Z^/'96(
M!NLX^)<8QZ,R@'&&[QY@T1+2N1!9>/<HLTL\>R;N<<U,[?OL<0@$3[TOBU+"
M^0)JYV$@5>.^RB[6VOI$0O+F19XJQUX^%9C&KO!EGM5=HXQ!-G]VCE11ODFY
MP;*9)8J!E3'>,:BC0GB\;E`4Y'F')4<</Y6(+M,7NKXV+10'CR\R'XXW=YW.
M3DN*`H((X]I9X_RROTX-E^@/U[WD.CU&X[R>"[")%7)B`AB(@W$#<16`O=E9
MGG$1'EG19AFT;&S,>C;LP@URRQMD,3Z^:B:N:2*@>G=G/E/2.QR^OC.F9&?L
MR+#T&DCC<D8&1+0&A&I'-9:2G68@43PU^6#0F+NC3,<[45R<B>S=/E1:2J>6
M07+R6Y->K<E'";[7I2;`2@^7DR^<>D`=&4,&41!+'R#P+$'6.3X^,$#FRCLR
M^458,1###M,EEEU$&JH5?;FN?4;/1K704D>S@=!]PR-P#93,`^`D)5I'<\:T
MW,H'%S3%BZD\G*7=25(DSS;`.V?H9)-&K=<@IDT2#,R[O`^/D!::DRE[V4,2
MNZ=8`-I0H&(CSB4OW@Z3!7AP&`__`->5?I*R$LV%/L6V*=\VRN;-2W;6ODEV
M@8A#O"]1&4)N0A\5V7+`^O\`1FV-U'7[:*KA\UG&GF^NW4LUD(0/YC$R$_')
M;(9X.T;JIMFB]NSR5ROE>^`8V&=Y5Q[D92$160-Y]")]/9@YB0:&%H4??O+(
M6F><"&R]8D*8.1GD42D^;=EXPQ4NFW<K]"ML44U%L0G!3F8!CQJ09GX,71A#
M6>2W5$-+A#0F1S^>;.@TB'1F01H3J5CCA(4V:KYRZ69OL%W&%V0]5P]P8I+,
M\G00T7WE_&4]9!6/9[2/,RCL4/BA(9JF7YCYP2D4H+0V+#HBZ<,6^)-Y*9#'
M"J++'/L;98BW"BMTD^QR5#CJ]Y]Q.L1<"F4@FAA^V!B).HV"P&0DEL8X_B4C
MFQDTLBW;W69-(3'XF04-8N,45VF;>Z>":N>6%L@FWKVZ7L8C-O\`S^\)F$ZC
MFI`D_P#%;M$,AM\R@H^+P&2HO4&F<37B+%PQ3?/'RB3>Y5Y<8CVC]NNA@$4D
M_>,Z/AFW]QZA/L96L3U+G$V*#V+BE)8YG1LL.\:301&@@G')_P!?5S9^-\<*
MJWLFGF_ZF-^L@KC8)$%[PKC,<6))H2*4LD&*+LBU?EH/)!K`]'VD\PUEE*`#
MARQP\8Q]><678I+=&&>>3553J=E;!3,(@U[QC5,M@>XYWJL`?G+33U]9C231
MPB2#+D)1LW8Q+7P\$FU&`I2:43'XMVA/)=@Q)J.6;]--!!1SAFA8,1#>]`X_
MR%J!'EF$X:3T\Q'NF4-BD/ELRP).)#L9SKB$,`IB\<CZEWL]=))D1K8JS$/D
MQR^-WK=FOBHA@'.DG>?<:Q,4(2B-M=H;`RM')')XL(BNO3.+R>#H9&I!)9NK
M&71VP<79"#8QAVR,*O%VN#1_A9&W:7SPZP6OL_F[I/4LN>P64);`=2AJ0"Q]
ML.CL!/';&)F;'10XE`PSMFC=F^EC&-3D44=(=IBB@P>64NK>Z:N*88"3\VXB
M!G#`4RC;\SKE72&N]ZO=AMFTX6<JQW:Q.:!X((`QT1KDV,<2`X2BB"*34P9!
M+K*DDL$$ULL%;8AA%>\>X\V63;LAVWS#C,RO&,T0^IY4^4;RQ@\U\&,Q9SC@
MWQNB9`2K:T>#O;7_`(!$D3PP[7)-)PJB$UV#R_"1;\F:D5@A^;C=R:K:[(UM
M),B@>+QLR\/["TEKJ'Q8IF35<24"N8?[T&/GCQ85DW'#T5;W[9SU6U!52G>/
MZS<23CI!0<8(&YOR(1'(-!C8Z,N`UD?N=B0LZ"VI,&J#X+#W+5I)NN'Q=73=
M2A]=FP%MUW#]&V(94KWC.F8E)]OQN?QW8<5OJC81'7_A[>+$Y.A)':`9R^CS
MEIXA:N4F#C8)8`>8@&>:BB[S((KFMX-VS?!0,E/N\#U5JW=)W4FPXCL:+"XM
M%A4HDVS70#$C#`+<VIKELPL4\1N"A1FR0(;*9,W;I1'%)N\Z,+643RNK@$N$
M\Z^.Q75<6W+X_DHR#3`X:C`9X9A$G&OU),#RMFJ`4&+CO"_&9%E;-TQPPLIB
M\;(J9I99=GG:P57AWIW$18;$23:13EUC.K$DHNP1US*/'!4BT2<NQ(EN(59I
MOU'DN'-%'(I3'#)HX2QZN:R2O\'06+L;GQQ]UCL61ZE/.)X1V)%T(Q8E&8OK
MZ2R)?(O+&T;(C(PU?CFB@A:1)!I>-?+(7<8X8,W77MGEV:UDPK-SWIG%AC,6
M$=($YFU`R$7'2\,F_D-*'`28C2LEFL4D!X.T;BE"MHG!S,-R;DR2J.&":SG&
MV.&6&&2E!.!?-3&=QQD9U1JLU("!O>>.EXX)GIR^L,2R>7'Z_(I&:K.G<?D3
MD6&*0W&V#%)5KUE\U4LU,T$\LKIA&X-WG'%W8&3-F`(3QP<<)`\W(5&`2%WF
MRN\C#^6RS.Y5HV5!O6FL1(A[E(%V[E5-MX+E="[C'-')0/0+[T/BJ=9#R8%Y
MM`V-(-G)#P\9J2<+M&8A(.:E#,V]5R%I]F),0^./B[1;#KV49-5+96P<6["@
MQPCO3N+R@R-*RUQ.X7(9"&)R7.+O(')S#X9%&#9JX9S)=R%%NFZ\/D*C]N@.
M?)].*ZZW5RQ3Q35SP"Y)SRN5AQW7K-OJ&:'@FR=9R><`7:+\()D:4G`Z^EFS
M1^MBT<,KLV,?D4AC,->6;9DR;&RCO'+%'!9%H278A(ICR+<`..L.Y``($K(T
MYA&(1*FL-=RL5'R>#>:@VQD>#8/%6A'.0R\@Z>("10Q@U7<%C+MLAA9))11P
MB%/0KG:WF3J+M$=+3)JK-9^%BH#"TEAJJK2/RZ$[2EL+/RI)R3'W!G33_4[\
M4X#H7?\`BUVN@HNZLVOFM@&;7YWZPAFG(MN#=`Y_K<3*=BE-<C[BG5I^#)+C
M3+L3C,HS(1#-AG)]>N[-K+(E$&>%ET\NT0360NFLH'%C/>#:7G4FUM$H2&V*
M6-;`F,6B[M`K"S,8QA+&<PTK/8-)96L7:IHM!TXC(N[H0GCEDLZ3RO;.R2F&
M2=!"&7>F<8FHT6I.%)]!I$_O(W3B+O(%*#;YA'H\LBWM-+N@8MVU>0XP[>M6
M[1\CUK9N7%L<L<,$U5,`YSGO...^,H1B[!ALM^Z&G"HB>*6U_(F]X`W`0R62
MZ3F"R>3)1(@RAF4.>,C6#151<>NG?*^"B?4RS"TY1SJXZQ'53_=!>2F,=?BI
MLVUZ2*(QPGDZ9RFT<1E)T>H,531?*J0T7DOB8P2P459O&+IIU,G2&:-@@U^\
MKXN()YNB16?AAC43E)BQ<KK.7MQH&'N5X^RCDR,+8#EE6T<FI.5#V@=3'#-9
MVX<6QNEA;!3+`.`4[ROC\)>2,8Y&[*S-1=D24.1U&!2"QZ-EA!D;%'D?F*+E
MFV%1HDM-I`*#MLLGBS=9T314NI@WQ56P"41[G/!=BZV,3+5,8-'94$V%J'5Y
M"`3E1;7!$7*MP2>,1</D:=.!<@?L0`]W(5,KOT1[I%_BQ5S9>$HY)+9A#6G>
M9:`'(.\-@H2N%D@3DV.F:3*/F9H%AI2-D!$;)HEI-'1:HMRR)3,TW&AW#2[C
MQGDY14ZB%\EDT`F\WYHC0T=B\I@^O"TO'/X[OJ638?(C2>NY'!1/&PD*#;5#
MKB"P<F@1FHHN05;-V*KEBQ<*-<\O#\$LDU<@A;CO/N+HN,2B6'"4T&B(FS)O
MGS[R'D=QY+`#>*N)*UCSQ^P&>."<5#SD0](ML,,54DGG41LNHDKAB%@\D>:<
M/XXN=4J%8H<EH#;,1VE)0D@"/631%L_@D5!GHC&U&1+%)TN2VN:D3,&(O;JV
MP*NVZ2MOX:W0'#1YBNER&KUL=6.,8G-]><89S*#.<T'V.0QSRMFAO7L`",8U
MB%R0F%@TH#VQ*KHD&JB;5:RS=!S?#).@W<H%`H%!UWOVIW_!@Y!?G+XR_2&U
MQ0=A`/\`<D7_`#<R_DR5!D:!0*!0==:)?ZIS:_\`DR1'Z5`^@[%-`H%`H*O*
M:1TT;/&Y29U/K<M)9+85:1'R4)C;XR=\1NQ3\-<N2<C57A'(6]!,56]U<\[I
M*,F^6/1=%+JAAV7&_CT.N&R8:*T^SRCH]R)`7;ZVAR5PHQX64/.AXJ^`>UV#
M-P;6S>9II=7')SGDK>W7RO>X<Q;0&B7&(#%QIC52V,55:KQJRNOHFI8`LR?&
M"C-0/UA-_%V;4I(7[E.Z74ZCAZNK;HS54RR#C)\=./R+Y8HCH[42))P6"G5R
M".N8@D]6,QM%TVCQ15TF(Q6S?`T'R^#12^5\F^*ZED[X]IGTAE,M'Z8SN=OE
MJ76N5Y/$V4#D?3!XUT'80-9M!P^(%K>+>A_&60]@W028J]9M@BW2PMA;%/"V
M(8Q?CKQ_<QY2(N-':A7BRUW-U8XKK>'Y@U<GN855[DH+R#W99Y/%(V.R5O?"
M]U;L&_6Z>Q3ZH3G*!P?)B0&90V*9#2P(7%RH^\>$78DHR#3>(A8Z_:79^#O`
M8A$@XP:M%,<F[?%=2R>&-L\ND(:XT%I59^;-(:L@`R22`F\/$I8(B,?&RO.3
M/7+)^I*T9$U')E4)4D4&MGB1'%7PM-XV27QSLKACE8/%CH#2C&):S@]]70@C
M&--CPXW5XTY'!9ZT);@6+(>,4`.##9ZZ8/46PY#K.,,[+*YIXYYY996Z:#@-
M^,_'-JZ?OFVA=-MWA1QDZ).T=9PU-P_<YN$G:BSM;`-91=15RA@IG?*]^OEA
MC>_3?&W0$A':5TZ(9MQXO5&MQ[%HD@@V:LX1&FZ""+9<2Y;IIII#,<<<47(%
MBIC_`+%&:&5O=23OB'":Z"T6Q$7`,],ZK;`[Y)YW$(Z_BF`V^:*9M)'.[/$5
M9O?)!&3$L,+WQZ<,'[C''HLLI;(/84T7IH^.`BI)J^#2EE%P+^+@,99&A4I7
M%QXLTLP*AVSR0-B+RS`HSMV;E.ZE\5\?<SZU!P1_'7C^*=I/QFC]1#WJ`AR`
M0=L]<0]NY1!O<2N#T0DND'Q43'/<#KW%9&U[)JXNUK9VO93/I#D2?0&BIJ4L
M<F&F=5RHUB&8QW$O(8!%3)/``+>-R`T*F^("G#I,6P?-4ED4,<K))J)898XV
MOC;H#B8\<>/F'A%D]&ZB3L[#NH^ZQ2US$$\%P3UBU%N@RN&`C'',8N-8HM\D
M+V[.Z*>.'1U;=%!E"&C].DH<1U^OK&"I0TI#&NNW4=8Q<,.&6@X]1XN+BS5L
MQ9MTV04.[?K+LFZ-L$VCA2ZJ-L%/WU!P(OQ[T5#(T#B$:U!K85'8XD$P#C$(
M7';HM%(WB7L$>]90=FHL3'9R`@HFZSODXLJ0=*=?KN%LLP../.A'9@[(76EM
M5N3LHD@V920NX@,76(GY>'[/Q7*C+M07DL2D8_%'#%)\M?-SACC;&V?1:UJ#
MD/-"Z6)NHL0,:M@I\K"!ID-$C,BC8R0G(\'D3A)U(!(LV:;ORK48<<H)YNV^
M*W9.,DL.TQRZF'0'NST7I12)LH'GJ+6F<)'!GD='Q+*#1F\<8`"!H9)'X5D'
MN,\`:BWTC"LR"R&">*:KYHBOE:ZJ6&>(>XMI/39XP$D)S4VMC!Z,BQP..&2D
M'C+\F`#!\GF0@4&?.ABK@8.%9$''@R*&6":';J=2V/:9](>+72&F&)&0&&.I
M-9LRTLC3R&R@FT@L8;/Y%$2/9^,8L;=HB\%RD>(=CAV[);+-NMU,>OAEU<>@
M/U'26FF[F.O&^IM;-WD0<L'D5=H0B-(NHXZ%J/%AC@(X2&XK#%AZY!=1')&^
M%TE%L\\>C+*][APS^@M&2LE)S,GTWJV1%YLT9,)B4-P*+%",I9#EQSI@UD#U
MZ+6<ET&;D.S43Q7R4MAFT0O;W44^J&,F'&S0<\C2L/D^H=>OXVN2`EG`I.*!
MF+==W&Y0XF(S%?P!FVR5:>4#YVLNAE>Z+K%^[36QS3=N,5`YK/CQH(<_?%&&
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M=J?6T5$DW(9X2&QV#QH,Q(NXX\3(QYT_:CQC=%XY`D$L%V6:ELLFJV-LTKXY
M6M>@BTSXO<=]@)$4I;I?6Y7(P4'ES3C*(A&[TVZ'SYEM"Z9IZU9HNRK$G/&&
M!)^V<9J($'&:EW."ME5+9!GDM!Z,06-.$=-:L27D8_$0?63U_%,%#0K"-/X9
MB,)YXBK9/6%H@5="NQ4ZR?BYRJVZ.Q4SPN&3<:=U*\DEID\UAKYY+L1XD5:4
M.X='G,AL-`.$'8-A8RN/4(>"AW35)1MAVG50S2PRPZ+XX]`95?76OG0@C'W,
M&AZX(Q%QL(+!E8T&S%$X8%2((!XD_89,[M7<:$HEW>+5BIADU;XN5;)X8V4S
MZ0Q0S3NI`K4>R$:NUX+:";-O%;9A"XXT0'>!Y1;)K=DF@-PP:Y-\H,$OA?"U
MKXW#LKV]UJAV8<\MK'6Y\&WC!S7\*+QMI&'<*:`"47"/0S2'$,1.#Z*-!KAB
MHS;1QY@`8649)X8ML_`F_3A?L4^J'B[U?K5^*'`WVOH2\"B`HV."13F+`UQP
MN/!B`@L(!CF:C')NR$"BL?8.FS9+'%%!PR04PQQS13RQ#&%=*:<.'$Y.:U1K
M8O(TO&E\#Q.#QE\8QN<R3R,Y>,G0Q5W?,KDCC=QE?/I5Z/WW309$GJS61H\0
ME)G7<&+28L/%""LA)Q,"_-$A0(LS/!1S\HZ8*O7;$0<'-WC9)3/+!!TW25PM
M;-/#+$(ZKH;45V6NQ+2"1\/']53#*?0>+@![8%%P\O\`%QL:@<\GQ2;06Y>,
MDY$[60NHGEBD[4LOC;ML,,\0X37C9QW9.0SQIHC3S=W'.CR?<HZUAV"X3H>O
M26%Q*M@_7'W3($G"V%TKX7P4<*98]%U,ND):0U5K`O)7$S*ZZ@Q.7.FX]JYE
M!&)@GL@<-Q*V+@6BL7<L%7ZB8Y;#')"UU+]E?''J]'5MT!&6W'7C^S)^.F>C
M]1M#'C8,>\:M-<Q!L1\=1Q%=O'RGAJ(C!QX<$0=*XM%.MUF]E<^SOCULND/%
M7CEQ^6B5X$KH_4F<(O)<YG>(7UW$K1K*7*LLQBLHR"6$V'7D"HQ3)KD\NGX1
MDURNC?.Z=[XT'+(:"T867>NBFFM6D7!(K'CI!9]`8L[4>FHDWS:1<LZR7%*7
M7(QUHIDDR6RZ5&R>5\4[XXWO:@Y([1VEA#91F+U'K(<T5N]NHV9P2+MT%/&*
M)EN_MFDD+QPRQ>-I$024M>W1FD^7PO\`O55+9!B6?'#CV/00;,-%Z@9-6I(V
M8;-FFMX>V;(%9*P1%R(BDW1#X(X/#HULD@[4MCUG"26&*E\K88VL$S>:VUX0
MDH^9OX)#WLN$@',5%R=W&@[@^.C#S%QBZCS$NJSS?M0CC!VMCFUP4Q1RQ64M
M?'HSRZ0CIO1.F),$\FI+JV"2.-X'P<I:1T_&11H"*D,9C@Z(QPN##$FSH<!>
M`HT*09L\F22'@Z.%[)]6^>=\@YC'2^GQC$N,':KUTQ'2`\1E)Q@TA<<;LS$E
M+BW8,K(2;9(=BB]-D@S]=HNZ4MDNJV743RROAGE:X8/U<N/UXI'8)EI#4RD(
MB#U4C%(@MKV*+1F-/ET,FJSH""5%9C!"RC;*Z=[H))_O.C']RUK4&93TGIM$
M_'I6CJ;6J,GB6>*D6D24&C*9N-J8`V$834!%,!F+T2HE&A38?ADAFG?!BW30
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MI9987"PQ.A='`620X+IO5@E@@/0%(LQVOXHS;)C&IAE(6P_%%`3AAX$A(!K=
M]@ET=3%X@FM:W:88Y6#BMN/&A&4:/0QEI753.(RA<*YDD9:P"+-P1US&UF[F
M.N"PM$7@S?K@'35-5EFKAEDU5PMFE?'*W309'#1^ETF=QZ>HM8X,,A@X)DRQ
M@46LUR#"$AB`D5DW\5=ED.&(A&>#="]NS1Q:(VPM:R6'5#B.]`:+?AX9'GNF
M]7.P.N7#AU``KB!Q=85"W#M=-T\6BX]09DU!J/'26"JUVV"?:JX8YY];*UKV
M#\,<?]#R%AF*/:5U.:&*/WY50<4UW$7[%0F5L+Q*$,VKD0HAF\*8!&>+E2^-
M\W&#1'%2^5D\+6#,_DCU=F/%"G6OH@2'`2#\H":&``TRD#?$I2RFSI8-XU;O
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MF=SZ%G#ASDR;9^#N+VRZMP]T>U/S>'ZXY,-)/(XO--B;@),H[%7CS:!$`+B4
M=>:\6A9N6PI6-:P&VA6`N1N;%Q@>Z#U]=LEE@X*JN[X*V"(CM/=Z!A>2KO\`
MDA"KKCS<J>PM@Q#Q9F$))K3#7Z,9:',7VN)`8QBS?6R<@QLULZQ?HFKHJ*N'
M">>.280:6\7N\?>G6TK$\D!;T]!QCIG"GSXD&;.CF!UT`;R9U*`@G6@*'$)6
MUC+D\Q`/7#;)L,NY2S[+M,LUL0VA'Z^Y>!(;K8Q*Y<-W!LN+[]<S>5B6DD'Z
M[CI366>NIO!V,;"YBH:S:98MBIQ@869$4G%E'::N5G/[QOA@%9QG5W><I,B&
M9SD)J[(J2V.3S<)KQ88L+%:]<YM$458GX)%+/,'B*)!TNV;$,E<TE6#=-17/
M!9:]!:^_([S2FOD6_P"/\J$ZLZL3E3,T-E9*+.U!LNS>-4@QF2M_(.<(2T>[
MCS=RFR;CG@GQ<5<HNG5GJ">;7$(;NK3_`#GDLT$BM8[PCXS4R.IH?'"-CS00
MG*R,^'G'.4QEA8HUB3A7`Z387'NAKD<DT9MU&;E+)JGVV&5PH^)\=>\R@T6A
MH>,\CQ2MW4B%&M@83@N+V"::*I$I0DY3CLC*:Z'NW@8BV7$O3*#K)15SD@LD
MQ\$MEEBL%W;)U)SL,ZUU3$X?N]BWEJL-F`[<4PS)1X(NI,Y*]#+IE!W@6K72
MCZ-`XVH;&!4!F(!\/(+CGRZ[RS=2U@A,@XN<PA&Q-7GM4;U)`HWK;CQJ^"M!
M$BFRAV-E]CQ%ZF-E:\IBA*#$O'HZ71S*ZK\K@Z;%'3A%.R633.W:W#%1_2?>
MAN032\IY1@&4A9#25L,`8R!(C'YW./[*526+>&Z@-N5@BL^PBJK;!!1NL@`S
M>MU,<E\;7S"X.0#3F_.)C!V^@']M3#LM9[%<R%U(R4'?1D;/$I,!&Q.QILK!
MIT5D:Q*+>,5AZ#-V,;L'"R3EYX5V%VF00(UJGO'T31)E'-V1U_%6\V"YW>28
MG$5"TGURR?RKQF,%MAVDVF$/D1B).P;-=9PL3Q\=L7KY')%LX3;4&!B&K.]#
MCI:-O#^Z-;R4*#V3`712)#D0H,(9UL,9%&TH%-R-X`\D36V0A1DE9/M<%G)E
MKFMU\&R^5TPV'W7#>8LY(C'>GI_$]<PR2:^61E\/E[`46DX"7/@A.]FH0NS`
M'!ETD'^+)LOGFJY2M=1TLGU[8HX7"F-"<<>:&ORLU6G6^"4A%2]ELX.X8OIH
ME(KL%'PO/\F<MB[UWKT>6C)<,5<YHW;).?`FP]-+')!PKABI8(=!N-7.P6YT
M)#9+M`"YUKHLEK2RQ)+89E65;!'`Y>H8D3F3*#X($>F'2$-\%#Y8$7KK`JY:
MJNE>SR7RSS#//(/WE$FFLT(A=G,89!'.VYZQC(XV2@2IIA%FFSI6U@LN9,4-
M,O\`#/7K35V+%-Q'7+U8V9(=D\L88XV606#*']8]YZZ)1IT.Y`ZI:,F<\R4*
M,!D8'88.H5T,7K+,HH3B:N;K-!11\P=-V]TU5DK-%TU;*8K6H,CL[2_.F[/4
M9/6F[7;N4A]&*0S::I&7QP$T/[17>"2]IBP'+Z=DD3_@I)C;)5Q@);*9Q]HX
M'(I(JO<5T@;JUYWDA2:SY]J?<&NF,/):\AP:&A_!AH#(3+;9Q).8R"S@E#)>
M_P`2F!!J:=M\5%5&BPUX@UZ4W"5E[!'H_I;O$B,RA,PG&Z@38I#,LERB$>DH
M*\&F>1V9:E<'06$&MI1@[$QAOKF/&F>2CHJ_**'<[.62XYNX4PR"QVNE>6<D
MY,QJ:["V>@KHR`[:E4W"PP/)FK5,Z,?Q#;$<@S58((U\!>8BHJ/E`#%Z-+%B
M]GAY@L4171PQ2;YA0Q_4'>F']<'H"0VK`'CDZN02\LFDR81B6,Q8Q38#U#LG
M`?2ZS(<7EA(Z!205:86;C&8*^>:.5W2S+(/;)]&]YI*'J.#K=<<Q!M24//#F
M>$J#"W36[47,`+Z,R"X#3@\?-AZ#61-7YG)=!F@1*#DU6:2*62:#0.&MH'O*
M7$-B,#7W$'78P11P\1DCW9&#N13UPZA<=BXT9.G=M1HNSH$!(,3AATFX7RS*
MX/VR>?0JV3ND%IQ#7'>,C)*SDLRW&",1^,F&9=Q!!3J$N;[!ZDCA%IJQS?J:
M>CZX:-'(DVD%XL,L\1=AGSEMB0)/,;=HW">;:@'-V9[80=ZWVJPUGJ,LGKS$
MHU;/8@O(0,>P+@%=D!PXPOJR76OL==%-_FT-J%5Q7@.>+3%@FYZK_`*YV3J+
MO#7I:+R+6.WHF"E:_&76L(GI`J68O(4]V_&6>U7,^.,8`MKA7JDY.<EP;,.8
M:$!K9EBP5L]'.D,$&^05RIHGO1H[")<O$>0,4+;&GCQX0=YR4H"1"1(FTBVI
M140+Q]K?4II-%7Q@`.8R)@FIB->8*XN6B6"RJB2@2P9QTYQP73F^LX/M@8\Y
M!;4GT7)Q@Y(9X_+1F"0\:+3P=CHVC(($<;C4$)"^>N,F-FM\%T%L[XKXY]1*
MX<8QH_O(C=HTS/;V`F`Y65PR2S@<'.QZ(9@W@;>3F2$10`F*TS8N1UM^1<.Q
M'*";+M"KXTZRSS)8-L%[+AL)#-8\MAF^Y+*9#M@1EI$E-9)<7KX;@"R["$FP
M^R7+<HLJI`D9!:;,)2M%<4O_`#C)G@Q0>VOAEGGTJ!I]%N-7>@0.$`A$3Y+B
MU2Q`RR>3G.<FQFQ"B68B+Q..C",9D1O6S)UV)D\.=E3S9UVF#IM:R37!!=56
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MRN"3"<B(\36BN.9:/2(N6C8[M"#_`%1*P4K:3",@--"&DM*NYY*\<XTMX2R%
MAF;%)5XS>+X)WN$E(Z;[S!4+'$\=\P\^7(X2D/,QAKR8#Q-`$_U%#04<(HX!
M-5+G5I$.V#C('CK'!PHT=JKM[]5)"V&+4*_@,6[U&>);'+8[26UD\CA58-`A
MNT!&NE@,KD_;0%G)),N&`:LN?2U,DRO(U@+&Y#P]-UDVLH]>H8XJXA;VJ=8<
M^`.S=13#=,^;;)BD-&'T#D?`2>-Q_-XK+5'4?9)G8^R@85I+9!$FQ#`BL5R-
M-F-V#6Z*`U1_;PA<)_!=8<S(UR6/G"FT&ACCP7V;+Y6@!+25B9=LX:=C9K%*
M*H!'.O$#K1PTE"X*XBS:0(,A3461[5-W=\GC0:_2G6G>E1]P+S8;N:S8.0':
M@$&!\=MKJ/R-,P4D$24VT_;2,OJ$L+!,A*F)W)J^Q#NK6!+M&^+7PU+)SB&>
M):=[TCJ#/!^3$-6<NH'L#RD5'`H>W;MY^\+SM*,X1Q$AKKH;@\8VI%LA_;89
MJLWS0GX4JKBX24L'Z+U/WII-Z;<23D'`8V@H,&NPHV(-8T\:MC`K4\C1#C<R
M4EU85>.6+O;^(Q61**-D[OQ^:EV=V^.-T,PY,BXP<SR\9XV#1V_I4&D.NQNQ
MV^SI`WV7B\S/'EI^(DD!DJC4MKDF.F"EP@U9CV1!KA@P9N\D,DW%\LE;!9>N
M8=WA0&+;9?;%V1KJ<3=S.M6'=;A!28V-QB\3!SW$OLZ*H%?(U\_"-Y=K6Z0=
M!1XV?+H%$5G*>:."V*E@HV3:'[ST_KMZ!)\@0!(S,(VZ&2UH$D$:AWB$UF*D
M`@2O"I4.T9D391O!R^9/3>&:-BC_`,'O@Q<C[]/:!E5-0=Z:K&9:N\Y&1!26
MMWQM[#QP-A#@X$F[<R^`J-VA5<AK,T3:1#.*#SN+-+!PF18W>XV55<9X)73"
M(L(9WFI?;SW7.>PR,'AS)E*)`=V#&D=>_D]4'FS<7,1"+0%>3ZB,29]-V+IR
M>2)OG./@V;')-.[5LHDV77#.D])]Z%)AY47,-YPAZQ+S^+/UF<+(#()@/`#I
M$.,.<AYG#6QP\I%L(XTN/?B,,V1(@2_WA$BV;9*IK!=R.MN<)/EFG-9%L4&W
MXR`-C-#4?@$>E:+0N1COY/-FQ5;`\WPUVR5)"[E90&?K"7)!2UB`VZZ3C*Z2
M62H:ZC>-/>8PF'25M!>2C9:1R&2/52%YQ(QT[<8!10[4(B/EHH5.:W04"R(S
M<%)%GR3G)8?@S6;IV1\+4S<X!;.]^//(S8^R69Q@P:/`X36VOALA?"M[3B#M
M-YE6,KCA;96O)+%60UT.UQ#"0(.Z3%N1":CER2)9JO<TT$K)+!B)+Q-Y+.((
M:"H;!*2>9&XQQ90%25YO/8(1""[*U)"97'IS.!3/Q$12(QPN:7%K/!N.#1R8
MQ5=DNV;F$6J]!.-B:)YF&N04QVE!-W"8A`YTI`]6Y0UBZ>YEH+J2)R6#RHIL
M.,+2$=*X"OM`^I>9C,T%(Y@I9B?9Y*$E<AK;!((2/UIWHH,0@\SW9KV92,N&
M+CS@LHXC(8''CS@;.@<:D,6<C=*V=*#PN3T$6(,W>*V3YXU633R21O=-4.()
MX\\[Y['N2X?=^U`"%]E:MV=KC5&<(G1D60A5IPE%<6KVQF-0N&*,GP5^T+K#
M2R2.11DW=(88WPOC=-((F+X[=Y[&YB4D49Y"ZX88S5PL5DS8QF4F01I)([KR
M.Z\ABR(R1@,E1T/=AXG@\(L!'@:JLA(+OE<ENG+*@YL=X\=Y,J>!%I)R/0;J
MEA$4'2\LS+195_'QPN72%4NQA\?>:I,11G)"40=-$7I7!&UB&>&'6P35;X+Y
M!??#UUS%6V/NECR:5,.@((1!A$;++-(FPALBG"9O82LN,ZP8AHN#D;2'7B&<
M:1S\9NB%EW^"RR5VV>:[9(/H#0*!0*#KO?M3O^#!R"_.7QE^D-KB@["`?[DB
M_P";F7\F2H,C0*!0*#KK1+_5.;7_`,F2(_2H'T'8IH%`H%!JY).7^G@>UH;I
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M1PV&E228=PJU0N?705\68NT^S44"W&?+;0)")22;,9L]>`XG/W.K#:36$3]Q
M(DMB,E<D7T08PU*+9R\R;89I*^$),F+BZ&+=?)3JXH+7P"FG'>*:+:Q^+2O,
M%MAW&IYM*9:O@Q@+KHU(4)5G!Y]$];DYF+;A,7SY6(%I%+4KAU,4LGAENCGD
MS;JJ9))*!/1O.?B_(P>RS4*V>.G>>J(:-G$L#15D2<FL1!MHV<A6XUN1:#6K
M\H_</F[/-"RV-V#Y?!![=MGUK8A[2?,K4<(PR8[F3E&F):WPP4(0^3@G,K?,
ML7RYM*,)W-ZM\O8HL1GB<;(*Q\=B_P#&IC!@ZLV:YYMEL<`X0KGGQ4-.D&;#
M9CWMUFEW^5GFN=IC$V3/-HR=CW!9<G"6:`9,_P",44!7A>2-R[U2S5EX0YM=
M*P(_SUXERA9LD&V\R62<M[+V)/(M.A()NI8FW#N!S^0EHNQ!#3C`BZ3P=CW#
MA)ZSQRMFNDFG^^H,T\YEZ"&3S\G9>2'A)E6/:VE3(@_@TSPCCR/[5=9L(P7S
M.H@UF(84V)*,VA)X2NQ9C'A1BW<JIK.DT[A%2W/_`(LQ4G)@NP=AY:W+1G8A
M[6N3*:Q^0#/'Y>.D2@TF7B+Q`8\'RF+,%`SC-\09++-Q&.-K$;L\\K87#F2W
MGAQEUS)-CQ79L\5UR3UI*T(D24E4>D"(Z0/5HU"94JXAA,<-(L)0B+&SUCD0
M1:J9O1F'66=H(MNHOF'LAO.+0DW*KC!A@VU0%PK;D_DDA(@G:$/B\<TP6B@^
M69E)BEX1&G1/(;-!Q5-DQ=/':`IRDX=IMK+(65"217F'Q[FTH7A$9FI!Y,6H
MXL^>1PC!M@1E^-<A&QYZ1CAO.518(RCTU081A^YN#?JMB_@;51QX/V%NTH*(
M@W>>\89>)%'R[R9Z]!$-6:JV8^+S*-]=I&W6UBLQ$M==R2T4>RAP+G,.4ABJ
MQVV6%Q+!N[:YV?*64OU`OB7\J]=A-9'MK0YF>VO&8H98!Y3:#XAVKP%F\CS*
M4*>$8S8O$6[TD@,*,D,1;11P77*OVP]-KD[4NE@#2/*>#[[!;'+PD#*[D-:/
M,FQ>)NTX_E*G=G(M<N#03'LI`Z;!3YILVS3N'++CBPUS;L2#=IG[E!2*'>*Z
MY\`DQ)_JO<;5O#H_/7Y^S(;")!GY4P$'L25.H)'\H_."*$L)G8IJTP_'E!V;
MB.JII88*$$E<LL,`N\5RF@CF4;+CD@!R^&-]::VB^W7,@.CF#P7)M>R=,MBF
M?B[:,DSYQ_XM>A'#=PVS:)NL<^ROBGEBNC?,*Q*=X3H##6DHVU%E)7-(1%IA
M&X:X/LPJ<4!$'4CU^RV9B4'R+8CV'@/%`N-.\D7.:[E!:QE+Q9@GD]5114#D
M2[G;KJ.2<9%Q,&V3,5Y(K#`,-?B&$:#L95L78+,49B>N6>$RD\9(C"Q*+F$B
MMR+]!J#P9VRMX;=;JI9!;4=Y2:6D)+2,?QE"PB4\AH6RG6KHT8#%F[XT)>Q@
MC,/`UR+9F\CC`VV!!GJV;-1]9;.S):Z5E,<.FX>.H.5>A]\&G,>U9-'<B+-@
MV<ANW=PN>Q=%R%30BSS,@-?2V,`F!9#$?.`KO_=55LO`R[)QT=BY1SS"`3#F
MSJV";QD.DI*,D35W$Q3(K(Y.R4CIIN);/H*>V$D0<0D*=(;24C:8:/*-5"Z8
M/,=B67;L^UNJMC01F4]XQQE#Z]=;(B9^3;2")H)^+DM?P>7/U)"5<`L3Z48C
MQ$F&%1\G*V;-=#(F-Q>6>A$U\5""3;&U[T%AVY=:W,:DV)MG7["2[)9ZPAF$
MVD@6.#%!GA3%$1D<-C8S+Y?Y-Z^E)F-L&Z^+]!B66NR=H7:N+I.,L4[A&+\\
MM`@W.`/8Q8[KN;)-AKLQ#'47DDU?1M,K$<YTTQ/G-:B)C$QV?DJU>/LNL_Z,
M6@]TOT]BW5SQ"W-;\E]%;?CT^E>L]D`YG'M8D"@R;E`B9%P@&<AV&11VIACD
MQP6*L%!^&2S9TRQ<-GF&-[MU%>B]!3&/>"<<WT'V7L:,D9Q,8CJNVMDY"3CF
MO94KX8^VA/3&M`HH(T)#QKU\3"3`"Y;&DLDTLA%L.NOU<;VH)-K'G'QDVR?U
M]"XQL=%ML/9(3$V`UW(0DAC\Q;8>)7TAR'G!A,4W3"DE0XIVY:)KJ88DVK55
MPQR<M[65N''#\T=6JA!4MF8F9ZVA4O1;EM:RV3B&I4;L*(JHD7CR;,V4&(RT
MY$(J`%L,'Y9[(V@9N)8/FBSO-'M<L$PQC7O".)#U--5KLTJKBMBHJVM^2O<"
M>;UJWC+>;/R+!)6`X*/A(F$/&YM\\1MFU8AG2#YPHFU715S#(J\].)R9LE'+
M;73<&0QI\!,-&,,V&1Q%/6+F-,;N"3IA$G+-B%($9D*:L"*JF`\D[(((-%EE
M<[84$LBW+'2\NV,(UB*/NLCTNRD>>N'UQCQS']EL(6CAC-RT1-#TWC/(5$C'
M:#7*S[)EBL_04P;=OC:V=PH39/>9<>(&9C(0(QV5LM>1V=KKD(7`)!@#C@E(
MQ#0X^3'R\E:`&^,.D.,T2>C##3PL:1'LW2[=97%/"R@640Y^<1A&07`SN,8'
MO)$9$\CBA2.35BUD8R*X]4T>C;US&DV<CB^+RV3-J68J.!I$AADT:+KN<<DK
M!EYUS8XX:\U["MG2"=.\HMLJ/'9)KO,;$9@^(S-J`&9%'#`4/P!8KM#1##J(
M,6C[P-5Z[5P11MDIE;&@P^U.9<3U0]C"1?7&R2(J:0\9*HO(6J4,%"W"A4A'
MAV`Z0)2:8`RT%'BEY6/Q)G#C8?'AJSM-!=[BOE9*@JDWWF.G(^P$'BD'V4TB
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M9:CV.5U]+XSL#!,8.BCU*3C`XL@//J3`D!&#L(:#3-X3&;,1Z\B;V)/1(YXU
M&7LIX3FE;#K7#%O.\?X3CD7:Q/?<>%9,@T?/K-"P*9BR>8N4M@I`"JU$D(TV
M*/7!`+(QY*S=%%1S@)?(/LT\6BN"UPLC/E+`7NB#_(.+!)S+X:$D4AC*#(5&
M';4Z;=1O9;O5K\T+9%LF":L.\=,E'_C?)3%GB#PR?7RLECE:P5J:[P7CI'M:
ML-D$CI1;%VS).58A'F*4SE6+D)%HE,#(D5Y%NI!')238A9X&SMB*(O$5[O\`
M"R:F79K]D$O<<U=!/-2[HW'`I(_VS'-"V*8["%ZX$.BDD:.0Z.3AZ@P'E_$;
M=ZWP;)JJ^&V7Q']D@MGX1U45+XA7A?O`M:AYT0@J\`V:JX'%3>>9I!O"\A"\
M`B6T"&E9IM%&V4RQ)6C46VD-S&+,LV^!UPEG@[;,5FV5\\0G&ZN9VK=";8B6
MJY\V*,<I*"%21[+\B,38QV,AS)\K'6I$H@7D8X^[8#W85=<DNS9N$AK+&RZV
M5L>GH"/,.\1XF&B>OQT<V7E(DMBR1A$1)8=&Y,B(82,TPG[N.Q\J[*"1U\)/
M(G.M"K=F&0Q<&,[H=ODUQ9VR<XABVG>7<+7JZ:B&Z@>0!WE'V@J56:%<PQDS
M(5I+=N&&H)L<SJBK01&<BB[O-G@-L*>-76+G-);'*P7R]Y(ZFPU5+MQ@SZLO
MAL-Q:HOE8RQ<N'S\P1&Q\D)CHI`AB-17,DO*H>WMBHJDBV=N+HNE$,T7%D@J
MZ8\W=4:P:C1VV1<LUML<JD[<,-6'68HA(GK-D<5$+OV$BC9<UKQVVR9MER>"
M=C%GF8QNJKV'73R3L&`AO>)<:98R*OG9R5Q5-C+W4-&8'(!-G&<G)8%G0(+Y
M.Y`0)A)Z[FI020O'QN629DRQ'+O6[/)KADK8,EGWA?$M$0XDKG:%V,79CVQ-
M^;)PV?BLF#)\D%>CR+P*2BC20-P!`/(&KY$KDUL,S9J65LOU.F]@NC<7(S2^
M@;QG\K\X:PE.7K$VX!R^%GGK)VL(0;N'J:[T0*(M!N75=I8(V<YH^$K*8I(]
M=2]L:"`1+FAH6?SN':\@YV1R,]+EI6V4RQ@LS!,8B^AX<J:*!IRYE0,%>+R9
M1B(440#N,<2ZC;--UX-9FI@XN'JA'-KCML9U/,8;+3)D5K2$JSN9R1.$31J#
M#C&IDR$>BE%'H)N16E+-4)FXR&X-LG:C-=!=+%1-7&]!C8_S[XC2=!1X&W$P
M7')CG9.YAU%IT,!J(C0HL^5:MCI.+LP[LN&&G6'AK%)?-ZS<$&K=9+!PY12S
M#;]%7!=%)=/KV363P5PLJDJ@I;!3&V>/:(+X)K(Y]%_=QSQQRQO[E[6O[E![
M*!0*!0*!0==[]J=_P8.07YR^,OTAM<4'80#_`')%_P`W,OY,E09&@4"@4'76
MB7^J<VO_`),D1^E0/H.Q30*!0*"GVF@-,,=BNMMM-=1M#8[LI<WG+,6N=R2)
M=4*[CKPDQMDKDU&/2P=[FB_4;)I9$.C#-S=7-)++`(2\X=\9G]W.;K4$946<
M$,R:3G%0NB[$N+J%W"",;>(DDW45&C2)]X^9,QN;1HP).,WK9))UT+6#CI<+
MN*J"V*Z&BX"AFEB-\#L@,412%K"F38>T?!4$W&*`,IDW9HW7=L\4'3I5+!59
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MEAF]O:V;BZF=K96#`M>'?&5J[&/\=.Q5P0$J9.4")&Q(L1=D?&#PF@:./RA!
MX\DDA'NR3KP,B1S=/V23I=)NLFDLKAF&#.<'>+LEE]YB>U/'RCG."JZ\7!NL
M%,XL[`*IX-L5'X"V>+0@5:,4\$&KE?M,V>&&.2'9JXV4L'B5X.\8G^ORNLA^
MK04:B9U1WXY:Q]NDDZ)LC)`:]E8UT]))%%O!YF@,LU)K87Q>*H*J9)+)+WQ6
MQ"R9=QTTA/9L.V-,-;1P]-A>$>2:2!ZBX\*NWBI-P:C[-XDBY2:$AXPPO9W@
MW<IJH9.44%,\,LVS?)((R7XA<:3Y\Q*3&GHF0D9Z4I30D:<)O[D,Y)AF04</
MVKG%]CF,3+9%G7C%LV[%J3LX4L[36ME>UPS<VXRZ#V,Z=OYKJV+'R+TR[D*Y
M)TV72)V.$&L28D"K<BT<-WK-\_'042U74143R6:,\4,^LEFIAF'J$<7N/@$T
M?D`C4D.8DI3%I+"I%V0Z^0\Q%YFJ.5EXEZ&45S#*HRBP=DF0S\'[5X@R;I*Y
M9I((X8!R8CQJT3!,FZL4UE&Q+INNY=V(8I.G91R^>BI$#?$B)5^Z=DBI1Z(E
MA)NLZ<JJN%4WBEL\[]-N@(,9X/<1Y`/P%%^/^N78],AXULU\3>#IY/[CUA*C
ME7P59')?)P-<9H+6SOEBLGE?%2V5J#,H<3=(90IA!#$87D`L?MZ2;\2(/"CT
M,<SW#*9-)):4GUR4-4C%VQS`Q*WF3>[?!%)MA=/%/#'LD[XA)@?'?3L99R@7
M'8<@##S=K,VDQ#"R1EF,DV,]3%(2%<PV2(8V<NK,Q";=BITVR%MU%DF?88+*
MVR".Q[B/QQB^`Q(-JH"E@&@+[5PO%\Y-&?`M?D&A(:M&$;F2A"]AZ`<P[8-K
MWZ568YTJS0S3;*9I7#.O>->B2*$_:O\`64:>-MH`D(S.6[E%RLB:`MTTL<1>
M":CG+`2U650P<+696;77>)XN5;YN,<5+!A&?$GC>/@Y+6K#4<690,N^!%"46
M:8/VXIT1C:.#40]S12?898N4F6%FZV>-\;NVW2BOVJ5[X7#FRGBUQ_FI8@>E
M&L0)<T3!(QQP476*I/D1;4PD='V&N6Q%!4.0#D&Z7@#UI=!ZP;HIMVZJ3=/!
M+$.0^XR:$(2R!SI?5T92E^KXR,ANO)`P1="R,-BX5B<&!PH!48Z9XCV8H9)B
M39M;"ULD&[]PEA>V"RF.0<P?QWTV$:Y-XW"!\34L#>QUL0BCDC'"K`0^CT1B
MJS4>3$O&KQGCB"@(1##J9V[/Q2URQZ,T<<K!G)'IG5TO"3J.R>%ASHC9K,4P
MG[4C@LOE*VX-BV'![EG/;6=+.1C1FEB@MCGBLGDGCGCE;.ULJ"JPG"GBG&\4
M4P>BX&-0;()-VK1N/7LR:8I,\A^:S1CFZR:-7KUE?%)TX3PQ7>8(HV7S4[!'
MJ!.(QQST?#&<S'1;6D9!C=A`&\6F(UBV53'&H\W%+A?%*C#)?)HT:.A[I2SF
MS?!*[M53)5>ZBU[YT'X1XXZ++$SAHEJ^)O"LE1;MSS]9A?)R51:0XUKYLF[4
MLI:ZF*,*D3X9C^YT-7.>/_3TT'%C_&G1\5%2N.QR`"@T3G0N8AYC#&2Q!.'2
M(=.TQS>1M2,8R=Y!\D%V0ZS9NG@E@FQ;+N$FV*6#A;',,,%XB\;(Y#9+KX%J
M*+"X;,6H=I*`#2Q%-H<P`2HS.`[@AGX?=PL282Z0/".#OKV=7=.,L[J7OT=`
M2$%QOT7&)N,V1'=8Q<).`[/)@QD8QJJS?8M/%&`!%)SB@O@W?^`!<<FK3)Q@
MKDS166Q0NG9=;KA%G'#KC$[<KNW6F(<X7<&DSN5UF[Q1-!?!P6=YB6*&3RZ`
MZ(NW9Y\JY!-\4@KI1XMDLUSR5SO<,?*N%G&B88PI$KJ\*BT@9FYD.R%YNAC9
MUCE`&>LE`ICP1;!8E'7,/$CFJ[++.R+E,:VP6LHECFFH&0C?#SC3"G)TC"-/
MPR'F)`^1+/2X,2VQ>)EF<ICTW%D6J+_!^-2S#R^)"R#1"[?)HBN/0QLC=+#L
MZ#G0WBGH:$"](C16OQ+I3CN&N&U,3*XY.R$9NL/6'/BZ>.%T!RQX@F[<**.\
MF_:)JNE\D>R[7.UP]3/B+QH8)D$FFF(2E@46(K/+7'J*=?`FL)7<,4<E5\\F
M@A#,$TLU8HW39LL$,<&Z26'3C<.$VX:<7F1)(NRTM#69)!8\J@Z:-WK;-!*2
MH61+#4<47N":0+/.W;MQV-K,&3R]W+=%)QEDK</Q]PRXM$A.OP1#1\&>B-6M
M3K.!,7(]99*/H2<PE(9#V5\W-U'RQJ0)6?N575UU57M\E\LKJYYYY!E3/%/0
M,@*D#9C7K=Z4+:^CFJR;K*02Q*[^!0]RL^B@!TD@>207QC9%PHZ8N<L;NVKS
M.[A-7%:_7H,2CPSXQ-U"V2.H(XFW.R&.RHJ*LY.7C[H_%`3>+`2'DW<M<`A=
MG%VB0S)--M@BN-3Q:JX*(6[.@D4WXOZ"V0<-R2<ZPCTD-2)%OB4>D+D+WS?,
MVPIDSD3)NB]1:B9DT'@F39(XTP0,)M6:*.+FR26&&(>E_P`5>.I-5@X>Z@AB
MCH:7BIUH]3'9-G^)*%15E!HRHN_;+(O'C<;#QR`WP=;-1NNS1P35P4QQM:@]
M2G%#CDJ[0?9Z?AMW3:..HDDI9BKC;R;>0%GJQ8.HE@OBDLT_)VP3$86SQRND
MRZV&%\>OG?(,A*N,VAYP;?R.5ZSCYLN39,6;UPZN0Q15S&,FHL:7Q8H/4AZ$
MG'B&2+)`NFE@528IXML'%D+63H(\5X<\8C=WV1+3$/6R("8D%<9)(/6>6#*"
M,!`B)J,LF3UO<83#A(^Q88OFW9/5![-%JHKFW3Q2L$O2X^:C1`RR*)1/!.*3
M,PWD16,(E33<&QD3>1.I?A((NP;D4DX<=\K'=RGA8KP-QB0P3<8Y8JIX98A`
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MEEQ(XV,`C&.H:>A^8D:]$DF*#UHY(KMR8%.1I!"F+\@Z=$,B@=.7$L6KG)6Z
MZ%G>?4RQZ,>J&/9<-.+HYN&;,=*0QJG'BXXT"R1;/,'`AV)5*J#FX]W9YX4U
M#M$C3IM@.PSL/\!5\%NCX-CBEB$@A'&O5,'@Q?7+4.Y.Q&2CI4PE822N\2`>
M4+3J7RN=S4N7CS9!A&;&93)YH_7=KMF3?I3S313Q30013P"(Y\(>)ZQ0><=:
M.AA`X,;N&Z!PJF2+&G-W3LX]<O2Y8D0=$#Q=9>2O^L^?*.'ETW2B?:]G?JT$
MA:<2^-K`N&.LM.0ML3C]V*@==$>I@FQ=BSSF2BB:;2R_@69D48?.%&KW-/)V
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M->I_`YI]-^D,:ZX3<:,HF)@P?6`"+Q45)1<FR$1YDT01)+#I?KJ=N!A%1^V(
MKY"CDFU)&UW]D<D7#FPE%.ZML+J8YAM;0*!0*!0*!0==[]J=_P`&#D%^<OC+
M](;7%!V$`_W)%_S<R_DR5!D:!0*!0==:)?ZIS:_^3)$?I4#Z#L4T"@4"@^7$
MQD_>/%ME[:2U@`9H:X![#.`HCG)`6NQ3M^.80T*[@+Z(*G3S)Z:@)*=/'*,Z
M?D4TR:0E/#R9P<.\5>@*L-DN]<%2,.^>L7#O(U)IK"&+6$#]-DHQ8?9&13"&
MS0^#,ENO"PV3L>S"*N7!DBYS$8+Y98I%G;)O<+2;9=Z@X(.W>?Y*6%Q*CL@F
M(?-8BI%Y5)59U#!JL='D1Q5W*Q^E&NOGA4@+?.L6LR5(-%$WJ6.-VB*X82&M
M.]F=BAA.8'-8CBXY!@HM&TXUK]-K(%T5)83?-3S\?*#N0_%T]:"!O;CET_\`
MRETHKBDF^MDHB&`=".]SD>NY*W*R*`Q:8+QV2C1R,.%:Y9O,C!T+)VZ9(49*
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M$AYN0EX_;)Q;(H\%//"`K5)U=RFHTZ'.>*BW0I08O!OWL.4F%!5BVJ$HDH&'
M-2,P;QZ%K&L7Y8Y@M)RBXU:3(MF)6)C7>"0!%!F08O&C1QXQM=UFW5R#BRV`
M]X\>T;*Q:4Z-#-R$MS)$1Y*,%-7!QB&L'7&K&'X,!2F2J60P8SWGU3KY'MDR
M>*UE+LU,VW51N&=2;=Z@KL$D$4+:G;:[;.60L)+\PD34+%0S#8;9.TG-HIG,
ME!<M.0I!QD19MA"XQ%HNCFSLF_P4;T%;/P?>VSG6N41DI:+0J4R>.$!9&50'
M+7D==1K%^G*;2!U<QC*9(483-@^P"I0]V'1R99BEGRA>S4DFUSN&QO)V0\ZW
MF.K%N'T+%,QSD7*_+S\J+N&I/1SKJMQ$;3)"S)CQFNY;VR5)(*,GN6*N:5L'
M=KXY]2X1N-1KG^^V^U:3J388:[CT<W@%#R>/YZ^#BY-F]Q>BM02Z9!&+]<WG
ML:^2:;Q9HW&VCC1KDCG:V#R[A#$.5IJW>&BX#-D-B-H\8F,<UC#W$$0E3B`I
M>6FQXXKDL_C]S<()O\6K&>QL<BUD!0H@W\6R1^NN*25&I)6H*RFX_O6LWRSB
M)DH6X=1L@2=LD<6^N1D/ECAYKO8(D"BU;N"ZDE=1<>8("GI5$GD.>XR9!O9E
M=8/9SG8)7MN_>6$-;:'!Z^%Q+*:EXG)F7(20M24*C'BX@1Q;"0^8AJL>)KBY
M*/%O%7Z;H&0<,DRS:]KVR;723N'$V'$^\34ANEX-`#*2?AVMB`?<,N4D,22E
M,9GOE`T=C):TE!0D\)R/-D);W2P&-&2+9UVRF3E[;'#%NH'%:*]ZN\V`F&5;
M:T$01L)39J3!_E`GGC8R`S9N!I?`2-<+&0[6>6LLV.)70=>`XWLJ-Q1RZ,:"
M1Z(?]YOC)&&.\!&LW@-UJ69=91)*(QYB$VPB1(+PWR@M%I--#4D9O[=@V4L-
ML+9M1EK+J9+OL\T4@X<%C?>%^"[<G\N.*93#+4,.B>HH,4?Z\2&HR-.:R`ML
M>4%(U%C"^O\`/9"P59)M'UW+^XG-B@-3>YH*YEK4&(>?WI91P1;AU8E&6F*)
M)VT?R(9J8JZR\70Z0N8&,:(!#ZR*S^1R%$>A.,G&*#=F05RQCZN0_KNL`YF0
M[O36KB0/F4EUD4N)(R<=%`9P#"6HF4BQCV!!X=()*2#/TRXMY)!)62%R*#2R
M.*+T8R11301441<!/]28]X%E,KD-EN8YA`+LI.(%`RXO75I;BT\42PA#I?-5
MH.>6$6G?CQL'8$1X=YD!\&<+*)7Z_P#"HA1432[V9!0>6/HQM8T2#PYB\%$7
MFI%H4VD@&33A%T5.L0[]N:C,-ET??LW$B0"N3QEEB@.3%KN5;$>@+=TBV[P9
M+:)`UM=N'4@A74#09BP-E(2FJ.W@&4F#^Q#Q/!RA5@QU"27+XM$EF>>4F<MF
MXK-]:V2;W!,(,$@?>)2$/M>52^;2&.2Q33D3C&JHV&*ZL8W2FJ$Y3DNPCK\*
M,=&=?XR8DU:*B@CUPX40QC>3.SB[8BH2O09+50?O-HK-M'1B8&(/*M2CKALM
MIRD\WC!*>ND'4)@ZT@"DW3*2C556X"3*'&XLHQ2?$'CM-'-\FJTO990.6=CG
M...KR][K\3,B$S>2Z:9&9:>VE"9+!9+&GLFFY;4R6I]2RV0X@X.T`CU8\-E2
MR]@#O`+@0LR;&BN34BF$(EY#O3(LQ!$UGH>392>;@P)P!K:%ZT)%(:&.R`?=
MV3BKJ3EV`UTR",456]G1Y;!%)HLHNYO=;%*V`9<2X[V(M+SV)UEJZ(Q=BN#*
MBE!64$D#4V^'I%VD@C(_-V\;&V$)D&2;%V@L]2Q--LE%DKKXXVPZ`M(?*N><
MCT3'YU$0FO%-IOIM(TUH+.!)"&#GFMHXOX!'3B^9#!N<!'=FXPO)ZFT<MTU0
MZ,TQLNG?(3V:H5.O%>\WB)-=`=*!>P8\[DDR.$BF&<$;2\()+;:EF&(C7`N1
MR$9%";A35_BUZ$:R;+-B*<JW:J+88)=G8):'A?/Y+2>U0AV8/%-@%)+"IAKI
MX&(Z_O*`+1]R4FYS9.NFAXJJH#>!$=%LPB#!5]V:J.1!PV07P[!'%N'GI,5W
MDT9V-I:+;/+P.3Z8!QM@RV1,'C6//)W(2%]<L7!7QVY92)DZ;OA6P5/`Q+P>
MT>W?MT'*A/'IS;N<PPV;[O3RBKP@R$:TC2D>!"1X\`;\A2(?8$LN.A@:2'7I
M$.=>F`,2P(K'2XI)/)L_SLDU2=)86OFVR"+0$1WJR$HN&+&``[7!4^_>)R.9
M--8R'98D!(=]/7[]<S@!ESZ+#I?'M2.L<!XT6U)1U-IA9.V=GF."=@@,CV/W
MJD(&PVTBA^!"428R$B;-:$Q6-3-$N>QGY/+$C-!0@D_A^IM;+P4NID]<XOW)
M9%1BROX<XM9VFB%I+V[VD<4"L&KC4A\&WB3UR6-N@T,;&"DH(P,63*#5&J,H
M$L!2T<G#MR/BJJ"#EH\\%O<W?%OG@\S"S``GO``6M--#PS^*EY6_,3-/<#K;
M+L"]DH`,7V2>M%S#5Q#R)".$C0R#RAL_7'LEE!Z.4=Q8-\[X/+9I!5Y-7O2R
M(63QI<!&\L92-6#CY0,+ZVCIN&%[M65Y868.!LFS4\CW:SEPA"G.":TA332Q
M5-(-EK899ARE8SWBCF$[",D"<B;;%5W=JXW&Q<8-:GQ9)P()$$V&P1<(%&9.
MG%58*1EF6>;5&0.&AIZP_AG2.+O''&X2L4[[S[+5W(-21,=.I[8\H8-AI)K%
MV@52.(1W.8.$=CN`#H[*4\C3E/75FZP=.4)B<K2'PC%QEFQNCU`A!J/=Z65\
MFG;R2Q;#.YJ[TV$AZ,$C0IIAC%YM'4&*[IX:?'G<7<%2`LTX33(*D4'K9--%
M15OBLBH$8@H3O9XC82+>OXY)P-HSBXD!B6NM>2"?$9#8,U'27)DNWDX.+!#O
MA`Y)U$FR+90`LZ<NK&O!4U$\D@ESR-=Y)'(CI]W%S94Y)4=+&0^RQ9@AJ(P[
M3VC>3%#$<-/+G3#(.Y>N\E1;(OFQ?.&36.X%;,,;D<1MU`O3=RG.Y$N0QU(E
M"7$72!Q8GBL$1BR\P<2,FQ6&R.+Q]IL,F&CGB>-'H^W)*/R2Z2SP1(7*#?#P
MP>WLJ%8:38=Y:.G4N$[B=04OKJT0VRZ!$D+QE4@^G)B4R(M"6HPR'.B#XP&'
M2?MF(Q-T-]R/H)7>+)D\5,KA&E--<_K:YTJ.;[AFK&>$-USB1[J*MY#`RJ(6
M%'-KQLM%6K%,WCFDYBL-UL&=-F@L=FIFNJZLD]2=8JN<Z#@A;][N0R.^4:NG
M@%V;9N0!X`P\-?-RST-K25O!P2[U_*G3A)G,]BM@[4_DJT;*,+N%[BW/@N-E
MDPM'<6?>,D]\2X-IY.(Q?0B@5DG')@1MKTX>1,,@4>)YN!@<LX0))>.)`N4&
MO,"23A))%!!=M=/K9Y7"&6C/>*2*'[Z?R(N1C$_+J<?<-="X69UDWCK)&/;A
MFA7;XW7F9`L2R9AC>IR(EJN^D-V1IT\3<)HYVP1:*4&#&".]B!N(M$$C^N#$
M9%0EB'?3\J,AQ*8%3JX9MXX-G\'$D'MDS@`LO@F&S;LWC0BDU=9%,.T4;K9!
M*5Y!WCT?U',_*\<*+;+(<@H?&X)GJJ*P4J4;ZA(G4F<C.-L9')\8=DP3%867
M0>G\!+EKCFOX2CTV0QN$=3Q[V\@VG=S#W3T<?M<#SV)X0J.Q`Z.>D&P(LE'0
MP567S1@\>QXH\48JN%"Z8I\V)I+VLJHPR3QH.>DKWJ9G*]\VT"A2F(=T4>H*
M7UK*6%C8K7!]_$(O&R:3H<_(M)5/6S!E,GA%@.\#6<=(+JLK*.4@@11WWH3<
M[)]FS`2S"1K71?8\HB,*BY@))<YC&T(?@1C,)-QJ#9.GLJ4*RT?F,'+6:6)-
M4"&#A?KJ)7OB%M;,/]XFY/P",:O8"VA5QHV*2'8)PA&H5GKT-LB1EY6TF8G`
MR8+HDR$@AS!NQN!9C\'#)PKAVI7+!NNG?((P\=][6P,E/%P_3TA8M=ESID`;
M/T(D"$D(/9B69:_-GY&VD1$]:/)WQ'OWK5H";'G1#)VWZ[-GX.K8.*,%=ZB5
M$0YW,)"!&^"RO6=Y:$AHC4XJ3/H<*GSZ33IYX:[D,A!XR<C&1#`(HV;.L![E
MD0<J)8HN;XJ-POK?)/F\:D<:=<<A8R/1(Y`X^Y<XS1A!LG4:/%_*Y28VEC,L
M=N;PF$;:YQOR?:CL'89=QXWP*+6QQ8WR"LMFP;O"SSG2;V(;#6`$X]%]C([%
MS"_DY2C9V5@B9>^MC$A`DLL,WRDV#)LDW35CG<:T5<.,\TFV23?+$-A>+#GF
M"[6VHMRQ90(;VDJ3SUHP@C=CX`S`9.#7A""))K("Y`H*P&6%]EF3;LB6+Z[V
MV5E&]VU\0VXH%`H%!UWOVIW_``8.07YR^,OTAM<4'80#_<D7_-S+^3)4&1H%
M`H%!UUHE_JG-K_Y,D1^E0/H.Q30*!0*#7XMRLXW`9D:UX9W7KP;.(XJ\0.1=
MU(F21@8X8!'$C>-G;2^?73=(!&V;C)+W5.KU;6MUL\<<@K1'O".'"QTL"OO:
M(-[A07E(]./,B#.)7%7;:[=8YM)<Y9)1U^\RQVF&3\%1<YN;+JK)73LHU<XI
M!;D2Y+\?YY*"<+A>X(!*).&&ES)42#D3`BJP$`2*X@L5<KME<VB8UF4:.&]U
M[J=EDLU7PQRO=!:V`0,MSAXFB`P0XIO6!/VDE%"3L;;A"OCPK(09R7H0848"
M!A:;HJ4&O9$O?!-9%'/#-N@NYM>[9!97`)5+N5_&N`GB\7FF[]<1F0@"3(08
M#F),/9OAY)^-7-)M%T%%;965:AVV;MWT=-F+6W:N+I)WME<,(:YC\<XUN(KH
MJ3;(%1C8`3!3QHA)$W(`$U=8A8%(DA_E*629A%WCH+LH2NG9-;-.]U[IWRLM
MA=.@S2O+#C6C$8Y/5=W:XQALN\J/)N1>4K"XPO>%8*9R[!JMBI?^$CET^H\Q
MRMCD@KE@GE:RBF&.0>MURVXQ,0@:2.]]:K;@9"X;M0A969A<6))=TF-63P;+
M^%=3*V#8LW64ROT8HH9W54OBGAGEB&*RYH\3\&4C)9\@M68#HAXO\I7^<K'X
ML@URQ1P'&8O'62ED,,R#UHIV.-LKW41PNMC:Z-NTH)3*.2VB(<:=QT_M.$,C
M0P5')`98JR4*ED#CDM5<)1Z0F%W+Y!JR%%;-5%$,LL^T71PNHEAGA[M!C=5<
MK./NZ2S>.Z[VA%SDH>-Y609Q3QB@UE#H1#9>6A!HRD!<9IDO%N)L,K=/+)/'
M/-MDFM?&R:F-[AL+0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0==[]J=_P8.07YR^,OTA
MM<4'80#_`')%_P`W,OY,E09&@4"@4'76B7^J<VO_`),D1^E0/H.Q30*!0*#6
M:;\/N/.Q/*S*5P19ZO-B3DS(G;.63,.[=%75\+JOV[D1(&*HY?K)XWMX/=+&
MW1T='1>]KA6F7=P\/L@C*.8ZN=IA1O3F.883W8=T&#K)R`=YD6F*DI4L@3S6
MB[#I<8]"O4;]2U[8YJ6R"U(]Q)T#%)A%9U'8/F*D,)C\QB\75:R:668B`T^.
M2&12EL@*R.9#<\B!65D,[9YI99(V7MBG?"R2'9A68#NZN(<7<9/0>KEV!'-G
MX(H33FT\R)J*)'7<C'D<B&<ER=^-PI0@XR9.K9V6;)KJ)X7MAE>U!.Y)PTXZ
M3"7R&<26!N"QZ2HS1!]=>7S7`2SMLF&/(!L54"`;R%$'&W,[C#SLBRK!NW4?
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M!0*!0*!0*!0*!0*#KO?M3O\`@P<@OSE\9?I#:XH.P@'^Y(O^;F7\F2H,C0*!
M0*#KK1+_`%3FU_\`)DB/TJ!]!V*:!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0==[]J=_P8.07YR^,OTAM<4'80#_<D7_-S+^3)4&1H%`H%
M!UUHE_JG-K_Y,D1^E0/H.Q30*!0*"@77)K40_:#[3Y4G*`TU8$HH'SQ,:\GX
MR-.24ZL;\CFPZ;/(TE#R>4CRC)+%MDW?*8Y9L%\;WQRPZ+A@`',?CM+)#&(M
M%IVYD9N7.46XAF$ALZ(]FFY9PI\@3+K-XUFB!!*);&"8^,'N2#+!1_CADKCE
M@K9,.(;YG:"`'R<6?G9AD?82M]!V0UAJK:))65RL1(A<3/!8(JPA[AO.7$<D
M1MHU(Y"LW23+-?"ZV6.%^M0>3/FCQT)#T3(V:EB0%<%F<2D0[7^Q7L>SS1A"
MNRG,8Q.-HHJ,OL%G`$%"ZT;[7Q\DR3SSR:6OC>U@SD3Y8\?YT?!1B(;#92`U
M*W*"<.;#!1]PC-1KB\OQ3ED*?X"O%\M@-O(,M?*0CU7`7'%K;*[JV*S>ZH1Z
MW-SB_DMFVQVFTR<IW@.*K;&.3')PCGLT3(#</P51M'KJ)YO!\7?9.L;VZ1BB
M5DGG@ZJJ6&87/%-KZ_F[P&/B\A3*NY'KR/;7"HX,"C:[V`2I51`#(<<GK%M@
MBF052RM9!2^#K#H_?I8VH*/8<W>/)=1NV"'YF<)OC?B,6$#ZEVL0.F,KLY<_
M3-"`[>&Y$",57:P,QDF623R'J78*8XK7RZML@G\SY+:3UZY.,IC-T0C^.2`9
M%R[!8-(7#]$V9@SS8XEHV8LA+ET2Q)Q0<X405;8+)+.T<V6&5WF-V]!`R7-C
M0`C-#`F6GK++(3/3)/%?3>W<,XLUU>-3,S]":)>1':PTG&0KIL]6:$L6SE5F
M]:KHX*I.4,U`S[+ECIMT>CL;<N9Z$*R9.-*M,9)J3:4=8C,)K*RL&A%Y06+Q
M!H)B/EK+PCD>)\9KM?#W2>."76NHEUP]\NY8:&A!><QX[-5_*+7,C@41E,?$
MQ68'S2$GV:)>G80#$CP@%^XDI$X)&N%K)C;.[HV04Q5[//&^-!RI3R@TS"S@
ML#)9`<&K%(K$YI<IG`YZM&PX">$#8B$+RF3MXTJ!B3V6F(X]9,&A)PU=N'B-
MD+)]JHEAF$"MSLXUYJ62;2N5OE79"PJ/X,=4[5=Y3,EA)H]#7C&#61AF7EBX
M$R65CFKW$?V_@F3K')7J)VRSL$G.<N-*QY*2*D7T[OA#X^M(91F.U%M<PD"3
M91L3,2P(BX$PQZV1F@&)&VQ(@"Z]R[-GGEFJVQ[-2V(8Q'F9I!PV,NDL]GY(
M@',0&%.MH_<B:J$AGOD1>'1)-NI!\7#J6GT]CA,T1J6.;JR;_#+/#&V"M\`D
MI;E/I(+$XO-'<F,+@Y<SE1(;B+@L]-&V`J`ODQ>PB\HC`B,O9)#A6O"BN+0\
MX*M6:0AWEB@ZNDMECA<,CK?DAJ';4J+PV"R(@4-B6TB?X7=Q65A!)\7$9>Y@
M,F,P\^;"CP<Q#!9@TR8+.QCATA97)/+'*Z:J>>8>N)\E-23N9FH+#R\@D!>-
M)$E)(_8P6<>2P!421D(EVQ+S!>/(QEF2\/BS[!-ODZ[5;LK988Y8J)WS"!C>
M<O%\]%X[,8QLA:7@93$A,]#*P^$[`E1%6$EF18A>5/`0*+/S@H*#;@W.)A5T
MV1\2.,,6[^S=PJDEF%@2/DGIB*FVP,O,?WRL:'3%Z=&`I(<AD=BYIB;)`3LO
MG0400AT.'2%A&WRK!0F^:XO,&V5TNM:^'6"!Y<X.,;4@@&-;&7BD@<@)U*$8
MS-(3L"&R?(#KB/1V72DA>.R:+"S&&*44E3,DS2R1LN497759X+XLWG8!P"'.
MCCN'Q+J&"VPQ*<?+3@2=S):3W&TP$WUF@+<[#+/<E8-:R4;A;<VSS($[=+%'
M%SA?M;VO?H"027F/QZBN<F0?3,D1=PV?2#6<G81F#SR5D!$LBD$4V7)T%V,=
MC1)RJ(`0QNNZ<DDL5!V"C5PVLO=TW60P#*,^6.@2(:;'QL_2)C=<1"03J=9#
M0,G?.XM&HZ[<M7#LP-:A52+-V7Q9JN!#/)+PPXQP\+'I.6U[*W"./^:_'H;=
M!HYD4N\H5GK@<K"4-4[3<S\>09M)&1>LR\(;PY22B'#03$WS[/%RV2O=@FFY
MQZR#ANHJ'-%<QM"'A94\"D,H-1X:^"B&I\7K/9+X/*)!(\Q"82,05ZA%,TYU
M)B.1Q"^#`3X8YMA97/+"R:"^28>-N9&@TS604B?E@"Z86$2%P:E&K=H1>*L1
M.QR[F/PUR3E<@AXZ/BLBQX<\9Y).7"*K1PP=8.<4?!U>J&-4YR\7VCD>P,['
M<1<J6#S.1"PDO@^PHF=(@(%"T=BGS+,+(8H.)KCU8.KD2'9V2_\`-T&[FS&S
MA1HZP1";RGD_I2'3=IK<U*WN4X=D68W&-AXE,I"11R>CP)7$@[P`@"*;4(T8
M2@<HZ?9Y6:,[.\.W43_?=4.!(>6W'>*;!-:KD6RQPJ?Q\>^*E(XY$R/PE-B,
M7UTW(JM7*8;-@3S8Y;8C^2J;9597!)_VE\>S1<9)!'QW-CC@1'LW]IH9'9E&
M0\F#$'-=[(!222##C9HZBY&,QDM$V9^1,IG9\FB$S9MUK&'?6:M.U<IJ)8!G
MW'+#2+9=$>J>DF,A7UO)]L80_+7.QDYM:%0R3>1\G=JP]6*IR)$N*D."J.0O
M-OB35P:N%DFZB#=93`(PTYN:!?"29UL1V+F'"Q>.R\N0OI7<."(P3,6C-_#T
M'F.<'Q62.2MF3:*#QO5N_<8NT>JETJ8VH+:&[RUB3@K?8Z<A691166L8&[<F
M`<@"$@<R?S=IKA..2<`6%LST8)MIH^29.<7[9OBVOG957+!#^%H*VBO-/C--
MW4+9Q?9[4JXV$U$NXC@G')@A8HF<E+:&#4<\W<>0P&O5I&]10R;N[H+I8K)J
MJ88HYXJ7"RC^\-:1N!2+91`X[7B46E;Z"EW0F/20T1M,!\\QUBO'6``4)>'2
MQ'*=YXCD[-6RV"RN5LL,LDK]>@B^O^3^H=IR%*,P`E*I&^R"LSCQXUUUL!N"
M#(/V9!\U''I"^C34*$D.:0M?#(:Y73?)KX=EFEBK>V%PP3[F3QV9M1#M*<OC
M.)J%@=BM&\8A$]E9!""2$:_,-Y45&1R,%"`4.+%#LURBCM)&XG!5"SRR&3IM
MBJ'!RYH:+R.O8TT<[)*&6DJPA:+</I7;Y=`R?4AMMBX)1LB/A+@9)&&<!51,
MXO6*R[/(<Z05LK>RR?6"0L.5VCB#?8[NTF,,&FK([/I=*G)F"SP*@O%]6&2D
M<V&>B:A6-M+3L;$9"'79/<POA]TG-TL.B_A#?M0X3CEYHT?=M8V:EL<[1@S)
MDLY'K#981"*M2[DHSC?EN[?Q-%I"',Q=!G"85`KFT7+YVPQ:8*W61LH&>@W)
MG3>Q(\ZDT>D9%!BSDL)B+EG)(E+H@?3/[(:1LA`V=HW*0@@\IA*QTN'.6:V+
M?)'-!QU[YVQ35O@')C/)#3LWCQ"3PB4KS$:/`2"3XI1F.2<L6*A8M,9+K\^[
MCH)L'R,R/Q=+XD^998,4%\\LL4L\;9).6V:H0%MS=XU+P1;8Z\\(BHN@/!%L
M\CL"V$$-Y#93#SVP(P]2BY2+-9(LWD4-C+T@SOBUOVR*/1;]_GACD$V+\D-;
M@HU#9,5;;%:)S^2$8G$H_?4NS%9J6-"1!T^11M"4(JK*&;1L$C;UU=RX:I-K
MHH]-L[WSPMD'B1Y,:D88P:R!.3'7.QS4W`1(?%M?3V3DWQ#6YZ\8G5W@X)&W
MKL,RC)ZW@SAR]Q;M^O>U\,\\;VRH(N_YD:+8L+E4G^P#`I23QJ),"L=TUMZ0
MBCA.9'W<4B;R-$P\(>,)+')%*668YH68*.!BKJ^&-E^JJEEF'!,\X>,D?&&S
MQ?83QK&XT.DSZ12C&";#=1D&[B(@^?-QDF>9Q1P,:SG`'&'KMN!R4\</D,$\
MFS97PEMVP3I;DOI?R9M+1<N6E0A>3AX8*QA$;E4W*R23'X.+V6*%1(%%0A<S
M+,W.OS")BZHY!R@D/LJLIGCB@O=,/5!N3&I-FNY(WUX2D\R;Q4(B<+&`.OIX
M[C^6+B,QZ7H!!IZ\<P$F)8H`E3!7Q0U55)8J+70R1LNFJE@$9`<S>.LAB:LU
M2FQ$,"1&10WTRR"SZ(%E@LYEY:!Q,LUC\EC`PZ['FY8!>-$E$VV5L;M\E,^J
MEU<[A)6G)C53O70;:-EINVC,G,#0$29O=7;):3&8%3(K`X):Q+7ZT5QF\C\8
M!;YN\,V@]7"S9NNKE?%-NMDF`ERAT4'UL;VZ4G20_7T;D`&*G#CP!*&RPR02
M12-)BA;D(L$P/X.+^5S#)Q_NM\6::F>;BZ6*"]T@P)GF'H`$XF#9[+#*JL)F
M3;79;Q;`-@ET7T\<%'`3*'1=R,B[MK,)*S*M%47+(7F[<-LD\KJ8XXVZU!,9
M/R&U)$!1LN=D;U!"/0");.)LVT5EQ`SA#IX9(QV(/FX)@"<&'I`Z=%+M$AZ*
M&9#!;"V*B&'6QZ0K(USEXU@4V]B$PD=R"K(R1>Q]GK':!"3Q]E&E)VE*%I3&
MV4/7,Q>\8RUH;N0P?HH*-L&5L\L>HNWR5#/H<NM(O&Q5Z.*3,NQ'2=6%,7@;
M5>SC"$PEK9R9;/(]KOQ;$G2FQ";#R=(+.,`N+ZR#1BNYSO9NEFK8.'ES'T98
ML3!V?;"S*C6L.<H,D],[?47D%]@L716&,H@EA"+JS`J>$C7KS!H-Q<N46@]V
MLO@DDU7R3##NN=W%YE9ZX=;$>-Q+`>J]7D:T%V`G%\G:$(;;&<QI"19Q?$0O
M-6D-=8NU@N*MRB.6*B&:&+A)5'`+G>[KUT+U&8WD9+$@6MX_'CDG-E#L6E0<
MP-%QS)ZF7Q<0\@%;S#(HBX'JI),DV.;QVMU,&Z:N2B=LPJLOS:XP!;RQ-UM-
MBY>0JT-R/BQ,?EILNEAL/6I#;L&5&BQ(!X^.MI7`13EXR68X.$55D<VG6L\Q
MNA06**Y`:D+QX7)\)8F+&E)!*(KV4D%F8N7$R.$"CYR8B)*"D(\:9B[J,AHP
M^=O+D$&R:+9&RM\NS42RS#-:QW#K?<@1I(M;R9O)!+^.PV6LW&#(H,67C.P8
MXTED--V8&6(XA@P/@GN*J.>26/0I@JCG;%9%5/`++H%`H%!UWOVIW_!@Y!?G
M+XR_2&UQ0=A`/]R1?\W,OY,E09&@4"@4'76B7^J<VO\`Y,D1^E0/H.Q30*!0
M*"@Y]QGU#M"3KRF>1S&3.79+695Z),7;DHV^=:D7G;F&6?`7[5RP=H-'.Q"*
MJN"F.5E5+(Y>Y='&]!4`3@!H&-J0?$$G,A@N`2J+3$*!1D2*@>QF$B]?"8JL
MBBY%KNH\H)9ZR%I7<!5A;UVTQ69.EUQZZC2X3`MPHXSR!.2IG]4Q,]E-=GN=
MLS=<U'P)5S-I$X*O3-ADP7?BEU))%&KY]>Z`UW=5NC9-/J6M?"UZ",L>"FH1
M@5C&!LFVX/BPT<T;L(^RV"[:M&AICK_#4K.9MGZ#),\WE[75R>(1-S@\Q3P3
MPQ>V2L5QL_L%GZPXPZAT\Y@*T$!*BV^JXEL77VM!N:Z2X^":]V7*8=+2T!C"
M63?%89#@3^"#6X5ABIV`H<ABS0M9O@DFF%8^H-QSL:)G\04BP)ER^S#3Q7"3
MD+)W>;5V3!]HG\4D/_HHMA)V!-6H=/&UL10IT\9H=5)TK:X2S7'%6/ZO/P>0
M`-H;<>*P.$,M9CAQHK"'@TGKH,K=Q&H<;P;P)D]=#HRXRSS:.$5T".77OBX<
MKX=7&P4TR[M'CN+S1<BUY8R(-)5E*Q[W-AJXJDT=79SYE@W7!'M9EHJ=<(I;
M**=4N48/I%?K(XY$;IMT<,`OW87%C4>SYL\V)+6!QS+'FL<M5W),)`_%6;"$
MI,REPF2,&[#)!!C/(X=9=H-,)8XNV::RR.%^R64PR#!N^(&JBP`^&D3Z;29_
M+@FX`DPEAN0HK264?EPC`*%S<D4S:#681)]A%HP.8CTVK%LR'MF:>"2%L;7M
M<,!'.$NL8X4CCY*43YT/`80O!U%4;Z^BL0D]M;STWL[7_E''M?Z^A[)6T4G,
M@<$$\6EF>#Y7J6?V=X8VQH,=)>`/'R1%Y;)46$ECTLV"[ECO8<F"E1ZSS8GE
M;+$Y=FRV"(D08_%)P)C3K#)J$9E1SMJ(99]1LGAG@BHF$HD7#C54E7`HO2VP
M48R%USK75[N$MY7?..RF-Z=)R`WK-26.G[!]*RY2*')&N]Q5\9IXO7&">3W!
MS;#JW"MR'=M<87#1-(5'R<:)*+LG!L^*PBI`G,E@VP!NRXSG/FTJBLD`SKR1
MD[#.XOQJR=^!M7CE##]XKT6"TF/$C7['&2,\)5LR\=F$7+@)/#&DI:@869*'
MX"PUF:FCF-1@,#&IR-]$!B*.+=+!,&U=8^&-AZ+N]U[A'#'"'5A*72^;#Y%-
MXP>F1/79Y\^CZ6N<"3"0ZL0U@A##`R2E]=EY?T#_`,D0;/,>Y(N0ZRB:N6;.
M_:7Z`DQ7B1K8E$HQ$VY[8X/R=&;#!O9*#F*[663$%N`TG)=MB)@879N[/T=B
MR9+$B]6;I-'C1YC90>LRO:U!XZVX@Z?TM+U)MIL<OK8P8\-:SK&/("?!-BAW
M,UE4_9#9>BZ&KY/G$>.S,@D,?X98$6@YQDTLMDCU;8AG]?<6],:SD4XE\:BZ
M5Y;L#$J@=E!2S4C(D6!HU(9`0$"#:S2Q(6&7+2=VK=JFKV/6RQO?&]\>F@J`
M-W>^@XF\.DX&[V1KXO)@H"-'2L/F[D<Z?1P1!F&OBX9-%RS?#QJ$X#"FCHTL
MT0;NW!IOB4160(Y*.<PLV1\3M52,E=6ZDQ`1E_"0&NY;KV*RI_'X1/8A$Q)X
M)%`TO9,<<##IJ!%R1TAC@U?-,'J-TDGUG22"&"85G+^[XT)L87(6FRGFR-@'
M),(Q"$IQ))LXM-TV;,A!"`#,8;#,A&(AY&?R>M$6JS9))1=%V0L\NZR(O,E@
MF4^X3\?=G^&Y3>*+'UW!S8<K'.G[I-R[B\PV02A1DG,8DY<M5E8[*@)C7PQT
M'?-KX+CE4L^I>^*F>-PK<AW9_$4UD[S/Z^5D-S0D^UF-C;_`AC/9/)$Y_B1V
MC+[*M.@AME-QM$ZNVD"/@[]HL^ZR.6%D4+)!?#SC3KA_&MTQQWG(%E>0,>%Q
M[9\FN2;8RH[8-KL9K%@9N5P'XIX'$XX)1R[;)+/#PFU\^SMC?J4%4F^[^XXS
M5Z\);2`%]PD3>1A>7N=F/F!]&;/C,?ET45(R$2V$C06#L=&YBLS'^`-6*0]-
MHTR;X)J(6SN`!P0U1&EI"\$RK8J!<^>!3*TENX@-YD*GD<5#JC)LWFV&O\)<
M;+8^*+X*M3+TH'71>.4E&622O4Q"P3/$[4TG$9AI=Y7S%N\C^K8T<=2N7%3I
M23#M23&53N.Y2`H^45>OW!&030AD0O;/#%9!7%%/%%--/'$*OEO=ZZ"V(`D8
M39#K9.P'<DAKJ!+2N2SAW>8B8SCE%LXZVCQX0T$K!7\+6B2"HU\CC9]DNZ>*
MO%7:KQQGF$\V9PYU#M>3OY5)E)<D\,R"+2(XP%GDVX@J[AP\*.!=5BZ'OO$#
MYBB`;W0*B<QYUIUEL&KY!-RX35#&;&X.:!VI)I1,)B'D+J02J7PF=.R#&2/A
MC@;(X$\A+D.[!+LK).!:#YI!&K`BCAG=(B,<O&B^.:#I3"X8-EP(TP@T`6(G
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MD]GDBP!!>"79JIG)PG9Z\9%$B0_.W2A@WP;WNE<,?J/A1J'2,\';`@3B0,RK
M*/,HXX:/F.OWS9^T8M##5'+`EE!,)3&VMKFU<\1@,B*"(]1--%DFAA9&@\;\
M(]-,T9#:,/=@P=_*IALR5G#41F3H>7=,MOI"&\^@J"[ML00&P(DWC[#%HQ:I
M(J!\F2*@Y9HKA92@Y,WX6:8FN`S#P<K'KA9R-V`'P&M8<>8##(G3HC13!LU`
M;#B,WC5AS;7P)LBE;)EDNBY3[9)7#.]^D.0/X=:L;C]E"2Q:>2D5LN';8U^Z
M'2&0M%6<4AN\9,4F.T0</0%AQ6#-.5R0IX0LN]\.=X8M6Z*:N*".*5![)1PW
MTK)5G#9`>9B$0*"H^*DNM8&_:1/74JM#UR3V%OS4;&#<,$WT4)$\G*%V2K-%
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M@V.4BP^2Z]D41B1N9.G\:@">KY[CLB(`8>,LW1P:B&<E3PQ44=Y/"*S!)%ED
MZ\$;MT4@@3[@=HY^-+QU1WL)*&R$F?DQZ#MYBNE&"T[/-#@V^PG3;P/)_C*Q
M0PY=%K=)RFPM=FS75;*N6B"^`28/PZU%$P!L%`5YGKW(ENN0[_#F(G),D2<'
MV'*@.<7/Y0I(NR,!1,5?QURZ96"*LW`I%L\5P203QLC9()GIGC5IO0:D@=ZV
MB#,88E"HU0[)7UL"TL))C(U%XPBT>RI\FJ?>LEV\2;.UDEW"N*A!19Q?^$5R
MO05F5X(<;C@\8R,PRY5R"BD#AL>/$%6KR2QP+KN>2/8H/&/'G#%0B$=NY#*7
M5GRK;-/)XUZB.?[W"U!E8OP_UY#M5QC5,=DDT#,8)*1<R@$J`):^BDKA1\1'
M;Q)N\$VA\`C\4)9.8TX=,G=R@HCD^0?+XN<E>MAU`C;W@;I&0-GP&>/)[M#7
MY.47G!+66RY(UF,/*392`_DY=2LVY)A\IE(BSL+?)QEXQ+NVZ9/*SM))-;!/
M+`,7_=]Z6R0/X+2+:+]Y((X!B3HJ:DXB1D%H\!7:N<!,@O(HR59[('NUVF-[
M-Y<C($!^'\&.P9)VQPQ"SC?$[59F+OXI@K+A+1YJ+6FE6Y(?)%G!L9$-1G2,
MD@CIF1.-S-W$B%F">:RCQYBZR=WQQLOBI;K=8*RD7=V\9IMF[<;#CAC8I$H*
MDC(T4F9)H6>%S,J<[!>DYLIC@+:LA4V:O-ED5!S\:BRN)O@VQ8X-\&R6.(98
M3P<UB!(2$T"E^Q@LD.SAYLQO+1*FO!LO!3\JZDBYR3,Y2RUV@=/K&V\S,-7#
M,\N8&XM"2J:39+JHW2"P"?%V`$.R>MSVQ!4K9):UN'G[68NR,V$$]5@Y1&8X
M>3,21`ZD9-/X_-2K,JH51()E$7RMG&&=\NFP5HV[OKC>-<9F`(211R9+MSK%
M]L4+(56^PRPJ40F/0N2`STM7;N2<@`'E8H/,O&#[)PT<'$,G"B>2:SA%4)H.
MXB:O;:N0T>56-273[<W&Y)CK\Q8&F#=&0<_)[.?6(-!`46R5CLCF+U!=P#01
M;`VS=DBT9M&S3KHYA4K[NS^+SD8#',A<U`K15S)+Q0N$F#ML4C@>0:^&ZS9Q
M)GDX;.V+Z'PV,@A]@(Y^@\0%KL$5$K?_`%,5`LXWPZU?(04=CQUS()&S9S.=
MS.;/)$4<*F-E/-DAB8R6XR$C'E(S<6JY<N&*[7(7@R18X"T&R".#7K)7":Z0
MX[P[0MGK6'/C;D3A!]7ZTCS(X2?FG@6#ZG%FFT='O#A9X_+2`JN7E15XX?.5
M.U4LZP1MC;!#&]POZ@4"@4'7>_:G?\&#D%^<OC+](;7%!V$`_P!R1?\`-S+^
M3)4&1H%`H%!UUHE_JG-K_P"3)$?I4#Z#L4T"@4"@T'V06Y<1G>Q936[H].]?
MNY+H9L)ATI#12/:_8AI:IME+;2F>P8YJL[-VJ,50BH!;!97,ADU4)735QRLY
M1S;A6'&W;',.3$]D6W<(FH&1#M>K$(C$KZ_*L8FK(D]7:Z,7NR>WX]B!A5UC
M.R)ELG?*?Y+N,DKI7"H=3I2"L(UNCO)8^!B[.0ZLE,SDD<F\+V#M"V4>CCNY
M71#36FOW,[BT/DP_7VJ@!_8,FFLP+*"@;(/@?#+Q9RS<JO4G;5QF$_E);GN(
M<B8]$)%/)8I)MP;,`N3\CA>M8U>*Z]CN]M61N$DDY($TI(@HAM(-4$SS_(@]
MCIFSBR62Z2*>*5KX!)/RL<HXU/I$WG3'<2D3ATF4Q@(_7NAV.P5]VBADD<-9
M6*F,B8@`PV((LHBT;.@Y)+*-X$7+Y=5#%_DWQ$4$&C\U[PPO"8^\G+"9P/9T
M7);J\KXY$(3KJ3PR:#%M0&=LZ74:$W$./KXW%3`@TA#W$<106?.A:G7LDX=I
MJT'X4VCW@#W,&VA`LO>?D)>S3GL6G&FG`W4\`CPS;4%:Q=O%Y\S$L7<J:[5U
M>J4L>>MWYQ6.*.%'O8#,V&(YT$P([FY;F-0:GF"D0VAK:6R>#[ADSR*L].-9
MK+;;9&2]FEI;3&S`S(8=80J('8RX<X%#B2H]JKFUQ5L:'87PS=!/(HOS$)\;
M=_RV9&I%&-RK([:*:?!1]C`I$0!JQ&13R\$#"XH1TH%PNWDXX<*;=B1=REP_
M:*8N&[YNJM^]"G=O[)[P"$A)4*AD:*2H2$G;(**V9A'D2.RB\9RT=KB0DR2N
MO8QI`Y&$Q[?8Y<V@F88-2BEG33P2P9?L^ID%F;"VYRK!0SC<_P!4P*8;(6P,
M/YWR)?EHY=K('>JXL99@3T,##Y#K#23Q?8A]&39D@S=K&1+]VE'<\,6U\'6*
MB@5-&7W>;&1FK$W1!(00G(,N?*.#R$":WA9UA'0:B#?8N;;1%DA4(('BW2UC
M#1MC*LDVKO#.16RMAV08N:;=Y_VC!C&`"9PXF[T1(L96D;T&A8!J79&0/:MH
MY&]9=9B/OMO7B+T:)<*$+O2^*JB#7&Y7"Y;P-N&4+3GO!Y:)FA9JA-]4RR,L
MN3L>'10+K6$2J#'97K?5L+_)'*P;^0P\O)ST*V+LU^6>";8D&CD@-Q19JX(.
MD'-KA'([O#GR6VC%K["B4_UYK0N<:-';,#K)ZX<C\HV(U_%3Z)$T%T)OURN)
MF,W&2@X/LLW!)W#/66-RS;L_WX2'7,V[PJ9LP<>V7A-M;GH\]XLJ%IA"-8P3
M$)L:-[8FFQ5]IO<V,RC,VO%))K"#HAQY]BG9*PLHSR?8WS9D$$\0G_)C9?,2
M.R+:;+28V:D9`.3R8ZOB+#4S<WKLU!W&GG!@ALPCM!Q'"[=KLL)MO)0>S!YN
MKV60:(87!ODW=WJ82S;4EY/0!SQC!-R\U(-#16=X[OE$4#-YZZ0\$<`7$08/
M#T+XB2QDDP<-'SQ/#/&'1C!UX/;%0@VSPOFN&K;3;_>>Q]1,J]@1F48L&5MA
MOH8XA08JYFL03@^]GAJ&122!8)KD=K>>('AD82%1\WF==JE$$$UBR[$MFJU"
M8#-C\[I2#V<S5<;3C4G:Q>`R**D`^EH\*:!2R\EB(@_#;B9_J\BP,$W\>,$"
M*JPPM*D<L67;+9QQ7"X=8-AI3M+DC&.;FGM8CX=.Y-QK+ZQ<B)G-FT!:$T+;
M-<-Y"6&S:43$4,&@H[&FS6,IC'*+99!YB9*-K8A\QSBY(>$$D,PYD`WDD;2X
MY*Q,)";,E4#&S?4NCTMASDQ&`L)=36`3Y6&91J0=MC.I#*&L9+Y,!CD6R5C.
M:B2[+(MFL+""EMR]X2780V.QJ`7CNUFDP2>[&0.ZQ*NM5-HV5G^D7,:`LYNW
M3<#B0PG#"\I8/WH8@3?@,457;S&ZC1+%P&>TOO3E]+)CJ1_LK6VW8>A,Y1BU
M*:U=:M$-`<<UL3$S)\XEFR9S@#>LADTBDE;MA6;!L?%=+1FV=(,"^!.R^`3T
M/R'W1:T;8&XAL[`OD)Y/QV273X];048(['`3P`VX_8X$FD*S%7CIJ%YOU<2B
M*^05WU;9+.\<^I:X1=60]X4$XL7S:"6DIY+[$/P-GKU,FA$'5];C'D*`R'8!
M':SP?#-;P=JU9%@9YLP0L.P405?CVBKITYRZU!,M`[1Y&[2VQL`?/0.SM>02
M1P%P<B;<KK=O%5=1F%V\)081I<E*X!D(E$Q06,%%DG;4S+1I#%AEF\'`,DL&
M+P*@_*%WAD8UNRNSC9/8AYSK#1$E-R651T.!F8"=2O8NS1VS(U'M>P_5S..R
MI(+$@X3)RBY>#G`A!QBXRS<Y+6QL%A1C97(IWQRUV?/E-L#Y06V.*%;@E;#4
M!66;-@,-<0=X2=OX?K0CQIU"[.6\O4QHU;-*%'L6+-^Z5LJ[\&R5;!4TZVIS
MZ>1J0HZS:3MOM9_@B,!Q^5\?QX_7T?AKJ*Q-Q%]K+R%/`LR7V"9F;S-N<C&)
MXGXJ:.GB?@#6POQBL'[#-K=X?-)V3E9*%2:!:T9/76RVD+.0P&P?L];X9ZH-
MVU63:7@DEE$]V4O$%9(T:H"B@%5*1K6P7<*-V]DL0B;+>O>>CF8^TJTP3N5#
ML73&=BHY"A!O-QEMK9NMG>MYC`9`RNM'S6>BHC(RP*4B+V57<L1JYF]NW03;
MN@N>92/G0(UE(98XE2S$^"V>7UD.CT/TT]-/I3!(L=Q%#=RJJ#X+M*21<ULE
M`*LZRP91:4A1R1=!+%O9%)0HD'YN+;W.<(8U8:U5K,V<!-],0G8NS(.4@@_(
MU(9'?7^]"<_UH//,7[@/%]F8F!,9\6H>%N!MR^+=BKG9L0S<8!2SC=W/+R9%
MO6K7;RY]_(63?:(U_H%W&VNKH_ELS7(P"\UP7::&V`]E2TF@14VX+V2#3K,7
M9MVN6`^Z=L%0F$QG/>!(#YK-8JZDUH$*EVI8V,;/X<S<S@O$C[;CW:62V(Q%
MAQ;>3EJ_#O#TP4+%",>)(8-V^6+>--%4/]W#"RK=W/X,Z>LAD7GAC7DDD`>\
M<V4"TVX,SZ"QD!IK7[J?)2.*D=:19[(W,BG,B?OXX0PA3#/-Z+(#'`O#JLDU
M@\B^X>="A*?#PU]H-FC74$Z<Z..O](/TW,ZE:4AY!C())-A0]MQW,#FTE5#@
M(B[<A'<HUSUL5DE+L<+OLFV`7CJ26\RYUM2(9;/;S/6$=!;/VE#9[%P<,A:\
M`E`6!:\UVO&9B"EAZ(FY7:"[)GKTTN,<ID&;O,?DFS4Q0>-5\J#7Z2;7[Q$&
M?)IE1DZ'Q,YL%\H')QZ"MY,\'0-OL3>P9.S96*<6]CE(!=C'`$.R5:%`,W=%
MD#"+QH1;)X/^R"T9!N3F(/EY)C'(OM(^JY+V;-AM]/LLH-'H&UF6K$HM+DI$
M0BL/<2:6SN#D#"Y5M8P@J*?++-U@@?!AD\Q#B0.7\V9A#XD1*2':X$\+VA)P
MTH5PU##@XN81='CI*9^->(@YYIZ.S&.AVVY@+"/VMX(E9/(BHQ1,&\O!R]P@
M4>VOS_*"-+FA[;8+U!$3&2N\,9!`+LG0DF5V!IH3(6:$5-\1]2229CHW#S,C
M>JA`2@I_BD@JHW.D54,&^`<<3NKFRO!(X_*N=WCY\N#VJ0>A&/'XA)F3O:`<
M'$E]4:V-X/>+6N6L5@DJ.NRJ#U\B3?MD4V^.5Y4CC:V>87]M24<YF6RMI'X`
M.52UE`6VNGK2/Y"`)^TL$NHBT);%8:]`(0*TSEDT'2!U?L'=I'BQ\&;+,TA:
M[W-'.P:_S7D'S[QV%,"$(@^PUX(N)V"6UT(<Z4.)*OHV@VY*^2A8B'?ZHQ(-
MI.B[B4)438$Y2%+7;$,,/)\BN]QM@%[3C=G(@IL,^XC#+<44TEDV1>P&11KC
M4?D\W/S)O&(>L-@9R$S6.##@6'2,XZ.^&E'Z05-NLR00R+BTU,5E@]N\-Q<S
M`.ZIJQUUJV1+:$0C,?@(J7"H@QELF%[$\(`3N<;3"Q;'*QV2QT3K`D4$#4+I
M+L'DM%(-L<5\W-D%0Q"^V.4R3YQC&ORS23-I%W2VFF$FXWL@+#=I;QEM=J]<
M;P)9LHVCIG$.W$1W-GDLZA[AZW<>%8BG*CSQ<R##L]U\MAKR1,18G;<\BA6'
M$P^JII+N/+V(2\GNM_EJ/-(3,HNPBH-O#H)'LR<AQ:G"S`8'522727>NLV:#
MQX&-B$U[P.69*1F<8S77[T$5T&6:SN%:S@_BZ>0W:W(Z31Z;,'0^9Q>9XQR7
M:BTOBEB<;V11L@LQ;&<;W:$;M4@B>>Z^\N%.R>%M7D),'/RF2AXP1PUJS:%H
M4VANHIX>=/90+S>ATY`"G1W,2J!=-\FMKGQ2@A?.R95MDD%XVFG+27:YCH_7
MUMD(&7'*0A"<IWL.(QK6DK.:#::^D,C2G1%D:T2<'1%JXEB38;BL\@;5;-9+
MP7'"^*J9-<*"V!LOO+VAF?+1(1)&X%@OLV'0\CEKH"=QL41%\B<=;RAS`FNL
M['I&W)E0$-QQ,-Y(T$M57*=W8E5LZ46P"SXYLOGS,M?;:>O(:8A$S=;)XT1G
M6(AS&!`%<-%W,DBL$Y"';G24,V,/S&OWX8_(&A!R%+X"@1%EGX/GU.FX>C8,
M]YRBG4EC,(\NB\Y;R+&*XL'6LP-]?"==61AK<#MT!N1#6"@"1;`/%WCC`FSQ
M%OVS)NX=J^33),9VBX3J*R'FI)PG&T.43/Q8^]V3NUAR`?+LXF+>!(A#9(8:
M0-HK+7NCY1$)1D4#XM;MR(F.QMI*+="[=47CEEA8*9`[MYXJ$"*4DC&PT$'D
M7C"Q585I!3'\FXK.0ZN:S25"0[J'N&\^G+>-%9$]$LAI\ZNY7;V:N8LVNTLL
M1#G2O?\`S<`&4BD3USM69:9%1)*'*S0YI-`/LZ0;$=RS.7M=DN-1AF#F78Q)
MKJH7@$7Q;"V=E316ZV3%DNADQ1"[N4.Y-[L7.NEN-;/9+HI(H-L"5XA2?'V8
M/(2[2#@':@T9-SI:)I2&([$+%U6J,;".,P>"B^+AP254;IIM5PKA?8_,R\(D
M!%(O-4!:NI)RY@DG<<=BF.PU)D$Y$.XSKF0SJ(L8B:?LGFP=0K#W9$4SAF#H
M*UR=O_%N:EK-6@6=N+=7)_+1^I2N@M9OY5NMT6!DMNQ]\%;#18!EKH`E*]M0
M)5T7=*B&DAFIYHG$Q>35T[Z%"2SMHLM9E?.X:UM-[\ZGLF`!9Y'-M:_UL6D,
MKE.>UM><>UI7*V>MI+.]KXZVAYJ`KPG8I$/L6%"8Z&'FL;B%$GHP@R(XY(+N
M'6+4/J?J`I.C>J=;&-GB4@6QRD%BI"=AD$<6R0R6NPC)<^RQ:8.7N#.[<GFK
MC=#%=?%"]KX654MCU\@L:@4"@4'7>_:G?\&#D%^<OC+](;7%!V$`_P!R1?\`
M-S+^3)4&1H%`H%!UUHE_JG-K_P"3)$?I4#Z#L4T"@4"@J24;XT[#"DM!238<
M;''X**@YF5QZSO)[(1`_99TE&->YY@1Z;HNZ<S61!W#$8W015</72?9I899Y
M86R#\<;YT\V?:^&J;!C^3W:C%D3@2""ZSJ\@&$G8P:-)X9M45DQXTD6-,V+=
M=W=!)=^Z2:IY9.%,4[A&7W*OCNQCXJ49;9BK\(=*2,("=`UW<C6-F(A-D=<2
M<8&'@&A,D5?`IRO@,<I((J9I.;]%[='3>@YYKDOH:/80I<OL^,M6.PP#>5Q$
MM@NX=@B<7>/@PIE(USS)LX#!P;TK(6+1!V]7;(+.G:2.&62N=L;A'4>87&A4
M(C(<MNQQJ,7=M6MKDD3`I^DB]!,Y2W-.PY,8T,,HIG&2"!&YE9!,3@Q5Q7R<
MV2OUJ#+F.4_'8#B8N6V_"VN4?S-HFT?&?A#H6ZCJ\P;%F+UHU26=($4%M?F[
M8-KX=NXL,<9(X*8IWO09H'R!U!(I,"A8R9(6ETC8W(BXV2$R`&:NVOG(+-L2
M`XX)'.@KPFG$RBK%L]Q;N'[<<Y6;8*I(*9XA$$N7_'!RFMFRV>-)+)G<8ZD.
M%!I05-$"624J6QS"@1H-T:/"LTX,9O8@R0<,+^*W5K+=**G5#-(\G=$+&VL>
MRV*+:$B&P4-3B[E&!P0-,[,<+'VV$$!G"HMF$.2G!U%2**C-HX66269*IYXX
MYX7QH,R*Y`Z3.1[6LL$[0AK^-;DE"D*U6;0--<AT^E:3>1.L@$7<7RQP*DO!
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M;/L&ZYD4E`P+XPB]:XJM'8UDX<-U%4D5,L0D![D3I&+FL(](-E1D46SC;*6Y
M(.G:F*#<`3:$R`IZ](8(YCF"A@>%>N&3==5-R\;LG"J*>::"N6`>H]R0T5&#
MN,9/;1B8PYXR)"'`]=_>^8XB*S31=-C*J2:C<)?-VMBV;Y/,T,';N_@Z%U%O
MX.@S!#>&I!8`W*'L^CV`..IQ50L]2=9.[M\IRS'/H6U1:-$UWK\A+6Q=K<:U
M;IJN'N3A/!'#///'&X0QIRRX[OC@J/,]H!7!(V!%287=-D<N,=`C9UI%1K^Q
MWQ58&C@M*WR0G+!1S@HD5S\#4QP<VNE8.48Y2:$!$I2*);&&XNH.P-$IHJS&
M2`H-B36/.Y(/+6DID6(>APCIL_B!)#%NY72766:9X)89Y=6UPS0WD)I8JA#E
MVVQ(^CE/]@$]41)D35<A"Q79H4+()&5@.04RV8%QTN8@8L_>*,'2"#FS=MEG
MU.C+"^01?'ESQK5C#F9,]Q0XI&V>K@.[7)$*[<G+IZADQ@H`![)\"$-7I#.&
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M<EI*P2#NDNNS)6=I9MU5$\K94'CGR=X^)^$=;;\%Z6K3<3]?#`XV4438\?)$
MA$]W/>S3ODIDTU=(G.+4RIC:^#)3K7SO;'#/+$.5)^1ND8<+L:/[$"-A64J/
MPKPYFF1,(6DL3%/CDL'Y7"LB%\$XJ(&.7!-S>UFH]-LM=PHGV6?5"/)\N.."
MR)IPCM>/+)@W&#96R2!A18PIG(R,1ME#F^`S)Q/6]I.)<L;J@\2"6+E#/"^5
MKVH/4YY?\:6JKM++;L97LU8AW^#AA@5)LB>)]A&"H=C'B`X<Z8R<X_%S04YP
M'#E'1#P=^BI=&V&=KT'+SY7\>T"M@I#90P*2\'9+9H2(7(HW@@N1!8RAB(=.
M3X8<U:21U&,[$L!2N>!*[#I<=AV-KYV"QTMJZY7EJT#2F0+.:-S#T"XB]GF-
MCB!0;%A,V?-UQ][6<))MHH>8OLELL;(=B\0O;.]U<+9!6&7+SC3@'5/WW'#[
MB4BUP^3O!RZ4ZRF(NYW(JD@FTR<KQ3$%C=_<WAAD'LQQNXNY[&U\[`)\O.,P
ME-#-WNB$*9O)-.X8Q9CB*A@D1ENLI`$BD]C8P4(0?$B9J,2.2#V;EL@DHKV[
MY#'&V7:X=8)29Y":=CEH)>135L`OLI#-U$,#8H\)5>LTRT?`*/2:)`4W5C#+
M`]*QC&ZQ2S)+PP@W0ZW:JX8Y!@`_*K0\@O%;!INN1O.'+A"(6;P^=97D2#3$
M#DZ,BK7C.-W47;8RD=VA?'_RO#PU'I<6Z]J#'K\P^-"`]8I^5R.NF2!!=AGF
M,;F2RV>#8*7DBII!H+%O';J(^3P!\^Q-IIYA\VC-=7%S?!+/+$):'Y"Z?D3*
M:%(_+KG1&OT"3B3F0\?E),(@D'>.AY3Q099!%QDH48/F2R2N`M5[G@HGE:]N
MFU!@1_+#CJ3A2VQ6VV(SA#&[5B^5./;D!B6+(K'RTK$/+-"3%H0S:F(R"=OV
M:F*-\7;1&ZJ-\\+XWN$M;[TU0LVU^Z<3!H&MM26OH)KQM)V!B)$I;,!H*12=
MY'1(F3CA!14DG'HD2>8X9(X]HW9J9X7RM:W2%>AN9/&B1@G,ICFU1<CBS9A'
M2.4GCP:4G(VX3EV47QB[,>?%`G8@H9/Y3439H/;+*OU_&"/51OU[4'/4Y:\>
MFQEU'R.QFP0NQ!`I,^:2*/2Z-^`@Y.\\71Y^^<'@`YJSP-$L<VS;!3/%19RD
MHECC=1)3'$.4XY6<<FPH"<ON*$.0\F8`RX(D.*V*M"(&1QD),Q$F36&)N\4X
MHO$Y(.(J%5.H.;M'R"JRR>*N%\@V"H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H
M%`H%`H.N]^U._P"#!R"_.7QE^D-KB@["`?[DB_YN9?R9*@R-`H%`H.NM$O\`
M5.;7_P`F2(_2H'T'8IH%`H%!HK.^`FKIQ.YMM%:6SUE/MB/WZLQ(/',<E\8D
M8'//7RH"%E]<SB/2.`+QB)J:M"Y,NR'($+9MU%<G=UULU:#*2KA-&Y*%TZ)1
MVUMH*]TO%F47CDQ:/XH0V&I8<]%DVAM*?&XH2E(,LN\$(I/\![ELP*#^LS=M
MED;)62"!A>[;U1!<P"FIY_M/75H<982.$M,3(B<L(N=2;ZS:&G[5/88:3OGF
M$G1U6/S=H.'*B&#A9RJA@EFK^]"TL.$.DU<($D80D,D3UUJ\KK((B=*INF;S
M`S)PTT?3`^,0:-1!N5>5@-$@AV[?(>T=6[1!JE?!/J!7<<[NO5L!9$F&LIYL
MG7S<Y&,X0<R$JPTLY(1`S"8+!)L$3<R>(FU6"<N8:T"/>NC?'Q43;++#[-DW
MCM%8,1(^[.TW(6<_:WFNRQ^6SR.4@FV:+Z,O434I'ZWFNF8<>S:%8T^;M,H5
MIV7MXPT:H62:N18$;=Y@X=)+N7(6I%>',?CFQ=<[,5V!)W)O73-5DT9B(]KZ
M'L2K7HF>#<00>1>*#I)E$KVF[A=R$\89"71!JV>70P<8*YK!5Q#NY862\EW3
M[:T]*%8`36RU\Z.`-:EA\8BZ^.R+K13,&K#$AYU)5QLUTMD^>65?V48L^HIA
MC@OBX#D'>[FUY)6TP8%MC3UNTE.S9!N)H]CPZ!QZ41S8QY>?D4I$,E+.)9D5
MU8T;V*[>B<'%E;,UV[:U[J8)YXJ!)S7=]Z7-135T.R-[$%"-()RMWJ"T?D]@
M"D#E,DV,%V6PF++`2R:-3!>'EH\T:BT"2;T:FPQ436;+9+*9Y!PF7=_:\6"Q
M,5+]A;&F3B$KZA&1XH\M"PCA'6VF498P":E?-H]$1K,E"I8&GAEE([+89/"[
M=_?&ZZ=DF]D@QI3NYM6F26:C[8&T<0+]L^'2,"*?Q:-N9:",R)V>D$0D\RC$
M7#3HQ"3.)!='Q:L2R38J*Y.&6;9Q_"4$0<]UOJ.Q)T\#[(V@%;-V:+2)(64A
MYLG#&XIL>&Q00/E,DBQ>3&(M%0YRS5N.)NGN+C!DUR<J+9)WOF&P$*XFB8QL
MG8^RCDZ,3<CMX3XOV,R,QB$C/'RRD"ANNW2S<Q'`0DZ(8NPD':9Y,T'%D<7.
M:N>/1;+''`*CF?=MZKV2"5$;$V-M>4OV.MW&IX3*O#H<!DVNHDS!DP\)<Q)]
M'8<,;H2Z!N3+I^T+.$5W+MTODF]\(9WNUN$]V=P=@&U)&S/&9K/!"+37C?7=
MV4:M#Q#U<:PC4BC0[)Q*$HIE*7PAO>1Y$LP;IVY`*EV35UX%;+!;%</%APL'
MCG,J(--V;99EMI).DMWDV"6O6B^V,<C$B,BDG^'D.JE#VP;RH>,<$P5A_A(U
M3L7%U5/X>@Y,:X-:D@<2)Q?73^20=5>0ZGF8(T(N!7=QB9Z<B8.&1J1,6!$(
M["D5284%@F30?-W*#JRZW4Q1ROADF'M*\(M82*,KQF42":R1N5"KBI2[).P.
M"\K=%=[H<B907*(,0#1@V=2C8&"UG"+-%LS18.<T&Z2/53RP"L5>[4TXD0V)
MB&D<F"Q7:0"41F511`3"'F#<+*Y'LJ2OQT7//HRN=CS'%UM!ZE9+!97'-!%+
M'/IR[3)0)E(.`6H#FO!NL6\@GT>C,<V_--SPY0"4#-SL2DTW;G<7S46?>`7Q
M-VQ%/9.^68*/<W3ULDK@U[?)H@BA@$9C?=KZ-B>!A4')=HLB9R`[`U$_(IRI
M'L/R0SR!M(+AK5M&_%GDBT`1/Q2/*"UDQ^)#`FQQS6<+(JKHJ!:VX.($)V_<
MNY(R61B")171B]E4F<9,CD%M!'YE((I=4,>!D&3](JXG#O`A@MUK9X)HW1['
M+#++(*T>]W;J9X4,RG&2R=O-)0U.-)::5":\-!9.U-?DU6\7DH')X8=A6`Q@
M]U6-NDF@R26NT5<M<ULD5,+)!(#W`W6<I#:>'2&=[>)$M"@F['5<DRFRS<S&
M9*C.8M/KS;*[9JDR-%\24+&LT&A!)V*:BF_@J+7##/.^0<-MP#UG^2V:ZF)3
M6?OHW-)E%9KGX#Y&QE*/E87BUN!=1F/Q>)"(@$*JO6*+X@^;CDW)$DGBZ5OV
MEK=`8V#]W-I."2^,3L=)-G$)1"SK<M%WI64HJL!XYZK-UIY''D>:#6<;/B]I
M9[).7.JD&;IZKF^MF@NAFBCE@%E-^%FDD]<:#U,Z&$GL!X],WC*+1VSM$4PD
M#<C"#L#(HS!`"V$I%FA(7(W:KMMA9%L\75R[=-1/++#(*^!=WQJJ#R>TYUA+
M9QKJ;(D21QF>$81`HDRD!"6[,D?C)N$D,6*!6Z&(G<!\(LS102:.AR[;-9/-
MZP9.T`XRG=PZ#Q@\QBC1:4Y&I<8C)^\Z..QDE.AB\=OK9P\="1)86K#VEY@1
MUFW6,W2&IYO,'SIOCDDUR111#&R/NWM32>[LX[E\S&[#?(),G$[!LX<PSQ%M
MM9@]8LP[6(K1I[#6K)BQC+!^@KBR\.0>IK8).,&;QXU7#98#Q]BS*>%]IR9\
MXF>QI/I\)I262=^)CP9>01,+()1(K762CPH:HS<OW4I436P15P0[-NAU4\<\
M+YW"H4>&&+8*#$H;_P!RX.(K#R6JHF6NAJ]1S'=-&@X,(7UVS8YZ[R#KJ$F\
M8&N%3:[94U=X/0S\(LE91!0*>(=U/Q_56=N`LFV*#S\=)GPC&[N+FP8!_P"5
M64I>XM1!R,/4WK8XHQ$-"-G.:JCYH`864SNJFJJJ%P[%X0PW:*&D<)/-9&FX
MTH'=@A[H*#A`O(NP<S'6\Y2502\G'"42*L#.K!F+=T)LU52;Y+8V_?YX*)AC
MM4<`]2ZUMK](F2)SQIJP#*8Y!69@/%0*0]I+6>OAY$D3SB(4&N:D6#+6[)--
MXKEC?H67Z<+WRPNF$=D7=O:?G8T:,V7,]ESQ*-P?\F,,<OR$9!/HEKYA$9A$
M(T$'NHG%P6;PE'&TW>NL";NR[UVYLG9SDJACDCF%TZ+XO!]%$]@O!$Q*R!ML
M0B>-%&Y*,08.[1,2:1%Y06=X$XK'`2R[>Q(ZYQ:M<\?!FB&6*:>%L<,:"E)E
MW:.@9O'O$Y9_,L2:4!@>N6,K3<QY20#X]K[3\TTP*3;J.8\LQRR(1R=O7+W'
M-#))9[U,L<<$K72N$ZEG"2$3[5\`UE+9I+;(ZVEY>:1:11!C$846'&"C`R-Q
M4:MQ,=S%M,F38\YZBB2."N=U+]?+*V65KA58KNS-6QV/3.'QN<RD9%)@ZA9'
M(8O&M<$W8I]`2^L3,<;-BSR(W=NXVW<:I')YC'':-\T<UL;7QO?"Z879(>'4
M*E\6<QN1RN5JJ/H1J6"O"01",1__`,NTY.I-/HRY8"V0'(8.<N2<H60=8II]
MEDV23LG@GG;+/(*C9]VIJ6.HSEMK_8NWM=MM@H.@II"+G0".`B&%HUKL,=A\
M'4=1IPY@X]Z?UNVD+98>HDX&F7SSP;)-BKBR3#Z#"&*XT>W8N"#DHHW[;#%Z
M\Q1Q<J(775S:I+7033P5S:-LL$>TO;KJVPZ^=[YY97N&2H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%!UWOVIW_``8.07YR^,OTAM<4'80#_<D7_-S+^3)4
M&1H%`H%!UUHE_JG-K_Y,D1^E0/H.Q30*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*#KO?M3O^#!R"_.7QE^D-KB@["`?[DB_YN9?R9*@R-`H
M%`H.NM$O]4YM?_)DB/TJ!]!V*:!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!
M0*!0*!0*!0*!0==[]J=_P8.07YR^,OTAM<4'80#_`')%_P`W,OY,E09&@4"@
M4'76B7^J<VO_`),D1^E0/H.Q30*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*#KO?M3O^#!R"_.7QE^D-KB@["`?[DB_YN9?R9*@R-`H%`H.N
MM$O]4YM?_)DB/TJ!]!V*:!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0==[]J=_P8.07YR^,OTAM<4'80#_<D7_-S+^3)4&1H%`H%!UUHE_J
MG-K_`.3)$?I4#Z#L4T"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@Z[W[4[_`(,'(+\Y?&7Z0VN*#L(!_N2+_FYE_)DJ#(T"@4"@ZZT2_P!4
MYM?_`"9(C]*@?0=BF@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4'7>_:G?\&#D%^<OC+](;7%!V$`_W)%_S<R_DR5!D:!0*#Y3]X$0$AYI%
M%R[:+N'<CB24,BWY8XD2DNJ&Q$B]E14P9B9L8MVNOMJ"6@=LWP<^"$E2JQ(4
M@FBFF@Y<)A\]M"];[2H6Z^,KPS_N+-3=?">96SG.&7K%1_K8S//&V..<KQO[
MA&]K6M=YVE!V8:!0*!0*!050+WGJ$UN:5\>!6P(X_P!VP:#QK94MUJW=Y9R8
M#!9@3*!XW)7[3L[)X#RI(,X2PZ,\L\;XXWSQQQ52OF'L8[MU22ON.S&<!G-^
M/I98%N?L\G/_`./2[>!Q[9ZS`]UF]NHNG`)6.*7[+M;>#.\+]/6Z<;!+(3,X
MOL>&1'8<'-,Y)"IY&`$SB$B'W4NP/1>4"FAR/FF-UDTE;LR@E\BNEUL<<NHI
M;IM:_N4$GH%`H(&/V?`2NR91I\=*!KO9D+B$/GLJAR62URP2'3\I+@D-/O,<
MD;-[,9`5@1A!"^.>65\QZO6QM;JWN$\H%`H(I#9S$M@BWQJ%G64B$C9/+H:]
M(#[JY-49/`I.6ADP$65433Q6<`)4">,5\L.LG9PWSQQROT=-!*Z!0*",3.;0
M[7,8+S6?RF/PJ'@$$W)N42HNP`@1*"[E%F@H0*DUVS)KBX>.4T4^OG;M%5,<
M,>G+*UKA)Z!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0
M*!0*!0*!0*!0*!0*!0*!0*!0*#KO?M3O^#!R"_.7QE^D-KB@["`?[DB_YN9?
MR9*@R-`H%!J#O@4J4V1',,(5R\F&.,"-7NCH?:C/6>ND<K2$3:V<B<K[BU.H
MZGB=E.JSPLHMCF/57RZ,KI=9(/D'KO#L_P!J&V&G=`BUOAW*<$PNV+N[/RS?
MJ\GQ6/8%'^+TE9Z12Z.JNM9PXLHK;++M,^GK7#L=4"@4"@4"@ZS>].Z+YX[*
MW=R@Y)0[D=J6(S_E8KRGU%*8TV8RL`ZC'&J>0"#PW1(.^XHZTO+CKL8KQZAJ
MA02B,8(A+RB2+CWKI?J6>!$C/<W\E2(W:ZHS5W$@#"ME[MW_`#T'Q)0W3MK#
M2>ND-Q<*-$<<]=[)92\=I5B^+[%T+.]8FWHY@C'1[+!A)%UACL<\22O0;B\7
MNZEE.OCDKFNX"T->;.CW%3B!IWC7LF.2"7R(EHG:VG.*A'1.V-A1($4;1X,&
M\?R-9HY15;X]L:9,6]GN*62"*>`:<1;N:.7(SB.=TU*97K\[+'&W])35**"M
MT-F^N2[K6&AY;JB:[7=C))P_D4"-3#;\MD+<T=#2F)2;(GDQ2)+FDY$BD1L&
MTC3NW^6S;E9PLWXYE>EGK[2FKN,,'W))?*23D`+W'4D5F,?VR-U7JV5ZUD,S
MA+B8>5/5#$0^Q00Y[;I5D84FHV;6S#Z(=X'QZV/R8T$QU_K-W%GI(/MS3VQY
M+K.?R$]$M<;[@>NYX(E$QT1L241D%*C`*(;'$,<VZZV(DLVS5322>,G+-1PC
MD'RD4[H;<Y@\IL]2/\?=:;)C$(X"B-&#];[,W47"Z"=\?.>>W.0NYH]!I9-Q
M+Z3Y#B.@]A(QH<]LBU;D%\W@Y(:%"9IMK!`)=W0O,6>[NVY.#IC1`&';AFXM
M_LH7"]CS8,QV>%C_`'D6CN404Z:C['4HJ3-#Z''"'2"-YV-2J6.\#+U1JS?,
M0CC!!L&KG/+N_P#E;JV`RO3FL]*O^0<?V1$N\$@?&J&0MKN`U!>)J.]^5@7:
M6CI-!C$5A)H-`-A-=;%LXZNU,*16.!!33+!O(\F-GH]R'UHXQ\`^4NC>=G(#
ME#+MBQV:Q>87Y%%8NHPFEVDCV<UVQ+(-)=2:XVE&%-1,G3,+Q]#Q)0(">JS`
MR@.:JW\6L6:+U\A8(KNWNW-[RG0G"F$AH[HS>CW2NK]SA]WZ1WOLS9^OM13#
M?6_8^`(O>1K"4:RB$FDI26:DV=>0NQ:-V@]]FSDKMP/)"2:2#F@USY.]T'S"
MW#+N0;^)373C"2[0;[-)A^3#W:VZ!VV2NOYKQ!4T&$X1&X(O&),.#\?X]M53
M&4IF\I,7>8XM477BO(VHY(*!J\\[@7F&K@1`-9]IU&$X[8+;%``+;7VRFB*R
M4*[28A'+9/"&=+$D.@IV.CL,45+8(IB\$\+]5LAED&U''KNC.:VL]S<=YQ/-
MSPR0A-5:IUO$5S`K81>\CA@O7NC]I:J*Z)CK8YI<J=EFG=BR.9,#C_#&21UM
M=?#-9P.<O1PU?(,;GW'.REN).TN/.2NF_#-A<"N`FOB+)[+]@/XK)N<7%N3;
M&,[5VW(W;B-KD46>Q(^9$!49+BV<%EF:/0X8639MT<PVDW#W??(_8G)WAAR`
MU['-*Z@8Z0BNA8W(H8\VH:V9$=;@M7[.-R281:#1DWH0<:+OBT!+>+Q<AC<C
MUVZ>/;8(R%H6&M6Z5!]<M;0U:,3#>)E77L)AF$\V2-D[>1160D3)O9Z3;6<!
MB]YGL`<]CH5M&)4R5CV01)DU<E$,Q(EFYNYQ474;(!;]`H%`H%`H%`H%`H%`
MH%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%!UWO
MVIW_``8.07YR^,OTAM<4'80#_<D7_-S+^3)4&1H%`H-$N3D>UP:V"(ML.>["
M?QO&'MBTOT9$==S?88.1#8WE.T8I+98K`([("T,%,I%*EG%EW5DFI!X%:Y8W
MOD/SOB'R+T+BEC^TIEL6YQQ)T,>XLU+BC)'99L?=2%*W(J/V3..3K/!-H:<%
ML.AQF[2QQ3<Y*74QM;'*UJ#LPT"@4"@4%&[OV!*(NUA\*UPB+7VIMB1J1.%N
M#C=5Z`B[5B*?'Y=L&1CV[M@Y)!H7'!RJR;)-=#(D469,.V;V=W<)!%&_$K51
M%%-SL=><;@E"F-\R<LV+/)4_=/72F>2BRH^-AR@:#1!GEGE?J,@@H:R3QZ+8
MI=/3>X>[U/.-OFO'?'<J^7J!ZGG&WS7COCN5?+U`]3SC;YKQWQW*OEZ@>IYQ
MM\UX[X[E7R]0/4\XV^:\=\=RKY>H'J><;?->.^.Y5\O4#U/.-OFO'?'<J^7J
M!ZGG&WS7CO=]S[MRKY>H'J><;?->.^.Y5\O4#U/.-OFO'?'<J^7J!ZGG&WS7
MCOCN5?+U`]3SC;YKQWQW*OEZ@>IYQM\UX[X[E7R]0/4\XV^:\=\=RKY>H'J>
M<;?->.^.Y5\O4#U/.-OFO'?'<J^7J!ZGG&WS7COCN5?+U`]3SC;YKQWQW*OE
MZ@>IYQM\UX[X[E7R]0/4\XV^:\=\=RKY>H'J><;?->.^.Y5\O4#U/.-OFO'?
M'<J^7J!ZGG&WS7COCN5?+U`]3SC;YKQWQW*OEZ@>IYQM\UX[X[E7R]0/4\XV
M^:\=\=RKY>H'J><;?->.^.Y5\O4#U/.-OFO'?'<J^7J!ZGG&WS7COCN5?+U`
M]3SC;YKQWQW*OEZ@>IYQM\UX[X[E7R]0/4\XV^:\=\=RKY>H'J><;?->.^.Y
M5\O4#U/.-OFO'?'<J^7J!ZGG&WS7COCN5?+U`]3SC;YKQWQW*OEZ@>IYQM\U
MX[X[E7R]0/4\XV^:\=\=RKY>H'J><;?->.^.Y5\O4#U/.-OFO'?'<J^7J!ZG
MG&WS7COCN5?+U`]3SC;YKQWQW*OEZ@>IYQM\UX[X[E7R]0/4\XV^:\=\=RKY
M>H'J><;?->.^.Y5\O4#U/.-OFO'?'<J^7J!ZGG&WS7COCN5?+U`]3SC;YKQW
MQW*OEZ@>IYQM\UX[X[E7R]0/4\XV^:\=\=RKY>H'J><;?->.^.Y5\O4#U/.-
MOFO'?'<J^7J!ZGG&WS7COCN5?+U`]3SC;YKQWQW*OEZ@>IYQM\UX[X[E7R]0
M/4\XV^:\=\=RKY>H'J><;?->.^.Y5\O4#U/.-OFO'?'<J^7J!ZGW'3']\VU[
MD-<8^ZD^#3">!"C7.WNXK,BHB4,B3%QA?W<5$54\\;^[:]J#'1I[,=(;-BNK
MY+)SL_U5M)4R.U9*Y:]S+3B#3D$%(2ESK*521;&SR:`)!$PY!^#*O\E2[=44
MY:OG+W)=HI@&U%`H%`H%!UWOVIW_``8.07YR^,OTAM<4'80#_<D7_-S+^3)4
M&1H%`H/GOS%.0T?*@K.1:Q!%GRD"++(362S_`&GK1M(6*I%9);5X1_JN"39>
M<ELED[.U`9;'!K?%VED@@YNLY[$/E=H_+K?M+I[*P9]'+9=QIJO+R>)BQP0D
M!Z>1P&_B8@%$8)B1#X7_`/05:M<<6[=3"Z:=K88XVH.RS0*!0*!0:Y37&V7*
M30%LK6RMAJ?D<KAT^[U5;&^/Z-E,?]F=DE\\>G]WJY7M_P!-Z#8V@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4
M"@4"@4"@4"@4"@4"@4"@4&M/([W'W'/.WN9I\EH%U,[?_-AVL<F[=7JW_=Q[
M1!;/#+_;CE>W[EZ#9:@4"@4"@Z[W[4[_`(,'(+\Y?&7Z0VN*#L(!_N2+_FYE
M_)DJ#(T"@4&G7(C=4@U[-@$58;)TW#`Q^(OEW`R=:PVMLV6%Y&[+8CX^($#M
M?22.#[)RAJ@^0'L5%%"Q=^SS18-W-\5NP#X_ZL220_:>)L@@@DU11[DC7:2+
M5`4]`H-DD^3(?!-!$&2RS(ADD<+6QQ:.,KKM[6[/.]\L;T'9%H%`H%`H-<YG
M_:ET'^:/D?\`^O\`'J@S!D-R85+DU8]L?13`"H_<YAF)G2D_+EV8S)7*[-L3
M*L=_!&1)^BAT65729M4U,[7OBEA:_5L&,\1<L/.EQX]`FR?K)4#Q%RP\Z7'C
MT";)^LE0/$7+#SI<>/0)LGZR5`\1<L/.EQX]`FR?K)4#Q%RP\Z7'CT";)^LE
M0/$7+#SI<>/0)LGZR5`\1<L/.EQX]`FR?K)4#Q%RP\Z7'CT";)^LE0/$7+#S
MI<>/0)LGZR5`\1<L/.EQX]`FR?K)4#Q%RP\Z7'CT";)^LE0/$7+#SI<>/0)L
MGZR5`\1<L/.EQX]`FR?K)4#Q%RP\Z7'CT";)^LE0/$7+#SI<>/0)LGZR5`\1
M<L/.EQX]`FR?K)4#Q%RP\Z7'CT";)^LE0/$7+#SI<>/0)LGZR5`\1<L/.EQX
M]`FR?K)4#Q%RP\Z7'CT";)^LE0/$7+#SI<>/0)LGZR5`\1<L/.EQX]`FR?K)
M4#Q%RP\Z7'CT";)^LE0/$7+#SI<>/0)LGZR5`\1<L/.EQX]`FR?K)4#Q%RP\
MZ7'CT";)^LE0/$7+#SI<>/0)LGZR5`\1<L/.EQX]`FR?K)4#Q%RP\Z7'CT";
M)^LE0/$7+#SI<>/0)LGZR5`\1<L/.EQX]`FR?K)4#Q%RP\Z7'CT";)^LE0/$
M7+#SI<>/0)LGZR5`\1<L/.EQX]`FR?K)4#Q%RP\Z7'CT";)^LE0/$7+#SI<>
M/0)LGZR5`\1<L/.EQX]`FR?K)4#Q%RP\Z7'CT";)^LE0/$7+#SI<>/0)LGZR
M5`\1<L/.EQX]`FR?K)4#Q%RP\Z7'CT";)^LE0/$7+#SI<>/0)LGZR5`\1<L/
M.EQX]`FR?K)4#Q%RP\Z7'CT";)^LE0/$7+#SI<>/0)LGZR5`\1<L/.EQX]`F
MR?K)4#Q%RP\Z7'CT";)^LE0/$7+#SI<>/0)LGZR5`\1<L/.EQX]`FR?K)4#Q
M%RP\Z7'CT";)^LE0/$7+#SI<>/0)LGZR5`\1<L/.EQX]`FR?K)4#Q%RP\Z7'
MCT";)^LE0/$7+#SI<>/0)LGZR5`\1<L/.EQX]`FR?K)4#Q%RP\Z7'CT";)^L
ME0/$7+#SI<>/0)LGZR5`\1<L/.EQX]`FR?K)4'N;`^5.+EMD[V?Q^5:8N$,G
M:3;1.QF[E5K97"[E)LX5Y%N4F[A1"V6."F22N.&=[97PRM;JW#%<C_\`C..W
MZ2VOO_0IG0;+4"@4"@4'7>_:G?\`!@Y!?G+XR_2&UQ0=A`/]R1?\W,OY,E09
M&@4"@IW8G'[3.V30N1[$U\"E!X*W;-A1A[B[1(L463A\Z8XH.V+IJMCFP<DW
M.;?/IOFADY5NG?'M,^L'PO@S-L/_`&I#9C!FE9!FQ[EN%,VJ..665D6S;E&,
M102MEGEEGE9-+"UNF][WOT>[>@[&5`H%`H%!KG,_[4N@_P`T?(__`-?X]4&Q
ME`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H
M%`H%`H%`H%`H%`H%`H%`H%`H%`H%`H-:>1__`!G';]);7W_H4SH-EJ!0*!0*
M#KO?M3O^#!R"_.7QE^D-KB@["`?[DB_YN9?R9*@R-`H%!K]M+=I[6TE\!;:@
MG4WB`>(^6,XF$4P0>N(\-</R`YHF"BF.&1B>/F-Q2SDHS&WS(M&6:&;=L]46
MLC8/A9I>4I3G]IED\U18.124N[CS6<EP%O>GPT98WR5"D<AKVUTTKV>#\G%T
M5K7PQOBIAE:^-KVZ+!V5*!0*!0*#7.9_VI=!_FCY'_\`K_'J@E!#D5Q]$OWP
MHKO738PH,=N1Y(:0V="63\>_9K9MWC%\S<FTW#1VU<)Y8*)*8XYX9XWQRM:]
MKVH.)ZS7&[V@](>E>!_+]`]9KC=[0>D/2O`_E^@>LUQN]H/2'I7@?R_0/6:X
MW>T'I#TKP/Y?H'K-<;O:#TAZ5X'\OT#UFN-WM!Z0]*\#^7Z!ZS7&[V@](>E>
M!_+]`]9KC=[0>D/2O`_E^@>LUQN]H/2'I7@?R_0/6:XW>T'I#TKP/Y?H'K-<
M;O:#TAZ5X'\OT#UFN-WM!Z0]*\#^7Z!ZS7&[V@](>E>!_+]`]9KC=[0>D/2O
M`_E^@>LUQN]H/2'I7@?R_0/6:XW>T'I#TKP/Y?H'K-<;O:#TAZ5X'\OT#UFN
M-WM!Z0]*\#^7Z!ZS7&[V@](>E>!_+]`]9KC=[0>D/2O`_E^@>LUQN]H/2'I7
M@?R_0/6:XW>T'I#TKP/Y?H'K-<;O:#TAZ5X'\OT#UFN-WM!Z0]*\#^7Z!ZS7
M&[V@](>E>!_+]`]9KC=[0>D/2O`_E^@>LUQN]H/2'I7@?R_0/6:XW>T'I#TK
MP/Y?H'K-<;O:#TAZ5X'\OT#UFN-WM!Z0]*\#^7Z!ZS7&[V@](>E>!_+]`]9K
MC=[0>D/2O`_E^@>LUQN]H/2'I7@?R_0/6:XW>T'I#TKP/Y?H'K-<;O:#TAZ5
MX'\OT#UFN-WM!Z0]*\#^7Z!ZS7&[V@](>E>!_+]`]9KC=[0>D/2O`_E^@>LU
MQN]H/2'I7@?R_0/6:XW>T'I#TKP/Y?H'K-<;O:#TAZ5X'\OT#UFN-WM!Z0]*
M\#^7Z!ZS7&[V@](>E>!_+]`]9KC=[0>D/2O`_E^@>LUQN]H/2'I7@?R_0/6:
MXW>T'I#TKP/Y?H'K-<;O:#TAZ5X'\OT#UFN-WM!Z0]*\#^7Z!ZS7&[V@](>E
M>!_+]`]9KC=[0>D/2O`_E^@>LUQN]H/2'I7@?R_0/6:XW>T'I#TKP/Y?H'K-
M<;O:#TAZ5X'\OT#UFN-WM!Z0]*\#^7Z!ZS7&[V@](>E>!_+]`]9KC=[0>D/2
MO`_E^@>LUQN]H/2'I7@?R_0/6:XW>T'I#TKP/Y?H.0SY'<>2+QH/'[YTP^?O
MW3=BQ8L]HPAR\>O7:V#=JT:-D3F:SETY<*8X)IX8Y9YYY6QM:][VM01#D?\`
M\9QV_26U]_Z%,Z#9:@4"@4"@Z[W[4[_@P<@OSE\9?I#:XH.P@'^Y(O\`FYE_
M)DJ#(T"@4&NFVIKR&#RD>$TYJN'2T-<.Q>&I--9:9CK1D\)O#B=[#VH>.FUB
MB<>;`4[O6^.6+M?(NUNWPRQ1<4'P@X]L\F?[2M*KJ"2X!R4[E.+RE_'S^2.9
MH`4FO+K"9EP!+)NW:)7=`RI]9I?H3QO:R-NMTY=-[AV:J!0*!0*#7.9_VI=!
M_FCY'_\`K_'J@N]6+QI9119:.@EEEL\U5551+!11513*^>:BF>;>^6>>>5[W
MO>][WO>]!X>2<5^]F/\`Q,.][4#R3BOWLQ_XF'>]J!Y)Q7[V8_\`$P[WM0/)
M.*_>S'_B8=[VH'DG%?O9C_Q,.][4#R3BOWLQ_P")AWO:@>2<5^]F/_$P[WM0
M/).*_>S'_B8=[VH'DG%?O9C_`,3#O>U`\DXK][,?^)AWO:@>2<5^]F/_`!,.
M][4#R3BOWLQ_XF'>]J!Y)Q7[V8_\3#O>U`\DXK][,?\`B8=[VH'DG%?O9C_Q
M,.][4#R3BOWLQ_XF'>]J!Y)Q7[V8_P#$P[WM0/).*_>S'_B8=[VH'DG%?O9C
M_P`3#O>U`\DXK][,?^)AWO:@>2<5^]F/_$P[WM0/).*_>S'_`(F'>]J!Y)Q7
M[V8_\3#O>U`\DXK][,?^)AWO:@>2<5^]F/\`Q,.][4#R3BOWLQ_XF'>]J!Y)
MQ7[V8_\`$P[WM0/).*_>S'_B8=[VH'DG%?O9C_Q,.][4#R3BOWLQ_P")AWO:
M@>2<5^]F/_$P[WM0/).*_>S'_B8=[VH'DG%?O9C_`,3#O>U`\DXK][,?^)AW
MO:@>2<5^]F/_`!,.][4#R3BOWLQ_XF'>]J!Y)Q7[V8_\3#O>U`\DXK][,?\`
MB8=[VH'DG%?O9C_Q,.][4#R3BOWLQ_XF'>]J!Y)Q7[V8_P#$P[WM0/).*_>S
M'_B8=[VH'DG%?O9C_P`3#O>U`\DXK][,?^)AWO:@>2<5^]F/_$P[WM0/).*_
M>S'_`(F'>]J!Y)Q7[V8_\3#O>U`\DXK][,?^)AWO:@>2<5^]F/\`Q,.][4#R
M3BOWLQ_XF'>]J!Y)Q7[V8_\`$P[WM0/).*_>S'_B8=[VH'DG%?O9C_Q,.][4
M#R3BOWLQ_P")AWO:@>2<5^]F/_$P[WM0/).*_>S'_B8=[VH'DG%?O9C_`,3#
MO>U`\DXK][,?^)AWO:@\\(M&$L\%4HX!343SQ434P$#\,TU,,K989X9XM[98
MYX96M>U[>[:]!0W(_P#XSCM^DMK[_P!"F=!LM0*!0*!0==[]J=_P8.07YR^,
MOTAM<4'80#_<D7_-S+^3)4&1H%`H/FQS00,J[/UUD,UI>5=L`;BE#$EV+O>&
M:_<#2TM;XR-JX<ZOZ(+#SD.%M,2:AJ1J(J+LG.3-C@Y5OFEB'S8T^[R?_M-D
ML?9@R<9S>]Q_K1WG&S6>:IF/9.>2@1;(&64457S4)B;Y]@OEEGG>ZJ>5[Y7_
M`':#LG4"@4"@4&N<S_M2Z#_-'R/_`/7^/5!L90*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*!0*
M!0*!0*#6GD?_`,9QV_26U]_Z%,Z#9:@4"@4"@Z[W[4[_`(,'(+\Y?&7Z0VN*
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MOV^=T0<KQ0Y`!G+"4BDKXHOV[D>/<(NL,\5&J&=KI8A*O$G*_P`Z7'?T#[)^
ML?0/$G*_SI<=_0/LGZQ]`\2<K_.EQW]`^R?K'T#Q)RO\Z7'?T#[)^L?0/$G*
M_P`Z7'?T#[)^L?0/$G*_SI<=_0/LGZQ]`\2<K_.EQW]`^R?K'T#Q)RO\Z7'?
MT#[)^L?0/$G*_P`Z7'?T#[)^L?0/$G*_SI<=_0/LGZQ]`\2<K_.EQW]`^R?K
M'T#Q)RO\Z7'?T#[)^L?0/$G*_P`Z7'?T#[)^L?0/$G*_SI<=_0/LGZQ]`\2<
MK_.EQW]`^R?K'T#Q)RO\Z7'?T#[)^L?0/$G*_P`Z7'?T#[)^L?0/$G*_SI<=
M_0/LGZQ]`\2<K_.EQW]`^R?K'T#Q)RO\Z7'?T#[)^L?0/$G*_P`Z7'?T#[)^
ML?0/$G*_SI<=_0/LGZQ]`\2<K_.EQW]`^R?K'T#Q)RO\Z7'?T#[)^L?0/$G*
M_P`Z7'?T#[)^L?0/$G*_SI<=_0/LGZQ]`\2<K_.EQW]`^R?K'T#Q)RO\Z7'?
MT#[)^L?0/$G*_P`Z7'?T#[)^L?0/$G*_SI<=_0/LGZQ]`\2<K_.EQW]`^R?K
M'T#Q)RO\Z7'?T#[)^L?0/$G*_P`Z7'?T#[)^L?0/$G*_SI<=_0/LGZQ]`\2<
MK_.EQW]`^R?K'T#Q)RO\Z7'?T#[)^L?0/$G*_P`Z7'?T#[)^L?0/$G*_SI<=
M_0/LGZQ]`\2<K_.EQW]`^R?K'T#Q)RO\Z7'?T#[)^L?0/$G*_P`Z7'?T#[)^
ML?0/$G*_SI<=_0/LGZQ]`\2<K_.EQW]`^R?K'T#Q)RO\Z7'?T#[)^L?0/$G*
M_P`Z7'?T#[)^L?0/$G*_SI<=_0/LGZQ]`\2<K_.EQW]`^R?K'T#Q)RO\Z7'?
MT#[)^L?0/$G*_P`Z7'?T#[)^L?0/$G*_SI<=_0/LGZQ]`\2<K_.EQW]`^R?K
M'T#Q)RO\Z7'?T#[)^L?0/$G*_P`Z7'?T#[)^L?0/$G*_SI<=_0/LGZQ]`\2<
MK_.EQW]`^R?K'T#Q)RO\Z7'?T#[)^L?0/$G*_P`Z7'?T#[)^L?0/$G*_SI<=
M_0/LGZQ]!Y)L>2XY9!_(=J\>4P31P@X,W3TM/Q2UQ22N"A#%`F]Y#/&8]QFT
MQSLFNJBLFEG>V62>>-KXW"$8RAAR/VUKY:`K(G=,:1D12<']C-+7<1B=;/PC
MIZ'1B$0,MAG9I*1D/1DSXJ;*,\EF#8FU8,4E5G%B*3,-O:!0*!0*#KO?M3O^
M#!R"_.7QE^D-KB@["`?[DB_YN9?R9*@R-`H%!\R.<9;7T?V%"BL_A6NW%UX(
M8$Q:3[/8;5E8:6F%SJ#M?64>B^M\EF8638W:MG%C!%!57LG_`&+5-;&SO'$/
MG1J!5TO^TV2Q=['<X@]6[C_6BKN)*.F[Y2+NE.2@3-Q'<WS3I:O,PBM[MKJI
M?P:ETNMC[E[4'9.H%`H%`H%!4LLT'HN>EUI!.-,ZJF!]Q@DFX.2?7T3.F5TT
M<+)HIKE"8ER^532PM:V..2E[8V]RU!&/5.XN>SCHST4P;Y#H'JG<7/9QT9Z*
M8-\AT#U3N+GLXZ,]%,&^0Z#4/D%&]!:M:[\;PCB'QPD1K1G%<YR-?92>!Q00
M()O;NYJG#HEUQ<2)OT6YEMJZ07>/,4U,FF>#3JI*V5SZH<.`1#6,PWW#=0/N
M$/'<7'<>-,)W?L38;>%:Z>#+R>?ORX81$(,)S9MY&H+'$HR_NN^(L4LUL.I;
M%)/HMFH$<E&TN[^C\KDD`'<1(Y+Y_$)!*(U)H='](:?;$PI.+,MB291(@]DY
M2.@FMY!K35I>6",%'>*I(!@W42P\)=(-LPL73;_N_=[9W\@>.>LUFV6OC6SF
M[XKI"`#4'<2"[/GVIU':*.;-1^DY?2+7+]=NDLBEE=EFCGGV:N6:*84;']_]
MWQ(!0@I;A:S$>&A`DW,CR^C]%X$(CJN2!-,'@>T3V`^3D&CF/OF>^X[CD/&+
M$)"@JHYQ5'8>"J7H.+;?7!2-QF!&=K<(`.OC$X.[B04CP_36I=AJQ:%::V^)
MTW(MCGWD(R*64C^,DD@ZRC9DDZ*IVS<9XM56S?PE0+.U&;X@;)@W(?:1SAOJ
MW7<$T;B$-M<I1KW2^$AD\&,Z"U]O9I*%DV#E]%0/C`5.>Q;(.2V&2>*.-WEV
MBEU$D@J0+R7[O(ZD478\(U%FT<\<LY:X;Z"TD]\G)&&MO-7**J,V4D<%#I=\
MRX[25P@H+;OF/9X-+9N,%'2>%!9FX)3PUB7$Z2<G=6<5-$['1<GUH7IP$1@$
M"`"]ORMSL%36\;<@3PN-297&%R8L@J_:$\&JUU@J?AN*-TLL;W"J;<B^"AB<
MZK"07A3#IQ#-J#G@^,S$3JS2;/RFV4Z'<?34<UQ%!YHH*RL_\3[[06*$#>80
M4SR'K)H.72F.6&(>R%<@.%9G3H#:DJX%!PR9%OI*/O<`FHM(&A#K<&\8/K>?
M1S5,87<F1AXH0:`=EM57)1T.8A4/!7*>;O%;%))4)$[W[W=Z"$F7;\.6KO*/
MZWU[M!BPSXZZT$G)7'=A9:UQ3SC4;.KBY"[1AF6U1N,B?*M4107-%W@X=8YH
M6LH%C[(%\=\&W'5/2O%CB>?=\A(O)-E!CFS`$'C,'&:[AT($3HHHM)(A%)J@
MY-F&4@9I-56WA3!NW\*?74<(M;)+AKR%Y2<#V.NADQVAPAB4+,.\[$LP0W66
MB9`@1@BTGV7'$-EQ-QXZ8%)%$D,M7$,W*/@2!M#^#SR']@LBMF$W?[_X`,?'
MB=N$&#MX'#3::MQS?2&@L'9W5FN#.R([-MI",W<P:L<(X$.:L)H68O%VDA=V
MS;*MQRJ*W:8APFW)GNUWS=(DSXE"LH^XG@F&MI:]X]ZR!P[,2:*RX(PV$[E4
M@<"@06'*EH0^0Z""[0IVEV^/@?6=-[*!=G)*1<`^+<@B$?V)QBUN_5EK3-_=
MQ%-0ZC*9`&"AD?&QKTR(>N1<CR9EI"31:(KM&3I#!2]^VS2M:W2%+X;KX;'B
MT+C,0X%Q_P`IS&RM%0^?#)AJG1H-'5<9WU)8J+@\KD;P.9D:9A62A)1@\8,P
MMBBB*B>2).X[*W303NT[X1C&\;<R+A_K[P22)(R3,O'-1:M(AHOKB;;H*Z8T
M;+Y)F7L!+N;[;-MFN2#<0S*9#K.;J/+HM<+.<PDII#C4OQC8<A8QP>U@"7FA
M/4@;6D8VSKO4,<L6_+I,=?PO7DMD;V$_E!PC\4\*V,T=OT5>J6;HMG".;5-:
MV%L@J65[BX7:?$GF^X.&^KB<EA!];7$I+:4UEJ:;:^,[B:A@,L7UO#",GSA<
MGS.8P:3LBSG,F-9"AZEW`[(BL^:Y8*!4X[G;W8#YSDW<<+GPA/KXC,'A+CQI
M/-LM+W5TD!4'3Q%2DF\\?ER#MNU15NC8;@LO:ZSI)+!53`+%><B>"SJ'[&DT
M1X&MS+F!P'9$E;LCVEM*PQF>FNL-6CMNR75^+PL54*"CC*(D[+YD5F%PRN*"
MO@KIUG=M@X#8N+8<+9!O`/Q[*\0H)#-BE];,-BI82C4NFVP%;PD<Q*DHJ$+,
MGSZ\QD,=9O\`#,AD%2(,6EK?PKC'K8=<-?I[O;A#&=KOM11/A!$-@2:,S4T"
ME:(+6>A<,',8BT6W*4F$DA[UX>;"GKZ(R'4*S)\,+.`[ZR:U\DDU%L<4,PSB
MN_\`NTV31"1%N,D/#ZZ*-9*2C.T2.BM7)PZ2AH>7<1&1F&Z*:ZLK!-&>QKL(
MRA@8&#7+\R88X-4ED%<W"86OH@MP2Y!3N<:]BG$V*1\S!,"UB3N:<?X&'#O7
MT8ES[7\U#,"+5J22P-0R=#5QCQLY\'S643NLT\);?P]!(MW#.%&AI+#(Y*^)
MT!+)RL43D1$_&M-ZH=A(3%Q,YUCKIY(918FL(,KM<91MT.GBW$LRC[)"[A6R
M'40RZ0U]5VGPSU_F*C^Y>(VJ,)@6VYNO7Z.&K-)Q66A643TWLF&:]*;'-8OP
MPXLP%(NME`;NVK9)^\PNX741361;J9XAZ8KR([N*6&8R&:\3(L/M)-G#=87.
MDM.:.M#PQ"0A=<GHB<*S1B??13,/,F&TA?BI)H\=$7ZN+E)!LHHC;',)KK_9
MW=\;*T?M/?L<XF`+0[58(9*73`GQ[UX+/S",R./-I/$3,*2>V1#$4I.,=X62
M1=/6;EHMTIO4VN71TA30CEYW9Y4<.)Y\/QXY-X$FQAZP=Z.T4X.`UH9`-C[/
MP$%P@F4$B#=]*X7JTHZ$JXX9,G"ET4,UTULE<$0NJ(R;B(=Y,!^,LEX2P2`3
MB6ZMBNT8J+DNJ]0KD<`Y,EM]K(%)*1CRIV#LLF336[%<>P8&21Y\F455R'HM
MQI!9L&;F!_A-%)9)HDVX7QJ4N@>Q0VFA!(!J/1#<7--R&&L+)6UO'/*611XF
MV)#Q$[:.W!(HV'`;)(N<<'V:J6*:@10'LW@S*H5*=D17@XC(('%U]6!;R1IH
M_1#5,Y-]P8:B5B,"!BBLJ'G5CN&&Z1/AKE=JW#MLD7>-WN5T<;*A&Y'OGN_X
ML9V#&2W"-7RDUDDV:2L2-XZZI-X,I<GCJU:20JYP(2(QO`G#&6WQ#H@_S>8`
M\FJ;Q5J^<X-%;T'-1W;W?3XD/%!N'<=.N985&1O5BXG47']X+VY+7Z.H7#J.
M0HTE+,@[:XAONX&HL1,+B@R^'A5VCMS9O^_#!QKD7W>DT7#-8CPK;&EYB=M#
M-<8_D-T6,PV)L%JUU@]D,("*%I0QP#$HHTVR-S>/#?BH2KX.\Q9NW6:&.*H<
MF`[0XJ2"$`Y;)>!\"9DY)K/A7+X]#(OK72YDU(I'S+>R0)&1`<B8?QT$V"@I
M.!48N719P*52\&<+YI>#]@HJ%HZ%EG`WD5+`D:@G$F),V,FB$IE<>ETDTIJ(
M;'B:T"1U/E/8OX*V?D)4QD,2=[E#MEKN1J0]VM@ZNS=.4D;**!1\>Y$\',A"
MF$WX-1T#,&,7V'L\F`"ZDTD<8_D+UI+=A1B4[L&%E2X[PN*A_P`GCG)86JDW
ME2RBJ=FHERGGBK<-F(,OP(G:/)-VSXUZT#L.)\BD43W(_-:4UYB@)D,4".I8
M<'ATA;4H\/8M(5<>7Q702NW5;%VZ&&=WR3YHS"HHYMW@A()^(UJIPA:!),L_
MUPSEF)32FA%AVNDMQ%(.)U2]E3\+*RZ3Y";N=DA+I8!;%UF.#S*[[!K=NXLD
M&8WT2X^Z;F&T(@,[OW6TRMKJ$<=)DR/LXCI!DPF+K?N]2.F&T1#C'>21MB;'
M9B'#ELN]1;CW*Z>22Z[1*R3E</=K#9'=][8VS'--1[B7'F4L.,E<2:Y?C]KG
M$'#)6@%ETB<0.6F!-R[1K($`\'(*7=-+O`BBF***;_-9PBGD'%V1LC@OK!2;
MY'>$;)Z-B&VL=%CS`;1VD7S2=[32B6<_)QF&LKR%(\HD)@Z"Y%1\19CF"MFR
MK=%91YCBWS"&2+DCW:8$?=PAQ2$GR^!!D)=1(1QQU_C*1Q4R'F<RC`LN+*V&
M>*"<NUCK\K*AC=SFDJX"()Y7M@Z71:YA*)5M/@M%(=/-C..#J3_7<"EH6$NY
MHUT3I)H**'2L?%2QWF@Q,2$9(8\"CT9,H.B)0\R$#FE^NBHM9=)1/$+'T:4X
M"\@]ASW7>O\`C)`%%X+<W>TK)Z)@:$)EJ<6ESV!RA2)R%HQ?)/,0DM8*-KV<
MX-<GB?0Y9V<-;]M05U$]A<)MB"(,:AO#N`LVTDY%!>/LE9S/4>H0AZ#$S<<Q
MDXDK)XPU?OY*%QD#!RWLQ;KM+.[74[5PBBVNFNH%0`N4W`IY.5(P>X0!`PN0
M-]<R37#QGH_5TC-R#5\]C>NS6.V#H6.YE,0,5;NMJ!4DV6"[F0W274S7&H7;
MK88!OEM/47%G61+4MG7&'1!`'L7:PC59-\EK&$8O`)"4AY!E&2*#;$!G@_17
ME8MH/<IWR3R13>W7Z;V1RPR"X/5.XN>SCHST4P;Y#H'JG<7/9QT9Z*8-\AT#
MU3N+GLXZ,]%,&^0Z#V)<4N+Z*F"J?'/1F*F&5LL,OR3P3*^.6-^G'+'K`KVM
MEC>W3:_[MKT%[-FS9DV;LV;=!HT:(I-FK5LDF@V;-T,,4D4&Z"6."2***>-L
M<<,;6QQQM:UK=%![Z!0*!0*#KO?M3O\`@P<@OSE\9?I#:XH.P@'^Y(O^;F7\
MF2H,C0*!0?*_GD61BVP@!9::#M2^5&JRT0QE9>%-MH-MI=0X[<Y:A81Y>.2/
MR!?H^,;.<C]\4DW&)+!+/%?P3&R0?/#0X_Q1^TJEQ7D^M$_%G<7:F'^2KDSY
M1.(SX%R+`-O)]>0==3QZL&[+P;)YULO"LD[J=-^MTT'9?H%`H%`H%`H%`H%!
M5$RTAJ[89DR8G,/#RS"3Z[?:JEX&1,VYF*S.!O3"1W"/RV-$DG(@^S'D/";M
ML7"6=DL"#O#HOBOG:@EL>@T+B5A]HO$HW'?%,7"PD7D%"CAN8^&QN[G*/11F
MHT;I9MXX#R>+7:,L;V;M[JYW3PQOEETA4N?%G11%79Z\NU]']BK;?V"PV9.E
M-B"1,ML2D@2-#89&,442;#-NT&1.("DA@Y'##^!:9*XY99Y.%\E`G<8TWJ2%
M'Y=*H?K&`Q>33[J^6\@`1($),RS'%9TYLE(23%B@\+(6=OW"W9KYYX=NX54Z
M.NJIED&*=\?M%/UHTX>:;U>X7AC\,4B:JD%C-U(X0CHL*#`.@V5AMKCU0@>-
M#6S3LNK9N@.:X8=6S9&V`>I7CQH=9^B46TWK-4BWFY392#W.%1_)RCL`XY'O
M34R35NPOEA(BY`2T<NG5OX5PZ:I+9WR53PSQ#FQW1.E(C$I7`8MJ36\=A$[R
M(YS:(A87'AL<E^184W`DO*8,T'I,#EG@)HBQSLY35M=DBFA_])/##$,+AQPT
MH.C9N-Q'7,0UY8VB\O<]`8O'(W)Q9=TRE#%.5"#380HNUEK#&:EU&Y#*RCA-
M8DZSZU[N%NN$LBFIM;PJ&:UU]'(8`8Q#3HV/"M8A<QS=XWA+:*QU:)`%0&;S
M!=8>^&QMRJSP<X967[!93&^=[*9](09?BIQD<KD7*_'S3.;DL&2CQ%Q^36(8
MKN@:+\252%9K8B<5,66!(`/<=GC>V/;#VN?_`,S=&^`2O/1^F<H2[UM;5.NT
M=?/L06+J%-8;'VD76\EAH,-&,K@VK!$=BI&Q,8&M1^6*=LF3<>V31OAB@E;$
M,&\XT\>7^9-1YI#52^9D($C9//*"1O')V!C5@-H\*SRP'8WP9A,8J*LUQQZO
M86%L[8='@K?LPD,HTMI^;1B,0J8:MU])X="G`AW#XJ>B`$I'8LX`,<Q@7./A
MGC!8>(\6"U,FJ-D$T\<&N>2-K=GEEC<,(?XX<?94B,;232&ICK8,AX(*;E=>
MQ1Z@P9=N:=78-D5Q6::8[)W(WZN3>UNQR5>K9WQODIE>X5YNOA;QXWU'@T5F
MD$',`0@FD]48Q)D)C>)ACBM)W*X`NHT&9*J!W+N:EU^E#)!VW<DW:S9=!5RO
MFH$[<<9N.SQ5VNZT;JARL0E7EP^47@495S>2[I=WRD#F^8V]UB2F1!QEFIET
M]?)PKEETW5SOD$AG&D].[,+BSVQ=6:^G9H(UR8B2DOB`&1/1[+)\W)V:-G!9
MB[43;IDVB;E/#IZJ;C"RF-K9VZU!PWV@M&DY#'I:0T]K)Y*(D0;EHO(7$'C:
MAF/%63$(,8DPY'(;=T.(CQ\;'(MUTLL56Z;%OBGEC9%/JARW^D=.%'D$(D]6
MZ_(O]8#L`^NGCZ)`W;F$"4FS9HB-C"SADHH&8((,D;8)(7P3PNCA?&UKX8WL
M$C*0&#G(4OK<Q#XP4UZY!)1A>#OP0QU$U8X@V39-P64?6;9BO%#=HC@FFW[+
MLD\,,;8XVMC;H"N6?&+C@/6079:&U`V5;1QA$$,TM=1/'LXP*>-2(X'CCXJZ
MOBYD_8H+)IWMT8J(X9?NX8]`>_+C5QVN@];?D(T]@B2Q>X/\$M;0]+PNQ)HJ
MP?W7R2#X99YO&2V:2F5[];)/*]KWZ*#."](Z:"#,`PC5&N!HG!N]:V',X5'$
M&=VY*--X82240P'635Q)1%HD+<]:U[KCT\6ZG62M;&@]$6T3I:$&P\EA^J=?
MQF0Q^-MX<"-A(F%'%1$6:(V;-0(Y^U9IN6@QNUQLC@EAE;'%&UD[?O+6QH(T
M;XJ\9I*]/$Y%Q^TT<)2<HL;D)`MK>)$'Q@NY=/GSLB^=NA*KA=V\?%7:Z^=\
MNE99XXSSZV2ZU\PS^?'_`$4J\EQ!;3>KUWL_<!'<X<.()&7&<M<QHFS-1]Q(
M>V&9XEE@QH>W>MLEK9W1>()KX]"N&.=@_76A-+.WLK)YZPA;<K.B\<.S(L/`
ML19:3EXG(V4NC[XV4&I-7Y!8=)AR+ZW:*96S<8WSSZU\LND/V9Z*U1L386O]
MHSF%!)9,-6CY`P@+X^Q;E6\94DAN&2$@6%LGJ2S9L=2*P`8JV>88V7;70OV>
M5KY=-!S#VD].RA86XD>K-?'%PLF?S,2J4B`%ZHPEI5TV?%9&VR789WP,E'[)
M!=RX_P#J+KH)**7RS3PRQ"+A^+O&Z/+A70'0VH@SJ.&VLD!.1FOHNQ<BCS!(
M2@.*LEVPQ-5%X-1CX[!MG:_2VQ'-+)]6S5#LPE0'2VH(N`DD5CFKX`$C$Q?+
M$I9'1D2!,PDD>N$T4E7!L6BQP9$\KHMTT[66PSQQ33QQQM;'&UK!&/5?XV^,
ML#'Y`M-V)ILUA^#VVM8?BM9FX%E@:R%[V$6MEBH#/OV-[WM>_@3YPAT]DNKA
MF%AD->0(L9:2,G"HH0D`]U'WS$Z\CXIR89O(GA($HNZ:DU6N3UNO'4I:5P8Y
M89VNUP)N\4^K9PM;,(=)^/.AYH9DTBEVG-9R603,:/$2LX;A4>)%Y".%+B70
MQJ6(NF"KM[@/<Q\?FC?/.^2>0]K?&]KMD>H$M8ZUUV,#9QP;`X:/CZKV-D5`
M;*,A6HA0A#6L>91%]F-098,\WD69Q$4D.5OAUV28QKBC?"S=*V`162<?M&3`
MQ(Y#*M0ZXD!^7LAX^4&R\/!/BQYH*<"'8Q,F1799NW63!S'AZB6>6?7PR'M;
MVO;P9'J!"PG#[C*!_*)X+I/7+G#:C]F\FJ9*)`B"9)L+:1-F%!HX.&&5F,;`
M8P42H/8(]1LR68(*(XX9I)WQ"8O^/&A"8&\7?Z6U6ZCET[I6"*0&+^+,$[XQ
M7"^*3/$7BBE^\@H2W3C:U^@0RM__`(J/4"1LM4:N&MA3,=K>!CV8)A!101HR
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MMK94'$'::U((EK">BM90,9-13!\+&2H?%`C,\P'DWA,@1:LR;=DF[;IO7IIZ
MHKU,K7SR>.+WO_#*]8/;)]0ZKF@,S&9;KB$2./2$[C*3P8Q&`S\<8DV";='&
M1$FJ[/-)X<[!HDGX7G;)>Z:>.%\^K;HH,2<T%HZ3#S@H_I[61<=)G<=?R)F^
M@\;61./8B%1C<6=EL<AO^_N([&T,!S+-7K9-A^/@R=\4?WE!D)%IC44MCKZ(
MR;6,".Q<F:2D9"/DXF#="'L@0:HL4CCE@HRNW5+8L$,&_A%\;JW;X]E?*Z?[
MV@YL8U5K.$R"0RN':_AL6DLLP:)R4['XV)$%3B;'K>")$WK!H@N[20RSOE;'
M+*^/7O?*]NM>]Z#'1K2>G8:/P%1/5FOHX,3E+:<),`T0`CVB,Q9(8-&$G0;M
MF*:2!T<S2P0;.<+8JMD,,4T\L<,;8V"+,>+?&L8H@J-T'IX>JVE>$Z158ZZB
MC13"8)6:8HR/M&XI//(JA@/;8IJWO?)/%LC;'HLBG;$)D2U/`R;Z(/5`#-KA
M"9X:V<&'#D$!XI2?'V,E9$I248-44TB9=967D7?:J]-[D''A6767PP4Q"QJ!
M0*!0*!0*!0*!0==[]J=_P8.07YR^,OTAM<4'80#_`')%_P`W,OY,E09&@4"@
MHK9>A`6R)`I*;2Z;0DX]AKG7QU[#U8DK:10QP]=$;`B3::1&8M&F#=X_<YX.
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MF1")A&X_+8^X6=@92$$R(([<,2`M=T(-L&Y,:X7&%FK$H.669.L,LD'*"+A'
M*]\%,,,[7QL&;H,>5*CP8LD;+.DF(H./>%2;Y;K=BS'CVZCMXZ5ZF.679-VR
M.6>71:]^BW[E!$]7;.@6ZM<0;;NK9,/F>MMEQ4)-X++15G.(V2122#T"H,VQ
ML\0:NK-"(]RFKAVB>&?5RMTXVO[E!/*"M)WN+66LI%JR)SR8"XS(]V39?7&J
MQ+^SJ[F:S=M%)'.%XZ*\';+I8ODHG$B+V]ULDD^R:9VZW6OCCD&='3Z#F)E)
M]="9?&B<]A(F,G9E#!YH>\D\4#3/,UA$2<C"-W"A`*RD^4;(>`*.$T\7=F2U
MTNM9/*]@X.T=G0+2NN)SMW:<F'PO6VM8J;FTZEQ6SBXR-Q2.#URALT_LT0<N
MKM!P]MFKGV:>>?5QOT8WO[E!*PY<;(!`H\&>)$`YL<Q+BGZ'6[!\-)-DGC%X
MCU\<,^R<M5L<\>FUK]&7NVH,C00V\_BMM@XZMN_=>6^4-SG^(SQ*=\!O%4S>
M$=R?^47BWR:LZL74LGX%X9X=?"_:]CV5KYT$RH%!69K<>LHYM6!Z0-S$6.VO
MLZ,3B9P*$+V=>-Y-%]:KQAM.C(^Z;;-I9K&UYF+Q7[17#.]WF'4QR_?=4+,H
M%`H%`H%`H(;-Y_%==#19>7/W0Y@9E,7A@Y5H%.'5%I',S;..QUFHV`#2CIHW
M>%WZ2:CM;!-FTPRNJX522QRSL&&+[BUD!VO"M&EY@+8;9V+$9I/(3!UK.O&\
MBB&NGL7&S4ZQO@VS9V9QY]-!::_:*X9WR>8=3'*ULKXA9=`H%`H%`H%`H%`H
M%`H%`H%`H%`H%`H%`H%!UWOVIW_!@Y!?G+XR_2&UQ0=A`/\`<D7_`#<R_DR5
M!D:!0*!0==:)?ZIS:_\`DR1'Z5`^@[%-`H%`H%`H%`H%`H%`H%`H%`H%`H%`
MH%`H,>68Y%!1,9@[<#\R(]ZQP?L\NH[99.VRC?%VUS__`+7#:ZG7PO\`]&6-
MJ#KE\8.*'>.ZQXWZ@[O_``XV\<]7MN,&DN2FMH)WBC_8H"9G[S68:YV!$=.[
M?XTZ_""[;.U;LF22>7-"4W<GDVF"+3`@BV4(J.$\J#5Z+]UKS87UD9BT6T0K
MQJAYD9W8<$VEI@'R7#R=SO':&@>4`J<\O>7V4P"RU%(/>;:9R6%W7</&TSF:
M:>69-DDY1:IJ!ZLNZ'Y2P_<X^:1'1(YS&-?[%[ZB&:`1";9A@Y72.I.6$-A;
MWAD?B8XI-1Z(*&`I@WE+?Q0ROXRCZY[%Q=GBE:^:(2?7'=9<W1LXU;MV9Q!X
M]VMK;E1W,<ICLN>;L#E"T6T=Q_XP:6U=SR:@U;S)9LU;R:2`S[,VR3Q\(F22
M::EL'B=F^=@KB2=W%WN$NU(QT*"%D-:$]1<;>\PU&(WA?D=''@O=I_DCRXU_
MNK5R0ED*,OIO$A4ETL#(Q=-^98).@SEZNDL@@SQ35<!FVO=8<OQL#U1XWX]2
MK;^GQ6S>:9E3A!/-[Z!@3+5<CW9J#6T(T+NB*LM1YQW1<-CVNY7$I"\RC80D
M9>Q=S*G!H-=<@HJS1#=>>\)N627<]]W=P]&Z2A.R-@ZB%<4HER=UL8D<&,.A
M,1UMKYT+FKG7[:8S`'H?9$E!S1J.[-E*URL9786<./%[]TBT2N'S9R[G[O#I
M;Q38P;9,,(23;VK>Z8>Z(TOXPY!1]]:*\TXCS*V5L+64GCAEO,!@MC(8YIIV
M&N&E*B;3`:R4NQQS:Y]NUP#;2)]V]RZ8=X=J#=<XT2.F;R&=Y/N7E!,^:+G=
M$3>$))QFV%QUGD#U'IM'6Q$\G,V[C2Q>0M0=V&+#$</3;>%BE'&!,ED@$EYB
M=V;R3G'+_O!-S:=U$*.1WDY#N[P,J&&>WA6O,]U0?C7M91[RLX@21S8XWDT/
M>\AM<L1*38KDRM'G3<9=B^>MDW*]LPMX#P3Y/Y]U)WG7&QGKUCKZ0<IE>6+K
MB%Q/5V+')`.XZZ[VKK8;%H%I56:MBSK7D>0(3AD4D"@X01<QN/7/W9M'.:*%
M\K!\WI/W3?/<R"+O()I"VE-"6VEP^*;`X*!-P:9VC?>3[3>@=O:_W1NAHGLL
MT]T$6SF6RIE%"&(>5O&:TF3BEC!5-J839I9!]2=T\%.0,H[H/CWQ/=M-N;0W
M%K1?0Q65@7&ZM0R::$&<$E:!YW$9L9VK"P^C.24;B0RZ(]Y&#^$?#2AH/PPS
M)-U,4U\P^86YN%'>`Z_XDGCFT6,-TC#X+W;Z>H9G&(!MB8#=>K.PW>01K<;W
M4SUD%F>UY/""VV>)C)Q'CI@:Z)Q.-+%G+)J_1!M\>Q"-<-.(DMYL['-2Z):*
MS#<!!7/'F005U&OM9J8U)^2N4]W5IW6VJP40\6R-**['UZ.Y",W&'@,:4)Q<
M&9;+IME5&[*R]!87';NL.\J`[WX.S_?#_81AUJ[67=[C5-A1S<NE'1/COCQS
MBAL1R(U9)C\K;S'8\@`[2*]7)\PA/A8>=,RV:)IZSS8-E[!L#W>'=P\K]$\W
MN-NVMPZ%&!G^G]6\[X5R+Y7X[HBTZ(\L-D;UW%!9EK+:F$6R/.IX.3>PT#FW
M5R*LFK]AGA8;DE9@P'K+!D9]W=W-HQS$V/L8/"$5)B9YD[+WT)YS8;N')OB?
M"N0<>CL$C'`C#6#LLWES+%M+GS1AX"JQ3AS;!MY0X/KE;]C07CW57`#D/P^W
M3K:63F)YQ2+R7NJ>)^LN13C#9;&8*S/GEKV;S=?9DCDK9.2FW4DD3&$EV3).
M18649+,<$VB#C)-#%/`/GWL?N>^83W0.MR+;7SV6["+<QN:NR.5>L&>R-326
M7;IUG-9+OACPQ+HD]W'"NEWH?28.:LGK$,]<MEHVH87)CV_CMGBEF&XFON[4
MYIQ?DMQ7"$-F2TOQ/\@^-'(+E$;F&W<9GL'UT>(FF#NHX/&UG2%HRM/(MLPP
M]ALGD;QN):#C!+7F:CM-%0G?%8/G]J;N>>\0%:6GD!G[78R\WE<MX:Q[=Y=I
MOW48.(\E;03FDSV?OK?(]S`\@6S"4D5TO<AAE(YD7934FR*YA+#E4V3-:X;.
M27NN^8L*YM[ID7$C7,>T]K6:07=T#U]O&=[!B!I+2L9DW$.^H-1I<>#^N#<)
MWU#AT3V,-%8IZ[ED:E<+CJ*#DR(*8$LT,<`W#[FSA%R*XGZVWZ,W-'IWK=WL
M"-:9`"X`4V=IU]'%Y]!-8/(UL?;$+;Z)`NA\+?[$DCY*SR0$7;Z3R:XYN6*L
MVI#M$U0^=W&;NSN\1U/"C,"$:J0UU&$N3'=M;"RDAW:VLEM^38=H;E%Y:[\,
M3^8:EF@O5F[(X,U-DHKY5%XS$=C39ROFU*CG.*2%L0J]AW0O>*Y,)*+BNM!F
MIN0#/A'W@6BY[S1QY!`2Y'E-OO>V[M9SJ#;-MBQ,O]C0I/8FNXN_%*EB(]N5
M"9N[,E4<6(T<JL'W=[HKBWM?BSI;;4?V=&YKK=M.=UDYK!]/2R3:5,L=<QR\
M+AL?=81..<?1J.J]:A92?"NR*@(4_*(V>*K$,U4W+]PW2#ZQ4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@Z[W[4[_`(,'(+\Y?&7Z0VN*#L(!_N2+_FYE_)DJ
M#(T"@4"@ZZT2_P!4YM?_`"9(C]*@?0=BF@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"
M@4"@4"@4"@4"@4"@4"@4'7>_:G?\&#D%^<OC+](;7%!V$`_W)%_S<R_DR5!D
M:!0*!0=7CG7L\YW:/?917O*=Q:=W%/\`AQNS@/CQ%D.S-)P4GL=[IW:D=W#^
M4D?E/XX'ZQ!F!D@ULW09.;=';KKJ8I8J9-E<:"X/M0/=C_!W+W]4O:OO"@?:
M@>['^#N7OZI>U?>%`^U`]V/\'<O?U2]J^\*!]J![L?X.Y>_JE[5]X4#[4#W8
M_P`'<O?U2]J^\*!]J![L?X.Y>_JE[5]X4#[4#W8_P=R]_5+VK[PH'VH'NQ_@
M[E[^J7M7WA0/M0/=C_!W+W]4O:OO"@?:@>['^#N7OZI>U?>%`^U`]V/\'<O?
MU2]J^\*!]J![L?X.Y>_JE[5]X4#[4#W8_P`'<O?U2]J^\*!]J![L?X.Y>_JE
M[5]X4#[4#W8_P=R]_5+VK[PH'VH'NQ_@[E[^J7M7WA0/M0/=C_!W+W]4O:OO
M"@?:@>['^#N7OZI>U?>%`^U`]V/\'<O?U2]J^\*!]J![L?X.Y>_JE[5]X4#[
M4#W8_P`'<O?U2]J^\*!]J![L?X.Y>_JE[5]X4#[4#W8_P=R]_5+VK[PH'VH'
MNQ_@[E[^J7M7WA0/M0/=C_!W+W]4O:OO"@?:@>['^#N7OZI>U?>%`^U`]V/\
M'<O?U2]J^\*!]J![L?X.Y>_JE[5]X4#[4#W8_P`'<O?U2]J^\*!]J![L?X.Y
M>_JE[5]X4#[4#W8_P=R]_5+VK[PH'VH'NQ_@[E[^J7M7WA0/M0/=C_!W+W]4
MO:OO"@?:@>['^#N7OZI>U?>%`^U`]V/\'<O?U2]J^\*!]J![L?X.Y>_JE[5]
MX4#[4#W8_P`'<O?U2]J^\*!]J![L?X.Y>_JE[5]X4#[4#W8_P=R]_5+VK[PH
M'VH'NQ_@[E[^J7M7WA0/M0/=C_!W+W]4O:OO"@?:@>['^#N7OZI>U?>%`^U`
M]V/\'<O?U2]J^\*!]J![L?X.Y>_JE[5]X4#[4#W8_P`'<O?U2]J^\*!]J![L
M?X.Y>_JE[5]X4#[4#W8_P=R]_5+VK[PH'VH'NQ_@[E[^J7M7WA0/M0/=C_!W
M+W]4O:OO"@?:@>['^#N7OZI>U?>%`^U`]V/\'<O?U2]J^\*!]J![L?X.Y>_J
ME[5]X4#[4#W8_P`'<O?U2]J^\*!]J![L?X.Y>_JE[5]X4#[4#W8_P=R]_5+V
MK[PH'VH'NQ_@[E[^J7M7WA0/M0/=C_!W+W]4O:OO"@?:@>['^#N7OZI>U?>%
M`^U`]V/\'<O?U2]J^\*!]J![L?X.Y>_JE[5]X4#[4#W8_P`'<O?U2]J^\*!]
MJ![L?X.Y>_JE[5]X4#[4#W8_P=R]_5+VK[PH'VH'NQ_@[E[^J7M7WA0/M0/=
MC_!W+W]4O:OO"@?:@>['^#N7OZI>U?>%`^U`]V/\'<O?U2]J^\*!]J![L?X.
MY>_JE[5]X4#[4#W8_P`'<O?U2]J^\*!]J![L?X.Y>_JE[5]X4#[4#W8_P=R]
M_5+VK[PH'VH'NQ_@[E[^J7M7WA0?.?O0N\QU7WU'&ACW;O=_:6Y3[)W=O_<F
ME;D3\OT-+]<:XU)`X)LF.SF3;%V%+),FW:C@`]$!@C>]L>KT*Y7OG93%))<.
MYNT;^"-&K6V77LV;HM[9WMU>OV*>*?6ZO3?J];J]/1TWZ*#D4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
M4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@
E4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4"@4'_V3\_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g484784g97e79.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g484784g97e79.jpg
M_]C_X``02D9)1@`!`@$`8`!@``#_[0N"4&AO=&]S:&]P(#,N,``X0DE-`^T`
M`````!``8`````$``0!@`````0`!.$))300-```````$````'CA"24T$&0``
M````!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X
M0DE-)Q````````H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&
M```````!`"]F9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4`
M```!`"T````&```````!.$))30/X``````!P``#_____________________
M________`^@`````_____________________________P/H`````/______
M______________________\#Z`````#_____________________________
M`^@``#A"24T$"```````$`````$```)````"0``````X0DE-!!X```````0`
M````.$))300:``````!M````!@`````````````!G0```F`````&`&<`.0`W
M`&4`-P`Y`````0`````````````````````````!``````````````)@```!
MG0`````````````````````````````````````````````X0DE-!!$`````
M``$!`#A"24T$%```````!`````(X0DE-!`P`````".4````!````<````$P`
M``%0``!CP```",D`&``!_]C_X``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`
M9(`````!_]L`A``,"`@("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.
M%!0.#@X.%!$,#`P,#!$1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`S_P``1"`!,`'`#`2(``A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$`
M`````````P`!`@0%!@<("0H+`0`!!0$!`0$!`0`````````!``(#!`4&!P@)
M"@L0``$$`0,"!`(%!P8(!0,,,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$`
M`@(!`@0$`P0%!@<'!@4U`0`"$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D
M8N%R@I)#4Q5C<S3Q)086HK*#!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4
MI(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1
M`Q$`/P#U)K6[1H.!V3[&^`^Y1-M=;6![MNZ`/P'\5"M]SV!^Y@W:Q!,?]))2
MUS<H/'V=E)9^<7D@_+:QR@YF:X%I94`YH$M>YK@3.[:[T_;^;L<C?IOWV?YI
M_P#)I?IOWV?YI_\`)I*:C\')<"!8\;G`DB]X,#]WV>W=^<Q-7B9S6M!@Q[B3
M?:?<1M<W6OW5MG]&KGZ;]]G^:?\`R:7Z;]]G^:?_`":2FD[#SG#>3%A)<6-O
ML#)(:V&_H]WIM_<3C#S1O()DB`#>\C41N_FO9]%7/TW[[/\`-/\`Y-+]-^^S
M_-/_`)-)32;B]0V:[=P(<!Z]A$M;MVEWIC]&Y[6[V?\`&*1Q,R-'23H9N?H-
MWJ;F17]/W[/^+]-BM_IOWV?YI_\`)I?IOWV?YI_\FDIK54YU-`8QM;[!SZMC
MWZ1_I7,W?]%$(S_5$5T>EI)W.W1(W:;-O[R+^F_?9_FG_P`FE^F_?9_FG_R:
M2F>QO@/N2+6P=!]R&76@P7LGP#23]V]/4ZUS7^JUK2UQ#=IF6QHYVGL=_(]Z
M2G__T/42ZP-9L9OF),Q'";'GT*_ZH2<U[FUEMAK`B0`#/'M]P*IXAS*:657V
MFXD$UV[&M+M=XK+&;&-L8SV?RV5^I_I4E.AKX):^"&Q^\D-?JW0@B"/[)3'[
M5ZP:`ST2TEUFX[PZ6[&BGT]KF._2;W^O[/W'_P"#2DNO@EKX*!;9_I('?0?Q
M0[7?HK`UUEK@P^VO:''0^UC_`-&QEG[GZ1B2D^O@E)'/Y4!C;"QD,(]HD6ND
MB1P[;ZC'/_M*3J7N()>`!^ZT3/\`;WI*9-NJ<XL:]I>T`N:'`D!T["1_+VNV
MI_4$P-?A)Y^2%]D;ZKK399N>&M(WD"&%SF[6-VL;_.>_]]2.,"(]2S3P>0DI
ME9:6-W;'/U`VM$G4AO?;XI/<0)L<&-F.8Y]L;C\4.["KN86/LN#3$[+7L/M+
M7_3J<Q_YGN_D>Q$]%FX/@;A,&!(GY)*6%C`2&B>Y+03_`-*$U-ECQ:7U.JAY
M#=Q:=P`;^D'IN?MW?RO>B;3^\?P_N3-_/[Z_P"2G_]'U"PL%3-["\2T`!NZ"
M?SH0ZZZK,5K+&;FN:)T/8[MTC\[=[FN13ZGIM].)TG=/'YW";'GT*X_="2D#
M2&O;1DC?,^A<1!=`G:[]R_;^[_._SBF:[O6;M>WT-IWM=63872W866[FLV-9
MO^E2]&LK;:PUV-#FNY"!59?59]GL:ZWVEU=P&A:"UNVUWM:V[W?]>24S]&DC
M](TV:S[Q(YD>V-GM_JHGL_=_`H9MR2Z*Z-.[K'AH_L[/6<E9]M<R*C56_6'.
M#K!/YOL!H_ZM)22*_P!W\$'[10YVVEAN,D$L'M!'TMUI_1_]).,8NUR'>LZ!
M(.C)'[M/];]_U/ZZ.`0(```X"2FKLRSJ755R![!6Y\'7=^EWU;_S?\$Q.*\C
M\ZQD>51'Y7N5G7R2U\DE(#4XMCU'`Z:AC?'S:4FLN!,N8X=OT1!^?O1]?)+7
MR24UW'(!]M5=@\27,/W>G;_U2G27EK]]8K(<=`=P.@]W#477R41^?\?X!)3_
M`/_2]1>USJ89]*`1J6ZB'1N:')JZB&PX;0/HAKG'3Y[5-GT1\`I)*8>FWQ/^
M<?[T,MNWZ`%DB";'`[?SO;M^E_:2<UY<"TM#8,@L),_UMS4P;9I[F>?Z,_\`
MDTE)=C?$_P"<?[U&QC@!Z>IG4.>X:?+<H;+>SV?]M'_R:6VZ-'LGQ](_^324
MD8QQ'Z30R=&N<1$^WG;^:GV-\3_G'^]":VT$;G,(UD"LC2=/SW);+?5<[<ST
MBV&L]([@^7>\V;_<S9L_1^G_`-<24R:RV?<`!N.H>XG;^8>/I?O*>QOB?\X_
MWH0;;W<P^'Z(_P#DU)X<7,-9:UH=-@=67$MAWM8X.9Z;M^SW_I$E+N8_<W9J
MW\^7N!']7Z6Y.UGM&\D.CW`.)$^2&6VR8<R.WZ(S_P!6EMN_>K_[:=_Z424E
M],>+O\X_WJ-8N`]X:)!+H<7>[RW!OMVJ;-&CQ[P(_P"BG/!24__3]39]$?`*
M2&WU=H^CP/%/^E_D_BDIFDH?I?Y/XI?I?Y/XI*9H-F2VLP]C@V8WG:&_>YP4
M_P!+_)_%!?'K>[?O@?1]79R/W/T7TO\`78DI7VZD3/8D'W,[?VT_VVF8/C'+
M>?\`.0CZ??UNW'K^4<?])(^G&OK=O]/_`"?]?];$E)FY;'@[&N<X1+!M+M3M
MXW(ZJLV[:X]2)]N[UI_ZYO\`_1J/^E_D_BDIFDH?I?Y/XI?I?Y/XI*9ICP5'
M]+_)_%(^K!^C^*2G_]D`.$))300A``````!5`````0$````/`$$`9`!O`&(`
M90`@`%``:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T
M`&\`<P!H`&\`<``@`#8`+@`P`````0`X0DE-!`8```````<`"``!``$!`/_N
M``Y!9&]B90!D0`````'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!
M`0$!`0("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`P,#`__``!$(`9T"8`,!$0`"$0$#$0'_W0`$`$S_Q`">``$`
M`@(#`0$!````````````!@<%"`0)"@,"`0$!`0$```````````````````$"
M$```!@(!``<$"`,$"@("``<"`P0%!@<``0@1$A345I87$Q:7UU05M7;6-Q@)
M(2)2,2.TMU%A,B1U-K9W.'A!&24U0C,TU298"A$!``(`!P`#`0`#`0``````
M``$1(3%189$"$D%Q,H&AL2)2_]H`#`,!``(1`Q$`/P#W+5Y7D`'`(,,<&AXQ
MCA\9$(0HRRB$(0F5%L0A"VBWO8M[W_'>!,/3JOO`D-\L,G<<!Z=5]X$AOEAD
M[C@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C
M@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/
M3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/3J
MOO`D-\L,G<<!Z=5]X$AOEAD[C@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/3JOO
M`D-\L,G<<!Z=5]X$AOEAD[C@:UH;RXD.8'=Q;&U@<HDQ3\VK'2QT%4N2JL4D
M_1O(X\[L)M@DQ<46"EC[X#:%P=>T_4B-P"-$8LTM+-3@+4L*S\EN%3T@B[NG
MW&T;-/J^F=JUH[NU0R!H0VE7=>M#>_3*45OMPAJ<^9)V=D<BUX4R(LQ>M;>E
M>D(/0;"I$*EQT/*3@LYP2D[);76(+X?R)L(=4U`N1T]+5+C*+")?W2*JXPLC
M9,!')HDM;I,S*&]6-Z1MQ"18#11PRQF%A$*EDX+R+X4V/9VZ;B:J)GV1N66Q
M!$\<>J@E,2^LIE1NHZ9:\997>701C8GQYAB65H%*@A&J/&8C/VI)T:06:8`5
M.;E3._\`A;7])6%R,E#E7Y%,U3*I1";!FK/7BZ6DQF3PR>GUG)&I8S1"*OTB
M.-;)JGVC$(A(:6+0@'!%L@83-BINOE@)#REX,11+)5,A<(PV&0ZZ8;QYE34=
M2LU'(X_;UAEM9T$BKK%B*\-DB-/+R'I*8W.@TFF=64=H9:H0="WH5+-CY`\-
MB&>:RE<9"FR#5^TVF]2>Q'*O#D=>HD5)RAMA%HE@F1L=TQ'.<5E[H6W]AT=V
MU>>$S:(I266,>A4L/)^3G"R#-4U=9TE;H8.OZ[8+=DL?D-%S1+-2JME,B.BC
M!/6N!D0%3,Y`PJY`5I(HTA0J%+4I-+)<"4AQ@2]BI777[UQXM1N;7NO&F$2N
M/O,+BMALLG;(.`44>H=-2G`Z-O+-*CV$F/.H5I36?LPA.I,4I=`UV@LKK`ZQ
M%51+D'PUFZF`EQS<26-UM.LS8ZCDAM8.***6J]5]MY][&JO9(LBQ#3*%R4B/
MK5"$"<T7UXB2FJFKMJ8HPX):E)J6M/BSR&98W)*A96N41Z7,,@DL>?%5)R^*
MM#@TQ>4:ACV/ZQF,"CZ1*N2R30TX$9XRUBC11II)1A))I@!5,A44\XWWFJFB
M:M8AIS+@;HG:'IU?Z#G4!CCBI5F.1:55!Y38%>1>-V8R'A:C#`N4;5NK?L@P
M@[VWLE*89HJGP?[)XL1:X$]#21'$F.T5E92*XD#$YUBZ(VMSKN)+4C?*'UJF
M1T2#"'11'U"XG:QO3N)KDG*,":-/HK?7P5.:'HN0?#UQG4DK-&T>VGT.CE:R
MV5Q3?'&T2G>.1VW.U;@CH])SJN+TVDKRT"@Q8$W83&8I,>-Q"D`2:(`J5PIU
MG']78TDJ-*U5ZILB(PF,V+(8>GC+2<\M\-F#M*6.//8DI3:,1Y+@ZPQP)T`K
MKF@$4#8PAT<3LP5A:CJ:Y.<'.0#G`F>J7*(/SA:4<L.5UR2ZT_*X47-F2IIL
MHKNR3HTIG4#C25V6PR7)A)ER,H8EA1?54^RVE&`X0J82>3W%Q7BTALJ,J6!K
M>W*F&1&_V^.&5"\3=!6:)S:37YK32Y?%(H[ID+VN8R>W?5Q8C5Z9O&6L4DDI
M#BCQBIP?6N[@XH6QJ3;KQI;)/J&W1,>/4G[)1TU3[9K?K\"\<RB:H+A7Z3?4
MC^FP[V[B#K-76"'05(MC+T(5*M4W,/@`LI=7R$32&'FU,WVNEHYQD.J8FH71
MMM=:_M\820QRA0Z\#.F]Q4/#LE"$PYL`FV0I*4>T[.8$W8J<J65&[@XH3"3V
MM#8TTMCQ)Z1FL/KNT6A+1TT[1%IA/26=3%&DP9E?ED.P')(_I#A*D`U2-*0=
M[0\TH`1B"*R2&E9QQFY#L,CD]0M,8E+'$IU+:TD"U55SK%.P3B"NIS'+6'26
M91*/K%AK*ZIQD&'$%FIA"#_(8+71O"53]HYKQG=&R=.[(VP^2HZTM!+2\V#$
MJ\/EZ]ALY6X1-J]TE#/%XV[O!JY"NF[:%8,L@9"$LX1R@91))QA9:E1R+F'P
M+<(C7,]2*4)D-MV>P6KZUD0^.5K$-LPG]DS":0&&Q=I-/JDK8W%SEM?NJ,WK
MZ`6AV248K$04J2&'BI6?#K?XGV`5.APYL:'PZM+C/H&<-J>E)>2^,-L)?JT:
MF,'1]7`D[XK3D(GA,L&YITYS0%N,[9M5V4(C@BI?"C;GXE\DFF-O]+MC7,(_
M+F></D>D!M'36,,+@@KB=>FDP#MZF%?1]K2.+9-0F(RT1YI2U;I.>>E*.3IS
MCBQ,4X*.^.(2ZPSZI3M2;4]21F/356Q*./UB(M(X9*K'?:F8)>L=EE:D,B6+
M.$ZC*Y-IQ,4A1EI4^UQA@$`@*A"I8-IY.<)WIMBKX@%'36"PHS8<PJ]\]'I'
MMNMB/U4UJ'N<JJM$"%C43U:W,J,Y<B0MI9Z]\;B3%K42N1AV?BRI3VK+.XO7
M2_RF-5NPMSZZPF3SR%2OM=(3"--K%+JS6Q-OFL:7/LJ@3(Q`>VE3-F[J)M*1
M&K2S#3$NCBTJH1`I&'[D+PKC=60NZW%Q@BFK;$LE!4<+F$=K5TF+?(+!=)NY
M5PVL"0F'Q%^7%=LFC0H0!5'%%HPFE](S0AWH6Q4K8MASH"CZRFMQ6A'XG&JY
MKN.+I;,G\%>&OQK+'FPGM#@Y#8XU''B1+`(R.D9A:9(<:$&M[V'H#OH)LUV>
M^87`*.0NS9^^/D5;8U38J=W99BFD9V%[BB7D"-I*IAU5Q,-<"EBMAL(]Z(*0
M.*9">A$=[4L9H!ISPEEJ4LGG(7AY6#/(9!/F<489(H_,\9D#HX<;[3VB;7N1
M2Z$02/HS#DU6'A-"^RVQ&E$C-+ZY*D9QPBQB+2+!IQ4LPVW1Q.=K8*HQ$RIM
MVR?6<NN$F#JZ"L!N=C*X@TX.K>1R0(G&N$J+8$\U)["F2^U[:XB-*,2$GDG$
MF#%2@*[ESP+:I-*HB[NL;97J"NE&,TU^NZ,GS,T1%?R4+4CI#4FDCG6Z2.,:
M2>"2B*)4J5929(?L!*LQ.:86`0J4TB-[\.9Y,+2KZ([BSW.:6FL=K^S8BFJ&
M3%2.,2*6/`H_'CC&A5!B%SK%G)Z+,3!?D(%3$`TDW0U@?8F]05+93TZK[P)#
M?+#)W'"'IU7W@2&^6&3N.`].J^\"0WRPR=QP'IU7W@2&^6&3N.`].J^\"0WR
MPR=QP'IU7W@2&^6&3N.`].J^\"0WRPR=QP'IU7W@2&^6&3N.`].J^\"0WRPR
M=QP'IU7W@2&^6&3N.`].J^\"0WRPR=QP'IU7W@2&^6&3N.`].J^\"0WRPR=Q
MP'IU7W@2&^6&3N.`].J^\"0WRPR=QP'IU7W@2&^6&3N.`].J^\"0WRPR=QP'
MIU7W@2&^6&3N.`].J^\"0WRPR=QP(?8=>0`$`G(P0:'@&"'R801!C+*$01!9
M5NPB"+2+6]"UO7\-X'__T/>-77Y?03[FQC[$0X$RP&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&!UTT'PME5,<99MPJ62J-R.C'Q=?C6QS@&GE%9Y%:W]([`E[O%G9
MC&G41TR8QEWL-401("W`298F*+&-I),ZVMQJ9N;^5.`_;EL%WB'#Z*2R?0HW
M]"W&ZX:)JQRCZ:1(1VF\V)0R+CG'YK.DBPM5J`-['`DARE:U(39`)<Z+-#+5
MIR$WL%0N+G=R9!^VN\)9BEET!F3,D0K/W`JXYQGP:0JG$Q@@'U0PD*[6@5?.
M21B4+#AVA:*YQ?E"PPA`GUUTQ8DFQD;,$+6A2O"5VJ-QY)V:)/7;[?-H7??]
MFT_.%BZ0JBJDCM]&Q4+RRM8W)D6%,KP`,63'.2IL0E#?.R)4RD>B""Q`J7E'
MPUJN#]K6Q9)47/GCQ55CPV+4SS$!5DLBS/)0O2]PK6W(R9"R+,E1Q;0RHD+F
MV62W0E`(XH&P*-+TG:1F"$I-"7*7UE.C+2[]M&U7"-3^!L=DPUSC4EYV4WS5
M89/.CY0]VJ07"GF.R.551.YT:VK72QF]J5QT#9$WIP,$X-S%[%&H":!(3K%%
MQ_@MW]IM+=K;R+;54R;Z0%R=KVQ6.Y@5&X2IS@MIV@^3Z(3FL[HE-12(UMB3
M%.8(;%3"GI6T'$*Y:8YJC##D&A^SQ1ZR;`R#A_9,]Y(I>64T>(`GL5BI2IZ-
M8H'''"3>YBQHB7)"&\B+`E+O)7)B&ZEJ94OA:)N:FL+6>6U%%F&'K5PE`=)1
M>%+2XX\-XMQH-OJ)0B0N8J0MF0;D<&J@S^Z:J3#(BGY38,,@`P[$%M@;U*GQ
M4](4!>BR6Y6Y*BRB]`Z!#J3-UJUCK']N65PV'\%JGD,]C;Q7O`.>R2Q8*]M1
M#RV3&VG-.PS2.5DT2Q`:2H9X"D8$,T$<]J$BA\^N%",.B$Z`HX19<6\YU;`\
M!N(SAQ"H5EK>1OZ>1SDI(XM\A?F=^E;E%ER?WWGTM8S8^R2(9!D3"F)GAI*E
M*AT2G..)[1__`#C31BJ3-RXG%;A@U<=4MP'1E*P4P&Y8[$VUXKRB7F0&U9#Y
MS&=V"F=[BK!@G:%4WP663ULES8!Q;BF]0A"?'$AQQBXPPT619FZ8F]>&4FL=
M1PT<FBP5,PE/%^^UME/]BVZX$@G\]K*2QF;1R>U*I7US$8TR"9IHGDS<2L*$
M@*0*4#"G3+$ZS1IH\J1-6C#EPWM%OYPV[S!BKM`EZJ<PNHHM!FE_E,\9P0AU
MKV-61#WJ4OT>8F14Q6`)RC]G+@HD"DU,%&>4$P*C6S!=6+>%,JMXB6D7RKIO
ME[')5$6BQ&L-NPJ_&50XNRQEL*E9T<U*81!F1Q311O<0+JY<8PT+4BA8#V/:
M$9^M%?[Z:,L7A,?"@N"W[9UE<.)I2DO4V?%;`!$:XOBK[!8'D,D<VUL069?$
MFO*,S*AS'@@\^L7XXR1`9I<VD>R:Y*0W(UAF@K"`BQ1/:X;<U'QJL&A;IY2S
M:`R.'2"$\H[-C]R*4LN+?4DFK6<%Q*.0>8(TQ34!2W6!%W=NC*=<WE"4Q]0W
MG[&F&8I+$$\NI<3$,+QJXI3WCQ,;M*3R.)OT!LWE[=?+ML7]=W22P#E=["[)
M7>LG9D&UJ6E$WQZ1NG;$[\G<CS5*8K2<;:4(6S\$S$M3IO\`M5R!WKRUV>)3
MU@99%<R/A8XR&,+CG4RNXU8O&2:5N^6-8;"<E8PNCB[7-%*6BK2(!B-)M`8E
M4*A&*-G")%*7UDVQK?BE/:SY$\H++:)'$UD%Y26=1]OO!:H;N"70!^J6+Q&/
MOD4;V[36:S3%FFHX>`9+B8L9SV@"L>MI5@B@;'4N*A$^,'&;DEQ@@,[A$9?Z
M:=S)IR$Y*WN>[.:Z8&%"*N$Z3R.$PTQK*BR<Q,"/S9Y0G.;B6K$-0A;AE$IP
MC6=9,)F)2>@^(LNXZ\D[ELZ$2EK75)>=95L*;0:0+U2F5'\A*Y2*XWJS2WML
MC#4S"3S*#"2(GU0-()R='!`4XGB&<(P`Q,W$-=6O]NBU$/$SA+Q[.G%?F2/B
M?S%KCDV\/I0Y&%DF+)7MPS*T@15M`-EVN:W1V3RL*':DT!I)`T^SNH9H?L@1
M;QF6Y43XK)85RXN;DVQ28XEGN*#5D6^5=['93.JN>OD$RAV[=/<`Z-,1N:ZJ
MWANCXBB2A`.*3#./T886E]G4O"(4A^WKPVLWA97,6JMV>(+(FQ%JPE4UF39)
M9TYNDF4O]LV99$*:8["W]I31^`M$;)M%82X"2+#]NBHD"CV)`S#]F"9M9S]Q
M8?99R_M>]7YX9`UK:'#>/<45L>;ECB7,T_U5/K*FKA*2E!S0-F3E+4UEG(BR
M.N:(H2,"C8A>UV06+PK=1M3?M\RV*%_M^QF<3V,N42_;Q2S(J%.L80/2.07`
MM<8&LJ^#KY.TKS=H*])C\4<#E+FE2KG[3JY^S]F:B3`&2=%O/=;%+\9;6J>%
M<K(Y[PQ`YPY&\I[,NM"XLSY)&I5%();JR+HY.S)W;4<&I33QCCC2LVUKRB!I
M0N)Q!AA?4)$$VI<8-2Y;^V1:@8]9575Y/Z];J9<^<U,<U*IBST4[HE\(7Q5[
M9IG<$#$&/1DI@;6"?SEG&X-)+<D*2L@G!3KV1X=A!J4OKFF\W)"D+:Y)<5N3
MU%/KU`XU(KNB<S@<(4H#7QT8(5&Y+&&V/)3GYR,9VQSD3F4X!7.9OLD24&NT
MEHP[V$KM(ZD83$NNV7?M1VTOX]\J./S%:T*=&WDHX<59H1-9V9+'FP(3*Z%D
M59N\EA*F8C0+7R8U"I2UP$N&H#C4@X<4O/2DEG)NH$$IKU&#<"^.*%K7/Q*E
MG&UO75["Q'VK3LB@)BF63R<I6&`U/;-7W)M'*94_1]/*9A+Y!(H0O2"4&EEZ
M)1KDYAIRI0G.&K)$Q$VFD]XT6$HYHPWF)7K_``XMW(XM3;BY*8K+!O)29H;Y
M)9$5M%CL*.+6MM7>\:YA?8\8F4,ZHML+7ICM""N3##T;J7A33BR?VN;$DW(J
MW^046M.,HE3[..#DYKF#2<,A>:_?M\0V*21ATB]ZPPI,7'Y<V3%%)?K)F7$%
M;<8H_-R1:B'U]#ZTI8[84VC=N$`9!:E/W\4_)J]N>I[8L9R<GR&K5;@WVW05
MDVQ(+3<J9L<"MH9#%[>S2![3N;7URU0&YY;`J"!`[4;LH7A,?#L(RLF`P&`P
M&`P&`P&`P&`P&`P&`P&`P(;8OY?3O[FR?[$78'__T?>-77Y?03[FQC[$0X$R
MP&`P&`P&`P&`P&`P*9Y`S280:I)FZ5JUE/MJKV=:PU0Q'HUKBF<[%>$:A-&!
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M(DI(6;LD^3196MC"P`6UP;2C]"4F+22!&#BU&<ZK]EG(7E+<_&*FN2'#U2R(
MY3>SO#IK5=/VRUQX]KDD$::7F=F/]=R!];DK<KCTDM!RAQZ-$YA<-D-X3DAH
M]I@C4%DBHNI<EUYN6'-N$]@\BN.$.EDSMA\.F@*UIV?0]:BDD,E=;1L*ZUZQ
ME[+'H\D>D[G`Y;&'^.$J52<XHR0";TYZCV*C2C8K&I?RQ><#PUN7`SDC!G<Z
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M`N6Z>W-`E:4Z(/1I,A["<,19PE/]U4BE%UCR(Y$OG.3DQQADDX7+83Q\2<+G
M,-B((97;<R)T\]K"?6%</J3VD@#DG26,=`!-[(8VA3%LIZP0S5`O9D)U,6HJ
MUE\3;DN_EE`IQ<@["*JO;9R?L2JD-3ZBD66M\4@-.V^97[VR298\M*B8#MJ8
ML;&J4;4C5IT"%6X)P`;=@*V(X3484T9I3GWRBGIG[<J&12,E+^J*MOW"I#9C
MP5$8&G(<7?C0G`&MU<((3%N*AB)2&F=9S*7)Q:5CZNB]=3K8)B,4G4?N$\I*
M8I_DNW7I%D+WR8XP<:I]R`CI<=BQK93G(ZKW97%RZNN=!LA$X/;&5"#G5<BF
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M=P\=ZNJJ\CK(12?G^3Q<N14_5BWLS[%&W5$#GKO`E+R*%QF+.TR;I`TA<M+V
ME(`HEH>TY!Q8QZ*4F"L\/A$N-O+'EA=U1\JI4E?61+85-VCR5K*G_?MKK^,U
M';C_`!R2VY#JJB&WA+MOD#1+8BYU^VJGM6<>0A/2.NQ;3Z+_`+X@3$8-S.%O
M(]=<T>G378VK$@]L1&RM0F0U#>$>A<6LZ".Y-90J5JHV%Q@J=LA5JLC@!:K?
MFF0LJ4DA6R+R0C*`-.:+=28X:[R+E%R+J[E1NO+04`4\;KXNMAJ:@K7B$3;A
MOM66HUR1GT\TU:VC6QT:UC':454+#8T^[3%')U:0Q(>(0^HIW%J*OY6\KYD/
M[#SE%QYE+$C8:@L2H9:HHVRG=$Y-[?)+RHUR<'"[XDH<U!9"=8C(B3\E-3`(
MZPBQ1=U'H8@F`ZHK"_EUZ3K]PGE5`:)G)DY(DU5<H()+^&K3+()-857DBKUQ
M8+KN]VK:7V=1%C1%'[OV'3<X;CPEL@%77?8\O:1EKE"OVN]C+48:-N8]R[Y!
M.L%Y]02,L#98EU<=+ED=%\=I:ACZL;1:DJ>ZM:+(BB.5LS`6:W#DU7%/9@)1
MI!V-(H(;^N$A&8;[+1*C#1CJXYWR;E-:/"&%UBK759!.1_&:W+^G,H2M+&[3
M%MG%7O4(@KY1K&9,&A]B[2\0.9R1?J1#.;W!7O2(@HL*70QG#$Q5LE4W)ODG
MR%_;N,MN)+(I".1:^QWZFH;,#8SI57DGD#%R.-H=DGPXP[FK!`C<J+)"K5)R
M5/00HV<$@W0``U@J(G97]`\^[=OZX_V_T@41,$@5]4UR;,NJ)N<9*2/:2^.,
MA%5M-AMC(ZN851J6&Q^?3-S9^L6+VQZAK/UL0-`"(8F(B)9&3?N!683$_P!S
MME4LJ>O['X[<=I/RRXG+'5B4)R;"H,5,.J^(RY8P21,4L>!-5PP%T3OW2426
M24Z)4A>PF`]KMJ5^6JZ3]R;DX[\7.6]M,\C8R7VB:WX-O[&DD<-CK18!5C7F
MW0E=:B=3$#"RVAUI1];I22HB#R(M.<I/&J+TK4`2B]F6HP7M=G[@\^.X@SOD
MO2TH>([-(YREJ?CY(:.GD-AA4WIA>?<,6J^<0RQVM06;H-CR%H?-O)9@5WU4
MF"M1Z2#/3`&H4DK&(7=RFNWD'3?$IQY%1JQUS5(`R3C<@#6\SA->JY'"#+]N
M^@(K((A82EF0_5Y\D@43G[DG2=C*2!$8J(/4;5>R`,X1$72<\[KJN3C)2E//
ML-FR=PE4NY<494;U(':,1XX:NOK=MOW>6(Q-H$`&HA^:(HY$IREI))0!JD_M
MQ$]`Q%94BIOZ50EY0<C8)R/0U?<*SVM)<B;ED4'XPW##XDU=OB,UK&VI'$IK
MQ_MWVK2YL85,UKZ)+'V-O>TJ,9PDZI'US3R0BR+45<9M;Z$_<)Y+2-+QH6RY
MV8YF#D=9G/NH7=L;8JS-3U7P>,"BPG.`6E&_JY-HE:V$M\73MLD(<R5249ZU
M*H(&F%H:98)B,5]<,^0'*#E9P20WDYVFWU);TFI=[<6!TFT+KT5=K9@TL<6E
MR2VV)M;0_6@*G1GR,Q@?$RTXU248E$:4-(9H/MA,1$U\+\X"\J7KDI6CC+K3
M=2H':T?F)-)V/0;ZF;V5^K"XX7'$QDN9E6UK(P/3VNFXTJB0MFB@"3:9%!6B
M@[&2HZB#M%.5RPY?2#CG;O'%!J-A64A)+6C5<<BI^<@<-IJY%<C=(HQ2K@%]
MT5[N-S<59R)`5(NVJ$ZE$B=FTTH!I:H>P5(BXG52<BY1<BZNY4;KRT%`%/&Z
M^+K8:FH*UXA$VX;[5EJ-<D9]/--6MHUL=&M8QVE%5"PV-/NTQ1R=6D,2'B$/
MJ*=Q:BK^5(5?SYY%;L9B+D+@QV#'Y'^[MR0_;O'`4T9:VR0(*K@S9+7B&6PT
M.+(4F7&.U?%1`0Y,8I*4H%B!7H02T)@-&C%1C]-J)MR4N*&<SBZAG**712DY
MS.H%!:9MB#,4'G5:+9*Z5JDD,GJ2ZNE(ML6H[@<G]5M;'',[1L;=&@]$GVG)
M4>V4FBL+^6I/"CGER+Y/LO[>D)F<E20^0<FZ,Y#7[95H,$4C"92[G4[926OV
M:K:S:GUH=XHU&C3NI+J]'J$CJM`D+"$G1'M_;EB8B+;L\K+UN/CI6?'J/(I&
MR22><@>9%>\955M;C2,MLKB(VG,ILJ1S%3&0&:85<J8(>P)F!-I2(+<=)51)
MQI!Q>]HCA%3,L-=EN7O5/(WB5QS;K#$[1;E1:=C1Y;;"^)1,<TK2.U'Q[?;2
M5Q4($;`BKU=-[+E+5KL*Y4U^Q1M(#2P-RDX/:M5(JIEI\S<\.2LQNRJZ/*?D
M460N'[C',#A8^V`DB,<5.4W@=+U$=84'G;<C=FU8Q-\O:7E:6UNPTJ?ZK6*F
MQ3L"9/LP2=-%J*M'JD_<;Y-7//>"$:&U&M:+D7%>3<?L4=71R*J2E;U2][QF
ME6"]X(?/P/FT5>&-3T?)G!"(3IOL9&R4XC@E[/.+48M\^5E^VK4$P_;QB\.F
M3,O2<@^1T<J*T'U(PLRI)*(ROJZ6RQ6\QH*D+F4QG+W>,E&IQDFG%@2J!@_O
M-^S,!68C-0E<\L>2[+;:BB;^<-)3+%3VK:W%NY89#V=.P6174&ATU4R>HY^G
M5L[LTL5KU6^-3>O&>F"C(?6A0$T`"A!,)W%J*N&I\-_<QY4?INAT]=G2,RZ7
M6Q^UER?YGE.C?$&E$;4%K<=T9YS.I<&Q"7MN<*GL)0M2HM)EQ/;2W),:$E<(
M!VBB%KYB_P"MY6.W.6EE\&'2[:^G:>*7XXT_4UA06%6/#X`I;I%*C(XD=WMJ
M1(XT2(W<.OY6Z%H(K_>J'-N7>P&8888)0UEDJ+KX;1\)N01/*6DDEXD/"O6Y
M7(7Y`X5LYH$J!_HY_BZT4>D513`'U&P.QTWBSR@.^M!JR`AV<;KLOM$GL5!]
M28J:;=X0P&`P&`P&`P&`P(;8OY?3O[FR?[$78'__TO>-77Y?03[FQC[$0X$R
MP&`P&`P&`P&`P&`P,&Z1B-/CC'W=ZCS&\.T3<%#M%71T:4#@XQEU5MRMG5N4
M?6JTYREF<%32O/2F')A%F#3'&%[WL`Q!V%?,?'ZAHSMQW&Z2J*/;=U<T7NVV
M.MH:T[=%UDA2`L1:X[0,J?MJN>@;T^GHPWK#==$%Z4[-Z@>@MSJY"VB:0<EM
M@.3C3=5.#C;)+0FM1>MKR(JEMEIV`(`,)%@*CV@P^9$L@"PZ2!<1*0IM!UHO
M0>C6"YU9!JJ"J&,M$4T5K`V_3=*=SI$8GB;$!0GG(FPQF,FX578=J13(YI.&
MF,=1#VO,(&(`C=A%O6Q<ZN<^5I7<F;W!ID4%B3ZVNDA1RYP0NT>:EZ55+&X*
M$+;*3"524P&I(W;;$PDZ_70J(&06(!@1`#O1+8\FG:D(A4GK4FKJ[!7<V-DI
M\T@>H7'/<Z8'S0]0IF*B51K;;MFD2B6J5AQKH8L).&X&&C$?LP0Q;V+E^(E3
M-/0!A=HK!*HK6%1=_3ITC[&XE!8O&V%Z2I&LED2IG9G9FM&WN2=,RIRT98#B
MQA`E`$K6M%ZT'0N=7[CE.U'#V.&1B)597$6C5<KANE>QZ.0>,LC'`W(U"X-A
MKC#&EL;$J"+KC&UV5)Q'(2R#-D*32][ZA@];#+%UY`27P$G*A$1!)"BI&03(
M`QQHT]D$3$]L52Y.0Z=C[<0GE2ME1G.18!A`N.2E#/T,98=Z#$Q>G:D@\.9:
M[A-75Y#:_C;PED$=@T3A<<CD/87Y%(`RU(\LT:9FU$S-CHGE(=.0%!!(#=+O
M[_K>U_FP6_$IIFGIRUS5CFU45K,&6RA-0K%9Y3!8O(&N?"8BTY3(*:M[LUJT
MDJ$S%)"@I=K@']G"4#1?5T'70+G5B7WCU04I9E,<DU'4_(H\ME33.UC$^UI"
MW=F5S=A0)FIBF2EK<&50A/E3*UHR4R1Q$#:M,G*`668$`0ZT6YU2F:UG6]DZ
MCFK%KZ$3[4.DC=,HCJ:Q1AE6HM+V<0AM$KCFGU`O^HY(UC'O:9<E]DJ(WO>P
M##TX2T3=..W'Y\E+S.7NBJ<>)M(W&*O$AF+I6,)<)2_.\%-T?"'1YD"MD.=G
M1QAQ^NNU'GG#-;Q_Q3B+WA;G5F2:9J%-(WF7IZMKLB52)T"^R"1DPR.E/3Z^
M@;-L@'UY<@-P5;F]A9!;1:5GC&HTDW['K^R_EP7*)M/%OC*PI8@A8^.E$LJ*
MO6Z6L\!1M-15^W)8.T3XO9,Z:X@G1QXDF--TU)%L+L0BT04Y!WT*`F:P7.JS
MRH3#22F\@F)QLE.TQM?#6M,4R-I29NB+K]5_6470IP)@DI8\O^I$?MD8`A3F
M:2E:$#?LP]!+E`">.7'TB.2"'ET=47NE+(VWPR3Q<RN8@='I##&@2@;/#GIF
M.:#&YRB+/M6;V-L.+&A2Z,%HHH&A;ULMSJY:>@:(1L[U'DE*5(E8)(WQ9ID3
M&GK>'$,[^UP;KZA+:]-A;,%$Z-\/T8+ZJ)/`86W];?L-%].\)<ZLF33E2$15
MQ@P*Q@`H:\O(9(]Q<^(,*EA?)*%<C=-R5\;%*`U(]2,;HW)U0UZH)JL:HD!H
MC-F!T+1;E@2^.7'TLQG.]#JB-4QZ:*+)8UJFN8@K<&JR%C6C9%MB(G!4T'+2
M)ZO9V\A*H>M&?61Z<D`##A!#K6A<L.GXH\7$A:DI'QNH5&6M<),ZK`)*@KY*
M%6YS5,>CF;@JTGCQ?:%LO1*C2'4P?2-Q)-&6HV8`8@[%SJSI]`4T=)(!+2ZW
MAJ.05A*7^:PMT0QEA2KV>4R>%*:\?'I.XEMWUB6M<H<ITA.$`X'MB"$X3.OI
M,GT6+E-2H%!TY+@G3PV+)B':4IIPZE)F!J3EN<T1N:)Z2RYQ`2E!I;)D[PVI
MU05QO65:4$%F=?K`#O1+E$7"@Z+=D\02NE,52X)J]>'>0P`E97D14%P60/XE
M`GU^A@36@7NL]O(UAHE2M#[!0H$:/8QBV+?26YU8YPXU\=G>,FPIWH:FW>&G
M#C)AD2=JRA;G&1"A1RE1#-:85S*H:@@B"A:<-J#HK06X9PQ)]%[&+>Q<ZI6R
MU-5<:!&RHY6=?L!<-7/;I$"V6&1QJ!%'.2EG%2-QC8$+:0%C7/Y2DP*TY+[(
MQ4$P6C=BT+?2+G54\VX>\<9I5CU3Q-5Q6`1%V=7^2)3:D9VVK)!%YI*$ZE*_
M3V'/\)2,[A&IN\IEAQ*UR3"">X)CSDZO9Z8\\DP7.=K(B]10]@K>)U:[(&Z<
M1B&%,0&8B51.`$)B3(HY)W6)*2(U$(A$X*TJ(HK0I1-VVYI1!2#2$F%ZT<#V
MFR;OP_T724K=VY_E%.U9)'YG0S!K:7M_KZ)/#NUMMAJ3UL_;FYR<6A2L1(9R
ML4F'/!)0PEN9I@A*=&"%O>RW.KB2#CY0DL6B<I52%0R9Q%7JZHQ+Y!6L,>5H
MJI<PZ`Y5B)4XLJD_=>N`0ZT>R];ZM-UK^8G>"YU81YXK\89$D$@D''&AGU"*
M(QF`"1O-05ZZ)!0.%NFGN'0D2=;'CR=Q&)O6NV-C;T=C0*O[T@L!G\V"YU?I
M\XL\8Y.ME[E)>.=$2%QL%PC+M/5[Y4-?.RV;NL*"`$-<Y>J7QY0?)7")`*#I
ML.6B.,0:#K1&R^C6"YU9=?QZH)UB3Q`72CJ?<H+(9.FFS_"E]:0M9$GR9HQM
MIJ27/$<4,IC.YR=*8S(Q%KSB1JP"2D["9K90.J2YU2>:UC6ME-34PV-7D&G[
M&Q/+1(V1FFL38)4U,\A8#M*&)^:FY];UZ-O>60\.AI%1(`'IAZZ2Q!W_`!P.
M4EKZ!H&\QJ00J)H&LV3&S0UN0QUH1H39@>Z?7:B5&I4R0H@R1J7G_>C%NP[4
MF*-[,$/8M[W@N4)B''/CY7HG4<!HFFH.-];WMI>Q1"L(3&A/+7)EHG*2-KJ)
ME8T6W!OD#B/:A<2=URU9V]C-T,7\<+<ZL<Q\7.,L90I6R-\=*)C[:B9RH\C;
MV.HJ_:4*1@(?$4G)8TJ1!'TZ<AG)DC:F<`I@!T2%<G+/T'VH`CT+G5\GWBYQ
MWD,X(LUPI6K0V,&>1&S%\_1U]#DDZ>YM`6MP9X5('F:DL896L<XPW.1B=(HT
ML`H`C$8CV,2$]2F/%SJELJI*F)TRS*-S>HZQF,=L5V:WZP6"50&*R%EG;ZQD
MM"=E>IDU.[2L0R=V9T\?0%I5*TL\Y.!"G"6(.B2]!)<ZL^EKZ!(4JQ$AA430
MHW&3(YHX)44=:$:=?,&]R0O"&5+24R0HM5(TCLV)E):TS0E(3R"QZ'U@!WH7
M*)Q&@*(@$E<)I`Z4J2$S%V<Y&].LLB-;PZ-R5S>9@H(62UV<'UF9D3HM<Y2K
M2EFN)YAHC5QA81'"'L.MZ+<ZLV*IZN')W":CKJ$#E[LXZ>'63CB[*-]<W@,5
M304MW<702+:Q:Z$PE(6SEJ31B.+:];2!%H@0B]DN49;^.7'QHC4.AC/1=/L\
M1KMU4OE?1AGK:'-3!`WM:!44M>(6T-[,F015U6%+CP&J$!9!QH#C`B%O0Q:V
M6YU2]YK.MY'"C*UD-?0A]KDY(F0&P!YBC"Z0HU"C/*4I$1D57(#V(:1*I)`8
M67LC8`#`$0=:WK6\);&+*:J5Q8"HLNK2"JX\0_(I6G:5$69C4B>6MI)1#=+T
MP1H]B3RYN+3E]G=`;"O)V6$0#@B#K>A;`//&WCK(FR*LL@H.EGUF@JMX7PAI
M>:L@SFV0Y=(M*=2!;%4"UB/2QY6^Z6'=L,2`)&J]J/VFQ=8726YU<A\X\4!)
MU48726C*>D*Z$1E7"X6L?*RA3LJB,.7IRTBZ)QA0O9%!S!&5J4H)9J!)LI*8
M6'01`WK6M8+G5EW.F:?>TU>HGFJ*U=T=1J$*NJ$CG!8NO35BJ:VT+,V*:](5
MM9I4+4-S.#20@;;I,(E-K10-Z!KJX1DRJSKA.RMD;3P&%IXXRFNQS/'T\79"
M&-K-?FUX9GP:!I*1`;THGEID*],KZA>NT$+3P&=8)H]"+<H0P<9N-\4BLA@L
M6X_4C&H1+HYN'RR&L%4P-FBLGB6P+"]Q:0QYN84S0]1S9;BH#V%22:FZIYFN
MIT#%TBYU<MAX[<?HL(L<8HJG(X,D4,$4)AK&$M`BA5QMPW7@BQ-[(GV`4"V[
M*]LN]='U7VDWLWLO:#Z1<ZI3#*NK.N5DO<:]KJ"P1PL&2*YE/5T,B,?BZR;R
M]P__`*^5R]2R-Z$Z2R1;T_WRY:(Y49__`!#WA+3K`8#`8#`8#`8#`8$-L7\O
MIW]S9/\`8B[`_]/WC5U^7T$^YL8^Q$.!,L!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@0VQ?R^G?W-D_V(NP/__4]XU=?E]!/N;&/L1#
M@3+`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8$-L7\OI
MW]S9/]B+L#__U?>-77Y?03[FQC[$0X$RP&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&!#;%_+Z=_<V3_8B[`__];WC5U^7T$^YL8^Q$.!
M,L!@,!@8&52=BA,7DDSE"\+5&HBPO$GD3F(A4J"W,3`WJ'5W7B2H2%2U2%&W
MI##-EDE&&CZO0`(A;UK:,<(%,@Y0U$:`!A9MEF%F!",LP%#7P,`P#UH01@$&
MMMA$$0=].MZ_AO6:\=MN83U&_$OW^IVI?ZK-^`E\_+7'CMMS!ZC?B3]3M2_U
M6;\!+Y^6N/';;F#U&_$GZG:E_JLWX"7S\M<>.VW,'J-^)/U.U+_59OP$OGY:
MX\=MN8/4;\2?J=J7^JS?@)?/RUQX[;<P>HWXD_4[4O\`59OP$OGY:X\=MN8/
M4;\2?J=J7^JS?@)?/RUQX[;<P>HWXD_4[4O]5F_`2^?EKCQVVY@]1OQ)^IVI
M?ZK-^`E\_+7'CMMS!ZC?B3]3M2_U6;\!+Y^6N/';;F#U&_$GZG:E_JLWX"7S
M\M<>.VW,'J-^)/U.U+_59OP$OGY:X\=MN8/4;\2?J=J7^JS?@)?/RUQX[;<P
M>HWXD_4[4O\`59OP$OGY:X\=MN8/4;\2?J=J7^JS?@)?/RUQX[;<P>HWXD_4
M[4O]5F_`2^?EKCQVVY@]1OQ)^IVI?ZK-^`E\_+7'CMMS!ZC?B3]3M2_U6;\!
M+Y^6N/';;F#U&_$GZG:E_JLWX"7S\M<>.VW,'J-^)/U.U+_59OP$OGY:X\=M
MN8/4;\2?J=J7^JS?@)?/RUQX[;<P>HWXD_4[4O\`59OP$OGY:X\=MN8/4;\2
M?J=J7^JS?@)?/RUQX[;<P>HWXD_4[4O]5F_`2^?EKCQVVY@]1OQ)^IVI?ZK-
M^`E\_+7'CMMS!ZC?B3]3M2_U6;\!+Y^6N/';;F#U&_$GZG:E_JLWX"7S\M<>
M.VW,'J-^)/U.U+_59OP$OGY:X\=MN8/4;\2?J=J7^JS?@)?/RUQX[;<P>HWX
MD_4[4O\`59OP$OGY:X\=MN8/4;\2?J=J7^JS?@)?/RUQX[;<P>HWXD_4[4O]
M5F_`2^?EKCQVVY@]1OQ)^IVI?ZK-^`E\_+7'CMMS!ZC?B3]3M2_U6;\!+Y^6
MN/';;F#U&_$GZG:E_JLWX"7S\M<>.VW,'J-^)/U.U+_59OP$OGY:X\=MN8/4
M;\2?J=J7^JS?@)?/RUQX[;<P>HWXD_4[4O\`59OP$OGY:X\=MN8/4;\2?J=J
M7^JS?@)?/RUQX[;<P>HWXD_4[4O]5F_`2^?EKCQVVY@]1OQ)^IVI?ZK-^`E\
M_+7'CMMS!ZC?B3]3M2_U6;\!+Y^6N/';;F#U&_$GZG:E_JLWX"7S\M<>.VW,
M'J-^)/U.U+_59OP$OGY:X\=MN8/4;\2?J=J7^JS?@)?/RUQX[;<P>HWXD_4[
M4O\`59OP$OGY:X\=MN8/4;\2?J=J7^JS?@)?/RUQX[;<P>HWXD_4[4O]5F_`
M2^?EKCQVVY@]1OQ)^IVI?ZK-^`E\_+7'CMMS!ZC?B3]3M2_U6;\!+Y^6N/';
M;F#U&_$GZG:E_JLWX"7S\M<>.VW,'J-^)/U.U+_59OP$OGY:X\=MN8/4;\2?
MJ=J7^JS?@)?/RUQX[;<P>HWXD_4[4O\`59OP$OGY:X\=MN8/4;\2?J=J7^JS
M?@)?/RUQX[;<P>HWXD_4[4O]5F_`2^?EKCQVVY@]1OQ)^IVI?ZK-^`E\_+7'
MCMMS!ZC?B3]3M2_U6;\!+Y^6N/';;F#U&_$GZG:E_JLWX"7S\M<>.VW,'J-^
M)/U.U+_59OP$OGY:X\=MN8/4;\2?J=J7^JS?@)?/RUQX[;<P>HWXD_4[4O\`
M59OP$OGY:X\=MN8/4;\2?J=J7^JS?@)?/RUQX[;<P>HWXD_4[4O]5F_`2^?E
MKCQVVY@]1OQ+X*N4].(4RE:M56,C1HR#E2M6JHJ]4Z9*F3EB-/4J3S:W`400
M04#8AC%O00AUO>]ZUK'CMMS!ZC?B5]MK@C=VY`ZMYW:$#FB2N"%1[,TKVZ-:
M06I3'>R/`4<5[4DT(NJ,(1!Z>C>M;_AF5<W`8$-L7\OIW]S9/]B+L#__U_>-
M77Y?03[FQC[$0X$RP&`P&!K_`,L?_%CDM_Z_W+_EU(\UU_77[2<I7-&_^76'
M_@K7_@2,DYRK-9`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!')/,(E"4*1SF
M4ICD2;7!Y9HX@<).]MC"A6R&1.!#3'V%(K=520A2\OKJI+3(TH!"/5*#`EEA
M$,6M;#JM_==EO+J<<0^4-0<1**GKE-S`QJOWZQ7:25O`(\?5DMA+G,[<F%;N
M,KGC*OD2>-1M,3&5H@DIE.G1[,["!3MO5#)8SA&:Q48]IP;"_MEE\E$?!OCV
MR<M8SJ,7=%H87$WPD4DCDJ4O,;CBQ2U5_)G%XBSP_M)[P_0-,W'K=]L./&K$
M88=HLT8B@/LFKPR;X80P(;8OY?3O[FR?[$78'__0]XU=?E]!/N;&/L1#@3+`
MP\AD#)$V!\E,F=4+%'(TSN<@D#VZ*"TC:S,C,B.<75U<59VPE)4+>@3&''&"
MWH("P;WO^&L"!(+JKAQ/@J0IY<$ZRR)&JB,/2.,7E;6>Y25'7[I:AS.H"X,B
M8+0I'7S(K="=K-IRU2<@7L1&"Z`[+3#*N151(/K@;G(G9H2L;R^,:MT>H-/F
M9D5'1=N=7:4.K$^ND72,TFB<70,BDQS?&T]6S-_L^JH5%B$`(A4L;RQ_\6.2
MW_K_`'+_`)=2/-=?UU^V9RE<T;_Y=8?^"M?^!(R3G*LUD#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8&'D+ZV19@?),]&J"&>.,[F^NQR1O<'942V-"(YP7FIFMH
M2KG5R4%I4X]@3I2#E!PM:`6`8]Z#L*_:IG,YBIJ.10F*HB:NF<<=9/-W.P_?
M*OK.BQ"MC:UD%8V^JGV%D.8'QV<'(WZX*>E3,H9"T(BMIU!Y_53EUU?6&50V
MQEETU262RJWE9,Z>+";Y%;1S!)7MC?')P5K6XF._5L>8F:.MT33*]HVDM$C(
M&D2ZZ-C&:,TTP6^UU_DU;?\`VRGO_2KKEZ_KK]L]OS/TS5<?EY`_N9%_L-#B
M<Y(RA,\BF!#;%_+Z=_<V3_8B[`__T?>-77Y?03[FQC[$0X$RP,')VH;[&I"R
M%DLRDQY8W9J`GD;7I[CR@;@@4)`DOK*(Y.%W9C1'=54EV8#2@C8B^MKK=.@T
M_K+B[*Z_9:$9=2QO.8Z7NASLIFB)JY^>FV(0]SX_3ZE05="G]W+^M3F!H?+!
M6/S?I200F;DNPLJ1,G0DI1IRS-H1+>!S?)4LQ/9G*(UNMG\(N"N)%&:]CR]F
MK-(WW?"]1&<V,RPSZS$E3V@Z+$+<XJS];+3+RT`4IVNT&'.AD6\E_P#+IG2*
MN*7(<@PYT"!MH2W3DXD[X]I#C!IJWD8"]+U"1P)4.I0M:_O`*A'`-W_$>A;_
M`(YOK^NOVQ.4K*CL&911]B%M;,-;$SM@MZ#8<_`'IVB(WOJ@!)@@#K_1K6M:
MU_\`&2<Y5F/<1D^G3+XBV#^)\@>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC
M)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>
MXC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?
M`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_
MB?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M
M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^
M(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/IT
MR^(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/
MITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$
M9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#
MW$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3
MX#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'
M\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%
ML'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].F7
MQ%L'\3X#W$9/ITR^(M@_B?`>XC)].F7Q%L'\3X#W$9/ITR^(M@_B?`>XC)].
MF7Q%L'\3X#W$9/ITR^(M@_B?`B,B'5L1=X='I1.G%@?[#>U$;@;&[6Y-$3O,
MGY&TKGY:TQEM/EH%KVN0,;8I6J"TX#-D)"##C.J6`0M!7J^'6#9,4L-F83[&
MX[2-LL0,;A<W?YHLLE3)8/'W>-*WB=L\60V.I:FE/.&X+LV-);N9VQ!OV+BJ
M0#UT(AE3=#QZJAML!^M5$S/Y-BR9@:8J]R_=A6,:\*XVQGGJVQC`>=+#`HVP
MA6I$:(D@)0#3>@9FAB"'>B;)S[B,GTZ9?$6P?Q/@/<1D^G3+XBV#^)\"MKEA
M3,GJ"U3P+9:(9-;3DT`3I_.U)(AEQAT&'1J=1)#4Z@K>P_S`,"(`]?P%K>M[
MUEZ_KK]IVRGZ617'Y>0/[F1?[#0XG.2,H3/(I@0VQ?R^G?W-D_V(NP/_TO>-
M77Y?03[FQC[$0X$RP&`P&!K_`,L?_%CDM_Z_W+_EU(\UU_77[2<I7-&_^76'
M_@K7_@2,DYRK-9`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!!IU/V>!Q>5292@D<I,B38
M4Y+HI`&!QFLZ7[6#V2V(&>(L12IW7N#LHUL"</4"7OH$,8P%`,&$."2.S7&P
M$YPBX<WTPHKCKG(SPR(%N&6:X/1(@%C/3*D\78H<R10H83-`VL<5CFKUL(T9
M2+_?@_=;UDP5G#XI#VYPE<JU$$*Y&AEEDRM\L2P'`QV5F.#RX/<XEBQSD+DN
M=UQNS#MB.T4$.@%%`+(***`%B8#`8#`K*Z_R:MO_`+93W_I5UR]?UU^T[?F?
MIFJX_+R!_<R+_8:'$YR1E"9Y%,"&V+^7T[^YLG^Q%V!__]/WC5U^7T$^YL8^
MQ$.!,L!@,!@:_P#+'_Q8Y+?^O]R_Y=2/-=?UU^TG*5S1O_EUA_X*U_X$C).<
MJS60,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@0IRL6%M,[C-9+WTDF=S!FD$BCT<`F7J5BUB
MBPV\I]=S34J4Y&W-Z`]U3%>U5&$A,..`67L8]]7`@;>EMZR(]$7*1FN?'AY8
M[2/?'Z+15ZA5D*9O7D:='U,R19^D+Q$5#='D5@I=-S@Z@:2]N*`K1B%.XZ$,
M2K1<%@1RO('#WR9R:*PV,1R1V,\(Y!/W]E8VUM>IJ]MS6E9&]UE3HD3E+7Y<
MWLZ(I*08I&:(E.6$L'5#KHPB8X#`8#`8#`K*Z_R:MO\`[93W_I5UR]?UU^T[
M?F?IFJX_+R!_<R+_`&&AQ.<D90F>13`AMB_E]._N;)_L1=@?_]3WC5U^7T$^
MYL8^Q$.!,L#`2R4L,'BTEFLJ<`-$7A[`\RF2.IA*E06V,,?;E+L\.!B=$2I6
M'@1-Z0PS8"BS#1:#T!"(6]:V%<-E\0%Q%5Y(MR1`JN"2'1.$D+8L]B(6/1-7
M/MRA+5/*%(MCJ1"JKV.*EA"S:S:10<#:4LT2H(R0%I"U/+:H$NE:8T4Y*D!4
MX::^;H:LKJ9-$RDS](&1QDS"?$XZ^-#8NDC&[QMF6+B5Z71B712,\`Q@.)-*
M"*9KEC_XL<EO_7^Y?\NI'FNOZZ_;,Y2N:-_\NL/_``5K_P`"1DG.59K(&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P*GF-M-S"PN3M"XX_W0ZM$U:Z^=HI5"F+/CZQR5P4MI2PF3
M#=I(Q-$:31E$ZDKG7:Q44H2(1:,"2:,919@?AVA<YE[C;,>F<N:=5#-X:BB,
M28X*@F$$M.,&.;.\-L[?5EML\\TK"YN0G,K;.<S-[*M9!)0G`5&GBT,LJPHY
M'VJ)QYABS$0<F9(TS-<?9DRE<O=%"=J9D)#<WD'N;JJ7.CB<4D3`"(]2<<H.
M%K8S!C'O8MD9G`8#`8#`8#`8%0WZ[M3/2MJGN[FWM1"BNIRC3G.2U,A*/5FQ
M-Y&4E),5&E`-4F@*%L(`[V(6@[WK7\-Y>OZC[3ME/TSU4N+>ZUG`5C6O1.20
M4/C9852!40L3",)9T91Q83TXS"MC*-#L(M=/2$6MZW_'$YRL90L#(&!#;%_+
MZ=_<V3_8B[`__]7WC5U^7T$^YL8^Q$.!,L#%OB)6Y,CPW(%21$N<&MP1(EJ]
MM`\H4BM4D.(3JEK08H1ENJ1.<9H9B81I6CP:V#8PZ%UM!J36W$O=;M5--+5-
MTY#54=S.]NMD61QQ?J(M:9[H^:TRLKZ`-JR6*E,(BNCITN?PE:.6IB710>6E
M2I$(R4B8MN8NXY3B91Z=1>UII3\Q;K"?ANKXN:*)D,?D"0`&PIK:W6/N[W>4
MV"QSV+ID*';0\DD^R;3&\@TI%H_0S1BTNY@-J=QXL<C>T&.!?8Z(N%65V!V=
M&KKFE5U).J!5]6+$?;DV^G^8@[VA(_\`^(.\UU_77[9G*5C1V#,HH^Q"VMF&
MMB9VP6]!L.?@#T[1$;WU0`DP0!U_HUK6M:_^,DYRK,>XC)].F7Q%L'\3Y`]Q
M&3Z=,OB+8/XGP'N(R?3IE\1;!_$^`]Q&3Z=,OB+8/XGP'N(R?3IE\1;!_$^`
M]Q&3Z=,OB+8/XGP'N(R?3IE\1;!_$^`]Q&3Z=,OB+8/XGP'N(R?3IE\1;!_$
M^`]Q&3Z=,OB+8/XGP'N(R?3IE\1;!_$^`]Q&3Z=,OB+8/XGP'N(R?3IE\1;!
M_$^`]Q&3Z=,OB+8/XGP'N(R?3IE\1;!_$^`]Q&3Z=,OB+8/XGP'N(R?3IE\1
M;!_$^`]Q&3Z=,OB+8/XGP'N(R?3IE\1;!_$^`]Q&3Z=,OB+8/XGP'N(R?3IE
M\1;!_$^`]Q&3Z=,OB+8/XGP'N(R?3IE\1;!_$^`]Q&3Z=,OB+8/XGP'N(R?3
MIE\1;!_$^`]Q&3Z=,OB+8/XGP'N(R?3IE\1;!_$^`]Q&3Z=,OB+8/XGP'N(R
M?3IE\1;!_$^`]Q&3Z=,OB+8/XGP'N(R?3IE\1;!_$^`]Q&3Z=,OB+8/XGP'N
M(R?3IE\1;!_$^`]Q&3Z=,OB+8/XGP'N(R?3IE\1;!_$^`]Q&3Z=,OB+8/XGP
M'N(R?3IE\1;!_$^`]Q&3Z=,OB+8/XGP'N(R?3IE\1;!_$^`]Q&3Z=,OB+8/X
MGP'N(R?3IE\1;!_$^`]Q&3Z=,OB+8/XGP'N(R?3IE\1;!_$^`]Q&3Z=,OB+8
M/XGP'N(R?3IE\1;!_$^`]Q&3Z=,OB+8/XGP'N(R?3IE\1;!_$^`]Q&3Z=,OB
M+8/XGP,6YL,)943FY/,F?FEN94FU[PX.=JS9`B:4(0#,$M<U2J6E$($@2RA"
MV8:(`-!#O?3T:W@0]5(J.1/U9Q97;*1/);H2/3A3\?-O21!>K3;HVP$RJ1.5
M>->YOVV9-S#&E!2]8H;P*"4R0XLTP00&`V(4C>[&I0V,65+6E_MN5ME1R]U@
M4[0P0GD?8$L02UC6H&]W9V:"0A-()O,AH%;B`)AK*W."?6@'"Z_53J-EBG51
M^[G^Z5%/VV=T,PQ.&RBR;`L^0-4MD,9DEB6JPHTM&MJI4EEYJ!>5+TSBPV$Z
MK@D(VK:U"I2I1;/.4)SMD=G')FFNO7U;LXKN`FW3#N.UT/5D3B/J=19-8*V*
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M(AB"'7^G`H:UKNX^T^R0A\D,FMR5$V<W*W6M$%.I^1M[/,_0)$C.N[7%FFFB
M9RL7H5*60(C"56P@2&%J0F:-]GH8PEJ7P5RB<2FG4=C4Q1EJ/$Q<W82%OJ^^
M+EL7CR\$MA:I4E,?WY6?ZC.3$B%HDL\M.-L,7#3F].R`FA]EL?UU`_NZ<'N<
M/,/A`FBZUGI0B>P2^H]<9D<A]S6U)HTR5E$ZCN!JDW;)1;B)D!)I,4\R5$%,
M-(Q-0AI]F?R:Z1:Q4S4+$]>LS/Q3?G]FOC79_$S]OVGZ8N!*S(INV.4]DJHA
MA=R7QNTUS>:/4K8A@<""RBQG&-#J3LT'1TEF;V'?\=8JL$[3$S<9.T?"&!#;
M%_+Z=_<V3_8B[`__UO>-77Y?03[FQC[$0X$RP&`P&!K_`,L?_%CDM_Z_W+_E
MU(\UU_77[2<I7-&_^76'_@K7_@2,DYRK-9`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&!^1""`(AC$$``!V(0A;T$(0AUTB$(6^C
M6@ZUKIWO>!J!(^=?'",<J:>X=+)H4LN*\(++Y_"@-)C4X1C39$52M*%K=GHI
MUT:E?I.)C>1-9!2<\L[ZA6@.,(-[,6I+4U?PN-;?51HV2RI`"9HG=!3[L:P6
M21%T#Q+WN*OI.T^ALJR-15N>)&I=M[5%]5,G2''#T+^4.^C?0*9DFS653)8;
M&DK'/U`IS&3Y6T2`%=S0N)-[>2F`K`BE<E4,I#7#7]409K9+:Z#2+C!_R>R]
MI_+A$156W,U-?3"81?CY;3W)(U,3HHSUH[+*RA<JG*))(VIC63:-.$FL)'$T
MT.`WKE#H08YN"!>J1(#=%)!'F)B3R_U.CGF>!L5(P$0=L-K<R)FNBZQ#)D62
M[)I;IS&F3Q--`PL)QRQ$-L!I48YB<B`%B$$H)!F^L,)$")-Y-.,!;1J$5$P^
MT??0L+NG)=+`LB`^G93V:$XYM5C9ZJD/OHOCF@""4:1V%(N$(.S%)0=#$7!,
M2F2SM6!(W<^P(R.LU\31-T:@Y%>*29;'9D4>8)PE"ZPS)PI;G]F6)1!`4T^[
MZ09!@>OM88'?L]$1,BK+!60NL&&2<A;(.E<$FK',99.HBP5;$U5NHF5>YJCZ
M^FT?5P23LC9`)`G7$IUY;$!I>1EHRMD.1`A';-+>R2#JYO422QI"MF%FJR;*
MC;7%ET;!8<G:8W$T+:WN#:<OKE*P+FA?`I([EN(C53JW*27':@HHTHXH90-Z
M(Q9%"564U5*SJ(^X/*:C52)?6*N3RZ:2U\8'%O;!LZ5T7263R%WD4J=@MY@@
M#5O"I>H-V(0QC$/>Q;%LXCI^I6Y78:]OJZND"ZW3B%-KK4<)C2579ZA*@&UI
M3[#4D-@#IJ<F;#1)BQ.0E(@$"V7K>@;WK!<ZIXB1(VU&D;FY(F0-Z!,0B0($
M1!25&B1I2@$)4B1*0`LA,F3$%A`66`(0``'6M:UK6!R<"I[!H6C+:<$+O:M,
M5/9CJUHMMS:YV#74/F;@W-XCS%(D"%;(V=R4I$6U)HS-E%B"#KBV+HZ=[W@6
M.SL[1'FAK8&!K;F-A8VY"SLC(SH4S8T,[0V)BD3:UM;:B*(1M[<WHR`$D$$@
M`444`(0AT'6M8&1P&`P&!%I+-X?#F27224R=C8&*`QQ;+YLZ.;DD2I(I%VYO
M7NJZ0/XS#=?5;2F;6I2>(\[02_9)S!:WO0!=`433_+VG+\E(HW49=H2UN+9U
M;P98HZ2MZ+U$,M,:D*+0-EIS.%QR$R5T7:5]<DAJ6+A"++&(6PZ#_$M3#!PR
MQ^9,SG+46[<9:UI^J2'@\N0/-@<@`2FV%K*6(\HDV/5]6->2:!IE:CH+-ZRN
M9;T`.]@V5UOYM##5]9E0%XSV>N[TY\RK8@];&.9"M@JVG()3L-$F;R4Z8`FR
M3V-+839,]>_;*BS31'-BI@%L)O4ZO0#6]BXT2VS>)7&JZITTV-<=+P6UY2PM
M:)H9!62TZG$>:$S>L<5Z-4V0J3&.<*0O9*IT-%]9%MX7`6M%AV=L)).@"YRM
M?;6UMC(V-S*RMR%H9VA"D:VEI:TB=`V-;8@3EI$#<W($A925$A1)2@%$DE`"
M666'00ZUK6M81SL"LKK_`":MO_ME/?\`I5UR]?UU^T[?F?IFJX_+R!_<R+_8
M:'$YR1E"9Y%,"&V+^7T[^YLG^Q%V!__7]XU=?E]!/N;&/L1#@3+`8#`8&O\`
MRQ_\6.2W_K_<O^74CS77]=?M)RE<T;_Y=8?^"M?^!(R3G*LUD#`8#`8#`8#`
M8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`QBEZ9D8UQ:MV;$IC8WB=G("E>E(&WM
M8-&B&Y+@FFA$D;PA)'O9QG5+UH`OX_PW@5NKONE$;=6[P.U(&I:+BDR6&U4[
M-DF:W=LL.4+>V=G98>X-2A:D?UH@MZ@0M)QF:+`G-$/80ECWHM2Y8[?APG:V
M6!`3,7A_I5G:'F;-+57D[4FGEO\`'5DI9FV%+Q1TIFLA^7-*(72@CZER5)E!
MA*=0`D\\HL9'"3VLM7E4\K;*EMU:WVRG[6O6*(^P1TVGTPHZ%^)'<+'+I3'I
M.PJ#E`]-O9FQ"[JRW'>PFE`)"(_17#7S2YS6&V#X_2*'<IB3P>W56TS&TV2/
MQRWD!:5"<0_GR6,,5@.M>-RA0>>3[)<SJ5@-D:%LC83-;"1)!FVT;*X*(I!7
M2*#FL#J;9A(W:2NDK0RD21'MC0054%E:&AT8"EXE&E:MP)1J#"0%[+3`$,02
MQ@B#C$;_`'J$66QFW1#8G,W^<N2RK9Q"*?%OTYK33NSF,D;D$=G5@39JL*>:
M8T2PI<^:TT-QJA>$9+02%+H)Y<-$Z50YW4V,U3H-D3I*QMD5<8X95"4$(#7+
MJY.#BG7:FSJ8;"C;$.E2!.FTD3A+D!326G$/>T(CAB.V1`R^/<04P1+7LEE=
MP3)G13H%@IW5^N2R$<NT[II".2MK4IE\5D<:D+E#FM=L)1;*J4'-AJ,`4YY)
MQ.NIA;3<FK*[(GK_`&@7$&;W_E$60PF0R@:?9KB[Q-M4G*T;"L]J,:<QO*4'
MB%L/4UL?\-#V+00ZT1U<2K]C[A9(N3<;Y6,RBVZSGT+DT!D\'B]4RF*P:L(.
M=7`&?4?9X?"FR"[3QZ.&J&CVZM$F.`4H4*U)F^C9X\E->IJG<-E9,!@,!@,!
M@,!@,!@,#`NLIC#"<6F?)&PLR@XKVY)#J[M[<<:3UQ%^V+*6*"1C*ZX-ZZVM
M;UTZWK_XP,PF4IUB<A6D/)5)%1)2E*J3&@/3J4YX`FDGD'%"$6<2<6+0@B#O
M81!WK>M]&!JE9/.?BK5<S>:TD5M-[Y:,=`C$_P!4U?'9E=5IL8W).2K;2'FN
M*?CLYFC0I<4:@HX@M2B*&80:`W6O9C"+9:EG[DMN](?)6^)TUQ7E-TG+&-.\
M*IVXVC5M650QJE2]R0%1UU=WI[?K/4/A`&_2I1]6P]P1E)%!.]*!G"$0`1$?
M,OU,H_REG]?P0B,6)67'"?*"MK+1$VPU?R)3HC#$NM%QZNI#)'&GFX`DJL>Q
M&.SK'583@%Z`!`5UO:!&&F`DXZ>\5/NE1WM;UM7R5('LM[?Y8YR!'34B4A(5
MMRY+&6Y3QL;:<$W0M*I;M:V@&-0-:2::2N.6$F;!@O&X26EN-M!\<V]X;:,J
M*!5>7)#4"B4K8E'4#<^2]4UA6`;%DQD>BAR"7+F\#@?H@]R4JCBM'F:"+6AB
MZ1,S.<KMPA@,!@,!@5E=?Y-6W_VRGO\`TJZY>OZZ_:=OS/TS5<?EY`_N9%_L
M-#B<Y(RA,\BF!#;%_+Z=_<V3_8B[`__0]XU=?E]!/N;&/L1#@3+`C<RE;/`X
MA*IS(1JRV"&1M\E;X8@0+'5<6SQUK5.[F-$UMY*A>Y*PHD8]ED$%C..'T``$
M0MZUL*E8>1$3D"6E%R9AE(&Z^Y'N-01X*]UW1B/.,IV37@W/!CRR2=S0+XR]
M0N(K0I%S<)<5M<7H@W10M[WHM9J]-YP4<2W$N8E,CV0IKH5V(RPMS;M0MH7<
M=DTH37@G*^N?XP!<TQ-7LD(MA>1&^S*V@T,P(<%(/^YER3J3C#PUN25W$_+8
M^RSV&S*GXRI0L;N_&+)Y/H#+DT8;#D[,C6'HTRTY$9H:DT(4Y/1TC&'6]98F
M(F)G*TJ9N(S6QP^Y2TSS!HV.W%0\A7R>!&*ED3"Z.,?>HTIV]Q@M*B>$WU8_
MHD#AHM.H'K03/9^S,U_$.]ZR9K,3&$MH,(8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8$>DTNBD*;0O,RD\>B3.-<@:P.TF>FUA;1N3JI+1-C<%<ZJ4B42YQ6&A*()
MT/VAQHM!!K8MZU@1X=KUT&>/-7!ES2HL:/0T%A/4)1&&KY,W0PY:)N32!0T(
MBE"P*):O`(E/K0=F*#`""4$>PBZ!2*I[Q;'>'UG.(I75S2AEM":-$20I?3&0
MPB41!N=5;LD,GUBPFURJ^F,,@K2%HV<I/5(>W[(4)QDI#M'@Z2TSH)19:EZM
MAI3582C11)L9C*KDS_/&=&P6Z].4<5.3@A/*86^3R>O&F/2`!+8J6+FU2>;[
M0:A,E/++"$PCX-_KBO;ZK6.NZIBKKK>E%W1UO#+Y^WF!,95`=L]5S-2*M5).
MT<B$4+ZR=V$SM*(`P]A(-'H99<'0MPVH#]W<'-KE=9/(8MYHFE^6;FAD*B25
MS9E#3V3U*HK9>E*K*/QYAE;;9K*)O<:S3'11S4$,^U0Q'D+PFE&I@CU,6IGK
M41\O0+[C:W9FK+W+YUO88**#`@/O$(-9AT8_A?S9?N)@2A`=.C/9@1:<3#A[
M+;P[)+`#KFB'6$#3\;*@!`8K6;DR2271.%3=/8\>!8EEV?9DC(FR21.$L1OS
MA.+"F,FG#\H1/[H<>06X.*H@G6PE@`$HLL`"VL1+7->H9A(;#102&HY_+F9L
MCDLG"6+LB>82>/,FU&V9AD,F*0@>GIF:-JS>RI5)YI"?VH_9A#UM])$B:FEK
M8FY&T,C:WL[2WDA3(&MJ1IV]N0IP=/4(1HDA9*9,2'I_@$`0AU_HP,A@,!@,
M!@0:Q[.K>GH@Z6#;,^AM901D[-IXF4^DS-$8PVB6J2D2$M:^/RQ`VISERT\L
M@@`C-#..,"6#0ABUK8S5)7G+.E;FBMDRZD7A_N-OK%FV[.0(+#90,N4G&M;P
MZ-S'7+[(VN/1"P'QV"RF$E%-;DH*)4&D!4F$:/*$,M3&;\5+<EU65+34TGXH
M6%1]=A9E:U-+;6L.G5,L7NQ:E(6A;"*\JB:VAV-*N3'''"/6NR0XC16@#3]<
M?0$5&KRZ7M^WY^\A.OW3R+_311\4T.;R+I:8.;I7?(F(L-;Z@$85P'4E-;*]
MEEM-<V[&F;6=5I8D-:`G+5`#MDD#`:7H4QMN^OFOEZ?W"N^62J:J'1#R;K=L
M@(Y?]:)H@#C0:JD*>&!?0K@1(<U4W<-(>YC8@]@,=?J</6'O:@*4`N@L-8P<
M6W:LY6RV9'/%1<L8[4$-&WH$Y$,<N.4=LQ40X$%B"O<-RASGT>5&@7F;T+1.
MTV@D]'1H0NG!AHF,ZKZ]9"P0-!"^0Q5?/["SC23F0$5'%).3/W@2)F)T\$LS
MXYB)B)1:U$L/"E3''AZ%O4$/>B0"V,-'U-@%W#JQ-$RN07LK-*<Q*E%M>E$1
M,[2W;7'GA:_<,2W4?)ZJ(P"?VX3/:;]GU^CK"W@_C^0B`7>Q1:<M,RY!>_<F
M?FPY+"Y;Z41&+^X+B-N<$Q3K]0M2TYOE/L7!2G4^P5B`6+LWL][ZI@MZ&&CA
MUA7-]162&.=D\D/5:.B;%24$8]'X9!?9N)IJ8:9U^NF%<H7#[(448#V&P^S,
M]KT[WTAU@PT05HI+E&CLA%*W;FQ(7B"$2<#NLJL-"4PW-B^/!6^W%$O>PAI-
MEJ5.8C_N-K0*.UZ_V]"T+^P8:/[:-(\H)?.GR15WS8DU1PYP^K/J>O&^AZ4F
M:./]D9V]"X>QDLN8UDA<OK9T3'KA=H,%[$2G91?04`&M##18EFUA;,S.8#81
MR5G5/@:VOL3PFBL"IN2DR9PV,`OKE:*Q(#+5#<HUH.PZ)1F$)^@7\0;WK6\)
M_'Z>ZPM=RK.-0UKY*3R/3=G<PK'NWD,#II;)I:AT%Y#MH<HR[U^OK]M3"$X)
MA>U0-:51TH"_Y^@P_P!H/XP,2IFZ&"KYM"'_`)>VU.9Q)5!AL9N9[KOCFU3"
MNBAID)($L>C44IQAK-Y**.3&G:$\LCD9L:D>MBV`)80%_A2E,W16S^ZNME<O
M;:Y$-2]GVWH(Q8-=\<X<VLCAM:E4Z?D2ZFJ<K=]5+M)B!I_9*E1Z3V9PA>R]
MH$`PC^/.?^[=^R-S9YF736TZK+D&GNMIBU7@B2]_Y+O%7065M3B&5R)XVT,+
M?Q\XY5U&ED>TF<RSM'+4IZ[M)IH?:^R"6`,F&NO:(^'<MP__`&VZ:I*I>,PK
M4BRZR;[INKZB;5DEGEJ6C<$<A-C0>&L+:O44\R6+)'*+U_'F)];S0LI;(TM(
M$:0!6BRBNCJZ4D]IF]'946024,\PHDHL:DW1ZD998`#4'!))3!./$'6MFFA3
MIRR]"%T[T``0_P!FM:U67UP&`P&`P&`P&`P&!65U_DU;?_;*>_\`2KKEZ_KK
M]IV_,_3-5Q^7D#^YD7^PT.)SDC*$SR*8$-L7\OIW]S9/]B+L#__1]XU=?E]!
M/N;&/L1#@3+`Q[LD4N#6Y($3DI9EBUO6)$CPB+2'+&I2I3F$D.20E>0J0FJ4
M)H]&EA.*,*$,.M#"(/3K8:N0'B?'Z^35L6SR0Y/NOKH?+QTVMS(D:XJJE$EJ
M"64Y(&QCCA:P_45C[NW35Q?5)12@\]1)U1R\TT>CU!!I;M7AG[>E."0E)"G%
M^2'(Z#3\36MP2E-)2UKXQ(HU+HLW56E'I%U!*&M'-5:E.\&!&M[:4G&;HTD!
MB<X6K/\`=UX=Q+F!P?G\%?Y,YP=#4J1TO-E51YK;%9JEQJ^!3,YNC8B%N@$H
MFER`O]F:,KH&6`&M!UB(N8@CMYN77!Q9X6-'[7]F0&&75+G2V^+<MV>X\9)]
M)4+9$8?7/)"P6YH;EU=7DXQT!0T"2Q1IMIXTXOVWN-'KE(4Y:=K=`$B=Y52U
M,^HPS=CU1D5--Y)9],SVE.1W&:[+<.<)6L:IRX/T[BB<36C3)G97QGNM(NL2
MF8ZP%%)M*PL38H8UY8#QG&,J;6A!+K._PW*UQ^C!<JA,A3O;JG9HC&UT>=(%
MN+5(MBMA*%28@A))ILO=*T7SW4D:#"/;$&,[VT)C3!B[20H!OJ83^(@IH"9I
MJ\L!C8Y_7!UE/\J=GN`6!-./,*?F"O(\N=V]6W0Q7`8D\UV.9MS(TD*$92P]
MW2N!PE&CCCAB+T`1<-%B'UGTSU"H31BFP5>&,J2G)G/KKVD]-F.W#0D:]#)"
MW4J/)XR6U](#4AC4:J&H_G"I"#^[PG^U>EQ&TFZ``6K*(XRRJS??(Q,='VN4
M/$/A@:].?3"R7E-)7&G9:[GS)NC0@&F-HVTE"K6!$6%>G+V$>BX)K[N)P3QX
M8C./\0,@B*($/;3/DAL)-5O<IVM&2JA08>J;D*UN.+1:">4X&JNQF[WL`ME;
MUT[(B:)R:M0BM91(>(\LC\AG<L8(G(:[+CU(RF353]=N"UN.ET\<HA/GR&J(
M.S;2%J52ME<W=84D5DCVDT9I04G']2,Q74B9\L1E7U,M;BJT8T4B>9"IIAR'
M%GML6-)KP9J#OB..*TLY<VTA.,I4A:^TKB%`=%;)ZXR]#+2/D3[C*8RU(_*F
M5@9$EZ.:%EJ]%*:D?HC(I$\.*(]Q2M:J)2B&M$JC#AM`F,.,)=D:$PDL&]F:
M!K6"DD3O'&58LLAN2.M$JG"FRB#[>0IUU?GK*K)4LYTA3'60E*-$?!RE#`F,
M7`$YA2Z&C+$=KI+#L6B)6DCE.KRF,]"Q5HM)DZ+3C&CDC7%E)4A;]HRG#2]C
M,)(&!V1;0'@/]JGV8#V(PCZ>KO6\#,^G5?>!(;Y89.XX$"KI;QWMV+>^]8%5
M3.XA];R1@U)(PVQIV9MO$0?7&-21"%>E2C($:TO;4H(,WK>P[V7U@[$`01;!
M(W#C=#DD/7RY;2$60V%,66NX`MD:F!L:2<6!)1K"X[!H>H<QI29-,7\QO4!1
M-B+9ZU5L@S118M@%T!CU3S0Q#S9D:30YH>914<8:Y=,XTPU6O>7L#4^-CN[,
MQ$<2((R=J:/;FE8SM%M[.)<N"<,DL90#%*<)H8PA?%7-NJAU8.,,H=4-G&IS
M'0:Z#5M#%M2-)R,I:-VM5@GTCBTG;=E!,]AV!I0O+KVK^0:8!>AF@*'Q>6.+
M;;:=IH.EHX^,AJM!2SC*79$[,$]-^J='(WV:H8Y"-.T':`O(]$C3$#<UAA(!
M#U[/>PAV,&1*JF1*7^MW!2WT0TQAO8%HK8BJ.H3WMZE$M4M!9#?[BSI3+&5'
M#XLSO(S5!I:V/.ZUQ*"47HY%T&",&"-./%QMD4,LB'R:P9&(R;S]1*8Y+(=$
MZK@$PJ^(A>6%U:JQASO'X$$"M@1$LIJ4]P=BG%Z6IW%4$:O72G[./XG1W'*E
M%%CHK7-@3=N9((B?!TPP+GHJ+!CZETV\':.KTIS!7RI[VNW_``=36L;J`G^Y
M"IT3K1>$OX<=MXP<<&B/BB:&AJA!&A2-9+Q,1]>11<V;E3@Z'/:R1;2+FM25
MMY.=U`U/:.CVNCA;%H6MX6Y6%Z=5]X$AOEAD[CA#TZK[P)#?+#)W'`>G5?>!
M(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;
MY89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX$+3CX]*Y@97B45,J9^2A5NAT&
M3[A!TP*;4!R=.N<3(R7L3T!"B/6%`-.V1HLL9H-"WK8@ZV*:\1'D;QML:>-L
M$K6C;4G05;V-B<Y\W\3;%C=2QQ43LSM1[G:-@P6&PQQ2(^IKVHFE6Y"UL8=:
M#L6^C"T6"GY)GS=\BU-\.N,X(@V*$I3?;-T6V6P)7T@U(0>I4L=:5Q2]@OQX
M4R@T1'4<G1F$(90A:Z0;"+8P^92>X^,]@V#*&XZMKJCM"P,A@+1N3-#>.E.S
M*>.$DVN<3%#X1.+4;9K%T#9MM.2DDM_NN:,LX@PT:DT)P221%:/M*^#M$6/%
M*TBUIIIM8'IHW[3E/FYU(*R=)TZF(F]"HDMFH:)4U1%IJ['`0B&$A0VZ:TQB
MH\2=(3[3HT+K)94$XO\`'*LHFE@T#HZK(W$TCB>\ELJ&$1\:8UZ4K=.2E[6F
M*D*A2XO:A?K1PUB@9JD9@="V/>PZZ!<K$].J^\"0WRPR=QPAZ=5]X$AOEAD[
MC@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@
M/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/3
MJOO`D-\L,G<<!Z=5]X$AOEAD[C@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/3JO
MO`D-\L,G<<!Z=5]X$AOEAD[C@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/3JOO`
MD-\L,G<<!Z=5]X$AOEAD[C@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/3JOO`D-
M\L,G<<!Z=5]X$AOEAD[C@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/3JOO`D-\L
M,G<<!Z=5]X$AOEAD[C@5M<L`@B:H+54)X5$DZA/6TY.(/)C;,4<2<5&'0PHT
MHTM&$99I8PZV$6MZWK>NG67K^NOVG;*?I9%<?EY`_N9%_L-#B<Y(RA,\BF!#
M;%_+Z=_<V3_8B[`__]+WC5U^7T$^YL8^Q$.!,L!@,!@:_P#+'_Q8Y+?^O]R_
MY=2/-=?UU^TG*4Z=X)#;/JM17EAQEFF<'F<,)CTIBTA0DN3*^LKDUE)UK>X(
ME`1%G$G%B_U"`+6A!WH6M;UF<Y5HA!)W,N"<RC-"WU)GF9\79F\H8IQKY*2M
M<<Y/5</3D<%)'>.G(N1*Q",...,$!'#)FL'H+R'1;6Z&:=-)U#E&L\8S7Y6_
M$AKI*Q&J2TK:]JP6KQJ7@Z7\<W*0[L&FW8+@S.2=`=!D,[`^2FF%+5(U)#CV
M>,.:!D4Z+.).;AB."<34N\W]2\I':.VV;4UTT5:%6EO\T/C%46RVH=6A2EDI
MG!Z5M\-TLFT(3*E]52Z0(BBA'M<M;6=,0M-[*D7N&O9'G"L,);<80P&`P&`P
M,>XM+4[HW%N=FUO=&]X;SFEW0.*-,M1NC4I*4$*&UQ2J2S2%S>>0K-`,DT(B
MQ`-'K>MZ%OI")KJLK%SD5>R]RKF!N$MJ1,^HJIE"Z(1]7(JR1RAG3QV3)*]>
MSV\QRA::11](4A7EMIJ8"M&4`DW0RPZ#H*)N[B^WS"C.2U;T@YH:/L#D:AD2
MUVLMI*D`E+9/Y"V(V@RPNS,4CCSA]?)$R(LT&TRM,68I+",X)H1&@,+>,6T"
M_:7_`&EG[]MU-;R&;W)&;U0V"B:V^-%IX&\Q<R)(#S%!DX;!E.4TDC2O:9>8
MA:1FDZ2%CT8@Z=F;",0=R(I>W;U\.X")5]`8#&8Y"H)"(A"H;#P:+B42B4:9
M8Y&8L7K2H.BXXPLZ)&U,@-!7'ZZ$Q16N@X?]8NFLI?@,!@,!@,!@,!@,!@="
M?'3_`/Z,.!'(ZVXU4#3&^0U;.LI"XA;9-:$+KU#%-+4*!0N3M0Q0FUYU)E#H
M\F$:3HR4K8H$:H,#H74!UAAEM3TF':Q<G(=YJR2M\.C'&_D;>L@<V-.^)QU'
M$H>"))0*E[DW$MSO8MG3VMH`UNP#FT1IR4;D)20F-*.$7U32^M4B-R>OW*U\
MA<"<Z4@%0PV5R!L-63QEY"RY_5*ZZ5GIFXU`UI&ZFT,K89VX)5!JHM;[&1-Z
M0.R2]IU)X3!"+&'R_8:VY`3"HSXA8W(8$*LQQ?!K5ME\9JUC<'TVQS2@.P19
MB8;V.Y(HBCCT6A%J'4WK*]C'[1,%(((<&&CD5_QKBL,B$^A<EG-QW:V6@SF,
M$Y'>EG2&P0NK,J:W-G<6QM93C&^)Q!"\-[P>!:4R-S:6JZ0>T"+V174%I-5/
M':@:)2:0TI2-2U&F[/M*,NMJ[B4*$>0(83#`JS8ZTMQRP1YP-&&"-$,1AG\X
MM[%_'!<S\KCPA@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M"LKK_)JV_P#ME/?^E77+U_77[3M^9^F:KC\O(']S(O\`8:'$YR1E"9Y%,"&V
M+^7T[^YLG^Q%V!__T_>-77Y?03[FQC[$0X$RP&`P&!K_`,L?_%CDM_Z_W+_E
MU(\UU_77[2<I7-&_^76'_@K7_@2,DYRK&SN"0VSX;)J\L.,LTS@\S9ET>E,6
MD*$ER97UE<B1)UK>X(E`1%G$G%B_U"`+6A!WH6M;U!U[02=S+@G,HS0M]29Y
MF?%V9O*&*<:^2DK7'.3U7#TY'!21WCIR+D2L0C#CCC!`1PR9K!Z"\AT6UNAF
MG32=0Y1K/&,W9KE9:C2;B*R>IYER4[:%I4%.WJ3()%8R2"/J9YK2W?8[(3N)
M%A5+.44E@ACLYM18D^WQH2M$@+_NQ=N%HDL&BWK#\6SRE?*&F[T&UZ&LLB@D
MR)M5-G(RM$PK>8FHPQO`<]DVE6,-0'VW`$34X:,`!U2-#\QZ2`TI6KD'3LH(
MIMYA#`8#`8#`8#`8#`8#`8#`8#`8%.-/(:B)!:)])Q^X*XD-NI&=P?W&N&"7
MLCW,&AF:U*=$M<'QC:EBM<QIRU:H!8=K`$[-'UM`T+8!]4M35_"H8?<G*2QI
MZSI6OBB*HZ@(>#=26=WU:T4;[!=F)*8H3;,@-15,7:18E;F<$LTD<B?V`PE-
MT[,2[,%HK0J(^7WDG%-PL*QU<VL[DAR+DT33/Y+S$Z5BDX2TS5T?3)%!:M$V
M/6Z<:(385E)0JB@[/)DK^Z(%18=%F)=E[,",7ADTKX@?L;\+N$E[1GD13;I=
MBF?1-NDK6UDS2<L#W'Q)I4PKXXY[5-R"$LJDTT+>XF;*V%0#0#.C>]"UKHW*
M6>TS%2[CLK)@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@5E=?Y-6W_VRGO_`$JZY>OZZ_:=OS/TS5<?EY`_N9%_L-#B<Y(RA,\B
MF!#;%_+Z=_<V3_8B[`__U/>-77Y?03[FQC[$0X$RP&!2D]O.,P&S:KJ56T/[
MO,+<&]&QI*U!9B"`M<9.:"Y.ZB.?'EG^LP1I,]DK5R9!I6M(;@&G^QWU2P&E
MI4DDYDLD+;G]9-::MN'+&F:PFOVIIDKWQ\;!2R33QN>GEG0-4C-OC<%CZDAD
M9PJCTTC=F-;U5Z$HHDU2L()$*6)ROWL7%;DJ+81`WOC[<>]@%U=B!O=<R/>P
MBV`0P;$'^S?1O>O]&\UU_77[9G*5T1O_`)=8?^"M?^!(R3G*LUD$3G<$AMGP
MV35Y8<99IG!YFS+H]*8M(4)+DROK*Y$B3K6]P1*`B+.).+%_J$`6M"#O0M:W
MH.O:"3N9<$YE&:%OJ3/,SXNS-Y0Q3C7R4E:XYR>JX>G(X*2.\=.1<B5B$8<<
M<8(".&3-8/07D.BVMT,TZ:3J'*-9XQF[-<K)@:N73Q-@UORQ%:+3,+2I6[6E
MC1QIIN2EIJJBTG^H&YP7.S?'Y5&71/(*OLV.HW)S4&E()0P/*8@2@W9`2A&"
M%LL36'P_EIV[;-%%0DPRC+%Y#0,B.$)K'L:ICXNX68R/Z(HI.<_&43O3`NE;
M&Z:+$J/!%U;@ZD&CV2F:#PZ#O!$7\K[A$SC]B1"-3N*'N"F-RUF0/[&>ZL3]
M%W,UM<DX%*03A')2V,TD8EOLAZ]HD7)$RL@?2`TL`];#HB4X#`8#`8#`8#`8
M#`XZM6E0)5*Y<I3HD2).<K6+%9Q:9*D2IBQ'*%*E0<(!)"<@D&Q#&+>@A#K>
M][UK6!1,LY(5\SUFCM2!)93R&CKK(S8DQD<;&3UH6/$@2KG1J<49:R)*U$<9
MT3*[,RE(XN#HO0-C:K*]@J4$F["#9:8:,R[D3;E6S-836H.)U@K',#=77J\;
M$+L<4;$+ZJ-42R6PNI;%11M*["3G+"4K63+502E!11R@T9?73"&$?-OQ5G'R
M2QEOG0+JOJR^2SC9;&&.RINL%N@D<K5`RC(<4:QFA58P**QYF8&QT0.0R%@U
MI[LXK`!#H]89T:Z!>D+:K:IJMIJ-IH=4=<06KXFD"$*:-U]$V*'L974ZW0/3
M9'T+>CV;O8Q;V/8-B%L6][WO>][PEWFL#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`K*Z_R:MO\`[93W_I5UR]?UU^T[
M?F?IFJX_+R!_<R+_`&&AQ.<D90F>13`AMB_E]._N;)_L1=@?_]7WC5U^7T$^
MYL8^Q$.!,L!@49<E#1Z[CX)[U/TA2-<"GL-LAN9FLJ.;(-E4"=AOD:=TSBZ1
M]R?8^Z)%N]E"5MBI(>)(886$03-E'DEB:<J24BRRJ-S6*.DDD@&6S'N4N%EI
M$A,5,!/&.4QT4,40Q\V\1EX&CCR.&D(FXHQL$WN.RF\D0E6Q"/V:+1CF`TM;
MKQ8Y&_6;:WN/8:(N%:B[>C3K.QK"JZDGLE:7M!9G9U)73_*8#H&'_P"-YKK^
MNOVS.4K&CM>0`<?8AC@T/$,3.V"$(4991"$(2(C8A"%M%O>][WO^.\DYRK,>
MG5?>!(;Y89.XY`].J^\"0WRPR=QP(]+:.IJ>1>00N8U77\BBLJ9W!@D+$YQ)
MD/0.S.Z)C$:]"J+[$'>RE"<T0>D.]"#O?2'>MZUO0=:4:6(/V^IE$:0Y",3-
M,^(DS>4T2X_\J)2UM3D]4^].1Q"6*4#R8>5;>(PYL.,%M%%9ZJ.T%8'1#>\;
MTLUI>JC6>,9NT[TZK[P)#?+#)W'*R>G5?>!(;Y89.XX#TZK[P)#?+#)W'`HF
M\N%_'CD`A8`S*#A89+#%#BO@%B5LY+JXL6`NCJ2F(7N$7E<3-;5985I:(D*I
M&K"K;%Y1>BE:8\G8BQ%B9A$'^$3B@:EAY,<J,KF>]1IT<4TZ7N)=.5W=#Y"A
MJ'E<UNL<:RXG"JGFLW8D8D3>:C/5Q4IS+*&JT?I2+LYHP6?3[W35T0Q',V*J
ME<1T>XK6-PB=J4TMK*=,$A;"]&N3([Q:7L#8OVH2E[ZX%*7M3>L)_ODJ@\C8
M3=D6MZ=5]X$AOEAD[C@/3JOO`D-\L,G<<!Z=5]X$AOEAD[C@/3JOO`D-\L,G
M<<!Z=5]X$AOEAD[C@<=3!:S1@+&KAL%2@-4)TA0U,>8"`&JE9P$Z1,6(U&'0
MU"I08$LL&ND0QBT'6M[WK6!J?9]]4Q!9R\U3".,MJ7[:<>$TEOD2IZ@2#6)A
M.?VE&]LA4AN.Q"Z]H=C-7M;@4?[$^4!5%E;V(1.NCHV6(2"YZ3O"7R="S4J]
M<;:9K@<>($_3%^HL=KVZ;)AN#D%2CB3*LD4/KB.-:9K`C&6O<BI`,X\T\`D!
M82RS#!%?,,K+>$/&VU6:JD-\UA#KV=ZI;B"T+U8$5C92"42(:!E2/,QF%>Q1
MJCE5O3V]JF,"K90V/2!`8<<!"G2DFF%"%S%TOA!557M2)(VM=;P)M;D"<I(A
M;T$/CR-$B2D`T60F2)4[<60G3DEAT$``!T$(==&M=&$<OTZK[P)#?+#)W'`>
MG5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5
M?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>
M!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(
M;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y
M89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89
M.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.X
MX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#
MTZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZ
MK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[
MP)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)
M#?+#)W'`>G5?>!(;Y89.XX%;7+`((FJ"U5">%1).H3UM.3B#R8VS%'$G%1AT
M,*-*-+1A&6:6,.MA%K>MZWKIUEZ_KK]IVRGZ617'Y>0/[F1?[#0XG.2,H3/(
MI@0VQ?R^G?W-D_V(NP/_UO>-77Y?03[FQC[$0X$RP&`P&!K_`,L?_%CDM_Z_
MW+_EU(\UU_77[2<I7-&_^76'_@K7_@2,DYRK-9`P&!$YW!(;9\-DU>6'&6:9
MP>9LRZ/2F+2%"2Y,KZRN1(DZUO<$2@(BSB3BQ?ZA`%K0@[T+6MZ#K$@D[F7[
M<,RC-"WU)GF9\*YF\H8IQKY*2M<<Y/5#/3D<%)'>.G(N1*Q",.B9Q@@(X9,U
M@]!ZNBVMT,T9I.H%&L\8S=L^5DP&`P*ON"EZRON%J*^MF*IY;%3W%L>BD@G!
MW97%K?614%:RR"/2*.N#1)(S(6A6'VB5>W*TJQ.+IV68'IWTEB:R5.Q0"X^/
M533A%7DLF_+"0H7A`[5I#K\L1BCLA01K9C&D>H+NYT4"<G:1J$3>4X+6E=)D
MZ]>K6C)1N#H62(2\D7$OQ"N7$&<X38\QMZ(V/Q?W3:1M76JAY"1H,.9HPWNI
MC@G1OC19;>M?*FL",*%;2I+TX1]]<BR-@!I4%,,XH`Q3EUYS8XAVS%[(F]:\
ME*7FL-IYI1/UJRI@L&.+8_7C*Y$/2I`ZS!W`NTA8&]6GCJ\99JD98!!2&[UO
M^3>"IT?2H^6-97\]/[73+98\R9V2/*'M-9:RK[`AU-R584H2)B&"'V?,(VRQ
MV9N*C:T!OM683BC"0$P6SNL`0,$Q6;!U>#F]*)LPRNY#^.U15JE"ZGN=,5XG
MG%PSYYVL:ER1E(=[R?SZOC3$)H<5!"Q20WPU;H\9&TX%OLA;-V)KX?9NX1\<
MR[.W<TJB#O;%F))HJGD7D]US>:W`&N'\;H:ZM)E41^P7Y_BM6E18T82VO;`@
M;SD990-Z,V9K9FQ<Y-LL(8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8'6U;G[M'
M!JB^6#'PZM"WF^)V8Y,PG)]DSJ)M0577;F>D3.;%$[(GB]T2(HG)I,TJ>UI`
M&E"2%$]3M:A*-2D`HEM>9F+6T+]QG]O<`1"WSLX;[T$.Q;T'DY2@Q;UK73OJ
M@!-A#&+^'\-:UO>__C*E3HA__P!J7[;O_P#N_P`:/BS$_P#^X8*G27Y#^Z5^
MW^8$)A/)R"J21AT,I0D12M6E4%BUUBSDRM-'34RE.:'>A`,+$(`P[UL.]ZWK
M>"IT`_N@\(C===+;4A<4^Q"T4N:*/O\`>&Q4$(M@V:B=&NK5C<O3[$'?5,)-
M,+%_\"W@J37[F_$4W8MH7B_'E.$75TX1WA9S4DC0<+JA$(*9Y8./CDU*Q%;%
MU3-%'#]F9H0!=`PB#H5)K]R&BUVQ&1FL.:\T;RQ>R,=HM^W_`,TE;<4KT$)A
MB$PQ=1C<>%6248`8@^SZ.J8'>M[Z?X"IV/\`["X6I%O3/QBY^O`"PAV>;^B.
M_8T$D8]BZA>BYU$HFH5BWH&][$G`<`'\-"$'>]:V*W@_7R!0+0&?A?S]>1Z"
M(1X?TWG1L*<&MAT#>SIU+8HG4B,V+?0%.,X8>KO8M!UT;V*W@WSGEY^PEM/[
M?O/UX4[%TB3:KJCH[HLG01;$>)?-N0T6:!!"/00^S`H$>+8];"7L.AB"*W@W
MS.NM=L*1@_;2YPJ70X7^[E2%TX811IV$L(C3MJ7U9R\5ID8@D@%[/0P?WIG5
M!K>A"U@J-07*CEL;KV:3]L3D,4H,$$!1KO??"-&V%"$+6MF+E+5R1?G$E.`.
M][%LE&I,_A_`&\%1J"Y(\VA!$$G]N"5:.V'>BMJ^4O'<E+HS>N@O:DY,]KE)
M*?K='7$60<,(>G80#WT!V*C5U=_N7\X?WCJ=1\?S:$X;M=>)I3:S6Q/[C&Y0
MP\HEDT=U!Z0N-5:\MC=#X\.!1N:#-/+/<B@`6G&%@+3.#<8'_>9-M=8ZS=R[
M,&CF)R=86MK'</[:?)UH<S&]")W5TY/N+=T1U,Z"3I1N@41:>^8I-SVQ&H/$
M``Q,H5!W4%U"AZUUMUFH^)<K_P"Q^JF?>O4>B><-4%=77M5TLX4\B)&T$&["
MIWV<;[4T&LIC,4==(,.@EJ3.MKH,UTDBT9M96\,@D_=$_;^-6$M[ORGK*"+C
MS=$EI;85.].'^T%[+>M&%VLTPT1.O9G@,ZP^J'1(PF=/LQ:%M9YG1L3#.3/&
M^QPDCKSD#2,\`I``U..&6M`Y0$\LPDI0682)C?EVC0&)S@##L/3K8!A%K^&]
M;P5.B[L(8#`8#`8#`8%977^35M_]LI[_`-*NN7K^NOVG;\S],U7'Y>0/[F1?
M[#0XG.2,H3/(I@0VQ?R^G?W-D_V(NP/_U_>-77Y?03[FQC[$0X$RP&`P&!K_
M`,L?_%CDM_Z_W+_EU(\UU_77[2<I7-&_^76'_@K7_@2,DYRK-9`P&`P(G.X)
M#;/ALFKRPXRS3.#S-F71Z4Q:0H27)E?65R)$G6M[@B4!$6<2<6+_`%"`+6A!
MWH6M;T'6)!)W,OVX9E&:%OJ3/,SX5S-Y0Q3C7R4E:XYR>J&>G(X*2.\=.1<B
M5B$8=$SC!`1PR9K!Z#U=%M;H9HS2=0*-9XQF[9\K)@,!@,#57G!Q[>>5O$R]
MN.L?D+9$WJVX,KB;=(WE*J6M;0H4+42H*M:E1;TK/)"%+O6PE[ZW3O"Q-3$N
MM_\`9K_:9GG[9)7),BQ+3A%L$WH&GPMQ,887EL*9PUKZH[7!<RWP1@%87/<_
M)]EH&OY.SCZW]H<D12]NUT[RLK)@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@?@
MPPLDLPXXP!110!&&FF""`LLL`=B&88,6]!```=;WO>]ZUK6L#067?N*TN;(W
M2N^.+#.N9]KM2CZO<HAQG:V^712+N0@AZI%BW@[.;'1M>A3&F!"J(7R#3F3K
M>]!1F#Z"]RVO,_."-^DW/?D9_?7?=D?X=ULM_F-J#B:I!,;F<&X_^^"W3#E#
M/8XG21I:2(`"SPPV+(%.M;,T0\=&PCT+B,HMAV']GK@!'KIK:_R*7->K.K0I
MT4)7V:S*76$;-)2XJB%J6P;--G;Q(UT^GK`K"<8WN*\\P:<:CK=46TJ#:11Z
MFJ=@_IU7W@2&^6&3N.5E,L!@,!@,!@,!@,!@,!@,!@<98B1N*4Y"X)$R]$I!
MLM0C6$%*DJ@O>];V6<G/`,HT&]Z_L%K>L#72:<,^(%C[-%8'%;CE-S3^MLP^
M5TE6K^IV,0U)GM0JG2-*E!9P35AHPC"+0PC,$+6]"%O>%N=5)_\`U;<$$O1[
ML4056O4$(17HS9%O4AV<0C0G[$E]()_">RBT?H0];+ZO5&:;O71LXWKJ/4ZO
MCK]O&-M`0%P+ECSZKQ.2$!:1&W\M;`L)`A(+3F)B4J-#>FK92$I""ME^S*ZF
MP`V2'HUKK&^T%[0^WZ5^6\?Z"X-^Y1=*Q$4(6TR*YJ)XN63U="-"=L*ESA=6
M4V_K=#$8=K?76=(0[*"7LL)6]&"XT?GW+_<_BX?9-7(#A9;:</\`,$4WXU7!
M5#T9OV/5T2:[PSD9/68(.N0'K#"SZV(:@P>M!`6`@;$_YTE^O4?]S&+].G[B
MOQ-M%/L0=!65ERUL*%N@0:-$`0QQRQ^,@VT1I@3BQ:+T^=4`"3!>T&,996##
M5\-\O>3<;",VPOVT>3):,`1[$X5'9W%.VBOY$Y9XMA:S[S@LJ,T#83M;T%N$
M(?5+T6$PPWV87\*C_P!/O_\`8E7C1TBL3COSGJ],6((5+C(.&EYS)H1[$:(C
M7:GJEXO:;26$1VR@`WH[>C1'@T#K;T9[,5O#Z)OW2.`(CR4SWR:@U?J%`P%E
MDV\AEE+&^T,]CU"S`6W'86(D8@G=;H'U=]0!@O\`9*,V!9YG1\N0?/+A>T\9
MKML`OE+0LBB[96,L`-9"K5A,W4K5;RR+VID;6ENB;T[KW9T>G126G2D)RS##
MC1ZT'7]N]6)B)B4GK,Q,5BV(XOVW7-Y\?:BM&IY8U36"RB"Q\YH?V<[9B<PU
M"WDMKHWJB3`EJ6YW9G5&<D6I#P%J4BHDPDT`#`"#J9E3&$YKYP&!#;%_+Z=_
M<V3_`&(NP/_0]XU=?E]!/N;&/L1#@3+`8%`V=?+?6MGTU5RE@.5N5RNSDV,K
MTX.9$?8`',VV\US:&]T6)3T3S-0M"PYR3,GM$RM>W-ZTU-LW:8P&BQ%VI8_G
M!'4P96%1"7%.YL4GLEG;HFX.2R.SQ0Q53!)%8LGD\GA4NC<<?H<G=(VQIQL9
M9A:HIU^MT)NCRDAIBDH4L;E1+(RKX@WP^E/S6%HE''>TU4=7*%A*,EY*=ZP?
MUC9V#M8B!J#5J4T(RR]:]H+6_P"S-=?UU^V9RE:\=L.``C[$`<YAX1A9VP(@
MBDS*$01!1$:$$0=K=;UO6]?QUDG.59CU%K[QW#?,[)W[('J+7WCN&^9V3OV`
M]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^\=PWS.R=^P(G.U5%V?#9-7EANM:
M3.#S-F71Z4Q:0O,><F5]97(D2=:WN")0L$6<2<6+_4(`M:$'>A:UO0=:-:W?
MO]O:=Q?CS<UI([$X;S5V2QGC3R*?)8A?I%1#LL'[%CX\<B7L:P]2?$/]E+#I
MJK%U`EA`V.A@1A3J-S)JO6,9NUKU%K[QW#?,[)W[*R>HM?>.X;YG9._8#U%K
M[QW#?,[)W[`>HM?>.X;YG9._8#U%K[QW#?,[)W[`>HM?>.X;YG9._8#U%K[Q
MW#?,[)W[`>HM?>.X;YG9._8#U%K[QW#?,[)W[`>HM?>.X;YG9._8#U%K[QW#
M?,[)W[`>HM?>.X;YG9._8#U%K[QW#?,[)W[`>HM?>.X;YG9._8#U%K[QW#?,
M[)W[`>HM?>.X;YG9._8#U%K[QW#?,[)W[`>HM?>.X;YG9._8#U%K[QW#?,[)
MW[`>HM?>.X;YG9._8#U%K[QW#?,[)W[`>HM?>.X;YG9._8#U%K[QW#?,[)W[
M`>HM?>.X;YG9._8#U%K[QW#?,[)W[`>HM?>.X;YG9._8%?65R<XZ4Y&%LRM*
M\JI@D90%#,.=9).XVWEG"!L`0I&\@UQ[6ZN)YIH"R4J4LY2>:8`LL`AB"'98
MB9R:0"_<"L:^1"0\+:9:U,:4"V$GD;RWD1]"4Z),/?\`<.\,K0\A1R#M!.<6
M`8R="9(TVJ-=3>G,`1Z'D6HC.7Z+XB0FX#"W;G1RW6\K#!C"?NG4$C9J5XIM
M@RQ:-3DAI"#R(Q=8'8S##0Z-FS]*-&!%K>BBNJ$.A=90W[B3K2$!CK5$(*Y5
M5"HFQ)0(F2+Q)9$8Y'6=&7T]1(U,C.8C;6]*#I_@624`&O\`1E92/U%K[QW#
M?,[)W[`>HM?>.X;YG9._8#U%K[QW#?,[)W[`>HM?>.X;YG9._8#U%K[QW#?,
M[)W[`>HM?>.X;YG9._8#U%K[QW#?,[)W[`>HM?>.X;YG9._8#U%K[QW#?,[)
MW[`>HM?>.X;YG9._8#U%K[QW#?,[)W[`>HM?>.X;YG9._8#U%K[QW#?,[)W[
M`>HM?>.X;YG9._8#U%K[QW#?,[)W[`>HM?>.X;YG9._8#U%K[QW#?,[)W[`>
MHM?>.X;YG9._8#U%K[QW#?,[)W[`>HM?>.X;YG9._8#U%K[QW#?,[)W[`>HM
M?>.X;YG9._8#U%K[QW#?,[)W[`>HM?>.X;YG9._8#U%K[QW#?,[)W[`>HM?>
M.X;YG9._8'Q4SVMEB<](KF<'5)%1)J94E4R)A/3J4YX!%'$'DFK!%G$G%BV$
M01:V$0=[UO71@==O.SAUP/Y0<>+9C$VAM,)I#N)R&1QJ=PDB!1^RX_+F5K7N
MC.Z,4F;DNW,P\;@#J'I3O;I5Q1@RCBC`CWK$1$S$+ZGK<PV@X2<<JSXH\6Z<
MI&I$#@BA\9B2)Q":[N!CH\.[]*-;DLG?W9:8$LL;@^/[JH4F`)+)3$^TT604
M42`!855@EWBVJP&!#;%_+Z=_<V3_`&(NP/_1]XU=?E]!/N;&/L1#@3+`8%/V
MG2L6M\Z*AEZ]^,9XM*HK,P1M(K1@971_A#V7)(HO6`4MZI>A5LSV2`\)S>>B
M.-T'031CT`KV98FD:DG&BOIHD,#,5TJDCX>G<6U1,5CJC0RM1'G2'R^!*8P:
MX,;6TI?J346G;J2`(2`J`*56UNC>WA"IT+?CE.D3(.)W(U"B(*2HT?'>WDB1
M,2#19*=,GK60DD$%%AZ`@***!H(=:_AK6LUU_77[9G*5W1O_`)=8?^"M?^!(
MR3G*LUD#`8#`8#`B<[@D-L^&R:O+#C+-,X/,V9='I3%I"A)<F5]97(D2=:WN
M")0$19Q)Q8O]0@"UH0=Z%K6]!UB02=S+]N&91FA;ZDSS,^%<S>4,4XU\E)6N
M.<GJAGIR."DCO'3D7(E8A&'1,XP0$<,F:P>@]71;6Z&:,TG4"C6>,9NV?*R8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`TSN+GMQQJ"6GU<3(WRXKS+)4FD<?
MN/L:<KCN,9B474,*>(Q$@JD<$)]I_#:R2K&5O!T;V-0`.M[T6(F?I5>A?N,<
MC1Z$#W%_;]JY2:4,(C`QOD-RO=F_9/2:`9(M*>/-2*%`5&M:WO<[/*,*_B$K
M?\!#"-Y6I3O`KCI4,K36>I8'^YKR)))*,Y`\A9,XW)<?20<,\O;+)I9M0A@:
M8)H][TCC2)E0`_AU2`]&"9F?IN9A#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`K*Z_R:MO_ME/?^E77+U_77[3M^9^F:KC\O(']S(O]AH<3G)&
M4)GD4P(;8OY?3O[FR?[$78'_TO>-77Y?03[FQC[$0X$RP&`P&!K_`,L?_%CD
MM_Z_W+_EU(\UU_77[2<I7-&_^76'_@K7_@2,DYRK-9`P&`P&`P&!$YW!(;9\
M-DU>6'&6:9P>9LRZ/2F+2%"2Y,KZRN1(DZUO<$2@(BSB3BQ?ZA`%K0@[T+6M
MZ#K$@D[F7[<,RC-"WU)GF9\*YF\H8IQKY*2M<<Y/5#/3D<%)'>.G(N1*Q",.
MB9Q@@(X9,U@]!ZNBVMT,T9I.H%&L\8S=L^5DP&`P&`P&`P&`P&`P&`P&`P&`
MP&!');,(E`8ZZR^=2F.0J)L24:U[E$M>VR.1UG1E]'75NKV\*D;:WI0=/\3#
MC0`U_IP-!3/W`3[?,VT\&J&L#E88<:>F#<"OVU,<56LTD`M&J#KPG#4)3/"D
MYPR^D$)8Y1UP[WK9A>]=.RU6<OGKB'R+OOJK.:/*%\,C*KLAJGCAQ&,?Z*J'
MJ!Z>W,TQM0M>;R$M%O6`T$LW07B,-YX.OUFT.A]4,6XC*&Y=/4537'R(IX'2
M%80BJXBG%HSZCA$=;6!*K4_S;&X.@T)!:EX=3Q&"$:K5C.4G#$(0QB%O>]UF
M[S6M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"LKK_`":M
MO_ME/?\`I5UR]?UU^T[?F?IFJX_+R!_<R+_8:'$YR1E"9Y%,"&V+^7T[^YLG
M^Q%V!__3]XU=?E]!/N;&/L1#@3+`8#`8&O\`RQ_\6.2W_K_<O^74CS77]=?M
M)RE<T;_Y=8?^"M?^!(R3G*LUD#`8#`8#`8#`B<[@D-L^&R:O+#C+-,X/,V9=
M'I3%I"A)<F5]97(D2=:WN")0$19Q)Q8O]0@"UH0=Z%K6]!UB02=S+]N&91FA
M;ZDSS,^%<S>4,4XU\E)6N.<GJAGIR."DCO'3D7(E8A&'1,XP0$<,F:P>@]71
M;6Z&:,TG4"C6>,9NV?*R8#`8#`8#`8#`8#`8#`8#`8&M=[<ON.7&T]I:K;L]
MF9IC(^@,1K)C3.LXMV;'#ZX2D\+J:$H)!8<I&:8#8>LB;3B@;_B,80ZWO18B
M9:Y>KG/3D9_<4=23'P^K=;_=ZN#EJF#*KD5H3_Y-N4*XO0)_+2,JDH(1#)%,
M94V*`[&#V[3OJC+W%J(SFTBB7[=5.*9$U6)R4D<\YHVNU*@NC=*^23DW2:&Q
M5X%TC/5UI1+*VL5'5P`!PNE.8@8=N)(`AT)8:+0AB4>I^,&_A999)99))8"B
MB@!+**+"$!998`Z"`LL`=:"```ZUK6M:UK6M967[P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!65U_DU;?_`&RGO_2KKEZ_KK]IV_,_
M3-5Q^7D#^YD7^PT.)SDC*$SR*8$-L7\OIW]S9/\`8B[`_]3WC5U^7T$^YL8^
MQ$.!,L!@:X7#?IE3V52$"5QE)]4W))Q14B>25^/C,0;7[MC6G10XIY`QO#;N
MP)*D<#CV%J7'-^W\]$-$B,,4"%[$L0J^;<J++K^+V2]26D&-.IK^?L494NK?
M8\RD=;M$4>(>.;N$ULF7Q2C'Z50$F&,X"]/WL8T\-#8->C,&Z;2B5J40K=9W
M+YV;6OBMR+^MG%N;!KJ'M]$E"M7)TP52XZN9'U$:,2D1&U2@S>M]0`==<71_
MLYKK^NOVS.4K'CMAP`$?8@#G,/",+.V!$$4F90B"(*(C0@B#M;K>MZWK^.LD
MYRK,>HM?>.X;YG9._9`]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^\=PWS.R=
M^P'J+7WCN&^9V3OV`]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^\=PWS.R=^P
M'J+7WCN&^9V3OV!$YVJHNSX;)J\L-UK29P>9LRZ/2F+2%YCSDROK*Y$B3K6]
MP1*%@BSB3BQ?ZA`%K0@[T+6MZ#K1K:[]_MZSB-\?;GM)'8?#.7N::.\;N1K[
M+$+Z_P!".*LP)#)Q\Y&OHUAR@R&ZV("6'398+180:+;'4T(])U`HUGC&;M:]
M1:^\=PWS.R=^RLGJ+7WCN&^9V3OV`]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1
M:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^
M\=PWS.R=^P/R*R*\`$0QSV%@``.Q"$*4L80A"'72(0A;7:UH.M:Z=[W@4=*>
M<G"R$$+5,OY<\9XV6WB&6K`\7I6*)24>`H9_9`HSI.%6<N,++WL!``".,WKH
M"'>_X86IT4<Z_NN\%TA0!QRUI/:(E*C:-N]%J0O:Y$;LLUU=@2MKW6U:R6.*
M#3@#",O>U@0&%C`((MA&#8EGF4>U^Y6&1])%7<-N6DX4F=.TRF4(J&H=E$$)
M!:C8E2N_+UKEY2=<&S``UMN$+9I6P;T'KE;,%;OUOE'S=E@AIHIQJXJ5D4,/
M26]W?SC0N*A-T[4`_O(C3-+S\A8:#JEF:#I]("/6_9[&#>]F`&&KJ3XN57^[
M99O,KDNT<Q.:#G4W&5U?"G%^<Z.MF%M+9.A%(%.H+&N+3B]-DCE%0PI,B/3B
MD"U`!D>U`$X2%2@US&<I)F+<SUJ*C%WQT/1_#/C04Z&4RS59%GZ0B]I*YXKE
M".4V?-5&^H(:J;VC+7I\L"8*!F@Z_2XN2C01[WL.M=.\K$S,_+8SU%K[QW#?
M,[)W["'J+7WCN&^9V3OV`]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^\=PWS.
MR=^P'J+7WCN&^9V3OV`]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^\=PWS.R=
M^P'J+7WCN&^9V3OV`]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^\=PWS.R=^P
M'J+7WCN&^9V3OV`]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^\=PWS.R=^P'J
M+7WCN&^9V3OV`]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^\=PWS.R=^P'J+7
MWCN&^9V3OV`]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^\=PWS.R=^P'J+7WC
MN&^9V3OV`]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^\=PWS.R=^P'J+7WCN&
M^9V3OV`]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^\=PWS.R=^P'J+7WCN&^9
MV3OV`]1:^\=PWS.R=^P'J+7WCN&^9V3OV`]1:^\=PWS.R=^P*VN6?P134%JI
MT\UB2A0HK:<DD$$R1F-...-C#H644446L$,PTP8M:"'6M[WO?1K+U_77[3ME
M/TLBN/R\@?W,B_V&AQ.<D90F>13`AMB_E]._N;)_L1=@?__5]XU=?E]!/N;&
M/L1#@3+`8%8V!3T#M!5'U,U;W-U+C;RROR-M*DDC;&18XQUP^MV,QZ8VMU1M
M+V!L=@A/+"J)-Z>C90NL0:<486T6:>-U7M#4YL98[/=&9Z<U+H\-<IOF]IF@
M=3%R9X2N3<X)9=9#V2LCCL!_5C6-)FA-:PXS1QR<PTLL8!;C<L?_`!8Y+?\`
MK_<O^74CS77]=?MF<I7-&_\`EUA_X*U_X$C).<JS60,!@,!@,!@,!@,")SN"
M0VSX;)J\L.,LTS@\S9ET>E,6D*$ER97UE<B1)UK>X(E`1%G$G%B_U"`+6A!W
MH6M;T'6-`IS-/VY)G&:$O>2/<UX63)X1Q?C7R3E*T]S>Z&>%YFD[!QVY%R%4
M(9IL2&+84L-FBP>@Z!HML=#`C"G4;C6>,9NTF.2>-3!J+?8E(6.4LAREP1%/
M,<=D#VU&K&E>I:G5(6X-BA4D&I;'1$<F4%Z'L9*@H98]:&$6M5E_9!)8Y$VX
MQXE+^R1IH)WL)KI('5"S-Q0M%&G["8N<3TR8&]$DC'T;%K^4`M_V:W@:DS']
MQK@3`U0&Z1\P>.P7@9NB01]CM:(RV3"-$864$&HS$G-[?^ML9GT;_9",7^R`
M>PEJ=$+U^Y11+[TAJRNN6UX"ZFA:/J[AYR-4L>Q#]OHHOWRF-=PV#!]L-*8`
M(Q.>BO:`$#8]"`/014_+]!Y<\FI4+IK/]MSD8-%UA%!>+LLSC32[>,W2C9(3
M--2.W;(G($(R1EGZ,,90&Z+]H'96C0`*,%1J;E/[H<L#LYJIOA)2R4X.O8@F
M=XW/>+\EWK16_P#?F>(4Q4#&,0^@>NJ2]#T#8M?S#T7TFL3_`)W?GT1_<0E6
M@'S#G;5M>[.Z?;M=!</F=%I%KJ'E:"B?[SMV[>U#%TEG:&:VA"`>M@V`8?X[
M%QH_6N!S^^C$HLSG9STL$Y2+VJY,UW'$J-:AG","::%O3<;:TIYR:T@A;,T$
MLM8+98#.KH?\A6RQ>T/[K]KC@XNZ!S6G'"X%(NJ)2KONU[EOLY<=KV(AGJP7
M#8,U2C&<<G+,$$)82M&%E["`/LR^JH]2V,@/%OC+57L]U?QTHFM]DBV(KW!J
M*OX?[(6S3#]B+]WH\W=06SCACZ=='\P][_MWO!<ZKVPA@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@5E=?Y-6W_VRGO\`
MTJZY>OZZ_:=OS/TS5<?EY`_N9%_L-#B<Y(RA,\BF!#;%_+Z=_<V3_8B[`__6
M]XU=?E]!/N;&/L1#@3+`8#`8&O\`RQ_\6.2W_K_<O^74CS77]=?M)RE<T;_Y
M=8?^"M?^!(R3G*LUD#`8#`8#`8#`8#`8%'<F*00<E./MQT"YR9YAC?;]>R:`
MJY3'RDBAV8R9$VG(!+TR5<`298`OVO0:0+9>SB=C`$TH0M&`+$U-NF3]NG]C
M1+QCJ"3P/DKR!N"SQR*:.[X16M+<@>0%+T6TMNP;:D+DICE>S&NW*4S"2-:5
M,>Z'K]"(3[+*1$!-+),5+)$-=NUY0[)6#]LS@"P.93WOB52TJ?B!!&5(+-B2
M:W)"6:!1I66<%^M,<Q=]*"572:`SVW7`8(0@[T(0M[M,W.K;6'US7M>)-M\`
M@D-@R#8`%[10^,,D92;++"`!9>TS*A1$[``!0=:UU>C6@ZUK^S6$3+`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`K*Z_R:MO_`+93W_I5UR]?UU^T[?F?IFJX_+R!_<R+_8:'$YR1E"9Y
M%,"&V+^7T[^YLG^Q%V!__]?WC5U^7T$^YL8^Q$.!,L!@,!@:_P#+'_Q8Y+?^
MO]R_Y=2/-=?UU^TG*5S1O_EUA_X*U_X$C).<JS60,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,"LKK_)JV_^V4]_Z5=<O7]=?M.WYGZ9JN/R\@?W,B_V&AQ.
M<D90F>13`AMB_E]._N;)_L1=@?_0]XU=?E]!/N;&/L1#@3+`8#`ZSDG.B8:8
M52-X@[&R6LUCM(Z95NZ$R-$LK<ZK(/9<Z7,#JY![6US!OE)$*0I&*4-R@EM=
M@JUZDI)HUH4H!QJH_C8[DU)T3WP_NQ[0()`<3,N.MEJF9$1''M>[:^OJO?%:
M!.X-S4A7J&T_J*`@,]MH("S/Y=BZ<UU_77[8G*7%8^6]%I65G2J'V9EGIFMO
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M/,7C^H!LPB32X\`33R!#)IZYS`!.3'&)E).Q`KX6M&IU!0BQA_M`,.P[Z-ZW
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MA)/"&OM[*-$G4%F:"+HWL`PB_LWK>WF2XU?7]7]"^()G\&KI^7N/,Z%QJ?J_
MH7Q!,_@U=/R]QYG0N-3]7]"^()G\&KI^7N/,Z%QJ?J_H7Q!,_@U=/R]QYG0N
M-3]7]"^()G\&KI^7N/,Z%QJ?J_H7Q!,_@U=/R]QYG0N-3]7]"^()G\&KI^7N
M/,Z%QJ?J_H7Q!,_@U=/R]QYG0N-3]7]"^()G\&KI^7N/,Z%QJ?J_H7Q!,_@U
M=/R]QYG0N-3]7]"^()G\&KI^7N/,Z%QJ?J_H7Q!,_@U=/R]QYG0N-7RWS%X_
MA.+3"DTN"H-*./*(W3USZ.,)3C(+/.+*W7W7&40-27H8M:WH.S`ZWT=;72\R
M7&KZ_J_H7Q!,_@U=/R]QYG0N-3]7]"^()G\&KI^7N/,Z%QJ?J_H7Q!,_@U=/
MR]QYG0N-3]7]"^()G\&KI^7N/,Z%QJ?J_H7Q!,_@U=/R]QYG0N-3]7]"^()G
M\&KI^7N/,Z%QJ?J_H7Q!,_@U=/R]QYG0N-3]7]"^()G\&KI^7N/,Z%QJ?J_H
M7Q!,_@U=/R]QYG0N-3]7]"^()G\&KI^7N/,Z%QJ?J_H7Q!,_@U=/R]QYG0N-
M3]7]"^()G\&KI^7N/,Z%QJ^1W,7C^G!HP^32X@`C2"`C.IZYRP".4G%IDQ.A
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MS6M"^3`U<Y5],T",H=07$F`:J61QR3IRQJ%,!)3$!&<9K6QF#``.M](MZUK>
M\L=9B8G=)F)B8;55X683`(.2<6,HTJ'QDLTHP(@&%F`9401EF`%K0@#`+6];
MUO6MZWK,SG*QE"89%,"&V+^7T[^YLG^Q%V!__]'WC5U^7T$^YL8^Q$.!,L!@
M,"CB>-M(EMRIK/@#8YIUG7*4&O2MV>W$3>-NES/]1!=G9P6.A49`SS]]2:;`
MG:0=F>EX-D[TL4^U+<KD6MZ)Q;U;4L3@.;ER(]O5)?YBRS42D@:8]/\`W0@#
M``9`]A_EWK>M;_AO6$<W`8#`8#`8#`8#`8#`8#`XB)"D;B1IT1(2"3%:]<,`
M1#%H2MT7*7->=TC$(764+E9AF]=/1K8NC6M:Z-:#EX#`8#`8#`8#`8#`8#`X
MB9"D2'+U"<D)1SHK`N7CT(>]J%9:%$V`.%H0A!"(*%N)+Z`ZUKH+UOHZ=[WL
M.7@,!@,!@,!@,!@,!@,#B#0I#%R9S&2$2Y(D6H4ZCK#ZQ21Q.0*%I.@Z%HO8
M3SFL@6][UO>O9ZZ-ZUO?2'+P&`P&`P&`P&`P&`P&!Q%J%(XD@3K20GDEJT"X
M`!"&'05;6N3.:`[I`((NLG7)"S-:Z>C>P]&];UTZV'+P&`P&`P&`P&`P&`P&
M!Q%Z%(Z(5K8O)"H0N*12A6IQ"&$)Z162-.H)$(L0#`A-),V'>P[UO73_``WK
M>!R\!@,"&V+^7T[^YLG^Q%V!_]+WC5U^7T$^YL8^Q$.!,L!@,#KOY*E30=FV
MH9'A\D@+BN*Y>JG%5)EU:B6KM/D5@D,0BB(SL50J)4`\QKV?[P@&@`ET4)QU
MI#H>]1J/C)PFB_N5B'V;3-:\"VJV5[:8+/WABH>\YT**KE2->%MLR/)H^0V,
M%SPZ6N&F_2DF*KSQQ4#B,;EL.F]6#!4.;R,>^43D2F-A$7EK1M'0=^'PM1"U
MCU[*0<I!)JJWQU/E+0P"4.$?@OM!RK2Y'(3#V$'7*TY;$,L@6"*;#U1`-QRU
M;PDB5WM!0SN*Z*1Y.V3NSK0G3`I?TR)SG<JF$%99M*7J+Q!D=3[%2LVT3"D0
MH4IT=&066666`@JI/PV)PA@,!@,!@,!@,#57DP6YF2#C0$K=O:BNKQ>S+'](
MC+>*4^YQ7'>^#6_4N%3H@/>XSNQP1_0`JM]E&Y]D#T;,V#6RQ\M3H==/,2!M
M,ICIE;2N7H6-NNR?U<9.:XMJ23J<5RFF?(/=51)WEK,C*CK/8#/$XW"CRVN3
MKD4I>6UQ[*>`3T>8>FBX-C;!EEWR.KF$V-,DA4E.-E52JD$PC\9F=8RTRK1<
MB8HEG;6DJ]].4V@PO">ENV:<%6A$*5`0*5*$A.(U*474^5#4B?RH]=*M,GZ6
MSCZW/9C6QP3NVYJC.:`)F>^%<%DDJ/5F&PIZCKM#2F)"_)'(LF=)9SIO/.$-
M`,SK19JG:/E9,!@,!@,!@,!@:Z\M?>3].-M>Z'O_`.\_NS_^#]+??7W_`/K'
MZR0>P]VO3K__`#3MO6_V^P_S^QZ_7_NNOA8S:GK;"Y%UO8-CI:QC5A/]-29_
M@T;K-VMV$7U8ZZ.6"DK^7*YMHU`G;W>X$55/SPWQT@#VZZ`Q)'+;CHI2#2HH
MP$7#YS;"0ZS[YF,=F2A/`1HI.2L>H^@8'^&2:N`PA[0O$P:B5PI)-%JMEN&.
M#2H6M20X,1)*-4`1AP![`I*)35,,&EC4R\SW9O9U+([6<`GZLK-B:&"9OECQ
M:4%67(8SQ7=9M9SRY+6Y6A<X!5*Y@EHE[&[&)VMZ/=7)&DTH-]@D,C6#N)RL
M&`P&`P&`P&`P/P9U?9F=;K]7J"ZWL_:>TZO5WT^S]C_>]?H_LZO\W3_9_'`Z
M=HI+N15=1.AY?`&#D=*EC9`)*9R99[>8>1,S"`IXF,`9F%]98Q.T;O.G^>1!
M"H>'4IJAJ94J6-:162I3&FG-811K#&VX=:7!?D@?7]IE4!!M>P-C">W-:.K[
M.@[#8#<\Q&`N_OU'[,GBDN.Q0".3NS\VJH>ZIARE+MO)&<`DO^]4U)B$#G8[
ME]4+4!'B+;3Q-7/.':M_(1F6.K0)8FJ?70BW4U6+T^A(0`(0A;-2$,9$#8$N
ME!AP0G",%L0V?X[F3XVC:K':);B5/10ME]X@O7MOK[M.DVM)AR(*D(5()(8W
MZ)$XA,UHP"W9NA?S:W@G.:7-A#`8#`8#`8#`8'6+*"[A!:=L'UOOD(*=CYLT
M)J#E/IESBI8SCPFA'&3?(LLLJ7B]&4\0'&UE@[;QI?9G&RH)>F\0E98-!C4;
MY)E6?(7D?+5%:@E=<JHJFFW:%C@=OC[?@!1QW:!TR!ZJ^5`D0(V9$7!9N1RS
M;9+U01Q4\*%,(!JGL:K2\5"XWA;/G&^>/RU<PSV--:R'7L@F+.S.\H>X`F.U
M[@'10Z8+8\$$#*>S^RJQ-)S@$"TOK*"DH_YS@BJ?#/\`%<4FW2$8+E_OU]>)
MWNPTPMV4&7ZF8F@BR):7&A.YL\U[V*0BC(4>TYJS8S#$OLQ:$(.];P2V&PA@
M,!@,!@,!@,#0CD@4^F6^K$4/DD6S$\8+$$RBIDR\PL6K--EC$EA^PE5]O<"4
MSH"=0K$F"[@,ZJ?7M%&NR`ZP2P@$%O[F&ACT=:;5KS3;*6445@MMO#%0]TSH
M<5DRIE4!]3(\FB1#9$[GATM?-(M*28>O/#%0.(QK]A`WJ@9%J%^W.[V@YUY$
M%1$;G#'(FV^N*YY"NNUDM-6/T8/O2NRK35/<<AXU+JV0<%<G/&W9"]"4H2D(
MA[4[V(H(]5')ILQ*?>]ZJVEUOOZI/31UM4,-H,=]IH/[U,<@FHY)*:Y<[984
M<"2,SL4]HT*5'"E(6P]*UZ5FE&`,2&Z$Y-L,(AMB_E]._N;)_L1=@?_3]XU=
M?E]!/N;&/L1#@3+`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#
M`8#`8$-L7\OIW]S9/]B+L#__U/>-77Y?03[FQC[$0X$RP&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!#;%_+Z=_<V3_8B[`__]7WC5U^
M7T$^YL8^Q$.!,L!@,!@,!@,!@,!@5DHC4<?[#D(WU@9'H::%P@*83LU(7$2<
M)KY8>S0D"6$';*"9L`=BT'HZ>C73_9@9OTZK[P)#?+#)W'`>G5?>!(;Y89.X
MX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#
MTZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZ
MK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[
MP)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)
M#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?
M+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#
M)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W
M'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`
M>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G
M5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?
M>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!
M(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX#TZK[P)#?+#)W'`>G5?>!(;
MY89.XX#TZK[P)#?+#)W'`>G5?>!(;Y89.XX'&KA$C;HT>A;TB9`B32^Q2TZ-
M&04E2IR]6%*-Z+)3D``44#6][_@'6M8$[P&`P&`P&`P&!#;%_+Z=_<V3_8B[
M`__6]XU=?E]!/N;&/L1#@3+`8#`8#`8#`8#`8$-0_F#)_N;!/MNQ<"98'Y$(
M(`B&,00``'8A"%O00A"'72(0A;Z-:#K6NG>]X'&0+T+JA1.C6M2.38Y)$R]N
M<4"DE8A7H5A(%"1:B5IQF)U214G,",LP`A`&`6A!WO6];P.7@1LJ91`Y`I="
M95&S6Q&:40L<2GQL,0)3C]ZT22I6!5;3D&G;%K00B%K8M[_A@<LF1QY0X'M)
M#\S'NB4G:E2VDNB$QP3I]`+,V>>C`>)043HLX`NL(.@]46M]/1O6!R$CPT+R
M$ZE"Z-RU,K3J%:50D7)E!"E*C,+)5J4YI)HRSDZ4XX`#!AWL(!"UH6];WK`^
M*20L"_3=M"^-"S3P%8)IVD<D2C3H%N%U'`3=LDX?;0H!_P`#ME=;V6_X"Z,`
MHD+`D^K]JWQH2Z=RAGM7:')$3]9DE%%GFG-_M#@]M*+).`,0B^MK01:WO^&]
M8'%52Z*(4:)P6R>/(V]R",3<N5/3:G1N`2^K[02)2:I`2J"#K:Z=EB%T=.NG
M`_2"5Q9T6_5K9)6!Q<>H(SL"!Y;E:WV8`Z&,SLJ=28?U`A%K>]]7HUK>!\")
MI#E)1!Z:61E00J&O+3'$/S6:4H,:B@G.A9!A:H0#AMI(PC4:#O>R0[UL?1K>
M!]RY7%CD)KF3)6`UM3G$ICW`MY;AH25"G16TY!JL*G:<LY1H\&P!V+0A]</1
MK?3K`^A\ECB8+J-2_LB<#$:F(>Q'NJ$H+.<MT5M&2ZB,/#IO-5Z.![()W4V9
MUP]7IZ=8'*4/#0D^KNU.C<F^N%!21I[0N3$_6BH\H1Y*9N]H:'MJ@XD`AA`5
MUA"#K>]:Z-8'%5R6.(%QC8N?V1$Y$H3',YO5NJ%.N*;2BU!QKB8D./`>!"44
MD-$([8=%A"6/>]]`=]`?!',(DXK26UOE$=7N*D&C$[>C>VQ4M4%[3;6:,)2D
M*1GF@VCU[7I"'>O9_P`W^S_'`YB%^8G1M$\MKTTN+.`!I@W5"XHU;:`L@'M#
MS!+DYQB4("2]=8>]BZ`Z_CO`^()/&C$B!>7(6,:!U6(VYL6@=D`DCBX.`0C0
M($"D*C9*Q8N`/6R2BQ"&;K>MAUOIP&I/&MF.9.I"Q[-9`&&/)6G9!LQH+*%L
M)ICF#M'60`*$'>A;-T#0=Z_C@?OWCCW8VYP^O6;L#NM3MS2N^M$/8W1P5&C(
M2H&Y3[?V*U:I.+$`LHH0AC$'>M:WO6\#ZI'QD<%JQM0/#6M<6X6PN"!(X)%*
MU`((]E["L2DG#/2BT9KJ[T,(?YOX?VX'X7R%@:D@5[H^-#:A$K-0!6KW)$C2
M"7$C4%G(@J%!Q9.U91B0T(B^GKAV4/6]=(=]`<0N81(Y.N5E2B.FI&M,2M<U
M1;VV#3MR-0#VJ=6N."IV6D3'E[ZP##-A`(/\=;WK`YAC\Q%%K#C7II**;DR5
M:X&F.*,!:%&N",2)6L&([04R98$H6RC!["`S0=]7>^C>!DRS"SBRSB3`&E&@
M"84:6((RS"QAT(!A8P[V$8!AWK>MZWO6];P/W@,"MR[DJ`V1[AY5JUN9+=.Q
MC!N+%SF,#D>GTE4)$<R[9`NFW/3L4L`(D2;V7M@FZV'8>MKHP4LC`X9KBWD*
M-I#UZ,E6%&<XB2FJB"U&F],,!2A?LD8]&:1D&&A",WHZ@1"UK>];WK`_*1T;
M5Y:4U"XH5I2Y.:K1&)%:=26L2D#)*.4I1DF#"H3DF*"PB&#>PA$,.M[Z1:Z0
MPQDVAA/3[671@KH5GH-^T?VH'0N2FB(4HM]97KH5IS@[`,O_`&P"UO6]:W@2
M(1Y(#2B!G%!.."8(DD1@`FFA)ZNS1%%[WH9@2M##UMZUOJ].NG^W`XQ#HVJE
MR]L3.*%0Y-04@G-O(5ISES<%>68:A$O2%F"/1A6E%"$5LP(?:!#O8>G6MX'!
M2R>-+1)0HY"QJQ+E*E$B"E=D!XEBQ&6$Y6D2Z*4#VH4I2AA$86#I&`.];%K6
MMX'+1O#2X*W%`@=&Y<N:#2B'9$C7)E*MK./`(P@EQ3DFC.1&G%@V(`3=!V+6
MM[U_#6!D<!@,#A#<6\MP(:!KT0'54B5N*5L&J("X*6]`>B3+EY"+8]*3D2)2
MY)RSC0AV`L:@L(MZV,.MAS<#B&KT)"DM$<M2$K#DYZLI(:I)+4FI4NRPJ5)9
M`QZ-&G3B.!HP>M;"#8M=.]=.L#Y(G9K<BDIS<Y-Z\E<2>I1&HEB=44K3I32B
M%)Z4P@PP*@E.><`!@@;V$`QAUO>M[U@8DZ:0Y,!28HED9(+1N!K2L&<_-90$
MCH1LT)[:I$-4$)#@2(@>ADBZ#`[`+IU_#>!(-J4X>SZ$>2':P?LTFMF@UVHS
MV!JKV:?I%_?C[,0,SH#T[]F`0O[-;W@<<MT;37!0TE.*$QU2)R5:ML+5IQN"
M9*I$,"=2H1!,VI)3J!%BT`8@Z"/8=]&]]&\#'E2F,'C,*)D;"<82XD,YI93N
MWF#*=E1AA29K,`!1L0'%0:2,)9&^@T8@;UH.]ZW@9[`8#`8''2JTJY.4K1*4
MZQ*<'8B5*4XM0G.#H6P[$4<2(99@="#O73K>_P".L#\)EZ%:8N)1K4BLYL5]
M@<BDRDD\QO7;2I5VD2X!0QB2*^Q+B3O9F:"/V1P!]'5&'>PC$$__`$B[[Y6+
M_F#)\"98#`8#`8#`8#`AMB_E]._N;)_L1=@?_]?WC5U^7T$^YL8^Q$.!,L!@
M,!@,!@,!@,!@0U#^8,G^YL$^V[%P-?[9XS3NS9HMEK'S0Y94PVJTC>E)@53*
M..),+;AH4H$YJQ$&Q..5BRK:MS,#LY1L]U.![46]%A++T$`2WLTXY3?MMW_<
M?'JV:P@W[DW,,<HFD0<&5K0V6MX^:K][$?[,9\<F)U4\<JYGZ6.R5,6-`L-;
MG4L99"@0C"%A.C$9\6)B)R0'@K^UER!XX\8JXJ:=?N'\J(W)6%(M4N$1I)SH
MX^JH:-U6&N`HO"S[DX^63-%#6UF'BULT2Q(E..$,PE$E"/8-B9B9R;W5[Q2L
M.#3./RQTYU\R;,;V1;M4K@EA*N+QL,DI0DYQ&V^0%P[B_#9/M%TG:,UV)T1'
M:,`'>C.C6];J7LJ>"<27MW-BR&SX9&6R',];\FH#/6IL>$ZM_M!IO2S4\P8X
MJ<:VID:9!'8LVIQ+`JAKREZ9],#V31)(3E"F+:0Q_CA:+_4M*II^_FM/)&'L
MCY+'6\6TQI>E+-?Q3?&V5#-79$F4,'OM%9+&FA0P.+6`*4*R+JAMW2AULH:>
MI>.S[+:=O\<KX_6.E*AS<]T0D@,*4PIG6+A-DJA4FB[:P7[]53`QY92DK1[=
M22X-;.XQ\T:YT@[$;M8WEK%FDHPQ2^,T?95<:MY-$G-A,9U4ADY''5(E(**7
M57';H>FB9VXY/"8\+2@>S8]82Q>N8&PM023II0(VT)R71AIP1:F3.+]P:I#T
M!2Z9FY35MBRN6<=;G9E[DA5P-@"Q.;Q"F-G83)L=,8^F0.4J=:^,0@?C?:UU
MO0!KPGK#B4L6\;;&677,CG-/U<W-M=1N,36,SKC8_JXPUKV4QKA<<K&]*@M&
M>Q:*R`*-J*4,@F>LMD-A12=$6N/(0:/)2!T(2:I\J%GG&6T9%^I5EBQ"%B9K
M/L!ND<&9EJZ)(:_*C$<I#CU7FV)V+;8T\3-D-GAE,.<75@1Z&C1Q"3*3M%FJ
M@A2!BQ,+QFE:2J2V13<]88KN$`C4KG$IFJAE<(:;*%ASC41U=M>U*=Q0N$?7
M.*P92-&`S1QV]-B!/[0TG8`IRJE[J&J'BA9,#BU#JV\QFBL]KZ)\8:VMYK4K
M0.T&M:NZEBU>(W%&A&@V)8W2RL)E'7%UB;J<C+]J0N6(#B2@.>U3?%O-'7_B
M1;I],5[7B';4ODM5\?Y[3SS*5<@3!7WK*)9(JZ4ESR1G;;"])S9(LAZN7/YJ
MS05I4E7#*3]L`(Y6<+C%<]GTW9MC2.[Y"./-AZ*W>..Z"AS#)9,DV"L'1`]3
MYR4S<_ZN0N(426R13M"-\TU*52LG<(9=`+4#'[1"(F,$;:N/]V1=B1PS3DUS
M8:>\[TM.1V>^"C"J43R(V36EP-T2:C2W6.B6QBPX@^S-BB))J(TM..#,XNES
M`,\3>$3,(]!N-]GM<<ET;D\41/2:2P.`1GW>4S%B:8:X&Q_BR52LH(>I,V,#
MQ8S`-S=S525*K90@.`C-`>+J])J<8N+30J@+C])E,4628J4JF/D36=IL*69"
MC;=+;#K.".5<O#A#;C?X9'R(J[S?;E'7#ZN<DB0!;@F0LP78T1YCHH$+Q2*?
M4=)7Z:SF9M<-CSFVV51,UJD<%?7I$B;(S*9.\#<%4M<NR-+@G*26,C4)R):<
MWC7*P>[[<(@AQ$(8B:E[M:!<-[I;Y=;<E6+4EC`EL%L2N8_M]>6IE=M.DMXI
M<>::-ME>L1HQGN:B8S"D%9;TS.*D\A.C<4;BDUVPA2F-BW"RF7AVY0-7-GB/
MMH)T*XZ.E$+E\:G3^U)&J,VC+4[.F>I`F3L[#]3MT3FC4V($,D,:4XU@]1M`
MITE<U:A4HT+P8FN>,UUU=>+]<:D26UM)27QHCB![D37&GA:[*.-W&NM!V<M=
MT+<I4*E,ZF-!JB'EK<#U1*1&Y(W-(':Q.I3&BXJG-4\9KB14QRZIU5[LS\NX
MH5-)#5DD.3@C&H]<US5U*:_M4LYA=I1-Q11I<'ASU)E*]O7FZ6.$DD!1*1.2
M%*4LJ7&"=2.@IPJY#IK;9F=(1"X]-ZMF>X24XLR`J;;9ZXOB*2'M"`H(T`'Z
M*RRVV^0-VU1P$RMQ;31[&6?I*L`+P0DCB38Z)K6N\>=6>.V4E*LDEH-4+!N=
M=NM96_=-LV#)>.\C1$DI'-1&(O%)NV)F%R`B#]3.[64<E*^KNTM:R+?#LCRL
MJXM>!.]EPEQB+':5CTTY+U#<>3/ZH,@Y4V:P(5Q"PU,W#L2$6)%=)W0HG:=1
M[=J/'[`P7LQ%F=4P(5C4O'Z8UBEFB9]Y7<E;I'+6<IK;EEM***-50)066X%B
M>X7NN**KA.!X.VN`(>W4MU3=9,5T$ZU[31A;V>7VK/V'.;<"_="8^6[S.:RF
ME4LO,AUO!5)I-.SS;=E<*.M-QEI3])F:/5A&HANP'MI4!4N"=`!"W:<#3`D`
M*)Z@0RL6_4>:>E-7Q5L!39"F?`YR\Q$30HFYTO!5:17QEU6Z1M-?A/0:_3%J
M.,JB<ZA!"47U<#1CX8[=@UK0EPE'2HW6+V32]JA?+,>80^Q%R'$)[7#?+GVM
M[&"$I6DB\W7#C1*-LDK"%>A62F`3%F1+FU^;@B!L]$?H1!J9:6D6I1$TIW=.
M7HFLRC;20EQ9%NH&^.58XPIN5*M!D%5O\(2I+24-LH.>TK8D3>_Y38Z)VTUA
M"I<10MHUM4B`H5`+%X3"M(7QDMZ$JJ83&1QFE\'K&:M<B01:32*..TICK$GX
MMWS2+A6FIW[OLV[&KIF?K*9DT?<7Q(.3;CZ==MT&>:4B2#BW#F,'&GD!#&[C
MPK:G2+*W3C0YQ\+#&TBE>%H>XM/'AY;KBA,<D8WE@`1#855LE*:(TD>V)0,]
M;%6I3H2#9AXP"XQ2RGZFL:)V'2$1DS8^-YE%--JKI!<R<EL5,W(PRUEKR)0C
M,VS%K5[$X*W5*EE<L*?"V?8)(4WDM1CTGVL5)A/SBG-6TI-JW:TD>,:D3R"&
M<B^6W(MC=RY$F;TDC5<@;,OJ?1F'A2C:EBU&-M;;]5)'!2>$@M.K:BQ$[5E*
M!"*J6Y='5)9%56).73V*0ZOYTHVM/8GE^;7Y]A;\NFEDS5WU!Y8FCK7(':KU
MCG-#%Y#&_F*UK,Z.ZXI`J"VE$$C#<'"(18\0<I]"7Z(M%@3>K')Z3IR$L_K@
M<4+FT;&0N2K!J6$<XBDXBH5"DM,).9VQJ6`]@</JA"9U#`!CSH$[FSR*30-I
M6.0UQJ,.,=75R29!_<.9K5VRME2Z5@-A!LO%)VSV6^S[;GAN0?SB]HE,_AT!
MYW+3_;E_==DO[H#;RJB/)=.CI!CDB2!1YQ66?'45LQ_C;(I(ED$_AS8T)^/*
MNO!F]O7+CVXI<V.*L)*="2I6J3TI:S4Q;OK55B]%?N2Z>J7J/ZDS_P"I/<#W
M)]'^O#O2WZT]XOKWU)]G[G>H/O\`]D__`!?6]X/J;ZN_A]7]I_WG*PUWE7&J
M3N;#`V0FW+*E<]@"N?2^OK]GWN(XS""3]U7-JN-#=V2$Q^L6.4P@;&8X1QP:
MB41!KE'%AZ50J`<=VT);X0Q;3M_CE?'ZQTI4.;GNB$D!A2F%,ZQ<)LE4*DT7
M;6"_?JJ8&/+*4E:/;J27!K9W&/FC7.D'8C=K&\M8LTE&&*#QOC1;L2.A!!3.
MVR&$PNPZFEC+#GR01YYE$001.'7$PRV$L,^-96%3.:L9#IBSE0\<B`*3$D"<
M@+C@D!0D`BS+X:XQ\@&2)U^FC"V%M;M2-IRZ[ZZC"%4XFQP*ZQ[PFLM<J<C,
M@TX1W43B,.HJ2G0-.Y*F%<2)L?'+2)M1%$H""Q<8IC$*HLADLRJ(P]M#^G!!
M[[OKD&YW@E*:%:.Q8[;9=Q)&BH'<IG^L7-H?&!+9+.2Z:<TZ5B$DB:`32H-.
MT04TU/ACRN)#B);/)XX-CR9/I!=RA4SE,TH9V1.W4XX\FX;>KZ<A<VK3,[DR
M9W;8OU"C#UIJQM7B&!`:B`I5*C(M\/A$*OYH*GEE2V3*U!D2/;J?9Y$=%K87
M)92<NC38<AL*4''H([&T2`J1D.@]F$-/91C5I`CV`TS12W8F8^']1UMS":B4
MBE`\OCHZ%QR)H'!+)+>4!9U;GZ33!AL962:G`\'EC=[`1Q9:V=0A.<E]BN&2
MI0&*E1RH7#(Q^ON<2*&JD<CED8>)NW,\%2-CVUV2\-S8[1YL=H$78L-6-BRO
M5I8)O(FN,OJEGF1G^]I1R(I,J*&%%L\RI@XFJ9Y8?7C`WK)BYR""1_W9<5)C
M]=#L7+Y*O:97Q$DPPNSA%()$T!C@E!7UDIS!D$($"W3^2'LQ*<W1"2+<,K#Z
M^YB,\8$D?71G?G](W05*S*SK4>F!'MF"\P0%@1V2-+3$W33E)"],;XZH)"E7
MI%JU,\`:C1I-%:6%BX6EQ,KBWJ[8;!,NY6W.\]F\AJ^4O<B:G(AR2O[XQ<8*
M!J29.9HRT+280K<)Y5[JKT#LA16TBH@0/YA&%E5)7_!/_P!(N^^5B_Y@R?")
ME@,!@,!@,!@,"&V+^7T[^YLG^Q%V!__0]XU=?E]!/N;&/L1#@3+`8#`8#`8#
M`8#`8$-0_F#)_N;!/MNQ<"98#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`AL$__2+OOE8O^8,G
MP)E@,!@,!@,!@,"&V+^7T[^YLG^Q%V!__]'WC5U^7T$^YL8^Q$.!,L!@,!@,
M!@,!@,!@0=<AE*.4N+VR-S`YI'-@8&HPMU?W%E4)E#*XR=6,8`)(P_%J"5!;
M\#6M[&6((B]_PWK>MX'V[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[
M^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY
M=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU
M@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`
M[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#M
MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6
M#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/
MAB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&
M(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8A
MOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^
M>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[
M>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[
M^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY
M=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76!RX@V.32RB3.X$)3@H>Y2['E-JM0O
M1DA?I0\/B<@I8J0-9Z@1*9Q``8MD%_SZWT:WKHWL)/@,!@,!@,!@,"&V+^7T
M[^YLG^Q%V!__TO>-77Y?03[FQC[$0X$RP&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P
M&`P&`P&`P&`P&`P&`P&`P&!#;%_+Z=_<V3_8B[`__]/WC5U^7T$^YL8^Q$.!
M,L!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@0VQ?R^G?
MW-D_V(NP/__4]XU=?E]!/N;&/L1#@3+`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8
M#`8#`8#`8#`8#`8#`8#`8$-L7\OIW]S9/]B+L#__U?>-77Y?03[FQC[$0X$R
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`
MP&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&`P&!#;%_+Z=_<
MV3_8B[`__];WC5U^7T$^YL8^Q$.!,L!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@?@PP)19AHM#V$L`C!:++,.,V$`=BWHLDD(S31[UK^`0AV(6_X:UO
M>!US.Z3E`ZDV*U+%LW9@S60P6XH`^(D\E?F>%HG-*]1^2T/,$,.>:OG:"-QY
M%%F<\P4?6Z<Q.[Z>X;$K1DJD@XU@B?NIRH4NI+B4WVLE0JDE*REZ8%=HRG;]
M`?<VSN,JVU:R:GQ--RX'<#=.JT9Y=I"ZDM[$]%*D;@G7=K^NDQX1-+(E[9R-
M(O)HGE:&3TJ&/*&2Q^0P^0O+DX1MHC4O<&QA16@BCDA./:R9I`G^.)I"C9"1
M$JC8RY."(28*PXLE/4P^5>5A&>0I%4IFF5.E_)9T/CW!V5]6[62N13`-F@XU
MN[3.7V+/,IL1NK@N4H[0[,,K2L@:98]!T<4/11@E947Y3.8,/(??%QC;VTN8
MCMF,6LO6I4<;DEEDD6Q'D4TDRA$G?GN12UXMRKXC.F1668D`I=W8^(J^PEJ1
MN#:D/+/&%[,E<;%R4=6^U2:M5S)L<G&Q9@KBP1O[H00D4./$1!'ZZ$U."I45
MM)6[;R2("<X)TP0$:6=*P\GZO&J&,13&+8[RE*I3E(F6+YDIG#K1;FV5OMGD
M"TN0'<C]KKO`X2*OE2=Q`.,P9S1N$%^I2RCD2-*!*?LY.G-TM$94PN&<6U?>
M,F72R&I9S9[;`IPIN1?%;"]\)&P3:C7Y83(V2/,^DOUPT.U@0QR4K6F11T2S
MM@FA0A7(3S=(E*)*0+?1T;KV<V>M97)$$YB4YE+3-WJ=PZ+OTXEL1@[M[BQU
MECD0)30Z?1].J]L]-!:HA68IV2%>I6FC&4`TP6A\H(JB'(+ZCNL1BFX%J@R5
MU@^UR]ES"P&*3A;'BYI*ML*#.,3:YT^Q4XV#P4)>P/+#V!J>6=S2)M-R=<V&
M=>+@SEC1JZ$:/D,UP=7<!^QF_5]6`(>K*5._LTE6TPB0OS-,G&?B:"F?<K;I
M&F4)=(?K94[';7;'I((Q0<,$K-8^1P8Y<(X\KE),87<E*A=ZV:'UW.6V*'CJ
MB74R*^43>\.3T)^:!R4U%,E#,E6J-O:5"I"0F"C-&A(15,,$"?8CRE`?*7Z(
M/$]<42)=<A$5K%TDSRU'2ZEY,;!&^.)3IFZN^SXS=D=D:=_D$46GN*18%G/)
M9G3:,)H5#3%P3.]H_?2Z;VN35"FPDSHLJ?CPAHUQ32-X30%DM1HLRZ%MCOTM
M2JW<B.+&-NB2F,&OY*\I0<]-I>DB,E8KULC51QVZT>9PFYV6+Z4"%_!$9@^1
MZ,%`BYK.JL)CB))2:L7J5FSUN&1&'6:Z&H9Y,4E+TH0&;2GIMC3A7+HM1JQT
MNL7F:W-#HX1&*IGI<DB#BY,3`YU:J2+W.2;8+PD4>8'EU23\UL&<<YQ6$,:M
M:04WDC%(U*H21N$6,A`,&+K5YYHQ%:PQ%]C2MZ@ZJ2/BA5/GY'[US"+#%;DC
M/]U7EN6V$6[3*).%2$DJ43T0>F-:UZH@CJ+-$";L&']7,>BNZ35SQV7/*AP3
M6Z&1UM+;&(902N`Q8EL%)(TKM")N*%FE#TV$',\3<%P$2=Z"]('7ZM.3%B2K
M5B1>EJ88I_6#F]MC0OBDF23\QX7RSD9(DCPZ@<',Q'&$ERNRN(H"75T/5*/]
M[A\T;!,"0L)I)3>C&GUHG:3V&A+2670_F&JA;T71;O94<DRTIS75*3:\J<'A
M)!9$NM1@>).@L%PD3M('B7QXVHSU2)CT\?6Q*-V`L+3^P+TUG;BX-@X)7]G+
M)%#75[<;0;V1KM"8/[6E?+*EG:4E3)(TL"RQF=M:>4*4,GD[W93[I85IP"Y@
M(8T79PFIPEE)\J-SL(8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`8$-L7\
MOIW]S9/]B+L#_]?WC5U^7T$^YL8^Q$.!,L!@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,#67DU?"NCHPA>&1"WO3BWC'.YFUGDN:YP;:.@2UM<KBE
M;4V-!1BE8[-4<5:3H`FB*3=O6$B-%L`!@$6(MKG*N7$]22N?L,:<JR?"T:@I
MSKPQFD,)6,TZAJ>:0AE>D<;FCK8;0S,MQH&F0FID[%*R&-J=W56B,;G-4D[5
MV>+$0SL)Y4RJ5U_/W\R405(^MRNK'BMDJ^'NT?7RZN)?QQJNYWZ9.,3=)HI=
M4B$IUD\G`!0`\"5`FCIB0T9ZI,K/&/XIU#SRM):WP1.[I*LA+XEI.PG^SE+P
MWNWU2[W-7MD\<XIM!79#W.XR(BKYE#[DV^LRE2K6FK4[NVA[:68@7EJ1381N
MY*2PZ]*M@J]?"U$.FJ=P;CS(Q[M/<A!)0NM\(4I,C9VJT)`Y1EA="*O1?4[R
MVZD"`:UND")V`VGZ1"(J5@I&X>;]HUY%;$D3`.HI(MB4JYDQ\^.@:7H#A!6#
MCY5]KSZ#V3.SB[$-&LBBR65RUQ)Z(+3-8E;E+49B54B$3V=3%B%I6OR0N&M8
MURGV,$"^O*$K6=7O&9&X1*0F0J45,352AWJXEV-33A*2@DC];#&_-BSV;AUE
M3=&51Q29%VY&82,,$!L_F?94*#8)C$XT](38M9=V0<MI)9WC3C'8K7/&YYN5
MKMB5G`LHPI1$&:8M25F>B_8MI2DMY3%D+DBSV(%0B%AV1RCL&$H5,G:BX'*8
M@RQRT5LY3LR`AVG$+21UF@*J-V<D9(E:,S;Y?"HVX2W1TC:B3DSGID5!7$'%
MFHA(5]2(Y0:4<OK:9SCFY@74=(7@=O<DJI5-KG]:1,N`,]412P7F%6Q8DA-G
M#ZE:X@=+H6V1=X$:WHDVW26(CP*4A:<:=3%B(9N<\N[!CU%4O8\39D[Y);#M
M.Y*[=XV\PI&OE0%%:U]R2D);$S1N,VZD8'Z7-TOIE$VJ#&E]<D3\5M08SEF#
M6(`!%1<Z,3*.:4H::NOV>,LNHU_45A7\CET65L:I`_1%S=&3BA&;W3(5+F&V
M&>32)G<Y8Y*^SGHV5&$V/@``1Q2L(U(JE8K&57A>CM('RO8QNL`RA_=K4)I2
M>ZCLB?ZQDID"89BCW"9\6VS0#A$9Y&YXP-REQ)[=[-YB[B8-LT!8F7B:Q4,:
MHY5RY4RUO-D9L3BD:LIIG"]FC$^8T;+-TFX)"6-;(OK@V3VS7S20<P3[3DW*
M]:`47I.$DP&]@&$\8I%)%RRLUG9N4C@4\5>E=*35JWJ.A5,FY9"':(%V%9U?
M($IDECEHLKJTRXA9&FU&^-;TC;'!KD2!V(3%+4"E"I21:R9FU.5%@5K'.4BH
MN1U&\/E'LD_<XP$YC*1(EBZ,\962[FAIDC5N\/>Q2H7/KB<'_<D)90FDL(?;
M@/"(\52LFQE+6K([!EUW1QS]V7U@K691]@C%A0U,I11V3@>84QR5X8A)E+_*
M`&O\*<'/LZY0G6;3F=H*![$DXHX&"?AL)A#`8#`8#`8#`8#`8#`8#`8#`8#`
M8#`8#`8#`8#`8#`AMB_E]._N;)_L1=@?_]#WC5U^7T$^YL8^Q$.!,L!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"*3N6)(%"9A.G!(K7MT,C#]*W!$
MW^P^L%;?'6M4[K4Z#2HY,E&N.2HQA)"::46(S8=#&`.]BT(:R2+FG7T<9V-^
M5Q29"99-#91.&A_+4P5?'$K#"[!IZLY8ZR=X8)F^:C3'%9+=*$QV7FE#(:VU
MH=UBGV9*,K:HM+$@/(-HM`UP]Q(F_2!-&G&N6*<J$;M#5`8G(;)@L!M!"U;.
M0R58VR$J,UU930[NJMM4J4FTR\CZO,<1;/TG%/S&N1T2F*AK21IDDS@H<+K?
MZ05%FIVQN^IW=DA+U9Z27+-KW,CMD&E=9M2=[9E:'M9Z]&\MPPD!*/--3BF<
ML:[&:LI;#8F^1B6+3+`1/A4.=V@AD/:GZ;,XF\Q'5R4:U\0*R9Y)VM6H<6X*
M@HEJVVM#D>I7)@I.@P1%L0T<AXPZMDU6B87Y&L@H;$+=6;:^&N;RN6US,G."
M*$;0RL4J=7XTV7/S6/3$%2D2FKRS"@B+)4#]AH4A'ZS:J-D=21I`U3)T5W5%
MJQET),1)8O[8]MM)Z<F9`0='U<L23%2X1`II4.$C+0MJS3(TISUB@6B$JH1`
MK-.91R#8(K)IK$CXI*75ZAK9MU"C:G*NRE<H3Z@SQ.M$QAM?9ZQNRQ2)$P*T
MO]^0G*"J+Z1&!3]8\(I%D/+&'OCA"&^(PN?S(RQ$SD.+Z9BH8V*=NC&R3!TD
M47D3=,YG%'")2R..<%<F=P;W$M.H0O"<2=1HKJC&$4BD>YV4W(V-EF*-KG1%
M>.[W7#0HL56T,Q,5C26TZW!949D<N!N0^\L>C"%$H(;GA:>W:)97`W9BO9;8
M2H<212=1[D[%)(L5D)&-P0)V&7UY7<Q5/C_"6C49L&SXC![`C,.]FKDH=/KR
M3!K%9G%8!`(_^#FG*1]M-[4%**8Z7\M85"GR7,KS#K`"5$+0+II2^DIX8)C<
MK#<*9CMW1QF;M[FNGH*>41Z4I$"14I1)TY;L+92D2<C6E`A3)L?)V)RY\C\3
MAT?>Y%+Y%&))-T\<2O4!,4IHE$DM<J7E>M<4$Q<F1&XJ#[2:42%$<I*-4+31
M;-VG1EF+`"D.E'-2OH57\@L:40Z>-[/#)-[NS=`E-KYVD,42D7*@I)UEKG'V
MV>J'DJ)L[XN$['&C(+6"8$IYQ:8:L`4(Q5N#-N==2P20SAC=&*:*4L#?I#&G
M*3$G5ZU1EP=HI5ZNU7\MJ<I98$;V8G1-2`]N"8>`CVKL084'7L-!4C%,^\<Q
M:]86^:N#G&9HF]Q5$=+=V\]17J!Z&CE`:E/;'4#&\3YL>&YN(170SFK#'$A#
MV/85!9FM&@*`<*2L[DI$M41KD,FC\C.@VOK)48!6X01D5?4;7('&/^\R-V>Y
MHWPQXCC\)O"J9%J%U4IGM&M1J$AAA"D!NA6-+9C$R32AYL)E(:W1N.KN8I(:
MN4N/U;V9Z4K('"9\6Z,G8'%<H^JPH9P2EWVPM(I[6E/Z"=D^Q..(H*6\MXA`
MULU;YE![`CY\%#)7AU-5)XHL1J(##(0GL*76"B4M$K<M":V"-JR=G-INBG_M
M"E,'L'LSRSMEI-W.]4[<2G5EUU/W)%ZR(Z:=5#?[F&C8ESE,F*#-DO7)C9B2
M>IB:UTD:99OLFE+BG:M''GI"C"1I]"E[X0P&`P&`P&`P&`P&`P&`P&`P&`P&
M`P&`P&`P&`P&!#;%_+Z=_<V3_8B[`__1]XU=?E]!/N;&/L1#@3+`8#`8#`8#
M`8#`8#`8#`8#`8#`8#`8#`8#`8#`8#`P,IC++-(S(8?)$IJZ/2ID=(Z^HB5S
M@V&K&=Z1'MSDD`XM2I"YHA*4:@8/:ISBC@=;I`,(M:W@5ZXT16CFOASHH;I(
M0YP&);@L3<&NQ+&9%K9%S)1`)BL;AJF:6(#G(UV?ZN8S%ZE6(]6X$(Q)E)IJ
M90J).%N'$^.]20-"O;(1'W>(M[JU,[2Y)(U.I^R$+0,+"3%VEV4@;I0GT;*D
MD?2)DGUUO_\`,&$H481J1=C2^Q+<N$FXS4LWR%%*6>*N,=>&\V-*$HXM-Y]%
M6X*N)1B7PMC7G,<=E#8QJG$F+3MS1'J34PSUI)A/:1G;2)-D"Y6$KKN*KR(`
M0J3O!NJP=$3U#3O>J5EK$3D@C;M$"5#JO*>P+I5HV.OJM.H+=C%Q2KVXC#@F
M&]`]$18NB*S`48F&V2%4@.D[S,3VE?8-AN3(>_R&=%V4\*#V-PE2EH/0K)H5
MI9V$9&T)8>D@!(4PA$[%H:DXC4`@7Z=$$,=$*\IQ$[(%"*PK+2"8W$=E/EMB
M4QD">8%EQ47OO)G(WJMH4H--S@I;-:^JSS48RW*P'6FH$]/,H?G!-)A.$S))
M3R0*2PK";&UP)3QE;$4X`,;9*4C(W^P9'`W0-IDY.PJ]A6:WVL`#PBV!<^.5
M/NLF43,<9<6R6*W56^JI#&9I.X@[*7Q="]5ZJ>E"R*R9F..>#8?K2/M0M[/#
MT:-T+1VM&8+(SQPI:'`-3QJ$E-36>4Q)C8\4^R8Z)C;XU7>ZG9&?<05/1\7T
MPHJ^W]7?5^DG8C0_WIA0U&M&X+E_(WQOIJ'@1D1B)J65$B)K$H#4AEDT+9%1
MM-M[,TULY.S'N1"9WM\C35&FQ-IP6$'KE2=K1%J3C@(TP2A<OR\\;J=D#W(Y
M$\1IT6NDKDZZ;/0Q3F?E(C9@X5BWTV9)T#21*"FEE?DE;-1#8C5(B$YR#0-G
MIA%*1C.$+9-'1%:('"/NZ1NDA3S%6YS96![W8EC&/;>PO*"+MSI'0/!LL&YG
MQM<"%-1XVXTT:+:Y$6L]EVOK'"(X@^/54&MQK,I9G]:RG29PEYS(X6%8SBRG
M/SK8*2TUZ@UH72Q0VF(E$Z1%K.QB*VB"#K)@E:2C&0(MRAZ'AWQZ:P)2VF&/
M;0!"W)FI%IGLRU&GL:))77I02%+MNFR;:=1N`_[B8>#H/-%O:D8Q*M[/V+EE
M_P!+-(:CSE$R(P^(HPZ+8\O4,#;8UFMC0G41)#"VR,::$#=,4J9A3,#;7C,G
M2$(0IR""$6BP@T`PW1@N4N34E6J2%+*X3L2XJ!N#C)7!7$M2F7;8329=];:?
MH[IO$^B(+@JDM\4EE1T&@L*0H0"TZ,H!100$9DBN(\BD:N4MATA;'-VFA4\D
M):65R?37(7PBO!5BG+=&4UX,9QLY,;*2"T@`0!#M>WIENRMK"0'Z+:$K>-]/
MNA;H2\Q][?R'IT?'9R3R*P+%D*=29*$+FV2AL[.]2M>21&).VNQJ9R9BP@:7
M!.`@M0F,`E3!*%RS)](U\>Y(G;V$N3+F^;O=BIAM]FV8UI_>^1!3%.SB>A;I
M>E0K$AR1-M,6A.+,;TZ10I3DD%D*U)9PM;6$,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@0VQ?R^G?W-D_V(NP/_]+W+5XMG^H!!M`C,/$#W/C/5$*<
MO0!;#]2HNKL0=5X/01;U_;KIWT?Z=X$P[=8/AB&^>WOY=8#MU@^&(;Y[>_EU
M@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`
M[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#M
MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6
M#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/
MAB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&
M(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8A
MOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^
M>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[
M>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[
M^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY
M=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU
M@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`
M[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#M
MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6
M#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/
MAB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&
M(;Y[>_EU@.W6#X8AOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@.W6#X8A
MOGM[^76`[=8/AB&^>WOY=8#MU@^&(;Y[>_EU@0^PUL_W`)SH<9AX0>Y\FZP@
:SEZ&+0?J5;UMA#NO`:$+6O[-=.NG_3K`_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
